Prevalence Estimate Name,Publication Date,Grade of Estimate Scope,Country,Alpha3 Code,State/Province,City,Sampling Start Date,Sampling End Date,Sample Frame (groups of interest),Sample Frame (age),Denominator Value,Serum positive prevalence,"Serum pos prevalence, 95pct CI Lower","Serum pos prevalence, 95pct CI Upper",Sampling Method,Test Manufacturer,Test Type (Reviewer),Isotype(s) Reported (Reviewer),Sensitivity,Specificity,Overall Risk of Bias (JBI) archive,Source Type,First Author Full Name,Lead Institution,URL,Date Created,Last modified time,Data Quality Status
210331_Bulawayo_UniversityofEdinburgh_Primary,"March 31, 2021",Regional,Zimbabwe,ZWE,Bulawayo,,"June 9, 2020","June 22, 2020",Health care workers and caregivers,Multiple groups,635,8.90%,6.90%,11.50%,Self-referral,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",98.51%,88.21%,High,Journal Article (Peer-Reviewed),Simbarashe Rusakaniko,University of Edinburgh,https://dx.doi.org/10.1371/journal.pntd.0009254,4/17/2021,3/2/2024,Verified
211023_Harare_BiomedicalResearchandTrainingInstituteHarare_February2021_Overall,"October 23, 2021",Local,Zimbabwe,ZWE,Harare,Harare,"February 10, 2021","April 17, 2021",Household and community samples,Multiple groups,1530,53.00%,49.60%,56.40%,Simplified probability,NA,Other,Not reported,99.20%,98.65%,Moderate,Journal Article (Peer-Reviewed),Arun Fryatt,Biomedical Research and Training Institute,https://dx.doi.org/10.1016/j.eclinm.2021.101172,11/10/2021,7/17/2022,Verified
211023_Harare_BiomedicalResearchandTrainingInstituteHarare_November2020_Overall,"October 23, 2021",Local,Zimbabwe,ZWE,Harare,Harare,"November 20, 2020","December 20, 2020",Household and community samples,Multiple groups,620,19.00%,15.10%,23.50%,Simplified probability,NA,Other,Not reported,99.20%,98.65%,Moderate,Journal Article (Peer-Reviewed),Arun Fryatt,Biomedical Research and Training Institute,https://dx.doi.org/10.1016/j.eclinm.2021.101172,11/10/2021,7/17/2022,Verified
221129_Bulawayo_MidlandsStateUniversity_Primary,"November 29, 2022",Local,Zimbabwe,ZWE,Matabeleland,Bulawayo,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,53,18.87%,,,Unclear,"Wuhan UNscience Biotechnology Co. Ltd,SD Biosensor",LFIA,"IgM,IgG",,,,Journal Article (Peer-Reviewed),Arthur Vengesai,University of Zimbabwe,https://dx.doi.org/10.1016/j.actatropica.2022.106781,1/13/2023,3/2/2024,Unverified
210309_Zambia_ZambiaMinistryofHealth_overall,"March 9, 2021",National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi",,"July 4, 2020","July 27, 2020",Household and community samples,Multiple groups,2704,2.10%,1.10%,3.10%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lloyd B Mulenga,Zambia Ministry of Health,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00053-X/fulltext,3/13/2021,3/2/2024,Verified
210330_Zambia_ZambiaMinistryofHealth_HCW,"March 30, 2021",National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi, Pooled",,"July 2, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,575,2.20%,0.50%,3.90%,Stratified non-probability,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sombo Fwoloshi,Zambia Ministry of Health,https://dx.doi.org/10.1093/cid/ciab273,5/3/2021,3/2/2024,Unverified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Lusaka2_Infants,"May 6, 2021",Local,Zambia,ZMB,Lusaka Province,Lusaka,"August 15, 2020","December 15, 2020",Household and community samples,Children and Youth (0-17 years),150,6.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,5/20/2021,7/17/2022,Verified
210506_Zambia_CentreForInfectiousDiseaseResearchInZambia_Kalulushi1_HCW,"May 6, 2021",Local,Zambia,ZMB,Copperbelt Province ,Kalulushi,"August 1, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),237,8.00%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Natasha Makabilo Laban,Centre for Infectious Disease Research in Zambia,https://wellcomeopenresearch.org/articles/6-97/v1,5/20/2021,7/17/2022,Verified
210801_Zambia_USCDC_Outpatient_Primary_Adj,"August 1, 2021",National,Zambia,ZMB,"Kabwe, Livingstone, Lusaka, Nakonde, Ndola, Solwezi",NR,"July 2, 2020","July 31, 2020",Residual sera,Multiple groups,1657,8.20%,5.10%,11.40%,Convenience,EUROIMMUN,ELISA,IgG,65.70%,100.00%,High,Journal Article (Peer-Reviewed),Jonas Z Hines,US Centers for Disease Control and Prevention,https://wwwnc.cdc.gov/eid/article/27/8/21-0502_article,7/28/2021,8/15/2023,Verified
220316_Zambia_Zambart_Primary,"March 16, 2022",Local,Zambia,ZMB,Zambian Central Province,NR,"October 15, 2020","March 15, 2021",Household and community samples,Multiple groups,2977,13.50%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kwame Shanaube,Zambart,https://dx.doi.org/10.1016/j.ijid.2022.03.021,4/3/2022,3/2/2024,Verified
221212_USA_RTIInternational_Zambia,"December 12, 2022",National,Zambia,ZMB,,,"February 1, 2020","February 29, 2020",Pregnant or parturient women,Adults (18-64 years),1793,27.80%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
230720_Zambia_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Zambia,ZMB,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2667,33.70%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
211216_Aden_HadhramoutUniversity_Primary,"December 16, 2021",Local,Yemen,YEM,Adan Governorate,Aden,"November 15, 2020","December 15, 2020",Household and community samples,Multiple groups,2001,27.40%,25.60%,29.30%,Stratified probability,"Healgen,Beijing Wantai Biological",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Abdulla Bin-Ghouth,"World Health Organization Country Office, Yemen",https://dx.doi.org/10.1016/j.ijid.2021.12.330,1/18/2022,3/2/2024,Verified
230330_Yemen_UniversityofAden,"March 30, 2023",Local,Yemen,YEM,,,"June 15, 2022","September 15, 2022",Health care workers and caregivers,Adults (18-64 years),404,94.30%,92.10%,96.50%,Convenience,Roche Diagnostics,,,,,,Preprint,Watheq Thabet Taher,University of Aden,10.21203/rs.3.rs-2669249/v1,5/4/2023,5/5/2023,Unverified
221109_Aden_Epicentre_round1,"November 9, 2022",Local,Yemen,YEM,,Aden,"September 27, 2020","November 8, 2020",Health care workers and caregivers,Adults (18-64 years),356,19.40%,18.00%,20.70%,Convenience,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,100.00%,,Journal Article (Peer-Reviewed),Rami Malaeb,Epicentre,https://dx.doi.org/10.1371/journal.pgph.0000767,5/8/2023,3/2/2024,Unverified
201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall,"November 18, 2020",Local,Viet Nam,VNM,Đông Nam Bộ,Ho Chi Minh City,"August 23, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),408,0.00%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Nguyen Van Vinh Chau,Oxford University Clinical Research Unit,https://dx.doi.org/10.1016/j.jinf.2020.11.018,1/24/2021,3/2/2024,Verified
210302_Vietnam_UniversitatsklinikumTubingen_HCW_ELISA_TotalAb,"March 2, 2021",Local,Viet Nam,VNM,Red River Delta,Hanoi,"March 1, 2020","January 8, 2021",Health care workers and caregivers,Adults (18-64 years),1065,0.56%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/11/2021,3/2/2024,Verified
210302_Vietnam_UniversitatsklinikumTubingen_patients_ELISA_TotalAb,"March 2, 2021",Local,Viet Nam,VNM,Red River Delta,Hanoi,"March 1, 2020","January 8, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,4/11/2021,3/2/2024,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_overall,"June 11, 2021",National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ","September 4, 2020","November 23, 2020",Household and community samples,Multiple groups,3034,0.40%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,6/22/2021,3/2/2024,Verified
210610_Vietnam_TheUniversityOfSydney_HCW2_overall,"June 11, 2021",Local,Viet Nam,VNM,Da Nang,,"November 24, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),148,0.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,6/22/2021,3/2/2024,Verified
210302_Vietnam_UniversitatsklinikumTubingen_patients_RDT,"March 2, 2021",Local,Viet Nam,VNM,Red River Delta,Hanoi,"March 1, 2020","January 8, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,0.00%,,,Unclear,Beijing Wantai Biological,LFIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Le Huu Song,Universitätsklinikum Tübingen,https://dx.doi.org/10.1016/j.lanwpc.2021.100113,7/1/2021,3/2/2024,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_Male,"June 11, 2021",National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ","September 4, 2020","November 23, 2020",Household and community samples,Multiple groups,1624,0.37%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,9/29/2021,3/2/2024,Verified
210610_Vietnam_TheUniversityOfSydney_GenPop1_Female,"June 11, 2021",National,Viet Nam,VNM,"Hanoi Capital, Quang Nam Province, Da Nang Province","Hoi sub-commune in Ha Loi commune, Me Linh district, Hanoi Capital,  Giao Ai sub-commune in Dien Hong commune, Dien Ban, Quang Nam Province, Luu Minh sub-commune in Ha Lam Town, Quang Nam, Le Son Nam sub-commune in Hoa Tien commune, Da Nang ","September 4, 2020","November 23, 2020",Household and community samples,Multiple groups,1410,0.50%,,,Unclear,Roche Diagnostics,CLIA,IgG,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,The University of Sydney,http://dx.doi.org/10.3390/ijerph18126353,9/29/2021,3/2/2024,Verified
210927_Hanoi_NationalCenterforGlobalHealthandMedicine_primary,"September 27, 2021",Local,Viet Nam,VNM,,Hanoi,"June 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1243,0.20%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shoko Matsumoto,National Center for Global Health and Medicine,https://dx.doi.org/10.1007/s10461-021-03464-w,10/13/2021,3/2/2024,Unverified
220126_HoChiMinhCity_PasteurInstituteOfHoChiMinhCity_PopAdj_Overall,"January 26, 2022",Local,Viet Nam,VNM,,Ho Chi Minh City,"August 27, 2020","November 7, 2020",Blood donors,Adults (18-64 years),885,0.20%,0.05%,0.81%,Sequential,NA,Neutralization,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Hanh Hong Ho Nguyen,Pasteur Institute of Ho Chi Minh City,https://dx.doi.org/10.4269/ajtmh.21-0259,2/2/2022,7/17/2022,Unverified
211211_Vietnam_UniversityofSydney_BacMaSubCommune,"December 11, 2021",Local,Viet Nam,VNM,Quang Ninh,,"January 1, 2021","February 28, 2021",Household and community samples,Multiple groups,897,0.10%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,6/29/2022,7/17/2022,Unverified
211211_Vietnam_UniversityofSydney_TienSubCommune,"December 11, 2021",Local,Viet Nam,VNM,Hai Duong,,"January 1, 2021","February 28, 2021",Household and community samples,Multiple groups,1172,0.40%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,6/29/2022,7/17/2022,Unverified
220620_Vietnam_UnitedStatesCDC,"June 20, 2022",National,Viet Nam,VNM,Red River Delta,Hanoi,"February 1, 2021","February 28, 2021",Health care workers and caregivers,Multiple groups,617,0.16%,,,Convenience,Roche Diagnostics,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Dien Vu,U.S. Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciac493,6/30/2022,3/2/2024,Unverified
211211_Vietnam_UniversityofSydney_HCWs,"December 11, 2021",Local,Viet Nam,VNM,Quang Ninh,,"January 1, 2021","February 28, 2021",Health care workers and caregivers,Adults (18-64 years),15,6.70%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,6/30/2022,7/17/2022,Unverified
211211_Vietnam_UniversityofSydney_LogisticandSecurity,"December 11, 2021",Local,Viet Nam,VNM,Quang Ninh,,"January 1, 2021","February 28, 2021",Health care workers and caregivers,Adults (18-64 years),11,0.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,6/30/2022,7/17/2022,Unverified
211211_Vietnam_UniversityofSydney_SpecimenCollectors,"December 11, 2021",Local,Viet Nam,VNM,Quang Ninh,,"January 1, 2021","February 28, 2021",Health care workers and caregivers,Adults (18-64 years),24,0.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,96.80%,99.80%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,University of Sydney,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665841/,6/30/2022,7/17/2022,Unverified
221031_Hanoi_VietnamNationalChildrensHospital_Overall,"October 31, 2022",Local,Viet Nam,VNM,,Hanoi,"March 13, 2022","April 3, 2022",Residual sera,Children and Youth (0-17 years),4032,59.15%,,,Simplified probability,Siemens,CLIA,IgG,96.41%,99.99%,Moderate,Preprint,Dien Minh Tran,Vietnam National Children’s Hospital,http://doi.org/10.20944/preprints202210.0471.v1,11/10/2022,3/2/2024,Unverified
210731_Caracas_UniversidadCentraldeVenezuela,"July 31, 2021",Local,Venezuela (Bolivarian Republic of),VEN,,Caracas,"February 1, 2021","February 6, 2021",Health care workers and caregivers,Multiple groups,86,31.40%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Franklin Claro,Universidad Central de Venezuela,https://dx.doi.org/10.1016/j.ijid.2021.07.070,8/11/2021,7/17/2022,Verified
210301_Uzbekistan_ResearchInstituteofVirology,"March 1, 2021",National,Uzbekistan,UZB,,,"August 27, 2020","September 11, 2020",Residual sera,Multiple groups,86879,23.10%,23.00%,23.20%,Convenience,Beijing Wantai Biological,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),R A Rakhimov ,Research Institute of Virology,https://ejmcm.com/article_9453.html,5/18/2021,3/2/2024,Unverified
200424_Brevard_OMNI_GeneralPopulation,"April 24, 2020",Local,United States of America,USA,Florida,,"April 17, 2020","April 24, 2020",Household and community samples,Multiple groups,1000,1.00%,,,Self-referral,NA,LFIA,"IgM,IgG",100.00%,100.00%,High,News and Media,Alessandro Sassoon,OMNI Healthcare,https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/,5/3/2020,7/17/2022,Verified
200422_Idaho_CrushTheCurveIdaho_Patients,"April 22, 2020",Regional,United States of America,USA,Idaho,,"April 20, 2020","April 22, 2020",Residual sera,Multiple groups,1946,1.75%,,,Convenience,NA,Not reported,IgG,100.00%,99.60%,High,News and Media,Ryan Morrison,Crush The Curve Idaho,https://idahonews.com/news/coronavirus/crushthecurveidaho-finds-small-population-with-antibodies-we-are-far-from-herd-immunity,5/3/2020,12/13/2023,Verified
200423_BatonRouge_BatonRougeGeneralHospital_GenPop,"April 28, 2020",Local,United States of America,USA,Louisiana,Baton Rouge,,"April 21, 2020",Household and community samples,Multiple groups,432,4.40%,,,Unclear,NA,Not reported,Not reported,,98.60%,Unclear,News and Media,Blake Paterson,Baton Rouge General Hospital,https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html,5/3/2020,7/17/2022,Verified
200508_Seattle_UniversityofWashington_Adults,"May 8, 2020",Local,United States of America,USA,Washington,Seattle,"March 1, 2020","March 31, 2020",Residual sera,Adults (18-64 years),221,0.40%,,,Convenience,NA,Not reported,Not reported,,,High,Institutional Report,Anne Schuchat,University of Washington,https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf,5/3/2020,7/17/2022,Verified
200503_SaltLakeCity_UniversityofUtah_HCW,"May 3, 2020",Local,United States of America,USA,Utah,Salt Lake City,"April 13, 2020","April 19, 2020",Health care workers and caregivers,Adults (18-64 years),270,5.90%,,,Convenience,EUROIMMUN,ELISA,IgG,95.40%,98.30%,High,Journal Article (Peer-Reviewed),Troy Madsen,University of Utah,https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext,5/14/2020,3/2/2024,Verified
200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG,"May 6, 2020",Local,United States of America,USA,Georgia,Atlanta,"April 17, 2020","April 27, 2020",Household and community samples,Multiple groups,127,2.36%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Jun Zou,Georgia State University,https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1,5/14/2020,7/17/2022,Verified
200515_Winona_WinonaHealth_GeneralPopulation,"May 15, 2020",Local,United States of America,USA,Minnesota,Winona,"May 10, 2020","May 15, 2020",Household and community samples,Multiple groups,1000,7.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Mal Meyer,Winona Health,https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA,5/19/2020,7/17/2022,Verified
200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj,"July 24, 2020",Regional,United States of America,USA,Indiana,,"April 25, 2020","April 29, 2020",Household and community samples,Multiple groups,3518,1.09%,0.80%,1.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.60%,Moderate,Institutional Report,Nir Menachemi,Indiana University Fairbanks School of Public Health,https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w,5/20/2020,7/17/2022,Verified
200523_SouthCarolina_MUSCHealthLancaster_HCW,"May 23, 2020",Local,United States of America,USA,South Carolina,Lancaster,"March 16, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),230,2.17%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Lisa Geraci ,MUSC Health-Lancaster,https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA,5/26/2020,7/17/2022,Verified
200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation,"May 20, 2020",Regional,United States of America,USA,Iowa,,"April 1, 2020","May 20, 2020",Household and community samples,Adults (18-64 years),18160,10.00%,,,Self-referral,NA,Not reported,IgG,,,High,News and Media,Jeff Montgomery,Iowa Department of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q,5/31/2020,7/17/2022,Verified
200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,"June 17, 2020",Regional,United States of America,USA,New York,,"April 19, 2020","April 28, 2020",Household and community samples,Multiple groups,15101,14.00%,13.30%,14.70%,Convenience,NA,CLIA,IgG,87.90%,99.75%,Moderate,Journal Article (Peer-Reviewed),Eli Rosenberg,New York State Department of Health,https://dx.doi.org/10.1016/j.annepidem.2020.06.004,5/31/2020,7/5/2023,Verified
200510_US_StanfordUniversity_MajorLeagueBaseballEmployees,"May 10, 2020",National,United States of America,USA,,,"April 8, 2020","April 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),5603,0.70%,0.28%,1.15%,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Susan Slusser,Stanford University,https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php,6/3/2020,7/17/2022,Verified
200601_LongHillTownship_SummitMedicalCenter_FirstResponders,"June 1, 2020",Local,United States of America,USA,New Jersey,Long Hill Township,"May 1, 2020","May 14, 2020",Essential non-healthcare workers,Adults (18-64 years),70,4.29%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Alex Parker Magyar,Summit Medical Center,https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw,6/3/2020,7/17/2022,Verified
200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers,"June 3, 2020",Local,United States of America,USA,New York,New York City,"March 24, 2020","April 4, 2020",Health care workers and caregivers,Multiple groups,285,32.63%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mayce Mansour,Icahn School of Medicine at Mount Sinai,https://link.springer.com/article/10.1007/s11606-020-05926-8,6/4/2020,7/17/2022,Verified
200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop,"June 2, 2020",Local,United States of America,USA,California,,,"May 26, 2020",Household and community samples,Multiple groups,1000,1.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Shomik Mukherjee ,Humboldt County Department of Health and Human Services,https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA,6/8/2020,7/17/2022,Verified
200612_Guam_USNavy,"June 12, 2020",Local,United States of America,USA,Guam,,"April 20, 2020","April 24, 2020",Essential non-healthcare workers,Adults (18-64 years),382,59.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",96.00%,99.30%,High,Journal Article (Peer-Reviewed),Daniel Payne,US Navy,https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm,6/13/2020,7/17/2022,Verified
200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj,"June 12, 2020",Local,United States of America,USA,New Jersey,Long Branch,"May 14, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),121,0.83%,,,Convenience,SD Biosensor,LFIA,IgG,96.20%,96.60%,High,Journal Article (Peer-Reviewed),Mohsin Mughal ,Monmouth Medical Centre,https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7,6/14/2020,3/2/2024,Verified
200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop,"June 14, 2020",Local,United States of America,USA,Colorado,Steamboat Springs,,"June 10, 2020",Household and community samples,Multiple groups,649,2.60%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Kari Harden ,Routt County Board of Health,https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ,6/16/2020,7/17/2022,Verified
200617_Indiana_IndianaUniversity_Wave2GenPop,"June 17, 2020",Regional,United States of America,USA,Indiana,,"June 3, 2020","June 8, 2020",Household and community samples,Multiple groups,3600,1.50%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Shari Rudavsky,Indiana University Fairbanks School of Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ,6/24/2020,7/17/2022,Verified
200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders,"June 22, 2020",Local,United States of America,USA,Nevada,,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),132,14.00%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Anh Gray,Truckee Meadows Fire Protection District,https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0,6/25/2020,7/17/2022,Verified
200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders,"May 4, 2020",Local,United States of America,USA,South Carolina,Charleston,"April 27, 2020","May 2, 2020",Multiple populations,Adults (18-64 years),920,2.00%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Nick Reagan,Medical University South Carolina,https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/,6/28/2020,7/17/2022,Verified
200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees,"May 22, 2020",Local,United States of America,USA,Florida,Coral Springs,"May 17, 2020","May 22, 2020",Essential non-healthcare workers,Multiple groups,700,0.00%,,,Self-referral,Cellex Inc.,Not reported,Not reported,,,Unclear,News and Media,Jenny Staletovich,Coral Springs City Government,https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw,6/28/2020,3/2/2024,Verified
200520_LosAngeles_UniSouthernCalifornia_GenPop,"May 20, 2020",Local,United States of America,USA,California,,"May 8, 2020","May 12, 2020",Household and community samples,Multiple groups,1014,2.10%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,CBS Los Angeles,University of Southern California,https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg,6/28/2020,7/17/2022,Verified
200520_Madison_UWHealth_UniWisconsinHealthClinic,"May 20, 2020",Local,United States of America,USA,Wisconsin,Madison,"May 13, 2020","May 20, 2020",Household and community samples,Multiple groups,5303,1.50%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/28/2020,7/17/2022,Verified
200520_Madison_UWHealth_UnityPointClinic,"May 20, 2020",Local,United States of America,USA,Wisconsin,Madison,"May 13, 2020","May 20, 2020",Household and community samples,Multiple groups,433,0.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Michelle Alfini,UW Health,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/28/2020,7/17/2022,Verified
200624_BaskingRidge_FellowshipVillage_Residents2_Overall,"June 24, 2020",Local,United States of America,USA,New Jersey,Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Seniors (65+ years),371,34.77%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,6/30/2020,7/17/2022,Verified
201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall,"November 3, 2020",Local,United States of America,USA,New York,New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,6590,11.10%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,6/30/2020,7/17/2022,Verified
200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop,"May 29, 2020",Local,United States of America,USA,North Carolina,,"May 29, 2020","May 29, 2020",Household and community samples,Multiple groups,329,1.52%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Steve Ohnesorge,Psalms/Solid Rock Medicine Group,https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA,7/5/2020,7/17/2022,Verified
200529_CoachellaValley_Desert Healthcare District_GenPop,"May 29, 2020",Local,United States of America,USA,California,,,"May 28, 2020",Household and community samples,Multiple groups,896,6.00%,,,Self-referral,Phamatech,LFIA,"IgG,IgM",,,Unclear,News and Media,Nicole Hayden,Desert Healthcare District,https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg,7/5/2020,3/2/2024,Verified
200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa,"May 28, 2020",Local,United States of America,USA,Michigan,,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Multiple groups,1248,92.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,7/17/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_MacombCF,"May 28, 2020",Local,United States of America,USA,Michigan,Lenox Township,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Multiple groups,1201,65.60%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,7/17/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_DetroitRC,"May 28, 2020",Local,United States of America,USA,Michigan,Detroit,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Multiple groups,57,35.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,7/17/2022,Verified
200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF,"May 28, 2020",Local,United States of America,USA,Michigan,,"May 14, 2020","May 22, 2020",Persons who are incarcerated,Multiple groups,867,12.22%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Angie Jackson,Michigan Department of Corrections ,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,7/17/2022,Verified
200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj,"July 29, 2020",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 4, 2020","June 3, 2020",Pregnant or parturient women,Adults (18-64 years),1293,5.20%,,,Sequential,NA,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Dustin Flannery,University of Pennsylvania,https://immunology.sciencemag.org/content/5/49/eabd5709,7/14/2020,7/17/2022,Verified
200507_Boise_UniversityofWashington_GenPop,"May 7, 2020",Local,United States of America,USA,Idaho,Boise,"April 20, 2020","April 26, 2020",Household and community samples,Multiple groups,4856,1.79%,,,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Andrew Bryan,University of Washington School of Medicine,https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20,7/19/2020,3/2/2024,Verified
200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW,"June 9, 2020",Local,United States of America,USA,New York,New York City,"March 1, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),91,12.10%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",93.10%,99.20%,High,Journal Article (Peer-Reviewed),Miguel Morcuende,Columbia University Irving Medical Center,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/,7/19/2020,3/2/2024,Verified
200717_Chittenden_UniversityVermont_GenPop,"July 17, 2020",Local,United States of America,USA,Vermont,,,"June 30, 2020",Household and community samples,Multiple groups,455,2.20%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Cat Viglienzoni,University of Vermont,https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw,8/1/2020,7/17/2022,Verified
200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop,"July 8, 2020",Local,United States of America,USA,Nevada,,"June 9, 2020","June 10, 2020",Household and community samples,Adults (18-64 years),234,2.30%,,,Stratified probability,NA,Not reported,Not reported,,99.60%,High,News and Media,Mary Hynes,Washoe County Health District,https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw,8/2/2020,7/17/2022,Verified
200715_WashintonDC_DCPublicHealth_GenPop,"July 15, 2020",Local,United States of America,USA,Washington D.C,Washington DC,"June 15, 2020","July 15, 2020",Household and community samples,Multiple groups,13706,5.90%,,,Self-referral,DiaSorin,CLIA,Not reported,,,High,News and Media,Julie Zauzmer,Washington DC Public Health,https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw,8/3/2020,3/2/2024,Verified
200721_Idaho_UniversityofWashington_TotalPopTestAdj,"July 21, 2020",Local,United States of America,USA,Idaho,,"May 4, 2020","May 19, 2020",Household and community samples,Multiple groups,917,23.10%,19.80%,26.50%,Self-referral,Abbott Laboratories,CLIA,IgG,92.90%,99.60%,Moderate,Preprint,Colleen McLaughlin, University of Washington,https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1,8/4/2020,7/5/2023,Verified
200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj,"July 24, 2020",Local,United States of America,USA,Indiana,Indianapolis,"May 2, 2020","May 3, 2020",Household and community samples,Multiple groups,898,5.80%,,,Convenience,NA,CLIA,IgG,100.00%,99.60%,High,Institutional Report,Nir Menachemi,Indiana University Fairbanks School of Public Health,https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w,8/5/2020,7/17/2022,Verified
201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,"October 28, 2020",Regional,United States of America,USA,Connecticut,,"June 4, 2020","June 23, 2020",Household and community samples,Multiple groups,567,4.00%,2.00%,6.00%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,9/24/2020,3/2/2024,Verified
200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall,"August 4, 2020",Local,United States of America,USA,Florida,Miami,"April 23, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,677,5.60%,4.00%,7.60%,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",57.10%,85.00%,High,Preprint,Dena Cohen,DaVita Clinical Research,https://doi.org/10.1101/2020.08.03.20163642,9/25/2020,3/2/2024,Verified
200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop,"July 27, 2020",Local,United States of America,USA,California,,"July 6, 2020","July 20, 2020",Household and community samples,Multiple groups,1726,5.90%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,ABC7 com staff,Riverside University Health System,https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/,9/27/2020,7/17/2022,Verified
200721_NewYork_ShermanAbramsLaboratory_Overall,"July 21, 2020",Local,United States of America,USA,New York,New York,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,28523,44.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Josh Reifer,Sherman Abrams Laboratory ,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128,9/27/2020,3/2/2024,Verified
200904_USA_CDC_HCWs_Overall,"September 4, 2020",National,United States of America,USA,"New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio","Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus","April 3, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),3248,5.97%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Wesley Self,CDC COVID-19 Response Team,https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm,9/29/2020,7/17/2022,Verified
200723_JeffersonCounty_UniversityofLouisville_genpop,"July 23, 2020",Local,United States of America,USA,Kentucky,,"June 10, 2020","June 19, 2020",Household and community samples,Multiple groups,2237,4.00%,,,Self-referral,NA,Not reported,Not reported,,,High,News and Media,Spectrum News Staff, University of Louisville,https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results,9/30/2020,7/17/2022,Verified
200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj,"July 24, 2020",Local,United States of America,USA,Georgia,,"April 28, 2020","May 3, 2020",Household and community samples,Multiple groups,696,2.50%,1.40%,4.50%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgA,IgM",93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Holly Biggs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm6929e2,10/2/2020,3/2/2024,Verified
200803_Indiana_IndianaUniversity_healthcareworkers,"August 3, 2020",Regional,United States of America,USA,Indiana,Indianapolis,"April 29, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),734,1.63%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Benton Hunter, Indiana University,https://dx.doi.org/10.1017/ice.2020.390,10/4/2020,3/2/2024,Verified
200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,"July 30, 2020",Local,United States of America,USA,Louisiana,,"May 9, 2020","May 15, 2020",Household and community samples,Adults (18-64 years),2640,6.90%,6.80%,6.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Oschner Clinic Foundation,https://dx.doi.org/10.3201/eid2611.203029,10/5/2020,3/2/2024,Verified
200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,"August 14, 2020",Local,United States of America,USA,New York,New York City,"May 7, 2020","June 25, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,952,5.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Sean McBride,Memorial Sloan Kettering Cancer Center,https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1,10/9/2020,3/2/2024,Verified
200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,"August 6, 2020",Local,United States of America,USA,Florida,,"April 16, 2020","April 17, 2020",Essential non-healthcare workers,Multiple groups,203,8.90%,,,Convenience,"BioMedomics, Inc.",LFIA,"IgG,IgM",88.66%,90.63%,High,Journal Article (Peer-Reviewed),Alberto J Caban Martinez,University of Miami,http://dx.doi.org/10.1136/oemed-2020-106676,10/10/2020,3/2/2024,Verified
200811_NewYork_StFrancisHospital_Overall,"August 11, 2020",Local,United States of America,USA,New York,New York City,"March 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1699,9.80%,,,Convenience,"EUROIMMUN,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Allen Jeremias,St Francis Hospital,http://dx.doi.org/10.1001/jamainternmed.2020.4214,10/10/2020,3/2/2024,Verified
200814_Oregon_OregonHealthAuthority_Overall_UnAdj,"August 14, 2020",Regional,United States of America,USA,Oregon,,"May 11, 2020","June 15, 2020",Residual sera,Multiple groups,897,1.00%,0.20%,1.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.80%,99.10%,High,Journal Article (Peer-Reviewed),Melissa Sutton,Oregon Health Authority,https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm,10/10/2020,3/2/2024,Verified
200818_Cambridge_CambridgeHealthAllianceOverall,"August 18, 2020",Local,United States of America,USA,Massachusetts,Cambridge,"April 13, 2020","May 24, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),24,16.70%,,,Convenience,"DiaSorin,EUROIMMUN,Abbott Laboratories",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Robert Stavert,Cambridge Health Alliance,http://dx.doi.org/10.1016/j.jaad.2020.08.049,10/16/2020,3/2/2024,Verified
200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,"August 21, 2020",Local,United States of America,USA,California,San Francisco,"April 25, 2020","April 28, 2020",Household and community samples,Multiple groups,3861,3.40%,2.90%,4.10%,Self-referral,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gabriel Chamie,"University of California, San Francisco",http://dx.doi.org/10.1093/cid/ciaa1234,10/17/2020,3/2/2024,Verified
200818_Oregon_EarleA.ChilesResearchInstitute_Overall,"August 18, 2020",Regional,United States of America,USA,Oregon,"Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie","April 8, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,10019,2.53%,,,Convenience,NA,ELISA,IgG,80.00%,100.00%,High,Preprint,Rom Leidner,Chiles Research Institute,https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1,10/19/2020,7/17/2022,Verified
200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,"August 26, 2020",Local,United States of America,USA,New York,New York City,"April 28, 2020","May 4, 2020",Health care workers and caregivers,Multiple groups,1700,19.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elana Sydney,Jacobi Medical Center,http://dx.doi.org/10.1017/ice.2020.437,10/22/2020,3/2/2024,Verified
200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,"August 28, 2020",Local,United States of America,USA,California,Los Angeles,"June 5, 2020","June 12, 2020",Assisted living and long-term care facilities,Multiple groups,150,17.30%,,,Convenience,DiaSorin,CLIA,IgG,92.00%,98.00%,High,Journal Article (Peer-Reviewed),Amy V Dora,Veterans Affairs Healthcare System,http://dx.doi.org/10.1093/cid/ciaa1286,10/22/2020,3/2/2024,Verified
200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj,"September 9, 2020",Local,United States of America,USA,Massachusetts,Chelsea,"April 14, 2020","April 15, 2020",Household and community samples,Adults (18-64 years),200,32.80%,27.20%,38.80%,Convenience,"BioMedomics, Inc.",LFIA,"IgM,IgG",90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Vivek Naranbhai,Massachusetts General Hospital,http://dx.doi.org/10.1093/infdis/jiaa579,10/22/2020,7/5/2023,Verified
200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,"August 21, 2020",Local,United States of America,USA,New York,New York City,"April 4, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),98,15.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ariel D Stock,Albert Einstein College of Medicine,https://dx.doi.org/10.3389/fmed.2020.00471,10/24/2020,3/2/2024,Verified
200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall,"September 20, 2020",Regional,United States of America,USA,New York,,"May 27, 2020","July 24, 2020",Pregnant or parturient women,Adults (18-64 years),1671,16.10%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Donald and Barbara Zucker School of Medicine,https://dx.doi.org/10.1016/j.ajog.2020.09.022,10/31/2020,3/2/2024,Verified
200911_NewYorkCity_WeillCornellMedicine_IgGorIgM,"September 11, 2020",Local,United States of America,USA,New York,New York City,"April 17, 2020","May 7, 2020",Health care workers and caregivers,Adults (18-64 years),2274,35.40%,,,Convenience,ET Healthcare,Other,"IgG,IgM",,98.80%,Moderate,Journal Article (Peer-Reviewed),Sabrina Racine Brzostek,Weill Cornell Medicine,http://dx.doi.org/10.1093/ajcp/aqaa142,11/3/2020,7/5/2023,Verified
201023_BatonRouge_LouisianaStateUniversity_Total_popadj,"October 23, 2020",Local,United States of America,USA,Louisiana,Baton Rouge,"July 15, 2020","July 31, 2020",Household and community samples,Multiple groups,2138,3.60%,2.80%,4.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amy K Feehan,Louisiana State University,https://dx.doi.org/10.3201/eid2701.203808,11/5/2020,3/2/2024,Verified
200917_SanFrancisco_UniversityofCalifornia_BloodDonors,"September 17, 2020",Local,United States of America,USA,California,San Francisco,"March 1, 2020","March 31, 2020",Blood donors,Multiple groups,1000,0.10%,0.00%,0.56%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/7/2020,3/2/2024,Verified
200917_SanFrancisco_UniversityofCalifornia_Patients,"September 17, 2020",Local,United States of America,USA,California,San Francisco,"March 17, 2020","April 13, 2020",Residual sera,Multiple groups,387,0.26%,0.00%,0.76%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,99.80%,High,Journal Article (Peer-Reviewed),Dianna Ng,"University of California, San Francisco",https://dx.doi.org/10.1038/s41467-020-18468-8,11/7/2020,3/2/2024,Verified
200925_UnitedStates_StanfordUniversity_OverallPopAdj,"September 25, 2020",National,United States of America,USA,,,"July 1, 2020","July 31, 2020",Residual sera,Multiple groups,28503,9.30%,8.80%,9.90%,Stratified probability,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext,11/23/2020,3/2/2024,Verified
200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem,"September 23, 2020",Local,United States of America,USA,Michigan,,"June 8, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1476,4.90%,3.80%,6.10%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Derek Dimcheff,Veterans Affairs Ann Arbor Healthcare System,https://dx.doi.org/10.1017/ice.2020.1220,11/23/2020,3/2/2024,Verified
200918_Arizona_VincereCancerCenter_Total,"September 18, 2020",Regional,United States of America,USA,Arizona,"Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler","April 24, 2020","May 21, 2020",Essential non-healthcare workers,Multiple groups,3326,1.50%,,,Convenience,RayBiotech,LFIA,IgG,90.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Vershalee Shukla,Vincere Cancer Center,https://dx.doi.org/10.1097/JOM.0000000000002027,11/23/2020,3/2/2024,Verified
200917_Nashville_VanderbiltUniversityMedicalCenter_60DaysOverall,"September 17, 2020",Local,United States of America,USA,Tennessee,Nashville,"June 2, 2020","June 27, 2020",Health care workers and caregivers,Multiple groups,230,3.48%,,,Convenience,NA,ELISA,Total Antibody,96.00%,99.00%,High,Journal Article (Peer-Reviewed),Manish Patel,Vanderbilt University Medical Center,http://dx.doi.org/10.1001/jama.2020.18796,11/25/2020,7/17/2022,Verified
200921_Detroit_Region2SouthHealthcareCoalition_Overall,"September 21, 2020",Local,United States of America,USA,Michigan,Detroit,"May 18, 2020","June 13, 2020",Health care workers and caregivers,Adults (18-64 years),16397,6.90%,6.50%,7.30%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Region 2 South Healthcare Coalition,https://dx.doi.org/10.3201/eid2612.203764,12/5/2020,3/2/2024,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall,"September 29, 2020",Regional,United States of America,USA,North Carolina,,"March 3, 2020","June 4, 2020",Residual sera,Adults (18-64 years),1449,0.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/8/2020,3/2/2024,Verified
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj,"September 29, 2020",Regional,United States of America,USA,North Carolina,,"April 28, 2020","June 19, 2020",Residual sera,Adults (18-64 years),2973,0.00%,0.00%,0.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Amir Barzin,University of North Carolina Chapel Hill,http://dx.doi.org/10.1128/mBio.02426-20,12/8/2020,7/5/2023,Verified
200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts,"August 16, 2020",Local,United States of America,USA,"Utah, Wisconsin","Salt Lake City, Milwaukee","March 22, 2020","April 25, 2020",Contacts of COVID patients,Multiple groups,178,25.80%,,,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Nathaniel M Lewis,Centers for Disease Control ,https://dx.doi.org/10.1093/cid/ciaa1166,12/17/2020,7/17/2022,Verified
201116_Tennessee_VanderbiltUniversity_HCW_Overall,"November 16, 2020",Regional,United States of America,USA,Tennessee,,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),11787,0.98%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Peter Rebeiro,Vanderbilt University,https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1,12/17/2020,3/2/2024,Verified
201105_Michigan_OaklandUniversity_testadj,"November 5, 2020",Local,United States of America,USA,Michigan,"Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton","April 13, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,20614,8.10%,6.80%,8.90%,Convenience,EUROIMMUN,ELISA,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew D Sims,Oakland University,https://dx.doi.org/10.1093/cid/ciaa1684,12/18/2020,7/5/2023,Verified
201030_Indianapolis_IndianaUniversity_Overall,"October 30, 2020",Local,United States of America,USA,Indiana,Indianapolis ,"May 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),31,3.20%,,,Convenience,"Abnova,NA",ELISA,"IgM,IgG",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Corina Nailescu,Indiana University ,https://dx.doi.org/10.3389/fped.2020.601327,12/18/2020,7/17/2022,Verified
201201_NewHeaven_Yale_SchoolofMedicine_newborns,"December 12, 2020",Local,United States of America,USA,Connecticut,New Haven,"February 19, 2020","May 26, 2020",Residual sera,Children and Youth (0-17 years),3048,5.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Feimei  Liu,Yale School of Medicine,https://dx.doi.org/10.1097/INF.0000000000002918,12/18/2020,7/17/2022,Verified
201021_NewYork_Serimmune_Overall,"October 21, 2020",Local,United States of America,USA,New York,New York City,"March 1, 2020","July 7, 2020",Blood donors,Multiple groups,1559,4.36%,,,Sequential,Serimmune,Other,IgG,91.00%,99.30%,High,Preprint,Kathy Kamath,Serimmune,https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1,12/18/2020,7/17/2022,Verified
201107_Lubbock_TexasTechUniversity_Overall,"November 7, 2020",Local,United States of America,USA,Texas,Lubbock,"May 12, 2020","May 13, 2020",Essential non-healthcare workers,Multiple groups,683,0.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Kenneth Iwuji,Texas Tech University,https://dx.doi.org/10.1177/2150132720971390,12/19/2020,3/2/2024,Verified
201013_PimaCounty_UniversityofArizona_Overall,"October 13, 2020",Local,United States of America,USA,Arizona,,"April 30, 2020","May 7, 2020",Household and community samples,Multiple groups,5882,1.24%,,,Self-referral,NA,ELISA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Tyler Ripperger,University of Arizona,http://dx.doi.org/10.1016/j.immuni.2020.10.004,12/19/2020,7/17/2022,Verified
201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall,"October 15, 2020",Local,United States of America,USA,New York,New York City,"March 1, 2020","May 1, 2020",Health care workers and caregivers,Adults (18-64 years),500,27.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Usha Venugopal,NYC Health + Hospitals/Lincoln,http://dx.doi.org/10.1016/j.ijid.2020.10.036,12/20/2020,3/2/2024,Verified
201030_Cleveland_CaseWesternReserveUniversity_Overall,"October 30, 2020",Local,United States of America,USA,Ohio,Cleveland,"April 20, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),296,5.40%,3.10%,8.60%,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yasir Tarabichi,Case Western Reserve University,https://dx.doi.org/10.1080/10903127.2020.1831668,12/22/2020,3/2/2024,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall,"October 26, 2020",Local,United States of America,USA,New York,Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Multiple groups,764,2.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,12/28/2020,3/2/2024,Verified
201027_Indiana_Harvard_Overall_testadj,"November 27, 2020",Local,United States of America,USA,Indiana,St. John Township,"July 15, 2020","July 20, 2020",Essential non-healthcare workers,Multiple groups,753,1.70%,0.27%,3.30%,Self-referral,NA,Not reported,IgG,100.00%,99.00%,Moderate,Preprint,Lilah Lopez,Harvard Medical School,https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1,1/5/2021,7/5/2023,Verified
201119_LosAngeles_CedarsSinaiMedicalCenter_Overall,"November 19, 2020",Local,United States of America,USA,California,Los Angeles,"May 11, 2020","June 28, 2020",Health care workers and caregivers,Adults (18-64 years),6201,3.50%,,,Self-referral,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Moderate,Journal Article (Peer-Reviewed),Magali Rivas,Cedars-Sinai Medical Center,https://dx.doi.org/10.1172/JCI145157,1/5/2021,3/2/2024,Verified
201120_Rochester_MayoClinic_HighRiskCohort_1_Overall,"November 20, 2020",Local,United States of America,USA,Minnesota,Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),320,0.63%,,,Unclear,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,3/2/2024,Verified
201120_Rochester_MayoClinic_LowRiskCohort_2_Overall,"November 20, 2020",Local,United States of America,USA,Minnesota,Rochester,"May 25, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),248,0.00%,,,Unclear,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Vishal Shah,Mayo Clinic,https://dx.doi.org/10.1017/ice.2020.1341,1/5/2021,3/2/2024,Verified
200810_USA_Illinois_PhysicianPractice_Overall,"August 6, 2020",Local,United States of America,USA,Illinois,Chicago,"April 22, 2020","May 26, 2020",Residual sera,Multiple groups,113,15.90%,,,Convenience,CLUNGENE,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gerald Osher,BioSolutions Services LLC,https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007,1/7/2021,3/2/2024,Verified
201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall,"October 13, 2020",Local,United States of America,USA,Pennsylvania,Pittsburgh,"March 15, 2020","July 4, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),485,1.00%,0.30%,2.40%,Convenience,"EUROIMMUN,Beckman Coulter,Siemens",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Megan Freeman,University of Pittsburgh School of Medicine,http://dx.doi.org/10.1093/jpids/piaa123,1/7/2021,3/2/2024,Verified
201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall,"December 1, 2020",Local,United States of America,USA,California,Los Angeles,"April 29, 2020","May 8, 2020",Students and Daycares,Adults (18-64 years),790,4.00%,3.00%,5.10%,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kimberly Tilley,University of Southern California,http://dx.doi.org/10.1016/j.jadohealth.2020.09.001,1/8/2021,7/5/2023,Verified
201103_NewYorkCity_MountSinai_UrgentCare_2_Overall,"November 3, 2020",Local,United States of America,USA,New York,New York City,"February 2, 2020","July 5, 2020",Residual sera,Multiple groups,4101,26.00%,,,Sequential,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Daniel Stadlbauer,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.1038/s41586-020-2912-6,1/8/2021,7/17/2022,Verified
200624_BaskingRidge_FellowshipVillage_Staff1_Overall,"June 24, 2020",Local,United States of America,USA,New Jersey,Basking Ridge,"April 15, 2020","May 6, 2020",Assisted living and long-term care facilities,Adults (18-64 years),305,23.60%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Tim Regan,Fellowship Village,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,1/9/2021,7/17/2022,Verified
201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients,"October 15, 2020",Local,United States of America,USA,New York,New York City,"May 3, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),912,16.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yorg Azzi,Albert Einstein College of Medicine,http://dx.doi.org/10.1016/j.kint.2020.10.004,1/14/2021,3/2/2024,Verified
201120_LosAngeles_TheLundquistInstitute_genpop,"November 25, 2020",Local,United States of America,USA,California,,"April 21, 2020","May 22, 2020",Multiple populations,Multiple groups,244,20.90%,,,Unclear,Hangzhou Testsea Biotechnology Co. Ltd,LFIA,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Khadije Ahmad,The Lundquist Institute ,https://dx.doi.org/10.1007/s10096-020-04111-3,1/20/2021,7/5/2023,Verified
201123_OrangeCounty_StJudeMedicalCenter_Overall,"November 23, 2020",Local,United States of America,USA,California,Fullerton,"July 15, 2020","July 27, 2020",Residual sera,Multiple groups,865,9.40%,8.00%,12.00%,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Jason Yamaki,St. Jude Medical Center,https://dx.doi.org/10.1007/s40615-020-00918-0,1/21/2021,3/2/2024,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW,"November 21, 2020",Local,United States of America,USA,California,,"April 8, 2020","August 31, 2020",Health care workers and caregivers,Multiple groups,1108,3.90%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,7/17/2022,Verified
201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders,"November 21, 2020",Local,United States of America,USA,California,,"May 19, 2020","August 31, 2020",Essential non-healthcare workers,Multiple groups,679,8.10%,,,Unclear,NA,ELISA,IgG,,,Moderate,Preprint,Megan Halbrook,University of California Los Angeles,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,7/17/2022,Verified
201127_DistrictofColumbia_DCHealth_Overall,"November 27, 2020",Regional,United States of America,USA,Washington D.C,Washington,"May 28, 2020","July 15, 2020",Essential non-healthcare workers,Adults (18-64 years),310,3.55%,,,Self-referral,DiaSorin,CLIA,IgG,97.00%,,High,Preprint,Jacqueline Reuben,District of Columbia Department of Health (DC Health),https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1,1/22/2021,3/2/2024,Verified
201130_SanFrancisco_StanfordUniversity_Overall,"November 30, 2020",Local,United States of America,USA,California,San Francisco,"April 20, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),12418,0.90%,0.70%,1.10%,Self-referral,NA,ELISA,IgG,,99.75%,High,Journal Article (Peer-Reviewed),Catherine Hogan,Stanford University,https://dx.doi.org/10.3201/eid2701.203892,1/22/2021,7/17/2022,Verified
200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall,"June 22, 2020",Local,United States of America,USA,New York,New York City,"February 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),50,46.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jordan Jeong,Columbia University Medical Center,https://dx.doi.org/10.1016/j.annemergmed.2020.06.038,1/23/2021,3/2/2024,Verified
201210_Atlanta_CDC_Lab_OverallPopTestAdj,"December 10, 2020",Local,United States of America,USA,Georgia,Atlanta,"April 27, 2020","May 1, 2020",Residual sera,Multiple groups,1343,4.94%,3.34%,6.64%,Convenience,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciaa1804,1/23/2021,7/17/2022,Verified
201215_SanDiego_SharpHealthCare_Overall,"December 15, 2020",Local,United States of America,USA,California,San Diego,"May 20, 2020","June 8, 2020",Health care workers and caregivers,Multiple groups,1770,2.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Norihiro Yogo,Sharp Healthcare,https://dx.doi.org/10.1017/ice.2020.1370,1/24/2021,3/2/2024,Verified
201119_USA_QuestDiagnostics_Overall,"November 19, 2020",National,United States of America,USA,,,"April 21, 2020","July 10, 2020",Household and community samples,Multiple groups,2402282,11.81%,,,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Harvey W Kaufman,Quest Diagnostics,http://dx.doi.org/10.1089/pop.2020.0256,1/24/2021,3/2/2024,Verified
201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall,"December 14, 2020",Local,United States of America,USA,Virginia,Richmond,"July 27, 2020","October 2, 2020",Health care workers and caregivers,Multiple groups,1962,1.37%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Emily Godbout,Virginia Commonwealth University,https://dx.doi.org/10.1017/ice.2020.1374,1/24/2021,3/2/2024,Verified
201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants,"December 7, 2020",Local,United States of America,USA,Massachusetts,Boston,"May 29, 2020","July 23, 2020",Multiple populations,Multiple groups,143,6.30%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,7/17/2022,Verified
201207_Massachusetts_MassachusettsGeneralHospital_MS,"December 7, 2020",Local,United States of America,USA,Massachusetts,Boston,"May 29, 2020","July 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,227,3.50%,,,Sequential,NA,ELISA,IgG,99.70%,100.00%,High,Journal Article (Peer-Reviewed),E Klawiter,Massachusetts General Hospital,https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,7/17/2022,Verified
201203_AraphoeCounty_UniversityofColorado,"December 3, 2020",Local,United States of America,USA,Colorado,,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),264,4.00%,,,Convenience,Exsera BioLabs,ELISA,IgG,85.00%,98.60%,High,Journal Article (Peer-Reviewed),Katherine Sabourin,University of Colorado,https://pubmed.ncbi.nlm.nih.gov/33298759/,1/29/2021,7/17/2022,Verified
200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium,"August 6, 2020",Local,United States of America,USA,New York,New York City,"April 20, 2020","June 23, 2020",Health care workers and caregivers,Multiple groups,40329,13.70%,,,Convenience,"EUROIMMUN,AnshLabs ,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,DiaSorin,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Joseph Moscola,Northwell Health COVID-19 Research Consortium,https://pubmed.ncbi.nlm.nih.gov/32780804/,1/29/2021,3/2/2024,Verified
201230_SanDiego_ScrippsClinic_Overall,"December 30, 2020",Local,United States of America,USA,California,San Diego,"April 14, 2020","July 28, 2020",Health care workers and caregivers,Adults (18-64 years),11993,0.94%,,,Convenience,"Diazyme Laboratories Inc,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Nicholson,Scripps Clinic,https://dx.doi.org/10.1016/j.ajic.2020.12.017,1/29/2021,3/2/2024,Verified
201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj,"December 22, 2020",Regional,United States of America,USA,Wisconsin,,"July 1, 2020","August 31, 2020",Household and community samples,Multiple groups,996,1.60%,0.60%,2.50%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/4/2021,7/5/2023,Verified
201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj,"December 22, 2020",Regional,United States of America,USA,Wisconsin,,"October 18, 2020","December 14, 2020",Household and community samples,Multiple groups,994,6.80%,4.30%,9.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,,99.60%,Moderate,Preprint,Kristen Maleck,University of Wisconsin,https://doi.org/10.1101/2020.12.18.20248479,2/4/2021,7/5/2023,Verified
210105_USA_MayoClinic_overall,"January 5, 2021",Local,United States of America,USA,Minnesota,Rochester,"May 16, 2020","May 17, 2020",Essential non-healthcare workers,Adults (18-64 years),255,1.20%,,,Convenience,NA,ELISA,IgG,88.10%,99.60%,High,Journal Article (Peer-Reviewed),Sarayna S McGuire,Mayo Clinic,https://dx.doi.org/10.1017/S1049023X2000151X,2/4/2021,7/17/2022,Unverified
201209_SantaClara_StanfordHealthCare,"December 9, 2020",Local,United States of America,USA,California,San Francisco Bay Area,"April 20, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),10449,1.30%,,,Convenience,NA,CLIA,IgG,87.00%,99.75%,High,Journal Article (Peer-Reviewed),Joelle Rosser,Stanford Health Care,https://dx.doi.org/10.1017/ice.2020.1358,2/4/2021,7/17/2022,Verified
201223_NewYork_MemorialSloanKetteringCancerCenter,"December 23, 2020",Local,United States of America,USA,New York,New York City,"May 5, 2020","September 10, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),257,7.80%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Jimenez Kurlander,Memorial Sloan Kettering Cancer Center,https://dx.doi.org/10.1002/pbc.28857,2/4/2021,3/2/2024,Verified
210119_NewJersey_CooperUniversityHospital_overall,"January 19, 2021",Local,United States of America,USA,New Jersey ,,"June 10, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),172,5.20%,2.40%,9.70%,Convenience,"EUROIMMUN,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Snehal Gandhi,Cooper University Hospital,https://dx.doi.org/10.1007/s11606-020-06462-1,2/4/2021,3/2/2024,Unverified
201106_Utah_UniversityofUtah_immunosupressed_primary,"November 6, 2020",Local,United States of America,USA,Utah,Salt Lake City ,"April 18, 2020","May 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,39,2.60%,,,Unclear,NA,Not reported,IgG,,,High,Preprint,Quinn Pritchett,University of Utah,https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/,2/5/2021,7/17/2022,Verified
210111_Michigan_ UniversityofMichigan_overall,"January 11, 2021",Local,United States of America,USA,Michigan,,"August 17, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),1385,1.88%,,,Convenience,"Siemens,Eagle Bioscience",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jeffrey Fletcher,Metro Health University of Michigan Health,http://dx.doi.org/10.1017/ice.2020.1438,2/5/2021,3/2/2024,Unverified
201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool,"October 31, 2020",Local,United States of America,USA,New Jersey,"New Brunswick, Somerville","April 28, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),3907,9.60%,,,Convenience,Abbott Laboratories,Not reported,IgG,96.90%,99.60%,Moderate,Journal Article (Peer-Reviewed),Emily Barrett,Rutgers Robert Wood Johnson Medical School,https://dx.doi.org/10.1093/ofid/ofaa534,2/6/2021,3/2/2024,Verified
210115_Massachusetts_HarvardUniversity_Overall,"January 15, 2021",Regional,United States of America,USA,Massachusetts,,"June 16, 2020","August 24, 2020",Household and community samples,Multiple groups,1872,3.15%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Aishani Aatresh,Harvard University,https://www.medrxiv.org/content/10.1101/2021.01.14.21249824v1,2/12/2021,3/2/2024,Verified
201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy,"October 21, 2020",Local,United States of America,USA,Washington,Seattle,"May 1, 2020","May 31, 2020",Essential non-healthcare workers,Adults (18-64 years),120,2.50%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Amin Addetia,University of Washington,https://jcm.asm.org/content/58/11/e02107-20,2/17/2021,3/2/2024,Verified
210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj,"January 29, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 9, 2020","August 8, 2020",Pregnant or parturient women,Adults (18-64 years),1471,6.00%,,,Convenience,NA,ELISA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Dustin D Flannery,University of Pennsylvania,https://dx.doi.org/10.1001/jamapediatrics.2021.0038,2/20/2021,7/17/2022,Verified
210117_Maryland_UniversityofMaryland_overall_adj,"January 17, 2021",Local,United States of America,USA,Maryland,Baltimore,"June 3, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),8399,3.52%,3.01%,3.98%,Convenience,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Kristin E Mullins,University of Maryland,http://dx.doi.org/10.1016/j.clinbiochem.2021.01.004,2/22/2021,8/15/2023,Verified
210201_Minnesota_UniversityofMinnesota_HCW_Primary,"February 1, 2021",Regional,United States of America,USA,Minnesota,,"April 13, 2020","May 21, 2020",Health care workers and caregivers,Multiple groups,1282,2.96%,2.04%,3.89%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/26/2021,7/17/2022,Verified
210201_Minnesota_UniversityofMinnesota_OutPatients_Primary ,"February 1, 2021",Regional,United States of America,USA,Minnesota,,"April 13, 2020","May 21, 2020",Residual sera,Multiple groups,2379,4.46%,3.63%,5.28%,Convenience,NA,ELISA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Stefani Thomas,University of Minnesota,https://dx.doi.org/10.1016/j.clinbiochem.2021.01.010,2/26/2021,7/17/2022,Verified
201026_UpstateNewYork_BassettMedicalCenter_Overall copy,"October 26, 2020",Local,United States of America,USA,New York,Upstate New York,"May 4, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),762,4.50%,,,Unclear,Ortho Clinical Diagnostics Inc.,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Wendy M Brunner,Bassett Medical Center,https://dx.doi.org/10.1017/ice.2020.1296,2/28/2021,3/2/2024,Verified
210201_Washington_ChildrensNationalHospital_Overall_TestAdj,"February 1, 2021",Local,United States of America,USA,"Washington, D.C, Maryland, Virginia, West Virginia",Washington D.C,"July 7, 2020","October 29, 2020",Residual sera,Children and Youth (0-17 years),385,9.46%,6.68%,13.00%,Convenience,DiaSorin,CLIA,IgG,97.60%,99.30%,High,Journal Article (Peer-Reviewed),Burak Bahar,Children's National Hospital,https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text,3/5/2021,7/5/2023,Verified
210125_NewYork_CDC+NewYorkCity_Total,"January 25, 2021",Local,United States of America,USA,New York,New York City,"May 18, 2020","July 2, 2020",Essential non-healthcare workers,Multiple groups,22647,22.50%,21.90%,23.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Samira Sami,CDC and New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.3201/eid2703.204340,3/5/2021,3/2/2024,Unverified
201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall,"December 14, 2020",Local,United States of America,USA,Arizona,,"September 11, 2020","September 21, 2020",Household and community samples,Multiple groups,260,10.70%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Fountain Hills Times,Maricopa County Department of Public Health,https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html,3/7/2021,7/17/2022,Verified
201203_Florida_FloridaDepartmentOfHealth_primary,"December 3, 2020",Regional,United States of America,USA,Florida,,"May 1, 2020","November 30, 2020",Household and community samples,Multiple groups,630838,11.03%,,,Self-referral,NA,Not reported,"IgG,Total Antibody",,,Unclear,News and Media,Frank Jolley,Florida Department of Health,https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/,3/7/2021,7/17/2022,Verified
201005_Wisconsin_UW-Madison_overall,"October 5, 2020",Regional,United States of America,USA,Wisconsin,,"July 15, 2020","August 15, 2020",Household and community samples,Multiple groups,1056,1.60%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Madeline Heim,UW-Madison,https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/,3/8/2021,7/17/2022,Verified
200830_VenturaCounty_OxnardFireDepartment_overall,"August 30, 2020",Local,United States of America,USA,California,,"June 22, 2020","July 6, 2020",Household and community samples,Multiple groups,6794,1.30%,,,Self-referral,"Abbott Laboratories,Bio-rad",Not reported,Not reported,,,High,News and Media,Jeremy Childs,Oxnard Fire Department,https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/,3/8/2021,3/2/2024,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_July,"August 24, 2020",Local,United States of America,USA,Kentucky,Louiseville,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1100,2.20%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/9/2021,7/17/2022,Verified
201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling,"November 24, 2020",Local,United States of America,USA,Kentucky,,"November 9, 2020","November 16, 2020",Household and community samples,Multiple groups,1091,2.00%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/9/2021,7/17/2022,Verified
201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall,"November 24, 2020",Local,United States of America,USA,Kentucky,,"November 9, 2020","November 16, 2020",Household and community samples,Multiple groups,1709,3.30%,,,Self-referral,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/9/2021,7/17/2022,Verified
200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay,"August 24, 2020",Local,United States of America,USA,Kentucky,Louiseville,"April 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1372,1.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louiseville ,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/10/2021,7/17/2022,Verified
210123_Norfolk_NavalMedicalCenterPortsmouth_Overall,"January 23, 2021",Local,United States of America,USA,Virginia,Norfolk,"April 28, 2020","May 12, 2020",Essential non-healthcare workers,Adults (18-64 years),432,3.01%,1.61%,5.09%,Convenience,LakePharma Inc.,Other,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tahaniyat Lalani,Naval Medical Center Portsmouth,https://dx.doi.org/10.1093/ofid/ofaa654,3/13/2021,7/17/2022,Verified
201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj,"October 28, 2020",Regional,United States of America,USA,Connecticut,,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,148,6.40%,0.90%,11.90%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,3/2/2024,Verified
201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj,"October 28, 2020",Regional,United States of America,USA,Connecticut,,"June 23, 2020","July 22, 2020",Household and community samples,Multiple groups,171,19.90%,13.20%,26.60%,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Shiwani Mahajan,Yale School of Medicine,http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,3/2/2024,Verified
210122_USA_YourCareChoice_GenPop,"January 22, 2021",National,United States of America,USA,,,"April 24, 2020","May 13, 2020",Household and community samples,Multiple groups,407,21.62%,,,Stratified probability,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Robert Morlock,YourCareChoice,https://dx.doi.org/10.1371/journal.pone.0245586,3/14/2021,7/17/2022,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj,"February 3, 2021",Local,United States of America,USA,Missouri,St Louis,"April 14, 2020","May 8, 2020",Residual sera,Children and Youth (0-17 years),555,1.71%,0.04%,3.38%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/14/2021,7/17/2022,Verified
210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj,"February 3, 2021",Local,United States of America,USA,Missouri,St Louis,"April 27, 2020","May 12, 2020",Residual sera,Multiple groups,503,3.11%,0.92%,5.32%,Sequential,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.01207-20,3/14/2021,7/17/2022,Verified
210212_Arizona_KingmanRegionalMedicalCenter_Overall,"February 12, 2021",Local,United States of America,USA,Arizona,Kingman,"September 28, 2020","October 9, 2020",Household and community samples,Adults (18-64 years),566,8.00%,,,Self-referral,Ortho Clinical Diagnostics Inc.,LFIA,IgG,87.50%,100.00%,High,Journal Article (Peer-Reviewed),Anthony Santarelli,Kingman Regional Medical Center,https://dx.doi.org/10.1515/jom-2020-0287,3/14/2021,3/2/2024,Verified
210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel,"January 20, 2021",Regional,United States of America,USA,North Dakota,"Fargo, Grand Forks","July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),247,14.60%,10.40%,19.60%,Convenience,BioSys Laboratories,LFIA,"IgG,IgM",93.50%,100.00%,High,Journal Article (Peer-Reviewed),Amanda Johnson,North Dakota State University,https://www.japha.org/article/S1544-3191(21)00025-X/abstract,3/14/2021,3/2/2024,Verified
210225_Denver_UniversityofColorado_NewOnsetDiabetes,"February 25, 2021",Local,United States of America,USA,Colorado,Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,129,0.80%,0.10%,4.20%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/15/2021,7/17/2022,Verified
210225_Denver_UniversityofColorado_EstablishedDiabetes,"February 25, 2021",Local,United States of America,USA,Colorado,Denver,"January 3, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,94,4.30%,1.70%,10.40%,Sequential,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/15/2021,7/17/2022,Verified
210225_Denver_UniversityofColorado_GenPopChildren,"February 25, 2021",Local,United States of America,USA,Colorado,Denver,"July 8, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),562,2.80%,1.80%,4.60%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/15/2021,7/17/2022,Verified
210225_Denver_UniversityofColorado_GenPopAdults,"February 25, 2021",Local,United States of America,USA,Colorado,Denver,"July 8, 2020","October 23, 2020",Household and community samples,Adults (18-64 years),102,3.90%,1.50%,9.70%,Convenience,NA,CLIA,Total Antibody,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Xiaofan Jia,University of Colorado,https://dx.doi.org/10.1089/dia.2020.0609,3/15/2021,7/17/2022,Verified
210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai,"February 2, 2021",Local,United States of America,USA,North Carolina,Parris Island,"May 11, 2020","September 7, 2020",Essential non-healthcare workers,Adults (18-64 years),3196,9.00%,,,Convenience,NA,ELISA,IgG,96.08%,97.14%,Moderate,Journal Article (Peer-Reviewed),Andrew Letizia,Icahn School of Medicine at Mount Sinai,http://dx.doi.org/10.3201/eid2704.204732,3/18/2021,7/17/2022,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Students,"February 26, 2021",Local,United States of America,USA,Pennsylvania,,"October 26, 2020","November 23, 2020",Students and Daycares,Adults (18-64 years),625,31.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,Moderate,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/18/2021,7/17/2022,Verified
210226_CentreCounty_PennsylvaniaStateUniversity_Community,"February 26, 2021",Local,United States of America,USA,Pennsylvania,,"August 7, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),345,8.20%,,,Convenience,NA,ELISA,IgG,93.30%,99.00%,High,Preprint,Callum Arnold,Pennsylvania State University,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/18/2021,7/17/2022,Verified
210204_UnitedStates_DaVitaClinicalResearch_Overall,"February 4, 2021",National,United States of America,USA,,,"May 27, 2020","July 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,12932,5.78%,5.40%,6.20%,Simplified probability,Diazyme Laboratories Inc,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Adam Walker,DaVita Clinical Research,https://dx.doi.org/10.1016/j.xkme.2021.01.002,3/19/2021,3/2/2024,Verified
210201_NewYorkCity_ColumbiaUniversity,"February 1, 2021",Local,United States of America,USA,"New York
",New York City,"June 24, 2020","July 16, 2020",Pregnant or parturient women,Adults (18-64 years),47,40.40%,,,Sequential,NA,ELISA,"IgG,IgM",92.00%,,High,Journal Article (Peer-Reviewed),Caitlin Baptiste,Columbia University,http://dx.doi.org/10.1016/j.ajog.2020.12.944,3/19/2021,7/17/2022,Verified
210208_Virginia_UniversityOfVirginia_Overall_PopAdj,"February 8, 2021",Regional,United States of America,USA,Virginia,,"June 1, 2020","August 14, 2020",Residual sera,Multiple groups,4675,2.40%,1.80%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Elizabeth T Rogawski McQuade,"University of Virginia
",https://dx.doi.org/10.1001/jamanetworkopen.2020.35234,3/19/2021,7/5/2023,Verified
210130_USA_UniversityofArizona_primary,"January 30, 2021",Local,United States of America,USA,,Detroit and New York City,"May 17, 2020","July 2, 2020",Health care workers and caregivers,Multiple groups,40938,16.20%,15.90%,16.60%,Self-referral,Ortho Clinical Diagnostics Inc.,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lara J Akinbami,University of Arizona ,https://dx.doi.org/10.1093/cid/ciab080,3/20/2021,3/2/2024,Verified
210129_Atlanta_EmoryUniversityHospital_primary,"January 29, 2021",Local,United States of America,USA,Georgia,Atlanta,"April 19, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),10275,3.80%,3.40%,4.30%,Self-referral,NA,ELISA,IgG,97.50%,98.00%,Moderate,Journal Article (Peer-Reviewed),Julia M Baker,Emory University Hospital,https://dx.doi.org/10.7326/M20-7145,3/20/2021,7/17/2022,Verified
210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall,"February 18, 2021",Local,United States of America,USA,,Washington DC,"July 27, 2020","August 21, 2020",Household and community samples,Multiple groups,671,7.60%,5.70%,9.90%,Convenience,DiaSorin,CLIA,IgG,97.00%,,High,Preprint,Adrienne Sherman,Government of the District of Columbia,10.1101/2021.02.15.21251764,3/20/2021,3/2/2024,Verified
210129_NewYork_NorthwellHealth,"January 29, 2021",Regional,United States of America,USA,New York,,"May 27, 2020","August 23, 2020",Pregnant or parturient women,Adults (18-64 years),2930,15.30%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Lylach Haizler Cohen,Northwell Health,http://dx.doi.org/10.1016/j.ajog.2020.12.631,3/20/2021,7/17/2022,Verified
201124_USA_CDC_July/August1_Alaska,"November 24, 2020",Regional,United States of America,USA,Alaska,,"August 6, 2020","August 11, 2020",Residual sera,Multiple groups,242,0.30%,0.00%,1.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Alaska,"November 24, 2020",Regional,United States of America,USA,Alaska,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,704,1.30%,0.50%,2.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Alaska,"November 24, 2020",Regional,United States of America,USA,Alaska,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,610,1.00%,0.24%,2.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Alaska,"November 24, 2020",Regional,United States of America,USA,Alaska,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,681,0.40%,0.11%,0.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Alabama,"November 24, 2020",Regional,United States of America,USA,Alabama,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,955,9.90%,7.19%,12.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Arkansas,"November 24, 2020",Regional,United States of America,USA,Arkansas,,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,992,4.90%,3.50%,6.41%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Arizona,"November 24, 2020",Regional,United States of America,USA,Arizona,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,1030,4.90%,3.05%,7.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_California,"November 24, 2020",Regional,United States of America,USA,California,,"August 28, 2020","September 9, 2020",Residual sera,Multiple groups,983,6.00%,4.20%,7.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Connecticut,"November 24, 2020",Regional,United States of America,USA,Connecticut,,"August 26, 2020","September 4, 2020",Residual sera,Multiple groups,983,4.30%,2.90%,5.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Colorado,"November 24, 2020",Regional,United States of America,USA,Colorado,,"August 24, 2020","September 4, 2020",Residual sera,Multiple groups,1025,3.60%,2.31%,5.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_WashingtonD.C,"November 24, 2020",Regional,United States of America,USA,Washington D.C,,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,643,5.00%,2.83%,7.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Florida,"November 24, 2020",Regional,United States of America,USA,Florida,,"August 27, 2020","September 9, 2020",Residual sera,Multiple groups,981,5.70%,3.93%,7.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Iowa,"November 24, 2020",Regional,United States of America,USA,Iowa,,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1006,8.40%,6.15%,10.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Delaware,"November 24, 2020",Regional,United States of America,USA,Delaware,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,914,4.50%,2.42%,7.12%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Georgia,"November 24, 2020",Regional,United States of America,USA,Georgia,,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,1020,8.70%,6.69%,11.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Idaho,"November 24, 2020",Regional,United States of America,USA,Idaho,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,790,5.70%,2.90%,9.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Maine,"November 24, 2020",Regional,United States of America,USA, Maine,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,759,1.50%,0.44%,3.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Kansas,"November 24, 2020",Regional,United States of America,USA,Kansas,,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,1025,2.90%,1.57%,4.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Massachusetts,"November 24, 2020",Regional,United States of America,USA, Massachusetts,,"August 27, 2020","September 5, 2020",Residual sera,Multiple groups,981,3.60%,2.36%,5.08%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Indiana,"November 24, 2020",Regional,United States of America,USA,Indiana,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,984,2.40%,1.36%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Maryland,"November 24, 2020",Regional,United States of America,USA, Maryland,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,980,7.90%,5.72%,10.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Minnesota,"November 24, 2020",Regional,United States of America,USA, Minnesota,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,974,9.20%,6.71%,11.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Michigan,"November 24, 2020",Regional,United States of America,USA, Michigan,,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,976,3.40%,2.16%,4.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Illinois,"November 24, 2020",Regional,United States of America,USA,Illinois,,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,979,5.60%,3.90%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Missouri,"November 24, 2020",Regional,United States of America,USA, Missouri,,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,1024,2.90%,1.74%,4.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Louisiana,"November 24, 2020",Regional,United States of America,USA, Louisiana,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1001,8.60%,6.65%,11.30%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Kentucky,"November 24, 2020",Regional,United States of America,USA, Kentucky,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,983,3.10%,1.91%,4.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Mississippi,"November 24, 2020",Regional,United States of America,USA, Mississippi,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,987,8.40%,4.89%,12.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NewHampshire,"November 24, 2020",Regional,United States of America,USA, New Hampshire,,"August 26, 2020","September 3, 2020",Residual sera,Multiple groups,1147,1.60%,0.73%,2.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Ohio,"November 24, 2020",Regional,United States of America,USA, Ohio,,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,983,5.00%,3.17%,7.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Nebraska,"November 24, 2020",Regional,United States of America,USA, Nebraska,,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,938,6.30%,4.47%,8.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Virginia,"November 24, 2020",Regional,United States of America,USA, Virginia,,"August 26, 2020","September 8, 2020",Residual sera,Multiple groups,1007,3.50%,1.97%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NewMexico,"November 24, 2020",Regional,United States of America,USA, New Mexico,,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,985,3.70%,2.28%,5.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Vermont,"November 24, 2020",Regional,United States of America,USA, Vermont,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,485,0.40%,0.00%,0.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Oregon,"November 24, 2020",Regional,United States of America,USA, Oregon,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,968,1.90%,0.92%,2.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_PuertoRico,"November 24, 2020",Regional,United States of America,USA,Puerto Rico,,"August 24, 2020","September 3, 2020",Residual sera,Multiple groups,980,2.50%,1.36%,3.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NewJersey,"November 24, 2020",Regional,United States of America,USA, New Jersey,,"August 26, 2020","September 7, 2020",Residual sera,Multiple groups,944,12.80%,10.49%,15.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_SouthDakota,"November 24, 2020",Regional,United States of America,USA, South Dakota,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,97,0.70%,0.00%,2.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NewYork,"November 24, 2020",Regional,United States of America,USA, New York,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1043,19.50%,16.88%,22.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Montana,"November 24, 2020",Regional,United States of America,USA, Montana,,"August 24, 2020","September 9, 2020",Residual sera,Multiple groups,518,0.90%,0.23%,1.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Nevada,"November 24, 2020",Regional,United States of America,USA, Nevada,,"August 27, 2020","August 29, 2020",Residual sera,Multiple groups,980,6.50%,4.63%,8.58%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NorthCarolina,"November 24, 2020",Regional,United States of America,USA, North Carolina,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Tennessee,"November 24, 2020",Regional,United States of America,USA, Tennessee,,"August 25, 2020","September 8, 2020",Residual sera,Multiple groups,950,5.40%,3.62%,7.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_SouthCarolina,"November 24, 2020",Regional,United States of America,USA, South Carolina,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,927,7.20%,5.12%,9.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_RhodeIsland,"November 24, 2020",Regional,United States of America,USA, Rhode Island,,"August 27, 2020","September 10, 2020",Residual sera,Multiple groups,786,3.10%,1.73%,4.64%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Oklahoma,"November 24, 2020",Regional,United States of America,USA, Oklahoma,,"August 24, 2020","September 1, 2020",Residual sera,Multiple groups,979,5.40%,3.83%,7.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Utah,"November 24, 2020",Regional,United States of America,USA, Utah,,"August 24, 2020","September 8, 2020",Residual sera,Multiple groups,1104,4.90%,2.82%,7.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_NorthDakota,"November 24, 2020",Regional,United States of America,USA, North Dakota,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,109,0.20%,0.00%,0.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Texas,"November 24, 2020",Regional,United States of America,USA, Texas,,"August 25, 2020","September 2, 2020",Residual sera,Multiple groups,979,5.80%,4.04%,7.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Pennsylvania,"November 24, 2020",Regional,United States of America,USA, Pennsylvania,,"August 26, 2020","September 9, 2020",Residual sera,Multiple groups,845,9.50%,6.58%,13.56%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Washington,"November 24, 2020",Regional,United States of America,USA,Washington,,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,820,4.50%,2.63%,6.94%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_Wisconsin,"November 24, 2020",Regional,United States of America,USA, Wisconsin,,"August 25, 2020","September 10, 2020",Residual sera,Multiple groups,976,2.60%,1.48%,3.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August/September3_WestVirginia,"November 24, 2020",Regional,United States of America,USA, West Virginia,,"August 26, 2020","September 10, 2020",Residual sera,Multiple groups,1128,1.50%,0.78%,2.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Minnesota,"November 24, 2020",Regional,United States of America,USA, Minnesota,,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,978,4.50%,3.05%,5.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_WestVirginia,"November 24, 2020",Regional,United States of America,USA, West Virginia,,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,637,2.20%,0.52%,4.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Wisconsin,"November 24, 2020",Regional,United States of America,USA, Wisconsin,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,838,3.30%,2.03%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Washington,"November 24, 2020",Regional,United States of America,USA,Washington,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1238,3.00%,1.79%,4.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Arizona,"November 24, 2020",Regional,United States of America,USA,Arizona,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1304,4.70%,2.70%,7.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Pennsylvania,"November 24, 2020",Regional,United States of America,USA, Pennsylvania,,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,887,10.10%,7.53%,13.74%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_California,"November 24, 2020",Regional,United States of America,USA,California,,"August 13, 2020","August 19, 2020",Residual sera,Multiple groups,980,4.30%,2.85%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Missouri,"November 24, 2020",Regional,United States of America,USA, Missouri,,"August 12, 2020","August 21, 2020",Residual sera,Multiple groups,1021,3.50%,2.23%,5.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Iowa,"November 24, 2020",Regional,United States of America,USA,Iowa,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,9.40%,7.12%,11.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Georgia,"November 24, 2020",Regional,United States of America,USA,Georgia,,"August 13, 2020","August 26, 2020",Residual sera,Multiple groups,1031,7.40%,5.52%,9.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NewYork,"November 24, 2020",Regional,United States of America,USA, New York,,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1122,20.60%,18.04%,23.14%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NewJersey,"November 24, 2020",Regional,United States of America,USA, New Jersey,,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1127,12.20%,10.15%,14.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Nevada,"November 24, 2020",Regional,United States of America,USA, Nevada,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,972,7.90%,6.13%,9.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Indiana,"November 24, 2020",Regional,United States of America,USA,Indiana,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,906,3.10%,1.53%,4.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Ohio,"November 24, 2020",Regional,United States of America,USA, Ohio,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,2.10%,1.06%,3.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Idaho,"November 24, 2020",Regional,United States of America,USA,Idaho,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,651,4.60%,1.67%,9.05%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NorthDakota,"November 24, 2020",Regional,United States of America,USA, North Dakota,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,135,0.60%,0.00%,1.45%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Florida,"November 24, 2020",Regional,United States of America,USA,Florida,,"August 14, 2020","August 14, 2020",Residual sera,Multiple groups,978,4.50%,3.15%,6.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Alabama,"November 24, 2020",Regional,United States of America,USA,Alabama,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,974,7.60%,5.33%,9.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Vermont,"November 24, 2020",Regional,United States of America,USA, Vermont,,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,382,0.30%,0.00%,0.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_SouthCarolina,"November 24, 2020",Regional,United States of America,USA, South Carolina,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1063,6.00%,4.37%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Virginia,"November 24, 2020",Regional,United States of America,USA, Virginia,,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1243,4.70%,2.51%,7.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_PuertoRico,"November 24, 2020",Regional,United States of America,USA,Puerto Rico,,"August 10, 2020","August 17, 2020",Residual sera,Multiple groups,986,2.20%,1.18%,3.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Massachusetts,"November 24, 2020",Regional,United States of America,USA, Massachusetts,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,980,3.70%,2.27%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_RhodeIsland,"November 24, 2020",Regional,United States of America,USA, Rhode Island,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,570,3.60%,1.69%,5.89%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Delaware,"November 24, 2020",Regional,United States of America,USA,Delaware,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,1004,8.50%,5.79%,11.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Texas,"November 24, 2020",Regional,United States of America,USA, Texas,,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,1001,6.50%,4.69%,8.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Michigan,"November 24, 2020",Regional,United States of America,USA, Michigan,,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,983,4.20%,2.88%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Oregon,"November 24, 2020",Regional,United States of America,USA, Oregon,,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,1086,2.40%,1.41%,3.60%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Kansas,"November 24, 2020",Regional,United States of America,USA,Kansas,,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,1016,3.70%,2.02%,5.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Maine,"November 24, 2020",Regional,United States of America,USA, Maine,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,609,0.60%,0.00%,1.44%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Montana,"November 24, 2020",Regional,United States of America,USA, Montana,,"August 12, 2020","August 24, 2020",Residual sera,Multiple groups,383,1.30%,0.38%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Maryland,"November 24, 2020",Regional,United States of America,USA, Maryland,,"August 10, 2020","August 26, 2020",Residual sera,Multiple groups,1174,7.00%,4.92%,9.33%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Tennessee,"November 24, 2020",Regional,United States of America,USA, Tennessee,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1029,6.70%,5.11%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NorthCarolina,"November 24, 2020",Regional,United States of America,USA, North Carolina,,"August 11, 2020","August 27, 2020",Residual sera,Multiple groups,982,3.80%,2.33%,5.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Kentucky,"November 24, 2020",Regional,United States of America,USA, Kentucky,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,1126,3.10%,2.05%,4.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NewMexico,"November 24, 2020",Regional,United States of America,USA, New Mexico,,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,976,2.50%,1.47%,3.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Mississippi,"November 24, 2020",Regional,United States of America,USA, Mississippi,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,968,10.00%,6.69%,14.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Oklahoma,"November 24, 2020",Regional,United States of America,USA, Oklahoma,,"August 10, 2020","August 18, 2020",Residual sera,Multiple groups,979,4.00%,2.72%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Utah,"November 24, 2020",Regional,United States of America,USA, Utah,,"August 15, 2020","August 25, 2020",Residual sera,Multiple groups,871,5.50%,2.94%,8.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Colorado,"November 24, 2020",Regional,United States of America,USA,Colorado,,"August 10, 2020","August 25, 2020",Residual sera,Multiple groups,1019,3.30%,1.83%,4.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_NewHampshire,"November 24, 2020",Regional,United States of America,USA, New Hampshire,,"August 13, 2020","August 25, 2020",Residual sera,Multiple groups,1125,0.80%,0.30%,1.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Washington D.C,"November 24, 2020",Regional,United States of America,USA,Washington D.C,,"August 13, 2020","August 27, 2020",Residual sera,Multiple groups,781,6.80%,4.59%,9.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Louisiana,"November 24, 2020",Regional,United States of America,USA, Louisiana,,"August 12, 2020","August 25, 2020",Residual sera,Multiple groups,989,11.80%,9.27%,14.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_SouthDakota,"November 24, 2020",Regional,United States of America,USA, South Dakota,,"August 12, 2020","August 26, 2020",Residual sera,Multiple groups,83,0.00%,0.00%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Wyoming,"November 24, 2020",Regional,United States of America,USA, Wyoming,,"August 13, 2020","August 24, 2020",Residual sera,Multiple groups,86,0.80%,0.00%,3.11%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Illinois,"November 24, 2020",Regional,United States of America,USA,Illinois,,"August 12, 2020","August 27, 2020",Residual sera,Multiple groups,985,4.90%,3.40%,6.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Connecticut,"November 24, 2020",Regional,United States of America,USA,Connecticut,,"August 11, 2020","August 24, 2020",Residual sera,Multiple groups,983,2.40%,1.45%,3.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Arkansas,"November 24, 2020",Regional,United States of America,USA,Arkansas,,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,998,3.00%,1.76%,4.35%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_August2_Nebraska,"November 24, 2020",Regional,United States of America,USA, Nebraska,,"August 11, 2020","August 25, 2020",Residual sera,Multiple groups,990,7.90%,5.51%,10.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Pennsylvania,"November 24, 2020",Regional,United States of America,USA, Pennsylvania,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,575,10.20%,5.71%,17.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_SouthCarolina,"November 24, 2020",Regional,United States of America,USA, South Carolina,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,840,8.10%,5.79%,10.69%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NewJersey,"November 24, 2020",Regional,United States of America,USA, New Jersey,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,871,14.80%,12.23%,17.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Texas,"November 24, 2020",Regional,United States of America,USA, Texas,,"July 29, 2020","August 5, 2020",Residual sera,Multiple groups,986,5.90%,4.04%,7.95%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NewYork,"November 24, 2020",Regional,United States of America,USA, New York,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,846,23.30%,20.07%,26.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Montana,"November 24, 2020",Regional,United States of America,USA, Montana,,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,199,0.50%,0.00%,1.67%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_PuertoRico,"November 24, 2020",Regional,United States of America,USA,Puerto Rico,,"July 27, 2020","August 7, 2020",Residual sera,Multiple groups,984,1.10%,0.43%,1.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Washington D.C,"November 24, 2020",Regional,United States of America,USA,Washington D.C,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,717,3.90%,2.18%,5.76%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Vermont,"November 24, 2020",Regional,United States of America,USA, Vermont,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,346,0.50%,0.00%,1.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Maine,"November 24, 2020",Regional,United States of America,USA, Maine,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,598,0.50%,0.00%,1.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NewHampshire,"November 24, 2020",Regional,United States of America,USA, New Hampshire,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,809,0.80%,0.22%,1.48%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Nevada,"November 24, 2020",Regional,United States of America,USA, Nevada,,"July 30, 2020","August 2, 2020",Residual sera,Multiple groups,979,5.10%,3.63%,6.66%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NorthCarolina,"November 24, 2020",Regional,United States of America,USA, North Carolina,,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,928,2.50%,1.31%,3.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Idaho,"November 24, 2020",Regional,United States of America,USA,Idaho,,"August 4, 2020","August 11, 2020",Residual sera,Multiple groups,246,4.50%,1.80%,7.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Colorado,"November 24, 2020",Regional,United States of America,USA,Colorado,,"July 30, 2020","August 7, 2020",Residual sera,Multiple groups,1001,2.40%,0.89%,4.53%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Florida,"November 24, 2020",Regional,United States of America,USA,Florida,,"July 31, 2020","August 3, 2020",Residual sera,Multiple groups,980,4.30%,2.77%,5.86%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Nebraska,"November 24, 2020",Regional,United States of America,USA, Nebraska,,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,954,7.40%,5.25%,9.75%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Kentucky,"November 24, 2020",Regional,United States of America,USA, Kentucky,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,975,2.40%,1.32%,3.62%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_WestVirginia,"November 24, 2020",Regional,United States of America,USA, West Virginia,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,317,1.20%,0.23%,2.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Alabama,"November 24, 2020",Regional,United States of America,USA,Alabama,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,938,5.80%,4.16%,7.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Mississippi,"November 24, 2020",Regional,United States of America,USA, Mississippi,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,769,7.10%,3.75%,11.09%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Louisiana,"November 24, 2020",Regional,United States of America,USA, Louisiana,,"July 28, 2020","August 13, 2020",Residual sera,Multiple groups,1002,9.60%,6.88%,12.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Kansas,"November 24, 2020",Regional,United States of America,USA,Kansas,,"July 29, 2020","August 8, 2020",Residual sera,Multiple groups,962,1.60%,0.70%,2.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Massachusetts,"November 24, 2020",Regional,United States of America,USA, Massachusetts,,"July 30, 2020","August 10, 2020",Residual sera,Multiple groups,978,4.20%,2.89%,5.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Indiana,"November 24, 2020",Regional,United States of America,USA,Indiana,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,579,2.20%,1.10%,3.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Oklahoma,"November 24, 2020",Regional,United States of America,USA, Oklahoma,,"July 28, 2020","August 4, 2020",Residual sera,Multiple groups,979,1.60%,0.85%,2.49%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Wisconsin,"November 24, 2020",Regional,United States of America,USA, Wisconsin,,"July 30, 2020","August 13, 2020",Residual sera,Multiple groups,814,1.80%,0.76%,3.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Delaware,"November 24, 2020",Regional,United States of America,USA,Delaware,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,804,5.70%,3.55%,8.22%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Iowa,"November 24, 2020",Regional,United States of America,USA,Iowa,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,811,8.60%,5.98%,11.34%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Maryland,"November 24, 2020",Regional,United States of America,USA, Maryland,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,783,9.70%,7.26%,12.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Connecticut,"November 24, 2020",Regional,United States of America,USA,Connecticut,,"July 30, 2020","August 3, 2020",Residual sera,Multiple groups,994,3.40%,2.04%,4.72%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Michigan,"November 24, 2020",Regional,United States of America,USA, Michigan,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,982,3.40%,2.16%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NewMexico,"November 24, 2020",Regional,United States of America,USA, New Mexico,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,964,2.00%,1.09%,3.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Arizona,"November 24, 2020",Regional,United States of America,USA,Arizona,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,591,8.20%,4.11%,13.59%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Missouri,"November 24, 2020",Regional,United States of America,USA, Missouri,,"July 28, 2020","August 10, 2020",Residual sera,Multiple groups,979,2.50%,1.44%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Tennessee,"November 24, 2020",Regional,United States of America,USA, Tennessee,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,1003,6.30%,4.41%,8.25%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Washington,"November 24, 2020",Regional,United States of America,USA,Washington,,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,684,2.10%,0.81%,3.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Virginia,"November 24, 2020",Regional,United States of America,USA, Virginia,,"July 31, 2020","August 11, 2020",Residual sera,Multiple groups,730,4.10%,1.80%,6.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Georgia,"November 24, 2020",Regional,United States of America,USA,Georgia,,"August 2, 2020","August 11, 2020",Residual sera,Multiple groups,985,6.80%,4.83%,8.81%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_RhodeIsland,"November 24, 2020",Regional,United States of America,USA, Rhode Island,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,684,3.00%,1.23%,5.51%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Illinois,"November 24, 2020",Regional,United States of America,USA,Illinois,,"July 29, 2020","August 10, 2020",Residual sera,Multiple groups,1004,3.90%,2.52%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_NorthDakota,"November 24, 2020",Regional,United States of America,USA, North Dakota,,"July 29, 2020","August 12, 2020",Residual sera,Multiple groups,121,7.30%,1.30%,14.28%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Arkansas,"November 24, 2020",Regional,United States of America,USA,Arkansas,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,937,4.10%,2.74%,5.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Utah,"November 24, 2020",Regional,United States of America,USA, Utah,,"July 30, 2020","August 11, 2020",Residual sera,Multiple groups,880,3.20%,1.70%,5.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Ohio,"November 24, 2020",Regional,United States of America,USA, Ohio,,"July 29, 2020","August 11, 2020",Residual sera,Multiple groups,786,2.30%,1.11%,3.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_California,"November 24, 2020",Regional,United States of America,USA,California,,"July 30, 2020","August 5, 2020",Residual sera,Multiple groups,980,5.70%,4.05%,7.77%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Minnesota,"November 24, 2020",Regional,United States of America,USA, Minnesota,,"July 29, 2020","August 13, 2020",Residual sera,Multiple groups,879,3.50%,2.06%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_July/August1_Oregon,"November 24, 2020",Regional,United States of America,USA, Oregon,,"August 5, 2020","August 11, 2020",Residual sera,Multiple groups,658,2.30%,1.03%,3.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Connecticut,"November 24, 2020",Regional,United States of America,USA,Connecticut,,"September 9, 2020","September 14, 2020",Residual sera,Multiple groups,982,3.10%,2.06%,4.37%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Wisconsin,"November 24, 2020",Regional,United States of America,USA, Wisconsin,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,976,3.80%,2.20%,5.73%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NorthCarolina,"November 24, 2020",Regional,United States of America,USA, North Carolina,,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,925,6.80%,4.83%,8.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NewHampshire,"November 24, 2020",Regional,United States of America,USA, New Hampshire,,"September 9, 2020","September 17, 2020",Residual sera,Multiple groups,1034,0.70%,0.26%,1.32%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Ohio,"November 24, 2020",Regional,United States of America,USA, Ohio,,"September 10, 2020","September 22, 2020",Residual sera,Multiple groups,978,2.80%,1.69%,4.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_PuertoRico,"November 24, 2020",Regional,United States of America,USA,Puerto Rico,,"September 8, 2020","September 15, 2020",Residual sera,Multiple groups,970,3.00%,1.78%,4.27%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NorthDakota,"November 24, 2020",Regional,United States of America,USA, North Dakota,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,113,1.20%,0.00%,3.40%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Michigan,"November 24, 2020",Regional,United States of America,USA, Michigan,,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,980,3.70%,2.54%,4.93%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Minnesota,"November 24, 2020",Regional,United States of America,USA, Minnesota,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1033,8.00%,4.74%,11.43%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_SouthCarolina,"November 24, 2020",Regional,United States of America,USA, South Carolina,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,975,7.80%,5.58%,10.19%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Florida,"November 24, 2020",Regional,United States of America,USA,Florida,,"September 11, 2020","September 11, 2020",Residual sera,Multiple groups,979,8.50%,6.55%,10.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Washington D.C,"November 24, 2020",Regional,United States of America,USA,Washington D.C,,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,976,6.50%,4.47%,8.29%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_WestVirginia,"November 24, 2020",Regional,United States of America,USA, West Virginia,,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,1.30%,0.51%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NewMexico,"November 24, 2020",Regional,United States of America,USA, New Mexico,,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1014,2.40%,1.19%,3.65%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Arkansas,"November 24, 2020",Regional,United States of America,USA,Arkansas,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,990,6.30%,4.60%,8.03%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Nevada,"November 24, 2020",Regional,United States of America,USA, Nevada,,"September 9, 2020","September 12, 2020",Residual sera,Multiple groups,979,7.80%,5.90%,9.99%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NewYork,"November 24, 2020",Regional,United States of America,USA, New York,,"September 11, 2020","September 24, 2020",Residual sera,Multiple groups,1168,17.00%,14.72%,19.23%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Maryland,"November 24, 2020",Regional,United States of America,USA, Maryland,,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1242,10.20%,7.91%,12.68%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Colorado,"November 24, 2020",Regional,United States of America,USA,Colorado,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1032,3.30%,1.90%,4.92%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Oregon,"November 24, 2020",Regional,United States of America,USA, Oregon,,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,971,2.60%,1.51%,4.06%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Oklahoma,"November 24, 2020",Regional,United States of America,USA, Oklahoma,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,5.00%,3.44%,6.54%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Montana,"November 24, 2020",Regional,United States of America,USA, Montana,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,508,2.20%,0.67%,4.38%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Kansas,"November 24, 2020",Regional,United States of America,USA,Kansas,,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,1007,3.50%,2.31%,4.84%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Alabama,"November 24, 2020",Regional,United States of America,USA,Alabama,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,905,8.70%,6.19%,11.31%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Maine,"November 24, 2020",Regional,United States of America,USA, Maine,,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,987,0.50%,0.09%,0.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Georgia,"November 24, 2020",Regional,United States of America,USA,Georgia,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1100,13.00%,10.51%,15.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Massachusetts,"November 24, 2020",Regional,United States of America,USA, Massachusetts,,"September 9, 2020","September 15, 2020",Residual sera,Multiple groups,988,3.70%,2.23%,5.16%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Wyoming,"November 24, 2020",Regional,United States of America,USA, Wyoming,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,111,1.50%,0.00%,3.97%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Vermont,"November 24, 2020",Regional,United States of America,USA, Vermont,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,497,1.70%,0.27%,4.15%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Illinois,"November 24, 2020",Regional,United States of America,USA,Illinois,,"September 8, 2020","September 17, 2020",Residual sera,Multiple groups,992,4.50%,3.10%,6.07%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Nebraska,"November 24, 2020",Regional,United States of America,USA, Nebraska,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,976,6.70%,4.80%,8.88%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Arizona,"November 24, 2020",Regional,United States of America,USA,Arizona,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1208,5.40%,3.08%,8.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Texas,"November 24, 2020",Regional,United States of America,USA, Texas,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,988,8.20%,6.16%,10.47%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Louisiana,"November 24, 2020",Regional,United States of America,USA, Louisiana,,"September 9, 2020","September 19, 2020",Residual sera,Multiple groups,952,12.50%,10.02%,15.61%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_SouthDakota,"November 24, 2020",Regional,United States of America,USA, South Dakota,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,99,1.80%,0.00%,4.82%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Tennessee,"November 24, 2020",Regional,United States of America,USA, Tennessee,,"September 8, 2020","September 16, 2020",Residual sera,Multiple groups,1028,6.70%,4.96%,8.57%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Hawaii,"November 24, 2020",Regional,United States of America,USA,Hawaii,,"September 8, 2020","September 22, 2020",Residual sera,Multiple groups,516,0.80%,0.00%,2.18%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Indiana,"November 24, 2020",Regional,United States of America,USA,Indiana,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1155,4.00%,1.44%,8.79%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Utah,"November 24, 2020",Regional,United States of America,USA, Utah,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,1022,5.10%,3.29%,7.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_RhodeIsland,"November 24, 2020",Regional,United States of America,USA, Rhode Island,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,795,2.70%,1.15%,4.91%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Mississippi,"November 24, 2020",Regional,United States of America,USA, Mississippi,,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,980,7.90%,5.35%,10.87%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_California,"November 24, 2020",Regional,United States of America,USA,California,,"September 10, 2020","September 16, 2020",Residual sera,Multiple groups,979,4.90%,3.17%,6.85%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Virginia,"November 24, 2020",Regional,United States of America,USA, Virginia,,"September 10, 2020","September 23, 2020",Residual sera,Multiple groups,1111,3.20%,1.81%,5.13%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Iowa,"November 24, 2020",Regional,United States of America,USA,Iowa,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,977,7.60%,5.56%,10.02%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Idaho,"November 24, 2020",Regional,United States of America,USA,Idaho,,"September 8, 2020","September 18, 2020",Residual sera,Multiple groups,732,5.20%,2.74%,8.46%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Kentucky,"November 24, 2020",Regional,United States of America,USA, Kentucky,,"September 9, 2020","September 18, 2020",Residual sera,Multiple groups,980,3.60%,2.33%,5.21%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Delaware,"November 24, 2020",Regional,United States of America,USA,Delaware,,"September 9, 2020","September 24, 2020",Residual sera,Multiple groups,980,7.50%,4.89%,10.50%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Missouri,"November 24, 2020",Regional,United States of America,USA, Missouri,,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,1031,3.50%,2.15%,5.01%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_NewJersey,"November 24, 2020",Regional,United States of America,USA, New Jersey,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1050,15.10%,12.65%,17.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Pennsylvania,"November 24, 2020",Regional,United States of America,USA, Pennsylvania,,"September 9, 2020","September 23, 2020",Residual sera,Multiple groups,1341,11.10%,8.85%,13.71%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
201124_USA_CDC_September4_Washington,"November 24, 2020",Regional,United States of America,USA,Washington,,"September 9, 2020","September 22, 2020",Residual sera,Multiple groups,968,2.50%,1.29%,3.83%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Kristina Bajema,CDC COVID-19 Response,https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/21/2021,8/15/2023,Verified
210305_Chicago_NorthwesternUniversity_overall,"March 5, 2021",Local,United States of America,USA,Illinois,Chicago,"June 24, 2020","November 23, 2020",Household and community samples,Multiple groups,1667,18.70%,,,Stratified non-probability,NA,ELISA,IgG,,,Moderate,Preprint,Brian Mustanski,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.03.02.21252767v1,3/23/2021,7/17/2022,Verified
210120_LosAngelesCounty_CedarsSinaiMedicalCenter_overall_adj,"February 12, 2021",Local,United States of America,USA,,,"May 11, 2020","May 11, 2020",Health care workers and caregivers,Multiple groups,6062,4.10%,3.10%,5.70%,Convenience,Abbott Laboratories,CLIA,IgG,88.30%,,Moderate,Journal Article (Peer-Reviewed),Joseph Ebinger,Cedars-Sinai Medical Center,https://dx.doi.org/10.1136/bmjopen-2020-043584,3/23/2021,7/5/2023,Verified
210316_UnitedStates_ClinicalReferenceLaboratoryInc_OverallGenPop,"March 16, 2021",National,United States of America,USA,,,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,61910,6.60%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Robert Stout,Clinical Reference Laboratory Inc,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777502?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621,3/23/2021,3/2/2024,Verified
210205_UnitedStates_BrownUniversity,"February 5, 2021",National,United States of America,USA,Multiple states,,,"August 1, 2020",Assisted living and long-term care facilities,Seniors (65+ years),272,43.00%,,,Convenience,NA,Not reported,"IgG,IgM,Total Antibody",,,High,Journal Article (Peer-Reviewed),Elizabeth White,Brown University,http://dx.doi.org/10.1111/jgs.17061,3/23/2021,7/17/2022,Verified
210201_Indianapolis_IndianaUniversity_HCW_primary,"February 1, 2021",Local,United States of America,USA,Indiana,Indianapolis,"April 1, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),34,35.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/25/2021,7/17/2022,Verified
210201_Indianapolis_IndianaUniversity_HDpatients_primary,"February 1, 2021",Local,United States of America,USA,Indiana,Indianapolis,"April 1, 2020","June 24, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),14,36.00%,,,Convenience,"Abnova,NA",ELISA,"IgG,IgM",94.40%,98.50%,High,Journal Article (Peer-Reviewed),Jorge J Canas ,Indiana University,https://dx.doi.org/10.1016/j.kint.2020.11.014,3/25/2021,7/17/2022,Verified
210221_Iowa_UniversityofIowa,"February 21, 2021",Local,United States of America,USA,Iowa,,"May 1, 2020","September 22, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.80%,,,Sequential,"DiaSorin,Roche Diagnostics,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haley Steffen,University of Iowa,https://dx.doi.org/10.1055/s-0041-1723938,3/27/2021,3/2/2024,Verified
120301_RhodeIsland_CDC,"March 1, 2021",Regional,United States of America,USA,Rhode Island,,"July 17, 2020","August 28, 2020",Health care workers and caregivers,Multiple groups,9863,4.60%,4.20%,5.00%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Lara Akinbami,Centers for Disease Control,https://dx.doi.org/10.3201/eid2703.204508,3/28/2021,3/2/2024,Verified
210208_Chicago_NorthwesternUniversity_overall,"February 8, 2021",Local,United States of America,USA,Illinois,Chicago,"June 24, 2020","November 11, 2020",Household and community samples,Multiple groups,3365,17.80%,,,Self-referral,NA,ELISA,IgG,,,High,Preprint,Thomas McDade,Northwestern University,https://www.medrxiv.org/content/10.1101/2021.02.04.21251170v1,3/28/2021,7/17/2022,Verified
210215_USA_SpaceX_overall,"February 15, 2021",Local,United States of America,USA,Multiple,Multiple,"April 1, 2020","June 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),4300,2.80%,,,Convenience,NA,ELISA,IgG,99.50%,,Unclear,Journal Article (Peer-Reviewed),Yannic Bartsch,"Ragon Institute of MGH, MIT and Harvard",https://dx.doi.org/10.1038/s41467-021-21336-8,3/28/2021,7/17/2022,Verified
210226_Washington_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Washington,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7544,2.00%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,7/17/2022,Verified
210226_Florida_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Florida,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7787,4.80%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_NewYork_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,USA,New York,New York City,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7746,17.20%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Pennsylvania_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8657,4.30%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Missouri_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Missouri,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,9356,2.50%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Utah_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Utah,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8769,2.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_California_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Local,United States of America,USA,California,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,4980,1.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Connecticut_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Connecticut,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,8929,5.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Minnesota_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Minnesota,"Minneapolis, St. Paul, St. Cloud","March 23, 2020","August 14, 2020",Residual sera,Multiple groups,7944,4.90%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210226_Louisiana_CentersforDiseaseControlandPrevention_Overall,"February 26, 2021",Regional,United States of America,USA,Louisiana,,"March 23, 2020","August 14, 2020",Residual sera,Multiple groups,2849,7.70%,,,Stratified probability,NA,ELISA,Total Antibody,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Travis Lim,Centers for Disease and Control ,https://dx.doi.org/10.1093/cid/ciab185,3/28/2021,2/2/2024,Verified
210204_OrangeCounty_UniversityofCaliforniaIrvine_Overall_PopTestAdj,"February 4, 2021",Local,United States of America,USA,California,,"July 10, 2020","August 16, 2020",Household and community samples,Multiple groups,2979,11.30%,8.10%,13.20%,Stratified probability,NA,IFA,"IgG,IgM",94.00%,100.00%,Low,Journal Article (Peer-Reviewed),Tim Bruckner,University of California Irvine,https://dx.doi.org/10.1038/s41598-021-82662-x,3/28/2021,7/17/2022,Verified
210222_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,"February 22, 2021",Local,United States of America,USA,California,,"April 3, 2020","April 4, 2020",Household and community samples,Multiple groups,3328,2.76%,1.32%,4.22%,Stratified non-probability,Premier Biotech,LFIA,"IgG,IgM",85.56%,99.53%,High,Journal Article (Peer-Reviewed),Eran Bendavid,Stanford University School of Medicine,https://dx.doi.org/10.1093/ije/dyab010,3/28/2021,7/5/2023,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_HCW,"January 17, 2021",Local,United States of America,USA,California,,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),2754,2.76%,2.18%,3.44%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,3/29/2021,7/5/2023,Verified
210117_OrangeCounty_HoagMemorialHospitalPresbyterian_First_responders,"January 17, 2021",Local,United States of America,USA,California,,"July 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),92,4.35%,1.20%,10.76%,Convenience,Ortho Clinical Diagnostics Inc.,Not reported,IgG,93.60%,100.00%,High,Journal Article (Peer-Reviewed),Michael Brant Zawadzki,Hoag Memorial Hospital Presbyterian,https://dx.doi.org/10.1093/ofid/ofab015,3/29/2021,7/5/2023,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_Undergrad_Primary,"March 9, 2021",Local,United States of America,USA,Massachusetts ,Amherst,"July 15, 2020","August 15, 2020",Multiple populations,Multiple groups,779,5.30%,3.10%,7.50%,Stratified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/30/2021,7/17/2022,Verified
210309_Massachusetts_UniversityofMassachusetts-Amherst_LocalPop_Primary,"March 9, 2021",Local,United States of America,USA,Massachusetts ,Amherst,"July 15, 2020","August 15, 2020",Non-essential workers and unemployed persons,Multiple groups,292,4.00%,1.60%,6.50%,Simplified probability,NA,ELISA,IgG,,,High,Preprint,Teah Snyder,University of Massachusetts-Amherst,https://www.medrxiv.org/content/10.1101/2021.03.05.21249174v2.full.pdf,3/30/2021,7/17/2022,Verified
210312_Cincinnati_UniversityOfCincinnati_overall,"March 12, 2021",Local,United States of America,USA,Ohio,Greater Cincinnati Metropolitan Area,"August 13, 2020","December 8, 2020",Blood donors,Multiple groups,9550,8.40%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Greg Davis,University of Cincinnati,10.1101/2021.03.11.21253263,4/1/2021,7/17/2022,Verified
210218_RhodeIsland_BrownUniversity_overall_adj,"February 18, 2021",Regional,United States of America,USA,Rhode Island,,"May 5, 2020","May 22, 2020",Household and community samples,Multiple groups,1032,2.90%,1.00%,6.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,88.40%,99.60%,Low,Journal Article (Peer-Reviewed),Philip A Chan,Brown University,https://dx.doi.org/10.2105/AJPH.2020.306115,4/2/2021,8/15/2023,Verified
210321_NewYork_WeillCornellMedicine_Pediatrics,"March 22, 2021",Local,United States of America,USA,New York ,New York City ,"April 9, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),1194,16.50%,14.40%,18.70%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/4/2021,7/17/2022,Verified
210321_NewYork_WeillCornellMedicine_Adults,"March 22, 2021",Local,United States of America,USA,New York ,New York City ,"April 9, 2020","August 31, 2020",Residual sera,Multiple groups,30232,18.60%,18.20%,19.10%,Sequential,ET Healthcare,Other,IgG,,,High,Journal Article (Peer-Reviewed),He Yang,NewYork–Presbyterian Hospital/Weill Cornell Medical Center,https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743,4/4/2021,7/17/2022,Verified
210116_Philadelphia_UniversityofPennsylvania_Overall,"January 16, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"May 21, 2020","October 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,124,1.60%,,,Sequential,NA,ELISA,"IgG,IgM",,,High,Preprint,Lova Sun,University of Pennsylvania,https://dx.doi.org/10.1101/2021.01.15.21249810,4/6/2021,7/17/2022,Verified
200901_Seattle_FredHutchinsonCancerResearchCenter_Overall,"September 1, 2020",Local,United States of America,USA,Washington,Seattle,"March 3, 2020","April 24, 2020",Residual sera,Children and Youth (0-17 years),1076,0.93%,,,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Adam S Dingens,Fred Hutchinson Cancer Research Center,https://www.nature.com/articles/s41467-020-18178-1,4/9/2021,3/2/2024,Verified
2010330_Bolinas_UniversityofCalifornia_Abbott+ELISA,"October 30, 2020",Local,United States of America,USA,California,Bolinas,"April 20, 2020","April 24, 2020",Household and community samples,Multiple groups,1880,0.05%,,,Self-referral,"Abbott Laboratories,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ayesha Appa,University of California San Francisco,http://dx.doi.org/10.1093/ofid/ofaa531,4/9/2021,3/2/2024,Verified
210224_USA_NationalInstitutesofHealth_primary,"February 24, 2021",National,United States of America,USA,,,"January 1, 2020","August 26, 2020",Residual sera,Multiple groups,3257478,11.60%,,,Convenience,NA,Not reported,"IgG,IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Raymond Harvey,National Institutes of Health,https://dx.doi.org/10.1001/jamainternmed.2021.0366,4/10/2021,7/17/2022,Verified
210312_Atlanta_EmoryUniversitySchoolOfMedicine_Overall,"March 12, 2021",Local,United States of America,USA,Georgia,Atlanta,"April 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),642,4.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Claudia Morris,Emory University School of Medicine,https://dx.doi.org/10.1016/j.ijid.2021.03.017,4/10/2021,7/17/2022,Verified
210302_NewYork_RenaissanceStonyBrookSchoolofMedicine,"March 2, 2021",Local,United States of America,USA,New York,,"April 2, 2020","April 18, 2020",Health care workers and caregivers,Adults (18-64 years),474,16.90%,13.60%,20.60%,Convenience,ChemBio Diagnostics Inc.,Not reported,"IgG,IgM",84.30%,88.90%,High,Journal Article (Peer-Reviewed),Lilian Talbot,Renaissance Stony Brook School of Medicine,https://dx.doi.org/10.1186/s13741-021-00177-5,4/16/2021,3/2/2024,Verified
210311_USA_IgenomixUSAandCanada_Overall,"March 11, 2021",National,United States of America,USA,"Utah, Massachuetts",Boston,"June 18, 2020","July 30, 2020",Multiple populations,Adults (18-64 years),337,1.48%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Russel Foulk,Igenomix USA and Canada,https://dx.doi.org/10.1016/j.ajog.2021.03.008,4/17/2021,3/2/2024,Verified
210317_Boston_HarvardMedicalSchool_Primary,"March 17, 2021",Local,United States of America,USA,Massachusetts,Boston,"June 16, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),433,11.30%,,,Self-referral,NA,ELISA,"IgG,IgM",80.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Lou Ann Bruno-Murtha,"Harvard Medical School
",https://dx.doi.org/10.1080/20477724.2021.1901041,4/18/2021,7/17/2022,Verified
201217_UnitedStates_UniversityofIowa,"December 17, 2020",National,United States of America,USA,,,"May 13, 2020","July 8, 2020",Health care workers and caregivers,Multiple groups,1606,1.74%,,,Stratified non-probability,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nicholas M Mohr,University of Iowa,http://dx.doi.org/10.1016/j.annemergmed.2020.12.007,4/19/2021,3/2/2024,Verified
201125_Washington_GeorgeWashingtonUniversity_hcw,"February 1, 2021",Local,United States of America,USA,District of Columbia,Washington ,"May 26, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),138,5.07%,,,Convenience,"Biolidics Ltd,NA",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eric Murakami,George Washington University,https://pubmed.ncbi.nlm.nih.gov/33340874/,4/19/2021,3/2/2024,Verified
210111_Burlington_UniversityOfVermont_overall,"January 11, 2021",Local,United States of America,USA,Vermont,Burlington,"June 25, 2020","June 28, 2020",Household and community samples,Multiple groups,454,2.20%,0.80%,3.60%,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eline M van den Broek Altenburg,University of Vermont,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800904/,4/22/2021,7/17/2022,Verified
210305_Mississippi_CDCCOVID-19ResponseTeam_Overall,"March 5, 2021",Regional,United States of America,USA,Mississippi,,"May 17, 2020","September 19, 2020",Residual sera,Children and Youth (0-17 years),1603,10.90%,9.40%,12.40%,Sequential,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Charlotte Hobbs,CDC COVID-19 Response Team,https://dx.doi.org/10.15585/mmwr.mm7009a4,4/23/2021,3/2/2024,Unverified
210312_NorthCarolina_WakeForestBaptistHealth,"March 12, 2021",Regional,United States of America,USA,North Carolina,,"April 16, 2020","December 20, 2020",Household and community samples,Adults (18-64 years),17688,32.60%,28.40%,35.00%,Stratified non-probability,"Syntron Bioresearch Inc. ,Innovita Biological Technology Co. Ltd",LFIA,"IgM,IgG",,,Moderate,Preprint,John Williamson,Wake Forest Baptist Health,https://www.medrxiv.org/content/10.1101/2021.03.11.21253226v1,4/23/2021,3/2/2024,Verified
210303_MontereyCounty_UniversityofCaliforniaBerkeley_Overall,"March 3, 2021",Local,United States of America,USA,California,,"July 16, 2020","November 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Joseph Lewnard,"University of California, Berkeley",https://dx.doi.org/10.3201/eid2705.204949,4/23/2021,7/17/2022,Verified
210305_Illinois-Wisconsin_AdvocateAuroraHealth,"March 5, 2021",Regional,United States of America,USA,"Illinois, Wisconsin (Midwest)",,"June 8, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,16233,3.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Veronica Fitzpatrick,Advocate Aurora Health,https://dx.doi.org/10.1177/0033354921999168,4/30/2021,3/2/2024,Unverified
210310_UnitedStatesofAmerica_EmoryUniversity,"March 10, 2021",Regional,United States of America,USA,"Georgia, Maryland, Illinois","Atlanta, Baltimore, Chicago","April 19, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),24749,4.40%,4.10%,4.60%,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jesse Jacob,Emory University,https://dx.doi.org/10.1001/jamanetworkopen.2021.1283,4/30/2021,3/2/2024,Unverified
210225_Florida_FloridaDepartmentOfHealth_overall,"April 12, 2021",Regional,United States of America,USA,Florida,,"May 6, 2020","June 3, 2020",Health care workers and caregivers,Multiple groups,5776,4.10%,2.60%,8.20%,Convenience,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,Moderate,Journal Article (Peer-Reviewed),James Matthias,Florida Department of Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040388/,5/3/2021,3/2/2024,Verified
210405_California_StanfordUniversitySchoolofMedicine_overall,"May 6, 2021",Local,United States of America,USA,California,,"June 15, 2020","August 15, 2020",Essential non-healthcare workers,Adults (18-64 years),983,2.54%,1.65%,3.73%,Convenience,"Abbott Laboratories,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jennifer Newberry,Stanford University,http://dx.doi.org/10.1080/10903127.2021.1912227,5/3/2021,3/2/2024,Verified
211231_Denver_DenverPublicHealth,"December 20, 2020",Local,United States of America,USA,Colorado,Denver,"June 2, 2020","July 28, 2020",Persons experiencing homelessness,Adults (18-64 years),334,16.72%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),David McCormick,Denver Public Health,http://dx.doi.org/10.1093/ofid/ofaa515.1909,5/3/2021,7/17/2022,Verified
201204_SantaClara_O’ConnorHospital_Overall,"December 4, 2020",Local,United States of America,USA,California,San Jose,"May 6, 2020","May 6, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,24,0.00%,,,Convenience,Diazyme Laboratories Inc,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Brian D McBeth,O'Connor Hospital,https://dx.doi.org/10.1177/1757177420976814,5/4/2021,3/2/2024,Unverified
200501_SanMiguelCounty_UnitedBiomedical_overall,"May 1, 2020",Local,United States of America,USA,Colorado,,"March 26, 2020","April 15, 2020",Household and community samples,Multiple groups,5283,0.53%,,,Entire sample,NA,Not reported,IgG,,,Moderate,Institutional Report,San Miguel County,United Biomedical Group,https://www.sanmiguelcountyco.gov/DocumentCenter/View/5717/San-Miguel-County-IgG-Antibody-Test-Statistics-and-Demographics-PDF,5/5/2021,7/17/2022,Verified
201231_WestVirginia_WestVirginiaUniversityMedicine_HCW,"December 31, 2020",Local,United States of America,USA,West Virginia,Morgantown,"May 26, 2020","June 5, 2020",Health care workers and caregivers,Adults (18-64 years),1042,0.86%,,,Simplified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Joy J Juskowich,West Virginia University Medicine,http://dx.doi.org/10.1093/ofid/ofaa439.694,5/6/2021,7/17/2022,Verified
201231_SanDiego_UniversityofCaliforniaSanDiegoHealth_HCW,"December 31, 2020",Local,United States of America,USA,California,San Diego,"April 22, 2020","June 2, 2020",Health care workers and caregivers,Adults (18-64 years),5589,1.02%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lucy E Horton,University of California San Diego Health,http://dx.doi.org/10.1093/ofid/ofaa439.630,5/6/2021,7/17/2022,Verified
200831_KingCounty_UniversityOfWashington_overall,"August 31, 2020",Local,United States of America,USA,Washington,,"August 8, 2020","August 29, 2020",Household and community samples,Multiple groups,1364,3.90%,2.40%,6.00%,Stratified probability,"Bio-rad,EUROIMMUN",ELISA,"IgG,IgM,IgA",82.94%,100.00%,Moderate,Institutional Report,Karen Cowgill,University of Washington,https://www.kingcounty.gov/depts/health/covid-19/data/~/media/depts/health/communicable-diseases/documents/C19/serosurvey-report-covid19.ashx https://kingcounty.gov/depts/health/covid-19/seroprevalence.aspx https://www.kingcounty.gov/depts/health/covid-19/seroprevalence-study.aspx page 9: http://www.co.cowlitz.wa.us/DocumentCenter/View/20793/8122020-Cowlitz-County-COVID-update-to-Board-of-County-Commissioners,5/6/2021,8/15/2023,Verified
201231_LosAngeles_UniversityofCaliforniaLosAngeles,"December 31, 2020",Local,United States of America,USA,California,Los Angeles,"June 1, 2020","June 15, 2020",Assisted living and long-term care facilities,Adults (18-64 years),121,1.65%,,,Convenience,DiaSorin,Not reported,IgG,,,High,Presentation or Conference,Debika Bhattacharya,University of California Los Angeles,https://academic.oup.com/ofid/article/7/Supplement_1/S165/6058251,5/6/2021,3/2/2024,Unverified
201231_Charleston_MedicalUniversityofSouthCarolina,"December 31, 2020",Local,United States of America,USA,South Carolina ,Charleston,"April 14, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),439,1.37%,,,Convenience,RayBiotech,LFIA,IgG,76.00%,95.00%,High,Presentation or Conference,Eric G Meissner,Medical University of South Carolina,http://dx.doi.org/10.1093/ofid/ofaa439.653,5/8/2021,3/2/2024,Unverified
210312_UnitedStatesOlympicandParalympicTrainingfacilities_MassachusettsGeneralHospital,"March 12, 2021",National,United States of America,USA,Colorado,Colorado Springs,"July 1, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),301,3.65%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Ankit B Shah,Massachusetts General Hospital,https://dx.doi.org/10.1177/19417381211002761,5/9/2021,7/17/2022,Unverified
210309_HarrisCounty_HarrisCountyPublicHealth_genpop,"March 9, 2021",Local,United States of America,USA,Texas,,"November 15, 2020","December 15, 2020",Household and community samples,Multiple groups,646,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Harris County Public Health,Harris County Public Health,https://publichealth.harriscountytx.gov/Portals/27/Documents/HCPH%20Antibody%20Results%20NR.pdf?ver=ZkoB5qeX0P1G--8gfGH8fg%3d%3d,5/10/2021,7/17/2022,Verified
201225_Seattle_UniversityofWashington_GenPop_ELISA+Neutralizaion,"December 25, 2020",Local,United States of America,USA,Washington,Seattle,"March 26, 2020","April 15, 2020",Household and community samples,Multiple groups,100,4.00%,,,Simplified probability,"NA,Abbott Laboratories",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jennifer Rathe,University of Washington,http://dx.doi.org/10.1093/infdis/jiaa797,5/18/2021,3/2/2024,Verified
210427_NewYorkCity_AlbertEinsteinCollegeofMedicine,"April 27, 2021",Local,United States of America,USA,New York state,New York City,"June 1, 2020","August 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,232,13.36%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Snehal R Patel,Albert Einstein College of Medicine,https://onlinelibrary.wiley.com/doi/10.1111/ctr.14329,5/18/2021,7/17/2022,Unverified
210315_NewYork_DiaSorinInc_overall_unadj,"March 15, 2021",Regional,United States of America,USA,New York,,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,1491,24.40%,,,Sequential,"Siemens,DiaSorin",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,5/18/2021,3/2/2024,Verified
210315_NewMexico_DiaSorinInc_overall_unadj,"March 15, 2021",Regional,United States of America,USA,New Mexico,,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,1931,1.97%,,,Sequential,"DiaSorin,Beckman Coulter",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Fabrizio Bonelli,Dia Sorin Inc,http://dx.doi.org/10.1515/cclm-2021-0023,5/18/2021,3/2/2024,Verified
210104_Louisville_UniversityOfLouisville,"January 4, 2021",Regional,United States of America,USA,Kentucky,Louisville,"December 10, 2020","December 14, 2020",Household and community samples,Multiple groups,700,11.16%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Betty Coffman,University of Louisville,https://www.uoflnews.com/post/uofltoday/covid-19-rates-continue-to-increase-with-highest-rates-among-18-34-year-olds/,5/18/2021,7/17/2022,Unverified
210401_Colorado_AnschutzMedicalCampus_primary,"April 1, 2021",Local,United States of America,USA,Colorado,Aurora,"July 1, 2020","August 31, 2020",Essential non-healthcare workers,Adults (18-64 years),264,4.20%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan S Schultz,Anschutz Medical Campus,https://dx.doi.org/10.1128/JCM.00290-21,5/19/2021,7/17/2022,Verified
210429_SanFrancisco_UniversityOfCaliforniaSanFrancisco_HIV1_TestAdj,"April 29, 2021",Local,United States of America,USA,California,San Francisco,"August 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,955,3.70%,2.40%,5.00%,Sequential,ET Healthcare,Other,IgG,89.00%,100.00%,High,Journal Article (Peer-Reviewed),Matthew A Spinelli,University of California San Francisco,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(21)00072-2/fulltext,5/19/2021,7/17/2022,Unverified
210315_SanFranciscoBayArea_StanfordUniversity_overall_unadj,"March 15, 2021",Local,United States of America,USA,California,,"August 3, 2020","August 15, 2020",Residual sera,Multiple groups,1080,10.65%,,,Convenience,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Wang,Stanford University ,https://dx.doi.org/10.1093/clinchem/hvab045,5/20/2021,3/2/2024,Verified
210519_Rochester_MayoClinic_primary,"April 5, 2021",Local,United States of America,USA,Minesota,Rochester,"May 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1339,1.90%,,,Convenience,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elizabeth B Habermann,Mayo Clinic,https://dx.doi.org/10.1017/ice.2021.38,5/20/2021,3/2/2024,Verified
210422_Orlando_JohnsHopkinsUniversity,"April 22, 2021",Local,United States of America,USA,Florida,Orlando,"June 11, 2020","October 19, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),3648,0.90%,,,Convenience,"Siemens,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Christina Mack,Johns Hopkins University School of Medicine,https://dx.doi.org/10.1001/jamainternmed.2021.2114,5/20/2021,3/2/2024,Verified
210413_NewOrleans_OchsnerClinicFoundation_HospitalStaff,"April 13, 2021",Local,United States of America,USA,Louisiana,New Orleans,"April 22, 2020","May 1, 2020",Health care workers and caregivers,Adults (18-64 years),13343,8.00%,7.50%,8.50%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,5/20/2021,3/2/2024,Unverified
210413_NewOrleans_OchsnerClinicFoundation_Surgeons,"April 13, 2021",Local,United States of America,USA,Louisiana,New Orleans,"March 1, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),105,1.90%,0.20%,6.70%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tung Vu,Ochsner Clinic Foundation,https://journals.sagepub.com/doi/10.1177/00031348211011090,5/20/2021,3/2/2024,Unverified
210419_Milwakee_UniversityOfWisconsin,"April 19, 2021",Local,United States of America,USA,Wisconsin,Milwaukee,"June 15, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),43,7.00%,2.00%,20.00%,Convenience,Abbott Laboratories,CLIA,IgG,,99.20%,High,Journal Article (Peer-Reviewed),Renuka Jain,University of Wisconsin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060043/,5/20/2021,3/2/2024,Verified
210309_Texas_UTSouthwesternMedicalCenter_Tarrant_overall_unadj,"March 9, 2021",Local,United States of America,USA,,,"August 15, 2020","February 15, 2021",Household and community samples,Multiple groups,5697,8.50%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/21/2021,7/17/2022,Verified
210309_Texas_UTSouthwesternMedicalCenter_Employees_overall_unadj,"March 9, 2021",Local,United States of America,USA,,,"August 15, 2020","February 15, 2021",Essential non-healthcare workers,Multiple groups,4098,5.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/21/2021,7/17/2022,Verified
210309_Texas_UTSouthwesternMedicalCenter_Dallas_overall_unadj,"March 9, 2021",Local,United States of America,USA,,,"August 15, 2020","February 15, 2021",Household and community samples,Multiple groups,11580,7.20%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,UT Southwestern Medical Center,UT Southwestern Medical Center ,https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/documents/DFWCPS_Update_03.09.21_FINAL.pdf,5/21/2021,7/17/2022,Verified
201202_Utah_UniversityofUtah_Phase1BWashington_TestAdj,"December 2, 2020",Local,United States of America,USA,Utah,NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1594,0.51%,0.00%,1.59%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/21/2021,7/17/2022,Unverified
201202_Utah_UniversityofUtah_Phase1BCache_TestAdj,"December 2, 2020",Local,United States of America,USA,Utah,NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1622,2.31%,0.68%,5.71%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/21/2021,7/17/2022,Unverified
201202_Utah_UniversityofUtah_Phase1BWeber_TestAdj,"December 2, 2020",Local,United States of America,USA,Utah,NR,"May 1, 2020","July 1, 2020",Household and community samples,Multiple groups,1211,1.39%,0.27%,3.66%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/21/2021,7/17/2022,Unverified
201202_Utah_UniversityofUtah_Phase2Prelim_TestAdj,"December 2, 2020",Local,United States of America,USA,Utah,NR,"July 7, 2020","August 15, 2020",Household and community samples,Multiple groups,1622,2.81%,1.00%,6.36%,Simplified probability,NA,Not reported,Not reported,83.00%,99.60%,Moderate,Institutional Report,University of Utah,University of Utah,https://issuu.com/ecclesschool/docs/utah_hero_report_11.24.20_gardner_at_front,5/21/2021,7/17/2022,Unverified
210429_Phoenix_VincereCancerCenter_October_IgG_Unadj,"April 29, 2021",Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,"October 10, 2020","October 16, 2020",Household and community samples,Multiple groups,1635,8.74%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,3/2/2024,Verified
210429_Phoenix_VincereCancerCenter_November_IgG_Unadj,"April 29, 2021",Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,"November 7, 2020","November 13, 2020",Household and community samples,Multiple groups,2037,16.65%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,3/2/2024,Verified
210429_Phoenix_VincereCancerCenter_December_IgG_Unadj,"April 29, 2021",Regional,United States of America,USA,Arizona,Phoenix Metropolitan Area,"December 5, 2020","December 11, 2020",Household and community samples,Multiple groups,3038,16.50%,,,Self-referral,Assure Tech. (Hangzhou) Co. Ltd,LFIA,IgG,100.00%,98.80%,High,Journal Article (Peer-Reviewed),Christine Lau,"Vincere Cancer Center,",https://dx.doi.org/10.1007/s10900-021-00991-4,5/21/2021,3/2/2024,Verified
210112_PlacerCounty_StanfordUniversity,"January 12, 2021",Local,United States of America,USA,California,,"November 1, 2020","November 30, 2020",Household and community samples,Multiple groups,810,2.34%,,,Simplified probability,NA,LFIA,Not reported,,,High,Institutional Report,Julie Parsonnet,Stanford University,https://www.placer.ca.gov/DocumentCenter/View/49523/2021-011221-PowerPoint-Item-02A,5/22/2021,7/17/2022,Verified
210415_KentCounty_UniversityofMichigan_S1,"April 15, 2021",Local,United States of America,USA,Michigan,NR,"August 17, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),1385,1.90%,1.20%,2.60%,Convenience,"Siemens,BioMérieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,5/22/2021,3/2/2024,Verified
210415_KentCounty_UniversityofMichigan_S2,"April 15, 2021",Local,United States of America,USA,Michigan,NR,"December 2, 2020","December 23, 2020",Health care workers and caregivers,Adults (18-64 years),1445,13.70%,11.90%,15.50%,Convenience,"Siemens,BioMérieux",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jeffrey Fletcher,University of Michigan,https://dx.doi.org/10.1017/ice.2021.167,5/22/2021,3/2/2024,Verified
210409_NewYorkCity_NYCdepthealth_overall,"April 9, 2021",Local,United States of America,USA,New York,New York,"May 13, 2020","July 21, 2020",Household and community samples,Multiple groups,45367,23.60%,23.20%,24.00%,Convenience,DiaSorin,CLIA,IgG,97.60%,99.30%,Moderate,Journal Article (Peer-Reviewed),Preeti Pathela,New York City Department of Health and Mental Hygiene,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab200/6219118,5/23/2021,3/2/2024,Verified
210412_NewYork_CityUniversityofNewYork_Primary,"April 12, 2021",Regional,United States of America,USA,New York ,"New York City
Bronx
Brooklyn
Long Island
Manhatten
Metro North
Queens
Staten Island","March 8, 2020","January 1, 2021",Household and community samples,Multiple groups,693205,21.60%,21.50%,21.70%,Sequential,NA,Not reported,IgG,,,High,Preprint,Madhura S Rane,City University of New York,https://www.medrxiv.org/content/10.1101/2021.04.06.21255009v3,5/23/2021,7/17/2022,Verified
210317_NewYorkCity_IcahnSchoolOfMedicine,"March 17, 2021",Local,United States of America,USA,New York,Mount Sinai,"May 26, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,383,10.44%,,,Convenience,NA,Not reported,Not reported,,,High,Preprint,Serre Yu Wong,Icahn School Of Medicine,https://www.medrxiv.org/content/10.1101/2021.03.15.21253615v1,5/23/2021,7/17/2022,Verified
210428_NewYorkCity_NewYorkBloodCenter_Ortho+Neut,"April 28, 2021",Local,United States of America,USA,New York,New York City,"June 15, 2020","July 15, 2020",Blood donors,Multiple groups,1000,9.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Daniel Jin,New York Blood Centre,https://dx.doi.org/10.1371/journal.pone.0250319,5/24/2021,3/2/2024,Verified
210415_ParrisIsland_IchanSchoolofMedicine,"April 15, 2021",Local,United States of America,USA,South Carolina,Port Royal,"May 11, 2020","November 2, 2020",Essential non-healthcare workers,Adults (18-64 years),3076,7.30%,,,Convenience,NA,ELISA,IgG,,100.00%,High,Journal Article (Peer-Reviewed),Andrew G Letizia,Icahn School of Medicine at Mount Sinai,https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext,5/24/2021,7/17/2022,Verified
210422_Illinois+Wisconsin_AdvocateAuroraHealth_Overall,"April 22, 2021",Regional,United States of America,USA,"Illinois, Wisconsin",,"June 8, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,14921,3.59%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Fitzpatrick Veronica,Advocate Aurora Health,https://dx.doi.org/10.1016/j.annepidem.2021.04.005,5/26/2021,3/2/2024,Verified
210501_UnitedStates_MayoClinic,"March 26, 2021",Regional,United States of America,USA,"Minnesota, Wisconsin, Florida, Arizona, Iowa",Rochester,"June 15, 2020","August 8, 2020",Health care workers and caregivers,Multiple groups,29606,0.60%,0.52%,0.69%,Convenience,"EUROIMMUN,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Rickey Carter,The Mayo Clinic,https://dx.doi.org/10.1016/j.mayocp.2021.03.015,5/26/2021,3/2/2024,Verified
210420_NewYorkCity_BronxCareHealthSystem,"April 20, 2021",Local,United States of America,USA,New York State,New York City,"May 18, 2020","June 26, 2020",Health care workers and caregivers,Multiple groups,2749,30.20%,29.00%,32.00%,Convenience,Roche Diagnostics,Not reported,Not reported,97.10%,100.00%,High,Journal Article (Peer-Reviewed), Murli U Purswani,BronxCare Health System,https://dx.doi.org/10.12788/jhm.3627,5/27/2021,3/2/2024,Unverified
201205_Maryland_MarylandDepartmentOfHealth_overall,"December 15, 2020",Regional,United States of America,USA,Maryland,,"May 24, 2020","June 30, 2020",Residual sera,Multiple groups,500,10.00%,,,Sequential,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",95.00%,100.00%,High,Journal Article (Peer-Reviewed),Keri N Althoff,The Maryland Department of Health,https://dx.doi.org/10.1093/ofid/ofaa611,5/28/2021,3/2/2024,Unverified
210506_Boston_BostonMedicalCenter_Overall,"May 6, 2021",Local,United States of America,USA,Massachusetts,Boston,"July 13, 2020","July 26, 2020",Health care workers and caregivers,Multiple groups,1743,5.45%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yachana Kataria,Boston Medical Center,https://dx.doi.org/10.1038/s41598-021-89107-5,5/28/2021,3/2/2024,Verified
210427_Connecticut_HartfordHealthcare_overall,"April 27, 2021",Regional,United States of America,USA,Connecticut,Hartford,"May 11, 2020","August 16, 2020",Health care workers and caregivers,Multiple groups,6863,6.30%,5.70%,6.90%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Pavlos Papasavas,Hartford Healthcare,https://dx.doi.org/10.1016/j.jhin.2021.04.021,5/28/2021,3/2/2024,Verified
210508_NorthCarolina_FirstHealthoftheCarolinas_Overall,"May 8, 2021",Regional,United States of America,USA,North Carolina,,"June 10, 2020","July 17, 2020",Health care workers and caregivers,Multiple groups,2076,3.00%,1.90%,3.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),GS Arnoczy,FirstHealth of the Carolinas,https://dx.doi.org/10.1016/j.ajic.2021.04.086,5/28/2021,3/2/2024,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_Dallas1,"April 13, 2021",Local,United States of America,USA,Texas,Dallas,"March 1, 2020","March 31, 2021",Residual sera,Multiple groups,2533,38.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,5/30/2021,3/2/2024,Unverified
210413_Texas_UniversityOfTexasSouthwesternMedicalCenter_DallasFortWorth2,"April 13, 2021",Local,United States of America,USA,Texas,Dallas-Fort Worth,"June 1, 2020","February 28, 2021",Residual sera,Multiple groups,21101,7.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Madhusudhanan Narasimhan ,University of Texas Southwestern Medical Center,https://dx.doi.org/10.3390/vaccines9040376,5/30/2021,3/2/2024,Unverified
210430_Baltimore_JohnsHopkinsUniversity_Overall,"April 30, 2021",Local,United States of America,USA,Maryland,Baltimore,"March 16, 2020","May 31, 2020",Residual sera,Multiple groups,3255,3.50%,2.90%,4.20%,Sequential,"Hangzhou Biotest Biotech Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM",84.00%,100.00%,High,Journal Article (Peer-Reviewed),Oliver Laeyendecker,Johns Hopkins University ,https://dx.doi.org/10.1016/j.ajem.2021.04.081,6/2/2021,3/2/2024,Verified
210519_UnitedStates_QuestDiagnostics,"May 19, 2021",National,United States of America,USA,,,"August 15, 2020","November 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),18148,5.00%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Yonghong Li,Quest Diagnostics,https://dx.doi.org/10.1001/jamanetworkopen.2021.11634,6/4/2021,3/2/2024,Verified
210430_UnitedStates_MedicalUniversityofSouthCarolina,"April 30, 2021",Regional,United States of America,USA,"South Carolina, North Carolina, Georgia",,"May 15, 2020","July 15, 2020",Blood donors,Multiple groups,60835,2.60%,,,Sequential,"GenScript,NA",Multiple Types,"IgG,Neutralizing ,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Connor Dwyer,Medical University of South Carolina,https://dx.doi.org/10.1016/j.isci.2021.102489,6/4/2021,3/2/2024,Verified
210316_MetropolitanDetroit_HenryFordHealthSystem,"March 16, 2021",Local,United States of America,USA,Michigan,Detroit,"June 17, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),374,2.41%,1.27%,4.51%,Simplified probability,Beckman Coulter,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christine C Johnson,Henry Ford Health System,https://dx.doi.org/10.1016/j.jcv.2021.104794,6/4/2021,3/2/2024,Unverified
210525_UnitedStates_RutgersUniversity_Primary,"May 25, 2021",National,United States of America,USA,,,"May 7, 2020","July 31, 2020",Household and community samples,Multiple groups,124,36.30%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Richard Martino,Rutgers University,https://dx.doi.org/10.1177/00333549211018190,6/5/2021,7/17/2022,Verified
210601_Providence_BrownUniversity,"June 1, 2021",Local,United States of America,USA,Rhode Island,Providence,"June 8, 2020","June 23, 2020",Health care workers and caregivers,Adults (18-64 years),101,2.90%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Matthew Murphy,Brown University,http://rimed.org/rimedicaljournal/2021/06/2021-06-20-contribution-murphy.pdf,6/5/2021,3/2/2024,Verified
210504_Texas_UniversityofTexasSouthwestern,"May 4, 2021",Local,United States of America,USA,Texas,Dallas,"June 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),549,3.28%,,,Self-referral,Abbott Laboratories,Not reported,IgG,,,High,Presentation or Conference,Gilberto Salazar,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249,6/5/2021,3/2/2024,Verified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Staff2,"May 24, 2021",Regional,United States of America,USA,California,,"August 18, 2020","September 24, 2020",Health care workers and caregivers,Multiple groups,856,40.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,6/7/2021,3/2/2024,Unverified
210524_LosAngelesCounty_LosAngelesCountyDepartmentofPublicHealth_Residents1,"May 24, 2021",Regional,United States of America,USA,California,,"August 18, 2020","September 24, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1806,25.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jason Malenfant,Los Angeles County Department of Public Health,https://dx.doi.org/10.1093/infdis/jiab281,6/7/2021,3/2/2024,Unverified
210504_DallasTexas_UniversityofTexasSouthwestern,"May 4, 2021",Local,United States of America,USA,,Dallas,"October 1, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),37,0.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Diercks,University of Texas Southwestern,http://dx.doi.org/10.1111/acem.14249 ,6/7/2021,3/2/2024,Unverified
210503_USA_HIV_ClinicalReferenceLaboratory,"May 3, 2021",National,United States of America,USA,,,"January 1, 2020","March 31, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1191,12.80%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,99.50%,99.80%,Moderate,Preprint,Robert Stout,Clinical Reference Laboratory ,10.1101/2021.04.29.21256302,6/7/2021,3/2/2024,Verified
210429_Indianapolis_IndianaUniversity_overall,"April 29, 2021",Local,United States of America,USA,Indiana,Indianapolis,"May 18, 2020","May 22, 2020",Health care workers and caregivers,Adults (18-64 years),44,27.27%,,,Convenience,Abnova,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Timothy Crisci,Indiana Univeristy,https://dx.doi.org/10.3389/fped.2021.633082,6/8/2021,7/17/2022,Verified
210527_NewYorkCity_NewYorkUniversityGrossmanSchoolofMedicine_primary,"May 27, 2021",Local,United States of America,USA,New York,New York City,"April 29, 2020","February 9, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,329,16.00%,,,Convenience,"NA,Abbott Laboratories",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Amit Saxena,New York University Grossman School of Medicine,https://dx.doi.org/10.1016/S2665-9913(21)00114-4,6/8/2021,3/2/2024,Unverified
210603_UnitedStates_EmoryUniversity,"June 3, 2021",National,United States of America,USA,NR,NR,"August 9, 2020","December 8, 2020",Household and community samples,Multiple groups,1454,4.68%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Aaron Siegler,"Emory University
",https://www.croiconference.org/abstract/us-population-based-survey-of-vaccine-willingness-and-sars-cov-2-antibody-prevalence/,6/8/2021,7/17/2022,Verified
210508_SouthDakota_SouthDakotaStateUniversity_Phase3,"June 8, 2021",Regional,United States of America,USA,"South Dakota, Minnesota",,"October 16, 2020","December 22, 2020",Health care workers and caregivers,Adults (18-64 years),235,14.80%,,,Convenience,Roche Diagnostics,Other,"IgG,IgM,IgA",,,High,Preprint,Jordan Neises,South Dakota State University,https://www.medrxiv.org/content/10.1101/2021.06.07.21258375v1,6/17/2021,3/2/2024,Unverified
210409_OrangeCounty_UniversityofCaliforniaIrvine_Primary,"April 9, 2021",Local,United States of America,USA,California,Orange County ,"April 14, 2020","May 13, 2020",Health care workers and caregivers,Adults (18-64 years),143,10.50%,,,Convenience,Superbio Biomedical Company ,Other,"IgM,IgG",100.00%,83.80%,High,Journal Article (Peer-Reviewed),Theodore W. Heyming,University of California Irvine,https://dx.doi.org/10.5811/westjem.2021.1.50058,6/20/2021,3/2/2024,Verified
210611_SanFrancisco_UniversityofCaliforniaSanFrancisco_mostadj,"June 11, 2021",Local,United States of America,USA,California,San Francisco,"March 28, 2020","June 26, 2020",Residual sera,Multiple groups,4735,4.20%,2.10%,6.30%,Stratified non-probability,NA,Multiple Types,IgG,93.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Isobel Routledge,University of California San Francisco,https://dx.doi.org/10.1038/s41467-021-23651-6,6/21/2021,7/17/2022,Verified
210602_USA_MontantaStateUniversity_Primary,"June 2, 2021",Local,United States of America,USA,Montana,Bozeman,"April 15, 2020","November 15, 2020",Blood donors,Adults (18-64 years),168,19.00%,,,Self-referral,NA,Neutralization,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jodi Hedges,Montana State University,http://dx.doi.org/10.3390/vaccines9060587,6/22/2021,7/17/2022,Unverified
210610_USA_BostonHeartDiagnostics,"June 10, 2021",National,United States of America,USA,,,"April 6, 2020","December 1, 2020",Residual sera,Multiple groups,81624,5.21%,,,Unclear,Diazyme Laboratories Inc,CLIA,IgG,98.40%,97.40%,High,Journal Article (Peer-Reviewed),Ernst J. Schaefer,Boston Heart Diagnostics,http://dx.doi.org/10.1371/journal.pone.0252818,6/22/2021,3/2/2024,Unverified
210604_NewYorkCity_NewYorkCityDepartmentOfHealthAndMentalHygiene_Overall,"June 4, 2021",Local,United States of America,USA,New York State,New York City,"June 1, 2020","October 9, 2020",Household and community samples,Multiple groups,1074,24.30%,20.70%,28.30%,Stratified probability,DiaSorin,CLIA,IgG,97.60%,99.30%,Moderate,Journal Article (Peer-Reviewed),Jannae Parrott,New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.1093/infdis/jiab296,6/22/2021,3/2/2024,Verified
210606_Pennsylvania_UniversityOfPittsburgh_Fall1_overall,"June 6, 2021",Regional,United States of America,USA,Pennsylvania,,"September 21, 2020","November 4, 2020",Multiple general populations,Multiple groups,199,2.01%,1.00%,5.00%,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,6/30/2021,7/17/2022,Verified
210606_Pennsylvania_UniversityOfPittsburgh_Feb2,"June 6, 2021",Local,United States of America,USA,Pennsylvania,Pittsburgh,"February 1, 2021","February 5, 2021",Residual sera,Multiple groups,194,16.49%,12.00%,22.00%,Sequential,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Lingqing Xu,University of Pittsburgh,http://dx.doi.org/10.3390/pathogens10060710,6/30/2021,7/17/2022,Verified
210621_Jacksonville_MayoClinic,"June 21, 2021",Local,United States of America,USA,Florida,Jacksonville,"May 6, 2020","July 1, 2020",Health care workers and caregivers,Adults (18-64 years),292,2.70%,1.20%,5.30%,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Martin L.De Ruyter,Mayo Clinic,https://dx.doi.org/10.1093/bjs/znab109,6/30/2021,3/2/2024,Unverified
210615_Nashville_VanderbiltUniversityMedicalCenter_FollowUp2_Overall,"June 15, 2021",Local,United States of America,USA,Tennessee,Nashville,"January 27, 2021","January 27, 2021",Essential non-healthcare workers,Adults (18-64 years),34,14.71%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sophie E. Katz,Vanderbilt University Medical Center,https://dx.doi.org/10.1016/j.jpeds.2021.06.015,7/1/2021,3/2/2024,Verified
210414_Holyoke_CityofHolyoke_Overall_PopAdj,"June 23, 2021",Local,United States of America,USA,Massachusetts,Holyoke,"November 5, 2020","January 31, 2021",Household and community samples,Multiple groups,328,13.90%,7.80%,21.80%,Simplified probability,NA,Not reported,"IgM,IgG",,,Moderate,Institutional Report,City of Holyoke,City of Holyoke,https://www.holyoke.org/documents/city-of-holyoke-serosurvey-report/,7/6/2021,7/17/2022,Verified
210602_UnitedStates_TranslationalPulmonaryAndImmunologyResearchCenter_Overall,"June 2, 2021",National,United States of America,USA,,,"February 1, 2020","April 20, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),172,4.00%,,,Convenience,"InBios International, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nathan Marsteller,Translational Pulmonary and Immunology Research Center,http://dx.doi.org/10.3390/antib10020022,7/6/2021,3/2/2024,Verified
210618_LosAngeles_UniversityCaliforniaLosAngeles,"June 18, 2021",Local,United States of America,USA,California,Los Angeles,,"August 10, 2020",Residual sera,Multiple groups,3075,8.81%,,,Convenience,DiaSorin,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Douglas Murad,University of California Los Angeles,http://dx.doi.org/10.1128/JCM.00431-21,7/7/2021,3/2/2024,Verified
210707_Monrovia_OakCrestInstituteOfScience_Overall,"July 7, 2021",Local,United States of America,USA,California,Monrovia,"March 27, 2020","May 26, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),33,6.10%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Manjula Gunawardana,Oak Crest Institute of Science,https://dx.doi.org/10.1128/mSphere.00542-21,7/14/2021,7/17/2022,Verified
210702_USA_DaVitaClinicalResearch,"July 2, 2021",National,United States of America,USA,"California, Connecticut, Minnesota, Nevada, New York, Ohio, Texas, Virginia, and Wisconsin",,"July 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,2337,9.50%,,,Convenience,Diazyme Laboratories Inc,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dena Cohen,DaVita Clinical Research,https://dx.doi.org/10.1681/ASN.2021030387,7/14/2021,3/2/2024,Verified
210703_Atlanta_CentersForDiseaseControlAndPrevention,"July 3, 2021",Local,United States of America,USA,Georgia,Atlanta,"August 31, 2020","November 23, 2020",Residual sera,Multiple groups,592,17.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Talya Shragai,United States Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/infdis/jiab349,7/14/2021,7/17/2022,Verified
210702_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall,"July 2, 2021",Regional,United States of America,USA,Northeastern Ohio,,"May 22, 2020","September 15, 2020",Essential non-healthcare workers,Multiple groups,3080,2.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Xiaochun Zhang,University Hospitals Cleveland Medical Center,https://www.medrxiv.org/content/10.1101/2021.06.27.21259432v1.full-text,7/16/2021,3/2/2024,Unverified
210616_LomaLinda_LomaLindaUniversityChildren'sHospital_Overall,"June 16, 2021",Local,United States of America,USA,California,Loma Linda,"March 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),146,6.16%,,,Sequential,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Matthew J. Bock,Loma Linda University Children's Hospital ,https://dx.doi.org/10.1016/j.healun.2021.06.009,7/18/2021,7/17/2022,Verified
210710_USA_EmoryUniversity_overall_PopAdj_TestAdj,"July 10, 2021",National,United States of America,USA,,,"August 9, 2020","December 8, 2020",Household and community samples,Multiple groups,4654,4.71%,3.30%,6.11%,Stratified probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,Low,Journal Article (Peer-Reviewed),Patrick Sullivan,Emory University,https://dx.doi.org/10.1093/cid/ciab626,7/20/2021,8/15/2023,Verified
210707_UnitedStates_NationalInstitutesOfHealth_Overall,"July 7, 2021",National,United States of America,USA,,,"April 1, 2020","August 4, 2020",Household and community samples,Multiple groups,8058,4.60%,2.60%,6.50%,Stratified non-probability,NA,ELISA,"IgG,IgM",,,Low,Journal Article (Peer-Reviewed),Heather Kalish,National Institutes of Health,http://dx.doi.org/10.1126/scitranslmed.abh3826,7/20/2021,7/17/2022,Verified
210712_UnitedStates_StanfordUniversity_Overall,"July 12, 2021",National,United States of America,USA,,,"January 1, 2021","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,21464,18.70%,18.10%,19.20%,Convenience,Siemens,CLIA,"IgG,IgM",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shuchi Anand,Stanford University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16572,7/21/2021,3/2/2024,Unverified
210710_Athens_UniversityofGeorgia_PopTestAdj,"July 10, 2021",Local,United States of America,USA,Georgia,Athens,"January 22, 2021","March 22, 2021",Students and Daycares,Adults (18-64 years),432,41.00%,31.40%,50.70%,Convenience,NA,ELISA,IgA,88.89%,88.89%,Moderate,Preprint,Mark Ebell,University of Georgia,https://www.medrxiv.org/content/10.1101/2021.07.08.21260201v1,7/22/2021,7/17/2022,Unverified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_1_Overall,"July 19, 2021",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff","August 15, 2020","September 5, 2020",Residual sera,Multiple groups,1301,2.60%,1.70%,3.50%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/27/2021,3/2/2024,Verified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_2_Overall,"July 19, 2021",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff, Fort Smith","September 12, 2020","October 24, 2020",Residual sera,Multiple groups,2098,4.10%,3.10%,5.10%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/27/2021,3/2/2024,Verified
210719_Arkansas_UniversityOfArkansasForMedicalSciences_3_Overall,"July 19, 2021",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Pine Bluff, Fort Smith","November 7, 2020","December 19, 2020",Residual sera,Multiple groups,2405,7.40%,6.00%,8.70%,Convenience,"Beckman Coulter,NA",Multiple Types,IgG,,,Moderate,Preprint,Joshua Kennedy,University of Arkansas for Medical Sciences,https://www.medrxiv.org/content/10.1101/2021.07.15.21260213v1,7/27/2021,3/2/2024,Verified
210720_LongIsland_StonyBrookUniversity_Totaladj,"July 20, 2021",Local,United States of America,USA,New York,Long Island,"March 25, 2020","September 18, 2020",Household and community samples,Multiple groups,1042,21.30%,19.50%,23.20%,Convenience,Abbott Laboratories,CLIA,IgG,93.40%,100.00%,High,Journal Article (Peer-Reviewed),Olga Morozova,Stony Brook University,https://dx.doi.org/10.1371/journal.pone.0254713,7/28/2021,3/2/2024,Verified
210527_NewYorkCity_HospitalForSpecialSurgery_overall,"May 27, 2021",Local,United States of America,USA,New York,New York City,"May 6, 2020","June 5, 2020",Health care workers and caregivers,Adults (18-64 years),143,9.79%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ellen Soffin,Hospital for Special Surgery,http://dx.doi.org/10.1097/JOM.0000000000002182,8/2/2021,3/2/2024,Verified
210721_FortCollins_ColoradoStateUniversity,"July 21, 2021",Local,United States of America,USA,Colorado,Fort Collins,"July 13, 2020","September 2, 2020",Essential non-healthcare workers,Adults (18-64 years),508,0.40%,0.10%,1.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tracy Nelson,Colorado State University,https://dx.doi.org/10.1001/jamanetworkopen.2021.16543,8/3/2021,3/2/2024,Unverified
210715_USA_GeorgeWashingtonUniversity_Overall,"July 14, 2021",Regional,United States of America,USA,"California, Connecticut, Michigan, New Jersey, New York",,"May 14, 2020","May 30, 2020",Household and community samples,Multiple groups,6665,30.00%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan Silverberg,George Washington University,https://dx.doi.org/10.1016/j.jaip.2021.06.046,8/4/2021,3/2/2024,Verified
210728_NewYorkCity_WeillCornellMedicine_overall,"July 28, 2021",Local,United States of America,USA,New York ,New York City,"May 28, 2020","December 12, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,72,31.94%,,,Sequential,NA,Not reported,IgG,,,High,Preprint,Michelle Lubetzky,Weill Cornell Medicine,https://www.medrxiv.org/content/10.1101/2021.07.25.21261066v1.full-text,8/4/2021,7/17/2022,Verified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Children,"August 4, 2021",Local,United States of America,USA,Missouri,St Louis,"July 22, 2020","August 16, 2020",Residual sera,Children and Youth (0-17 years),546,5.22%,2.76%,7.68%,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,8/11/2021,7/17/2022,Verified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Adults,"August 4, 2021",Local,United States of America,USA,Missouri,St Louis,"July 25, 2020","July 31, 2020",Residual sera,Multiple groups,506,4.52%,2.07%,6.93%,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,8/11/2021,7/17/2022,Verified
210708_Philadelphia_UniversityofPennsylvania,"July 8, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 13, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),2043,2.00%,,,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sigrid Gouma,University of Pennsylvania,http://dx.doi.org/10.1172/jci.insight.150449,8/15/2021,7/17/2022,Unverified
210801_Phoenix_DignityHealthResearchInstitute,"August 1, 2021",Local,United States of America,USA,Arizona,Phoenix,"June 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),1358,21.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,B. Tiffany,Dignity Health Research Institute,http://dx.doi.org/10.1016/j.annemergmed.2021.07.033,8/15/2021,3/2/2024,Unverified
210811_UnitedStates_NationalInstitutesOfHealth_Primary,"August 11, 2021",National,United States of America,USA,,,"April 15, 2020","October 15, 2020",Residual sera,Multiple groups,2542,7.87%,6.88%,8.98%,Convenience,NA,ELISA,"IgG,IgM",100.00%,100.00%,High,Preprint,Tran B Ngo,National Institutes of Health,https://www.medrxiv.org/content/10.1101/2021.08.10.21261849v1,8/17/2021,7/17/2022,Verified
210730_USA_AmericanRedCross_overall,"July 30, 2021",National,United States of America,USA,,,"June 15, 2020","November 30, 2020",Blood donors,Multiple groups,1531221,4.22%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross,https://dx.doi.org/10.1016/j.tmrv.2021.07.001,8/17/2021,3/2/2024,Verified
210727_California_EmoryUniversity_primary,"July 27, 2021",Regional,United States of America,USA,California,,"August 15, 2020","December 15, 2020",Household and community samples,Multiple groups,983,4.50%,2.80%,7.40%,Simplified probability,Bio-rad,ELISA,"IgG,IgM,IgA",92.20%,99.60%,Moderate,Journal Article (Peer-Reviewed),Katherine Lamba,Emory University,https://dx.doi.org/10.1093/ofid/ofab379,8/18/2021,3/2/2024,Verified
210806_Columbus_OhioStateUniversityCollegeofMedicine,"August 6, 2021",Local,United States of America,USA,Ohio,Columbus,"September 18, 2020","September 25, 2020",Health care workers and caregivers,Adults (18-64 years),126,21.43%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Miranda Kiefer,Ohio State University College of Medicine,https://dx.doi.org/10.1111/aji.13490,8/18/2021,3/2/2024,Unverified
210809_Chicago_NorthwesternUniversity,"August 9, 2021",Local,United States of America,USA,Illinois,"Chicago
","November 9, 2020","January 8, 2021",Health care workers and caregivers,Adults (18-64 years),4947,8.35%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),John Wilkins,Northwestern University,https://dx.doi.org/10.1017/ice.2021.367,8/18/2021,3/2/2024,Unverified
210804_StLouis_WashingtonUniversitySchoolOfMedicine_Jul_Primary,"August 4, 2021",Local,United States of America,USA,Missouri,St Louis,"July 22, 2020","August 16, 2020",Residual sera,Multiple groups,1052,5.89%,,,Convenience,NA,ELISA,IgG,98.20%,98.70%,High,Journal Article (Peer-Reviewed),Brittany K. Smith,Washington University School of Medicine,https://dx.doi.org/10.1128/mSphere.00450-21,8/19/2021,7/17/2022,Verified
210813_NewJersey_RutgersUniversity,"August 13, 2021",Local,United States of America,USA,New Jersey,"Newark, New Brunswick, Piscataway","March 24, 2020","September 22, 2020",Health care workers and caregivers,Adults (18-64 years),831,9.99%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",94.30%,99.70%,High,Journal Article (Peer-Reviewed),Daniel Horton,Rutgers University,https://dx.doi.org/10.1093/infdis/jiab411,8/25/2021,7/17/2022,Verified
201105_Detroit_OaklandUniversity_TestAdjustment,"November 5, 2020",Local,United States of America,USA,Michigan,Detroit,"April 13, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),20614,8.07%,6.83%,8.86%,Convenience,EUROIMMUN,ELISA,IgG,98.14%,99.35%,Moderate,Journal Article (Peer-Reviewed),Matthew Sims,Oakland University,http://dx.doi.org/10.1093/cid/ciaa1684,8/25/2021,8/15/2023,Verified
210818_Mongomery_WestVirginiaUniversity,"August 18, 2021",Local,United States of America,USA,West Virginia,Montgomery,"September 10, 2020","September 10, 2020",Hospital visitors,Multiple groups,150,10.00%,,,Convenience,Tecan,ELISA,IgG,,,High,Preprint,Alexander Horspool,West Virginia University,https://dx.doi.org/10.1101/2021.08.16.21262128,8/30/2021,7/17/2022,Unverified
210729_NorthernVirginia_InovaHeartandVascularInstitute_HCWOctoberNovember3_Primary,"July 29, 2021",Regional,United States of America,USA,Virginia,,"April 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),1323,4.80%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Abdulla Damluji,Inova Heart and Vascular Institute,https://dx.doi.org/10.1016/j.lana.2021.100030,8/30/2021,3/2/2024,Unverified
210729_NorthernVirginia_InovaHeartandVascularInstitute_Community4_Primary,"July 29, 2021",Regional,United States of America,USA,Virginia,,"June 1, 2020","August 14, 2020",Household and community samples,Multiple groups,949,4.53%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Abdulla Damluji,Inova Heart and Vascular Institute,https://dx.doi.org/10.1016/j.lana.2021.100030,8/30/2021,3/2/2024,Unverified
210820_Maryland_UniversityofMaryland,"August 20, 2021",Local,United States of America,USA,"Maryland
",,"June 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),778,2.60%,,,Self-referral,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Lyndsay O'Hara,University of Maryland,https://dx.doi.org/10.1017/ice.2021.373,8/30/2021,7/17/2022,Unverified
210825_RhodeIsland_LindsleyFKimballResearchInstitute_CLIA_OverallAdj,"August 25, 2021",Regional,United States of America,USA,Rhode Island,,"April 27, 2020","May 11, 2020",Blood donors,Multiple groups,1996,0.60%,0.20%,1.10%,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Nesbitt,Lindsley F Kimball Research Institute,https://dx.doi.org/10.1186/s12879-021-06438-4,8/31/2021,8/15/2023,Verified
210819_NewYork_ColumbiaUniversityIrvingMedicalCenter_Overall,"August 19, 2021",Local,United States of America,USA,New York,,"January 3, 2021","January 21, 2021",Household and community samples,Multiple groups,474,67.90%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alan Werzberger,Columbia University Irving Medical Center,https://dx.doi.org/10.1016/j.ajic.2021.08.015,8/31/2021,7/17/2022,Verified
210825_OrangeCounty_UniversityofCaliforniaIrvine,"August 25, 2021",Local,United States of America,USA,California,NR,"October 5, 2020","October 23, 2020",Essential non-healthcare workers,Adults (18-64 years),923,5.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.60%,100.00%,Moderate,Journal Article (Peer-Reviewed),Veronica Vieira,University of California Irvine,https://dx.doi.org/10.1136/oemed-2021-107461,9/1/2021,3/2/2024,Unverified
210429_Houston_HoustonHealthDepartment_MultipleTest_Primary,"April 29, 2021",Local,United States of America,USA,Texas,Houston,"September 1, 2020","September 19, 2020",Household and community samples,Multiple groups,685,11.53%,,,Stratified probability,"Bio-rad,NA",ELISA,"IgG,IgM,IgA",,,Low,Journal Article (Peer-Reviewed),Elaine Symanski,Houston Health Department,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiab203/6258999,9/3/2021,3/2/2024,Verified
210901_Utah_UniversityofUtah_genpop_popadj_testadj,"September 1, 2021",Regional,United States of America,USA,Utah,,"May 4, 2020","June 30, 2020",Household and community samples,Multiple groups,8108,0.80%,0.10%,1.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Matthew Samore,University of Utah,https://wwwnc.cdc.gov/eid/article/27/11/20-4435_article,9/8/2021,8/15/2023,Verified
210830_Conneticut_YaleUniversity,"August 30, 2021",Regional,United States of America,USA,Connecticut,,"April 15, 2021","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),988,10.40%,,,Convenience,NA,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Joseph Zell,Yale University,https://dx.doi.org/10.1371/journal.pone.0251114,9/9/2021,7/17/2022,Unverified
210901_Kentucky_UniversityofKentucky_Primary,"September 1, 2021",Local,United States of America,USA,Kentucky,Lexington,"June 22, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),322,1.55%,0.65%,3.71%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Derek Forster,University of Kentucky,https://dx.doi.org/10.1016/j.ajic.2021.04.005,9/11/2021,3/2/2024,Unverified
210529_NewYorkCity_RenalResearchInstitute_Primary,"May 29, 2021",Local,United States of America,USA,New York,New York City,"June 10, 2020","July 13, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,429,30.30%,,,Convenience,Diazyme Laboratories Inc,CLIA,IgG,100.00%,98.00%,Unclear,Presentation or Conference,Ohnmar Thwin,Renal Research Institute,http://dx.doi.org/10.1093/ndt/gfab100.002,9/14/2021,3/2/2024,Unverified
210812_NorthCarolina_UniversityOfNorthCarolina,"August 12, 2021",Regional,United States of America,USA,North Carolina,,"April 15, 2020","October 15, 2020",Household and community samples,Multiple groups,103,28.00%,,,Convenience,"BioMedomics, Inc.,NA",Multiple Types,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Carla Cerami,University of North Carolina ,http://dx.doi.org/10.1093/cid/ciab701,9/15/2021,3/2/2024,Verified
210818_NewYork_SunRiverHealth,"August 18, 2021",Regional,United States of America,USA,New York,,"July 15, 2020","September 15, 2020",Health care workers and caregivers,Multiple groups,325,15.40%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Anne Kauffman Nolon,Sun River Health,http://dx.doi.org/10.1097/JOM.0000000000002357,9/21/2021,3/2/2024,Unverified
210914_Louisville_UniversityofLouisville_July2020,"September 14, 2021",Local,United States of America,USA,Kentucky,Louisville,"July 6, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),915,2.30%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Krystal Hamorsky, University of Louisville,https://dx.doi.org/10.1038/s41598-021-97423-z,9/21/2021,7/17/2022,Unverified
210915_Monterey_UniversityofCalifornia_Primary,"September 15, 2021",Regional,United States of America,USA,California,,"July 16, 2020","November 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1058,19.00%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ana M. Mora,"Universityof California,Berkeley",https://dx.doi.org/10.1001/jamanetworkopen.2021.24116,9/22/2021,7/17/2022,Unverified
210729_SouthernUSA_WalterReedArmyInstituteOfResearch_Timepoint3,"July 29, 2021",Local,United States of America,USA,Southern United States,NR,"November 18, 2020","January 3, 2021",Essential non-healthcare workers,Adults (18-64 years),1211,9.50%,7.90%,11.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Shilpa Hakre,Walter Reed Army Institute of Research,https://dx.doi.org/10.1093/ofid/ofab407,9/24/2021,3/2/2024,Unverified
210731_Wisconsin_CentersforDiseaseControlandPrevention_1September,"July 31, 2021",Regional,United States of America,USA,Wisconsin,,"September 1, 2020","September 4, 2020",Students and Daycares,Adults (18-64 years),517,4.06%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hannah Segaloff,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab405,9/30/2021,3/2/2024,Unverified
210731_Wisconsin_CentersforDiseaseControlandPrevention_2November,"July 31, 2021",Regional,United States of America,USA,Wisconsin,,"November 9, 2020","November 13, 2020",Students and Daycares,Adults (18-64 years),413,18.64%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hannah Segaloff,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab405,9/30/2021,3/2/2024,Unverified
210913_UnitedStates_AirForceResearchLaboratory,"September 13, 2021",Local,United States of America,USA,Ohio,,"July 23, 2020","October 23, 2020",Household and community samples,Multiple groups,582,3.09%,,,Convenience,NA,Multiple Types,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Amy Breedon,"Air Force Research Laboratory, Wright-Patterson Air Force Base",https://dx.doi.org/10.3389/fmed.2021.749732,10/5/2021,7/17/2022,Verified
210924_Michigan_UniversityOfMichigan_BeforeDec14_Overall,"September 24, 2021",Local,United States of America,USA,Michigan,,"April 27, 2020","December 13, 2020",Household and community samples,Multiple groups,8026,9.20%,,,Unclear,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Zhangchen Zhao,University of Michigan,http://dx.doi.org/10.3390/jcm10194341,10/8/2021,7/17/2022,Verified
210924_Michigan_UniversityOfMichigan_AfterDec14_Overall,"September 24, 2021",Local,United States of America,USA,Michigan,,"December 14, 2020","May 3, 2021",Household and community samples,Multiple groups,2024,36.20%,,,Unclear,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Zhangchen Zhao,University of Michigan,http://dx.doi.org/10.3390/jcm10194341,10/8/2021,7/17/2022,Verified
211001_UnitedStates_OchsnerHealth,"October 1, 2021",Local,United States of America,USA,Louisiana,New Orleans,"March 1, 2020","May 1, 2020",Multiple populations,Adults (18-64 years),13343,7.99%,7.53%,8.45%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Journal Article (Peer-Reviewed),Edmond Kabagambe,Ochsner Health,https://dx.doi.org/10.1016/j.amjms.2021.09.006,10/12/2021,3/2/2024,Unverified
211002_UnitedStates_CohenChildrensMedicalCenter,"October 2, 2021",Local,United States of America,USA,New York,New York City,"May 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),262,13.00%,,,Convenience,"Abbott Laboratories,DiaSorin,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Heather Walters ,"Cohen Children’s Medical Center,",https://dx.doi.org/10.1093/rheumatology/keab730,10/12/2021,3/2/2024,Unverified
211002_NewYork_NorthShoreUniversityHospital_Delivery,"October 2, 2021",Local,United States of America,USA,New York,,"October 15, 2020","November 15, 2020",Pregnant or parturient women,Adults (18-64 years),149,14.10%,,,Sequential,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Cara Staszewski,North Shore University Hospital,https://dx.doi.org/10.1016/j.ajog.2021.09.037,10/15/2021,3/2/2024,Verified
211001_NewYorkCity_NorthShoreUniversityHospital_Overall,"October 1, 2021",Local,United States of America,USA,New York,New York City,"March 1, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,812,2.33%,,,Convenience,,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Janice Wang,North Shore University Hospital,http://dx.doi.org/10.1016/j.chest.2021.07.1326,10/19/2021,10/28/2021,Unverified
211011_NewYork_ChildrensHospitalAtMontefiore,"October 11, 2021",Local,United States of America,USA,New York,New York,"April 15, 2020","December 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,108,11.10%,,,Convenience,Eurofins-Viracor ,ELISA,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Neha Bansal,Childrens Hospital at Montefiore,https://dx.doi.org/10.1111/petr.14156,10/19/2021,3/2/2024,Unverified
211012_Colorado_UniversityofColorado_Followup_TestAdjusted,"October 12, 2021",Regional,United States of America,USA,Colorado,,"May 15, 2020","March 15, 2021",Essential non-healthcare workers,Adults (18-64 years),783,20.00%,,,Convenience,"Abbott Laboratories,EUROIMMUN",Multiple Types,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Brian Montague,University of Colorado,https://dx.doi.org/10.1093/infdis/jiab524,10/19/2021,8/15/2023,Unverified
210917_Lakewood_JointBaseLewisMcChord_Overall,"September 17, 2021",Local,United States of America,USA,Washington,Lakewood,"June 15, 2020","September 15, 2020",Essential non-healthcare workers,Adults (18-64 years),264,0.40%,,,Unclear,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Alex Koo,Joint Base Lewis McChord,https://pubmed.ncbi.nlm.nih.gov/34529807/,10/20/2021,3/2/2024,Unverified
211009_UnitedStates_AmericanRedCross_Overall_S1,"October 9, 2021",National,United States of America,USA,,,"December 7, 2020","June 25, 2021",Blood donors,Multiple groups,1567446,60.07%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Roger Dodd,American Red Cross,https://dx.doi.org/10.1093/infdis/jiab514,10/20/2021,3/2/2024,Verified
211001_Charleston_WestVirginiaUniversity_HCW,"October 1, 2021",Local,United States of America,USA,West Virginia,Charleston,"September 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),458,10.00%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Syed Mahmood,West Virginia University,https://www.sciencedirect.com/science/article/pii/S0012369221020201,10/20/2021,7/17/2022,Unverified
211001_Charleston_WestVirginiaUniversity_CEW,"October 1, 2021",Local,United States of America,USA,West Virginia,Charleston,"September 15, 2020","December 15, 2020",Essential non-healthcare workers,Adults (18-64 years),623,5.80%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Syed Mahmood,West Virginia University,https://www.sciencedirect.com/science/article/pii/S0012369221020201,10/20/2021,7/17/2022,Unverified
210801_SouthBronx_MountSinai_primary,"August 1, 2021",Local,United States of America,USA,New York,New York City,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),501,28.40%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Juan Manuel Carreno,Icahn School of Medicine at Mount Sinai,https://www.cell.com/iscience/fulltext/S2589-0042(21)00905-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589004221009056%3Fshowall%3Dtrue,10/23/2021,7/17/2022,Unverified
211018_WRNMMC_UniformedServicesUniversity,"October 18, 2021",Local,United States of America,USA,Maryland,Bethesda,"February 1, 2021","August 15, 2021",Health care workers and caregivers,Adults (18-64 years),17,23.53%,,,Convenience,NA,ELISA,IgG,94.00%,100.00%,High,Preprint,Eric Laing,Uniformed Services University,https://www.medrxiv.org/content/10.1101/2021.10.16.21265087v1,10/27/2021,7/17/2022,Unverified
211021_OrangeCounty_Children’sHospitalofOrangeCounty_Overall,"October 21, 2021",Local,United States of America,USA,California,NA,"May 14, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),282,0.30%,,,Convenience,"Superbio Biomedical Company ,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Theodore Heyming,Children’s Hospital of Orange County,https://dx.doi.org/10.3390/idr13040082,11/3/2021,3/2/2024,Unverified
211026_NewYorkCity_MountSinaiHealthSystem_Phase2_Overall_Spike,"October 26, 2021",Local,United States of America,USA,New York,New York,"August 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),176,38.64%,,,Convenience,NA,ELISA,IgG,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vidya Menon,Mount Sinai Health System,https://dx.doi.org/10.1136/bmjopen-2021-051045,11/5/2021,7/17/2022,Unverified
201027_Vermont_UniversityOfVermont_Student_Primary,"October 27, 2021",Local,United States of America,USA,Vermont,,"December 2, 2020","December 19, 2020",Students and Daycares,Children and Youth (0-17 years),196,4.90%,2.00%,9.30%,Convenience,NA,ELISA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Sean S M Bullis,University of Vermont,https://dx.doi.org/10.1136/bmjpo-2021-001259,11/9/2021,7/17/2022,Unverified
201027_Vermont_UniversityOfVermont_Staff_Primary,"October 27, 2021",Local,United States of America,USA,Vermont,,"December 2, 2020","December 19, 2020",Students and Daycares,Adults (18-64 years),336,4.60%,2.50%,7.70%,Convenience,NA,ELISA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Sean S M Bullis,University of Vermont,https://dx.doi.org/10.1136/bmjpo-2021-001259,11/9/2021,7/17/2022,Unverified
211103_NewYorkCity_NewYorkCityHealthandHospitals_Overall,"November 3, 2021",Local,United States of America,USA,New York ,New York ,"April 30, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,727,29.44%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Alexander Bryan,New York City Health and hospitals,https://dx.doi.org/10.1136/bmjopen-2021-053158,11/9/2021,7/17/2022,Unverified
211104_Bronx_MontefioreMedicalCenter,"November 4, 2021",Local,United States of America,USA,New York,New York,"May 3, 2021","May 5, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,1164,17.10%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Yorg Azzi,Montefiore Medical Center,http://dx.doi.org/10.1681/asn.2020030362,11/11/2021,7/17/2022,Unverified
210605_Bronx_MontefioreMedicalCenter,"June 5, 2021",Local,United States of America,USA,New York,New York,"May 3, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1042,15.74%,,,Unclear,NA,Not reported,IgG,,,Unclear,Presentation or Conference,Yorg Azzi,Montefiore Medical Center,https://atcmeetingabstracts.com/abstract/prevalence-and-dynamics-of-sars-cov-2-igg-in-kidney-transplant-recipients/,11/11/2021,7/17/2022,Unverified
210604_NewYorkCity_LiveOnNY,"June 4, 2021",Local,United States of America,USA,New York,New York City,"March 16, 2020","December 2, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,208,3.37%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Amy Friedman,LiveOnNY,https://atcmeetingabstracts.com/abstract/covid-studies-in-208-patients-with-consent-for-donation/,11/11/2021,7/17/2022,Unverified
211108_Virginia_InovaHealthSystem,"November 8, 2021",Regional,United States of America,USA,Virginia,,"July 31, 2020","October 13, 2020",Multiple general populations,Children and Youth (0-17 years),1038,8.50%,6.90%,10.30%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Rebecca Levorson,Inova Health System,https://dx.doi.org/10.1371/journal.pone.0259823,11/16/2021,3/2/2024,Verified
211109_Denver_CentersforDiseaseControlandPrevention_CommunitySurvey_Overall,"November 9, 2021",Regional,United States of America,USA,Colorado,Denver,"July 22, 2020","August 8, 2020",Household and community samples,Multiple groups,381,8.00%,3.90%,15.70%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Kiersten Kugeler,Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/00333549211055137,11/17/2021,3/2/2024,Verified
210908_SanFrancisco_UniversityofCalifornia_overall,"September 8, 2021",Local,United States of America,USA,California,San Francisco,"June 15, 2020","July 2, 2020",Essential non-healthcare workers,Adults (18-64 years),1231,0.24%,0.05%,0.71%,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Megan Grant,University of California,https://dx.doi.org/10.1097/JOM.0000000000002383,11/17/2021,3/2/2024,Unverified
211021_EssexCounty_RutgersUniversity_Overall,"November 8, 2021",Local,United States of America,USA,New Jersey,,"September 15, 2020","December 22, 2020",Household and community samples,Multiple groups,924,8.98%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Henry Raymond,Rutgers University,https://dx.doi.org/10.1007/s40615-021-01175-5,11/18/2021,7/17/2022,Verified
211104_OrangeCounty_UniversityofCaliforniaIrvine_2_HCW_May_Multiplex,"November 4, 2021",Local,United States of America,USA,California,Inrvine,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1060,4.00%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,11/19/2021,7/17/2022,Unverified
211104_OrangeCounty_UniversityofCaliforniaIrvine_1_SantaAna_Multiplex,"November 4, 2021",Local,United States of America,USA,California,Santa Ana,"December 1, 2020","December 30, 2020",Household and community samples,Multiple groups,3347,26.00%,,,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,11/19/2021,7/17/2022,Unverified
211104_OrangeCounty_UniversityofCaliforniaIrvine_3_HCW_December_Multiplex,"November 4, 2021",Local,United States of America,USA,California,Irvine,"December 1, 2020","December 30, 2020",Health care workers and caregivers,Adults (18-64 years),313,11.00%,,,Convenience,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Rafael Assis,University of California Irvine,https://dx.doi.org/10.1038/s41541-021-00396-3,11/19/2021,7/17/2022,Unverified
211109_Denver_CentersforDiseaseControlandPrevention_ClinicalResidualSera_Overall,"November 9, 2021",Regional,United States of America,USA,Colorado,,"July 22, 2020","August 8, 2020",Residual sera,Multiple groups,1598,6.80%,5.00%,9.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,93.20%,99.00%,Moderate,Journal Article (Peer-Reviewed),Kiersten Kugeler,Centers for Disease Control and Prevention,https://dx.doi.org/10.1177/00333549211055137,11/20/2021,3/2/2024,Verified
200515_Boston_BostonPublicHealthCommission,"May 18, 2020",Local,United States of America,USA,Massachusetts,Boston,,"May 15, 2020",Household and community samples,,750,9.90%,,,Unclear,NA,LFIA,,,,High,News and Media,City of Boston,Boston Public Health Commission ,https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents,11/24/2021,7/17/2022,Unverified
210430_StLouis_WashingtonUniversityinStLouis_Overall,"April 30, 2021",Local,United States of America,USA,Missouri,St. Louis,"August 29, 2020","September 19, 2020",Residual sera,Multiple groups,393,3.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kwaku Tawiah,Washington University in St. Louis,https://doi.org/10.1093/jalm/jfab021,12/1/2021,3/2/2024,Verified
211110_PalmBeachCounty_FloridaDepartmentofHealth_overall,"November 10, 2021",Local,United States of America,USA,Florida,"Lantana, West Palm Beach, Delray Beach, Belle Glade","June 29, 2020","August 5, 2020",Pregnant or parturient women,Adults (18-64 years),618,26.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Charles Gonik,Wayne State University School of Medicine,https://dx.doi.org/10.1055/s-0041-1739353,12/1/2021,3/2/2024,Unverified
211122_OrangeCounty_UniversityofCalifornia_Primary,"November 22, 2021",Local,United States of America,USA,California,,"May 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),654,13.30%,,,Convenience,"NA,Diazyme Laboratories Inc,Beckman Coulter,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shruti Gohil,University of California,https://dx.doi.org/10.1186/s13756-021-01031-5,12/2/2021,3/2/2024,Unverified
211121_NewYorkCity_ IcahnSchoolofMedicine,"November 21, 2021",Local,United States of America,USA,New York,New York City,"April 20, 2020","September 22, 2020",Pregnant or parturient women,Adults (18-64 years),708,16.40%,13.70%,19.30%,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Nina Molenaar, Icahn School of Medicine,https://dx.doi.org/10.1111/ppe.12812,12/2/2021,7/17/2022,Verified
211202_Philadelphia_UniversityofPennsylvania_Overall,"December 2, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 20, 2020","November 4, 2020",Health care workers and caregivers,Multiple groups,1740,5.30%,,,Convenience,Beijing Wantai Biological,ELISA,"IgM,IgG",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Brian T Fisher,University of Pennsylvania,https://dx.doi.org/10.1017/ice.2021.487,12/7/2021,3/2/2024,Unverified
210501_Ithaca_CornellUniversity_Primary_AntiRBD,"May 1, 2021",Local,United States of America,USA,New York,Ithaca,"June 1, 2020","June 15, 2020",Household and community samples,Multiple groups,332,5.10%,,,Unclear,NA,Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Cassandra Guarino,Cornell University,https://www.jimmunol.org/content/206/1_Supplement/114.11?ct=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=J_Immunol_TrendMD_1,12/9/2021,7/17/2022,Unverified
211128_SanFrancisco_UniversityofCalifornia_Round3,"November 28, 2021",Regional,United States of America,USA,California,,"February 15, 2021","April 15, 2021",Household and community samples,Multiple groups,4641,31.30%,,,Convenience,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Marcus Wong,University of California,https://www.medrxiv.org/content/10.1101/2021.11.25.21266786v1.full-text,12/9/2021,3/2/2024,Verified
211207_MayoClinicRochester_MayoClinic,"December 7, 2021",Local,United States of America,USA,Minnesota,Rochester,"November 1, 2019","December 31, 2020",Residual sera,Multiple groups,556,3.24%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Cristina Sanchez,Mayo Clinic,http://dx.doi.org/10.1212/WNL.0000000000012931,12/14/2021,3/2/2024,Verified
211207_Philadelphia_ThomasJeffersonUniversity,"December 7, 2021",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 1, 2020","February 28, 2021",Pregnant or parturient women,Adults (18-64 years),76,20.00%,,,Convenience,Meso Scale Discovery,Not reported,"IgG,IgM",,,High,Preprint,Rupsa Boelig,Thomas Jefferson University,https://www.medrxiv.org/content/10.1101/2021.12.06.21267328v1.full-text,12/15/2021,6/23/2023,Unverified
211205_CaliforniaBayArea_UniversityofCalifornia_Round3_primary,"December 5, 2021",Regional,United States of America,USA,California,,"February 11, 2021","March 20, 2021",Household and community samples,Multiple groups,4608,27.56%,22.84%,33.55%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"Total Antibody,IgG",,,Moderate,Preprint,Cameron Adams,"University of California, Berkeley",https://www.medrxiv.org/content/10.1101/2021.12.02.21266871v1.full-text,12/17/2021,8/15/2023,Verified
211210_California_SutterHealth_Overall,"December 10, 2021",Regional,United States of America,USA,California,,"October 1, 2020","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),4500,8.10%,,,Convenience,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Alice Pressman,Sutter Health,https://dx.doi.org/10.1177/17455065211063300,1/4/2022,3/2/2024,Verified
220101_Philadelphia_ChildrensHospitalofPhiladelphia,"January 1, 2022",Local,United States of America,USA,Pennsylvania,Philadelphia,"April 15, 2020","December 15, 2020",Pregnant or parturient women,Adults (18-64 years),6192,9.17%,,,Convenience,NA,ELISA,"IgG,IgM",,,Moderate,Presentation or Conference,Jourdan Triebwasser,Children’s Hospital of Philadelphia,https://dx.doi.org/10.1016/j.ajog.2021.11.092,1/11/2022,7/17/2022,Unverified
211102_Seattle_UniversityOfWashington_Baseline,"November 2, 2021",Local,United States of America,USA,Washington,Seattle,"July 20, 2020","February 28, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),125,4.00%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Georgene Hergenroeder,University of Washington,https://dx.doi.org/10.1016/S1569-1993%2821%2901450-8,1/11/2022,7/17/2022,Unverified
211006_UnitedStates_UniversityofMinnesota_PostexposureProphylaxis,"October 6, 2021",National,United States of America,USA,,,"March 17, 2020","May 20, 2020",Multiple populations,Multiple groups,266,11.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,1/11/2022,3/2/2024,Unverified
211006_UnitedStates_UniversityofMinnesota_EarlyTreatment,"October 6, 2021",National,United States of America,USA,,,"March 17, 2020","May 20, 2020",Multiple populations,Multiple groups,123,29.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,1/11/2022,3/2/2024,Unverified
211006_UnitedStates_UniversityofMinnesota_Pre-exposureProphylaxis,"October 6, 2021",National,United States of America,USA,,,"April 6, 2020","July 13, 2020",Multiple populations,Multiple groups,542,4.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Lofgren,University of Minnesota,https://academic.oup.com/ofid/article/8/11/ofab506/6382457?login=true,1/11/2022,3/2/2024,Unverified
211227_Chicago_NorthwesternUniversity,"December 27, 2021",Local,United States of America,USA,Illinois,Chicago,"May 26, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),4180,4.31%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Charlesnika Evans,Northwestern University Feinberg School of Medicine,https://dx.doi.org/10.1017/ice.2021.523,1/12/2022,3/2/2024,Unverified
122221_MaricopaCounty_ArizonaStateUniversity_popadj,"December 22, 2021",Local,United States of America,USA,Arizona,,"September 12, 2020","October 1, 2020",Household and community samples,Multiple groups,260,14.00%,7.20%,24.00%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Megan Jehn,Arizona State University,https://dx.doi.org/10.2105/AJPH.2021.306568,1/13/2022,3/2/2024,Verified
220110_NewYork_F.Hoffmann-LaRocheLtd_Overall,"January 10, 2022",Local,United States of America,USA,New York,New York,"January 6, 2021","July 21, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),212,10.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,81.00%,,High,Preprint,Ilya Kister,F. Hoffmann-La Roche Ltd,https://www.medrxiv.org/content/10.1101/2022.01.10.22268752v1.full-text,1/19/2022,3/2/2024,Unverified
220120_LosAngelesCounty_UniversityOfSouthernCalifornia_Overall,"January 20, 2022",Local,United States of America,USA,California,,"April 9, 2021","April 25, 2021",Household and community samples,Multiple groups,1335,66.90%,64.40%,69.40%,Stratified probability,Luminex Corporation,Luminex,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Neeraj Sood,University of Southern California,https://dx.doi.org/10.1001/jamanetworkopen.2021.44258,1/24/2022,3/2/2024,Verified
220119_JohnsHopkinsHospital_JohnsHopkinsUniversity_2021_Overall_All,"January 19, 2022",Local,United States of America,USA,Maryland,Baltimore,"January 11, 2021","March 10, 2021",Residual sera,Multiple groups,2824,23.83%,22.20%,25.40%,Convenience,"EUROIMMUN,Hangzhou Biotest Biotech Co Ltd",Multiple Types,"IgG,IgM",84.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Evan Beck,Johns Hopkins University,https://dx.doi.org/10.1128/jcm.02390-21,1/25/2022,3/2/2024,Unverified
220118_Denver_UniversityofColoradoDenver_Overall,"January 18, 2022",Local,United States of America,USA,Colorado,Denver,"June 2, 2020","July 28, 2020",Persons experiencing homelessness,Multiple groups,271,15.50%,,,Convenience,"Gold Standard Diagnostic,Beckman Coulter",Not reported,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sarah Rowan,University of Colorado Denver,https://dx.doi.org/10.1093/cid/ciac039,1/26/2022,3/2/2024,Unverified
220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Residents,"January 17, 2022",Local,United States of America,USA,Maryland,,"October 1, 2020","February 16, 2021",Assisted living and long-term care facilities,Multiple groups,124,57.00%,,,Convenience,Salimetrics,ELISA,IgG,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Morgan Katz,"Johns Hopkins University School of Medicine
",https://dx.doi.org/10.1111/jgs.17660,1/26/2022,7/17/2022,Unverified
220117_Maryland_JohnsHopkinsUniversitySchoolofMedicine_Staff,"January 17, 2022",Local,United States of America,USA,"Maryland
",,"October 1, 2020","February 16, 2021",Health care workers and caregivers,Multiple groups,28,79.00%,,,Convenience,Salimetrics,ELISA,IgG,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Morgan Katz,"Johns Hopkins University School of Medicine
",https://dx.doi.org/10.1111/jgs.17660,1/26/2022,7/17/2022,Unverified
220125_UniversityofMissouri_UniversityofMissouri_Random,"January 25, 2022",Local,United States of America,USA,Missouri,Columbia,"September 15, 2020","December 15, 2020",Students and Daycares,Adults (18-64 years),833,14.89%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,Preprint,Tyler Myroniuk,University of Missouri,https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text,2/3/2022,7/17/2022,Unverified
220125_UniversityofMissouri_UniversityofMissouri_SelfReferral,"January 25, 2022",Local,United States of America,USA,Missouri,Columbia,"October 12, 2020","December 15, 2020",Students and Daycares,Adults (18-64 years),69,17.39%,,,Self-referral,NA,Not reported,Not reported,,,High,Preprint,Tyler Myroniuk,University of Missouri,https://www.medrxiv.org/content/10.1101/2022.01.24.22269758v1.full-text,2/3/2022,7/17/2022,Unverified
220124_LosAngeles_UniversityofSouthernCalifornia_PopAdj,"January 24, 2022",Local,United States of America,USA,California,Los Angeles,"October 20, 2020","October 28, 2020",Essential non-healthcare workers,Adults (18-64 years),686,9.30%,7.00%,11.70%,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karen Mulligan,University of Southern California,https://dx.doi.org/10.1136/oemed-2021-107805,2/3/2022,3/2/2024,Unverified
220126_HillsboroughCounty_MoffittCancerCenter_Overall,"January 26, 2022",Local,United States of America,USA,Florida,,"October 15, 2020","March 15, 2021",Household and community samples,Multiple groups,867,19.50%,16.90%,22.30%,Stratified probability,NA,ELISA,IgG,96.80%,94.10%,Moderate,Journal Article (Peer-Reviewed),Anna Giuliano,Moffitt Cancer Center,https://dx.doi.org/10.3201/eid2803.211495,2/3/2022,7/17/2022,Unverified
220202_LakeCounty_UniversityofTexasMedicalBranch_Overall,"February 2, 2022",Local,United States of America,USA,Illinois,,"November 15, 2020","January 15, 2021",Household and community samples,Multiple groups,1008,4.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Ryan Kilpatrick,University of Texas Medical Branch,https://dx.doi.org/10.1007/s40121-022-00593-0,2/9/2022,3/2/2024,Verified
220117_ Milwaukee_AdvocateAuroraHealth_Overall,"January 17, 2022",Local,United States of America,USA,Wisconsin,Milwaukee,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),75,1.33%,0.00%,3.90%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Dennis Baumgardner,Advocate Aurora Health,https://dx.doi.org/10.17294/2330-0698.1846,2/10/2022,3/2/2024,Unverified
220203_USA_JohnsHopkinsUniversity_noCOVID_Spike,"February 3, 2022",National,United States of America,USA,,,"September 24, 2021","November 5, 2021",Household and community samples,Adults (18-64 years),246,10.57%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Jennifer Alejo,Johns Hopkins University,https://dx.doi.org/10.1001/jama.2022.1393,2/10/2022,3/2/2024,Unverified
220119_GeorgeWashingtonUniversityHospital_UniversityofNorthCarolina,"January 19, 2022",Local,United States of America,USA,,Washington DC,"June 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),237,12.66%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tara Narowski,University of North Carolina,https://dx.doi.org/10.1016/j.celrep.2022.110336,2/10/2022,7/17/2022,Unverified
220207_Indiana_IndianaUniversitySchoolofPublicHealth-Bloomington_Baseline,"February 7, 2022",Local,United States of America,USA,Indiana,Bloomington,"September 14, 2020","September 30, 2020",Students and Daycares,Adults (18-64 years),1076,4.55%,,,Simplified probability,BGI Genomics,LFIA,"IgG,IgM",64.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sina Kianersi,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1111/add.15835,2/19/2022,3/2/2024,Unverified
220207_Indiana_IndianaUniversitySchoolofPublicHealth-Bloomington_Cohort,"February 7, 2022",Local,United States of America,USA,Indiana,Bloomington,"September 28, 2020","November 23, 2020",Household and community samples,Adults (18-64 years),808,5.20%,,,Simplified probability,BGI Genomics,LFIA,"IgG,IgM",64.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sina Kianersi,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1111/add.15835,2/19/2022,3/2/2024,Unverified
220202_SanFrancisco_UniversityofCalifornia_6months_Overall,"February 2, 2022",Local,United States of America,USA,California,San Francisco,"March 1, 2021","March 31, 2021",Health care workers and caregivers,Adults (18-64 years),134,2.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Ralph Wang,University of California,https://dx.doi.org/10.1016/j.ajem.2022.01.055,2/22/2022,3/2/2024,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NV_May2021,"January 30, 2022",Regional,United States of America,USA,Nevada,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),237,30.40%,20.60%,36.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NJ_May2021,"January 30, 2022",Regional,United States of America,USA,New Jersey,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),393,44.00%,38.40%,50.20%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_NC_May2021,"January 30, 2022",Regional,United States of America,USA,North Carolina,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),648,26.30%,20.80%,32.30%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_CA_May2021,"January 30, 2022",Regional,United States of America,USA,California,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),651,43.70%,38.80%,50.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_OH_May2021,"January 30, 2022",Regional,United States of America,USA,Ohio,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),627,37.00%,29.40%,41.70%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_SC_May2021,"January 30, 2022",Regional,United States of America,USA,South Carolina,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),618,34.80%,29.50%,40.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_IL_May2021,"January 30, 2022",Regional,United States of America,USA,Illinois,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),942,41.50%,35.30%,46.90%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220130_USA_CentersforDiseaseControlandPrevention_TN_May2021,"January 30, 2022",Regional,United States of America,USA,Tennessee,,"May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),192,36.50%,27.50%,46.30%,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexia Couture,Centers for Disease Control and Prevention,https://doi.org/10.1093/ofid/ofac044,2/24/2022,8/15/2023,Unverified
220210_SpaceX_LondonSchoolOfHygiene&TropicalMedicine_TestAdj,"February 10, 2022",Local,United States of America,USA,"California, Florida, Texas, and Washington State.",,"March 29, 2020","August 23, 2020",Non-essential workers and unemployed persons,Multiple groups,4411,8.20%,7.30%,9.10%,Convenience,NA,ELISA,IgG,82.40%,99.60%,High,Journal Article (Peer-Reviewed),Emilie Finch,London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.1371/journal.pbio.3001531,2/25/2022,7/17/2022,Unverified
220214_Atlanta_EmoryUniversity_Follow-up_Overall,"February 14, 2022",Local,United States of America,USA,Georgia,Atlanta,"May 6, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),304,8.60%,,,Convenience,NA,ELISA,IgG,86.70%,99.30%,High,Journal Article (Peer-Reviewed),Jessica Howard-Anderson,Emory University,https://dx.doi.org/10.1017/ice.2021.518,2/25/2022,7/17/2022,Unverified
220207_USA_CentersforDiseaseControlandPrevention_202116_Overall_Anti-S,"February 7, 2022",National,United States of America,USA,,,"June 1, 2021","June 30, 2021",Blood donors,Multiple groups,133000,87.30%,87.00%,87.60%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Zheng Li,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciac105,2/26/2022,3/2/2024,Verified
220201_ParkRidge_AdvocateLutheranGeneralHospital_Dec2020_Overall,"February 1, 2022",Local,United States of America,USA,Illinois,Park Ridge,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Multiple groups,458,8.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.70%,99.20%,High,Journal Article (Peer-Reviewed),Eli Ehrenpreis,Advocate Lutheran General Hospital,https://dx.doi.org/10.3390/healthcare10020285,3/8/2022,3/2/2024,Unverified
220121_NewYork_UniversityOfOxford,"January 21, 2022",Local,United States of America,USA,,New York,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,235,8.94%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
220214_Bethesda_UniformedServicesUniversityoftheHealthSciences,"February 14, 2022",Local,United States of America,USA,Maryland,Betheseda,"August 25, 2020","December 31, 2020",Health care workers and caregivers,Multiple groups,263,4.18%,,,Convenience,NA,Other,IgG,94.00%,100.00%,High,Journal Article (Peer-Reviewed),Emilie Goguet,Uniformed Services University of the Health Sciences,https://dx.doi.org/10.1093/ofid/ofac030,3/9/2022,7/17/2022,Unverified
220219_USA_LombardiComprehensiveCancerCenter_Patients,"February 19, 2022",Regional,United States of America,USA,New Jersey,"Washington DC, Hackensack","April 15, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,733,3.10%,2.00%,4.70%,Convenience,"NA,Roche Diagnostics",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Catherine Lai,Lombardi Comprehensive Cancer Center,https://dx.doi.org/10.1155/2022/8798306,3/10/2022,7/17/2022,Unverified
220219_USA_LombardiComprehensiveCancerCenter_HCW,"February 19, 2022",Regional,United States of America,USA,New Jersey,"Washington DC, Hackensack","April 15, 2020","July 15, 2020",Health care workers and caregivers,Multiple groups,1220,3.70%,2.70%,4.90%,Convenience,"NA,Roche Diagnostics",Multiple Types,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Catherine Lai,Lombardi Comprehensive Cancer Center,https://dx.doi.org/10.1155/2022/8798306,3/10/2022,7/17/2022,Unverified
220803_OrangeCounty_ChildrensHospitalofOrangeCounty,"August 3, 2022",Local,United States of America,USA,California,Orange,"April 4, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),362,15.20%,,,Convenience,Superbio Biomedical Company ,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Natasha Li,Children’s Hospital of Orange County,https://www.mdpi.com/1660-4601/19/15/9562,3/10/2022,3/2/2024,Unverified
210914_AlfredIduPontHospitalforChildren_AlfredIduPontHospitalforChildren,"September 14, 2021",Local,United States of America,USA,Delaware,Wilmington,"June 15, 2020","December 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),81,6.17%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Domenic Filingeri,"Alfred I. duPont Hospital for
Children",https://www.karger.com/Article/Pdf/519117,3/10/2022,7/17/2022,Unverified
211031_Texas_UniversityOfTexas_PopTestAdj_AntiS_Overall,"October 31, 2021",Regional,United States of America,USA,Texas,,"October 4, 2021","October 4, 2021",Household and community samples,Multiple groups,88091,75.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Institutional Report,The University of Texas Health Science Center at Houston,University of Texas Health Science Center at Houston,https://sph.uth.edu/projects/texascares/docs/TexasCARES%20-%20October%20Report.pdf,3/15/2022,12/13/2023,Verified
012722_NewYorkCity_SUNYDownstateHealthSciencesUniversity,"January 27, 2022",Local,United States of America,USA,New York,New York City,"May 15, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),64,42.00%,,,Convenience,"NA,Abbott Laboratories",Multiple Types,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Stacey Frisch,SUNY Downstate Health Sciences University,https://dx.doi.org/10.2196/29539,3/15/2022,3/2/2024,Unverified
210609_Pennsylvania_UPMCChildrensHospitalofPittsburgh_RedPhase_Primary,"June 9, 2021",Regional,United States of America,USA,Pennsylvania,,"April 27, 2020","May 19, 2020",Residual sera,Children and Youth (0-17 years),1142,0.53%,0.19%,1.14%,Sequential,"EUROIMMUN,Beckman Coulter,Siemens",CLIA,IgG,,99.99%,Moderate,Journal Article (Peer-Reviewed),Glenn J. Rapsinski,UPMC Children’s Hospital of Pittsburgh,https://dx.doi.org/10.1016/j.jcvp.2021.100026,3/16/2022,3/2/2024,Verified
210609_Pennsylvania_UPMCChildrensHospitalofPittsburgh_YellowPhase_Primary,"June 9, 2021",Regional,United States of America,USA,Pennsylvania,,"June 22, 2020","July 3, 2020",Residual sera,Children and Youth (0-17 years),1196,0.92%,0.46%,1.64%,Sequential,"EUROIMMUN,Beckman Coulter,Siemens",CLIA,IgG,,99.99%,Moderate,Journal Article (Peer-Reviewed),Glenn J. Rapsinski,UPMC Children’s Hospital of Pittsburgh,https://dx.doi.org/10.1016/j.jcvp.2021.100026,3/16/2022,3/2/2024,Verified
220221_NewYork_DonaldAndBarbaraZuckerSchoolOfMedicineAtHofstra/Northwell_Overall,"February 21, 2022",Regional,United States of America,USA,New York,,"May 1, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,147,12.20%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Joseph L.Simonson,Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,https://dx.doi.org/10.1016/j.jcf.2022.02.012,3/16/2022,7/17/2022,Unverified
211201_Louisiana_TulaneUniversity_Primary,"December 1, 2021",Local,United States of America,USA,Louisiana,New Orleans,"March 18, 2020","May 15, 2020",Residual sera,Children and Youth (0-17 years),812,6.80%,,,Sequential,"NA,Zalgen Labs",ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Monika Dietrich,Tulane University,https://dx.doi.org/10.1016/j.jcvp.2021.100047,3/17/2022,7/17/2022,Verified
220310_USA_UniversityOfSouthCarolinaArnold SchoolOfPublicHealth_OverallAdj,"March 10, 2022",Regional,United States of America,USA,South Carolina,,"February 1, 2021","March 4, 2021",Household and community samples,Multiple groups,1803,16.40%,14.40%,18.50%,Stratified probability,"Healgen,Assure Tech. (Hangzhou) Co. Ltd",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Melissa S. Nolan,University of South Carolina Arnold School of Public Health,https://dx.doi.org/10.1177/00333549221081128,3/18/2022,3/2/2024,Verified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave1_Overall,"March 16, 2022",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf","April 2, 2020","May 6, 2020",Residual sera,Children and Youth (0-17 years),316,8.60%,4.90%,11.60%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,3/22/2022,7/17/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave2_Overall,"March 16, 2022",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf","June 6, 2020","August 10, 2020",Residual sera,Children and Youth (0-17 years),299,9.50%,5.80%,13.20%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,3/22/2022,7/17/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave3_Overall,"March 16, 2022",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf","September 8, 2020","October 17, 2020",Residual sera,Children and Youth (0-17 years),583,17.30%,13.60%,21.00%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,3/22/2022,7/17/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave4_Overall,"March 16, 2022",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf","November 7, 2020","December 17, 2020",Residual sera,Children and Youth (0-17 years),570,13.10%,10.00%,16.20%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,3/22/2022,7/17/2022,Unverified
220316_Arkansas_UniversityofArkansasforMedicalSciences_Wave5_Overall,"March 16, 2022",Regional,United States of America,USA,Arkansas,"Little Rock, Springdale, Fort Smith, Pine Bluf","April 5, 2021","April 28, 2021",Residual sera,Children and Youth (0-17 years),589,23.40%,19.40%,27.40%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Karl Boehme, University of Arkansas for Medical Sciences,https://dx.doi.org/10.1093/jpids/piac010,3/22/2022,7/17/2022,Unverified
211001_Phoenix_DignityHealthResearchInstituteArizona_Draw4_Overall,"October 1, 2021",Local,United States of America,USA,Arizona,Phoenix,"April 1, 2021","April 30, 2021",Health care workers and caregivers,Adults (18-64 years),1358,20.80%,18.60%,23.00%,Convenience,Abbott Laboratories,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Brian Tiffany,"Dignity Health Research
Institute Arizona",https://dx.doi.org/10.1016/j.annemergmed.2021.09.221,3/22/2022,3/2/2024,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Baseline_DBS,"December 4, 2021",Local,United States of America,USA,Maryland,Annapolis,"August 15, 2020","October 15, 2020",Students and Daycares,Adults (18-64 years),97,17.53%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,3/22/2022,7/17/2022,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Followup1_DBS,"December 4, 2021",Local,United States of America,USA,Maryland,Annapolis,"December 1, 2020","December 31, 2020",Students and Daycares,Adults (18-64 years),61,26.23%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,3/22/2022,7/17/2022,Unverified
211204_Annapolis_InfectiousDiseaseClinicalResearchProgram_Followup2_DBS,"December 4, 2021",Local,United States of America,USA,Maryland,Annapolis,"May 1, 2021","May 31, 2021",Students and Daycares,Adults (18-64 years),63,100.00%,,,Unclear,NA,Not reported,IgG,,,High,Presentation or Conference,Eugene Millar,Infectious Disease Clinical Research Program,https://dx.doi.org/10.1093/ofid/ofab466.1534,3/22/2022,7/17/2022,Unverified
211204_LA_UCLAMedicalCenter_Primary,"December 4, 2021",Local,United States of America,USA,California,,"September 15, 2020","December 15, 2020",Health care workers and caregivers,Multiple groups,1273,4.70%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Presentation or Conference,Evelyn A Flores,UCLA Medical Center,https://dx.doi.org/10.1093/ofid/ofab466.588,3/23/2022,3/2/2024,Unverified
211204_Seattle_UniversityOfWashington_Primary,"December 4, 2021",Local,United States of America,USA,"Washington
","Seattle
","September 9, 2020","May 7, 2021",Pregnant or parturient women,Adults (18-64 years),1304,4.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,Sylvia LaCourse,University of Washington,https://dx.doi.org/10.1093/ofid/ofab466.688,3/23/2022,3/2/2024,Verified
220303_Charleston_MedicalUniversityOfSouthCarolina_Period1,"March 8, 2022",Local,United States of America,USA,South Carolina,Charleston,"April 17, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),427,0.70%,,,Convenience,RayBiotech,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lauren Card,Medical University of South Carolina,https://dx.doi.org/10.1016/j.amjms.2022.01.025,3/23/2022,3/2/2024,Unverified
211204_Atlanta_EmoryUniversitySchoolofMedicine_Overall,"December 4, 2021",Local,United States of America,USA,Georgia,Atlanta,"January 15, 2021","March 15, 2021",Blood donors,Multiple groups,2406,17.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Graciaa,Emory University,https://dx.doi.org/10.1093/ofid/ofab466.572,3/23/2022,7/17/2022,Unverified
220312_California_StanfordUniversity,"March 12, 2022",Regional,United States of America,USA,California,,"May 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),2435,3.74%,,,Convenience,"Abbott Laboratories,EUROIMMUN,NA",Not reported,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sarah Doernberg,Stanford University,https://dx.doi.org/10.1093/cid/ciac210,3/26/2022,3/2/2024,Unverified
220323_UnitedStatesofAmerica_NationalInstitutesofHealth_Children_Spike,"March 23, 2022",National,United States of America,USA,"California, Arizona, Texas, Louisiana, Kansas, Minnesota, Illinois, Michigan, Tennessee, Georgia, Florida, Maryland, New Jersey",,"December 21, 2020","March 21, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),22,90.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Preprint,Eliza Gordon-Lipkin,National Institutes of Health,10.1101/2022.03.21.22272358,4/1/2022,7/17/2022,Unverified
220323_UnitedStatesofAmerica_NationalInstitutesofHealth_HouseholdMembers_Spike,"March 23, 2022",National,United States of America,USA,"California, Arizona, Texas, Louisiana, Kansas, Minnesota, Illinois, Michigan, Tennessee, Georgia, Florida, Maryland, New Jersey",,"December 21, 2020","March 21, 2021",Contacts of COVID patients,Adults (18-64 years),61,68.90%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Preprint,Eliza Gordon-Lipkin,National Institutes of Health,10.1101/2022.03.21.22272358,4/1/2022,7/17/2022,Unverified
220316_Minnesota_University of Minnesota,"March 16, 2022",Regional,United States of America,USA,Minnesota,,"December 8, 2020","March 24, 2021",Non-essential workers and unemployed persons,Multiple groups,706,7.93%,,,Convenience,Quansys Biosciences,ELISA,IgG,97.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Madhura Vachon,University of Minnesota,https://dx.doi.org/10.3390/ijerph19063501,4/3/2022,3/2/2024,Unverified
220320_Baltimore_JohnsHopkinsUniversity_FollowUp_Overall,"March 20, 2022",Local,United States of America,USA,Maryland,Baltimore,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),174,12.07%,,,Convenience,EUROIMMUN,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Anna Russell,Johns Hopkins University,https://www.mdpi.com/2227-9032/10/3/576/htm,4/5/2022,3/2/2024,Unverified
220320_Baltimore_JohnsHopkinsUniversity_Baseline_Overall,"March 20, 2022",Local,United States of America,USA,Maryland,Baltimore,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),191,5.76%,,,Convenience,EUROIMMUN,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Anna Russell,Johns Hopkins University,https://www.mdpi.com/2227-9032/10/3/576/htm,4/5/2022,3/2/2024,Unverified
220401_NewYork_LincolnMedicalCenter_May_HCWs,"April 1, 2022",Local,United States of America,USA,New York,,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),42,14.30%,,,Entire sample,NA,Not reported,Not reported,,,High,Presentation or Conference,Susan Kim,Lincoln Medical Center,https://dx.doi.org/10.1053/j.ajkd.2021.02.156,4/5/2022,7/17/2022,Unverified
220401_NewYork_LincolnMedicalCenter_June_patients,"April 1, 2022",Local,United States of America,USA,New York,,"June 1, 2020","June 30, 2020",Residual sera,Multiple groups,32,18.80%,,,Sequential,NA,Not reported,Not reported,,,High,Presentation or Conference,Susan Kim,Lincoln Medical Center,https://dx.doi.org/10.1053/j.ajkd.2021.02.156,4/5/2022,7/17/2022,Unverified
220325_Detroit_HenryFordHospital_Overall,"March 25, 2022",Local,United States of America,USA,Michigan,Detroit,"September 15, 2020","May 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),504,10.30%,,,Convenience,Beckman Coulter,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Smitha Gudipati,Henry Ford Hospital,https://dx.doi.org/10.1177/09564624221076629,4/6/2022,3/2/2024,Unverified
220330_NewYorkCity_MountSinaiHealthSystem,"March 30, 2022",Local,United States of America,USA,New York,New York City ,"April 15, 2020","August 15, 2021",Health care workers and caregivers,Adults (18-64 years),400,37.50%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,John Kubale,Mount Sinai Health System,https://www.medrxiv.org/content/10.1101/2022.03.28.22273068v1.full-text,4/6/2022,7/17/2022,Unverified
220331_Wisconsin_CDC_UniversityB_1September_AntiS,"March 31, 2022",Local,United States of America,USA,Wisconsin,,"September 1, 2020","September 11, 2020",Students and Daycares,Adults (18-64 years),36,19.44%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Christine Lee,CDC COVID‑19 Response Team,https://doi.org/10.1186/s12879-022-07314-5,4/6/2022,3/2/2024,Unverified
220331_Wisconsin_CDC_UniversityB_2November_AntiS,"March 31, 2022",Local,United States of America,USA,Wisconsin,,"November 9, 2020","November 14, 2020",Students and Daycares,Adults (18-64 years),36,36.11%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Christine Lee,CDC COVID‑19 Response Team,https://doi.org/10.1186/s12879-022-07314-5,4/6/2022,3/2/2024,Unverified
220228_Georgia_EmoryUniversity_MixedImmunity,"February 28, 2022",Regional,United States of America,USA,Georgia,,"February 11, 2021","May 7, 2021",Health care workers and caregivers,Adults (18-64 years),203,71.92%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),William Dube,Emory University,https://dx.doi.org/10.1016/j.jamda.2022.02.014,4/7/2022,3/2/2024,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round1_Overall,"March 18, 2022",Regional,United States of America,USA,Texas,,"October 1, 2020","November 30, 2020",Household and community samples,Children and Youth (0-17 years),218,34.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,http://doi.org/10.1542/peds.2021-055505,4/7/2022,3/2/2024,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round2_Overall,"March 18, 2022",Regional,United States of America,USA,Texas,,"January 1, 2021","February 28, 2021",Household and community samples,Children and Youth (0-17 years),218,40.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,http://doi.org/10.1542/peds.2021-055505,4/7/2022,3/2/2024,Unverified
220318_Texas_TheUniversityOfTexasSystem_Round3_Overall,"March 18, 2022",Regional,United States of America,USA,Texas,,"April 1, 2021","May 31, 2021",Household and community samples,Children and Youth (0-17 years),218,44.90%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.00%,,Moderate,Journal Article (Peer-Reviewed),Sarah Messiah,The University of Texas System,http://doi.org/10.1542/peds.2021-055505,4/7/2022,3/2/2024,Unverified
220225_NewYork_NewYorkUniversityLongIslandSchoolofMedicine_Overall,"February 25, 2022",Local,United States of America,USA,New York,Long Island,"February 1, 2020","August 25, 2020",Residual sera,Multiple groups,343,25.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Minesh Khatri,New York University Long Island School of Medicine,https://dx.doi.org/10.34067/KID.0006292020,4/12/2022,3/2/2024,Verified
210624_StLouis_WashingtonUniversitySchoolofMedicine_Patients,"June 24, 2021",Local,United States of America,USA,Missouri,St. Louis,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,226,8.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,High,Journal Article (Peer-Reviewed),Sumanth Gandra,Washington University School of Medicine,https://dx.doi.org/10.34067/KID.0001282021,4/15/2022,3/2/2024,Unverified
210624_StLouis_WashingtonUniversitySchoolofMedicine_HCW,"June 24, 2021",Local,United States of America,USA,Missouri,St. Louis,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),39,0.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,High,Journal Article (Peer-Reviewed),Sumanth Gandra,Washington University School of Medicine,https://dx.doi.org/10.34067/KID.0001282021,4/15/2022,3/2/2024,Unverified
220412_Boston_DanaFarberCancerInstitute_1_MayJul2020_TestAdj,"April 12, 2022",Local,United States of America,USA,Massachusetts,Boston,"May 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),519,9.20%,6.70%,12.00%,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jeffrey Meyerhardt,Dana-Farber Cancer Institute,https://dx.doi.org/10.1371/journal.pone.0266791,4/23/2022,7/17/2022,Unverified
220412_Boston_DanaFarberCancerInstitute_2_SepOct2020_TestAdj,"April 12, 2022",Local,United States of America,USA,Massachusetts,Boston,"September 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),479,8.50%,6.00%,11.00%,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jeffrey Meyerhardt,Dana-Farber Cancer Institute,https://dx.doi.org/10.1371/journal.pone.0266791,4/24/2022,7/17/2022,Unverified
220408_Tennessee_AccessBiologicals,"April 8, 2022",Local,United States of America,USA,Tennessee,,"December 22, 2020","February 25, 2021",Health care workers and caregivers,Adults (18-64 years),15,13.33%,,,Convenience,"DiaSorin,Progenika Biopharma, Derio, Bizkaia, Spain",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Francisco Belda,Access Biologicals,https://dx.doi.org/10.1016/j.vaccine.2022.04.006,4/29/2022,3/2/2024,Unverified
220413_Atlanta_EmoryUniversity_Overall,"April 13, 2022",Regional,United States of America,USA,Atlanta,,"May 11, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),1412,6.40%,5.30%,7.80%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Daniel Graciaa,Emory University,https://dx.doi.org/10.1016/j.amjms.2022.04.009,5/3/2022,3/2/2024,Unverified
220427_Arkansas_UniversityOfArkansasForMedicalSciences_OverallTestAdj,"April 27, 2022",Regional,United States of America,USA,Arkansas,,"May 1, 2020","December 31, 2020",Household and community samples,Multiple groups,1565,7.10%,5.80%,8.70%,Simplified probability,Beckman Coulter,CLIA,IgG,93.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Victor M. Cardenas,University of Arkansas for Medical Sciences,https://dx.doi.org/10.1371/journal.pone.0267322,5/3/2022,8/15/2023,Verified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_Baseline_Overall,"April 25, 2022",Local,United States of America,USA,North Carolina,Chapel Hill,"July 15, 2020","December 15, 2020",Multiple populations,Adults (18-64 years),910,6.24%,4.29%,8.19%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,5/4/2022,7/17/2022,Unverified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_1month_Overall,"April 25, 2022",Local,United States of America,USA,North Carolina,Chapel Hill,"July 15, 2020","December 15, 2020",Multiple populations,Adults (18-64 years),751,9.21%,6.74%,11.68%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,5/4/2022,7/17/2022,Unverified
220425_ChapelHill_UniversityofNorthCarolinaatChapelHill_3months_Overall,"April 25, 2022",Local,United States of America,USA,North Carolina,Chapel Hill,"July 15, 2020","December 15, 2020",Multiple populations,Adults (18-64 years),751,10.07%,7.41%,12.72%,Convenience,NA,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Audrey Pettifor,University of North Carolina at Chapel Hill,https://dx.doi.org/10.1371/journal.pone.0267353,5/4/2022,7/17/2022,Unverified
220421_NYC_UniversityofPennsylvania,"April 21, 2022",Local,United States of America,USA,New York,New York City,"April 15, 2020","December 15, 2020",Pregnant or parturient women,Adults (18-64 years),967,20.00%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Teresa Janevic,University of Pennsylvania,https://dx.doi.org/10.1016/j.ajogmf.2022.100649,5/4/2022,7/17/2022,Verified
220427_SanDiegoCounty&Tijuana_UCSD,"April 27, 2022",Regional,United States of America,USA,California,,,"September 10, 2021",Multiple populations,Multiple groups,571,30.10%,,,Convenience,"Genalyte (San Diego, CA)",Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Samantha Yeager,University of California San Diego,https://dx.doi.org/10.1186/s12889-022-13273-y,5/5/2022,3/2/2024,Unverified
220425_Minneapolis_UniversityOfMinnesota_Sample2,"April 25, 2022",Local,United States of America,USA,Minnesota,Minneapolis,"December 18, 2020","February 15, 2021",Health care workers and caregivers,Multiple groups,423,17.73%,,,Convenience,Quansys Biosciences,ELISA,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Talia D. Wiggen,University Of Minnesota,https://dx.doi.org/10.1371/journal.pone.0266410,5/6/2022,3/2/2024,Unverified
220504_SanFrancisco_UniversityofCaliforniaSanFrancisco_Vitros,"May 4, 2022",Local,United States of America,USA,California,San Francisco,"February 4, 2021","February 17, 2021",Residual sera,Multiple groups,915,28.42%,,,Stratified non-probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,83.80%,100.00%,High,Journal Article (Peer-Reviewed),Isobel Routledge,University of California San Francisco,https://doi.org/10.1038/s41467-022-30051-x,5/11/2022,3/2/2024,Verified
211018_Georgia_EmoryUniversity_PopAdj,"October 18, 2021",Regional,United States of America,USA,Georgia,,"August 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),1370,8.60%,6.30%,11.80%,Convenience,Bio-rad,ELISA,"IgA,IgM,IgG",99.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Allison Chamberlain,Emory University,https://dx.doi.org/10.1093/infdis/jiab522,5/12/2022,3/2/2024,Verified
220506_NewYorkState_NathanSKlineInstituteforPsychiatricResearch,"May 6, 2022",Regional,United States of America,USA,New York,,"March 8, 2020","July 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1958,29.21%,,,Convenience,Abbott Laboratories,Not reported,IgG,10.00%,99.60%,High,Journal Article (Peer-Reviewed),Katlyn Nemani,Nathan S. Kline Institute for Psychiatric Research,https://dx.doi.org/10.1001/jamanetworkopen.2022.10743,5/20/2022,3/2/2024,Unverified
220518_NewYorkCityDepartmentOfHealthAndMentalHygiene_PrimaryAdj,"May 18, 2022",Local,United States of America,USA,New York State,New York City,"September 15, 2020","March 15, 2021",Household and community samples,Multiple groups,2096,23.50%,20.10%,27.40%,Stratified probability,"DiaSorin,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Jannae Parrott,New York City Department of Health and Mental Hygiene,https://dx.doi.org/10.1017/S0950268822000875,5/30/2022,3/2/2024,Unverified
220521_PennsylvaniaStateUniversity_UniversityPark,"May 21, 2022",Local,United States of America,USA,Pennsylvania,University Park,"August 7, 2020","October 2, 2020",Students and Daycares,Multiple groups,1313,3.20%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Callum Arnold,Pennsylvania State University,https://dx.doi.org/10.1038/s41598-022-12499-5,6/1/2022,7/17/2022,Unverified
220516_LittleRock_UniversityOfArkansasForMedicalSciences,"May 16, 2022",Local,United States of America,USA,Arkansas,Little Rock,"October 25, 2020","April 15, 2021",Health care workers and caregivers,Multiple groups,54,26.00%,,,Convenience,NA,ELISA,"IgG,IgM",100.00%,94.60%,High,Journal Article (Peer-Reviewed),Hannah Wilkins,University of Arkansas for Medical Sciences,https://dx.doi.org/10.1002/emp2.12743,6/4/2022,7/17/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_1AprJun_TestPopAdj,"May 19, 2022",Regional,United States of America,USA,North Carolina,,"April 19, 2020","June 20, 2020",Residual sera,Multiple groups,3963,2.90%,1.80%,4.50%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,6/8/2022,7/17/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_2JunAug_TestPopAdj,"May 19, 2022",Regional,United States of America,USA,North Carolina,,"June 21, 2020","August 22, 2020",Residual sera,Multiple groups,3851,10.20%,8.50%,12.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,6/8/2022,7/17/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_3AugOct_TestPopAdj,"May 19, 2022",Regional,United States of America,USA,North Carolina,,"August 23, 2020","October 24, 2020",Residual sera,Multiple groups,2510,9.10%,7.20%,11.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,6/8/2022,7/17/2022,Unverified
220519_NorthCarolina_UniversityOfNorthCarolina_4OctDec_TestPopAdj,"May 19, 2022",Regional,United States of America,USA,North Carolina,,"October 25, 2020","December 26, 2020",Residual sera,Multiple groups,2147,12.80%,10.60%,15.20%,Sequential,NA,ELISA,Total Antibody,89.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Cesar Lopez,University of North Carolina,https://dx.doi.org/10.1128/msphere.00841-21,6/8/2022,7/17/2022,Unverified
220527_US_CityUniversityOfNewYork_Period1_Overall_TestAdj,"May 27, 2022",National,United States of America,USA,All 50 US states; the District of Columbia; Puerto Rico; Guam.,,"May 15, 2020","September 15, 2020",Household and community samples,Multiple groups,4232,2.20%,1.70%,2.80%,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",91.70%,98.80%,High,Journal Article (Peer-Reviewed),Denis Nash,City University of New York,https://dx.doi.org/10.1093/cid/ciac423,6/8/2022,8/15/2023,Unverified
220527_US_CityUniversityOfNewYork_Period2_Overall_UnAdj,"May 27, 2022",National,United States of America,USA,All 50 US states; the District of Columbia; Puerto Rico; Guam.,,"November 15, 2020","January 15, 2021",Household and community samples,Multiple groups,3883,7.37%,,,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",91.70%,98.80%,High,Journal Article (Peer-Reviewed),Denis Nash,City University of New York,https://dx.doi.org/10.1093/cid/ciac423,6/9/2022,3/2/2024,Unverified
220530_UnitedStates_NYUGrossmanSchoolofMedicine_Overall,"May 30, 2022",National,United States of America,USA,,,"September 23, 2021","November 5, 2021",Household and community samples,Adults (18-64 years),546,60.10%,,,Unclear,NA,Not reported,Not reported,,,High,Preprint,Jennifer Alejo,NYU Grossman School of Medicine,10.1101/2022.05.27.22275630,6/10/2022,1/4/2023,Unverified
211210_Athens_UniversityofGeorgia_Primary,"December 10, 2021",Local,United States of America,USA,Georgia,Atlanta,"January 20, 2021","March 22, 2021",Household and community samples,Adults (18-64 years),432,41.00%,31.40%,50.70%,Self-referral,NA,ELISA,IgA,77.78%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mark Ebell,University of Georgia,https://dx.doi.org/10.3122/jabfm.2022.03.210348,6/10/2022,7/17/2022,Unverified
220601_Philadelphia_ChildrensHospitalofPhiladelphia_OverallCrude,"June 1, 2022",Local,United States of America,USA,,Philadelphia,"April 13, 2020","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),5991,9.38%,,,Convenience,NA,ELISA,"IgG,IgM",100.00%,98.90%,Moderate,Journal Article (Peer-Reviewed),Heather Burris,Children's Hospital of Philadelphia,https://dx.doi.org/10.1097/AOG.0000000000004791,6/19/2022,7/17/2022,Unverified
220421_Massachusetts_MassachusettsGeneralHospital_Overall,"April 21, 2022",Local,United States of America,USA,Massachusetts,Boston,"December 17, 2020","January 27, 2021",Health care workers and caregivers,Adults (18-64 years),103,2.90%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Brian Yun,Massachusetts General Hospital,https://dx.doi.org/10.1016/j.jen.2022.04.003,6/21/2022,3/2/2024,Unverified
220615_NewJersey_RutgersNewJerseyMedicalSchool_Residents,"June 15, 2022",Regional,United States of America,USA,New Jersey,,"October 20, 2020","March 4, 2021",Assisted living and long-term care facilities,Seniors (65+ years),337,61.70%,,,Stratified non-probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,High,Journal Article (Peer-Reviewed),Stephen Friedman,Rutgers New Jersey Medical School,https://dx.doi.org/10.1007/s10900-022-01104-5,6/24/2022,3/2/2024,Unverified
220615_NewJersey_RutgersNewJerseyMedicalSchool_Staff,"June 15, 2022",Regional,United States of America,USA,New Jersey,,"October 20, 2020","March 4, 2021",Assisted living and long-term care facilities,Multiple groups,667,46.30%,,,Stratified non-probability,Bio-rad,ELISA,Total Antibody,98.00%,99.30%,High,Journal Article (Peer-Reviewed),Stephen Friedman,Rutgers New Jersey Medical School,https://dx.doi.org/10.1007/s10900-022-01104-5,6/24/2022,3/2/2024,Unverified
220602_NewYork_UniversityofNewYork_Phase1_Overall,"June 2, 2022",Local,United States of America,USA,New York ,New York ,"March 1, 2020","March 4, 2021",Residual sera,Multiple groups,699792,21.88%,,,Sequential,Abbott Laboratories,Not reported,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Madhura S. Rane,University of New York,https://dx.doi.org/10.1016/j.annepidem.2022.05.006,6/24/2022,3/2/2024,Unverified
220602_NewYork_UniversityofNewYork_Phase2_Overall,"June 2, 2022",Local,United States of America,USA,New York ,New York ,"March 5, 2021","July 20, 2021",Residual sera,Multiple groups,9367,34.67%,,,Sequential,"Abbott Laboratories,Roche Diagnostics",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Madhura S. Rane,University of New York,https://dx.doi.org/10.1016/j.annepidem.2022.05.006,6/24/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202012_Overall,"June 13, 2022",National,United States of America,USA,,,"December 1, 2020","December 31, 2020",Blood donors,Multiple groups,135026,11.90%,11.50%,12.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202108_Overall,"June 13, 2022",National,United States of America,USA,,,"August 1, 2021","August 31, 2021",Blood donors,Multiple groups,137583,89.60%,89.30%,89.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202112_Overall,"June 13, 2022",National,United States of America,USA,,,"December 1, 2021","December 31, 2021",Blood donors,Multiple groups,136156,94.70%,94.50%,94.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202008_Overall,"June 13, 2022",National,United States of America,USA,,,"August 1, 2020","August 31, 2020",Blood donors,Multiple groups,123200,4.80%,4.60%,5.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202104_Overall,"June 13, 2022",National,United States of America,USA,,,"April 1, 2021","April 30, 2021",Blood donors,Multiple groups,134510,71.40%,71.10%,71.80%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202106_Overall,"June 13, 2022",National,United States of America,USA,,,"June 1, 2021","June 30, 2021",Blood donors,Multiple groups,134788,87.40%,87.10%,87.70%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202110_Overall,"June 13, 2022",National,United States of America,USA,,,"October 1, 2021","October 31, 2021",Blood donors,Multiple groups,140121,92.90%,92.70%,93.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202105_Overall,"June 13, 2022",National,United States of America,USA,,,"May 1, 2021","May 31, 2021",Blood donors,Multiple groups,134949,83.30%,82.90%,83.70%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202102_Overall,"June 13, 2022",National,United States of America,USA,,,"February 1, 2021","February 28, 2021",Blood donors,Multiple groups,133288,33.50%,33.10%,33.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202007_Overall,"June 13, 2022",National,United States of America,USA,,,"July 1, 2020","July 31, 2020",Blood donors,Multiple groups,116513,3.70%,3.40%,4.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202107_Overall,"June 13, 2022",National,United States of America,USA,,,"July 1, 2021","July 31, 2021",Blood donors,Multiple groups,140224,88.80%,88.50%,89.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202103_Overall,"June 13, 2022",National,United States of America,USA,,,"March 1, 2021","March 31, 2021",Blood donors,Multiple groups,134557,49.20%,48.70%,49.60%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202101_Overall,"June 13, 2022",National,United States of America,USA,,,"January 1, 2021","January 31, 2021",Blood donors,Multiple groups,134632,20.50%,20.20%,20.90%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202010_Overall,"June 13, 2022",National,United States of America,USA,,,"October 1, 2020","October 31, 2020",Blood donors,Multiple groups,131731,5.90%,5.70%,6.20%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202111_Overall,"June 13, 2022",National,United States of America,USA,,,"November 1, 2021","November 30, 2021",Blood donors,Multiple groups,135135,93.90%,93.80%,94.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202109_Overall,"June 13, 2022",National,United States of America,USA,,,"September 1, 2021","September 30, 2021",Blood donors,Multiple groups,140567,91.80%,91.50%,92.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202011_Overall,"June 13, 2022",National,United States of America,USA,,,"November 1, 2020","November 30, 2020",Blood donors,Multiple groups,134061,8.20%,7.90%,8.50%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
220613_USA_CentersforDiseaseControlandPrevention_202009_Overall,"June 13, 2022",National,United States of America,USA,,,"September 1, 2020","September 30, 2020",Blood donors,Multiple groups,131052,5.00%,4.80%,5.30%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jefferson Jones,Vitalant Research Institute,https://jamanetwork.com/journals/jama/fullarticle/2793517,6/26/2022,3/2/2024,Unverified
210803_NewYorkCity_NewYorkUniversity_Overall_UnAdj,"August 3, 2021",Regional,United States of America,USA,New York,New York City,"April 29, 2020","February 9, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,329,16.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Amit Saxena,New York University,https://dx.doi.org/10.1136/lupus-2021-lupus21century.73,7/7/2022,3/2/2024,Unverified
220627_WashingtonDC_MedStarGeorgetownUniversityHospital,"June 27, 2022",Local,United States of America,USA,,Washington D.C.,"March 15, 2020","June 30, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),157,12.10%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Saikat Paul,Medstar Georgetown University Hospital,https://dx.doi.org/10.1097/MPG.0000000000003548,7/8/2022,3/2/2024,Unverified
220614_NorthernCalifornia_StanfordUniversity_Incarcerated,"June 14, 2022",Local,United States of America,USA,California,,"July 8, 2020","April 30, 2021",Persons who are incarcerated,Multiple groups,690,12.75%,10.00%,15.00%,Stratified non-probability,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",92.10%,100.00%,High,Journal Article (Peer-Reviewed),Yiran Liu,Stanford University,https://dx.doi.org/10.3389/fpubh.2022.854343,7/15/2022,3/2/2024,Unverified
220706_Boston_BostonUniversity,"July 6, 2022",Local,United States of America,USA,Massachusetts,Boston,"July 1, 2020","September 30, 2021",Health care workers and caregivers,Adults (18-64 years),527,16.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maura Dodge,Boston University School of Medicine,https://dx.doi.org/10.1093/jalm/jfac056,7/15/2022,3/2/2024,Unverified
220614_NorthernCalifornia_StanfordUniversity_Staff,"June 14, 2022",Local,United States of America,USA,California,,"July 8, 2020","April 30, 2021",Essential non-healthcare workers,Adults (18-64 years),292,8.22%,6.00%,12.00%,Convenience,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",92.10%,100.00%,High,Journal Article (Peer-Reviewed),Yiran Liu,Stanford University,https://dx.doi.org/10.3389/fpubh.2022.854343,7/16/2022,3/2/2024,Unverified
220513_California_CaliforniaDepartmentofPublicHealth_Adults_Overall,"May 13, 2022",Regional,United States of America,USA,California,,"April 20, 2021","June 15, 2021",Household and community samples,Multiple groups,7483,67.00%,63.00%,71.00%,Stratified probability,Enable Biosciences,Other,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Megha Mehrotra,California Department of Public Health,https://dx.doi.org/10.1093/ofid/ofac246,7/25/2022,3/22/2024,Verified
220513_California_CaliforniaDepartmentofPublicHealth_Children_Overall,"May 13, 2022",Regional,United States of America,USA,California,,"April 20, 2021","June 15, 2021",Household and community samples,Children and Youth (0-17 years),1375,41.00%,35.00%,47.00%,Stratified probability,Enable Biosciences,Other,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Megha Mehrotra,California Department of Public Health,https://dx.doi.org/10.1093/ofid/ofac246,7/25/2022,3/22/2024,Verified
220718_Chicago_NorthwesternUniversity_AntiRBDandNAbs,"July 18, 2022",Local,United States of America,USA,Illinois,Chicago,"June 24, 2020","November 11, 2020",Household and community samples,Multiple groups,4463,6.41%,,,Stratified probability,"Kantaro Biosciences LLC,Meso Scale Diagnostics",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Amelia Sancilio,Northwestern University,https://dx.doi.org/10.1038/s41598-022-15791-6,7/26/2022,3/2/2024,Unverified
220718_NorthCarolina_EastCarolinaUniversity_overall,"July 18, 2022",Local,United States of America,USA,"North Carolina
",,"August 26, 2020","March 31, 2021",Students and Daycares,Adults (18-64 years),695,9.78%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,,Preprint,C. Suzanne Lea,East Carolina Univeristy,10.1101/2022.07.15.22277688,7/28/2022,3/2/2024,Unverified
220804_UnitedStatesofAmerica_GeorgeWashingtonUniversity,"August 4, 2022",National,United States of America,USA,,,"May 13, 2020","July 6, 2020",Household and community samples,Multiple groups,6665,34.70%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonathan Silverberg,George Washington University,https://dx.doi.org/10.1371/journal.pone.0271310,8/10/2022,3/13/2024,Verified
220601_Colorado_UniversityOfColoradoDenver_Primary,"June 1, 2022",Regional,United States of America,USA,Colorado,,"August 15, 2020","December 15, 2021",Blood donors,Children and Youth (0-17 years),4172,31.10%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,CRISTY GENO RASMUSSEN,University of Colorado Denver,https://dx.doi.org/10.2337/db22-34-OR,8/17/2022,8/26/2022,Unverified
220426_UnitedStates_CDC_201109to201129_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"November 9, 2020","November 29, 2020",Residual sera,Multiple groups,63721,9.40%,9.10%,9.78%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_200824to200910_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"August 24, 2020","September 10, 2020",Residual sera,Multiple groups,45327,6.40%,6.07%,6.77%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_220127to220226_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states (except MT & NH), the District of Columbia, and Puerto Rico",,"January 27, 2022","February 26, 2022",Residual sera,Multiple groups,45810,57.70%,57.08%,58.27%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_200727to200813_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"July 27, 2020","August 13, 2020",Residual sera,Multiple groups,38776,5.90%,5.53%,6.26%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210621to210711_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"June 21, 2021","July 11, 2021",Residual sera,Multiple groups,59072,20.60%,20.17%,21.05%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_200920to201008_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"September 20, 2020","October 8, 2020",Residual sera,Multiple groups,45960,6.80%,6.49%,7.20%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_201005to201022_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"October 10, 2020","October 22, 2020",Residual sera,Multiple groups,46279,7.20%,6.83%,7.58%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210301to210321_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"March 1, 2021","March 21, 2021",Residual sera,Multiple groups,62296,20.40%,19.97%,20.89%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_211227to220129_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states (except NV), the District of Columbia, and Puerto Rico",,"December 27, 2021","January 29, 2022",Residual sera,Multiple groups,71902,43.30%,42.84%,43.78%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210906to211003_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states (except IN, MD, NJ, & VA), the District of Columbia, and Puerto Rico",,"September 6, 2021","October 3, 2021",Residual sera,Multiple groups,64969,29.20%,28.74%,29.71%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_200908to200924_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"September 8, 2020","September 24, 2020",Residual sera,Multiple groups,47909,6.80%,6.49%,7.18%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_201123to201212_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"November 23, 2020","December 12, 2020",Residual sera,Multiple groups,59563,11.50%,11.09%,11.82%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210215to210307_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"February 15, 2021","March 7, 2021",Residual sera,Multiple groups,59387,20.80%,20.24%,21.21%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_211101to211128_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states (except ND), the District of Columbia, and Puerto Rico",,"November 1, 2021","November 28, 2021",Residual sera,Multiple groups,81468,31.60%,31.15%,32.09%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_211004to211031_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"October 4, 2021","October 31, 2021",Residual sera,Multiple groups,73869,30.70%,30.30%,31.09%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210412to210502_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"April 12, 2021","May 2, 2021",Residual sera,Multiple groups,59368,21.40%,20.89%,21.93%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210510to210530_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"May 10, 2021","May 30, 2021",Residual sera,Multiple groups,58978,21.50%,21.01%,21.93%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_211129to211226_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states (except ND & SD), the District of Columbia, and Puerto Rico",,"November 29, 2021","December 26, 2021",Residual sera,Multiple groups,77680,33.50%,33.06%,34.01%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210201to210221_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"February 1, 2021","February 21, 2021",Residual sera,Multiple groups,59467,20.00%,19.52%,20.54%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_200810to200827_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"August 10, 2020","August 27, 2020",Residual sera,Multiple groups,45907,6.20%,5.86%,6.51%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210426to210516_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"April 26, 2021","May 16, 2021",Residual sera,Multiple groups,61208,22.10%,21.67%,22.64%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210607to210627_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"June 7, 2021","June 27, 2021",Residual sera,Multiple groups,63083,21.10%,20.70%,21.58%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210329to210418_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"March 29, 2021","April 18, 2021",Residual sera,Multiple groups,61095,21.80%,21.24%,22.23%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210315to210404_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"March 13, 2021","April 4, 2021",Residual sera,Multiple groups,60909,20.70%,20.24%,21.15%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_201025to201115_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"October 25, 2020","November 15, 2020",Residual sera,Multiple groups,64717,8.00%,7.72%,8.32%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220426_UnitedStates_CDC_210524to210613_Overall,"April 26, 2022",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"May 24, 2021","June 13, 2021",Residual sera,Multiple groups,60265,21.60%,21.17%,22.15%,Stratified non-probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,IgG,,,Moderate,Institutional Report,US CDC,US CDC,https://covid.cdc.gov/covid-data-tracker/#national-lab,9/1/2022,3/2/2024,Unverified
220822_NewYork_NewYorkStateDepartmentofHealth,"August 22, 2022",Regional,United States of America,USA,New York State,,"November 1, 2019","November 30, 2021",Perinatal,Children and Youth (0-17 years),415293,20.00%,,,Sequential,NA,Luminex,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amanda Damjanovic,New York State Department of Health,https://dx.doi.org/10.1001/jamanetworkopen.2022.27995,9/2/2022,9/2/2022,Unverified
220815_US_CDC_Round25_2021Sep_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states (except IN, MD, NJ, & VA), the District of Columbia, and Puerto Rico",,"September 6, 2021","October 3, 2021",Residual sera,Children and Youth (0-17 years),13384,38.40%,37.40%,39.44%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round26_2021Oct_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"October 4, 2021","October 31, 2021",Residual sera,Children and Youth (0-17 years),17068,42.00%,41.11%,42.92%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round27_2021Nov_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states (except ND), the District of Columbia, and Puerto Rico",,"November 1, 2021","November 28, 2021",Residual sera,Children and Youth (0-17 years),16734,42.90%,41.99%,43.70%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round28_2021Dec_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states (except ND & SD), the District of Columbia, and Puerto Rico",,"November 29, 2021","December 26, 2021",Residual sera,Children and Youth (0-17 years),14753,45.10%,44.04%,45.95%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round29_2022Jan_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states (except NV), the District of Columbia, and Puerto Rico",,"December 27, 2021","January 29, 2022",Residual sera,Children and Youth (0-17 years),14072,57.80%,56.79%,58.85%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round30_2022Feb_Overall,"January 27, 2023",National,United States of America,USA,"All 50 states (except MT & NH), the District of Columbia, and Puerto Rico",,"January 27, 2022","February 26, 2022",Residual sera,Children and Youth (0-17 years),11298,74.60%,73.53%,75.57%,Stratified non-probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round31_2022Mar-Apr_Overall_antiNorS,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"March 7, 2022","April 30, 2022",Residual sera,Children and Youth (0-17 years),28089,89.20%,88.65%,89.70%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220815_US_CDC_Round32_2022May-Jun_Overall_antiNorS,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"May 2, 2022","June 26, 2022",Residual sera,Children and Youth (0-17 years),26624,90.10%,89.57%,90.63%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,9/2/2022,3/2/2024,Unverified
220322_Maryland_JohnsHopkins_Overall,"March 22, 2022",Regional,United States of America,USA,Maryland,,"November 15, 2020","March 15, 2021",Household and community samples,Multiple groups,682,8.21%,,,Unclear,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Ruth Karron,Johns Hopkins University,https://doi.org/10.1172/jci.insight.157963,9/10/2022,3/2/2024,Unverified
220716_UnitedStates_MassachusettsVeteransEpidemiologyResearchandInformationCenter_Neoteryx,"July 16, 2022",National,United States of America,USA,,,"December 15, 2020","March 15, 2021",Household and community samples,Multiple groups,126,34.13%,,,Convenience,"InBios International, Inc.",ELISA,IgG,60.00%,88.00%,High,Journal Article (Peer-Reviewed),Tseli Mohammed,Massachusetts Veterans Epidemiology Research and Information Center ,https://dx.doi.org/10.1016/j.diagmicrobio.2022.115770,9/12/2022,3/16/2024,Verified
220716_UnitedStates_MassachusettsVeteransEpidemiologyResearchandInformationCenter_Tasso-SST,"July 16, 2022",National,United States of America,USA,,,"December 15, 2020","March 15, 2021",Household and community samples,Multiple groups,113,60.18%,,,Convenience,"InBios International, Inc.",ELISA,IgG,97.00%,80.00%,High,Journal Article (Peer-Reviewed),Tseli Mohammed,Massachusetts Veterans Epidemiology Research and Information Center ,https://dx.doi.org/10.1016/j.diagmicrobio.2022.115770,9/12/2022,3/16/2024,Verified
220704_NorthCarolina_UniversityofNorthCarolina,"July 4, 2022",Local,United States of America,USA,North Carolina,Chapel Hill,"November 18, 2020","January 19, 2021",Household and community samples,Adults (18-64 years),680,9.00%,5.40%,9.20%,Convenience,NA,Not reported,Total Antibody,95.00%,96.00%,High,Journal Article (Peer-Reviewed),Karen Diepstra,University of North Carolina,https://dx.doi.org/10.1016/j.jadohealth.2022.06.015,9/13/2022,9/13/2022,Unverified
220912_WashingtonDC_ChildrensNationalHospital_Overall,"September 14, 2022",Local,United States of America,USA,Washington DC,Washington DC,"September 25, 2020","January 15, 2021",Representative patient population,Children and Youth (0-17 years),100,19.00%,,,Self-referral,NA,ELISA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Pamela Mudd,Children's National Hospital,https://dx.doi.org/10.1002/lary.30382,9/20/2022,9/20/2022,Unverified
220909_Texas_UniversityOfTexas_2020Oct-2021Oct_PopAdj_Overall,"September 9, 2022",Regional,United States of America,USA,Texas,NR,"October 1, 2020","October 31, 2021",Multiple populations,Multiple groups,88605,35.00%,33.10%,36.90%,Convenience,Roche Diagnostics,CLIA,Not reported,99.50%,99.82%,High,Journal Article (Peer-Reviewed),Stacia DeSantis,University of Texas,https://dx.doi.org/10.1371/journal.pone.0273694,9/20/2022,3/2/2024,Unverified
220817_LosAngelesCounty_CedarsSinaiMedicalCenter_Overall,"August 17, 2022",Local,United States of America,USA,California,,"December 15, 2021","May 4, 2022",Multiple populations,Multiple groups,2479,10.65%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Sandy Joung,Cedars-Sinai Medical Center,http://doi.org/10.1001/jamanetworkopen.2022.27241,9/22/2022,3/2/2024,Unverified
220930_US_CDC_Round33_2022Jul-Aug_Overall_antiNorS,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"June 27, 2022","August 20, 2022",Residual sera,Children and Youth (0-17 years),27360,93.80%,93.32%,94.17%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,10/5/2022,3/2/2024,Unverified
210828_Georgia_EmoryUniversityRollinsSchoolOfPublicHealth,"October 28, 2021",Regional,United States of America,USA,Georgia,,"August 25, 2020","November 22, 2020",Health care workers and caregivers,Adults (18-64 years),749,23.50%,,,Unclear,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Avnika V Amin,Emory University Rollins School of Public Health,https://dx.doi.org/10.1017/ash.2021.193,10/19/2022,3/2/2024,Unverified
210916_Ohio_UniversityHospitalsClevelandMedicalCenter_Overall,"September 16, 2022",Regional,United States of America,USA,Ohio,,"May 22, 2020","September 15, 2020",Essential non-healthcare workers,Multiple groups,3080,2.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Xiaochun Zhang,University Hospitals Cleveland Medical Center,https://dx.doi.org/10.1177/00333549221119143,10/20/2022,3/2/2024,Unverified
220915_PittCounty_EastCarolinaUniversity_Overall,"September 15, 2022",Local,United States of America,USA,North Carolina,Greenville,"August 26, 2020","March 31, 2021",Students and Daycares,Adults (18-64 years),136,20.59%,,,Simplified probability,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Suzanne Lea,East Carolina University,https://dx.doi.org/10.3390/vaccines10091532,10/21/2022,10/21/2022,Unverified
221012_Rochester_OaklandUniversity_overall,"October 12, 2022",Local,United States of America,USA,Michigan,Rochester,"April 13, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),1895,31.93%,,,Convenience,EUROIMMUN,ELISA,IgG,99.35%,98.14%,Moderate,Journal Article (Peer-Reviewed),Ly Hoang Roberts,Oakland University ,https://dx.doi.org/10.1016/j.euros.2022.10.001,10/29/2022,3/2/2024,Unverified
221026_MiamiDade_UniversityOfMiami_Overall,"October 26, 2022",Local,United States of America,USA,Florida,,"October 15, 2020","September 15, 2021",Household and community samples,Adults (18-64 years),73,49.32%,,,Convenience,Hangzhou Biotest Biotech Co Ltd,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Emily Cherenack,University of Miami,https://dx.doi.org/10.1371/journal.pone.0276131,11/2/2022,11/3/2022,Unverified
221009_OlmstedCounty_MayoClinic_overall,"October 9, 2022",Local,United States of America,USA,Minnesota,,"November 15, 2020","February 15, 2021",Essential non-healthcare workers,Adults (18-64 years),755,7.70%,,,Convenience,Luminex Corporation,Luminex,IgG,96.10%,97.20%,Low,Journal Article (Peer-Reviewed),Celine Vachon,Mayo Clinic,https://dx.doi.org/10.1016/j.mayocpiqo.2022.10.001,11/3/2022,3/2/2024,Unverified
220207_SiouxFalls_SanfordHealth_Visit3_Overall,"February 7, 2022",Local,United States of America,USA,South Dakota,Sioux Falls,"October 13, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),201,55.22%,,,Convenience,"Siemens,DiaSorin",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Susan Hoover,Sanford Health,https://dx.doi.org/10.1017/ash.2022.9,11/8/2022,3/2/2024,Unverified
220930_Maryland_JohnsHopkinsUniversity,"September 30, 2022",Regional,United States of America,USA,Maryland,,"November 15, 2020","March 15, 2021",Household and community samples,Multiple groups,681,8.10%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Maria Garcia Quesada,Johns Hopkins University,https://dx.doi.org/10.1093/ofid/ofac507,11/10/2022,3/2/2024,Unverified
221012_UnitedStates_UniversityofWashington_infants,"October 12, 2022",Local,United States of America,USA,,Washington,"June 15, 2020","March 15, 2021",Residual sera,Children and Youth (0-17 years),24,37.50%,,,Sequential,NA,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Melanie Ann Martin,University of Washington,https://dx.doi.org/10.3389/fimmu.2022.1015002,11/14/2022,11/18/2022,Unverified
221012_UnitedStates_UniversityofWashington_mothers,"October 12, 2022",Local,United States of America,USA,,Washington,"June 15, 2020","March 15, 2021",Residual sera,Adults (18-64 years),57,80.70%,,,Sequential,NA,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Melanie Ann Martin,University of Washington,https://dx.doi.org/10.3389/fimmu.2022.1015002,11/14/2022,11/18/2022,Unverified
221114_UnitedStates_CentersforDiseaseControlandPrevention_overall,"November 14, 2022",National,United States of America,USA,,,"May 4, 2021","December 31, 2021",Blood donors,Multiple groups,85986,11.05%,,,Unclear,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Melisa Shah,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/cid/ciac883,11/22/2022,4/18/2024,Verified
210625_Ohio_OhioStateUniversity_Overall_PopTestAdj,"June 25, 2021",Regional,United States of America,USA,Ohio,,"July 9, 2020","July 28, 2020",Household and community samples,Multiple groups,667,1.30%,0.20%,2.70%,Stratified probability,"Abbott Laboratories,DiaSorin,Epitope Diagnostics, Inc.",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),David Kline,Ohio State University,https://doi.org/10.1073/pnas.2023947118,12/9/2022,3/20/2023,Unverified
221123_ChapelHill_UniversityOfNorthCarolina_Overall,"November 23, 2022",Local,United States of America,USA,North Carolina,Chapel Hill,"April 25, 2020","September 22, 2020",Pregnant or parturient women,Adults (18-64 years),388,4.90%,2.97%,7.54%,Convenience,NA,ELISA,"IgG,IgM,IgA",98.00%,100.00%,High,Journal Article (Peer-Reviewed),Kim Boggess,University of North Carolina,https://dx.doi.org/10.1002/ijgo.14587,12/9/2022,3/20/2023,Unverified
221202_USA_CDC_Overall_AntiS,"December 2, 2022",National,United States of America,USA,,,"August 15, 2021","May 15, 2022",Household and community samples,Multiple groups,1574,91.50%,,,Convenience,Ortho Clinical Diagnostics Inc.,,,,,,Journal Article (Peer-Reviewed),Lara Akinbami,US CDC,http://dx.doi.org/10.15585/mmwr.mm7148a4,12/17/2022,3/2/2024,Unverified
221215_US_CDC_Round34_2022Sep-Oct_Overall_antiNorS,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"August 22, 2022","October 16, 2022",Residual sera,Children and Youth (0-17 years),26174,95.90%,95.54%,96.26%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,12/22/2022,3/2/2024,Unverified
220922_Atlanta_EmoryUniversitySchoolofMedicine,"September 22, 2022",Local,United States of America,USA,Georgia,Atlanta,"January 22, 2021","March 12, 2021",Residual sera,Multiple groups,2406,17.00%,,,Convenience,Quanterix,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Daniel Graciaa,Emory University School of Medicine,https://dx.doi.org/10.1017/ash.2022.298,12/29/2022,3/20/2023,Unverified
221219_US_CDC_BloodDonors_2022Apr-Jun_Overall,"April 3, 2023",National,United States of America,USA,,,"April 1, 2022","June 30, 2022",Blood donors,Multiple groups,70584,94.31%,91.90%,96.03%,Simplified probability,Ortho Clinical Diagnostics Inc.,,,,,,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022,1/10/2023,3/2/2024,Unverified
221214_Omaha_UniversityOfNebraskaMedicalCenter,"December 14, 2022",Local,United States of America,USA,Nebraska,Omaha,"May 1, 2022","June 30, 2022",Health care workers and caregivers,Adults (18-64 years),69,100.00%,,,Convenience,Luminex Corporation,,,,,,Journal Article (Peer-Reviewed),Aaron Barksdale,University of Nebraska Medical Center,https://dx.doi.org/10.1016/j.ajem.2022.12.012,1/13/2023,3/2/2024,Unverified
20221220_Indiana_IndianaUniversitySchoolOfPublicHealthBloomington_Baseline,"December 20, 2022",Local,United States of America,USA,Indiana,Bloomington,"September 14, 2020","September 30, 2020",Students and Daycares,Adults (18-64 years),1076,4.69%,,,Convenience,BGI Genomics,,,,,,Journal Article (Peer-Reviewed),Christina Ludema,Indiana University School of Public Health-Bloomington,https://dx.doi.org/10.1371/journal.pone.0279347,1/14/2023,3/20/2023,Unverified
221222_USA_JohnsHopkinsBloombergSchoolofPublicHealth_Primary,"December 22, 2022",National,United States of America,USA,,,"June 14, 2021","December 16, 2021",Representative patient population,Multiple groups,475,9.89%,,,Self-referral,"Bio-rad,EUROIMMUN",Multiple Types,"IgG,IgA,IgM",,,,Journal Article (Peer-Reviewed),Andrea L. Wirtz,Johns Hopkins Bloomberg School of Public Health,https://dx.doi.org/10.1177/00333549221138853,1/14/2023,3/2/2024,Unverified
230127_US_CDC_Round35_2022Nov-Dec_Overall_antiNorS,"January 27, 2023",National,United States of America,USA,"All 50 states, the District of Columbia, and Puerto Rico",,"October 17, 2022","December 11, 2022",Residual sera,Children and Youth (0-17 years),26663,96.30%,95.91%,96.62%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#pediatric-seroprevalence,2/3/2023,3/2/2024,Unverified
221215_US_UniformedServicesUniversityoftheHealthSciences_blood_AntiS,"December 15, 2022",Regional,United States of America,USA,Maryland,,"August 15, 2020","February 15, 2021",Blood donors,Adults (18-64 years),97,8.20%,,,Unclear,NA,,IgG,,,,Presentation or Conference,Liana Andronescu,Uniformed Services University of the Health Sciences,https://dx.doi.org/10.1093/ofid/ofac492.1511,2/7/2023,3/20/2023,Unverified
221215_Flint_HurleyMedicalCenter,"December 15, 2022",Local,United States of America,USA,Michigan,,"April 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),192,19.80%,,,Convenience,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Sherry Demian,Hurley Medical Center,https://dx.doi.org/10.1093/ofid/ofac492.1518,2/10/2023,3/20/2023,Unverified
230119_NorthCarolina_JohnsHopkinsUniversity_Overall,"January 19, 2023",Regional,United States of America,USA,North Carolina,,"February 23, 2021","July 18, 2022",Household and community samples,Multiple groups,233,72.53%,,,Convenience,NA,Luminex,IgG,99.40%,99.30%,High,Journal Article (Peer-Reviewed),Carolyn Gigot,Johns Hopkins Bloomberg School of Public Health,https://dx.doi.org/10.1128/msphere.00522-22,2/10/2023,4/13/2024,Verified
230118_Holyoke_MassachusettsGeneralHospital_Primary,"January 18, 2023",Local,United States of America,USA,Massachusetts,Holyoke,"November 15, 2020","January 15, 2021",Household and community samples,Multiple groups,328,8.20%,,,Stratified probability,NA,ELISA,"IgG,IgM",70.60%,99.50%,,Journal Article (Peer-Reviewed),Wilfredo R Matias,Massachusetts General Hospital,https://dx.doi.org/10.1007/s40615-022-01502-4,2/11/2023,3/20/2023,Unverified
221203_UnitedStatesofAmerica_CentersforDiseaseControlandPrevention_OctNov2020,"December 3, 2022",National,United States of America,USA,,,"October 25, 2020","November 15, 2020",Residual sera,Multiple groups,63111,8.00%,7.90%,8.10%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Ryan Wiegand,Centers for Disease Control and Prevention,10.1016/j.lana.2022.100403,3/9/2023,3/2/2024,Unverified
221203_UnitedStatesofAmerica_CentersforDiseaseControlandPrevention_JanFeb2021,"December 3, 2022",National,United States of America,USA,,,"January 17, 2021","February 7, 2021",Residual sera,Multiple groups,57819,20.60%,20.40%,20.90%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Ryan Wiegand,Centers for Disease Control and Prevention,10.1016/j.lana.2022.100403,3/10/2023,3/2/2024,Unverified
221203_UnitedStatesofAmerica_CentersforDiseaseControlandPrevention_SeptOct2021,"December 3, 2022",National,United States of America,USA,,,"September 6, 2021","October 3, 2021",Residual sera,Multiple groups,63199,29.30%,29.00%,29.70%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Ryan Wiegand,Centers for Disease Control and Prevention,10.1016/j.lana.2022.100403,3/10/2023,3/2/2024,Unverified
221203_UnitedStatesofAmerica_CentersforDiseaseControlandPrevention_DecJan2022,"December 3, 2022",National,United States of America,USA,,,"December 27, 2021","January 29, 2022",Residual sera,Multiple groups,70091,43.70%,43.30%,44.20%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Ryan Wiegand,Centers for Disease Control and Prevention,10.1016/j.lana.2022.100403,3/10/2023,3/2/2024,Unverified
221203_UnitedStatesofAmerica_CentersforDiseaseControlandPrevention_JanFeb2022,"December 3, 2022",National,United States of America,USA,,,"January 27, 2022","February 26, 2022",Residual sera,Multiple groups,45509,58.20%,57.40%,58.90%,Sequential,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Ryan Wiegand,Centers for Disease Control and Prevention,10.1016/j.lana.2022.100403,3/10/2023,3/2/2024,Unverified
230309_USA_YaleSchoolofMedicine_Primary,"March 9, 2023",Local,United States of America,USA,Connecticut,,"March 8, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),1233,5.80%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Louis E Fazen,Yale School of Medicine,https://dx.doi.org/10.1097/JOM.0000000000002831,3/21/2023,3/21/2023,Unverified
230301_Michigan_UniversityofMichigan_Overall,"March 1, 2023",Regional,United States of America,USA,Michigan,,"July 17, 2020","April 30, 2021",Household and community samples,Multiple groups,409,7.10%,,,Convenience,Meso Scale Discovery,CLIA,,,,,Journal Article (Peer-Reviewed),Sydney Fine,University of Michigan,https://dx.doi.org/10.1111/irv.13106,3/30/2023,6/23/2023,Unverified
230321_Seattle_SeattleChildrensHospital_PrimaryEstimate,"March 21, 2023",Local,United States of America,USA,Washington,Seattle,"July 15, 2020","March 15, 2022",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),125,11.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,,Preprint,Rafael Hernandez,Seattle Children's Hospitals,10.22541/au.167937305.53541604/v1,4/4/2023,3/2/2024,Unverified
230315_NorthCarolina_UniversityOfNorthCarolina_Overall,"March 15, 2023",Regional,United States of America,USA,North Carolina,,"September 15, 2020","December 15, 2020",Multiple populations,Multiple groups,218,50.00%,,,Convenience,"NA,Wuhan UNscience Biotechnology Co. Ltd",Multiple Types,"Total Antibody,IgM,IgG",,,,Preprint,Michael Sciaudone,University of North Carolina,http://doi.org/10.2139/ssrn.4362126,4/6/2023,3/2/2024,Unverified
221030_Boston_BostonUniversity,"October 30, 2022",Local,United States of America,USA,Massachusetts,Boston,"July 13, 2020","July 26, 2020",Health care workers and caregivers,Adults (18-64 years),1743,7.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Manisha Cole,Boston University,https://dx.doi.org/10.21037/jlpm-22-19,4/12/2023,3/2/2024,Unverified
220713_NorthCarolina_UNC_Overall,"July 13, 2022",Regional,United States of America,USA,North Carolina,,"September 15, 2020","December 15, 2020",Non-essential workers and unemployed persons,Multiple groups,118,50.00%,,,Convenience,"Wuhan UNscience Biotechnology Co. Ltd,NA",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Melissa D. Klein,University of North Carolina at Chapel Hill School of Medicine,https://dx.doi.org/10.1371/journal.pgph.0000619,4/26/2023,3/2/2024,Unverified
230403_US_CDC_BloodDonors_2022Jul-Sep_Overall,"April 3, 2023",National,United States of America,USA,,,"July 1, 2022","September 30, 2022",Blood donors,Multiple groups,68881,95.99%,94.15%,97.26%,Simplified probability,Ortho Clinical Diagnostics Inc.,,,,,,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022,4/26/2023,3/2/2024,Unverified
230403_NorthCarolina_LevineChildren’sHospital_May21,"April 3, 2023",Regional,United States of America,USA,North Carolina,"Charlotte, Winston-Salem, and Raleigh","May 1, 2021","May 31, 2021",Residual sera,Children and Youth (0-17 years),1058,15.20%,9.00%,22.00%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,IgG,84.50%,99.00%,,Journal Article (Peer-Reviewed),Amina Ahmed,"Levine Children’s Hospital, Atrium",https://dx.doi.org/10.1017/S0950268823000481,5/4/2023,5/9/2023,Unverified
220815_NorthernCalifornia_UniversityofCalifornia_Round1_poptestadj,"August 15, 2022",Regional,United States of America,USA,"California
","Albany, Berkeley, El Cerrito, El Sobrante, Emeryville, Hercules, Kensington, Oakland, Piedmont, Pinole, Rich- mond, and San Pablo ","July 4, 2020","September 1, 2020",Household and community samples,Multiple groups,4670,0.63%,0.04%,2.00%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,80.60%,100.00%,Low,Journal Article (Peer-Reviewed),Cameron Adams,University of California,https://dx.doi.org/10.1371/journal.pgph.0000647,5/4/2023,4/8/2024,Verified
221207_NewMexico_UniversityOfNewMexico,"December 7, 2022",Local,United States of America,USA,,New Mexico,"June 15, 2021","October 15, 2021",Health care workers and caregivers,Adults (18-64 years),42,9.52%,,,Convenience,NA,ELISA,Not reported,,,,Presentation or Conference,Amy Armbruster,University of New Mexico,https://dx.doi.org/10.1016/j.amj.2022.10.004,5/4/2023,5/4/2023,Unverified
220327_Colorado_Colorado DepartmentofPublicHealthandEnvironment_Overall,"March 27, 2023",National,United States of America,USA,,,"May 12, 2021","July 13, 2021",Residual sera,Children and Youth (0-17 years),829,36.70%,33.40%,40.10%,Sequential,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Shannon C. O’Brien,Colorado Department of Public Health and Environment,https://dx.doi.org/10.3201/eid2905.221541,5/9/2023,3/2/2024,Unverified
230510_USA_AmericanRedCross_AntiS_Overall,"May 10, 2023",National,United States of America,USA,,,"June 15, 2020","June 15, 2021",Blood donors,Multiple groups,2448127,44.64%,,,Sequential,Ortho Clinical Diagnostics Inc.,,Total Antibody,,,High,Journal Article (Peer-Reviewed),James Haynes,American Red Cross,https://dx.doi.org/10.3201/eid2907.230173,6/1/2023,3/2/2024,Unverified
230516_OrangeCounty_UniversityOfSouthernCalifornia,"May 16, 2023",Local,United States of America,USA,California,Orange County,"May 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1557,10.80%,,,Stratified non-probability,NA,ELISA,"IgG,IgM",93.00%,98.00%,,Journal Article (Peer-Reviewed),Sebastian D. Schubl,University of Southern California,https://dx.doi.org/10.1186/s12879-023-08284-y,6/3/2023,6/3/2023,Unverified
230419_Torrance_UniversityofCaliforniaLosAngeles_Prospective,"April 19, 2023",Local,United States of America,USA,,Torrance,"December 1, 2021","April 15, 2022",Health care workers and caregivers,Multiple groups,200,33.00%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Meagan Jenkins,University of California Los Angeles,https://dx.doi.org/10.3389/fimmu.2023.1139915,6/3/2023,6/3/2023,Unverified
230512_Seattle_SeattleChildrensResearchInstitute_4thRound_12m_AntiS_Primary,"May 12, 2023",Local,United States of America,USA,Washington,Seattle,"May 3, 2021","June 15, 2021",Health care workers and caregivers,Adults (18-64 years),383,97.91%,,,Convenience,Abbott Laboratories,CLIA,IgG,95.60%,100.00%,,Journal Article (Peer-Reviewed),Kaitlin Cappetto,Seattle Children’s Research Institute,https://dx.doi.org/10.1016/j.ijregi.2023.05.001,6/28/2023,3/2/2024,Unverified
230615_Minnesota_UniversityofMinnesota_Overall,"June 15, 2023",Regional,United States of America,USA,Minnesota,,"December 29, 2020","February 26, 2021",Household and community samples,Multiple groups,537,9.50%,,,Convenience,Quansys Biosciences,CLIA,,,,Low,Journal Article (Peer-Reviewed),Jordan Abhold,University of Minnesota,https://dx.doi.org/10.1371/journal.pone.0279660,6/29/2023,4/26/2024,Verified
230531_LosAngeles_UniversityOfSouthernCalifornia_Children_PopAdj,"May 31, 2023",Local,United States of America,USA,California,Los Angeles,"February 1, 2021","May 23, 2021",Residual sera,Children and Youth (0-17 years),332,52.11%,49.61%,55.19%,Simplified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Jason Doctor,University of Southern California,https://dx.doi.org/10.1136/bmjopen-2022-070291 ,6/29/2023,3/2/2024,Unverified
230531_LosAngeles_UniversityOfSouthernCalifornia_Adults_PopAdj,"May 31, 2023",Local,United States of America,USA,California,Los Angeles,"February 1, 2021","May 23, 2021",Residual sera,Multiple groups,390,63.58%,60.39%,65.24%,Simplified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Jason Doctor,University of Southern California,https://dx.doi.org/10.1136/bmjopen-2022-070291 ,6/29/2023,3/2/2024,Unverified
230608_HowardCounty_JohnsHopkinsUniversity,"June 8, 2023",Local,United States of America,USA,Maryland,,"July 4, 2021","September 19, 2021",Household and community samples,Multiple groups,2293,11.90%,9.20%,15.10%,Stratified non-probability,NA,Other,IgG,98.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Alan Brown,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02765-22,6/29/2023,5/1/2024,Verified
230524_UnitedStatesofAmerica_RigattiRiskAnalytics,"May 24, 2023",National,United States of America,USA,,,"April 25, 2022","April 26, 2022",Household and community samples,Adults (18-64 years),2584,97.30%,,,Unclear,NA,,,,,,Journal Article (Peer-Reviewed),Robert Stout,Rigatti Risk Analytics,https://dx.doi.org/10.17849/insm-50-01-02.1,6/30/2023,7/4/2023,Unverified
230323_JeffersonCounty_UniversityOfLouisville_Probability1,"March 23, 2023",Regional,United States of America,USA,Kentucky,,"June 15, 2020","August 15, 2021",Household and community samples,Multiple groups,7296,13.20%,,,Simplified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Rachel J Keith,University Of Louisville,https://dx.doi.org/10.2105/AJPH.2023.307303,6/30/2023,7/4/2023,Unverified
230608_Fayetteville_UniversityofArkansas_Mar21_Overall,"June 8, 2023",Local,United States of America,USA,Arkansas,Fayettville,"March 1, 2021","March 31, 2021",Students and Daycares,Adults (18-64 years),241,45.00%,39.00%,52.00%,Convenience,"Beckman Coulter,NA",ELISA,IgG,,,,Journal Article (Peer-Reviewed),Jaimi Allen,University of Arkansas,https://dx.doi.org/10.1080/07448481.2023.2217456,6/30/2023,3/2/2024,Unverified
230323_JeffersonCounty_UniversityOfLouisville_Volunteer2,"March 23, 2023",Regional,United States of America,USA,Kentucky,,"June 15, 2020","August 15, 2021",Household and community samples,Multiple groups,7919,14.10%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Rachel J Keith,University Of Louisville,https://dx.doi.org/10.2105/AJPH.2023.307303,6/30/2023,7/4/2023,Unverified
230430_Texas_UniversityofTexasHealthScienceCenter_Overall,"April 30, 2023",Regional,United States of America,USA,Texas,,"October 15, 2020","November 15, 2022",Household and community samples,Children and Youth (0-17 years),3911,57.20%,,,Convenience,Roche Diagnostics,Not reported,Not reported,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Sarah Messiah ,University of Texas Health Science Center,https://dx.doi.org/10.3390/children10050818,6/30/2023,3/2/2024,Unverified
230726_US_CDC_BloodDonors_2022Oct-Dec_Overall,"April 3, 2023",National,United States of America,USA,,,"October 1, 2022","December 31, 2022",Blood donors,Multiple groups,66489,96.71%,93.85%,98.27%,Simplified probability,Ortho Clinical Diagnostics Inc.,,,,,,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022,7/27/2023,3/10/2024,Unverified
230628_US_CDC_BloodDonors_2022Jan-Mar_Overall,"April 3, 2023",National,United States of America,USA,,,"January 1, 2022","March 31, 2022",Blood donors,Multiple groups,70938,92.20%,89.57%,94.21%,Simplified probability,Ortho Clinical Diagnostics Inc.,,,,,,Institutional Report,US CDC,US Centers for Disease Control and Prevention,https://covid.cdc.gov/covid-data-tracker/#nationwide-blood-donor-seroprevalence-2022,7/28/2023,3/2/2024,Unverified
201128_LasVegas_SunriseHealthConsortium_Overall,"November 28, 2020",Local,United States of America,USA,Nevada,Las Vegas,"April 15, 2020","June 15, 2020",Multiple populations,Multiple groups,319,3.76%,,,Convenience,Hangzhou Testsea Biotechnology Co. Ltd,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Sassan Kaveh,Sunrise Health Consortium,https://dx.doi.org/10.36518/2689-0216.1158,8/2/2023,8/15/2023,Unverified
230624_UnitedStates_MountSinai,"June 24, 2023",National,United States of America,USA,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,235,8.94%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230717_Utah_UniversityOfUtah_AntiS_Primary,"July 17, 2023",Regional,United States of America,USA,Utah,,"June 10, 2020","August 15, 2020",Household and community samples,Multiple groups,8166,3.02%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Joel Hartsell,University of Utah,https://dx.doi.org/10.7717/peerj.15247,8/22/2023,4/26/2024,Verified
230723_Colorado_DenverHealthandHospitalAuthority_Overall,"July 23, 2023",Regional,United States of America,USA,Colorado,,"July 15, 2020","December 15, 2021",Blood donors,Children and Youth (0-17 years),4717,32.20%,,,Entire sample,NA,CLIA,Not reported,,,,Journal Article (Peer-Reviewed),Holly Frost,Denver Health and Hospital Authority,https://dx.doi.org/10.1177/21501319231189147,8/23/2023,8/23/2023,Unverified
230712_Oregon_OregonHealthAuthority_Point6,"July 12, 2023",Regional,United States of America,USA,Oregon,,"June 1, 2022","June 30, 2022",Residual sera,Children and Youth (0-17 years),289,29.80%,25.00%,36.20%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230712_Oregon_OregonHealthAuthority_Point5,"July 12, 2023",Regional,United States of America,USA,Oregon,,"April 1, 2022","April 30, 2022",Residual sera,Children and Youth (0-17 years),279,26.90%,22.20%,33.30%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230712_Oregon_OregonHealthAuthority_Point4,"July 12, 2023",Regional,United States of America,USA,Oregon,,"February 1, 2022","February 28, 2022",Residual sera,Children and Youth (0-17 years),215,38.80%,32.80%,46.50%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230712_Oregon_OregonHealthAuthority_Point3,"July 12, 2023",Regional,United States of America,USA,Oregon,,"December 1, 2021","December 31, 2021",Residual sera,Children and Youth (0-17 years),278,13.40%,9.80%,18.40%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230712_Oregon_OregonHealthAuthority_Point2,"July 12, 2023",Regional,United States of America,USA,Oregon,,"October 1, 2021","October 31, 2021",Residual sera,Children and Youth (0-17 years),370,11.80%,9.00%,16.10%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230712_Oregon_OregonHealthAuthority_Point1,"July 12, 2023",Regional,United States of America,USA,Oregon,,"November 1, 2020","December 31, 2020",Residual sera,Children and Youth (0-17 years),438,3.30%,0.20%,5.20%,Sequential,Abbott Laboratories,,IgG,100.00%,99.60%,,Journal Article (Peer-Reviewed),Rebecca A. Falender,Oregon Health Authority,https://dx.doi.org/10.3201/eid2908.230471,8/24/2023,3/2/2024,Unverified
230802_California_CaliforniaDepartmentofPublicHealth_Overall,"August 2, 2023",Regional,United States of America,USA,California,,"October 1, 2020","March 31, 2021",Residual sera,Children and Youth (0-17 years),2890,15.70%,14.30%,17.00%,Stratified probability,NA,Not reported,"IgG,IgM,IgA",,,Low,Journal Article (Peer-Reviewed),,California Department of Public Health,https://dx.doi.org/10.3390/ijns9030043,9/21/2023,9/21/2023,Unverified
230901_Baltimore_JohnsHopkinsUniversity,"September 1, 2023",Local,United States of America,USA,Maryland,Baltimore,"December 15, 2020","July 15, 2022",Residual sera,Adults (18-64 years),561,62.70%,58.60%,66.80%,Convenience,Meso Scale Diagnostics,Neutralization,Not reported,93.80%,99.50%,High,Journal Article (Peer-Reviewed),Eshan U. Patel,"Johns Hopkins University
",https://dx.doi.org/10.1016/j.dadr.2023.100184,9/22/2023,4/30/2024,Verified
230804_Missouri_WashingtonUniversitySchoolofMedicine_followup,"August 4, 2023",Local,United States of America,USA,Missouri,St. Louis,"December 15, 2020","April 15, 2021",Health care workers and caregivers,Adults (18-64 years),400,77.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,,Journal Article (Peer-Reviewed),Rachel E. Bosserman,Washington University School of Medicine,https://dx.doi.org/10.1017/ash.2022.375,9/22/2023,3/2/2024,Unverified
230829_Arizona_ArizonaStateUniversity,"August 29, 2023",Regional,United States of America,USA,Arizona,,"March 1, 2022","March 3, 2022",Multiple populations,Adults (18-64 years),1397,96.30%,,,Convenience,Beckman Coulter,CLIA,IgG,,,,Preprint,Ching-Wen Hou,Arizona State University,https://www.medrxiv.org/content/10.1101/2023.08.29.23293775v1,9/23/2023,3/2/2024,Unverified
230819_Aurora_UniversityOfColoradoAnschutzMedicalCampus,"August 19, 2023",Local,United States of America,USA,Colorado,Aurora,"December 15, 2020","March 15, 2021",Health care workers and caregivers,Multiple groups,43,4.65%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Ellie Hong,University of Colorado Anschutz Medical Campus,https://dx.doi.org/10.5858/arpa.2023-0014-OA,9/26/2023,3/2/2024,Unverified
230824_Seattle_UniversityOfWashington,"August 24, 2023",Local,United States of America,USA,Washington,Seattle,"December 9, 2020","June 30, 2021",Pregnant or parturient women,Adults (18-64 years),1284,5.06%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Alison Drake,University of Washington,https://dx.doi.org/10.1177/17455057231190955,9/26/2023,4/24/2024,Verified
231009_Maryland_JohnsHopkinsUniversity_Time1,"October 9, 2023",Regional,United States of America,USA,Maryland,,"April 15, 2020","December 15, 2020",Residual sera,Multiple groups,3109,14.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Patrizio Caturegli,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02183-23,3/9/2024,6/26/2024,Unverified
231009_Maryland_JohnsHopkinsUniversity_Time2,"October 9, 2023",Regional,United States of America,USA,Maryland,,"January 15, 2021","June 15, 2021",Residual sera,Multiple groups,3039,53.31%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Patrizio Caturegli,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02183-23,3/9/2024,6/26/2024,Unverified
231009_Maryland_JohnsHopkinsUniversity_Time3,"October 9, 2023",Regional,United States of America,USA,Maryland,,"July 15, 2021","November 15, 2021",Residual sera,Multiple groups,3724,75.38%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Patrizio Caturegli,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02183-23,3/9/2024,6/26/2024,Unverified
231009_Maryland_JohnsHopkinsUniversity_Time4,"October 9, 2023",Regional,United States of America,USA,Maryland,,"December 15, 2021","June 15, 2022",Residual sera,Multiple groups,3526,87.29%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Patrizio Caturegli,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02183-23,3/9/2024,6/26/2024,Unverified
231009_Maryland_JohnsHopkinsUniversity_Time5,"October 9, 2023",Regional,United States of America,USA,Maryland,,"July 15, 2022","February 15, 2023",Residual sera,Multiple groups,2422,95.21%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Patrizio Caturegli,Johns Hopkins University,https://dx.doi.org/10.1128/spectrum.02183-23,3/9/2024,6/26/2024,Unverified
231113_NewYork_IcahnSchoolofMedicine_Jan2023,"November 13, 2023",Local,United States of America,USA,New York,New York City,"January 1, 2023","January 31, 2023",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),175,68.00%,,,Convenience,Meso Scale Diagnostics,Neutralization,IgG,,,High,Journal Article (Peer-Reviewed),Ananda Rodilla,Icahn School of Medicine at Mount Sinai,https://dx.doi.org/10.1016/j.ccell.2023.09.017,3/9/2024,3/9/2024,Unverified
220704_Zanzibar_StateUniversityofZanzibar,"July 4, 2022",Regional,United Republic of Tanzania,TZA,Zanzibar Region,,"July 28, 2021","October 20, 2021",Household and community samples,Multiple groups,2051,56.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salum Seif Salum,State University of Zanzibar,https://dx.doi.org/10.1016/j.ijregi.2022.06.007,7/20/2022,4/1/2024,Verified
220916_Mwanza_CatholicUniversityofHealthandAlliedSciences_overall,"September 16, 2022",Regional,United Republic of Tanzania,TZA,"Mwanza
",,"September 1, 2021","September 30, 2021",Household and community samples,Adults (18-64 years),805,49.32%,,,Stratified probability,"KH Medics, Limited",LFIA,"IgG,IgM",90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Helmu Nyawale,Catholic University of Health and Allied Sciences,https://dx.doi.org/10.3390/ijerph191811664,10/4/2022,3/2/2024,Unverified
221112_Tanzania_NationalInstituteForMedicalResearch_Overall,"November 12, 2022",Local,United Republic of Tanzania,TZA,Korogwe,,"July 19, 2021","July 30, 2021",Household and community samples,Children and Youth (0-17 years),501,36.30%,,,Stratified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Eric Lyimo,National Institute for Medical Research,https://dx.doi.org/10.1186/s12879-022-07820-6,12/15/2022,3/20/2023,Unverified
221216_Tanzania_UniversityOfCopenhagen,"December 16, 2022",National,United Republic of Tanzania,TZA,,,"April 26, 2021","October 27, 2021",Household and community samples,Multiple groups,1147,37.10%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Omari AbdulMsemo,University of Copenhagen,https://dx.doi.org/10.1016/j.ijregi.2022.11.011,1/13/2023,3/20/2023,Unverified
200520_England_RutherfordHealth_HCW_IgG,"May 20, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Reading, Newport, Liverpool, Bedlington","April 14, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),161,1.24%,,,Convenience,"Sugentech, Inc.",LFIA,IgG,,,High,Preprint,Karol Sikora,Rutherford Health,https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html,5/22/2020,3/2/2024,Verified
200617_Gibraltar_GibraltarGovernment_HCW,"June 17, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Gibraltar,,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),1247,1.40%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Priya Gulraj,Gibraltar Government ,https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg,6/24/2020,7/17/2022,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,"August 21, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"February 1, 2020","March 31, 2020",Residual sera,Children and Youth (0-17 years),443,0.80%,0.00%,2.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,7/5/2023,Verified
200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,"August 21, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"February 1, 2020","March 31, 2020",Household and community samples,Children and Youth (0-17 years),106,0.50%,0.00%,3.60%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,7/5/2023,Verified
200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"March 26, 2020","March 27, 2020",Blood donors,Adults (18-64 years),757,2.60%,1.10%,4.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,7/5/2023,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,"July 9, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","June 28, 2020",Blood donors,Multiple groups,10318,7.20%,6.60%,7.80%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,7/5/2023,Verified
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,"July 9, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 4, 2020","May 31, 2020",Blood donors,Adults (18-64 years),7686,8.30%,7.50%,9.20%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,7/5/2023,Verified
200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"April 9, 2020","April 13, 2020",Blood donors,Adults (18-64 years),1085,11.10%,8.90%,13.60%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,"August 7, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 16, 2020","June 30, 2020",Residual sera,Seniors (65+ years),6000,3.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 2, 2020","April 3, 2020",Blood donors,Adults (18-64 years),916,2.40%,1.00%,4.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 23, 2020","April 24, 2020",Blood donors,Adults (18-64 years),1043,7.30%,5.40%,9.40%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 24, 2020","April 26, 2020",Blood donors,Adults (18-64 years),865,5.00%,3.20%,7.00%,Stratified probability,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 14, 2020","April 16, 2020",Blood donors,Adults (18-64 years),1017,4.60%,3.00%,6.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 15, 2020","April 20, 2020",Blood donors,Adults (18-64 years),936,6.20%,4.40%,8.40%,Stratified probability,EUROIMMUN,ELISA,IgG,79.00%,99.00%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,"September 11, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 1, 2020","May 31, 2020",Residual sera,Children and Youth (0-17 years),1061,7.30%,5.60%,9.20%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200821_England_PHE_WhatsTheStory_TestAdj_April,"August 21, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 1, 2020","April 30, 2020",Household and community samples,Children and Youth (0-17 years),201,3.80%,1.20%,7.50%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,"August 21, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),647,6.10%,4.10%,8.40%,Stratified probability,Abbott Laboratories,ELISA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/20/2020,7/5/2023,Verified
200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,"July 7, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 4, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),281,6.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Dimitrios Poulikakos,Salford Royal NHS Foundation Trust,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/,7/20/2020,3/2/2024,Verified
200709_London_UniversityCollegeLondonHospitals_HCW,"July 9, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"March 26, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),181,45.30%,,,Convenience,NA,Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Catherine Houlihan,University College London Hospitals,https://dx.doi.org/10.1016/S0140-6736(20)31484-7,7/30/2020,7/17/2022,Verified
201004_SEEngland_King’sCollegeLondon,"October 14, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,South East England,,"April 27, 2020","June 2, 2020",Household and community samples,Multiple groups,431,12.00%,9.10%,15.20%,Convenience,NA,ELISA,"IgG,IgM",90.00%,100.00%,High,Journal Article (Peer-Reviewed),Philippa M Wells,King’s College London,http://dx.doi.org/10.1016/j.jinf.2020.10.011,9/28/2020,7/17/2022,Verified
200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj,"July 25, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,King's Lynn,"June 1, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),70,21.40%,,,Unclear,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),D M Favara,The Queen Elizabeth Hospital,https://dx.doi.org/10.1016/j.clon.2020.07.015,9/29/2020,7/17/2022,Verified
200808_UK_PortlandHospitalforWomenandChildren_HCW,"August 8, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 15, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,22.00%,,,Convenience,Abbott Laboratories,ELISA,IgG,96.90%,99.90%,High,Journal Article (Peer-Reviewed),Asma Khalil,St George’s University of London,http://dx.doi.org/10.1093/cid/ciaa893,10/3/2020,3/2/2024,Verified
200810_London_UniversityCollegeLondon_Total,"August 10, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 11, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,200,14.50%,9.90%,20.10%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),S Bampoe,University College London,https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229,10/5/2020,3/2/2024,Verified
200729_London_WhittingtonHealthNHSTrust_Overall,"August 4, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 15, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,2004,31.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,99.80%,High,Journal Article (Peer-Reviewed),Joseph Grant,Whittington Health NHS Trust,https://dx.doi.org/10.1017/ice.2020.402,10/6/2020,3/2/2024,Verified
200922_Gateshead_NHSFoundationTrust_Overall,"September 22, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Gateshead,"May 28, 2020","June 8, 2020",Health care workers and caregivers,Adults (18-64 years),2521,19.40%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Salman Razvi,Gateshead Health NHS Foundation Trust,https://dx.doi.org/10.7861/clinmed.2020-0566,10/15/2020,3/2/2024,Verified
200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,"August 7, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 29, 2020","July 28, 2020",Blood donors,Multiple groups,9388,5.90%,5.30%,6.50%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/20/2020,7/5/2023,Verified
200930_Scotland_PublicHealthScotland_2BloodDonors_Overall_TestAdj,"September 30, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"June 29, 2020","August 9, 2020",Blood donors,Multiple groups,3220,3.10%,2.50%,3.80%,Sequential,NA,Not reported,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,10/26/2020,7/17/2022,Verified
200724_UK_ChelseaandWestminsterHospital_HCW,"July 24, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"April 8, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,504,10.60%,7.60%,13.60%,Convenience,"CTK Biotech, Inc.,NA,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Scott Pallett,Chelsea and Westminster Hospital NHS Trust,https://dx.doi.org/10.1016/S2213-2600(20)30315-5,10/29/2020,3/2/2024,Verified
200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall,"September 11, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Birmingham,"April 24, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),516,24.40%,,,Self-referral,NA,ELISA,"IgA,IgG,IgM",100.00%,97.80%,High,Journal Article (Peer-Reviewed),Adrian Shields,University Hospitals Birmingham NHS Foundation Trust,http://dx.doi.org/10.1136/thoraxjnl-2020-215414,11/4/2020,7/17/2022,Verified
200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex,"September 20, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,East of England,,"June 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),434,18.40%,,,Convenience,NA,ELISA,IgG,84.00%,100.00%,High,Preprint,David Favara,Cambridge University Hospitals NHS Foundation Trust,https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1,1/15/2021,7/17/2022,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients,"November 13, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,10.40%,8.50%,12.60%,Sequential,"Abbott Laboratories,Fortress Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Michelle Willicombe,Imperial College London,https://dx.doi.org/10.1097/TP.0000000000003526,1/17/2021,3/2/2024,Verified
201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren,"November 10, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,"Ireland, Wales, Scotland, England","Belfast, Cardiff, Glasgow, London, Manchester","April 16, 2020","July 3, 2020",Family of essential workers,Children and Youth (0-17 years),992,6.90%,5.40%,8.60%,Convenience,"Abbott Laboratories,DiaSorin,Roche Diagnostics",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Thomas Waterfield,Royal Belfast Hospital for Sick Children,https://dx.doi.org/10.1136/archdischild-2020-320558,1/18/2021,3/2/2024,Verified
201022_Oxford_UniversityOfOxford_unadj,"October 22, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,"April 14, 2020","June 15, 2020",Pregnant or parturient women,Adults (18-64 years),1000,5.30%,4.00%,6.90%,Sequential,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila F Lumley,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721,1/21/2021,7/17/2022,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj,"October 27, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"July 31, 2020","August 13, 2020",Household and community samples,Multiple groups,105829,4.83%,4.67%,5.00%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/21/2021,7/17/2022,Verified
201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj,"October 27, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"September 15, 2020","September 28, 2020",Household and community samples,Multiple groups,159367,4.38%,4.25%,4.51%,Simplified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Preprint,Helen Ward,Imperial College London,https://www.medrxiv.org/content/10.1101/2020.10.26.20219725v1.full.pdf,1/21/2021,7/17/2022,Verified
201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW,"November 17, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,"Belfast, Cardiff, Glasgow, London, Manchester","May 1, 2020","May 31, 2020",Contacts of COVID patients,Children and Youth (0-17 years),44,36.20%,9.00%,63.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Immunisation and Countermeasures Division,https://dx.doi.org/10.1093/cid/ciaa1737,1/23/2021,3/2/2024,Verified
200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35,"September 11, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 27, 2020","August 30, 2020",Blood donors,Multiple groups,8764,5.30%,4.80%,5.80%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/24/2021,7/5/2023,Verified
201103_London_PHE_LTCStaff,"November 3, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,"June 3, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,327,47.10%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Thomas Rowland,Public Health England,https://dx.doi.org/10.1016/j.jinf.2020.10.035,1/24/2021,3/2/2024,Verified
201223_Oxford_OxfordUniversityHospitals_HCW_Spike,"December 23, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"April 23, 2020","November 30, 2020",Health care workers and caregivers,Multiple groups,12541,10.08%,,,Convenience,NA,ELISA,IgG,99.10%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sheila Lumley,Oxford University Hospitals,https://dx.doi.org/10.1056/NEJMoa2034545,1/24/2021,7/17/2022,Verified
201119_UK_QueensUniversityBelfast_adj,"November 19, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,"Belfast, Cardiff, Glasgow, London, Manchester","June 26, 2020","August 15, 2020",Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Convenience,"Roche Diagnostics,DiaSorin",Multiple Types,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,https://dx.doi.org/10.1016/S1473-3099(20)30884-7,1/24/2021,3/2/2024,Verified
200911_England_PHE_WhatsTheStory_Summary_5_May_August,"September 11, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 1, 2020","August 5, 2020",Household and community samples,Children and Youth (0-17 years),568,5.20%,3.20%,7.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/24/2021,3/2/2024,Verified
201002_England_PHE_BloodDonors_Summary_Final,"October 2, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"August 24, 2020","September 18, 2020",Blood donors,Multiple groups,8230,6.10%,5.40%,6.80%,Stratified probability,EUROIMMUN,ELISA,IgG,83.00%,99.30%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/24/2021,7/5/2023,Verified
201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott,"October 2, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 15, 2020","August 16, 2020",Residual sera,Seniors (65+ years),4315,6.50%,5.50%,7.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Moderate,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/24/2021,3/2/2024,Verified
201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott,"October 2, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 15, 2020","August 16, 2020",Residual sera,Multiple groups,1212,5.20%,3.90%,7.00%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.70%,99.10%,Low,Institutional Report,Public Health England,Public Health England,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/24/2021,3/2/2024,Verified
200826_London_ImperialCollegeLondon_LTC,"August 26, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,"June 1, 2020","June 30, 2020",Assisted living and long-term care facilities,Seniors (65+ years),241,71.80%,66.00%,77.00%,Convenience,Abbott Laboratories,Not reported,IgG,93.90%,100.00%,High,Journal Article (Peer-Reviewed),Neil Graham,Imperial College London,https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext,1/24/2021,3/2/2024,Verified
201109_UK_WatfordGeneralHospital_ACU,"November 9, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,NR,Watford,"March 27, 2020","June 8, 2020",Residual sera,Multiple groups,443,1.58%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Muhammad Arif,Watford General Hospital,https://dx.doi.org/10.7759/cureus.11398,1/24/2021,7/17/2022,Verified
201215_Leicester_UniversityHospitalsofLeicesterNHSTrust,"December 15, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Leicester ,"May 29, 2020","August 3, 2020",Health care workers and caregivers,Adults (18-64 years),200,12.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,92.70%,100.00%,High,Journal Article (Peer-Reviewed),John Black,University Hospitals of Leicester NHS Trust,https://dx.doi.org/10.1111/tri.13791,1/27/2021,3/2/2024,Verified
201130_Bristol_NorthBristolNHSTrust_hcw,"November 30, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Bristol, South Gloucestershire, North Somerset","January 15, 2020","June 15, 2020",Health care workers and caregivers,Multiple groups,6858,9.30%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Christopher Jones,North Bristol NHS Trust,https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext,1/31/2021,3/2/2024,Verified
201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust,"December 22, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England ,Newcastle-Upon-Tyne,"May 29, 2020","July 6, 2020",Health care workers and caregivers,Adults (18-64 years),11103,8.40%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Preprint,Aidan Hanrath,Newcastle-upon-Tyne Hospitals NHS Trust,https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1,2/3/2021,3/2/2024,Verified
201211_London_RichmondPharmacologyLtd,"December 11, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"March 19, 2020","December 2, 2020",Multiple populations,Multiple groups,6061,6.40%,,,Unclear,NA,Other,IgG,,,High,Preprint,Jorg Taubel,Richmond Pharmacology Ltd,https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2,2/4/2021,7/17/2022,Verified
201124_Scotland_PublicHealthScotland_overall,"November 24, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 20, 2020","June 21, 2020",Residual sera,Multiple groups,4744,4.30%,4.20%,4.50%,Stratified probability,DiaSorin,Not reported,IgG,87.50%,98.60%,Moderate,Journal Article (Peer-Reviewed),E Dickson,Public Health Scotland,https://dx.doi.org/10.1016/j.puhe.2020.11.014,2/6/2021,2/3/2024,Verified
201022_Scotland_UniversityOfOxford_overall,"October 22, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"March 17, 2020","May 18, 2020",Blood donors,Adults (18-64 years),3500,3.17%,,,Simplified probability,NA,Neutralization,Neutralizing ,94.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Craig P Thompson,University of Oxford,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685,2/7/2021,7/17/2022,Verified
210111_UK_PublicHealthEngland_Round1_overall,"January 20, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","June 15, 2020",Multiple populations,Multiple groups,2198,13.60%,12.40%,15.10%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/2/2024,Verified
210111_UK_PublicHealthEngland_Round2_overall ,"January 20, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 7, 2020","July 21, 2020",Household and community samples,Multiple groups,1431,12.10%,10.50%,13.90%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/12/2021,3/2/2024,Verified
210111_UK_PublicHealthEngland_Round3_overall,"January 20, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 17, 2020","November 30, 2020",Household and community samples,Multiple groups,1216,10.40%,8.80%,12.30%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint, Shamez Ladhani,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/12/2021,3/2/2024,Verified
201116_Leicester_UniversityofLeicester_HCW,"November 16, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,East Midlands,Leicester,"May 29, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),10662,10.77%,,,Convenience,Abbott Laboratories,Not reported,IgG,93.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Christopher Martin,University of Leicester,https://dx.doi.org/10.1093/pubmed/fdaa199,2/14/2021,3/2/2024,Verified
210203_England_TheUniversityofNottingham_HCW_primary,"February 3, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,East Midlands,,"April 24, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),633,18.00%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/18/2021,7/17/2022,Unverified
210203_England_TheUniversityofNottingham_HHC_primary,"February 3, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),178,7.30%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",,,High,Preprint,Simon Craxford,The University of Nottingham,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/18/2021,7/17/2022,Unverified
201021_London_BartsHealthNHSTrust_primary,"October 21, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"May 1, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1253,18.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Kieran McCafferty,Barts Health NHS Trust ,http://dx.doi.org/10.1111/hdi.12883,2/24/2021,3/2/2024,Verified
210101_London_LewishamGreenwichNHSTrust_HCW_Overall,"January 1, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Lewisham, Greenwich ","May 27, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),6212,26.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mehool Patel,Lewisham and greenwich NHS Trust ,https://dx.doi.org/10.7861/clinmed.2020-0619,3/1/2021,3/2/2024,Verified
200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop,"June 25, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 8, 2020","June 4, 2020",Household and community samples,Multiple groups,1575,6.30%,4.50%,8.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop,"July 31, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 5, 2020","July 2, 2020",Household and community samples,Multiple groups,2392,4.18%,,,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
200826_UK_OfficeforNationalStatistics_July_020_England_genpop,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 3, 2020","July 30, 2020",Household and community samples,Multiple groups,3236,6.50%,5.20%,8.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop,"August 28, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 31, 2020","August 27, 2020",Household and community samples,Multiple groups,6189,5.60%,4.70%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop,"September 25, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,8742,5.80%,5.10%,6.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop,"October 23, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,15687,6.90%,6.40%,7.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop,"November 26, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,15834,8.70%,8.10%,9.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop,"December 24, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,21684,10.10%,9.60%,10.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop,"January 29, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,24150,15.30%,14.70%,15.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop,"September 25, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"August 28, 2020","September 24, 2020",Household and community samples,Multiple groups,236,4.70%,2.00%,9.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,2/2/2024,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop,"October 23, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,249,2.80%,1.20%,5.50%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop,"October 23, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,383,6.80%,4.30%,10.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop,"October 23, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"September 25, 2020","October 22, 2020",Household and community samples,Multiple groups,473,4.70%,2.90%,7.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,2/2/2024,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop,"November 26, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,397,7.80%,5.00%,11.70%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop,"November 26, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,333,3.50%,1.60%,6.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop,"November 26, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"October 23, 2020","November 19, 2020",Household and community samples,Multiple groups,497,6.10%,4.00%,9.00%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,2/2/2024,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop,"December 24, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,248,3.70%,1.70%,7.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop,"December 24, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,1034,5.90%,4.40%,7.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop,"December 24, 2020",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"November 20, 2020","December 17, 2020",Household and community samples,Multiple groups,631,7.20%,5.10%,9.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop,"January 29, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,313,12.00%,7.80%,17.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,High,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop,"January 29, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,1832,10.70%,9.10%,12.40%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop,"January 29, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"December 18, 2020","January 14, 2021",Household and community samples,Multiple groups,732,11.50%,8.60%,14.90%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office of National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/13/2021,7/17/2022,Verified
210107_London_UniversityCollegeLondon_June_PaediatricHCW,"January 27, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1134,16.93%,14.86%,19.22%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
210107_London_UniversityCollegeLondon_May_PaediatricHCW,"January 27, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1754,15.34%,13.73%,17.10%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Unverified
210219_England_PHE_UniversityStudents_Overall,"February 19, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"December 2, 2020","December 11, 2020",Students and Daycares,Adults (18-64 years),2905,17.80%,16.50%,19.30%,Convenience,"Abbott Laboratories,NA",CLIA,IgG,,,Moderate,Preprint,Amoolya Vusirikala,Public Health England,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684,3/15/2021,3/2/2024,Verified
210127_UK_UniversityCollegeLondon_overall,"January 27, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Nottingham, London","March 23, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),1364,19.94%,,,Convenience,"EUROIMMUN,Roche Diagnostics,NA",ELISA,IgG,,,High,Preprint,Ana Valdes,University College London,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805,3/18/2021,3/2/2024,Verified
210115_UK_UKBiobank_Overall,"January 15, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Scotland, Wales",,"May 27, 2020","December 4, 2020",Household and community samples,Multiple groups,18893,8.99%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,UK Biobank,UK Biobank,https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf,3/19/2021,7/17/2022,Unverified
210301_London_King’sCollegeHospital_primary,"March 1, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"April 22, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),625,21.00%,,,Convenience,NA,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Kat El Bouzidi,King’s College Hospital,https://dx.doi.org/10.1097/CCM.0000000000004878,3/20/2021,7/17/2022,Verified
210127_London_King'sCollegeLondon_September_PostgradStudents&Staff,"January 27, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"September 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1675,5.40%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Preprint,Daniel Leightley,King's College London,https://doi.org/10.1101/2021.01.26.21249744,3/22/2021,3/2/2024,Verified
210225_England_ImperialCollegeLondon_Round4_overall_adj,"February 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"October 27, 2020","November 10, 2020",Household and community samples,Multiple groups,161537,5.56%,5.43%,5.71%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Moderate,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,3/24/2021,7/17/2022,Verified
210119_Lacashire_PublicHealthEngland_overall,"January 19, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Lacashire,"June 3, 2020","June 4, 2020",Essential non-healthcare workers,Adults (18-64 years),195,9.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ranya Mulchandani,Public Health England,http://dx.doi.org/10.1016/j.jcv.2021.104739,3/26/2021,3/2/2024,Verified
210202_UK_SalfordRoyalNHS_primary,"February 2, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"March 15, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,237,5.10%,,,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Siemens",CLIA,IgG,,,High,Preprint,Olivia Wickens,Salford Royal NHS ,https://www.researchsquare.com/article/rs-154513/v1,3/27/2021,3/2/2024,Verified
210212_Oxford_UniversityofOxford,"February 12, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,404,3.00%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,3/27/2021,3/2/2024,Verified
210303_London_NorthMiddlesexUniversityHospitalNHSTrust_Overall,"March 3, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),3285,35.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Emily Martin,North Middlesex University Hospital NHS Trust,https://dx.doi.org/10.1016/j.jinf.2021.02.027,4/1/2021,7/17/2022,Verified
210211_UnitedKingdom_ImperialCollegeNHSTrust_GlomerularDiseasePatients,"February 11, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"May 19, 2020","July 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,493,7.70%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tabitha Turner Stokes,Imperial College Healthcare NHS Trust,https://dx.doi.org/10.1016/j.ekir.2021.02.006,4/3/2021,3/2/2024,Verified
201105_London_ImperialCollegeLondon,"November 5, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"June 1, 2020","July 27, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),161,11.20%,,,Convenience,NA,Other,Total Antibody,94.80%,,High,Journal Article (Peer-Reviewed),Simone Claudiani,Imperial College London,http://dx.doi.org/10.1182/blood-2020-142454,4/4/2021,7/17/2022,Verified
210322_TheUnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust_Overall,"March 22, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"September 22, 2020","December 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,6935,4.30%,3.80%,4.80%,Sequential,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Nicholas Kennedy,Royal Devon and Exeter NHS Foundation Trust,https://dx.doi.org/10.1136/gutjnl-2021-324388,4/10/2021,3/2/2024,Verified
210212_London_RoyalFreeHospital,"February 12, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"March 26, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),43,18.60%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Natarajan Angamuthu,Royal Free Hospital,https://dx.doi.org/10.1016/j.surge.2021.01.007,4/11/2021,7/17/2022,Verified
210401_London_PublicHealthEngland_Overall,"April 1, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"March 30, 2020","July 21, 2020",Health care workers and caregivers,Multiple groups,1069,29.00%,26.00%,32.00%,Unclear,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Madhumita Shrotri,Public Health England,https://dx.doi.org/10.3201/eid2704.204554,4/11/2021,3/2/2024,Verified
210302_London_UniversityCollegeLondon_HCW_Overall,"March 2, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"March 23, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),729,21.50%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Manisty,University College London,https://dx.doi.org/10.1016/j.ebiom.2021.103259,4/13/2021,3/2/2024,Unverified
210226_WestMidlands_BirminghamCommunityHealthcareTrust_Baseline,"February 26, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1507,16.30%,,,Convenience,The Binding Site,ELISA,"IgG,IgM,IgA",98.60%,98.30%,Moderate,Preprint,Adrian Shields,Birmingham Community Healthcare Trust,10.1101/2021.02.24.21252368,4/15/2021,7/17/2022,Verified
210316_Sussex_UniversityofSussex_RocheBSUH,"March 16, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Brighton and Sussex,"May 19, 2020","September 29, 2020",Health care workers and caregivers,Adults (18-64 years),14473,12.99%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/16/2021,3/2/2024,Verified
210316_Sussex_UniversityofSussex_AbbottWSHT,"March 16, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,West Sussex,"May 19, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),12388,7.89%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Alyss Robinson,University of Sussex,https://dx.doi.org/10.7861/clinmed.2020.1007,4/16/2021,3/2/2024,Verified
210417_Leicestershire_UniversityofLeicester_Diasorin+Siemens,"March 17, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,NR,"October 1, 2019","March 31, 2020",Residual sera,Multiple groups,428,0.00%,,,Simplified probability,"DiaSorin,Siemens",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1016/j.jinf.2021.03.007,4/17/2021,3/2/2024,Unverified
210323_Surrey_RoyalHollowayUniversityofLondon,"March 23, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Chertsey,"October 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),3119,19.65%,,,Convenience,Abbott Laboratories,CLIA,IgG,82.50%,95.00%,High,Journal Article (Peer-Reviewed),Gie Ken Dror,Royal Holloway University of London,https://dx.doi.org/10.7861/clinmed.2020-1096,4/17/2021,3/2/2024,Verified
210212_London_UniversityofOxford_Overall,"February 12, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,236,8.47%,,,Sequential,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Colleen GC McGregor,University of Oxford,https://dx.doi.org/10.1136/gutjnl-2021-324116,4/20/2021,3/2/2024,Verified
201113_London_ImperialCollegeLondon_KidneyTransplantPatients copy,"November 13, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Greater London,London,"June 1, 2020","July 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,8.10%,6.40%,10.10%,Sequential,Abbott Laboratories,CLIA,IgG,68.40%,100.00%,High,Journal Article (Peer-Reviewed),Michelle Willicombe,Imperial College London,https://dx.doi.org/10.1097/TP.0000000000003526,4/22/2021,3/2/2024,Verified
210316_Lancashire_LancashireTeachingHospitalsNHSTrust_OverallHCW,"March 16, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Chorley, Preston, South Ribble","May 29, 2020","July 4, 2020",Health care workers and caregivers,Adults (18-64 years),4474,17.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Robert Shorten ,Lancashire Teaching Hospitals NHS Foundation Trust,https://dx.doi.org/10.1136/bmjopen-2020-045384,4/22/2021,3/2/2024,Verified
200930_Scotland_PublicHealthScotland_1ResidualSera_Overall_UnAdj,"September 30, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 20, 2020","August 9, 2020",Residual sera,Multiple groups,9802,4.89%,,,Stratified non-probability,NA,Not reported,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/30-september-2020/,4/23/2021,7/17/2022,Verified
210322_England_PublicHealthEnglandColindale_Overall,"March 22, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,"London, Wythenshawe, Porton","March 23, 2020","November 18, 2020",Multiple populations,Adults (18-64 years),2246,11.80%,,,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Robert Harris,Public Health England Colindale ,https://dx.doi.org/10.1016/j.jinf.2021.03.015,5/14/2021,3/2/2024,Unverified
201221_London_PublicHealthEngland_overall_unadj,"December 21, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"May 5, 2020","May 5, 2020",Multiple populations,Adults (18-64 years),193,13.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hannah Taylor,Public Health England,https://dx.doi.org/10.1016/j.lanepe.2020.100015,5/18/2021,7/17/2022,Verified
210423_Blackpool_NHSFoundationTrust_primaryAbbott,"April 23, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Blackpool,"August 1, 2020","August 31, 2020",Residual sera,Multiple groups,225,5.30%,,,Convenience,Abbott Laboratories,ELISA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Jane Oakey,NHS Foundation Trust ,https://dx.doi.org/10.1177/00045632211015711,5/20/2021,3/2/2024,Verified
210421_London_DMGDental-MaterialGesellschaftmbH_overall_unadj,"April 21, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),14,21.43%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Linda Greenwall,DMG Dental-Material Gesellschaft mbH,https://dx.doi.org/10.1038/s41415-021-2849-7,5/21/2021,3/2/2024,Verified
210408_London_St.Thomas’NHSFoundationTrust_Primary,"April 8, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"July 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,681,18.65%,,,Convenience,DiaSorin,Not reported,IgG,97.40%,,High,Journal Article (Peer-Reviewed),Caroline Dudreuilh,St. Thomas’ NHS Foundation Trust,https://dx.doi.org/10.1016/j.ekir.2021.03.900,5/22/2021,3/2/2024,Verified
210409_England_PublicHealthEngland,"April 9, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"June 18, 2020","December 31, 2020",Health care workers and caregivers,Multiple groups,25661,29.43%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Victoria Jane Hall,Public Health England,https://dx.doi.org/10.1016/S0140-6736(21)00675-9,5/23/2021,7/17/2022,Verified
210316_UK_OfficeForNationalStatistics_England_overall,"March 30, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,34623,34.60%,34.00%,35.30%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/17/2022,Verified
210316_UK_OfficeForNationalStatistics_NorthernIreland_overall,"March 30, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,632,31.20%,27.30%,35.20%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/17/2022,Verified
210316_UK_OfficeForNationalStatistics_Scotland_overall,"March 30, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Scotland
",,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,2737,22.30%,20.60%,24.10%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/17/2022,Verified
210316_UK_OfficeForNationalStatistics_Wales_overall,"March 30, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"February 4, 2021","March 3, 2021",Household and community samples,Multiple groups,1224,30.50%,27.50%,33.60%,Stratified probability,NA,ELISA,IgG,99.00%,99.10%,Moderate,Institutional Report,Office for National Statistics,Office For National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/coronaviruscovid19antibodydatafortheuk/2021,5/23/2021,7/17/2022,Verified
201226_Scotland_UniversityofGlasgow_overall_unaj,"December 26, 2020",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Greater Glasgow area,"March 16, 2020","May 24, 2020",Residual sera,Multiple groups,6635,7.81%,7.17%,8.48%,Simplified probability,NA,ELISA,IgG,95.31%,97.20%,Moderate,Journal Article (Peer-Reviewed),Ellen C Hughes,University of Glasgow,http://dx.doi.org/10.1093/infdis/jiaa788,5/23/2021,7/17/2022,Verified
210324_London_ImperialCollegeLondon_Overall,"March 24, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"February 24, 2020","January 1, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,301,42.86%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Candice L Clarke,Imperial College London,https://dx.doi.org/10.1016/j.kint.2021.03.009,5/24/2021,3/2/2024,Verified
210426_England_CambridgeUniversityHospitalsNHS,"April 24, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),434,7.80%,,,Convenience,Abbexa,LFIA,"IgG,IgM",98.50%,97.94%,Moderate,Journal Article (Peer-Reviewed),DM Favara,Cambridge University Hospitals NHS Foundation Trust,https://dx.doi.org/10.1016/j.clon.2021.04.005,5/28/2021,3/2/2024,Unverified
210522_UK_UniversityCollegeLondon_overall,"May 22, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England and Wales,,"February 1, 2021","May 3, 2021",Household and community samples,Multiple groups,10330,8.20%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Preprint,Robert W Aldridge,University College London,https://www.medrxiv.org/content/10.1101/2021.05.10.21256912v2,5/28/2021,3/2/2024,Verified
210428_Europe_SorbonneUniversité_6London,"April 28, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,London,London,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,239,14.60%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,6/1/2021,3/2/2024,Verified
210427_EastLondon_QueenMaryUniversityofLondon,"April 27, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"June 15, 2020","August 15, 2020",Health care workers and caregivers,Multiple groups,2001,25.30%,,,Convenience,Abbott Laboratories,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Naheed Choudhry,Queen Mary University of London,https://dx.doi.org/10.3389/fmed.2021.642723,6/1/2021,3/2/2024,Unverified
210510_UK_PublicHealthEngland_Primary_RocheS,"May 10, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"February 22, 2021","March 21, 2021",Blood donors,Multiple groups,7720,46.40%,45.40%,47.50%,Convenience,Roche Diagnostics,CLIA,Not reported,97.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Heather J Whitaker,Public Health England,http://dx.doi.org/10.1016/j.jinf.2021.04.037,6/6/2021,3/2/2024,Verified
201212_Europe_UniversityOfGlasgow_UK1,"December 12, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),311,6.75%,4.46%,10.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,3/2/2024,Verified
210602_UK_dental_UniversityBirmingham_Follow-up,"June 2, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,West midlands,,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),944,51.40%,,,Convenience,NA,ELISA,"IgG,IgA,IgM",98.60%,98.30%,High,Journal Article (Peer-Reviewed),A M Shields,University of Birmingham,https://dx.doi.org/10.1177/00220345211020270,6/7/2021,7/17/2022,Unverified
210502_England_ImperialCollegeLondon_TestPopAdj,"May 2, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 20, 2020","September 28, 2020",Household and community samples,Multiple groups,365104,4.94%,4.85%,5.03%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Journal Article (Peer-Reviewed),Helen Ward,Imperial College London,https://dx.doi.org/10.1016/j.lanepe.2021.100098,6/8/2021,7/17/2022,Unverified
210225_England_ImperialCollegeLondon_Round5_overall_Primary,"February 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 25, 2021","February 8, 2021",Household and community samples,Multiple groups,155172,13.90%,13.70%,14.10%,Stratified probability,Fortress Diagnostics,LFIA,IgG,84.40%,98.60%,Low,Institutional Report,Helen Ward,Imperial College London ,https://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1,6/18/2021,7/17/2022,Verified
210607_EastScotland_UniversityofDundee_HCW1,"June 7, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Dundee,"May 28, 2020","September 2, 2020",Health care workers and caregivers,Adults (18-64 years),2063,14.50%,,,Convenience,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,Moderate,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,6/21/2021,3/2/2024,Verified
210607_EastScotland_UniversityofDundee_Control2,"June 7, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,Dundee,"May 28, 2020","September 2, 2020",Residual sera,Multiple groups,231,4.80%,,,Sequential,Siemens,CLIA,"IgG,IgM,IgA",95.00%,,High,Journal Article (Peer-Reviewed),Hani Abo-Leyah,University of Dundee,http://dx.doi.org/10.1183/23120541.00080-2021,6/21/2021,3/2/2024,Verified
210525_London_PublicHealthEngland_Week18_Euroimmun_Primary ,"May 25, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 1, 2020","May 3, 2020",Blood donors,Multiple groups,974,14.90%,12.10%,18.00%,Convenience,EUROIMMUN,ELISA,IgG,82.50%,99.10%,Moderate,Journal Article (Peer-Reviewed),Gayatri Amirthalingam,Public Health England,https://dx.doi.org/10.3201/eid2707.203167,7/1/2021,8/15/2023,Verified
210626_Leicester_UniversityOfLeicester,"June 26, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Leicester,"March 16, 2020","June 3, 2020",Household and community samples,Multiple groups,1779,11.35%,,,Simplified probability,DiaSorin,CLIA,IgG,97.00%,98.90%,Low,Journal Article (Peer-Reviewed),Paul William Bird,University of Leicester,https://dx.doi.org/10.1002/jmv.27162,7/8/2021,3/2/2024,Verified
210713_England_DepartmentofHealthandSocialCare,"July 13, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,NR,"May 26, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),1146310,16.30%,16.20%,16.40%,Convenience,NA,Multiple Types,"IgM,IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Cordelia Coltart,Department of Health and Social Care,https://dx.doi.org/10.1136/bmjopen-2021-049703,7/22/2021,7/17/2022,Unverified
210316_England_PublicHealthEngland_Round1_Students_Primary,"June 1, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","June 19, 2020",Students and Daycares,Children and Youth (0-17 years),816,11.20%,7.90%,15.10%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Shamez Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,7/23/2021,3/2/2024,Verified
210316_England_PublicHealthEngland_Round1_Staff_Primary,"June 1, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","June 19, 2020",Essential non-healthcare workers,Adults (18-64 years),1379,15.10%,11.90%,18.90%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shamez Ladhani,Public Health England,https://dx.doi.org/10.1016/S2352-4642(21)00061-4,7/23/2021,3/2/2024,Verified
210622_London_LondonSchoolOfHygieneAndTropicalMedicine_HCWs,"June 22, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 4, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),615,40.70%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,CTK Biotech, Inc.,Zhejiang Orient Gene Biotech,VivaChek Biotech (Hangzhou) Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Admire Murongazvombo,London School Of Hygiene And Tropical Medicine,http://dx.doi.org/10.1016/j.infpip.2021.100157,7/28/2021,3/2/2024,Verified
210601_England_UniversityCollegeLondon_residents_primary,"June 1, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"October 1, 2020","February 1, 2021",Assisted living and long-term care facilities,Seniors (65+ years),682,33.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,7/29/2021,3/2/2024,Verified
210601_England_UniversityCollegeLondon_staff_primary,"June 1, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"October 1, 2020","February 1, 2021",Health care workers and caregivers,Adults (18-64 years),1429,29.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,University College London,https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(21)00093-3/fulltext,7/29/2021,3/2/2024,Verified
210706_London_LondonSchoolofHygiene&TropicalMedicine,"July 6, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"October 19, 2020","December 7, 2020",Household and community samples,Multiple groups,1242,64.30%,61.60%,67.00%,Simplified probability,NA,CLIA,IgG,96.20%,97.40%,Moderate,Journal Article (Peer-Reviewed),Katherine Gaskell,London School of Hygiene & Tropical Medicine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291041/,8/5/2021,7/17/2022,Verified
201214_UnitedKingdom_UniversityOfSouthamptonSchoolOfMedicine,"December 14, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"May 13, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),135,13.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kordo Saeed,University of Southampton School of Medicine,https://dx.doi.org/10.1177/1757177420976798,8/5/2021,3/2/2024,Unverified
210808_Birmingham_UniversityHospitalsBirmingham_primary,"August 2, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Birmingham,"March 15, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,990,25.90%,,,Convenience,NA,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gemma D. Banham,University Hospitals Birmingham,https://dx.doi.org/10.1681/ASN.2021020188,8/18/2021,7/17/2022,Verified
210819_England_UniversityofBirmingham_Overall,"August 19, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"December 11, 2020","December 18, 2020",Assisted living and long-term care facilities,Adults (18-64 years),124,24.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gokhan Tut,University of Birmingham,https://dx.doi.org/10.1016/S2666-7568(21)00168-9,9/1/2021,3/2/2024,Unverified
210811_England_OfficeForNationalStatistics_Round6_StaffPrimary,"August 11, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 14, 2021","July 6, 2021",Essential non-healthcare workers,Adults (18-64 years),832,25.16%,19.73%,31.22%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,9/2/2021,3/2/2024,Unverified
210811_England_OfficeForNationalStatistics_Round6_StaffSecondary,"August 11, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 14, 2021","July 6, 2021",Essential non-healthcare workers,Adults (18-64 years),1574,23.36%,20.66%,26.22%,Stratified probability,Roche Diagnostics,CLIA,Not reported,97.20%,99.80%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,9/2/2021,3/2/2024,Unverified
210221_UnitedKingdom_RoyalDevonAndExeterNHSFoundationTrust,"September 2, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"January 29, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,13509,3.10%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Neil Chanchlani,Royal Devon And Exeter NHS Foundation Trust,https://dx.doi.org/10.1093/ecco-jcc/jjab153,9/9/2021,3/2/2024,Unverified
210910_SouthWales_PublicHealthWales,"September 10, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,Wales,,"June 2, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),276,38.80%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Favian Narrainen,Public Health Wales Microbiology,https://dx.doi.org/10.7861/clinmed.2021-0225,9/24/2021,3/2/2024,Unverified
210920_Dublin_UniversityCollegeDublin_overall,"September 20, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Ireland,Dublin,"May 4, 2020","May 15, 2020",Pregnant or parturient women,Adults (18-64 years),598,1.67%,0.80%,3.10%,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Kate Glennon,University College Dublin,https://dx.doi.org/10.1371/journal.pone.0253090,9/28/2021,3/2/2024,Verified
210929_England_PublicHealthEngland_Overall,"September 29, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","July 23, 2020",Students and Daycares,Multiple groups,2179,14.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Georgina Ireland,Public Health England,https://dx.doi.org/10.1016/j.eclinm.2021.101150,10/13/2021,3/2/2024,Unverified
210106_UnitedKingdom_OxfordUniversity,"January 6, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"April 23, 2020","October 20, 2020",Health care workers and caregivers,Multiple groups,3217,16.00%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sheila F Lumley,Oxford University,https://academic.oup.com/cid/article/73/3/e699/6064824,10/15/2021,3/2/2024,Unverified
201223_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"December 23, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"October 26, 2020","November 29, 2020",Residual sera,Multiple groups,3638,6.82%,5.74%,7.74%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/,10/25/2021,7/17/2022,Verified
201223_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"December 23, 2020",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"October 26, 2020","November 29, 2020",Blood donors,Multiple groups,2499,6.26%,4.55%,8.89%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-december-2020/,10/25/2021,8/15/2023,Verified
210512_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"May 12, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"March 15, 2021","April 18, 2021",Blood donors,Multiple groups,2493,46.60%,44.00%,48.90%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,10/26/2021,8/15/2023,Verified
210512_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,"May 12, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"March 15, 2021","April 18, 2021",Pregnant or parturient women,Adults (18-64 years),3326,12.50%,11.20%,13.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,10/26/2021,8/15/2023,Verified
210512_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"May 12, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 12, 2021","April 18, 2021",Residual sera,Multiple groups,708,43.80%,40.20%,47.40%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-12-may-2021/,10/26/2021,8/15/2023,Verified
210407_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,"April 7, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 8, 2021","March 14, 2021",Blood donors,Multiple groups,2492,25.20%,22.50%,27.90%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,10/26/2021,8/15/2023,Verified
210407_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,"April 7, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 8, 2021","March 14, 2021",Pregnant or parturient women,Adults (18-64 years),3355,9.60%,8.50%,10.70%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,10/26/2021,8/15/2023,Verified
210407_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,"April 7, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 8, 2021","March 14, 2021",Residual sera,Multiple groups,3436,23.70%,22.10%,25.50%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-7-april-2021/,10/26/2021,7/17/2022,Verified
210303_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,"March 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 4, 2021","February 7, 2021",Blood donors,Multiple groups,2497,15.20%,13.40%,17.60%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,10/26/2021,8/15/2023,Verified
210303_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,"March 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 4, 2021","February 7, 2021",Residual sera,Multiple groups,3606,12.50%,11.20%,13.80%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,10/26/2021,7/17/2022,Verified
210127_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,"January 27, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 30, 2020","January 3, 2021",Residual sera,Multiple groups,3485,9.60%,8.40%,10.80%,Stratified probability,NA,CLIA,Not reported,87.50%,98.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,10/26/2021,7/17/2022,Verified
210127_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,"January 27, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 30, 2020","January 3, 2021",Blood donors,Multiple groups,2499,5.90%,4.40%,7.10%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,10/26/2021,8/15/2023,Verified
210825_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,"August 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"June 28, 2021","August 1, 2021",Residual sera,Multiple groups,3427,72.90%,71.40%,74.40%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,10/26/2021,8/15/2023,Verified
210825_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,"August 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"June 28, 2021","August 1, 2021",Blood donors,Multiple groups,2493,99.50%,98.40%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,10/26/2021,8/15/2023,Verified
210825_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,"August 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"June 28, 2021","August 1, 2021",Pregnant or parturient women,Adults (18-64 years),2990,13.80%,12.40%,15.20%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-25-august-2021/,10/26/2021,8/15/2023,Verified
210616_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"June 16, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 19, 2021","May 23, 2021",Residual sera,Multiple groups,3589,48.61%,46.96%,50.30%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,10/27/2021,8/15/2023,Verified
210616_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"June 16, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 19, 2021","May 23, 2021",Blood donors,Multiple groups,2494,66.32%,63.80%,68.40%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,10/27/2021,8/15/2023,Verified
210616_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"June 16, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 19, 2021","May 23, 2021",Pregnant or parturient women,Adults (18-64 years),3333,10.84%,9.69%,12.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-16-june-2021/,10/27/2021,8/15/2023,Verified
211020_Avon_UniversityOfBristol_G1_Overall,"October 20, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"April 8, 2021","June 28, 2021",Household and community samples,Adults (18-64 years),1686,42.05%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.98%,Moderate,Journal Article (Peer-Reviewed),Daniel Major-Smith,University of Bristol,https://wellcomeopenresearch.org/articles/6-283,10/27/2021,3/2/2024,Verified
211020_Avon_UniversityOfBristol_G0_Overall,"October 20, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"April 8, 2021","June 28, 2021",Household and community samples,Adults (18-64 years),2555,96.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.98%,Moderate,Journal Article (Peer-Reviewed),Daniel Major-Smith,University of Bristol,https://wellcomeopenresearch.org/articles/6-283,10/27/2021,3/2/2024,Verified
210303_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"March 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 4, 2021","February 7, 2021",Pregnant or parturient women,Adults (18-64 years),3478,7.50%,6.60%,8.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-march-2021/,10/29/2021,8/15/2023,Verified
210127_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"January 27, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 30, 2020","January 3, 2021",Pregnant or parturient women,Adults (18-64 years),3052,5.80%,5.00%,6.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-27-january-2021/,10/29/2021,8/15/2023,Verified
211025_Ynysmaerdy _CardiffUniversity,"October 25, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,South Wales, Ynysmaerdy,"June 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),5,0.00%,,,Entire sample,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),David Barron,Cardiff University,https://dx.doi.org/10.1186/s12887-021-02831-9,11/2/2021,7/17/2022,Verified
210721_Scotland_PublicHealthScotland_1ResidualSera_overall_adj,"July 21, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"May 24, 2021","June 27, 2021",Residual sera,Multiple groups,3554,61.40%,59.70%,62.90%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,11/3/2021,8/15/2023,Verified
210721_Scotland_PublicHealthScotland_2BloodDonors_overall_adj,"July 21, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"May 24, 2021","June 27, 2021",Blood donors,Multiple groups,2494,81.80%,79.80%,84.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,11/3/2021,8/15/2023,Verified
210721_Scotland_PublicHealthScotland_3PregnantWomen_overall_adj,"July 21, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"May 24, 2021","June 27, 2021",Pregnant or parturient women,Adults (18-64 years),3052,12.10%,10.80%,13.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-21-july-2021/,11/3/2021,8/15/2023,Verified
210811_England_OfficeForNationalStatistics_Round6_StudentsPrimary3_PopAdj_TestAdj,"August 11, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 14, 2021","July 6, 2021",Students and Daycares,Children and Youth (0-17 years),3798,11.25%,8.93%,13.90%,Stratified probability,NA,Other,IgG,80.00%,99.00%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,11/10/2021,7/17/2022,Unverified
210811_England_OfficeForNationalStatistics_Round6_StudentsSecondary4_TestAdj_PopAdj,"August 11, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 14, 2021","July 6, 2021",Students and Daycares,Children and Youth (0-17 years),6927,12.95%,11.62%,14.37%,Stratified probability,NA,Other,IgG,80.00%,99.00%,Moderate,Institutional Report,Office for National Statistics,Office for National Statistics,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/covid19schoolsinfectionsurveyengland/round6june2021,11/10/2021,7/17/2022,Unverified
210804_Cambridge_RoyalPapworthHospitalNHSTrust_HCW,"August 4, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Cambridge,"April 20, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),498,14.00%,,,Convenience,NA,Other,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Helen Baxendale,Cambridge University Hospitals NHS Foundation Trust,https://dx.doi.org/10.2478/jccm-2021-0018,11/10/2021,7/17/2022,Unverified
210930_UnitedKingdom_QueensUniversityBelfast_Round2_overall,"September 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Northern Ireland, Wales, Scotland","London, Belfast, Cardiff, Glasgow, Manchester","June 16, 2020","June 30, 2020",Family of essential workers,Children and Youth (0-17 years),849,7.66%,6.05%,9.64%,Unclear,"DiaSorin,Roche Diagnostics",Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Cathal Roarty,Queens University Belfast,http://dx.doi.org/10.1136/archdischild-2021-rcpch.65,11/10/2021,3/2/2024,Unverified
211030_UnitedKingdom_QueensUniversityBelfast,"September 30, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,"Northern Ireland, Scotland, Wales, England","Belfast, Glasgow, Cardiff, Manchester,
London","April 16, 2020","July 3, 2020",Household and community samples,Children and Youth (0-17 years),992,6.85%,,,Convenience,"Abbott Laboratories,DiaSorin,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Presentation or Conference,Claire McGinn,Queens University Belfast,http://dx.doi.org/10.1136/archdischild-2021-rcpch.135,11/11/2021,3/2/2024,Verified
211103_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"November 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"September 6, 2021","October 10, 2021",Residual sera,Multiple groups,3132,77.60%,75.90%,79.30%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,11/11/2021,8/15/2023,Verified
211103_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"November 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"September 6, 2021","October 10, 2021",Blood donors,Multiple groups,2494,99.70%,99.30%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,11/11/2021,8/15/2023,Verified
211103_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"November 3, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"September 6, 2021","October 10, 2021",Pregnant or parturient women,Adults (18-64 years),3023,19.70%,18.00%,21.30%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-3-november-2021/,11/11/2021,8/15/2023,Verified
211201_GreaterLondon_PublicHealthEngland_Staff,"December 1, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 11, 2020","July 26, 2020",Assisted living and long-term care facilities,Adults (18-64 years),712,49.58%,,,Convenience,"Abbott Laboratories,NA",Not reported,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Anna Jeffery-Smith,Public Health England,https://dx.doi.org/10.1016/S2666-7568(21)00253-1,12/15/2021,3/2/2024,Unverified
211201_GreaterLondon_PublicHealthEngland_Residents,"December 1, 2021",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 11, 2020","July 26, 2020",Assisted living and long-term care facilities,Seniors (65+ years),459,57.73%,,,Convenience,"Abbott Laboratories,NA",Not reported,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Anna Jeffery-Smith,Public Health England,https://dx.doi.org/10.1016/S2666-7568(21)00253-1,12/15/2021,3/2/2024,Unverified
211208_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"December 8, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"October 11, 2021","November 14, 2021",Residual sera,Multiple groups,2882,80.50%,78.60%,82.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,12/16/2021,8/15/2023,Verified
211208_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"December 8, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"October 11, 2021","November 14, 2021",Blood donors,Multiple groups,2496,99.80%,99.40%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,12/16/2021,8/15/2023,Verified
211208_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Anti-S_Unadj,"December 8, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"October 11, 2021","November 14, 2021",Pregnant or parturient women,Adults (18-64 years),2890,86.16%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-december-2021/,12/16/2021,3/2/2024,Verified
211130_England_UKHSA_2020SepOct_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"September 1, 2020","October 31, 2020",Residual sera,Children and Youth (0-17 years),119,7.60%,3.20%,18.20%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2020NovDec_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 1, 2020","December 31, 2020",Residual sera,Children and Youth (0-17 years),711,14.80%,11.20%,19.80%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2021JanFeb_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 1, 2021","February 28, 2021",Residual sera,Children and Youth (0-17 years),970,23.30%,18.40%,29.50%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2021MarApr_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 1, 2021","April 30, 2021",Residual sera,Children and Youth (0-17 years),925,31.50%,25.30%,39.10%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2021MayJun_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 1, 2021","June 30, 2021",Residual sera,Children and Youth (0-17 years),1186,27.50%,20.70%,37.20%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2021JulAug_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 1, 2021","August 31, 2021",Residual sera,Children and Youth (0-17 years),685,26.40%,20.10%,35.30%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211130_England_UKHSA_2021SepOct_Overall_AdjustedS,"November 30, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"September 1, 2021","October 31, 2021",Residual sera,Children and Youth (0-17 years),600,46.10%,38.30%,53.60%,Convenience,Roche Diagnostics,CLIA,Total Antibody,95.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Clarissa Oeser,"UK Health Security Agency (UKHSA, formerly PHE)",https://dx.doi.org/10.1016/j.jinf.2021.11.019,12/24/2021,3/2/2024,Verified
211211_England_UKHealthSecurityAgency_Round4_Students_S,"December 11, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","May 20, 2021","July 14, 2021",Students and Daycares,Children and Youth (0-17 years),655,41.40%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Shamez N. Ladhani,The UK Health Security Agency,https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text,12/25/2021,3/2/2024,Verified
211211_England_UKHealthSecurityAgency_Round4_Staff_S,"December 11, 2021",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"Derbyshire, West London, East London, Greater Manchester, Hertfordshire and Birmingham","May 20, 2021","July 14, 2021",Essential non-healthcare workers,Adults (18-64 years),639,97.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Shamez N. Ladhani,The UK Health Security Agency,https://www.medrxiv.org/content/10.1101/2021.12.10.21267583v1.full-text,12/25/2021,3/2/2024,Verified
220101_England_UCLInstituteOfHealthInformatics_Primary,"January 1, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 1, 2020","April 30, 2021",Multiple general populations,Multiple groups,4722,28.80%,,,Self-referral,Abbott Laboratories,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maria Krutikov,UCL Institute of Health Informatics,https://dx.doi.org/10.1016/S2666-7568(21)00282-8,1/8/2022,3/2/2024,Unverified
220119_Scotland_PublicHealthScotland_1ResidualSeraOverall_PopAdj_TestAdj,"January 19, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 15, 2021","December 19, 2021",Residual sera,Multiple groups,2815,87.40%,85.70%,88.70%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,1/26/2022,8/15/2023,Verified
220119_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"January 19, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 15, 2021","December 19, 2021",Blood donors,Multiple groups,2493,100.00%,99.90%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,1/26/2022,8/15/2023,Verified
220119_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Unadj,"January 19, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"November 15, 2021","December 19, 2021",Pregnant or parturient women,Adults (18-64 years),3060,87.25%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-19-january-2022/,1/26/2022,3/2/2024,Verified
220124_SouthWales_PublicHealthWales_Overall,"January 24, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,South Wales,,"September 1, 2020","October 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),991,7.00%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",96.00%,95.50%,High,Journal Article (Peer-Reviewed),Alice Puchades,Public Health Wales,https://dx.doi.org/10.1186/s12889-021-12478-x,2/3/2022,3/2/2024,Unverified
211114_UnitedKingdom_UniversityHospitalSouthamptonNHSTrust,"November 14, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"February 15, 2021","March 15, 2021",Residual sera,Multiple groups,478,9.83%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Harry Chappell,University Hospital Southampton NHS Trust,https://www.sciencedirect.com/science/article/pii/S016344532100548X,2/18/2022,7/17/2022,Unverified
220216_England_UKHealthSecurityAgency_PrimaryStudents,"February 16, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 17, 2020","December 15, 2020",Students and Daycares,Children and Youth (0-17 years),60,8.33%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,2/24/2022,7/17/2022,Unverified
220216_England_UKHealthSecurityAgency_SecondaryStudents,"February 16, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 17, 2020","December 15, 2020",Students and Daycares,Children and Youth (0-17 years),106,3.80%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,2/24/2022,7/17/2022,Unverified
220216_England_UKHealthSecurityAgency_PrimaryStaff,"February 16, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 17, 2020","December 15, 2020",Essential non-healthcare workers,Adults (18-64 years),16,0.00%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1371/journal.pone.0262515,2/24/2022,7/17/2022,Unverified
220222_UnitedKingdom_QueenMaryUniversityofLondon_Overall,"February 22, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Scotland, Wales, and Northern Ireland",,"May 1, 2020","November 2, 2020",Household and community samples,Multiple groups,11130,15.20%,,,Self-referral,The Binding Site,ELISA,"IgG,IgA,IgM",98.60%,98.30%,High,Journal Article (Peer-Reviewed),Mohammad Talaei,Queen Mary University of London,https://dx.doi.org/10.1186/s12916-022-02286-4,3/8/2022,8/24/2022,Verified
220223_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"February 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"December 20, 2021","January 23, 2022",Residual sera,Multiple groups,2863,91.50%,90.50%,93.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,3/8/2022,8/15/2023,Verified
220223_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"February 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"December 20, 2021","January 23, 2022",Blood donors,Multiple groups,2499,100.00%,99.80%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,3/8/2022,8/15/2023,Verified
220223_Scotland_PublicHealthScotland_3PregnantWomen_Overall_Unadj,"February 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"December 20, 2021","January 23, 2022",Pregnant or parturient women,Adults (18-64 years),2914,91.01%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-23-february-2022/,3/8/2022,3/2/2024,Verified
220121_Oxford_UniversityOfOxford,"January 21, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Oxford,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,344,6.69%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
210525_Scotland_NHSLothian,"June 25, 2021",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 27, 2020","August 3, 2020",Household and community samples,Multiple groups,355,4.50%,,,Sequential,"Abbott Laboratories,Roche Diagnostics,DiaSorin,Siemens,EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,Unclear,Journal Article (Peer-Reviewed),Lindsay McDonald,NHS Lothian,https://dx.doi.org/10.1016/j.jcvp.2021.100028,3/18/2022,3/2/2024,Unverified
220330_Scotland_PublicHealthScotland_1ResidualSera_1Overall_PopAdj_TestAdj,"March 30, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 24, 2022","February 27, 2022",Residual sera,Multiple groups,2884,93.36%,92.80%,94.70%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,4/4/2022,8/15/2023,Verified
220330_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"March 30, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 24, 2022","February 27, 2022",Blood donors,Multiple groups,2499,100.00%,99.60%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,4/4/2022,8/15/2023,Verified
220330_Scotland_PublicHealthScotland_3PregnantWomen_3Overall_PopAdj_TestAdj,"March 30, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"January 24, 2022","February 27, 2022",Pregnant or parturient women,Adults (18-64 years),3217,94.30%,93.20%,95.80%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-30-march-2022/,4/4/2022,8/15/2023,Verified
220303_NorthernIreland_UlsterUniversity,"March 3, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,Northern Ireland,Belfast,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,80,11.25%,,,Convenience, Abingdon Health,LFIA,IgG,97.58%,99.59%,High,Journal Article (Peer-Reviewed),Louise Robertson,Ulster University,https://dx.doi.org/10.1016/j.vaccine.2022.02.087,4/6/2022,3/2/2024,Unverified
220310_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_Follow-up2_UnAdj,"March 10, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Sheffield,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),1166,27.27%,,,Convenience,NA,ELISA,"IgG,IgA",99.47%,99.56%,High,Journal Article (Peer-Reviewed),Hayley Colton,Sheffield Teaching Hospitals NHS Foundation Trust,https://wellcomeopenresearch.org/articles/6-220/v2,4/7/2022,7/17/2022,Unverified
220310_Sheffield_SheffieldTeachingHospitalsNHSFoundationTrust_Baseline1_TestAdj,"March 10, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Sheffield,"May 15, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),1275,23.10%,14.10%,33.30%,Convenience,NA,ELISA,"IgG,IgA",99.47%,99.56%,High,Journal Article (Peer-Reviewed),Hayley Colton,Sheffield Teaching Hospitals NHS Foundation Trust,https://wellcomeopenresearch.org/articles/6-220/v2,4/7/2022,7/17/2022,Unverified
220408_UKHealthSecurityAgency_England_May-June(1)_Euroimmun,"April 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"May 1, 2020","June 30, 2020",Residual sera,Multiple groups,5455,4.10%,3.10%,5.30%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,4/22/2022,3/2/2024,Verified
220408_UKHealthSecurityAgency_England_July-August(2)_Euroimmun,"April 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"July 1, 2020","August 31, 2020",Residual sera,Multiple groups,5781,5.20%,4.50%,6.10%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,4/22/2022,3/2/2024,Verified
220408_UKHealthSecurityAgency_England_Sept-Oct(3)_Euroimmun,"April 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"September 1, 2020","October 1, 2020",Residual sera,Multiple groups,5478,5.50%,4.80%,6.40%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,4/22/2022,3/2/2024,Verified
220408_UKHealthSecurityAgency_England_Nov-Dec(4)_Euroimmun,"April 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"November 1, 2020","December 31, 2020",Residual sera,Multiple groups,4934,6.60%,5.70%,7.60%,Sequential,EUROIMMUN,ELISA,IgG,72.00%,99.00%,High,Preprint,Heather Whitaker,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2022.04.016,4/22/2022,3/2/2024,Verified
220421_GreatBritain_UniversityCollegeLondon_Overall,"April 21, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Wales",,"February 1, 2021","June 8, 2021",Household and community samples,Multiple groups,3775,12.10%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sarah Beale,University College London,https://dx.doi.org/10.1136/oemed-2021-107920,5/4/2022,3/2/2024,Verified
220504_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"May 4, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 28, 2022","April 3, 2022",Residual sera,Multiple groups,2885,94.80%,94.50%,96.10%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,5/16/2022,8/15/2023,Verified
220504_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"May 4, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 28, 2022","April 3, 2022",Blood donors,Multiple groups,2499,100.00%,99.70%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,5/16/2022,8/15/2023,Verified
220504_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"May 4, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"February 28, 2022","April 3, 2022",Pregnant or parturient women,Adults (18-64 years),3181,95.40%,94.40%,96.90%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-4-may-2022/,5/16/2022,8/15/2023,Verified
220608_Scotland_PublicHealthScotland_2BloodDonors_Overall_PopAdj_TestAdj,"June 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 4, 2022","May 8, 2022",Blood donors,Multiple groups,2499,100.00%,99.75%,100.00%,Sequential,EUROIMMUN,ELISA,IgG,84.00%,100.00%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,6/22/2022,5/2/2024,Verified
220608_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"June 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 4, 2022","May 8, 2022",Residual sera,Multiple groups,2886,94.77%,94.47%,96.09%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,6/22/2022,5/2/2024,Verified
220608_Scotland_PublicHealthScotland_3PregnantWomen_Overall_PopAdj_TestAdj,"June 8, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"April 4, 2022","May 8, 2022",Pregnant or parturient women,Adults (18-64 years),3181,95.43%,94.41%,96.86%,Sequential,Roche Diagnostics,CLIA,Total Antibody,92.30%,100.00%,Low,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-8-june-2022/,6/22/2022,5/2/2024,Verified
220801_England_ImperialCollegeLondon_Overall,"August 1, 2022",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"July 1, 2021","August 10, 2021",Household and community samples,Multiple groups,3758,96.40%,95.70%,97.00%,Stratified probability,Roche Diagnostics,CLIA,IgG,98.50%,100.00%,High,Preprint,Christina Atchison,Imperial College London,https://www.medrxiv.org/content/10.1101/2022.06.08.22276154v1.full-text,7/1/2022,4/3/2024,Verified
230214_England_UKHealthSecurityAgency_PrimaryStudents_TestPopAdj_Overall,"February 14, 2023",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 10, 2021","December 10, 2021",Students and Daycares,Children and Youth (0-17 years),2706,40.10%,37.30%,43.00%,Stratified probability,NA,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2023.02.016,7/25/2022,3/10/2023,Unverified
230214_England_UKHealthSecurityAgency_SecondaryStudents_TestPopAdj_Overall,"February 14, 2023",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 10, 2021","December 10, 2021",Students and Daycares,Children and Youth (0-17 years),2274,82.40%,79.50%,85.10%,Stratified probability,NA,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Annabel Powell,UK Health Security Agency,https://dx.doi.org/10.1016/j.jinf.2023.02.016,7/25/2022,3/10/2023,Unverified
220623_England_UniversityofOxford_period1,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"October 1, 2019","March 31, 2020",Household and community samples,Children and Youth (0-17 years),2540,5.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220623_England_UniversityofOxford_period2,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"April 1, 2020","May 31, 2020",Household and community samples,Children and Youth (0-17 years),2540,13.50%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220623_England_UniversityofOxford_period3,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"June 1, 2020","August 31, 2020",Household and community samples,Children and Youth (0-17 years),2540,20.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220623_England_UniversityofOxford_period4,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"September 1, 2020","December 31, 2020",Household and community samples,Children and Youth (0-17 years),2540,18.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220623_England_UniversityofOxford_period5,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"January 1, 2021","March 31, 2021",Household and community samples,Children and Youth (0-17 years),2540,31.10%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220623_England_UniversityofOxford_period6,"June 23, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,,Bradford; Bristol; Imperial; Leeds; Manchester; Newcastle; Nottingham; Oxford; Plymouth; Sheffield; Southhampton; St Georges London; West Suffolk,"April 1, 2021","June 30, 2021",Household and community samples,Children and Youth (0-17 years),2540,10.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helen Ratcliffe,University of Oxford,https://dx.doi.org/10.1136/archdischild-2022-324375,7/27/2022,3/2/2024,Unverified
220713_Scotland_PublicHealthScotland_1ResidualSera_Overall_PopAdj_TestAdj,"July 13, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,Scotland,,"June 6, 2022","July 10, 2022",Residual sera,Multiple groups,2544,95.50%,95.00%,97.00%,Stratified probability,DiaSorin,CLIA,Not reported,97.30%,99.60%,Moderate,Institutional Report,Public Health Scotland,Public Health Scotland,https://www.publichealthscotland.scot/publications/enhanced-surveillance-of-covid-19-in-scotland/enhanced-surveillance-of-covid-19-in-scotland-population-based-seroprevalence-surveillance-13-july-2022/,8/9/2022,8/15/2023,Verified
220806_WestMidlands_TheRoyalWolverhamptonNHSTrust_Overall,"August 6, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"June 17, 2020","July 30, 2020",Health care workers and caregivers,Multiple groups,1082,27.60%,,,Convenience,NA,CLIA,IgG,92.71%,99.73%,High,Journal Article (Peer-Reviewed),Sonika Sethi,The Royal Wolverhampton NHS Trust,https://dx.doi.org/10.1016/j.bbih.2022.100492,9/7/2022,9/7/2022,Unverified
220901_Cambridge_UniversityOfCambridge_Overall,"September 1, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Cambridge,"June 10, 2020","August 7, 2020",Health care workers and caregivers,Multiple groups,5698,7.20%,,,Convenience,Siemens,CLIA,Total Antibody,98.10%,99.90%,High,Journal Article (Peer-Reviewed),Daniel Cooper,University of Cambridge,https://dx.doi.org/10.1016/j.jinf.2022.08.030,9/15/2022,3/2/2024,Unverified
220902_London_ImperialCollegeLondon_overall,"September 2, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,"London
","October 22, 2019","September 22, 2020",Residual sera,Adults (18-64 years),11291,6.20%,5.80%,6.70%,Sequential,Imperial College London,ELISA,Total Antibody,98.90%,99.60%,Low,Journal Article (Peer-Reviewed),Edward Mullins,Imperial College London,https://dx.doi.org/10.1371/journal.pone.0273966,9/22/2022,4/10/2024,Verified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round2_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 22, 2020","December 5, 2020",Students and Daycares,Children and Youth (0-17 years),2414,7.07%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round6_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 13, 2021","June 26, 2021",Students and Daycares,Children and Youth (0-17 years),7203,11.69%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round6_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 13, 2021","June 26, 2021",Essential non-healthcare workers,Adults (18-64 years),842,26.25%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round1_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 8, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),1034,11.51%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round6_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 13, 2021","June 26, 2021",Essential non-healthcare workers,Adults (18-64 years),1594,23.46%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round5_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 3, 2021","May 16, 2021",Essential non-healthcare workers,Adults (18-64 years),1985,21.56%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round4_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 15, 2021","March 31, 2021",Essential non-healthcare workers,Adults (18-64 years),1138,22.14%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round3_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 30, 2021","February 7, 2021",Students and Daycares,Children and Youth (0-17 years),1850,19.53%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round1_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 8, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),2773,11.25%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round3_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 30, 2021","February 7, 2021",Students and Daycares,Children and Youth (0-17 years),191,11.33%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round4_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 15, 2021","March 31, 2021",Essential non-healthcare workers,Adults (18-64 years),2214,19.56%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round5_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 3, 2021","May 16, 2021",Students and Daycares,Children and Youth (0-17 years),519,20.68%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round1_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 8, 2020","November 21, 2020",Students and Daycares,Children and Youth (0-17 years),2149,5.33%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round4_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 15, 2021","March 31, 2021",Students and Daycares,Children and Youth (0-17 years),7308,15.52%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round2_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 22, 2020","December 5, 2020",Essential non-healthcare workers,Adults (18-64 years),3291,13.01%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round5_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 3, 2021","May 16, 2021",Students and Daycares,Children and Youth (0-17 years),1343,15.13%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round4_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"March 15, 2021","March 31, 2021",Students and Daycares,Children and Youth (0-17 years),3628,13.74%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round5_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"May 3, 2021","May 16, 2021",Essential non-healthcare workers,Adults (18-64 years),1051,23.60%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStaff_Round3_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 30, 2021","February 7, 2021",Essential non-healthcare workers,Adults (18-64 years),467,17.56%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round2_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 22, 2020","December 5, 2020",Essential non-healthcare workers,Adults (18-64 years),1013,13.62%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStaff_Round3_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"January 30, 2021","February 7, 2021",Essential non-healthcare workers,Adults (18-64 years),66,25.76%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,3/2/2024,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round2_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 22, 2020","December 5, 2020",Students and Daycares,Children and Youth (0-17 years),4461,10.40%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_PrimaryStudents_Round6_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"June 13, 2021","June 26, 2021",Students and Daycares,Children and Youth (0-17 years),3850,11.49%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220824_England_UKHealthSecurityAgency_SecondaryStudents_Round1_Overall,"August 24, 2022",National,United Kingdom of Great Britain and Northern Ireland,GBR,England,,"November 8, 2020","November 21, 2020",Students and Daycares,Children and Youth (0-17 years),3032,9.05%,,,Convenience,NA,ELISA,IgG,75.00%,99.00%,High,Journal Article (Peer-Reviewed),Tanya Abramsky,UK Health Security Agency,https://dx.doi.org/10.1016/j.lanepe.2022.100471,9/23/2022,9/23/2022,Unverified
220927_Birmingham_UniversityofBirmingham,"September 27, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Birmingham,"May 12, 2020","May 22, 2020",Health care workers and caregivers,Adults (18-64 years),379,54.90%,,,Convenience,The Binding Site,ELISA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Sebastian Lugg,University of Birmingham,https://dx.doi.org/10.1136/bmjresp-2022-001258,10/10/2022,10/10/2022,Unverified
221012_UnitedKingdom_KingsCollege,"October 12, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,,"July 15, 2020","January 15, 2022",Pregnant or parturient women,Adults (18-64 years),960,20.40%,,,Sequential,NA,Not reported,IgG,,,High,Preprint,Daria Andreeva,King's College London,10.22541/au.166560306.61695696/v1,10/19/2022,10/21/2022,Unverified
220817_Harlow_PrincessAlexandraHospital_Overall,"August 17, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,Harlow,"April 29, 2020","June 6, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),10,10.00%,,,Convenience,Roche Diagnostics,Not reported,IgG,97.00%,,High,Presentation or Conference,Abirami Namasivayam,Princess Alexandra Hospital,https://dx.doi.org/10.1136/archdischild-2022-rcpch.433,10/19/2022,10/21/2022,Unverified
221101_England_UniversityofCambridge,"November 1, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Cambridge,"June 10, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),2044,10.90%,,,Convenience,Siemens,CLIA,"IgA,IgM,IgG",98.10%,99.90%,High,Journal Article (Peer-Reviewed),Daniel James Cooper,University of Cambridge ,https://dx.doi.org/10.1136/bmjopen-2022-063159,11/17/2022,3/2/2024,Unverified
221117_London_GuysAndStThomasNHSFoundationTrust_Overall,"November 17, 2022",Local,United Kingdom of Great Britain and Northern Ireland,GBR,England,London,"May 1, 2020","December 31, 2020",Residual sera,Multiple groups,2567,10.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Venkateshwaran Sivaraj,Guy’s and St Thomas’ NHS Foundation Trust,https://dx.doi.org/10.1136/sextrans-2021-055306,12/9/2022,3/20/2023,Unverified
230301_England_UKHealthSecurityAgency_Round1_Staff_AntiN_Overall,"March 1, 2023",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"West London, East London, Hertfordshire, Derbyshire, Greater Manchester, Birmingham","September 22, 2020","October 17, 2020",Essential non-healthcare workers,Adults (18-64 years),861,9.18%,,,Convenience,Abbott Laboratories,,,,,,Journal Article (Peer-Reviewed),Felicity Aiano,UK Health Security Agency,https://dx.doi.org/10.1097/INF.0000000000003890,4/12/2023,3/2/2024,Unverified
230301_England_UKHealthSecurityAgency_Round1_Students_AntiN_Overall,"March 1, 2023",Regional,United Kingdom of Great Britain and Northern Ireland,GBR,England,"West London, East London, Hertfordshire, Derbyshire, Greater Manchester, Birmingham","September 22, 2020","October 17, 2020",Students and Daycares,Children and Youth (0-17 years),893,12.77%,,,Convenience,Abbott Laboratories,,,,,,Journal Article (Peer-Reviewed),Felicity Aiano,UK Health Security Agency,https://dx.doi.org/10.1097/INF.0000000000003890,4/12/2023,3/2/2024,Unverified
230427_London_King'sCollegeLondon,"April 27, 2023",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,London,"July 15, 2020","January 15, 2022",Pregnant or parturient women,Adults (18-64 years),960,20.50%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Daria Andreeva,King's College London,https://dx.doi.org/10.1111/1471-0528.17508,6/2/2023,6/3/2023,Unverified
230523_Leeds_LeedsBeckettUniversity,"May 23, 2023",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,Leeds,"October 7, 2020","June 14, 2021",Multiple populations,Adults (18-64 years),1070,16.35%,,,Convenience,EUROIMMUN,ELISA,IgG,94.60%,99.88%,,Journal Article (Peer-Reviewed),P. Ferentinos,Leeds Beckett University,https://dx.doi.org/10.1016/j.jim.2023.113492,6/30/2023,3/2/2024,Unverified
230420_NottinghamAndGlasgow_NottinghamUniversityHospitalsNHSTrust,"April 20, 2023",Local,United Kingdom of Great Britain and Northern Ireland,GBR,,"Nottingham, Glasgow","August 1, 2021","August 31, 2021",Residual sera,Children and Youth (0-17 years),37,32.43%,,,Convenience,NA,ELISA,Not reported,,,,Presentation or Conference,Javairiya Afzaal,Nottingham University Hospitals NHS Trust,https://doi.org/10.1007/s00467-022-05865-y,8/1/2023,2/3/2024,Unverified
230624_UnitedKingdom_MountSinai,"June 24, 2023",National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,563,9.95%,,,Convenience,"Roche Diagnostics,Siemens,NA",Multiple Types,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230912_UK_UniversityOfOxford_May-Dec_Overall,"September 12, 2023",National,United Kingdom of Great Britain and Northern Ireland,GBR,"England, Wales, Scotland.",,"May 15, 2020","December 15, 2020",Household and community samples,Multiple groups,18887,8.84%,,,Stratified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Wemimo Omiyale,University of Oxford,https://dx.doi.org/10.1136/jech-2023-220353,10/11/2023,10/11/2023,Unverified
230920_NorthernIreland_Queen’sUniversityBelfast,,National,United Kingdom of Great Britain and Northern Ireland,GBR,,,"June 15, 2020","July 15, 2021",Residual sera,Multiple groups,4844,15.00%,,,Sequential,"Roche Diagnostics,EUROIMMUN,NA",ELISA,IgG,,,Moderate,Preprint,Michelle K Greene,Queen’s University Belfast,10.1101/2023.09.19.23295776,10/27/2023,3/2/2024,Unverified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_Households_TestAdj.,"April 24, 2021",Regional,United Arab Emirates,ARE,Emirate of Abu Dhabi,"Abu Dhabi, Al Ain, Al Dhafra","July 19, 2020","August 14, 2020",Household and community samples,Multiple groups,8831,10.40%,9.50%,11.40%,Stratified probability,"DiaSorin,Roche Diagnostics",CLIA,IgG,97.40%,98.50%,Low,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,5/15/2021,8/15/2023,Unverified
210424_EmirateofAbuDhabi_AbuDhabiPublicHealthCenter_LabourCamps_TestAdj.,"April 24, 2021",Regional,United Arab Emirates,ARE,Emirate of Abu Dhabi,"Abu Dhabi, Al Ain, Al Dhafra","July 19, 2020","August 14, 2020",Essential non-healthcare workers,Multiple groups,4855,68.60%,61.70%,74.70%,Stratified probability,Roche Diagnostics,Not reported,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ahmed R Alsuwaidi,Abu Dhabi Public Health Center,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyab077/6248207,5/15/2021,8/15/2023,Unverified
210709_Dubai_DubaiHealthAuthority_Overall,"July 9, 2021",Local,United Arab Emirates,ARE,NR,Dubai,"August 15, 2020","December 15, 2020",Blood donors,Adults (18-64 years),1418,13.50%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,96.77%,99.63%,Moderate,Journal Article (Peer-Reviewed),May Raouf,Dubai Health Authority,http://dx.doi.org/10.1159/000517456,8/17/2021,3/2/2024,Unverified
210927_AbuDhabi_SEHAAbuDhabiHealthServicesCompany,"September 27, 2021",Local,United Arab Emirates,ARE,,Abu Dhabi,"January 25, 2021","March 30, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,446,17.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Stephen Holt,SEHA Abu Dhabi Health Services Company,https://dx.doi.org/10.1111/nep.13980,10/6/2021,3/2/2024,Unverified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgG2,"May 1, 2021",Local,Ukraine,UKR,Poltava Oblast,Poltava,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,468,47.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,6/21/2021,7/17/2022,Verified
210501_Poltava_UkranianMedicalStomatologicalAcademy_IgM1,"May 1, 2021",Local,Ukraine,UKR,Poltava Oblast,Poltava,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,2375,5.70%,,,Self-referral,EKVITESTLAB LLC,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Alla Marchenko,Ukranian Medical Stomatological Academy,https://wiadlek.pl/wp-content/uploads/archive/2021/WLek202105116.pdf,6/21/2021,7/17/2022,Verified
220221_RakaiRegion_RakaiHealthSciencesProgram_HCWs_TestAdj,"February 21, 2022",Regional,Uganda,UGA,"Kyotera district, Lyantonde district, Masaka district, Rakai district.",,"November 30, 2020","January 8, 2021",Health care workers and caregivers,Adults (18-64 years),753,26.70%,23.50%,29.80%,Convenience,"Hangzhou Biotest Biotech Co Ltd,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charles Ssuuna,Rakai Health Sciences Program,https://dx.doi.org/10.1186/s12879-022-07161-4,3/4/2022,8/15/2023,Unverified
220221_RakaiRegion_RakaiHealthSciencesProgram_PreOfficialCOVID_TestAdj,"February 21, 2022",Regional,Uganda,UGA,"Kyotera district, Lyantonde district, Masaka district, Rakai district.",,"October 15, 2019","March 18, 2020",Residual sera,Multiple groups,636,2.30%,1.20%,3.50%,Unclear,"Hangzhou Biotest Biotech Co Ltd,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charles Ssuuna,Rakai Health Sciences Program,https://dx.doi.org/10.1186/s12879-022-07161-4,3/4/2022,8/15/2023,Unverified
220331_Uganda_MakerereUniversity_Primary,"March 31, 2022",Regional,Uganda,UGA,Amuru and Kyotera Districts,,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,72,31.90%,,,Stratified non-probability,Astel diagnostics® ,CLIA,IgG,93.30%,90.00%,High,Journal Article (Peer-Reviewed),Jesca Lukanga Nakavuma,Makerere University,https://doi.org/10.22541/au.164873468.80238886/v1,4/6/2022,7/17/2022,Unverified
220921_Uganda_UCSF_Round1_PopTestAdj,"September 21, 2022",Local,Uganda,UGA,,,"October 12, 2020","November 25, 2020",Household and community samples,Multiple groups,245,25.60%,19.60%,32.00%,Convenience,NA,Luminex,IgG,92.90%,100.00%,High,Preprint,Jessica Briggs,University of California San Francisco,https://dx.doi.org/10.1101/2022.09.20.22280170,10/5/2022,3/20/2023,Verified
220921_Uganda_UCSF_Round2_PopTestAdj,"September 21, 2022",Local,Uganda,UGA,,,"March 2, 2021","April 28, 2021",Household and community samples,Multiple groups,414,43.70%,38.60%,48.80%,Convenience,NA,Luminex,IgG,92.90%,100.00%,High,Preprint,Jessica Briggs,University of California San Francisco,https://dx.doi.org/10.1101/2022.09.20.22280170,10/5/2022,3/20/2023,Verified
220921_Uganda_UCSF_Round3_PopTestAdj,"September 21, 2022",Local,Uganda,UGA,,,"August 2, 2021","September 29, 2021",Household and community samples,Multiple groups,434,67.70%,62.50%,72.60%,Convenience,NA,Luminex,IgG,92.90%,100.00%,High,Preprint,Jessica Briggs,University of California San Francisco,https://dx.doi.org/10.1101/2022.09.20.22280170,10/5/2022,3/20/2023,Verified
220921_Uganda_UCSF_Round4_PopTestAdj,"September 21, 2022",Local,Uganda,UGA,,,"February 1, 2022","March 29, 2022",Household and community samples,Multiple groups,390,96.00%,93.40%,97.90%,Convenience,NA,Luminex,IgG,92.90%,100.00%,High,Preprint,Jessica Briggs,University of California San Francisco,https://dx.doi.org/10.1101/2022.09.20.22280170,10/5/2022,3/20/2023,Verified
230213_Uganda_UniversityofCaliforniaSanFrancisco_round4_popadj,"February 13, 2023",Regional,Uganda,UGA, Tororo and Busia districts,,"February 1, 2022","March 29, 2022",Household and community samples,Children and Youth (0-17 years),390,96.00%,93.40%,97.90%,Unclear,Luminex Corporation,Not reported,IgG,98.10%,99.20%,High,Journal Article (Peer-Reviewed),Jessica Briggs,University of California San Francisco,https://dx.doi.org/10.1001/jamanetworkopen.2022.55978,3/6/2023,3/20/2023,Unverified
230329_Masaka_InstituteNationalResearchBiomedical_M4_Overall,"March 29, 2023",Local,Uganda,UGA,,,"November 1, 2021","November 30, 2021",Health care workers and caregivers,Multiple groups,98,92.90%,,,Convenience,Luminex Corporation,Luminex,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Bolarinde Lawal,Institute National Research biomedical,https://dx.doi.org/10.1016/j.ijid.2023.03.049,4/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_Jan-Apr2022,"February 22, 2023",Local,Uganda,UGA,,Kampala,"January 15, 2022","April 15, 2022",Multiple populations,Adults (18-64 years),5393,82.50%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_Oct2019-June2020,"February 22, 2023",Local,Uganda,UGA,,Kampala,"October 15, 2019","June 15, 2020",Multiple populations,Adults (18-64 years),5393,1.00%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_Oct-Dec2020,"February 22, 2023",Local,Uganda,UGA,,Kampala,"October 15, 2020","December 15, 2020",Multiple populations,Adults (18-64 years),5393,33.60%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_Apr-Jun2021,"February 22, 2023",Local,Uganda,UGA,,Kampala,"April 15, 2021","June 15, 2021",Multiple populations,Adults (18-64 years),5393,45.50%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_Oct-Dec2021,"February 22, 2023",Local,Uganda,UGA,,Kampala,"October 15, 2021","December 15, 2021",Multiple populations,Adults (18-64 years),5393,51.50%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
230222_Kampala_NationalInstituteofAllergyandInfectiousDiseases_July-Sept2021,"February 22, 2023",Local,Uganda,UGA,,Kampala,"July 15, 2021","September 15, 2021",Multiple populations,Adults (18-64 years),5393,62.00%,,,Convenience,Meso Scale Diagnostics,CLIA,,,,,Presentation or Conference,Swetha Ashokkumar,National Institute of Allergy and Infectious Diseases,https://www.croiconference.org/abstract/sars-cov-2-seroprevalence-among-ugandan-blood-donors-2019-2022/,6/1/2023,3/2/2024,Unverified
231531_Uganda_JohnsHopkinsUniversity_Overall,"May 31, 2023",National,Uganda,UGA,,,"November 15, 2021","December 15, 2021",Blood donors,Multiple groups,1876,56.30%,,,Convenience,Meso Scale Discovery,Other,IgG,,,,Journal Article (Peer-Reviewed),Evan M. Bloch,Johns Hopkins University,https://dx.doi.org/10.1111/trf.17449,6/23/2023,7/4/2023,Unverified
210920_Serdivan_SakaryaUniversity,"January 15, 2021",Local,Turkey,TUR,Sakarya,Serdivan,"April 7, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),198,3.50%,,,Unclear,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cemil Bilir,Sakarya University ,http://dx.doi.org/10.19193/0393-6384_2021_1_103,3/28/2021,7/17/2022,Verified
210303_Turkey_UniversityofHealthSciences_Overall,"March 3, 2021",National,Turkey,TUR,Marmara,Istanbul and Kocaeli,"May 30, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),813,2.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gizem Alkurt,University of Health Sciences,https://dx.doi.org/10.1371/journal.pone.0247865,4/18/2021,3/2/2024,Verified
210310_Ankara_HacettepeUniversity_Overall,"March 10, 2021",Local,Turkey,TUR,Central Anatolia,Ankara,"March 24, 2020","September 10, 2020",Health care workers and caregivers,Adults (18-64 years),774,7.40%,,,Unclear,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Adem Ozdemir,Hacettepe University,http://www.mikrobiyolbul.org/linkout.aspx?pmid=33882653,5/18/2021,7/17/2022,Verified
210427_Turkey_SakaryaUniversity_Overall,"April 27, 2021",Local,Turkey,TUR,,,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),2988,3.61%,,,Entire sample,Beijing Hotgen Biotech Co. Ltd China,Other,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Aziz Ogutlu,Sakarya University,https://dx.doi.org/10.1186/s12941-021-00436-9,5/26/2021,7/17/2022,Verified
210523_Istanbul_KocUniversity,"May 23, 2021",Regional,Turkey,TUR,Marmara,Istanbul,"May 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),1732,15.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,Fatihan Pınarlık,Koc University,10.1101/2021.05.20.21257518,6/7/2021,3/2/2024,Unverified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_PROMPatients,"July 6, 2021",Local,Turkey,TUR,,Ankara,"June 1, 2020","July 31, 2020",Pregnant or parturient women,Adults (18-64 years),205,2.93%,,,Sequential,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,7/19/2021,3/2/2024,Verified
210706_Ankara_EtlikZübeydeHanımWomen'sHealthCareTrainingandResearchHospital_MiscarriagePatients,"July 6, 2021",Local,Turkey,TUR,,Ankara,"June 1, 2020","July 31, 2020",Pregnant or parturient women,Adults (18-64 years),230,0.00%,,,Sequential,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ozge Yucel Celik,"Etlik Zübeyde Hanim Women's Health Care, Training, and Research Hospital",https://dx.doi.org/10.5603/GP.a2021.0134,7/19/2021,3/2/2024,Verified
210707_Istanbul_FlorenceNightingaleHospital_primary,"July 7, 2021",Local,Turkey,TUR,Marmara,Istanbul,"March 20, 2020","June 20, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,83,3.60%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Savas Comlek,Florence Nightingale Hospital,http://dx.doi.org/10.22514/sv.2021.008,7/28/2021,3/2/2024,Unverified
210522_Adana_AdanaDr.TurgutNoyanTeachingandResearchHospital,"May 22, 2021",Local,Turkey,TUR,Mediterranean Region,Adana,"May 18, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),572,3.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hatice Hale GUMUS,Adana Dr. Turgut Noyan Teaching and Research Hospital,http://mikrobiyolbul.org/managete/fu_folder/2021-03/357-373%20Hatice%20Hale%20Gumus.pdf,8/3/2021,3/2/2024,Unverified
210930_Konya_NecmettinErbakanUniversityMeramFacultyofMedicine_Primary,"September 30, 2021",Local,Turkey,TUR,,Konya,"June 1, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),741,17.00%,,,Convenience,"EUROIMMUN,Vircell S.L.",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gokce Kader Arslan,Necmettin Erbakan University Meram Faculty of Medicine,http://dx.doi.org/10.5578/FLORA.20219706,10/27/2021,3/2/2024,Unverified
210927_Turkey_HacettepeUniversity_Primary,"September 27, 2021",National,Turkey,TUR,"Middle Anatolia region
Marmara region
Aegean region
East Anatolia region
South-east Anatolian region
Black Sea region
Mediterranean region",,"May 25, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),4927,6.10%,,,Convenience,Assure Tech. (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Pembe Derin Oygar,Hacettepe University,http://dx.doi.org/10.1016/j.ijid.2021.09.054,11/5/2021,3/2/2024,Unverified
211030_Turkey_BiruniUniversity_Other,"October 30, 2021",Local,Turkey,TUR,Marmara,Istanbul,"December 1, 2020","January 13, 2021",Residual sera,Adults (18-64 years),4258,35.30%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,11/16/2021,7/17/2022,Unverified
211030_Turkey_BiruniUniversity_AirCrew,"October 30, 2021",Local,Turkey,TUR,Marmara,Istanbul,"December 1, 2020","January 13, 2021",Essential non-healthcare workers,Adults (18-64 years),313,46.00%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,11/16/2021,7/17/2022,Unverified
211030_Turkey_BiruniUniversity_HCW,"October 30, 2021",Local,Turkey,TUR,Marmara,Istanbul,"December 1, 2020","January 13, 2021",Health care workers and caregivers,Adults (18-64 years),451,41.00%,,,Unclear,NA,IFA,IgG,,,High,Journal Article (Peer-Reviewed),Mehmet Islamoglu,Biruni University,https://dx.doi.org/10.1016/j.tmaid.2021.102190,11/16/2021,7/17/2022,Unverified
211108_Istanbul_UmraniyeTrainingandResearchHospital,"November 8, 2021",Local,Turkey,TUR,Marmara,Istanbul,"April 1, 2020","December 1, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),436,0.46%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Ferhat Demir,"Umraniye Training and Research
Hospital",https://dx.doi.org/10.1186/s12969-021-00632-z,1/3/2022,7/17/2022,Unverified
220119_Istanbul_IstanbulUniversity_Overall,"January 19, 2022",Local,Turkey,TUR,Marmara,Istanbul,"August 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),149,12.75%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Fatih Haslak,Istanbul University,https://dx.doi.org/10.1007/s10067-022-06067-5,1/27/2022,3/2/2024,Unverified
220208_Ankara_HacettepeUniversity_Overall,"February 8, 2022",Local,Turkey,TUR,Ankara,Ankara,"October 15, 2020","October 18, 2020",Health care workers and caregivers,Adults (18-64 years),1974,19.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Meliha Sonmezer,Hacettepe University,https://dx.doi.org/10.3390/vaccines10020258,2/24/2022,3/2/2024,Unverified
220315_Ankara_AnkaraCItyHospital_overall,"March 15, 2022",Local,Turkey,TUR,,Ankary,"September 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,91,30.77%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Dilara Gokce,Ankara City Hospital,https://dx.doi.org/10.6002/ect.2021.0494,3/25/2022,3/2/2024,Unverified
220712_Turkey_DokuzEylulUniversity_Overall,"July 12, 2022",National,Turkey,TUR,,,"December 15, 2020","January 15, 2021",Multiple populations,Multiple groups,888,29.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Oya Eren‑Kutsoylu,Dokuz Eylul University,https://dx.doi.org/10.1007/s11845-022-03095-7,7/20/2022,3/2/2024,Unverified
220622_Trabzon_KaradenizTechnicalUniversity_Controls,"June 22, 2022",Local,Turkey,TUR,,Trabzon,"January 15, 2021","February 15, 2021",Residual sera,Children and Youth (0-17 years),48,22.92%,,,Simplified probability,Roche Diagnostics,Not reported,Not reported,,,High,Presentation or Conference,G. Kaya,Karadeniz Technical University,https://dx.doi.org/10.1097/MPG.0000000000003446,8/12/2022,3/2/2024,Unverified
220622_Trabzon_KaradenizTechnicalUniversity_Patients,"June 22, 2022",Local,Turkey,TUR,,Trabzon,"January 15, 2021","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),141,25.53%,,,Sequential,Roche Diagnostics,Not reported,Not reported,,,High,Presentation or Conference,G. Kaya,Karadeniz Technical University,https://dx.doi.org/10.1097/MPG.0000000000003446,8/12/2022,3/2/2024,Unverified
221020_Istanbul_HealthScienceUniversity,"October 20, 2022",Local,Turkey,TUR,Istanbul,,"April 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),55,3.60%,,,Convenience,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Fatih Varol,Health Science University,https://dx.doi.org/10.14744/nci.2022.09634,12/9/2022,3/20/2023,Unverified
221027_Eskisehir_EskisehirOsmangaziUniversity_Patients_Overall,"October 27, 2022",Local,Turkey,TUR,,Eskisehir,"September 1, 2020","October 1, 2020",Residual sera,Multiple groups,633,2.36%,,,Self-referral,A.B.T. Biotechnology,,,,98.00%,,Journal Article (Peer-Reviewed),Sultan Ozkurt,Eskisehir Osmangazi University,https://dx.doi.org/10.14744/nci.2021.62447,12/16/2022,8/15/2023,Unverified
221027_Eskisehir_EskisehirOsmangaziUniversity_HCWs_Overall,"October 27, 2022",Local,Turkey,TUR,,Eskisehir,"September 1, 2020","October 1, 2020",Health care workers and caregivers,Adults (18-64 years),134,0.00%,,,Self-referral,A.B.T. Biotechnology,,,,98.00%,,Journal Article (Peer-Reviewed),Sultan Ozkurt,Eskisehir Osmangazi University,https://dx.doi.org/10.14744/nci.2021.62447,12/16/2022,8/15/2023,Unverified
221222_Samsum_UniversityCollegeDublinp,"December 22, 2022",Local,Turkey,TUR,,Samsum,"December 22, 2020","December 25, 2020",Health care workers and caregivers,Multiple groups,176,15.30%,10.40%,21.50%,Convenience,Lifotronic,,,92.50%,94.00%,,Journal Article (Peer-Reviewed),Mehmet Hakan Taskin,University College Dublin,https://dx.doi.org/10.1371/journal.pone.0279067,1/13/2023,3/2/2024,Unverified
221011_Trabzon_KaradenizTechnicalUniversity_Overall,"October 11, 2022",Local,Turkey,TUR,,Trabzon,"February 1, 2021","June 1, 2021",Residual sera,Children and Youth (0-17 years),107,22.40%,,,Convenience,NA,Not reported,Total Antibody,,,,Journal Article (Peer-Reviewed),Aysenur Bahadir,Karadeniz Technical University,https://dx.doi.org/10.1007/s12288-022-01565-7,4/26/2023,4/26/2023,Unverified
20220204_Tunis_UniversityofTunisElManar_AntiSAdj,"February 4, 2022",Local,Tunisia,TUN,,Tunis,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,1676,25.10%,22.20%,28.40%,Stratified probability,NA,ELISA,IgG,93.00%,95.00%,Low,Preprint,Ines Cherif,University of Tunis El Manar,https://www.researchsquare.com/article/rs-1317280/v2,2/18/2022,7/17/2022,Unverified
230120_Tunisia_UniversityofTunisElManar,"January 20, 2023",Local,Tunisia,TUN,Tunis,,"March 22, 2021","April 2, 2021",Health care workers and caregivers,Adults (18-64 years),428,32.90%,28.70%,37.40%,Convenience,NA,ELISA,IgG,95.00%,93.00%,,Journal Article (Peer-Reviewed),Ghassen Kharroubi,University of Tunis El Manar,https://dx.doi.org/10.1007/s00705-022-05636-y,2/9/2023,3/20/2023,Unverified
230612_Tunisia_NationalObservatoryofNewandEmergingDiseases_overall_adjusted,"July 12, 2023",Regional,Tunisia,TUN,Great Tunis,,"April 1, 2020","April 30, 2020",Household and community samples,Multiple groups,1049,0.80%,0.00%,2.20%,Convenience,Beijing Lepu Medical Technology,LFIA,"IgM,IgG",65.70%,65.70%,Moderate,Journal Article (Peer-Reviewed),Sonia Dhaouadi,National Observatory of New and Emerging Diseases,https://dx.doi.org/10.3390/epidemiologia4020020,8/1/2023,4/30/2024,Verified
200807_Lome_UniversiteDeLome_Overall,"August 7, 2020",Local,Togo,TGO,,Lome,"April 23, 2020","May 8, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),955,0.90%,0.40%,1.80%,Convenience,Hangzhou Clongene Biotech Co. Ltd ,LFIA,"IgM,IgG",77.10%,95.40%,High,Journal Article (Peer-Reviewed),Wemboo Halatoko,Universite de Lome,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124,9/24/2020,3/2/2024,Verified
220615_Lome_UniveristyofLome_Overall,"June 15, 2022",Local,Togo,TGO,,"Lomé
","September 1, 2020","October 31, 2020",Representative patient population,Multiple groups,243,5.80%,,,Convenience,CLUNGENE,LFIA,"IgG,IgM",77.00%,95.00%,High,Journal Article (Peer-Reviewed),Ameyo Monique Dorkenoo,University of Lomé,https://dx.doi.org/10.1007/s11686-022-00586-6,7/20/2022,3/24/2024,Verified
220929_Lomé_UniversityofLomé_Anti-S_All_Primary,"September 29, 2022",Local,Togo,TGO,Maritime Region,Lomé,"June 26, 2021","July 3, 2021",Persons experiencing homelessness,Multiple groups,299,63.50%,57.80%,69.00%,Entire sample,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Arnold Junior Sadio,"Paris Cité University and Sorbonne Paris Nord University, IAME",10.21203/rs.3.rs-2072529/v1,10/6/2022,3/2/2024,Unverified
230403_Lomé_UniversityofLomé_overall,"April 3, 2023",Local,Togo,TGO,,Lome,"June 26, 2021","July 3, 2021",Persons experiencing homelessness,Children and Youth (0-17 years),299,63.50%,57.80%,69.00%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,,Journal Article (Peer-Reviewed),Arnold Junior Sadio,University of Lomé,https://dx.doi.org/10.1186/s12879-023-08167-2,5/4/2023,3/2/2024,Unverified
221208_Togo_ResearchInstituteForSustainableDevelopment_PopTestAdj,"December 8, 2022",National,Togo,TGO,"Maritime, Plateaux, Centrale, Savanes","Grand Lome, Kara","May 5, 2021","June 30, 2021",Household and community samples,Multiple groups,7593,65.50%,64.30%,66.60%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.36%,100.00%,Low,Journal Article (Peer-Reviewed),Yao Konu,Research Institute for Sustainable Development,https://doi.org/10.1186/s12889-022-14794-2,3/31/2024,3/31/2024,Verified
220328_Dili_CharlesDarwinUniversity_FollowUp_Overall,"March 28, 2022",Local,Timor-Leste,TLS,Dili,Dili,"July 9, 2021","September 8, 2021",Health care workers and caregivers,Adults (18-64 years),157,94.30%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Paul Arkell,Charles Darwin University,https://dx.doi.org/10.1016/j.ijid.2022.03.043,4/13/2022,3/2/2024,Unverified
210401_Ranong_ChulalongkornUniversity,"April 1, 2021",Local,Thailand,THA,Ranong,,"April 17, 2020","May 17, 2020",Health care workers and caregivers,Adults (18-64 years),844,0.80%,0.40%,1.70%,Convenience,Baiya Phytopharm,LFIA,"IgG,IgM",94.10%,98.00%,Moderate,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0238088,4/6/2021,3/2/2024,Unverified
210714_Thailand_MinistryOfPublicHealthThailand_Overall,"July 14, 2021",National,Thailand,THA,"Eastern, Western, Central Thailand",,"January 18, 2021","March 5, 2021",Health care workers and caregivers,Adults (18-64 years),600,0.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Wanitchaya Kittikraisak,"Ministry of Public Health, Thailand",https://dx.doi.org/10.1371/journal.pone.0254563,7/20/2021,3/2/2024,Unverified
210720_Bangkok_ChulalongkornUniversity,"July 20, 2021",Local,Thailand,THA,,Bangkok,"August 15, 2020","January 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,210,0.95%,,,Unclear,Baiya Phytopharm,LFIA,"IgG,IgM",88.66%,90.63%,High,Preprint,Amarin Narkwichean,Chulalongkorn University,https://www.medrxiv.org/content/10.1101/2021.07.16.21259725v1.full-text,8/5/2021,3/2/2024,Unverified
211029_Thailand_ChulalongkornUniversity_overall_popadj,"October 29, 2021",National,Thailand,THA,"Northern Region, Northeastern Region, Central Region, Eastern Region, Southern Region",,"April 6, 2020","June 26, 2020",Multiple populations,Adults (18-64 years),857,6.30%,,,Convenience,Baiya Phytopharm,LFIA,"IgM,IgG",94.10%,98.00%,High,Journal Article (Peer-Reviewed),Tanawin Nopsopon,Chulalongkorn University,https://dx.doi.org/10.1136/bmjopen-2020-046676,11/10/2021,3/2/2024,Unverified
220121_Thailand_MahidolUniversity_HealthPersonnel_Overall,"January 21, 2022",Regional,Thailand,THA,"Chiang Mai, Bangkok",Bangkok,"May 14, 2020","May 21, 2021",Health care workers and caregivers,Multiple groups,472,0.00%,,,Unclear,"NA,Abbott Laboratories",Multiple Types,"Neutralizing ,IgG,IgA,IgM",,,Unclear,Preprint,Hatairat Lerdsamra,Mahidol University,https://www.medrxiv.org/content/10.1101/2022.01.18.22269501v1.full-text,2/2/2022,3/2/2024,Unverified
220202_Thailand_ChiangMaiUniversity_Overall,"February 2, 2022",National,Thailand,THA,Chiang Mai and Lamphun,,"November 15, 2020","January 15, 2021",Household and community samples,Multiple groups,1651,0.90%,0.50%,1.40%,Unclear,"NA,Innovita Biological Technology Co. Ltd,SD Biosensor,ACRO Biotech Inc",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Siriluk Takalay,Chiang Mai University,https://dx.doi.org/10.1371/journal.pone.0263127,2/8/2022,3/2/2024,Unverified
220415_MahasarakhamUniversity_Mahasarakham_Patients1,"April 15, 2022",Regional,Thailand,THA,Mahasarakham Province,,"February 20, 2020","April 30, 2020",Multiple populations,Multiple groups,78,2.60%,0.30%,9.00%,Sequential,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Samadhi Patamatamkul,Mahasarakham University,https://dx.doi.org/10.1097/IPC.0000000000001150,4/22/2022,3/2/2024,Unverified
220415_MahasarakhamUniversity_Mahasarakham_HCW2,"April 15, 2022",Regional,Thailand,THA,Mahasarakham Province,,"February 20, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,112,0.90%,0.02%,4.90%,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.33%,High,Journal Article (Peer-Reviewed),Samadhi Patamatamkul,Mahasarakham University,https://dx.doi.org/10.1097/IPC.0000000000001150,4/23/2022,3/2/2024,Unverified
220427_Thailand_MahidolUniversity_ReturnedWorkers_Primary,"April 27, 2022",Local,Thailand,THA,,"Bangkok, Chiang Mai","May 17, 2020","October 12, 2020",Multiple populations,Adults (18-64 years),553,28.00%,23.79%,32.80%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,5/4/2022,3/2/2024,Unverified
220427_Thailand_MahidolUniversity_AtRiskOccupation_Primary,"April 27, 2022",Local,Thailand,THA,,"Bangkok, Chiang Mai","May 15, 2020","May 17, 2021",Multiple populations,Multiple groups,2113,0.14%,0.03%,0.42%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,5/4/2022,3/2/2024,Unverified
220427_Thailand_MahidolUniversity_CloseContact_Primary,"April 27, 2022",Local,Thailand,THA,,"Bangkok, Chiang Mai","May 14, 2020","May 21, 2021",Contacts of COVID patients,Multiple groups,1856,2.04%,1.44%,2.81%,Unclear,"NA,Abbott Laboratories",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Hatairat Lerdsamran,Mahidol University,https://dx.doi.org/10.1371/journal.pone.0263316,5/4/2022,3/2/2024,Unverified
220525_Mahasarakham_MahasarakhamUniversity,"June 3, 2022",Local,Thailand,THA,Maha Sarakham Province,Mahasarakham,"July 1, 2020","March 31, 2021",Household and community samples,Adults (18-64 years),27,0.00%,,,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ploysai Rujkorakarn,Mahasarakham University,https://dx.doi.org/10.2147/OPTH.S366353,6/24/2022,3/2/2024,Unverified
221106_Bangkok_ChulabhornRoyalAcademy_Patients,"November 6, 2022",Local,Thailand,THA,Central Thailand,Bangkok,"March 4, 2021","May 31, 2021",Residual sera,Adults (18-64 years),200,0.00%,,,Unclear,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Teerapat Ungtrakul,Chulabhorn Royal Academy,https://dx.doi.org/10.1016/j.puhip.2022.100341,12/4/2022,3/2/2024,Unverified
221106_Bangkok_ChulabhornRoyalAcademy_Caregivers,"November 6, 2022",Local,Thailand,THA,Central Thailand,Bangkok,"March 4, 2021","May 31, 2021",Residual sera,Adults (18-64 years),200,1.00%,,,Unclear,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Teerapat Ungtrakul,Chulabhorn Royal Academy,https://dx.doi.org/10.1016/j.puhip.2022.100341,12/4/2022,3/2/2024,Unverified
221205_Bangkok_ChulalongkornUniversity,"December 5, 2022",Local,Thailand,THA,,Bangkok,"January 15, 2021","December 15, 2021",Household and community samples,Children and Youth (0-17 years),438,27.40%,15.70%,40.30%,Convenience,"Abbott Laboratories,Roche Diagnostics",,,,,,Preprint,Nungruthai Suntronwong,Chulalongkorn University,10.1101/2022.12.01.22283006,12/28/2022,3/2/2024,Unverified
221216_Thailand_MinistryOfPublicHealth_Overall,"December 16, 2022",National,Thailand,THA,,,"November 15, 2021","December 15, 2021",Household and community samples,Adults (18-64 years),26717,1.40%,1.24%,1.52%,Stratified non-probability,"NA,Abbott Laboratories",,,,,,Journal Article (Peer-Reviewed),Surakameth Mahasirimongkol,Ministry of Public Health,https://dx.doi.org/10.3390/vaccines10122169,1/11/2023,3/2/2024,Unverified
230315_Chonburi_ChulalongkornUniversity_GeneralPop_Overall,"March 15, 2023",Regional,Thailand,THA,Chonburi,,"October 15, 2022","January 15, 2023",Household and community samples,Multiple groups,1193,96.40%,,,Stratified probability,Abbott Laboratories,,,,,,Preprint,Jira Chansaenroj,Chulalongkorn University,http://doi.org/10.21203/rs.3.rs-2646719/v1,4/5/2023,3/10/2024,Unverified
230315_Chonburi_ChulalongkornUniversity_HCWs_Overall,"March 15, 2023",Regional,Thailand,THA,Chonburi,,"October 15, 2022","January 15, 2023",Health care workers and caregivers,Multiple groups,266,100.00%,,,Stratified probability,Abbott Laboratories,,,,,,Preprint,Jira Chansaenroj,Chulalongkorn University,http://doi.org/10.21203/rs.3.rs-2646719/v1,4/5/2023,3/10/2024,Unverified
230427_Bangkok_ChulalongkornUniversity_Preomicron,"April 27, 2023",Local,Thailand,THA,,Bangkok,"January 15, 2021","December 15, 2021",Residual sera,Children and Youth (0-17 years),241,9.10%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Nungruthai Suntronwong,Chulalongkorn University,https://dx.doi.org/10.1371/journal.pone.0279147,5/31/2023,3/2/2024,Unverified
230427_Bangkok_ChulalongkornUniversity_Omicron,"April 27, 2023",Local,Thailand,THA,,Bangkok,"January 15, 2022","December 15, 2022",Residual sera,Children and Youth (0-17 years),201,48.80%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Nungruthai Suntronwong,Chulalongkorn University,https://dx.doi.org/10.1371/journal.pone.0279147,5/31/2023,3/2/2024,Unverified
230519_Bangkok_MinistryofPublicHealthThailand_Overall,"May 19, 2023",Local,Thailand,THA,,Bangkok,"January 12, 2021","August 10, 2021",Household and community samples,Multiple groups,452,29.42%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Kamolthip Atsawawaranunt,"Ministry of Public Health ,Thailand",https://dx.doi.org/10.1016/j.heliyon.2023.e16501,6/23/2023,5/1/2024,Verified
230206_Tajikistan_SaintPetersburgPasteurInstitute_AntiNorAntiS_Primary,"February 6, 2023",National,Tajikistan,TJK,,"Dushanbe, Khujand, Bokhtar, Vahdad, Hisor, Istaravshan, Isfara, Kulob, Panjakent, Tursunzade","March 14, 2022","March 18, 2022",Household and community samples,Multiple groups,3674,99.20%,98.90%,99.40%,Stratified non-probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),A.Yu. Popova,Saint Petersburg Pasteur Institute,https://dx.doi.org/10.15789/1563-0625-AOM-2630,5/5/2023,5/5/2023,Unverified
210913_Syria_ArabInternationalUniversity_Overall,"September 13, 2021",Local,Syrian Arab Republic,SYR,Daraa Governorate,Ghabaghib,"February 17, 2021","March 31, 2021",Household and community samples,Multiple groups,94,63.83%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Preprint,Wafika Zarzour,Arab International University,https://www.researchsquare.com/article/rs-885678/v1,9/21/2021,3/2/2024,Verified
200611_Geneva_UniversityofLausanne_genpop,"June 11, 2020",Regional,Switzerland,CHE,Geneva,,"April 6, 2020","May 9, 2020",Household and community samples,Multiple groups,2766,7.81%,,,Stratified probability,EUROIMMUN,ELISA,IgG,93.00%,,Moderate,Journal Article (Peer-Reviewed),Silvia Stringhini,Geneva University Hospitals,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext#seccestitle10,7/16/2020,3/2/2024,Verified
200807_Zurich_UniversityofZurich_USZCohort_MarchQDA,"August 7, 2020",Local,Switzerland,CHE,Zurich,Zurich,"March 15, 2020","March 31, 2020",Residual sera,Adults (18-64 years),3806,0.30%,0.10%,0.50%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/17/2022,Verified
200807_Zurich_UniversityofZurich_USZCohort_AprilQDA,"August 7, 2020",Local,Switzerland,CHE,Zurich,Zurich,"April 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),4275,1.40%,1.00%,1.70%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/17/2022,Verified
200807_Zurich_UniversityofZurich_USZCohort_May-JulyAveQDA,"August 7, 2020",Local,Switzerland,CHE,Zurich,Zurich,"May 15, 2020","July 15, 2020",Residual sera,Adults (18-64 years),12831,0.90%,,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/17/2022,Verified
200807_Zurich_UniversityofZurich_BDSCohort_AprilQDA,"August 7, 2020",Local,Switzerland,CHE,Zurich,Zurich,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),1469,1.20%,0.70%,,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/17/2022,Verified
200807_Zurich_UniversityofZurich_BDSCohort_earlyJulyQDA,"August 7, 2020",Local,Switzerland,CHE,Zurich,Zurich,"July 1, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1067,0.70%,0.30%,1.20%,Sequential,NA,ELISA,IgG,100.00%,100.00%,Moderate,Preprint,Marc Emmenegger,University of Zurich,https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v4,9/27/2020,7/17/2022,Verified
201008_StGallen_CantonalHospitalStGallen_hcw,"October 8, 2020",Regional,Switzerland,CHE,St. Gallen,St. Gallen,"March 19, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),1012,0.99%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Sugentech, Inc.",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Phillipp Kohler,Cantonal Hospital St. Gallen,https://dx.doi.org/10.1017/ice.2020.1244,1/18/2021,3/2/2024,Verified
201108_Geneva_GenevaUniversityHospital_Overall,"November 8, 2020",Local,Switzerland,CHE,,Geneva,"April 1, 2020","April 30, 2020",Residual sera,Children and Youth (0-17 years),208,8.70%,,,Sequential,"EUROIMMUN,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Klara Posfay Barbe,Geneva University Hospital,https://dx.doi.org/10.1093/cid/ciaa1702,1/18/2021,3/2/2024,Verified
201103_Vaud_UniversityofLausanne_GenPop1_Roche,"November 3, 2020",Regional,Switzerland,CHE,Vaud,,"May 4, 2020","June 27, 2020",Household and community samples,Multiple groups,311,3.90%,,,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/24/2021,3/2/2024,Verified
201103_Vaud_UniversityofLausanne_CloseContacts2_Roche,"November 3, 2020",Regional,Switzerland,CHE,Vaud,,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,177,32.20%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Craig Fenwick,Lausanne University Hospital and University of Lausanne,http://dx.doi.org/10.1128/JVI.01828-20,1/24/2021,3/2/2024,Verified
201130_Fribourg_UniversitéDeFribourg_overall,"November 30, 2020",Regional,Switzerland,CHE,Canton of Fribourg,,"July 8, 2020","October 14, 2020",Household and community samples,Multiple groups,418,8.00%,4.00%,12.00%,Simplified probability,NA,Luminex,"IgG,IgA",96.60%,99.70%,Moderate,Institutional Report,Daniela Anker,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf,3/13/2021,7/17/2022,Verified
210419_Fribourg_UniversitédeFribourg_Overall_TestPopAdj,"April 1, 2021",Regional,Switzerland,CHE,Canton of Fribourg,,"November 30, 2020","February 5, 2021",Household and community samples,Multiple groups,449,19.00%,15.00%,23.00%,Simplified probability,NA,ELISA,IgG,96.60%,99.70%,Moderate,Institutional Report,Emna El May,Université de Fribourg,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2021-PopHealthLab-Corona-Immunitas-E2.pdf,4/20/2021,7/17/2022,Verified
210319_Geneva_GenevaUniversityHospitals_HospitalEmployees,"March 19, 2021",Local,Switzerland,CHE,,Geneva,"March 30, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),3421,7.90%,7.00%,8.80%,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Romain Martischang,Geneva University Hospitals,https://dx.doi.org/10.1017/ice.2021.117,4/24/2021,3/2/2024,Unverified
200929_Ticino_InstituteofPublicHealth_primary,"September 29, 2020",Local,Switzerland,CHE,,,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),647,11.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Universita della Svizzera Italiana,The Institute of Public Health on the Università della Svizzera italiana,https://www.biomed.usi.ch/en/feeds/8913,4/24/2021,7/17/2022,Verified
210402_Switzerland_UniversitàdellaSvizzeraItaliana_overall,"April 2, 2021",Regional,Switzerland,CHE,Southern Switzerland ,,"July 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),301,3.30%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Elena Giuliano,Università della Svizzera Italiana,https://dx.doi.org/10.1136/bmjmilitary-2021-001828,4/24/2021,3/2/2024,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseII_overall,"March 31, 2021",Regional,Switzerland,CHE,Canton of Neuchâtel ,,"August 21, 2020","October 29, 2020",Household and community samples,Multiple groups,381,4.90%,2.38%,8.14%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/28/2021,7/17/2022,Verified
210115_Neuchatel_EcoleSuisseDeSantéPublique_PhaseIII,"March 31, 2021",Regional,Switzerland,CHE,Canton of Neuchâtel ,,"December 23, 2020","March 17, 2021",Household and community samples,Multiple groups,559,22.00%,17.90%,26.30%,Stratified probability,NA,ELISA,"IgG,IgA",96.60%,99.70%,Moderate,News and Media,Republique et Canton de Neuchatel,École suisse de santé publique,https://www.ne.ch/autorites/DFS/SCSP/medecin-cantonal/maladies-vaccinations/coronaimmunitas/Pages/R%c3%a9sultats-de-l'%c3%a9tude.aspx,4/28/2021,7/17/2022,Verified
20210226_Zurich_UniversityofZurich_carehomeworkers,"February 26, 2021",Regional,Switzerland,CHE,Canton of Zurich,,"September 9, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),296,14.90%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,5/10/2021,7/17/2022,Unverified
20210226_Zurich_UniversityofZurich_spitexworkers,"February 26, 2021",Regional,Switzerland,CHE,Canton of Zurich,,"September 9, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),131,3.80%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Institutional Report,Canton Zurich,University of Zurich,https://www.zh.ch/de/news-uebersicht/medienmitteilungen/2021/02/zuercher-studien-zu-seropraevalenz-von-spitex--und-heimpersonal-sowie-zu-immunantwort-und-langzeitfolgen-bei-corona-positiv-getesteten.html,5/10/2021,7/17/2022,Unverified
210203_Ticino_UniversitàdellaSvizzeraitaliana_primary,"February 3, 2021",Regional,Switzerland,CHE,Ticino,,"November 1, 2020","January 13, 2021",Household and community samples,Multiple groups,1463,16.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Institute of Public Health of the Universita della Svizzera italiana,Università della Svizzera italiana,https://www.biomed.usi.ch/it/feeds/9035,5/19/2021,7/17/2022,Verified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana_HCW,"April 12, 2021",Local,Switzerland,CHE,Grisons,NR,"May 15, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),289,15.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,5/20/2021,3/2/2024,Verified
210412_ValMesolcina_UniversitàdellaSvizzeraItaliana__Genpop,"April 12, 2021",Local,Switzerland,CHE,Grisons,NR,"May 15, 2020","May 31, 2020",Household and community samples,Multiple groups,423,2.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gregorio Milani ,Università della Svizzera Italiana,https://dx.doi.org/10.3390/pathogens10040465,5/20/2021,3/2/2024,Verified
210608_Geneva_UniversityOfGeneva_overall,"June 8, 2021",Regional,Switzerland,CHE,Canton of Geneva,,"May 18, 2020","September 18, 2020",Essential non-healthcare workers,Adults (18-64 years),10513,9.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Silvia Stringhini,The University of Geneva,http://dx.doi.org/10.1038/s41467-021-23796-4,7/1/2021,3/2/2024,Unverified
210621_Geneva_GenevaUniversityHospitals_overall,"June 21, 2021",Local,Switzerland,CHE,,Geneva,"June 1, 2020","June 30, 2020",Residual sera,Multiple groups,1167,5.90%,4.70%,7.40%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Stephanie Baggio,Geneva University Hospitals,http://dx.doi.org/10.1016/j.ypmed.2021.106696,7/7/2021,3/2/2024,Verified
201207_Ticino_UniversitaDellaSvizzeraItaliana,"December 17, 2020",Regional,Switzerland,CHE,Canton of Ticino,,"April 16, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,4726,9.60%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Luca Piccoli,Università della Svizzera italiana,https://dx.doi.org/10.1016/j.lanepe.2020.100013,7/7/2021,7/17/2022,Unverified
210705_Lausanne_UniversityOfLausanne_Overall,"July 5, 2021",Local,Switzerland,CHE,,Lausanne,"May 18, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,1874,10.00%,8.70%,11.50%,Stratified non-probability,NA,ELISA,IgG,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Sylvain Meylan,Lausanne University Hospital and University of Lausanne,https://dx.doi.org/10.1136/bmjopen-2021-049232,7/14/2021,7/17/2022,Unverified
210719_Zurich_UniversityofZurich_T3_overallTestPopAdj,"July 19, 2021",Local,Switzerland,CHE,NR,Zurich,"March 15, 2021","April 16, 2021",Students and Daycares,Children and Youth (0-17 years),2450,16.40%,12.10%,19.50%,Simplified probability,NA,Other,"IgG,IgM,IgA",98.20%,99.40%,Low,Preprint,Agne Ulyte,University of Zurich,https://www.medrxiv.org/content/10.1101/2021.07.19.21260644v1.full-text,7/30/2021,2/3/2024,Unverified
210726_Zurich_UniversityofZurich_Adults_Overall,"July 26, 2021",Local,Switzerland,CHE,Zurich,Zurich,"June 16, 2020","July 9, 2020",Household and community samples,Adults (18-64 years),857,3.60%,1.70%,5.40%,Simplified probability,NA,ELISA,"IgG,IgA",98.30%,98.40%,Low,Journal Article (Peer-Reviewed),Agne Ulyte,University of Zurich,https://dx.doi.org/10.1136/bmjopen-2020-047483,8/4/2021,7/17/2022,Verified
210326_Vaud_UniversityofLausanne_CloseContactsOutsideHousehold2_Overall_ClusterAdj,"March 26, 2021",Regional,Switzerland,CHE,Vaud,,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,69,19.00%,10.00%,33.20%,Simplified probability,NA,Other,IgG,96.70%,99.20%,High,Journal Article (Peer-Reviewed),Julien Dupraz,University of Lausanne,https://dx.doi.org/10.1093/ofid/ofab149,8/5/2021,7/17/2022,Verified
210326_Vaud_UniversityofLausanne_Household1_Overall_ClusterAdj,"March 26, 2021",Regional,Switzerland,CHE,Vaud,,"May 4, 2020","June 27, 2020",Contacts of COVID patients,Multiple groups,302,57.20%,49.50%,64.30%,Simplified probability,NA,Other,IgG,96.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Julien Dupraz,University of Lausanne,https://dx.doi.org/10.1093/ofid/ofab149,8/5/2021,7/17/2022,Verified
210813_Geneva_GenevaUniversityHospital_Primary,"August 13, 2021",Local,Switzerland,CHE,,Geneva,"June 1, 2021","July 7, 2021",Household and community samples,Multiple groups,3355,29.90%,28.00%,31.90%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Low,Preprint,Silvia Stringhini,Geneva University Hospital ,https://www.medrxiv.org/content/10.1101/2021.08.12.21261929v1,8/25/2021,8/15/2023,Verified
210820_Solothurn_UniversityofBern_Primary,"August 20, 2021",Regional,Switzerland,CHE,Canton of Solothurn,,"June 1, 2020","July 1, 2020",Health care workers and caregivers,Adults (18-64 years),357,3.40%,1.70%,5.80%,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Kathrin Zurcher,University of Bern,https://dx.doi.org/10.4414/SMW.2021.w30021,9/15/2021,3/2/2024,Unverified
210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_Baseline_Overall,"July 6, 2021",Local,Switzerland,CHE,,Geneva,"April 15, 2020","July 15, 2020",Multiple populations,Multiple groups,187,12.30%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Javier Perez Saez,Johns Hopkins Bloomberg School of Public Health,https://doi.org/10.1016/j.cmi.2021.06.040,9/16/2021,3/2/2024,Unverified
210706_Geneva_JohnsHopkinsBloombergSchoolofPublicHealth_RocheS1_FollowUp_Overall,"July 6, 2021",Local,Switzerland,CHE,,Geneva,"November 1, 2020","November 30, 2020",Multiple populations,Multiple groups,187,27.27%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Javier Perez Saez,Johns Hopkins Bloomberg School of Public Health,https://doi.org/10.1016/j.cmi.2021.06.040,9/16/2021,3/2/2024,Unverified
210903_Grisons_CantonalHospitalGrisons,"September 3, 2021",Regional,Switzerland,CHE,Canton of Grisons,,"June 1, 2020","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),5109,9.30%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Presentation or Conference,Katarzyna Szajek,Cantonal Hospital Grisons,https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf,9/29/2021,3/2/2024,Unverified
210901_Switzerland_KantonsspitalStGallen,"September 1, 2021",Local,Switzerland,CHE,St. Gallen,St. Gallen,"January 10, 2021","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,77,5.19%,,,Unclear,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Andrea Rubbert-Roth,Kantonsspital St. Gallen,https://smw.ch/article/doi/SMW.2021.w30056,9/30/2021,3/2/2024,Unverified
211022_Switzerland_CantonalHospitalStGallen,"October 22, 2021",National,Switzerland,CHE,,,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Multiple groups,3334,20.34%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,88.00%,99.00%,Moderate,Preprint,Carol Strahm,Cantonal Hospital St Gallen,https://www.medrxiv.org/content/10.1101/2021.10.19.21265187v1.full-text,11/5/2021,3/2/2024,Unverified
211019_Geneva_GenevaUniversityHospitals_Overall_Adjusted,"October 19, 2021",Regional,Switzerland,CHE,Canton of Geneva,,"April 6, 2020","June 30, 2020",Household and community samples,Multiple groups,8344,7.80%,6.80%,8.90%,Simplified probability,EUROIMMUN,ELISA,IgG,93.00%,100.00%,Low,Journal Article (Peer-Reviewed),Aude Richard,Geneva University Hospitals,https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full-text,11/18/2021,8/15/2023,Verified
220105_Bern_InselspitalUniversityHospital_ELISA_S1,"January 5, 2022",Local,Switzerland,CHE,,Bern,"April 15, 2020","November 15, 2020",Multiple populations,Multiple groups,3658,6.29%,,,Sequential,EUROIMMUN,ELISA,IgG,86.20%,98.20%,Moderate,Journal Article (Peer-Reviewed),Michael P Horn,Inselspital University Hospital,https://dx.doi.org/10.1111/all.15206,1/9/2022,3/2/2024,Unverified
211228_Ticino_Ufficiodelmedicocantonale_Phase4_OverallAdjusted,"December 28, 2021",Regional,Switzerland,CHE,Ticino,,"May 3, 2021","June 13, 2021",Household and community samples,Multiple groups,722,22.30%,19.20%,25.70%,Stratified probability,Technogenetics,LFIA,"IgM,IgG",95.10%,98.90%,Moderate,Journal Article (Peer-Reviewed),Ottavio Beretta,Ufficio del medico cantonale,https://smw.ch/article/doi/smw.2021.w30116,1/10/2022,3/2/2024,Verified
220112_Zurich_UniversityofZurich_OAT,"January 12, 2022",Local,Switzerland,CHE,,Zurich,"July 1, 2020","October 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,122,9.80%,5.10%,17.20%,Convenience,Swiss Federal Institute of Technology,Not reported,"IgA,IgG",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Philip Bruggmann,University of Zurich,https://smw.ch/article/doi/smw.2022.w30122,1/19/2022,7/17/2022,Verified
220110_Grisons_ CantonalHospitalGrisons_Followup2_Overall,"January 10, 2022",Regional,Switzerland,CHE,Canton of Grisons,,"January 4, 2021","February 19, 2021",Health care workers and caregivers,Adults (18-64 years),2315,16.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Katarzyna Szajek, Cantonal Hospital of Grisons,https://dx.doi.org/10.1186/s13756-021-01047-x,1/19/2022,3/2/2024,Unverified
211020_Vaud_UniversityofLausanne_Center1,"October 20, 2021",Regional,Switzerland,CHE,Vaud,,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,82,13.00%,3.00%,14.00%,Convenience,NA,Not reported,"IgG,IgA",,,High,Presentation or Conference,K Morisod,University of Lausanne,https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true,1/20/2022,7/17/2022,Unverified
211020_Vaud_UniversityofLausanne_Center2,"October 20, 2021",Regional,Switzerland,CHE,Vaud,,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,42,50.00%,34.00%,65.00%,Convenience,NA,Not reported,"IgG,IgA",,,High,Presentation or Conference,K Morisod,University of Lausanne,https://academic.oup.com/eurpub/article/31/Supplement_3/ckab164.250/6405568?login=true,1/20/2022,7/17/2022,Unverified
220128_Zurich_UniversityofZurich_T1Children_testadj,"January 28, 2022",Regional,Switzerland,CHE,Zurich,,"June 15, 2020","July 15, 2020",Students and Daycares,Children and Youth (0-17 years),2473,4.40%,2.10%,6.20%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,2/8/2022,7/17/2022,Unverified
"220128_Zurich_UniversityofZurich_T1Personnel_testadj
","January 28, 2022",Regional,Switzerland,CHE,Zurich,,"August 15, 2020","September 15, 2020",Essential non-healthcare workers,Multiple groups,1608,4.60%,2.30%,6.70%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,2/8/2022,7/17/2022,Unverified
220128_Zurich_UniversityofZurich_T1Parents_testadj,"January 28, 2022",Regional,Switzerland,CHE,Zurich,,"August 15, 2020","September 15, 2020",Household and community samples,Multiple groups,2045,5.80%,3.50%,7.80%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,2/8/2022,7/17/2022,Unverified
220128_Zurich_UniversityofZurich_T3Personnel_testadj,"January 28, 2022",Regional,Switzerland,CHE,Zurich,,"March 15, 2021","April 15, 2021",Essential non-healthcare workers,Multiple groups,1435,16.90%,14.10%,19.80%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,2/8/2022,10/15/2022,Unverified
"220128_Zurich_UniversityofZurich_T3Parents_testadj
","January 28, 2022",Regional,Switzerland,CHE,Zurich,,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,1545,20.90%,18.00%,23.90%,Convenience,Swiss Federal Institute of Technology,Not reported,Not reported,98.30%,98.40%,Moderate,Preprint,Agne Ulyte,University of Switzerland,https://www.medrxiv.org/content/10.1101/2022.01.25.22269827v1.full-text,2/8/2022,10/15/2022,Unverified
220128_Switzerland_CantonalHospitalStGallen_Overall,"January 28, 2022",Regional,Switzerland,CHE,"Northern Switzerland, Eastern Switzerland",,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),3334,23.52%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,88.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Carol Strahm,Cantonal Hospital St Gallen,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac054/6516835,2/11/2022,3/2/2024,Unverified
211110_CantonofFribourg_UniversityofFribourg_Overall_Adj,"November 10, 2021",Regional,Switzerland,CHE,Fribourg,,"May 20, 2021","August 13, 2021",Household and community samples,Multiple groups,504,74.00%,69.00%,79.00%,Simplified probability,Swiss Federal Institute of Technology,Luminex,IgG,96.60%,99.70%,Moderate,Institutional Report,Emna El May,Swiss School of Public Health,https://zenodo.org/record/5665477,3/9/2022,7/17/2022,Verified
220216_Geneva_CantonalHospitalStGallen_Baseline,"February 16, 2022",Local,Switzerland,CHE,,Geneva,"September 2, 2020","September 4, 2020",Multiple populations,Multiple groups,168,2.98%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Johannes Sumer,Cantonal Hospital St. Gallen,https://dx.doi.org/10.3389/ijph.2022.1604147,3/16/2022,3/2/2024,Unverified
220316_Zurich_UniversityOfZurich_NursingHomes_Overall,"March 16, 2022",Regional,Switzerland,CHE,Canton of Zurich,,"September 21, 2020","October 23, 2020",Assisted living and long-term care facilities,Adults (18-64 years),296,14.90%,11.10%,19.60%,Convenience,Swiss Federal Institute of Technology,Not reported,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,3/25/2022,7/17/2022,Verified
220316_Zurich_UniversityOfZurich_HomeHealthcare_Overall,"March 16, 2022",Regional,Switzerland,CHE,Canton of Zurich,,"September 21, 2020","October 23, 2020",Assisted living and long-term care facilities,Adults (18-64 years),131,3.80%,1.40%,9.10%,Simplified probability,Swiss Federal Institute of Technology,Not reported,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,3/25/2022,7/17/2022,Verified
220316_Zurich_UniversityOfZurich_GeneralPop_Overall_TestPopAdj,"March 16, 2022",Regional,Switzerland,CHE,Canton of Zurich,,"June 17, 2020","September 14, 2020",Household and community samples,Adults (18-64 years),472,3.50%,1.50%,5.90%,Simplified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Erin West,University of Zurich,https://doi.org/10.1186/s12879-022-07222-8,3/25/2022,7/17/2022,Verified
220130_Zurich_UniversityOfZurich_T2_PopTestAdj_Overall,"January 30, 2023",Regional,Switzerland,CHE,Canton of Zürich,,"October 26, 2020","November 19, 2020",Students and Daycares,Children and Youth (0-17 years),2500,5.60%,3.50%,7.60%,Stratified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",94.00%,99.20%,Moderate,Journal Article (Peer-Reviewed),Sarah Haile,University of Zurich,https://dx.doi.org/10.57187/smw.2023.40035,6/8/2022,3/11/2023,Unverified
220620_Switzerland_Children’sHospitalofEasternSwitzerland_Overall,"June 20, 2022",National,Switzerland,CHE,"Basle-City, Basle-Country, Berne, Fribourg, Grisons, Lucerne, Neuchatel, St. Gallen, Ticino, Vaud, Zurich",,"October 18, 2020","February 15, 2021",Household and community samples,Adults (18-64 years),2393,17.30%,,,Simplified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",96.60%,99.70%,High,Journal Article (Peer-Reviewed),Jacob Blankenberger,Children’s Hospital of Eastern Switzerland,https://dx.doi.org/10.1186/s12916-022-02431-z,6/28/2022,3/31/2024,Verified
220524_Switzerland_FribourgHospitalHFR_Primary,"May 24, 2022",Regional,Switzerland,CHE,Fribourg,,"January 11, 2021","March 14, 2021",Residual sera,Children and Youth (0-17 years),871,20.70%,18.00%,23.00%,Convenience,NA,Other,IgG,96.60%,99.20%,Moderate,Journal Article (Peer-Reviewed),Paola A. Rouge Elton,Fribourg Hospital HFR,https://dx.doi.org/10.4414/smw.2022.w30173,7/7/2022,2/19/2024,Unverified
220527_CantonTicino_OspedaleSanGiovanni,"May 27, 2022",Regional,Switzerland,CHE,Canton Ticino,,"October 30, 2019","September 15, 2021",Household and community samples,Children and Youth (0-17 years),506,10.40%,,,Sequential,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Mazzara C,Ospedale San Giovanni,https://doi.org/10.4414/smw.2022.w30203,7/27/2022,7/28/2022,Unverified
220606_Bern_UniversityofBern_Baseline,"June 6, 2022",Regional,Switzerland,CHE,Bern,,"February 9, 2021","March 9, 2021",Essential non-healthcare workers,Adults (18-64 years),982,15.30%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,7/29/2022,3/2/2024,Unverified
220606_Bern_UniversityofBern_3Month,"June 6, 2022",Regional,Switzerland,CHE,Bern,,"February 9, 2021","March 9, 2021",Essential non-healthcare workers,Adults (18-64 years),978,12.90%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,7/29/2022,3/2/2024,Unverified
220606_Bern_UniversityofBern_6Month,"June 6, 2022",Regional,Switzerland,CHE,Bern,,"April 15, 2021","May 15, 2021",Essential non-healthcare workers,Adults (18-64 years),997,14.40%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1002/iid3.640,7/29/2022,3/2/2024,Unverified
220729_Geneva_GenevaUniversityHospitals_Any,"July 29, 2022",Local,Switzerland,CHE,,Geneva,"April 29, 2022","June 9, 2022",Household and community samples,Multiple groups,2521,93.80%,93.10%,94.50%,Simplified probability,Roche Diagnostics,Not reported,"IgG,IgM,IgA",,,Low,Preprint,Maria-Eugenia Zaballa,Geneva University Hospitals,10.1101/2022.07.27.22278126,8/11/2022,8/15/2023,Unverified
220803_Switzerland_UniversityOfLausanne,"August 3, 2022",Regional,Switzerland,CHE,,,"February 15, 2021","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),594,45.30%,41.20%,49.30%,Convenience,Luminex Corporation,ELISA,IgG,98.10%,99.20%,High,Journal Article (Peer-Reviewed),Damien Jacot,University of Lausanne,https://dx.doi.org/10.1099/jmm.0.001558,8/15/2022,3/2/2024,Unverified
220804_Ticino_UniversityOfZurich_AntiS_PopTestAdj_Overall,"August 4, 2022",Regional,Switzerland,CHE,Canton of Ticino,,"March 1, 2022","March 31, 2022",Household and community samples,Multiple groups,850,97.50%,95.80%,99.00%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,99.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Rebecca Amati,University of Zurich,https://doi.org/10.2807/1560-7917.ES.2022.27.31.2200561,8/17/2022,8/17/2022,Unverified
220804_Zurich_UniversityOfZurich_AntiS_PopTestAdj_Overall,"August 4, 2022",Regional,Switzerland,CHE,Canton of Zurich,,"March 1, 2022","March 31, 2022",Household and community samples,Multiple groups,1044,98.80%,97.90%,99.50%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,99.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Rebecca Amati,University of Zurich,https://doi.org/10.2807/1560-7917.ES.2022.27.31.2200561,8/17/2022,8/17/2022,Unverified
220825_Switzerland_UniversityOfZurich,"August 25, 2022",National,Switzerland,CHE,,,"May 20, 2021","November 26, 2021",Essential non-healthcare workers,Adults (18-64 years),297,15.49%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jeremy Deuel,University of Zurich,https://dx.doi.org/10.1016/S1473-3099(22)00449-2,9/8/2022,3/2/2024,Unverified
220912_CantonofVaud_UniversityofLausanne_Overall_Primary,"September 12, 2022",Regional,Switzerland,CHE,Canton of Vaud,,"March 1, 2020","April 30, 2020",Essential non-healthcare workers,Adults (18-64 years),428,15.90%,,,Simplified probability,NA,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Guilia Belloni,University of Lausanne,https://dx.doi.org/10.1097/JOM.0000000000002690,9/19/2022,9/23/2022,Unverified
220903_Bern_UniversityofBern_12Months,"September 3, 2022",Local,Switzerland,CHE,,Bern,"March 1, 2022","April 30, 2022",Essential non-healthcare workers,Adults (18-64 years),967,51.60%,48.50%,54.70%,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Parham Sendi,University of Bern,https://dx.doi.org/10.1016/j.cmi.2022.08.019,9/20/2022,3/2/2024,Unverified
220916_Switzerland_UniversityofFribourg_overall,"September 16, 2022",Local,Switzerland,CHE,,Lausanne; Romont,"December 8, 2020","February 11, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),425,16.00%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,96.60%,99.70%,High,Journal Article (Peer-Reviewed),Alexia Schmid,University of Fribourg,https://doi.org/10.3389/fpubh.2022.980482,9/23/2022,9/23/2022,Verified
220825_CantonofVaud_UniversityofLausanne_Follow-up_Primary,"August 25, 2022",Regional,Switzerland,CHE,Canton of Vaud,,"October 20, 2020","December 12, 2020",Household and community samples,Multiple groups,410,16.90%,,,Simplified probability,NA,ELISA,"IgA,IgG",,,Moderate,Journal Article (Peer-Reviewed),Audrey Butty,University of Lausanne,https://doi.org/10.3389/ijph.2022.1605048,9/23/2022,9/23/2022,Unverified
220825_CantonofVaud_UniversityofLausanne_Baseline_Primary,"August 25, 2022",Regional,Switzerland,CHE,Canton of Vaud,,"May 3, 2020","July 7, 2020",Household and community samples,Multiple groups,494,10.50%,,,Simplified probability,NA,ELISA,"IgA,IgG",,,Moderate,Journal Article (Peer-Reviewed),Audrey Butty,University of Lausanne,https://doi.org/10.3389/ijph.2022.1605048,9/23/2022,9/23/2022,Unverified
220130_Zurich_UniversityOfZurich_T4_PopTestAdj_Overall,"January 30, 2023",Regional,Switzerland,CHE,Canton of Zürich,,"November 15, 2021","December 14, 2021",Students and Daycares,Children and Youth (0-17 years),1875,46.40%,42.60%,50.90%,Stratified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",94.00%,99.20%,Moderate,Journal Article (Peer-Reviewed),Sarah Haile,University of Zurich,https://dx.doi.org/10.57187/smw.2023.40035,10/15/2022,3/11/2023,Unverified
220923_CantonOfGeneva_GenevaUniversityHospitals_Overall,"September 23, 2022",Regional,Switzerland,CHE,Canton of Geneva,,"November 23, 2020","December 23, 2020",Household and community samples,Multiple groups,2899,20.46%,,,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.98%,Moderate,Journal Article (Peer-Reviewed),Hugo-Alejandro Santa-Ramirez,Geneva University Hospitals,https://dx.doi.org/10.3389/fpubh.2022.874252,10/20/2022,4/11/2024,Verified
221017_Zurich_UniversityOfZurich_AntiS_PopTestAdj_Overall,"October 17, 2022",Regional,Switzerland,CHE,Canton of Zurich,,"June 2, 2022","July 11, 2022",Household and community samples,Multiple groups,964,98.90%,98.00%,99.50%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,97.00%,99.00%,Moderate,Preprint,Anja Frei,University of Zurich,https://doi.org/10.1101/2022.10.14.22281076,10/27/2022,4/24/2024,Verified
221017_Vaud_UniversityOfZurich_AntiS_PopTestAdj_Overall,"October 17, 2022",Regional,Switzerland,CHE,Canton of Vaud,,"May 30, 2022","July 2, 2022",Household and community samples,Multiple groups,850,98.40%,97.30%,99.30%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,97.00%,99.00%,Moderate,Preprint,Anja Frei,University of Zurich,https://doi.org/10.1101/2022.10.14.22281076,10/27/2022,4/24/2024,Verified
221017_Ticino_UniversityOfZurich_AntiS_PopTestAdj_Overall,"October 17, 2022",Regional,Switzerland,CHE,Canton of Ticino,,"June 1, 2022","June 25, 2022",Household and community samples,Multiple groups,739,98.30%,96.90%,99.30%,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,97.00%,99.00%,Moderate,Preprint,Anja Frei,University of Zurich,https://doi.org/10.1101/2022.10.14.22281076,10/27/2022,4/24/2024,Verified
221024_Puplinge_GenevaUniversityHospitals_Prisoners_Overall,"October 24, 2022",Local,Switzerland,CHE,Canton of Geneva,Puplinge,"June 1, 2020","June 30, 2020",Persons who are incarcerated,Adults (18-64 years),177,2.82%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Laurent Getaz,Geneva University Hospitals,https://dx.doi.org/10.1108/IJPH-01-2022-0002,11/3/2022,3/2/2024,Unverified
221024_Puplinge_GenevaUniversityHospitals_Staff_Overall,"October 24, 2022",Local,Switzerland,CHE,Canton of Geneva,Puplinge,"June 1, 2020","June 30, 2020",Multiple populations,Adults (18-64 years),227,4.80%,2.70%,8.60%,Entire sample,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Laurent Getaz,Geneva University Hospitals,https://dx.doi.org/10.1108/IJPH-01-2022-0002,11/3/2022,3/2/2024,Unverified
221021_Switzerland_UniversityOfLausanne_Overall,"October 21, 2022",Regional,Switzerland,CHE,Vaud Canton,,"October 1, 2020","December 31, 2021",Household and community samples,Multiple groups,224,22.76%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,96.60%,99.70%,High,Journal Article (Peer-Reviewed),Irina Guseva Canu,University of Lausanne,https://dx.doi.org/10.3390/antiox11102079,11/10/2022,4/17/2024,Verified
221121_Geneva_GenevaUniversityHospitals_Overall,"November 21, 2022",Regional,Switzerland,CHE,Geneva,,"June 1, 2021","July 7, 2021",Household and community samples,Children and Youth (0-17 years),660,31.30%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.80%,99.10%,Moderate,Journal Article (Peer-Reviewed),Roxane Dumont,Geneva University Hospitals,https://dx.doi.org/10.1136/bmjopen-2022-063504,12/8/2022,3/2/2024,Unverified
221115_Morges_UniversityofLausanne_Visit1,"November 15, 2022",Local,Switzerland,CHE,,Morges,"March 1, 2021","March 31, 2021",Health care workers and caregivers,Adults (18-64 years),587,45.32%,,,Self-referral,NA,Luminex,IgG,,,,Journal Article (Peer-Reviewed),Damien Jacot,University of Lausanne,https://dx.doi.org/10.1016/j.micinf.2022.105077,12/16/2022,3/22/2023,Unverified
221201_Geneva_GenevaUniversityHospitals,"December 1, 2022",Regional,Switzerland,CHE,Genève canton,Geneva,"April 29, 2022","June 9, 2022",Household and community samples,Multiple groups,2521,93.80%,93.10%,94.50%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),María-Eugenia Zaballa,Geneva University Hospitals,https://doi.org/10.1016/j.lanepe.2022.100547,12/16/2022,3/20/2023,Unverified
221129_Geneva_GenevaUniversityHospitals,"November 29, 2022",Regional,Switzerland,CHE,Genève canton,Geneva,"December 15, 2021","February 15, 2022",Household and community samples,Children and Youth (0-17 years),1034,55.13%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.10%,Moderate,Journal Article (Peer-Reviewed),Roxane Dumont,Geneva University Hospitals,https://dx.doi.org/10.1038/s41467-022-34616-8,12/16/2022,4/24/2024,Verified
230112_Ticino_UniversitaDellaSvizzeraItaliana,"January 12, 2023",Regional,Switzerland,CHE,Canton Ticino,,"November 15, 2020","January 15, 2021",Household and community samples,Seniors (65+ years),481,11.23%,,,Stratified probability,Swiss Federal Institute of Technology,,,,,,Journal Article (Peer-Reviewed),Miao Jiang,Università della Svizzera italiana,https://dx.doi.org/10.1186/s12877-023-03730-7,1/24/2023,3/20/2023,Unverified
230115_Switzerland_UniversityofLausanne_Overall,"January 15, 2023",Regional,Switzerland,CHE,Canton of Vaud,,"May 25, 2020","July 7, 2020",Essential non-healthcare workers,Multiple groups,428,15.90%,12.60%,19.70%,Self-referral,NA,Luminex,"IgG,IgA",,,,Journal Article (Peer-Reviewed),Giulia Belloni,University of Lausanne,https://dx.doi.org/10.1097/JOM.0000000000002690,2/7/2023,3/20/2023,Unverified
230103_Zurich_UniversityofZurich_BDS,"January 3, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"December 1, 2019","December 31, 2020",Blood donors,Adults (18-64 years),16291,4.00%,3.10%,5.10%,Sequential,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Marc Emmenegger,University of Zurich,https://dx.doi.org/10.1016/j.isci.2023.105928,2/10/2023,3/20/2023,Unverified
230103_Zurich_UniversityofZurich_USZ,"January 3, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"December 1, 2019","December 31, 2020",Residual sera,Adults (18-64 years),37745,6.30%,5.50%,7.20%,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Marc Emmenegger,University of Zurich,https://dx.doi.org/10.1016/j.isci.2023.105928,2/10/2023,3/20/2023,Unverified
230311_ Vaud_CenterforPrimaryCareandPublicHealth,"March 11, 2023",Regional,Switzerland,CHE,Vaud,,"May 4, 2020","June 27, 2020",Residual sera,Multiple groups,124,25.80%,,,Convenience,NA,Luminex,"IgG,IgA",,,,Journal Article (Peer-Reviewed),Kevin Morisod,Center for Primary Care and Public Health,https://dx.doi.org/10.1016/j.jmh.2023.100175,4/4/2023,4/12/2023,Unverified
230219_Ticino_UniversitadellaSvizzeraitaliana_Serosurvey3,"February 19, 2023",Regional,Switzerland,CHE,Ticino Canton,,"June 1, 2021","July 15, 2021",Household and community samples,Multiple groups,885,72.50%,69.10%,76.40%,Convenience,NA,Luminex,Total Antibody,,,,Journal Article (Peer-Reviewed),Rebecca Amati,Università della Svizzera italiana,https://dx.doi.org/10.3390/ijerph20043703,4/7/2023,4/12/2023,Unverified
230304_Switzerland_UniversityOfFribourg_Period1_Overall_PopTestAdj,"March 4, 2023",National,Switzerland,CHE,"Basel-Landschaft, Basel-Stadt, Bern, Fribourg, Grisons, Lucerne, Neuchâtel, Saint Gallen, Ticino, Vaud, Zurich",,"May 1, 2020","October 31, 2020",Household and community samples,Multiple groups,3402,3.70%,2.10%,4.90%,Stratified probability,Swiss Federal Institute of Technology,,IgG,96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Stefano Tancredi,University of Fribourg,https://dx.doi.org/10.1007/s15010-023-02011-0,4/12/2023,4/13/2024,Verified
230304_Switzerland_UniversityOfFribourg_Period2_Overall_PopTestAdj,"March 4, 2023",National,Switzerland,CHE,"Basel-Landschaft, Basel-Stadt, Bern, Fribourg, Grisons, Lucerne, Neuchâtel, Saint Gallen, Ticino, Vaud, Zurich",,"November 1, 2020","May 15, 2021",Household and community samples,Multiple groups,5611,16.20%,14.40%,17.50%,Stratified probability,Swiss Federal Institute of Technology,,IgG,96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Stefano Tancredi,University of Fribourg,https://dx.doi.org/10.1007/s15010-023-02011-0,4/12/2023,4/13/2024,Verified
230304_Switzerland_UniversityOfFribourg_Period3_Overall_PopTestAdj,"March 4, 2023",National,Switzerland,CHE,"Basel-Landschaft, Basel-Stadt, Bern, Fribourg, Grisons, Lucerne, Neuchâtel, Saint Gallen, Ticino, Vaud, Zurich",,"May 16, 2021","September 30, 2021",Household and community samples,Multiple groups,4278,72.00%,70.30%,73.80%,Stratified probability,Swiss Federal Institute of Technology,,IgG,96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Stefano Tancredi,University of Fribourg,https://dx.doi.org/10.1007/s15010-023-02011-0,4/12/2023,4/13/2024,Verified
230321_Switzerland_UniversityofNottingham,"March 21, 2023",Local,Switzerland,CHE,,Zurich,"October 15, 2020","May 15, 2021",Household and community samples,Seniors (65+ years),657,5.63%,,,Convenience,NA,Luminex,Total Antibody,,,,Journal Article (Peer-Reviewed),Sabatini Serena,University of Nottingham,https://dx.doi.org/10.3389/fneur.2023.1093852,5/4/2023,5/9/2023,Unverified
230417_CantonOfVaud_UniversityOfLausanne_GeneralPop,"April 17, 2023",Regional,Switzerland,CHE,Canton of Vaud,,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,473,8.88%,,,Simplified probability,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",,,,Journal Article (Peer-Reviewed),Antoine Equey,University of Lausanne,https://dx.doi.org/10.1016/j.clnu.2023.04.007,5/31/2023,5/31/2023,Unverified
230417_CantonOfVaud_UniversityOfLausanne_CloseContacts,"April 17, 2023",Regional,Switzerland,CHE,Canton of Vaud,,"May 15, 2020","June 15, 2020",Contacts of COVID patients,Multiple groups,286,48.95%,,,Convenience,Swiss Federal Institute of Technology,Luminex,"IgG,IgA",,,,Journal Article (Peer-Reviewed),Antoine Equey,University of Lausanne,https://dx.doi.org/10.1016/j.clnu.2023.04.007,5/31/2023,5/31/2023,Unverified
230504_CantonOfZurich_UniversityOfZurich_Baseline_NAb-Omicron_Overall,"May 4, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"March 1, 2022","March 31, 2022",Household and community samples,Multiple groups,1044,89.50%,,,Stratified probability,NA,Neutralization,Neutralizing ,,,,Journal Article (Peer-Reviewed),Kyra Denise Zens,University of Zurich,https://dx.doi.org/10.1016/j.ijid.2023.04.407,5/31/2023,5/31/2023,Unverified
230510_Zurich_UniversityofZurich_T1,"May 10, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"June 15, 2020","July 15, 2020",Students and Daycares,Children and Youth (0-17 years),2373,2.50%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,,,,Preprint,Alessia Raineri,University of Zurich,10.1101/2023.05.08.23289517,5/31/2023,6/2/2023,Unverified
230504_CantonOfZurich_UniversityOfZurich_Followup_AntiS_Overall,"May 4, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"June 7, 2022","July 11, 2022",Household and community samples,Multiple groups,964,98.80%,,,Stratified probability,Bio-rad,Luminex,IgG,97.00%,99.00%,,Journal Article (Peer-Reviewed),Kyra Denise Zens,University of Zurich,https://dx.doi.org/10.1016/j.ijid.2023.04.407,5/31/2023,3/2/2024,Unverified
230510_Zurich_UniversityofZurich_T2,"May 10, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"October 15, 2020","November 15, 2020",Students and Daycares,Children and Youth (0-17 years),2500,5.60%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,,,,Preprint,Alessia Raineri,University of Zurich,10.1101/2023.05.08.23289517,6/2/2023,6/2/2023,Unverified
230510_Zurich_UniversityofZurich_T3,"May 10, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"March 15, 2021","April 15, 2021",Students and Daycares,Children and Youth (0-17 years),2450,18.40%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,,,,Preprint,Alessia Raineri,University of Zurich,10.1101/2023.05.08.23289517,6/2/2023,6/2/2023,Unverified
230510_Zurich_UniversityofZurich_T4,"May 10, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"November 15, 2021","December 15, 2021",Students and Daycares,Children and Youth (0-17 years),1875,46.40%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,,,,Preprint,Alessia Raineri,University of Zurich,10.1101/2023.05.08.23289517,6/2/2023,6/2/2023,Unverified
230510_Zurich_UniversityofZurich_T5,"May 10, 2023",Regional,Switzerland,CHE,Canton of Zurich,,"June 15, 2022","July 15, 2022",Students and Daycares,Children and Youth (0-17 years),2105,96.90%,,,Convenience,Swiss Federal Institute of Technology,Luminex,IgG,,,,Preprint,Alessia Raineri,University of Zurich,10.1101/2023.05.08.23289517,6/2/2023,6/2/2023,Unverified
230510_Switzerland_UniversityofGeneva,"May 10, 2023",National,Switzerland,CHE,,,"November 8, 2020","February 2, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,368,3.26%,,,Convenience,Roche Diagnostics,CLIA,IgG,98.80%,100.00%,,Journal Article (Peer-Reviewed),Celine Lamacchia,University of Geneva,https://dx.doi.org/10.3389/fimmu.2023.1154058,6/30/2023,3/2/2024,Unverified
230705_Switzerland_UniversityOfZurich_Vaccinated,"July 5, 2023",National,Switzerland,CHE,"cantons of Ticino, Zurich, Vaud",,"May 30, 2022","July 11, 2022",Household and community samples,Multiple groups,2339,99.40%,,,Stratified probability,Swiss Federal Institute of Technology,Luminex,IgG,97.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Anja Frei,University of Zurich,https://dx.doi.org/10.1093/ije/dyad098,7/29/2023,5/1/2024,Verified
230628_Switzerland_CantonalHospitalStGallen,"June 28, 2023",Local,Switzerland,CHE,,,"March 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),792,4.40%,,,Convenience,Roche Diagnostics,,Not reported,,,,Preprint,Tamara Dorr,Cantonal Hospital St. Gallen,10.2139/ssrn.4489649,7/30/2023,3/2/2024,Unverified
200720_Uppsala_UppsalaUniversity_Total,"July 20, 2020",Regional,Sweden,SWE,Uppsala,,"May 27, 2020","June 25, 2020",Health care workers and caregivers,Multiple groups,8679,6.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna-Karin Lidstrom,Uppsala University ,https://dx.doi.org/10.1080/03009734.2020.1793039,8/1/2020,3/2/2024,Verified
200723_Sweden_Werlabs_GenPop,"July 23, 2020",Local,Sweden,SWE,"Skåne, Västra Götaland, Uppland","Stockholm, Gothenburg, Malmo","July 1, 2020","July 22, 2020",Household and community samples,Multiple groups,83000,14.40%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Local,Werlabs,https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ,8/3/2020,7/17/2022,Verified
200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,"August 5, 2020",Local,Sweden,SWE,,Stockholm,"April 1, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),1005,22.90%,20.40%,25.70%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Johanna Lindahl,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1789036,10/15/2020,3/2/2024,Verified
200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,"August 11, 2020",Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,"June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),123,4.10%,0.60%,7.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,3/2/2024,Verified
200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,"August 11, 2020",Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,"June 17, 2020","June 18, 2020",Household and community samples,Adults (18-64 years),90,30.00%,20.30%,39.70%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",100.00%,95.50%,High,Journal Article (Peer-Reviewed),Ake Lundkvist,Uppsala University ,https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,3/2/2024,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"April 20, 2020","April 26, 2020",Residual sera,Multiple groups,1200,5.30%,3.80%,7.10%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"April 27, 2020","May 3, 2020",Residual sera,Multiple groups,1200,4.00%,2.71%,5.67%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"May 4, 2020","May 10, 2020",Residual sera,Multiple groups,1200,3.90%,2.61%,5.42%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"May 11, 2020","May 17, 2020",Residual sera,Multiple groups,1200,4.50%,3.07%,6.15%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"May 18, 2020","May 24, 2020",Residual sera,Multiple groups,1200,5.20%,3.67%,7.00%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"May 25, 2020","May 31, 2020",Residual sera,Multiple groups,1200,5.70%,3.98%,7.72%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"June 1, 2020","June 7, 2020",Residual sera,Multiple groups,1200,6.80%,5.07%,8.80%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200618_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall,"June 18, 2020",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"June 8, 2020","June 14, 2020",Residual sera,Multiple groups,1200,5.20%,3.74%,7.06%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,High,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,10/25/2020,7/17/2022,Verified
200716_Stockholm_RegionStockholm,"July 16, 2020",Local,Sweden,SWE,Uppland,Stockholm,"June 15, 2020","July 15, 2020",Household and community samples,Multiple groups,149616,17.60%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,Stockholm Region,Sweden Public Health Authority,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,10/25/2020,7/17/2022,Verified
201008_Stockholm_DanderydHospital,"October 8, 2020",Local,Sweden,SWE,Sodermanland,Stockholm,"April 14, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),2149,19.10%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ann Sofie Rudberg,Danderyd Hospital,http://dx.doi.org/10.1038/s41467-020-18848-0,12/10/2020,7/17/2022,Verified
201222_Stockholm_KarolinskaUniversityHospital_LTCFstaff_primary,"December 22, 2020",Local,Sweden,SWE,,Stockholm,"May 11, 2020","June 17, 2020",Assisted living and long-term care facilities,Multiple groups,403,20.10%,,,Convenience,NA,CLIA,IgG,99.20%,99.80%,High,Preprint,Sadaf Sakina Hassan,Karolinska University Hospital,https://www.medrxiv.org/content/10.1101/2020.12.18.20248511v1,2/3/2021,7/17/2022,Verified
210129_Stockholm_KarolinskaInstitutet_HCW,"January 29, 2021",Local,Sweden,SWE,Uppland,Stockholm,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),3981,17.70%,,,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,Preprint,Susanna Klevebro,Karolinska Institutet,https://doi.org/10.1101/2021.01.28.21250664,2/22/2021,7/17/2022,Verified
201124_Vasteras_HospitalofVastmanland_HCW,"November 24, 2020",Local,Sweden,SWE,,Vasteras,"May 4, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),131,19.08%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),Mulki Rashid Abdi,The Hospital of Vastmanland ,https://dx.doi.org/10.1080/23744235.2020.1849787,2/23/2021,3/2/2024,Verified
210121_Sweden_CopenhagenUniversityHospital_Sweden,"January 21, 2021",National,Sweden,SWE,,,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),1248,8.30%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/26/2021,3/2/2024,Verified
210309_SkåneRegion_LundUniversity_UniversityEmployees,"March 9, 2021",Local,Sweden,SWE,Skåne Region,Lund,"September 8, 2020","November 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),192,6.00%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/2/2021,3/2/2024,Verified
210309_SkåneRegion_LundUniversity_HCWs,"March 9, 2021",Local,Sweden,SWE,Skåne Region,,"September 8, 2020","November 10, 2020",Health care workers and caregivers,Adults (18-64 years),271,5.90%,,,Convenience,ZetaGene Ltd.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),David Nygren,Lund University,https://dx.doi.org/10.1080/23744235.2021.1892819,4/2/2021,3/2/2024,Verified
210412_Stockholm_KarolinskaInstitutet_hcw,"April 12, 2021",Local,Sweden,SWE,Södermanland and Uppland,Stockholm,"May 11, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),403,20.10%,,,Convenience,NA,ELISA,IgG,99.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),S Hassan,Karolinska Institutet,https://dx.doi.org/10.1111/joim.13274,5/3/2021,7/17/2022,Verified
210317_Sweden_TheSwedishPublicHealthAgency_BloodDonors_overall,"March 17, 2021",National,Sweden,SWE,"Regions of: Jämtland-Härjedalen, Jönköping, Kalmar,
Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro",,"November 23, 2020","December 4, 2020",Blood donors,Multiple groups,3183,7.00%,5.75%,8.48%,Convenience,Sci LifeLab / KTH,ELISA,Not reported,99.40%,98.90%,Unclear,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency (Folkhälsomyndigheten),https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,5/4/2021,7/17/2022,Verified
210305_Stockholm_Västerås_primary,"March 5, 2021",Local,Sweden,SWE,,Stockholm,"June 4, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),70,4.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Elisabet Granstam,Västerås,https://bmjophth.bmj.com/content/6/1/e000616,5/21/2021,3/2/2024,Verified
200617_Norbotten_UmeaUniversity_overall,"June 17, 2020",Regional,Sweden,SWE,Norbotten,"Piteå, Luleå/Boden, Gällivare, Kalix, Kiruna","May 25, 2020","June 5, 2020",Household and community samples,Multiple groups,425,1.90%,0.80%,3.70%,Simplified probability,"Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Institutional Report,Mats Eliasson,Umea University,https://web.archive.org/web/20200623000020/https://www.norrbotten.se/publika/lg/kom/Corona/Rapport%20-%20förekomst%20av%20antikroppar/Förekomst%20av%20antikroppar%20mot%20covid-19%20i%20Norrbottens%20befolkning%20maj%202020%20-%20Region%20Norrbotten%20rapport%20200618.pdf,5/21/2021,3/2/2024,Verified
210518_Stockholm_KarolinskaInstitutet,"May 18, 2021",Local,Sweden,SWE,Uppland,Stockholm,"March 14, 2020","February 28, 2021",Multiple general populations,Adults (18-64 years),5100,19.20%,15.10%,24.40%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Xaquin Castro Dopico,Karolinska Institutet,https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13304,5/28/2021,7/17/2022,Verified
210507_Stockholm_KarolinskaUniversityHospital,"May 7, 2021",Local,Sweden,SWE,Uppland,Stockholm,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),839,12.00%,,,Convenience,NA,Not reported,IgG,99.20%,99.80%,Moderate,Preprint,Maria Froberg,Karolinska University Hospital,https://www.researchsquare.com/article/rs-493146/v1,5/30/2021,7/17/2022,Verified
210511_SkåneUniversityHospital_LundUniversity_HCW,"May 11, 2021",Local,Sweden,SWE,,Lund,"August 1, 2020","August 22, 2020",Health care workers and caregivers,Adults (18-64 years),107,35.50%,,,Convenience,ZetaGene Ltd.,LFIA,"IgG,IgM",95.00%,97.00%,High,Journal Article (Peer-Reviewed),Rasmus Strand,Lund University,https://dx.doi.org/10.1080/23744235.2021.1925739,5/31/2021,3/2/2024,Verified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_9_Week42-43_Overall,"April 27, 2021",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"October 12, 2020","October 23, 2020",Residual sera,Multiple groups,4500,6.70%,5.67%,7.79%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,7/17/2022,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_11_Week9-10_2021_Overall,"April 27, 2021",National,Sweden,SWE,"Jönköping, Kalmar, Skåne,Stockholm, Uppsala, Västerbotten, Västra Götaland, Örebo",,"March 1, 2021","March 12, 2021",Residual sera,Multiple groups,4749,20.70%,19.41%,22.08%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,7/17/2022,Unverified
210427_Sweden_SwedishPublicHealthAgency_Outpatients_10_Week48-49_Overall,"April 27, 2021",National,Sweden,SWE,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro",,"November 23, 2020","December 4, 2020",Residual sera,Multiple groups,4500,7.90%,6.79%,9.19%,Stratified probability,Sci LifeLab / KTH,ELISA,Not reported,99.40%,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-genomgangen-covid-19-blodprov-oppenvarden-delrapport-1.pdf,6/8/2021,7/17/2022,Unverified
210618_Sweden_PublicHealthAgencyOfSweden,"June 18, 2021",National,Sweden,SWE,,,"October 30, 2020","December 8, 2020",Household and community samples,Multiple groups,324,8.60%,,,Convenience,NA,Not reported,IgG,99.70%,100.00%,High,Preprint,Thomas Akerlund,Public Health Agency of Sweden,https://www.medrxiv.org/content/10.1101/2021.06.16.21258960v1.full-text,7/1/2021,7/17/2022,Unverified
210617_Stockholm_KTHRoyalInstituteofTechnology,"June 17, 2021",Local,Sweden,SWE,,Stolkholm,"April 15, 2020","May 15, 2020",Household and community samples,Multiple groups,878,12.50%,10.30%,14.70%,Simplified probability,NA,ELISA,"IgG,IgM",100.00%,96.00%,Moderate,Journal Article (Peer-Reviewed),Niclas Roxhed,KTH Royal Institute of Technology,https://dx.doi.org/10.1038/s41467-021-23893-4,7/6/2021,7/17/2022,Verified
200720_Sweden_TheSwedishPublicHealthAgency_Primary,"July 20, 2021",National,Sweden,SWE,,,"April 26, 2021","May 9, 2021",Blood donors,Multiple groups,2860,32.80%,30.60%,35.10%,Self-referral,NA,ELISA,IgG,,,Moderate,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/45eafde72689438a8a21efa93a5591a4/forekomsten-antikroppar-mot-sars-cov-2.pdf,7/29/2021,7/17/2022,Unverified
210805_Varmland_CentreforClinicalResearchandEducation_primary,"August 5, 2021",Regional,Sweden,SWE,Varmland,,"June 20, 2020","October 12, 2020",Health care workers and caregivers,Multiple groups,4955,5.70%,,,Entire sample,Abbott Laboratories,CLIA,IgG,97.00%,99.50%,High,Journal Article (Peer-Reviewed),Lukas Frans Ocias,Centre for Clinical Research and Education of Varmland,https://dx.doi.org/10.1080/23744235.2021.1959949,8/11/2021,3/2/2024,Unverified
210614_Gothenburg_TheSwedishPublicHealthAgency_Primary,"June 14, 2021",Local,Sweden,SWE,,Gothenburg,"March 1, 2021","March 16, 2021",Blood donors,Seniors (65+ years),724,6.90%,5.30%,9.00%,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Institutional Report,Swedish Public Health Agency,"The Public Health Agency of Sweden, University of Gothenburg, Sahlgrenska University Hospital and Region Västra Götaland",https://www.folkhalsomyndigheten.se/contentassets/eee8b4f90ef24a18b2a65865341710e1/forekomsten-antikroppar-sars-cov-2-aldre-goteborg.pdf,8/11/2021,8/15/2023,Unverified
210827_Linkoping_LinkopingUniversity_Overall,"August 27, 2021",Local,Sweden,SWE,Ostergotland,Linkoping,"March 15, 2020","January 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,100,36.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Johanna Sjowall,Linkoping University,https://www.frontiersin.org/articles/10.3389/fimmu.2021.724047/full,9/7/2021,7/17/2022,Unverified
200925_Stockholm_TheStockholmRegion,"September 25, 2020",Local,Sweden,SWE,,Stockholm,"June 15, 2020","September 20, 2020",Household and community samples,Multiple groups,483345,15.20%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/25-september-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,9/12/2021,7/17/2022,Verified
200929_Stockholm_TheStockholmRegion,"September 29, 2020",Local,Sweden,SWE,,Stockholm,"September 21, 2020","September 27, 2020",Household and community samples,Multiple groups,9648,14.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/09/29-september-lagesrapport-om-covid-19/,9/12/2021,7/17/2022,Verified
210821_Stockholm_KarolinskaUniversityHospital_Overall,"August 21, 2021",Local,Sweden,SWE,Sodermanland and Uppland,Stockholm,"April 23, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),12928,11.50%,,,Convenience,NA,ELISA,IgG,99.40%,99.10%,Moderate,Journal Article (Peer-Reviewed),Klara Miriam Elfstrom,Karolinska University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101518,9/13/2021,7/17/2022,Verified
201006_Stockholm_TheStockholmRegion,"October 6, 2020",Local,Sweden,SWE,,Stockholm,"September 28, 2020","October 4, 2020",Household and community samples,Multiple groups,11670,15.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/6-oktober-lagesrapport-om-covid-19/,9/14/2021,7/17/2022,Verified
210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week21-22_Primary,"July 19, 2021",National,Sweden,SWE,,"Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten, Västra Götalandoch Örebro","May 24, 2021","June 4, 2021",Residual sera,Multiple groups,3949,52.20%,50.37%,54.05%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf,9/15/2021,1/11/2023,Verified
210728_Stockholm_TheSwedishPublicHealthAgency,"July 28, 2021",Local,Sweden,SWE,"Södermanland, Uppland",Stockholm,"November 15, 2020","December 15, 2020",Essential non-healthcare workers,Adults (18-64 years),49,36.70%,,,Unclear,Beijing Wantai Biological,ELISA,Not reported,,,High,Institutional Report,Swedish Public Health Agency,The Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/u/undersokning-av-immunologiskt-svar-mot-sars-cov-2-hos-barn-unga-och-skolpersonal/,9/15/2021,3/2/2024,Unverified
201013_Stockholm_TheStockholmRegion,"October 13, 2020",Local,Sweden,SWE,,Stockholm,"October 5, 2020","October 11, 2020",Household and community samples,Multiple groups,11065,15.20%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/13-oktober-lagesrapport-om-covid-19/,9/27/2021,7/17/2022,Verified
201020_Stockholm_TheStockholmRegion,"October 20, 2020",Local,Sweden,SWE,,Stockholm,"October 12, 2020","October 18, 2020",Household and community samples,Multiple groups,10297,15.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/20-oktober-lagesrapport-om-covid-19/,9/27/2021,7/17/2022,Verified
201027_Stockholm_TheStockholmRegion,"October 27, 2020",Local,Sweden,SWE,,Stockholm,"October 19, 2020","October 25, 2020",Household and community samples,Multiple groups,8941,20.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/10/27-oktober-lagesrapport-om-covid-19/,9/27/2021,7/17/2022,Verified
211103_Stockholm_TheStockholmRegion,"November 3, 2020",Local,Sweden,SWE,,Stockholm,"October 26, 2020","November 1, 2020",Household and community samples,Multiple groups,9580,21.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/3-november-lagesrapport-om-covid-19/,9/27/2021,7/17/2022,Verified
201110_Stockholm_TheStockholmRegion,"November 10, 2020",Local,Sweden,SWE,,Stockholm,"November 2, 2020","November 8, 2020",Household and community samples,Multiple groups,11500,25.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/10-november-lagesrapport-om-covid-19/,10/5/2021,7/17/2022,Verified
201117_Stockholm_TheStockholmRegion,"November 17, 2020",Local,Sweden,SWE,,Stockholm,"November 9, 2020","November 15, 2020",Household and community samples,Multiple groups,13273,27.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/17-november-lagesrapport-om-covid-19/,10/5/2021,7/17/2022,Verified
201124_Stockholm_TheStockholmRegion,"November 24, 2020",Local,Sweden,SWE,,Stockholm,"November 16, 2020","November 22, 2020",Household and community samples,Multiple groups,15474,31.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/11/24-november-lagesrapport-om-covid-19/,10/5/2021,7/17/2022,Verified
201201_Stockholm_TheStockholmRegion,"December 1, 2020",Local,Sweden,SWE,,Stockholm,"November 23, 2020","November 29, 2020",Household and community samples,Multiple groups,16389,33.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/1-december-lagesrapport-om-covid-19/,10/5/2021,7/17/2022,Verified
201208_Stockholm_TheStockholmRegion,"December 8, 2020",Local,Sweden,SWE,,Stockholm,"November 30, 2020","December 6, 2020",Household and community samples,Multiple groups,16943,36.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/8-december-lagesrapport-om-covid-19/,10/5/2021,7/17/2022,Verified
201215_Stockholm_TheStockholmRegion,"December 15, 2020",Local,Sweden,SWE,,Stockholm,"December 7, 2020","December 13, 2020",Household and community samples,Multiple groups,20466,39.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/15-december-lagesrapport-om-covid-19/,10/15/2021,7/17/2022,Verified
201222_Stockholm_TheStockholmRegion,"December 22, 2020",Local,Sweden,SWE,,Stockholm,"December 14, 2020","December 20, 2020",Household and community samples,Multiple groups,23466,38.10%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/22-december-lagesrapport-om-covid-19/,10/15/2021,7/17/2022,Verified
201229_Stockholm_TheStockholmRegion,"December 29, 2020",Local,Sweden,SWE,,Stockholm,"December 21, 2020","December 27, 2020",Household and community samples,Multiple groups,17624,37.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/12/29-december-lagesrapport-om-covid-19/,10/15/2021,7/17/2022,Verified
210105_Stockholm_TheStockholmRegion,"January 5, 2021",Local,Sweden,SWE,,Stockholm,"December 28, 2020","January 3, 2021",Household and community samples,Multiple groups,15061,42.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/5-januari-lagesrapport-om-covid-19/,10/19/2021,7/17/2022,Verified
210112_Stockholm_TheStockholmRegion,"January 12, 2021",Local,Sweden,SWE,,Stockholm,"January 4, 2021","January 10, 2021",Household and community samples,Multiple groups,10378,42.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/12-januari-lagesrapport-om-covid-19/,10/19/2021,7/17/2022,Verified
210119_Stockholm_TheStockholmRegion,"January 19, 2021",Local,Sweden,SWE,,Stockholm,"January 11, 2021","January 17, 2021",Household and community samples,Multiple groups,18544,45.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/19-januari-lagesrapport-om-covid-19/,10/19/2021,7/17/2022,Verified
210126_Stockholm_TheStockholmRegion,"January 26, 2021",Local,Sweden,SWE,,Stockholm,"January 18, 2021","January 24, 2021",Household and community samples,Multiple groups,15498,44.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/01/26-januari-lagesrapport-om-covid-19/,10/19/2021,7/17/2022,Verified
210202_Stockholm_TheStockholmRegion,"February 2, 2021",Local,Sweden,SWE,,Stockholm,"January 25, 2021","January 31, 2021",Household and community samples,Multiple groups,11749,45.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/2-februari-lagesrapport-om-covid-19/,10/19/2021,7/17/2022,Verified
211023_Sweden_KarolinskaInstitutet_Overall,"October 23, 2021",National,Sweden,SWE,,,"October 6, 2020","June 23, 2021",Household and community samples,Adults (18-64 years),977,28.40%,,,Convenience,NA,ELISA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Sophia Bjorkander,Karolinska Institutet,https://www.sciencedirect.com/science/article/pii/S0091674921016262,11/4/2021,7/17/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_Outpatients_Week38-39_Primary,"October 28, 2021",National,Sweden,SWE,,,"September 20, 2021","October 3, 2021",Residual sera,Multiple groups,2959,75.60%,73.82%,77.29%,Convenience,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/publicerat-material/publikationsarkiv/p/pavisning-av-antikroppar-efter-genomgangen-covid-19-i-blodprov-fran-oppenvarden-delrapport-1/,11/5/2021,7/17/2022,Verified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week9-10,"October 28, 2021",National,Sweden,SWE,,,"March 1, 2021","March 12, 2021",Blood donors,Multiple groups,3067,22.40%,20.32%,24.49%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,11/5/2021,7/17/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week21-22,"October 28, 2021",National,Sweden,SWE,,,"May 24, 2021","June 4, 2021",Blood donors,Multiple groups,3009,51.90%,49.53%,54.36%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,11/5/2021,7/17/2022,Unverified
2101028_Sweden_SwedishPublicHealthAgency_BloodDoner_Week38-39,"October 28, 2021",National,Sweden,SWE,,,"September 20, 2021","October 3, 2021",Blood donors,Multiple groups,402,96.80%,94.46%,98.49%,Self-referral,Sci LifeLab / KTH,Not reported,Not reported,,,Moderate,Institutional Report,Swedish Public Health Agency,Sweden Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-mot-sars-cov-2-blodgivare.pdf,11/5/2021,7/17/2022,Unverified
210209_Stockholm_TheStockholmRegion,"February 9, 2021",Local,Sweden,SWE,,Stockholm,"February 1, 2021","February 7, 2021",Household and community samples,Multiple groups,11175,44.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/9-februari-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210216_Stockholm_TheStockholmRegion,"February 16, 2021",Local,Sweden,SWE,,Stockholm,"February 8, 2021","February 14, 2021",Household and community samples,Multiple groups,8108,42.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/16-februari-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210223_Stockholm_TheStockholmRegion,"February 23, 2021",Local,Sweden,SWE,,Stockholm,"February 15, 2021","February 21, 2021",Household and community samples,Multiple groups,9024,42.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/02/23-februari-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210302_Stockholm_TheStockholmRegion,"March 2, 2021",Local,Sweden,SWE,,Stockholm,"February 22, 2021","February 28, 2021",Household and community samples,Multiple groups,12605,40.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/2-mars-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210309_Stockholm_TheStockholmRegion,"March 9, 2021",Local,Sweden,SWE,,Stockholm,"March 1, 2021","March 7, 2021",Household and community samples,Multiple groups,9237,39.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/9-mars-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210316_Stockholm_TheStockholmRegion,"March 16, 2021",Local,Sweden,SWE,,Stockholm,"March 8, 2021","March 14, 2021",Household and community samples,Multiple groups,9769,39.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/16-mars-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210323_Stockholm_TheStockholmRegion,"March 23, 2021",Local,Sweden,SWE,,Stockholm,"March 15, 2021","March 21, 2021",Household and community samples,Multiple groups,9040,40.40%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/23-mars-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210330_Stockholm_TheStockholmRegion,"March 30, 2021",Local,Sweden,SWE,,Stockholm,"March 22, 2021","March 28, 2021",Household and community samples,Multiple groups,10146,40.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/03/30-mars-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210406_Stockholm_TheStockholmRegion,"April 6, 2021",Local,Sweden,SWE,,Stockholm,"March 29, 2021","April 4, 2021",Household and community samples,Multiple groups,10419,42.70%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/6-april-lagesrapport-om-covid-19/,11/22/2021,7/17/2022,Verified
210413_Stockholm_TheStockholmRegion,"April 13, 2021",Local,Sweden,SWE,,Stockholm,"April 5, 2021","April 11, 2021",Household and community samples,Multiple groups,2084,50.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/13-april-lagesrapport-om-covid-19/,12/2/2021,7/17/2022,Verified
210420_Stockholm_TheStockholmRegion,"April 20, 2021",Local,Sweden,SWE,,Stockholm,"April 12, 2021","April 18, 2021",Household and community samples,Multiple groups,868,57.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/mall-lagesrapport-med-tabell/,12/2/2021,7/17/2022,Verified
210427_Stockholm_TheStockholmRegion,"April 27, 2021",Local,Sweden,SWE,,Stockholm,"April 19, 2021","April 25, 2021",Household and community samples,Multiple groups,953,61.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,The Stockholm Region,The Stockholm Region,https://www.regionstockholm.se/verksamhet/halsa-och-vard/nyheter-lagesrapporter-covid-19/2021/04/27-april-Lagesrapport-om-ovid-19/,12/2/2021,7/17/2022,Verified
211102_Sweden_UniversityofGothenburg_BloodDonorsTP5_N+S,"November 2, 2021",Local,Sweden,SWE,,Gothenburg,"January 12, 2021","January 29, 2021",Blood donors,Multiple groups,253,11.86%,,,Unclear,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Emelie Marklund,University of Gothenburg,https://dx.doi.org/10.3389/fimmu.2021.750448,12/2/2021,7/17/2022,Verified
211102_Sweden_UniversityofGothenburg_HCWsTP5_N+S,"November 2, 2021",Local,Sweden,SWE,,Gothenburg,"January 12, 2021","January 29, 2021",Health care workers and caregivers,Multiple groups,280,29.29%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Emelie Marklund,University of Gothenburg,https://dx.doi.org/10.3389/fimmu.2021.750448,12/2/2021,7/17/2022,Verified
220525_Sweden_UppsalaUniversityHospital_Overall,"May 25, 2022",National,Sweden,SWE,,,"June 15, 2020","September 7, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),136,33.00%,25.00%,41.00%,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Emil Sundberg,Uppsala University Hospital,https://dx.doi.org/10.1002/pbc.29773,6/3/2022,7/17/2022,Unverified
220625_Sweden_PublicHealthAgencyofSweden,"June 25, 2022",National,Sweden,SWE,,,"April 26, 2021","May 9, 2021",Household and community samples,Multiple groups,2860,32.60%,30.30%,34.90%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jessica Beser,Public Health Agency of Sweden,https://dx.doi.org/10.1038/s41598-022-15183-w,7/8/2022,7/17/2022,Unverified
220630_Stockholm_FolktandvardenStockholm,"June 30, 2022",Local,Sweden,SWE,,Stockholm,"June 1, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),341,10.30%,,,Convenience,Luminex Corporation,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Lars Fredriksson,Folktandvården Stockholm,https://dx.doi.org/10.1080/00016357.2022.2095023,7/14/2022,3/2/2024,Unverified
220901_Sweden_UppsalaUniversity_Patients_Overall,"September 1, 2022",Local,Sweden,SWE,,Uppsala,"March 1, 2020","August 1, 2020",Representative patient population,Multiple groups,622,9.55%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,B. Ginman,Uppsala University,https://dx.doi.org/10.1016/j.annonc.2022.07.1530,9/27/2022,9/27/2022,Unverified
220901_Sweden_UppsalaUniversity_Staff_Overall,"September 1, 2022",Local,Sweden,SWE,,Uppsala,"March 1, 2020","August 1, 2020",Health care workers and caregivers,Adults (18-64 years),358,16.20%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,B. Ginman,Uppsala University,https://dx.doi.org/10.1016/j.annonc.2022.07.1530,9/27/2022,9/27/2022,Unverified
220929_Stockholm_ChalmersUniversityofTechnology_Overall,"September 28, 2022",Local,Sweden,SWE,Södermanland and Uppland,Stockholm,"April 26, 2021","May 7, 2021",Essential non-healthcare workers,Adults (18-64 years),262,49.60%,,,Convenience,NA,Luminex,IgG,99.70%,99.40%,High,Journal Article (Peer-Reviewed),Anna Sjors Dahlman,Stockholm University,https://dx.doi.org/10.1016/j.jth.2022.101508,10/15/2022,10/15/2022,Unverified
220609_Västerås_VästmanlandsHospital,"June 9, 2022",Local,Sweden,SWE,Västmanland,Västerås,"November 15, 2020","November 15, 2021",Health care workers and caregivers,Adults (18-64 years),69,18.84%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Anders Krifors,Västmanlands Hospital,https://dx.doi.org/10.1080/23744235.2022.2142662,12/16/2022,3/2/2024,Unverified
210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week38-39_Overall,"July 19, 2021",National,Sweden,SWE,,"Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro","September 20, 2021","October 3, 2021",Residual sera,Multiple groups,2959,75.60%,73.82%,77.29%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf,1/11/2023,3/20/2023,Unverified
210719_Sweden_SwedishPublicHealthAgency_Outpatients_Week47-48_Overall,"July 19, 2021",National,Sweden,SWE,,"Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten, Västra Götaland and Örebro","November 22, 2021","December 5, 2021",Residual sera,Multiple groups,2844,83.40%,81.48%,85.24%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf,1/11/2023,3/20/2023,Unverified
210719_Sweden_SwedishPublicHealthAgency_Outpatients_2022Week34-36_Overall,"July 19, 2021",National,Sweden,SWE,,"Jämtland Härjedalen, Kalmar, Skåne, Stockholm, Uppsala (0-19 years only), Västra Götaland and Örebro","August 22, 2022","September 11, 2022",Residual sera,Multiple groups,3068,94.20%,92.72%,95.54%,Stratified non-probability,Sci LifeLab / KTH,ELISA,Not reported,98.90%,99.40%,Moderate,Institutional Report,Swedish Public Health Agency,Swedish Public Health Agency,https://www.folkhalsomyndigheten.se/contentassets/9c5893f84bd049e691562b9eeb0ca280/pavisning-antikroppar-mot-sars-cov-2-blodprov-oppenvarden.pdf,1/11/2023,3/20/2023,Unverified
220330_Sweden_UppsalaUniversity,"March 30, 2022",National,Sweden,SWE,,,"October 15, 2020","June 15, 2021",Household and community samples,Adults (18-64 years),850,28.49%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Ida Mogensen,Uppsala University,https://dx.doi.org/10.1016/j.jacig.2022.03.001,2/9/2023,3/20/2023,Unverified
230504_Sweden_PublicHealthAgencyOfSweden_Mar2022_PopTestAdj,"May 4, 2023",National,Sweden,SWE,,,"March 21, 2022","March 25, 2022",Household and community samples,Multiple groups,2587,93.30%,91.50%,94.80%,Simplified probability,NA,ELISA,IgG,99.20%,99.30%,High,Journal Article (Peer-Reviewed),Ramona Groenheit,Public Health Agency of Sweden,https://wwwnc.cdc.gov/eid/article/29/6/22-1862_article,5/20/2023,5/25/2023,Unverified
230504_Sweden_PublicHealthAgencyOfSweden_Sep2022_PopTestAdj,"May 4, 2023",National,Sweden,SWE,,,"September 26, 2022","September 29, 2022",Household and community samples,Multiple groups,1554,93.10%,89.20%,96.00%,Simplified probability,NA,ELISA,IgG,99.20%,99.30%,High,Journal Article (Peer-Reviewed),Ramona Groenheit,Public Health Agency of Sweden,https://wwwnc.cdc.gov/eid/article/29/6/22-1862_article,5/25/2023,5/25/2023,Unverified
230718_Sweden_LinkopingUniversity_May2020,"July 18, 2023",Local,Sweden,SWE, Kalmar County,,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),362,14.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,,IgG,,,,Journal Article (Peer-Reviewed),Viktor Hultqvist,Linkoping University,https://dx.doi.org/10.1111/apm.13343,8/24/2023,3/2/2024,Unverified
230718_Sweden_LinkopingUniversity_Sept2020,"July 18, 2023",Local,Sweden,SWE, Kalmar County,,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),333,18.00%,,,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics",,IgG,,,,Journal Article (Peer-Reviewed),Viktor Hultqvist,Linkoping University,https://dx.doi.org/10.1111/apm.13343,8/24/2023,3/2/2024,Unverified
230718_Sweden_LinkopingUniversity_Dec2020,"July 18, 2023",Local,Sweden,SWE, Kalmar County,,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),277,21.00%,,,Convenience,Roche Diagnostics,,IgG,,,,Journal Article (Peer-Reviewed),Viktor Hultqvist,Linkoping University,https://dx.doi.org/10.1111/apm.13343,8/24/2023,3/2/2024,Unverified
230718_Sweden_LinkopingUniversity_May2021,"July 18, 2023",Local,Sweden,SWE, Kalmar County,,"May 1, 2021","May 31, 2021",Health care workers and caregivers,Adults (18-64 years),263,95.00%,,,Convenience,Roche Diagnostics,,IgG,,,,Journal Article (Peer-Reviewed),Viktor Hultqvist,Linkoping University,https://dx.doi.org/10.1111/apm.13343,8/24/2023,3/2/2024,Unverified
230718_Sweden_LinkopingUniversity_May2021_RocheN,"July 18, 2023",Local,Sweden,SWE, Kalmar County,,"May 1, 2021","May 31, 2021",Health care workers and caregivers,Adults (18-64 years),267,28.00%,,,Convenience,Roche Diagnostics,,IgG,,,,Journal Article (Peer-Reviewed),Viktor Hultqvist,Linkoping University,https://dx.doi.org/10.1111/apm.13343,8/24/2023,3/2/2024,Unverified
230920_Uppsala_UppsalaUniversity,"September 20, 2023",Local,Sweden,SWE,,Uppsala,"April 1, 2020","March 30, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,475,10.50%,,,Convenience,NA,Not reported,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Beatrice Ginman,Uppsala University,https://dx.doi.org/10.1080/0284186X.2023.2257873,10/21/2023,10/25/2023,Unverified
201023_Khartoum_FederalMinistryofHealthSudan,"October 23, 2020",Regional,Sudan,SDN,Khartoum,,"May 22, 2020","July 5, 2020",Household and community samples,Multiple groups,967,18.30%,,,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,William McCollum,Federal Ministry of Health (MOH) in Sudan,https://www.tephinet.org/sudan-fetp-conducts-targeted-testing-for-covid-19-in-khartoum-state,5/3/2021,7/17/2022,Verified
220501_GreaterOmdurman_MédecinsSansFrontières_TestAdjusted,"May 1, 2022",Local,Sudan,SDN,Khartoum State,Omdurman,"March 1, 2021","April 10, 2021",Household and community samples,Multiple groups,2375,54.60%,51.40%,57.80%,Stratified probability,"SD Biosensor,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Wendelin Moser,Médecins Sans Frontières,https://dx.doi.org/10.3201/eid2805.211951,5/4/2022,8/15/2023,Verified
211108_Colombo_UniversityofSriJayewardenepura,"November 8, 2021",Local,Sri Lanka,LKA,,Colombo,"April 15, 2020","May 19, 2020",Contacts of COVID patients,Multiple groups,2633,3.38%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,100.00%,High,Journal Article (Peer-Reviewed),Chandima Jeewandara,University of Sri Jayewardenepura,https://dx.doi.org/10.1371/journal.pone.0257548,11/18/2021,3/2/2024,Unverified
211112_Colombo_UniversityofSriJayewardenepura_Overall,"November 12, 2021",Local,Sri Lanka,LKA,Western Province,Colombo,"January 15, 2021","January 31, 2021",Household and community samples,Multiple groups,2547,24.46%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Chandima Jeewandara,University of Sri Jayewardenepura,https://www.frontiersin.org/articles/10.3389/fpubh.2021.724398/full,12/15/2021,3/2/2024,Unverified
230919_Tirupati_SVIMSUniversity,"September 19, 2023",Local,Sri Lanka,LKA,,Tirupati,"July 15, 2021","September 15, 2021",Health care workers and caregivers,Adults (18-64 years),1001,77.80%,,,Convenience,J. Mitra & Co. Pvt. Ltd,ELISA,,,,,Preprint,Anagoni Srikar,SVIMS University,10.20944/preprints202309.1211.v1,10/6/2023,3/2/2024,Unverified
200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,"June 16, 2020",Local,Spain,ESP,Community of Madrid,Madrid,"April 26, 2020","May 16, 2020",Multiple populations,Multiple groups,674,13.80%,,,Sequential,Vitrex Medical,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Soriano, Universidad Autónoma de Madrid,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269,6/18/2020,3/2/2024,Verified
200606_Leon_UniversidadedeLeon_HCWs_TestAdj2,"June 6, 2020",Local,Spain,ESP,Léon,Léon,"April 1, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),676,7.40%,5.50%,10.00%,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vicente Martin,"Gerencia de Atención Primaria del Área de Salud de León, Spain",https://dx.doi.org/10.1016/j.semerg.2020.05.014,7/30/2020,8/15/2023,Verified
200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM,"August 6, 2020",Local,Spain,ESP,Valencia,Valencia,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1153,3.50%,,,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Arantxa Valdivia,Hospital Clínico Universitario,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400,9/27/2020,3/2/2024,Verified
200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,"August 10, 2020",Local,Spain,ESP,,Marbella,"April 15, 2020","April 25, 2020",Health care workers and caregivers,Adults (18-64 years),498,2.20%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Julian Olalla, Hospital Costa del Sol ,http://dx.doi.org/10.1093/qjmed/hcaa238,10/4/2020,3/2/2024,Verified
200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM,"June 17, 2020",Local,Spain,ESP,,Torrejon de Ardoz,"May 29, 2020","June 3, 2020",Household and community samples,Multiple groups,104299,23.07%,,,Entire sample,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Daniel Flores,Municipality of Torrejon de Ardoz,https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml,10/8/2020,7/17/2022,Verified
200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj,"August 31, 2020",Local,Spain,ESP,Community of Madrid,Torrejon de Ardoz,"June 1, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,31.40%,,,Convenience,Hangzhou Testsea Biotechnology Co. Ltd,Not reported,"IgG,IgM",96.00%,100.00%,High,Journal Article (Peer-Reviewed),Luis Cabezon-Gutierrez,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.1016/j.ctrv.2020.102102,10/21/2020,7/5/2023,Verified
200918_Madrid_UniversityHospitalGregorioMarañón_Overall,"September 18, 2020",Local,Spain,ESP,,Madrid,"May 6, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),100,13.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Vinuela,University Hospital Gregorio Marañón,http://dx.doi.org/10.37201/req/088.2020,11/13/2020,3/2/2024,Verified
200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall,"August 6, 2020",Local,Spain,ESP,,Barcelona,"April 14, 2020","May 5, 2020",Pregnant or parturient women,Adults (18-64 years),874,14.00%,,,Convenience,"Vircell S.L.,Ortho Clinical Diagnostics Inc.",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext,1/4/2021,3/2/2024,Verified
200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall,"September 11, 2020",Local,Spain,ESP,Galicia,Santiago de Compostela,"April 14, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),175,4.00%,1.10%,6.90%,Convenience,Genobio Pharmaceutical (Shanghai China),Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ana Dacosta Urbieta,Hospital Clinico Universitario de Santiago de Compostela,http://dx.doi.org/10.3389/fped.2020.00547,1/6/2021,7/17/2022,Verified
201021_Spain_IVIRMA_Overall,"September 1, 2020",National,Spain,ESP,,,"April 27, 2020","June 26, 2020",Residual sera,Adults (18-64 years),6140,0.68%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,IgM,,,Unclear,Journal Article (Peer-Reviewed),Nicolas Prados,IVIRMA Global Headquarters,http://dx.doi.org/10.1016/j.fertnstert.2020.09.077,1/8/2021,3/2/2024,Verified
200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall,"September 11, 2020",Local,Spain,ESP,Catalonia,Barcelona,"April 21, 2020","April 24, 2020",Household and community samples,Multiple groups,311,5.47%,3.44%,8.58%,Stratified probability,"Zhuhai Livzon Diagnostics Inc,SureScreen Diagnostics,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Patricia Montenegro, Sardenya Primary Health Care Center,http://dx.doi.org/10.1093/fampra/cmaa096,1/9/2021,3/2/2024,Verified
201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall,"October 29, 2020",Local,Spain,ESP,,Madrid,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia ,Hospital Universitario Príncipe de Asturias,https://dx.doi.org/10.1017/ice.2020.1303,1/9/2021,3/2/2024,Verified
201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest,"November 12, 2020",Local,Spain,ESP,Catalonia,Barcelona,"April 28, 2020","June 3, 2020",Contacts of COVID patients,Multiple groups,1084,17.99%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",83.30%,,Moderate,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu,https://dx.doi.org/10.1093/cid/ciaa1721,1/24/2021,3/2/2024,Verified
201125_Valencia_HospitalArnauDeVilanova_Overall,"November 25, 2020",Local,Spain,ESP,Valencia,Valencia,"May 2, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,166,1.80%,,,Sequential,DiaSorin,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Javier Garde Noguera,"Hospital Arnau de Vilanova de Valencia, Spain",https://dx.doi.org/10.3390/cancers12123513,1/24/2021,3/2/2024,Verified
201130_Spain_UniversityofZaragoza_unadj,"November 30, 2020",Local,Spain,ESP,,Madrid,"March 31, 2020","August 31, 2020",Pregnant or parturient women,Adults (18-64 years),260,6.92%,,,Sequential,"Biozek,Abbott Laboratories,Vircell S.L.",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,University of Zaragoza,https://dx.doi.org/10.1016/j.ejogrb.2020.11.069,1/24/2021,3/2/2024,Verified
201026_Zaragoza_HospitalSanJuandeDios_HCW_primary,"November 13, 2020",Local,Spain,ESP,Aragon,Zaragoza,"March 20, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),289,5.88%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/28/2021,7/17/2022,Verified
201026_Zaragoza_HospitalSanJuandeDios_patients_primary,"November 13, 2020",Local,Spain,ESP,Aragon,Zaragoza,"March 20, 2020","April 21, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,229,6.99%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Luis Antonio Moreno Borraz,Hospital San Juan de Dios,https://dx.doi.org/10.1016/j.regg.2020.10.005,1/28/2021,7/17/2022,Verified
201014_Alicante_COVID-19GroupoftheInfectionsCommission,"October 14, 2020",Local,Spain,ESP,Alacant,Alicante,"April 24, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),4179,6.60%,5.80%,7.30%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Paula Gras-Valenti,COVID-19 Group of the Infections Commission,https://dx.doi.org/10.1016/j.eimc.2020.09.015,1/30/2021,7/17/2022,Verified
201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary,"December 28, 2020",Local,Spain,ESP,,Barcelona,"May 4, 2020","May 22, 2020",Health care workers and caregivers,Multiple groups,7563,10.30%,,,Self-referral,"DiaSorin,Abbott Laboratories",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Jaume Barallat,Institut Català de la Salut,https://dx.doi.org/10.1371/journal.pone.0244348,1/31/2021,3/2/2024,Verified
201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary,"December 2, 2020",Local,Spain,ESP,Canary Islands,Tenerife,"April 27, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,211,1.90%,0.07%,4.80%,Sequential,"NA,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alejandro Hernandez Camba, Quironsalud Tenerife Hospital,https://dx.doi.org/10.17235/reed.2020.7434/2020,1/31/2021,3/2/2024,Verified
201130_Madrid_UniversidadComplutensedeMadrid_primary,"November 30, 2020",Local,Spain,ESP,,Madrid,"February 28, 2020","May 10, 2020",Pregnant or parturient women,Adults (18-64 years),769,11.20%,,,Sequential,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Cecilia Villalaın,The Universidad Complutense de Madrid,https://dx.doi.org/10.1371/journal.pone.0243029,1/31/2021,7/17/2022,Verified
210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG,"January 14, 2021",Local,Spain,ESP,,Fuenlabrada,"April 14, 2020","May 13, 2020",Health care workers and caregivers,Adults (18-64 years),2439,16.90%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Javier Fernandez,Hospital Universitario de Fuenlabrada,https://dx.doi.org/10.1371/journal.pone.0245001,2/4/2021,3/2/2024,Verified
210112_Spain_HMHospitales_overall,"January 12, 2021",National,Spain,ESP,,,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,6038,11.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.66%,Moderate,Journal Article (Peer-Reviewed),Jose Varona,HM Hospidales,https://dx.doi.org/10.1093/ije/dyaa277,2/7/2021,3/2/2024,Unverified
201221_Spain_HospitalClínicoUniversitarioLozanoBlesa,"December 21, 2020",Local,Spain,ESP,Zaragoza,Zaragoza,"April 27, 2020","May 29, 2020",Pregnant or parturient women,Adults (18-64 years),169,8.28%,,,Sequential,"Guangzhou Wondfo Biotech Co. Ltd,Abbott Laboratories,Vircell S.L.",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Fabre,Hospital Clínico Universitario Lozano Blesa,https://dx.doi.org/10.1177/0004563220980495,2/7/2021,3/2/2024,Verified
210127_Madrid_UH-FundacionJimenezDiazUAM_primary,"January 27, 2021",Local,Spain,ESP,Community of Madrid,Madrid,"March 1, 2020","March 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,28,42.90%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Soledad Pizarro Sanchez,UH-Fundacion Jimenez Diaz UAM,https://dx.doi.org/10.1159/000512535,2/28/2021,3/2/2024,Verified
210209_Madrid_HospitalUniversitarioVirgendelRocio,"February 9, 2021",Local,Spain,ESP,Community of Madrid,Madrid,"March 15, 2020","May 15, 2020",Contacts of COVID patients,Children and Youth (0-17 years),113,41.60%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ana Mendez Echevarria,Hospital Universitario Virgen del Rocio,https://dx.doi.org/10.1097/INF.0000000000003088,3/12/2021,3/2/2024,Verified
210119_Madrid_HospitalInfantilUniversitarioNiñoJesús,"January 19, 2021",Local,Spain,ESP,Community of Madrid,Madrid,"April 13, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1292,17.20%,15.16%,19.35%,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Eva Escribano Ceruelo,Hospital Infantil Universitario Niño Jesús,https://dx.doi.org/10.1016/j.eimc.2020.12.011,3/17/2021,3/2/2024,Verified
210318_Barcelona_UniversitatDeBarcelona_overall,"February 8, 2021",Local,Spain,ESP,,Barcelona,"March 15, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),2225,14.10%,,,Sequential,"Vircell S.L.,Ortho Clinical Diagnostics Inc.,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Francesca Crovetto,Universitat de Barcelona,https://dx.doi.org/10.1093/cid/ciab104,3/18/2021,3/2/2024,Unverified
201218_Madrid_HospitalUniversitarioFundaciónAlcorcón_HCW_Overall,"December 18, 2020",Local,Spain,ESP,,Madrid,"April 14, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),2590,31.60%,,,Convenience,Palex,ELISA,IgG,88.90%,91.80%,High,Journal Article (Peer-Reviewed),Isabel Galan,Hospital Universitario Fundación Alcorcón,https://dx.doi.org/10.1016/j.eimc.2020.11.015,3/25/2021,3/2/2024,Verified
210216_Alicante_UniversityofAlicante_overall_PopAdj_TestAdj,"February 16, 2021",Local,Spain,ESP,Alicante,Alicante,"July 6, 2020","July 22, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1479,2.89%,2.06%,3.73%,Stratified probability,Cellex Inc.,LFIA,"IgG,IgM",87.80%,99.90%,Moderate,Journal Article (Peer-Reviewed),Jose Tuells,University of Alicante,http://dx.doi.org/10.3390/ijerph18041908,3/28/2021,7/5/2023,Verified
210223_Barcelona_UniversitatDeBarcelona_primary,"February 23, 2021",Local,Spain,ESP,,Barcelona,"September 29, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),507,16.40%,13.30%,19.90%,Simplified probability,NA,ELISA,"IgA,IgG,IgM",95.78%,100.00%,Moderate,Preprint,Natalia Ortega,Universitat de Barcelona ,https://www.medrxiv.org/content/10.1101/2021.02.22.21252150v1.full-text,4/1/2021,7/17/2022,Verified
210226_Mallorca_SonLlatzerUniversityHospital_overall,"February 26, 2021",Local,Spain,ESP,,,"April 28, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),2210,2.80%,2.50%,3.10%,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",96.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Adrian Rodriguez,Son Llatzer University Hospital,https://dx.doi.org/10.1016/j.ijid.2021.02.104,4/2/2021,3/2/2024,Verified
210316_Spain_HospitalUniversitarioPuertadeHierro_LymphomaPatients,"March 16, 2021",National,Spain,ESP,,,"May 22, 2020","June 11, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,150,6.00%,,,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fernando Franco,Hospital Universitario Puerta de Hierro,https://dx.doi.org/10.3390/curroncol28020118,4/23/2021,7/17/2022,Unverified
210401_Madrid_HospitalUniversitarioRamonyCajal_HCW,"April 1, 2021",Local,Spain,ESP,,Madrid,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),5875,23.10%,22.10%,24.30%,Convenience,"Hanghzhou AllTest Biotech Co. Ltd,Vircell S.L.",ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Mario Rodriguez Dominguez,Hospital Universitario Ramon y Cajal,https://dx.doi.org/10.1016/j.cmi.2021.03.018,4/25/2021,3/2/2024,Unverified
200828_CendeadeCizur_ISGlobal_primary,"August 28, 2020",Local,Spain,ESP,Navarra,Cendea de Cizur,"June 1, 2020","June 30, 2020",Household and community samples,Multiple groups,728,7.90%,,,Unclear,NA,Not reported,"IgA,IgG,IgM",,,Unclear,News and Media,Barcelona Institute for Global Health,ISGlobla,https://www.isglobal.org/en_GB/-/coronavirus-nuevos-datos-de-seroprevalencia-para-un-municipio-en-navarra,5/1/2021,7/17/2022,Verified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_firstwave_primary,"April 1, 2021",Local,Spain,ESP,,Madrid,"March 15, 2020","June 30, 2020",Residual sera,Multiple groups,968,12.60%,,,Sequential,Vitrex Medical,LFIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,5/19/2021,3/2/2024,Verified
210305_Madrid_UNIRHealthSciencesSchoolandMedicalCentre_secondwave_primary,"April 1, 2021",Local,Spain,ESP,,Madrid,"September 15, 2020","December 24, 2020",Residual sera,Multiple groups,601,7.70%,,,Sequential,Vitrex Medical,LFIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Vicente Soriano,UNIR Health Sciences School and Medical Centre,https://dx.doi.org/10.1016/j.ijid.2021.02.115,5/19/2021,3/2/2024,Verified
210501_CastillaYLeon_CentroDeHemoterapiaYHemodonación,"May 1, 2021",National,Spain,ESP,Castilla y Leon,,"July 15, 2019","October 15, 2020",Blood donors,Multiple groups,9886,6.73%,,,Simplified probability,Roche Diagnostics,ELISA,Total Antibody,,,Moderate,Preprint,Carmen Martin,Centro de Hemoterapia y Hemodonación de Castilla y León,https://www.medrxiv.org/content/10.1101/2021.04.28.21256242v1,5/22/2021,3/2/2024,Verified
210301_Madrid_HospitalUniversitarioLaPaz_primary,"March 1, 2021",Local,Spain,ESP,,Madrid,"March 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),105,5.70%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),G Santos Simarro,Hospital Universitario La Paz,http://dx.doi.org/10.1097/01.pcc.0000741352.50491.98,5/22/2021,7/17/2022,Verified
210507_Salamanca_UniversityofSalamanca,"May 7, 2021",Local,Spain,ESP,Province of Salamanca,Salamanca,"July 15, 2020","October 15, 2020",Non-essential workers and unemployed persons,Multiple groups,8197,8.25%,,,Convenience,DiaSorin,ELISA,"IgG,IgM",,,High,Preprint,Vicente Santiago Belen,University of Salamanca,https://www.researchsquare.com/article/rs-489321/v1,5/23/2021,3/2/2024,Unverified
210415_MadridZaragoza_GeneralUniversityHospital_pregnant,"April 15, 2021",Local,Spain,ESP,NA & Zaragoza,Madrid & Zaragoza,"March 31, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),1211,5.04%,,,Unclear,"Biozek,Abbott Laboratories,Vircell S.L.",Multiple Types,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Ricardo Saviron Cornudella,University of Zaragoza,http://dx.doi.org/10.1016/j.lfs.2021.119200,5/23/2021,3/2/2024,Verified
210420_Barcelona_CIBERESP,"April 20, 2021",Local,Spain,ESP,,Barcelona,"June 29, 2020","July 31, 2020",Students and Daycares,Multiple groups,1518,3.22%,,,Convenience,NA,Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Carlota Dobano,Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Públic,10.1101/2021.04.20.440593,5/24/2021,7/17/2022,Unverified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareResidents1,"May 4, 2021",Local,Spain,ESP,,,"July 7, 2020","October 23, 2020",Assisted living and long-term care facilities,Seniors (65+ years),9332,55.40%,54.40%,56.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,5/28/2021,3/2/2024,Verified
210504_Madrid_HospitalGeneralUniversitarioLaPaz_LongTermCareWorkers2,"May 4, 2021",Local,Spain,ESP,,,"July 7, 2020","October 23, 2020",Health care workers and caregivers,Adults (18-64 years),10614,31.50%,30.60%,32.40%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Francisco Candel,Hospital General Universitario La Paz,https://dx.doi.org/10.1093/ageing/afab096,5/28/2021,3/2/2024,Verified
210514_Madrid_HospitalUniversitarioLaPaz,"May 14, 2021",Local,Spain,ESP,Madrid,Madrid,"September 15, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),105,20.00%,,,Convenience,NA,CLIA,IgG,,,High,Preprint,Clara Udaondo ,Hospital Universitario La Paz,https://www.researchsquare.com/article/rs-505561/v1,5/28/2021,7/17/2022,Verified
210510_Cantabria_UniversityofCantabria_Overall,"May 10, 2021",Regional,Spain,ESP,Cantabria,NR,"April 27, 2020","May 29, 2020",Household and community samples,Multiple groups,1022,3.10%,2.20%,4.40%,Stratified probability,Hangzhou Clongene Biotech Co. Ltd ,LFIA,IgG,97.40%,98.89%,Low,Journal Article (Peer-Reviewed),Paula Iruzubieta,University of Cantabria,https://dx.doi.org/10.1038/s41598-021-89236-x,5/31/2021,3/2/2024,Verified
210428_Europe_SorbonneUniversité_4ComunidaddeMadrid,"April 28, 2021",Regional,Spain,ESP,Comunidad de Madrid,,"July 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,524,13.40%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,6/1/2021,3/2/2024,Verified
210403_Majadahonda_HospitalUniversitarioPuertaDeHierro_overall_Unadj,"April 3, 2021",Local,Spain,ESP,,Municipality of Majadahonda,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),50,12.00%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jesus Romero,Hospital Universitario Puerta de Hierro,10.5603/RPOR.a2021.0036,6/3/2021,3/2/2024,Unverified
210526_HospitalUniversitarioFundacionJimenezDiaz_Madrid_hcw,"May 26, 2021",Local,Spain,ESP,,Madrid,"April 6, 2020","April 25, 2020",Health care workers and caregivers,Multiple groups,5995,16.20%,,,Convenience,Biozek,LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Fabian Vazquez Rivas,Fundación Jiménez Díaz University Hospital,https://dx.doi.org/10.1136/oemed-2020-107001,6/6/2021,3/2/2024,Unverified
210614_Barcelona_HospitalUniversitariValld’Hebron,"June 14, 2021",Local,Spain,ESP,Province of Barcelona,Barcelona,"May 10, 2020","October 26, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),294,3.10%,,,Convenience,"Roche Diagnostics,DiaSorin",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Isabel Campos-Varela,Hospital Universitari Vall d’Hebron,https://dx.doi.org/10.1111/tri.13946,6/21/2021,3/2/2024,Verified
210531_Madrid_CentroDeTransfusiónDeLaComunidadDeMadrid_overall,"May 31, 2021",Local,Spain,ESP,,Madrid,"January 1, 2020","March 22, 2020",Blood donors,Multiple groups,2419,0.08%,,,Sequential,Quotient ,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),R. Alenda,Centro de Transfusión de la Comunidad de Madrid,http://dx.doi.org/10.1111/vox.13117,6/30/2021,3/2/2024,Verified
210617_Barcelona_UniversitatDeBarcelona_Overall_PopAdj,"June 17, 2021",Local,Spain,ESP,Catalonia,Barcelona,"December 14, 2020","February 25, 2021",Multiple populations,Adults (18-64 years),2775,14.16%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Videla,Universitat de Barcelona,http://dx.doi.org/10.3390/ijerph18126526,7/2/2021,3/2/2024,Verified
210622_Madrid_HospitalCentralDeLaDefensaGomezUlla,"June 22, 2021",Local,Spain,ESP,,Madrid,"April 27, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),2781,16.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maria Simon Sacristan,Hospital Central de la Defensa Gómez Ulla,https://dx.doi.org/10.1007/s00284-021-02541-6,7/7/2021,3/2/2024,Unverified
210626_Spain_HospitalGregorioMaranon_popadj,"June 26, 2021",National,Spain,ESP,,,"April 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1076,8.10%,6.50%,10.00%,Convenience,Bio-rad,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Juan Berenguer,Hospital Gregorio Maranon,https://dx.doi.org/10.1016/j.cmi.2021.06.023,7/7/2021,3/2/2024,Verified
210309_Madrid_FundacionRenalInigoAlvarezDeToledo,"March 9, 2021",Local,Spain,ESP,,Madrid,"March 1, 2020","April 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,672,15.02%,,,Convenience,Vircell S.L.,ELISA,"IgM,IgA",88.00%,99.00%,High,Journal Article (Peer-Reviewed),Roberto Alcazar Arroyo,Fundación Renal Íñigo Álvarez de Toledo,https://dx.doi.org/10.1093/ckj/sfab048,7/14/2021,3/2/2024,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Children1,"November 20, 2020",Local,Spain,ESP,,Barcelona,"April 28, 2020","June 3, 2020",Household and community samples,Multiple groups,672,17.60%,14.80%,20.70%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,7/20/2021,3/2/2024,Unverified
201120_Barcelona_UniversityHospitalSantJoanDeDeuBarcelona_Adults2,"November 20, 2020",Local,Spain,ESP,,Barcelona,"April 28, 2020","June 3, 2020",Household and community samples,Multiple groups,412,18.70%,15.00%,22.80%,Convenience,"Innovita Biological Technology Co. Ltd,Abbott Laboratories",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pedro Brotons,University Hospital Sant Joan de Deu Barcelona,http://dx.doi.org/10.1093/cid/ciaa1721,7/20/2021,3/2/2024,Unverified
201029_Madrid_HospitalUniversitarioPríncipedeAsturias,"October 29, 2020",Local,Spain,ESP,NR,Madrid,"May 1, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),2424,22.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",88.00%,100.00%,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia,Hospital Universitario Príncipe de Asturias,http://dx.doi.org/10.1017/ice.2020.1303,8/3/2021,3/2/2024,Verified
210528_Spain_InstitutodeInvestigacionesBiomédicasdeMálaga_Overall,"May 28, 2021",National,Spain,ESP,,,"April 21, 2020","June 3, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1500,8.50%,7.20%,10.10%,Unclear,NA,Not reported,IgG,,,Unclear,Journal Article (Peer-Reviewed),Mariano Provencio,Instituto de Investigaciones Biomédicas de Málaga (IBIMA),https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.8531,8/18/2021,7/17/2022,Verified
210817_Seville_HospitalUniversitarioVirgendeValme_HIV,"August 17, 2021",Local,Spain,ESP,Andalusia,Seville,"February 9, 2020","March 4, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,707,7.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Marta Fernandez-Fuertes,Hospital Universitario Virgen de Valme,https://dx.doi.org/10.1111/tbed.14293,8/25/2021,3/2/2024,Unverified
210806_Barcelona_InstitutdeRecercaSantJoandeDéu,"August 6, 2021",Local,Spain,ESP,Catalonia,Barcelona,"June 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),65,10.70%,7.00%,13.00%,Convenience,NA,Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Angela Deya-Martinez,Institut de Recerca Sant Joan de Déu,https://dx.doi.org/10.1016/j.clim.2021.108821,8/25/2021,7/17/2022,Unverified
210823_Madrid_HospitalUniversitarioPuertadeHierroMajadahonda_HCW,"August 23, 2021",Local,Spain,ESP,Communidad de Madrid,Madrid,"April 24, 2020","May 8, 2020",Health care workers and caregivers,Adults (18-64 years),4324,16.60%,15.50%,17.70%,Convenience,"Vircell S.L.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mireia Cantero,Hospital Universitario Puerta de Hierro Majadahonda,https://dx.doi.org/10.1080/23744235.2021.1963468,9/1/2021,3/2/2024,Unverified
210826_Borriana_PublicHealthCenterOfCastellon_PrimaryIgG,"August 26, 2021",Local,Spain,ESP,Castellon,Borriana,"June 23, 2020","June 27, 2020",Household and community samples,Multiple groups,997,51.00%,,,Stratified probability,"Roche Diagnostics,Healgen",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Salvador Domenech Montoliu,Public Health Center of Castellon,http://dx.doi.org/10.1371/journal.pone.0256747,9/8/2021,3/2/2024,Verified
211022_AlcaladeHenares_HospitalUniversitarioPríncipedeAsturias_primary,"October 22, 2021",Local,Spain,ESP,Madrid,Alcala de Henares,"May 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1339,22.63%,,,Convenience,"Hanghzhou AllTest Biotech Co. Ltd,Siemens,Vircell S.L.",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Felipe Perez Garcia,Hospital Universitario Príncipede Asturias,https://pubmed.ncbi.nlm.nih.gov/34675168/,11/3/2021,3/2/2024,Unverified
211021_Spain_AlcalaUniversity_Students_Overall,"October 21, 2021",Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara","June 8, 2020","June 16, 2020",Students and Daycares,Adults (18-64 years),507,17.20%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,11/5/2021,3/2/2024,Unverified
211021_Spain_AlcalaUniversity_TeachingStaff_Overall,"October 21, 2021",Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara","June 8, 2020","June 16, 2020",Essential non-healthcare workers,Multiple groups,132,25.80%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,11/9/2021,3/2/2024,Unverified
211021_Spain_AlcalaUniversity_AdminStaff_Overall,"October 21, 2021",Regional,Spain,ESP,"Community of Madrid, Community of Castilla-La Mancha","Madrid, Guadalajara","June 8, 2020","June 16, 2020",Essential non-healthcare workers,Multiple groups,66,13.60%,,,Stratified probability,"Siemens,Vircell S.L.",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ramon Perez-Tanoira,Alcala University,https://dx.doi.org/10.2147/IJGM.S332803,11/9/2021,3/2/2024,Unverified
211002_Madrid_HospitalLaPaz_Overall,"October 2, 2021",Local,Spain,ESP,Community of Madrid,Madrid,"February 26, 2021","March 26, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,338,18.64%,,,Convenience,NA,ELISA,IgG,,,High,Presentation or Conference,M. Hernandez Perez,Hospital La Paz,http://dx.doi.org/10.1002/ueg2.12144,11/9/2021,7/17/2022,Unverified
211103_Madrid_LaPazUniversityHospitalInstituteforHealthResearch_Overall_Testadj,"November 3, 2021",Local,Spain,ESP,Community of Madrid,Madrid,"April 15, 2020","June 15, 2020",Multiple populations,Multiple groups,449,33.69%,29.27%,38.21%,Convenience,Durviz S.L.,LFIA,IgG,100.00%,98.00%,High,Journal Article (Peer-Reviewed),Patricia Torres Martinez,La Paz University Hospital Institute for Health Research,https://dx.doi.org/10.1038/s41598-021-00990-4,11/10/2021,8/15/2023,Unverified
211103_Catalonia_BarcelonaInstituteForGlobalHealth_adults_popadj,"November 3, 2021",Regional,Spain,ESP,Catalonia,,"June 30, 2020","November 15, 2020",Household and community samples,Multiple groups,4740,15.30%,,,Convenience,NA,CLIA,"IgG,IgA,IgM",95.78%,100.00%,High,Journal Article (Peer-Reviewed),Marianna Karachaliou,Barcelona Institute For Global Health,https://dx.doi.org/10.1038/s41598-021-00807-4,11/11/2021,7/17/2022,Verified
211103_Catalonia_BarcelonaInstituteForGlobalHealth_adolescents_unadj,"November 3, 2021",Regional,Spain,ESP,Catalonia,,"June 30, 2020","November 15, 2020",Household and community samples,Children and Youth (0-17 years),260,11.50%,,,Convenience,NA,CLIA,"IgG,IgA,IgM",95.78%,100.00%,High,Journal Article (Peer-Reviewed),Marianna Karachaliou,Barcelona Institute For Global Health,https://dx.doi.org/10.1038/s41598-021-00807-4,11/13/2021,7/17/2022,Verified
211117_Catalonia_BarcelonaInstituteforGlobalHealth_Overall,"November 17, 2021",Regional,Spain,ESP,Catalonia,,"May 17, 2020","November 15, 2020",Household and community samples,Adults (18-64 years),4103,18.11%,,,Convenience,NA,Luminex,"IgM,IgA,IgG",95.78%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manolis Kogevinas,Barcelona Institute for Global Health,https://dx.doi.org/10.1289/EHP9726,11/25/2021,7/17/2022,Verified
220117_GranCanaria_InstitutoUniversitariodeInvestigacionesBiomédicasySanitarias,"January 17, 2022",Regional,Spain,ESP,Las Palmas,Gran Canaria,"October 15, 2020","August 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),33,3.03%,,,Entire sample,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Yeray Novoa-Medina,Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS),https://pubmed.ncbi.nlm.nih.gov/35026884/,1/23/2022,7/17/2022,Unverified
220209_Madrid_CityofMadrid_Overall,"February 9, 2022",Local,Spain,ESP,,Madrid,"June 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,473,5.10%,,,Convenience,JOYSBIO,LFIA,"IgG,IgM",94.00%,97.00%,High,Journal Article (Peer-Reviewed),Jose Olalla,City of Madrid,https://www.sanidad.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL96/ORIGINALES/RS96C_202202014.pdf,2/15/2022,3/2/2024,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_24Feb-9Mar_TestAdj,"February 4, 2022",Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,"February 24, 2020","March 9, 2020",Blood donors,Multiple groups,10170,0.00%,,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,95.00%,99.50%,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,2/25/2022,8/15/2023,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_16May-3Jun_TestAdj,"February 4, 2022",Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,"May 16, 2020","June 3, 2020",Blood donors,Multiple groups,3867,5.42%,4.47%,6.48%,Sequential,"EUROIMMUN,Beijing Wantai Biological",ELISA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,2/25/2022,8/15/2023,Unverified
220204_Catalonia_TransfusionSafetyLaboratory_4Jun-17Jun_TestAdj,"February 4, 2022",Regional,Spain,ESP,"The 4 provinces inside Catalonia (Barcelona, Tarragona, Girona, and Lleida).",,"June 4, 2020","June 17, 2020",Blood donors,Multiple groups,2962,5.65%,4.81%,6.60%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,95.00%,99.50%,High,Journal Article (Peer-Reviewed),Maria Piron,Transfusion Safety Laboratory,https://dx.doi.org/10.2450/2022.0232-21,2/25/2022,8/15/2023,Unverified
220309_Barcelona_HospitaldelaSantaCreuiSantPau_Overall,"March 9, 2022",Local,Spain,ESP,,Barcelona,"March 1, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),817,15.20%,,,Sequential,"Vircell S.L.,Ortho Clinical Diagnostics Inc.,Luminex Corporation",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Cristina Trilla,Hospital de la Santa Creu i Sant Pau,https://dx.doi.org/10.1159/000523974,3/16/2022,3/2/2024,Unverified
220311_Spain_InstitutodeSaludCarlosIII_AntiRBD,"March 11, 2022",National,Spain,ESP,,,"November 16, 2020","November 29, 2020",Household and community samples,Multiple groups,5827,5.40%,4.80%,6.00%,Simplified probability,Beckman Coulter,CLIA,IgG,98.80%,100.00%,Low,Journal Article (Peer-Reviewed),Mayte Perez-Olmeda,Instituto de Salud Carlos III,https://www.sciencedirect.com/science/article/pii/S138665322200066X,3/31/2022,3/2/2024,Verified
220302_Madrid_UniversidadReyJuanCarlos_Residents,"March 2, 2022",Local,Spain,ESP,,Madrid,"July 15, 2020","October 15, 2020",Assisted living and long-term care facilities,Seniors (65+ years),1218,50.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jesus San Roman,Universidad Rey Juan Carlos,https://dx.doi.org/10.3390/vaccines10030383,4/5/2022,3/2/2024,Unverified
220302_Madrid_UniversidadReyJuanCarlos_Staff,"March 2, 2022",Local,Spain,ESP,,Madrid,"July 15, 2020","October 15, 2020",Assisted living and long-term care facilities,Adults (18-64 years),755,35.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jesus San Roman,Universidad Rey Juan Carlos,https://dx.doi.org/10.3390/vaccines10030383,4/5/2022,3/2/2024,Unverified
220408_Spain_Osakidetza_Patients,"April 8, 2022",Local,Spain,ESP,Biscay,,"May 4, 2020","May 18, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),189,1.10%,,,Convenience,NA,Not reported,"IgG,IgM",,,,Presentation or Conference,Barrenetxea Ziarrusta G,Osakidetza,https://academic.oup.com/humrep/article/35/Supplement_1/i1/5867890?searchresult=1&login=true,4/12/2022,7/17/2022,Unverified
220709_Spain_IVIRMA_IgG,"July 9, 2020",National,Spain,ESP,,,"April 27, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1549,3.81%,,,Unclear,"Epitope Diagnostics, Inc.",ELISA,IgG,,,Unclear,Presentation or Conference,C Gonzalez-Ravina,IVIRMA Global,https://academic.oup.com/humrep/article/35/Supplement_1/i1/5867890?searchresult=1&login=true,4/12/2022,3/2/2024,Unverified
220411_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Residents_Overall,"April 11, 2022",Local,Spain,ESP,,Madrid,"April 18, 2020","June 20, 2020",Assisted living and long-term care facilities,Seniors (65+ years),942,70.60%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pilar Escribano,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.37201/req/008.2022,4/22/2022,3/2/2024,Unverified
220411_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Staff_Overall,"April 11, 2022",Local,Spain,ESP,,Madrid,"April 18, 2020","June 20, 2020",Assisted living and long-term care facilities,Adults (18-64 years),846,47.00%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pilar Escribano,Hospital General Universitario Gregorio Maranon,https://dx.doi.org/10.37201/req/008.2022,4/22/2022,3/2/2024,Unverified
20220418_Catalonia_InstitutodeSaludGlobalBarcelona_Primary,"April 18, 2022",Regional,Spain,ESP,Catalonia,,"May 26, 2021","July 21, 2021",Blood donors,Multiple groups,1076,92.57%,,,Convenience,NA,Other,"IgG,IgM,IgA",95.78%,100.00%,Moderate,Preprint,Marianna Karachaliou,Instituto de Salud Global Barcelona,doi.org/10.21203/rs.3.rs-1536936/v1,4/27/2022,7/17/2022,Unverified
220421_Catalonia_HospitalUniversitarideBellvitge,"April 21, 2022",Regional,Spain,ESP,"Catalonia Region (Four provinces: Barcelona, Girona, Lleida, and Tarragona)",,"May 21, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),1235,8.91%,7.44%,10.63%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Paula Peremiquel-Trillas,Hospital Universitari de Bellvitge,https://dx.doi.org/10.1136/bmjopen-2021-056637,5/5/2022,3/2/2024,Unverified
210430_Madrid_LaPazUniversityHospital,"April 30, 2022",Local,Spain,ESP,Community of Madrid,Madrid,"September 15, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),105,20.00%,,,Convenience,Vircell S.L.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Clara Udaondo,La Paz University Hospital,https://dx.doi.org/10.1007/s10067-022-06186-z,5/10/2022,3/2/2024,Verified
220429_HospitalUniversitarioArnaudeVilanova_IRBLleida_Overall,"April 29, 2022",Local,Spain,ESP,Lleida,Lleida,"March 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,259,20.46%,,,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Agustin Sancho-Saldana,IRB Leida,https://dx.doi.org/10.3390/jcm11092509,5/10/2022,7/17/2022,Unverified
220602_Catalonia_InstitutCataladeLaSalut_Stage1_OverallCrude,"June 2, 2022",Local,Spain,ESP,Catalonia,Vilanova del Camí,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,691,12.16%,,,Convenience,Salofa Oy,Not reported,IgG,93.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sandra Moreno,Institut Catala de La Salut,https://doi.org/10.1038/s41598-022-13290-2,6/8/2022,3/24/2024,Verified
220602_Catalonia_InstitutCataladeLaSalut_Stage2_OverallCrude,"June 2, 2022",Local,Spain,ESP,Catalonia,Vilanova del Camí,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,1479,8.38%,,,Convenience,Salofa Oy,Not reported,IgG,93.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sandra Moreno,Institut Catala de La Salut,https://doi.org/10.1038/s41598-022-13290-2,6/8/2022,3/24/2024,Verified
220610_Madrid_HospitalUniversitarioRamonyCajal_Overall,"June 10, 2022",Local,Spain,ESP,,Madrid,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),4943,21.40%,,,Convenience,Vircell S.L.,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Jose Casado,Hospital Universitario Ramón y Cajal,https://dx.doi.org/10.3390/jcm11123352,6/21/2022,3/2/2024,Unverified
220613_HospitalUniversitarioRamónYCajal_Madrid,"June 13, 2022",Local,Spain,ESP,,Madrid,"April 15, 2020","December 22, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,152,25.70%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Antia Garcia-Fernandez,Hospital Universitario Ramón y Cajal,https://dx.doi.org/10.1097/RHU.0000000000001876,6/25/2022,3/2/2024,Unverified
220527_ArgandaDelRey_ComplutenseUniversityofMadrid,"May 27, 2022",Local,Spain,ESP,Madrid,Arganda del Rey,"January 18, 2021","March 18, 2021",Household and community samples,Multiple groups,13560,24.20%,,,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,IgG,97.20%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kora-Mareen Buhler,Complutense University of Madrid,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137247/,6/29/2022,3/24/2024,Verified
220624_Spain_EmiratesSpecialityHospitalDubai,"June 24, 2022",National,Spain,ESP,,,"July 1, 2020","July 31, 2020",Residual sera,Children and Youth (0-17 years),233,7.30%,,,Convenience,Palex,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Zarife Perez,Emirates Speciality Hospital Dubai,https://dx.doi.org/10.1111/jpc.16068,7/13/2022,3/2/2024,Unverified
220624_Barcelona_GermansTriasiPujolHospital,"June 24, 2022",Local,Spain,ESP,Catalonia,Barcelona,"June 1, 2021","August 31, 2021",Health care workers and caregivers,Adults (18-64 years),5000,98.04%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gema Fernandez-Rivas,Germans Trias i Pujol Hospital,https://dx.doi.org/10.3390/v14071385,7/14/2022,3/2/2024,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_0-9,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,40,80.00%,67.00%,93.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_20-34,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,150,97.30%,94.70%,99.90%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_10-19,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,87,98.80%,96.60%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_50-64,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,173,98.30%,96.30%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_65-79,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,159,98.70%,97.00%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_35-49,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,181,98.30%,96.50%,100.00%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Age_80+,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,141,97.20%,94.30%,99.90%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/28/2022,Unverified
220719_Valencia_INCLIVAHealthResearchInstitute_Overall_PopAdj,"July 19, 2022",Local,Spain,ESP,,Valencia,"April 1, 2022","April 30, 2022",Household and community samples,Multiple groups,931,96.70%,95.50%,97.80%,Convenience,NA,CLIA,Not reported,,,High,Preprint,Jorge Camacho,INCLIVA Health Research Institute,10.1101/2022.07.19.22277747,7/28/2022,7/29/2022,Unverified
220726_Spain_DiputaciónDeAlbacete_Employees,"July 26, 2022",Local,Spain,ESP,Castilla-la Mancha,Albacete,"June 15, 2020","December 18, 2020",Health care workers and caregivers,Multiple groups,255,24.00%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sergio Salmeron,"Universidad de Castilla-La Mancha, ",https://dx.doi.org/10.3390/geriatrics7040078,8/6/2022,3/2/2024,Unverified
220726_Spain_DiputaciónDeAlbacete_Residents,"July 26, 2022",Local,Spain,ESP,Castilla-la Mancha,Albacete,"June 15, 2020","December 18, 2020",Assisted living and long-term care facilities,Multiple groups,107,51.40%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sergio Salmeron,"Universidad de Castilla-La Mancha, ",https://dx.doi.org/10.3390/geriatrics7040078,8/6/2022,3/2/2024,Unverified
220818_Navarre_NavarreInstituteForHealthResearch_AntiS_Overall,"August 18, 2022",Regional,Spain,ESP,Navarre,,"April 26, 2022","June 3, 2022",Residual sera,Multiple groups,1461,92.74%,,,Stratified non-probability,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Jesus Castilla,Navarre Institute for Health Research,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.33.2200619,9/1/2022,3/2/2024,Unverified
220826_Spain_InstitutodeSaludCarlosIII_Overall,"August 26, 2022",National,Spain,ESP,,"
","May 5, 2020","April 22, 2021",Non-essential workers and unemployed persons,Multiple groups,142,29.58%,,,Convenience,"Abbott Laboratories,DiaSorin,EUROIMMUN",Multiple Types,IgG,,,High,Preprint,Marina Penuelas,Instituto de Salud Carlos III (ISCIII),10.20944/preprints202208.0437.v1,9/7/2022,3/2/2024,Unverified
220928_Asturias_CentroDeSaludLaviada_Period3,"September 28, 2022",Regional,Spain,ESP,Asturias,,"July 15, 2021","September 15, 2021",Residual sera,Children and Youth (0-17 years),169,16.60%,9.50%,19.60%,Convenience,"DiaSorin,Roche Diagnostics",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Elisa Garcia‑Garcia,Centro De Salud Laviada,https://dx.doi.org/10.1007/s12519-022-00617-2,10/7/2022,3/2/2024,Unverified
220914_Sevilla_UniversidaddeCordoba_Children,"September 14, 2022",Local,Spain,ESP,,Sevilla,"April 1, 2020","September 8, 2021",Multiple populations,Children and Youth (0-17 years),57,54.39%,,,Convenience,"Vircell S.L.,NA",ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Esther Prados de la Torre,Universidad de Córdoba,https://dx.doi.org/10.3390/v14092039,10/17/2022,3/2/2024,Unverified
220914_Sevilla_UniversidaddeCordoba_Adults_Time1,"September 14, 2022",Local,Spain,ESP,,Sevilla,"April 1, 2020","April 30, 2020",Multiple populations,Children and Youth (0-17 years),190,19.37%,,,Convenience,"Vircell S.L.,NA",ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Esther Prados de la Torre,Universidad de Córdoba,https://dx.doi.org/10.3390/v14092039,10/17/2022,3/2/2024,Unverified
220914_Sevilla_UniversidaddeCordoba_Adults_Time2,"September 14, 2022",Local,Spain,ESP,,Sevilla,"June 1, 2020","June 30, 2020",Multiple populations,Children and Youth (0-17 years),172,18.60%,,,Convenience,"Vircell S.L.,NA",ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Esther Prados de la Torre,Universidad de Córdoba,https://dx.doi.org/10.3390/v14092039,10/17/2022,3/2/2024,Unverified
221020_Madrid_AlfonsoXElSabioUniversity,"October 20, 2022",Local,Spain,ESP,,Madrid,"May 11, 2020","June 5, 2020",Health care workers and caregivers,Multiple groups,195,20.00%,,,Convenience,"NA,T&D Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Patricia Cintora  ,Alfonso X El Sabio University,https://dx.doi.org/10.3290/j.ohpd.b3464887,10/27/2022,10/29/2022,Unverified
221117_Catalonia_GovernmentOfCatalonia_Students_PopAdj,"November 17, 2022",Regional,Spain,ESP,Catalonia,,"February 22, 2021","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),2007,15.20%,13.50%,17.00%,Convenience,NA,LFIA,"IgG,IgM",97.20%,87.90%,,Journal Article (Peer-Reviewed),Fabiana Ganem,Government of Catalonia,https://dx.doi.org/10.1371/journal.pone.0277764,12/14/2022,3/20/2023,Unverified
221117_Catalonia_GovernmentOfCatalonia_Staff_PopAdj,"November 17, 2022",Regional,Spain,ESP,Catalonia,,"February 22, 2021","March 22, 2021",Essential non-healthcare workers,Adults (18-64 years),520,22.60%,19.00%,26.70%,Convenience,NA,LFIA,"IgG,IgM",97.20%,87.90%,,Journal Article (Peer-Reviewed),Fabiana Ganem,Government of Catalonia,https://dx.doi.org/10.1371/journal.pone.0277764,12/14/2022,3/20/2023,Unverified
221123_Madrid_LaPazUniversityHospital,"November 23, 2022",Local,Spain,ESP,,Madrid,,"May 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),32,6.30%,,,Convenience,Thermo Fisher Scientific,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Elena Sanchez-Zapardiel,La Paz University Hospital,https://dx.doi.org/10.3389/fimmu.2022.1049188,1/7/2023,3/20/2023,Unverified
230109_Barcelona_UniversitatdeBarcelona_Month0,"January 9, 2023",Local,Spain,ESP,,Barcelona,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),580,13.80%,,,Simplified probability,NA,Luminex,"IgG,IgM,IgA",95.78%,100.00%,,Journal Article (Peer-Reviewed),Ruth Aguilar,"Universitat de Barcelona, Technical University of Munich",https://dx.doi.org/10.1128/spectrum.03165-22,1/25/2023,3/20/2023,Unverified
230127_Madrid_AlcorcónFoundationUniversityHospital,"January 27, 2023",Local,Spain,ESP,,Madrid,"April 30, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),580,28.45%,,,Convenience,Biozek,LFIA,"IgG,IgM",92.30%,99.00%,,Journal Article (Peer-Reviewed),Luis Alfredo Bautista Balbas,Alcorcón Foundation University Hospital,https://dx.doi.org/10.1177/21650799221135587,3/10/2023,3/2/2024,Unverified
230301_Asturias_CentrodeSaludLaviada_Round1,"March 1, 2023",Regional,Spain,ESP,Asturias,,"July 15, 2020","September 15, 2020",Residual sera,Children and Youth (0-17 years),195,1.80%,0.40%,5.10%,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Elisa Garcia-Garcia,Centro de Salud Laviada,https://dx.doi.org/10.1097/INF.0000000000003790,3/11/2023,3/20/2023,Unverified
230308_Spain_UniversitatdeBarcelona,"March 8, 2023",Local,Spain,ESP,,Cizur,"June 12, 2020","June 19, 2020",Household and community samples,Multiple groups,728,7.90%,7.30%,8.60%,Convenience,Luminex Corporation,Luminex,"IgA,IgG,IgM",83.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Marta Ribes,Universitat de Barcelona,https://dx.doi.org/10.1038/s41598-023-30542-x,4/4/2023,3/28/2024,Verified
230309_Spain_InstitutodeSaludCarlosIII_Primary,"March 9, 2023",National,Spain,ESP,,,"April 27, 2020","June 22, 2020",Household and community samples,Multiple groups,68287,6.00%,5.70%,6.40%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,IgG,82.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Beatriz Perez-Gomez ,Instituto de Salud Carlos III,https://dx.doi.org/10.2105/AJPH.2023.307233,4/4/2023,4/13/2024,Verified
230423_Madrid_OrganismoAutónomoMadridSalud_Primary,"April 23, 2023",Local,Spain,ESP,,Madrid,"March 10, 2021","April 21, 2021",Blood donors,Adults (18-64 years),512,24.20%,,,Sequential,JOYSBIO,LFIA,"IgG,IgM",92.40%,94.40%,,Journal Article (Peer-Reviewed),A. Martin-Gorgojo,Organismo Autónomo Madrid Salud,https://dx.doi.org/10.1016/j.ad.2023.04.017,5/30/2023,3/2/2024,Unverified
230229_Madrid_LaPazUniversityHospital,"April 29, 2023",Local,Spain,ESP,,Madrid,"February 26, 2021","March 26, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),392,17.65%,,,Convenience,"Siemens,Vircell S.L.",CLIA,"IgG,Total Antibody",,,,Journal Article (Peer-Reviewed),M. D. Martin-Arranz,La Paz University Hospital,https://www.nature.com/articles/s41598-023-33402-w,6/1/2023,3/2/2024,Unverified
230613_Catalonia_ConsorciSanitaridelMaresme_fu3,"June 13, 2023",Local,Spain,ESP,,Catalonia,"November 1, 2021","November 30, 2021",Health care workers and caregivers,Adults (18-64 years),1777,28.40%,26.20%,30.50%,Convenience,"Roche Diagnostics,Vircell S.L.",Multiple Types,"IgG,IgM,IgA",100.00%,99.50%,,Journal Article (Peer-Reviewed),Maria Pilar Barrufet,Consorci Sanitari del Maresme,https://dx.doi.org/10.1093/eurpub/ckad093,6/30/2023,3/2/2024,Unverified
230518_Valencia_FISABIO_Overall,"May 18, 2023",Local,Spain,ESP,,Valencia,"October 1, 2022","October 31, 2022",Residual sera,Multiple groups,785,98.40%,97.50%,99.30%,Sequential,Roche Diagnostics,,IgG,,,Low,Journal Article (Peer-Reviewed),Anibal Garcia-Sempere,Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO),https://dx.doi.org/10.1016/j.gaceta.2023.102312,7/30/2023,5/2/2024,Verified
230808_Madrid_HospitalUniversitarioDeTorrejon,"August 8, 2023",Local,Spain,ESP,,Madrid,"January 1, 2020","May 15, 2020",Pregnant or parturient women,Adults (18-64 years),707,8.20%,,,Convenience,NA,Not reported,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Adriana Aquise,Hospital Universitario de Torrejón,https://dx.doi.org/10.1002/ijgo.15027,8/22/2023,8/22/2023,Unverified
210427_Juba_WorldHealthOrganization_Overall_PopTestAdj,"April 27, 2021",Local,South Sudan,SSD,Central Equatoria,Juba,"August 10, 2020","September 11, 2020",Household and community samples,Multiple groups,2214,38.30%,,,Stratified probability,NA,ELISA,IgG,65.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kirsten E Wiens,World Health Organization,https://dx.doi.org/10.3201/eid2706.210568,6/3/2021,7/17/2022,Verified
200928_CapeTown_UniversityofCapeTown_overall_testadj,"September 20, 2020",Local,South Africa,ZAF,,Cape Town,"June 15, 2020","August 7, 2020",Residual sera,Adults (18-64 years),2791,44.60%,42.60%,46.60%,Sequential,Roche Diagnostics,CLIA,"IgG,IgM",91.20%,99.70%,High,Institutional Report,Marvin Hsiao, University of Cape Town,https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf,3/4/2021,7/5/2023,Verified
210107_CapeTown_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,South Africa,ZAF,NR,Capetown,"June 10, 2020","August 17, 2020",Health care workers and caregivers,Adults (18-64 years),222,10.36%,7.00%,15.07%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
210225_CapeTown_StellenboschUniversity_Overall,"February 25, 2021",Local,South Africa,ZAF,,Cape Town,"August 17, 2020","September 4, 2020",Essential non-healthcare workers,Adults (18-64 years),405,23.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,98.54%,High,Journal Article (Peer-Reviewed),Jane Shaw,Stellenbosch University,https://dx.doi.org/10.1371/journal.pone.0247852,3/27/2021,3/2/2024,Verified
210505_Johannesburg_UniversityoftheWitwatersrand,"May 5, 2021",Local,South Africa,ZAF,Gauteng Province,Johannesburg,"April 22, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),395,41.30%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Marta Nunes,University of the Witwatersrand,https://dx.doi.org/10.1093/cid/ciab398,5/30/2021,7/17/2022,Verified
210706_SouthAfrica_SouthAfricanNationalBloodService_Overall_PopAdj,"July 6, 2021",National,South Africa,ZAF,,,"January 15, 2021","May 15, 2021",Blood donors,Multiple groups,16762,47.40%,46.20%,48.60%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.50%,Low,Preprint,Marion Vermeulen,South African National Blood Service,https://assets.researchsquare.com/files/rs-690372/v2_covered.pdf?c=1627923426,7/14/2021,3/2/2024,Verified
211030_Gauteng_UniversityoftheWitwatersrand_Primary,"October 30, 2021",Regional,South Africa,ZAF,Gauteng,,"November 4, 2020","January 22, 2021",Household and community samples,Multiple groups,5584,19.10%,18.10%,20.10%,Stratified probability,NA,Not reported,IgG,100.00%,,Moderate,Journal Article (Peer-Reviewed),Portia Chipo Mutevedzi,University of the Witwatersrand,https://dx.doi.org/10.1093/ije/dyab217,11/10/2021,11/12/2022,Verified
211105_Gauteng_NationalHealthLaboratoryService_OverallFullAdjust,"November 5, 2021",Regional,South Africa,ZAF,Gauteng,,"August 1, 2020","October 31, 2020",Residual sera,Multiple groups,6477,27.80%,,,Convenience,Roche Diagnostics,CLIA,IgG,93.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jaya George,National Health Laboratory Service,https://doi.org/10.7196/SAMJ.2021.v111i11.15669,12/8/2021,8/15/2023,Unverified
220215_SouthAfrica_StellenboschUniversity,"February 15, 2022",National,South Africa,ZAF,"Eastern Cape, Free state, Gauteng, Limpopo, Mpulanga, Northern Cape, North West, KwaZulu Natal",,"November 8, 2021","November 12, 2021",Blood donors,Multiple groups,3395,71.10%,68.80%,73.50%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,100.00%,Moderate,Preprint,Russel Cable,Stellenbosch University,https://www.researchsquare.com/article/rs-1359658/v1,2/25/2022,3/2/2024,Unverified
220223_GautengProvince_UniversityoftheWitwatersrand_Overall,"February 23, 2022",Regional,South Africa,ZAF,Gauteng,,"October 22, 2021","December 9, 2021",Household and community samples,Multiple groups,7010,73.10%,72.00%,74.10%,Stratified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shabir Madhi,University of the Witwatersrand,https://doi.org/10.1056/nejmoa2119658,3/4/2022,7/17/2022,Unverified
220318_EasternCape_WalterSisuluUniversity_Primary,"March 18, 2022",Regional,South Africa,ZAF,Eastern Cape,,"November 4, 2020","December 18, 2020",Health care workers and caregivers,Adults (18-64 years),1295,37.70%,,,Stratified probability,NA,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),David Stead,Walter Sisulu University,https://dx.doi.org/10.1136/bmjopen-2021-058761,3/30/2022,7/17/2022,Unverified
220323_SouthAfrica_NationalHealthLaboratoryService_Urban_BD9_TestAdj,"March 23, 2022",Local,South Africa,ZAF,North West Province,Matlosana Municipality,"November 15, 2021","November 27, 2021",Household and community samples,Multiple groups,479,70.00%,66.00%,74.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,National Health Laboratory Service,https://dx.doi.org/10.3201/eid2805.220278,4/1/2022,8/15/2023,Verified
220323_SouthAfrica_NationalHealthLaboratoryService_Rural_BD9_TestAdj,"March 23, 2022",Local,South Africa,ZAF,Mpumalanga Province,Bushbuckridge Municipality,"November 15, 2021","November 27, 2021",Household and community samples,Multiple groups,550,60.00%,56.00%,64.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Jackie Kleynhans,National Health Laboratory Service,https://dx.doi.org/10.3201/eid2805.220278,4/1/2022,8/15/2023,Verified
220310_SouthAfrica_NationalHealthLaboratoryService_Overall,"March 10, 2022",National,South Africa,ZAF,"KwaZulu-Natal, North West Province, Western Cape","Pietermaritzburg, Klerksdorp, Mitchell's Plain","November 15, 2020","April 15, 2021",Multiple general populations,Multiple groups,7577,45.23%,43.70%,46.70%,Stratified probability,"Beijing Wantai Biological,Roche Diagnostics",ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Nicole Wolter,National Health Laboratory Service,https://dx.doi.org/10.1093/cid/ciac198,4/4/2022,3/2/2024,Unverified
220526_SouthAfrica_StellenboschUniversity_Spike,"May 26, 2022",National,South Africa,ZAF,,,"March 8, 2022","March 22, 2022",Blood donors,Multiple groups,3395,97.20%,96.50%,98.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,100.00%,Moderate,Preprint,Jeremy Bingham,Stellenbosch University,https://doi.org/10.21203/rs.3.rs-1687679/v2,6/5/2022,3/2/2024,Unverified
220531_Klerksdorp_UniversityofWitwatersrand_ThirdWave,"May 31, 2022",Local,South Africa,ZAF,North West Province,Klerksdorp,"August 1, 2021","August 31, 2021",Household and community samples,Multiple groups,501,55.70%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Kaiyuan Sun,University of Witwatersrand,https://doi.org/10.1126/scitranslmed.abo7081,6/10/2022,4/16/2024,Unverified
220331_SouthAfrica_HumanSciencesResearchCouncil,"March 31, 2022",National,South Africa,ZAF,,,"November 15, 2020","June 15, 2021",Household and community samples,Multiple groups,13640,19.60%,17.90%,21.30%,Convenience,"EUROIMMUN,NA",Multiple Types,Not reported,,,High,Presentation or Conference,Leickness Simbayi,Human Sciences Research Council,https://www.iasusa.org/tam/march-2022/,6/15/2022,3/2/2024,Unverified
220301_SouthAfrica_UniversityOfCapeTown,"March 1, 2022",National,South Africa,ZAF,,,"April 15, 2021","June 15, 2021",Household and community samples,Multiple groups,8146,6.27%,,,Unclear,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics",CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Sizulu Moyo,University of Cape Town,https://www.iasusa.org/tam/march-2022/,6/18/2022,3/2/2024,Unverified
220413_Gugulethu_ICGEB_Primary,"April 13, 2022",Local,South Africa,ZAF,Western Cape,Gugulethu,"October 15, 2020","June 15, 2021",Representative patient population,Adults (18-64 years),150,70.70%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Humaira Lambarey,International Centre for Genetic Engineering and Biotechnology,https://dx.doi.org/10.3390/v14061222,6/28/2022,7/17/2022,Unverified
220715_Gauteng_UniversityOfTheWitwatersrand_Primary,"July 15, 2022",Regional,South Africa,ZAF,Gauteng,,"March 1, 2022","April 11, 2022",Household and community samples,Multiple groups,7510,90.90%,90.20%,91.50%,Stratified probability,NA,Other,IgG,,,Low,Preprint,Shabir A. Madhi,University of the Witwatersrand ,10.1101/2022.07.13.22277575,7/26/2022,7/26/2022,Unverified
220916_Drakenstein_UniversityCollegeLondon_Wave1,"September 16, 2022",Local,South Africa,ZAF,,Paarl,"June 8, 2020","August 30, 2020",Residual sera,Adults (18-64 years),339,51.90%,,,Convenience,Meso Scale Discovery,Other,IgG,90.30%,94.70%,High,Journal Article (Peer-Reviewed),Heather J. Zar,University College London,https://dx.doi.org/10.1016/j.eclinm.2022.101655,10/2/2022,6/23/2023,Unverified
220916_Drakenstein_UniversityCollegeLondon_Wave2,"September 16, 2022",Local,South Africa,ZAF,,Paarl,"November 23, 2020","February 7, 2021",Residual sera,Adults (18-64 years),337,74.20%,,,Convenience,Meso Scale Discovery,Other,IgG,90.30%,94.70%,High,Journal Article (Peer-Reviewed),Heather J. Zar,University College London,https://dx.doi.org/10.1016/j.eclinm.2022.101655,10/2/2022,6/23/2023,Unverified
220916_Drakenstein_UniversityCollegeLondon_Wave3,"September 16, 2022",Local,South Africa,ZAF,,Paarl,"May 10, 2021","September 19, 2021",Residual sera,Adults (18-64 years),244,89.80%,,,Convenience,Meso Scale Discovery,Other,IgG,90.30%,94.70%,High,Journal Article (Peer-Reviewed),Heather J. Zar,University College London,https://dx.doi.org/10.1016/j.eclinm.2022.101655,10/3/2022,6/23/2023,Unverified
220916_Drakenstein_UniversityCollegeLondon_Wave4,"September 16, 2022",Local,South Africa,ZAF,,Paarl,"November 8, 2021","January 23, 2022",Residual sera,Adults (18-64 years),185,97.30%,,,Convenience,Meso Scale Discovery,Other,IgG,90.30%,94.70%,High,Journal Article (Peer-Reviewed),Heather J. Zar,University College London,https://dx.doi.org/10.1016/j.eclinm.2022.101655,10/3/2022,6/23/2023,Unverified
220924_SouthAfrica_RobertKochInstitut_Overall,"September 24, 2022",Local,South Africa,ZAF,,Pretoria,"March 23, 2021","May 20, 2021",Health care workers and caregivers,Adults (18-64 years),212,39.30%,32.70%,46.30%,Self-referral,"EUROIMMUN,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Sarah Kribi,Robert Koch Institut,https://dx.doi.org/10.1093/trstmh/trac089,10/5/2022,8/15/2023,Unverified
221005_Johannesburg_UniversityOfTheWitwatersrand,"November 5, 2022",Local,South Africa,ZAF,Gauteng Province,Johannesburg,"March 17, 2021","June 9, 2021",Pregnant or parturient women,Multiple groups,500,64.00%,59.60%,68.20%,Sequential,"Beijing Wantai Biological,Roche Diagnostics",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Shobna Sawry,University of the Witwatersrand,https://dx.doi.org/10.1016/j.ijid.2022.10.036,11/18/2022,3/2/2024,Unverified
221205_CapeTown_UniversityofCapeTown,"December 5, 2022",Regional,South Africa,ZAF,Western Cape,Cape Town,"August 17, 2020","November 27, 2021",Multiple general populations,Multiple groups,10339,54.26%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",89.00%,100.00%,High,Preprint,Hannah Hussey,University of Cape Town,10.1101/2022.12.01.22282927,1/4/2023,4/19/2024,Verified
230109_Pretoria_SteveBikoAcademicHospital_Overall,"January 9, 2023",Local,South Africa,ZAF,Gauteng Province,Pretoria,"March 24, 2021","March 30, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,760,33.16%,,,Convenience,Zhejiang Orient Gene Biotech,,,,100.00%,,Journal Article (Peer-Reviewed),Mankgopo Kgatle,Steve Biko Academic Hospital,https://dx.doi.org/10.3390/jcm12020529,2/10/2023,3/2/2024,Unverified
230221_Gauteng_UniversityoftheWitwatersrand_preBA1,"February 21, 2023",Regional,South Africa,ZAF,Gauteng,,"October 22, 2021","December 9, 2021",Household and community samples,Multiple groups,7010,73.10%,72.00%,74.10%,Simplified probability,NA,Luminex,IgG,,,,Journal Article (Peer-Reviewed),Shabir A. Madhi ,University of the Witwatersrand,https://dx.doi.org/10.3390/v15030597,4/26/2023,4/26/2023,Unverified
230523_SouthAfrica_UniversityofCapeTown,"May 23, 2023",Regional,South Africa,ZAF,Western Cape,"Cape Town, Cape Winelands","February 1, 2021","May 20, 2021",Multiple populations,Children and Youth (0-17 years),71,58.00%,,,Convenience,NA,Not reported,IgG,,,,Preprint,Ntombi S. B. Benede,University of Cape Town,https://www.medrxiv.org/content/10.1101/2023.05.16.23290059v1,6/29/2023,7/4/2023,Unverified
230629_KwaZuluNatal_UniversityOfKwaZuluNatal_Overall,"June 29, 2023",Local,South Africa,ZAF,KwaZulu-Natal,Durban,"November 10, 2020","February 9, 2021",Residual sera,Multiple groups,8829,22.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,69.50%,95.00%,,Journal Article (Peer-Reviewed),Kerri-Lee Francois,University of KwaZulu-Natal,https://dx.doi.org/10.4102/ajlm.v12i1.2065,8/1/2023,4/24/2024,Verified
240202_Gugulethu_ICGEB_Overall,"February 2, 2024",Local,South Africa,ZAF,Western Cape,Gugulethu,"January 1, 2023","April 15, 2023",Representative patient population,Adults (18-64 years),407,94.90%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Humaira Lambarey,International Centre for Genetic Engineering and Biotechnology (ICGEB),10.2139/ssrn.4583146,3/9/2024,3/10/2024,Unverified
220531_Klerksdorp_UniversityofWitwatersrand_SecondWave,"May 31, 2022",Local,South Africa,ZAF,North West Province,Klerksdorp,"April 1, 2021","April 30, 2021",Household and community samples,Multiple groups,514,40.30%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Kaiyuan Sun,University of Witwatersrand,https://doi.org/10.1126/scitranslmed.abo7081,4/16/2024,4/16/2024,Verified
220531_Klerksdorp_UniversityofWitwatersrand_FirstWave,"May 31, 2022",Local,South Africa,ZAF,North West Province,Klerksdorp,"December 1, 2020","December 31, 2021",Household and community samples,Multiple groups,530,27.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Kaiyuan Sun,University of Witwatersrand,https://doi.org/10.1126/scitranslmed.abo7081,4/16/2024,4/16/2024,Verified
220130_Benadir_SIMADUniversity_Overall,"January 30, 2022",Regional,Somalia,SOM,Benadir region,,"May 19, 2021","July 29, 2021",Household and community samples,Multiple groups,2400,44.80%,,,Stratified non-probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",87.12%,99.74%,Moderate,Journal Article (Peer-Reviewed),Mohamed Adam,SIMAD University,https://dx.doi.org/10.3390/vaccines10020220,2/15/2022,3/2/2024,Unverified
220609_Mogadishu_SIMADUniversity,"June 9, 2022",Local,Somalia,SOM,Banaadir,Mogadishu,"July 31, 2021","August 31, 2021",Pregnant or parturient women,Multiple groups,477,36.70%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",97.10%,97.80%,High,Journal Article (Peer-Reviewed),Maryan Nur,SIMAD University,https://dx.doi.org/10.1136/bmjopen-2021-059617,6/22/2022,3/2/2024,Unverified
220915_Mogadishu_SIMADUniversity,"September 15, 2022",Local,Somalia,SOM,,Mogadishu,"July 26, 2021","August 8, 2021",Residual sera,Children and Youth (0-17 years),500,6.40%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",87.12%,99.74%,High,Journal Article (Peer-Reviewed),Fartun Abdullahi H. Orey,SIMAD University,https://dx.doi.org/10.1093/trstmh/trac088,9/20/2022,3/2/2024,Unverified
230415_Somalia_FederalGovernmentOfSomalia_Overall,"April 15, 2023",National,Somalia,SOM,"Somalia’s 18 administrative regions, including the Banadir Regional Administration and Somaliland",,"March 15, 2021","July 15, 2021",Multiple general populations,Multiple groups,2751,56.40%,54.50%,58.30%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,,Journal Article (Peer-Reviewed),Md Shajib Hossain,Federal Government of Somalia,https://dx.doi.org/10.1016/j.jiph.2023.04.016,5/29/2023,4/22/2024,Verified
210407_Slovenia_UniversityofLjubljana_FirstRound_GenPop_ElecsysTestAdj,"April 7, 2021",National,Slovenia,SVN,,,"April 20, 2020","May 1, 2020",Household and community samples,Multiple groups,1316,0.87%,0.40%,1.38%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mario Poljak ,University of Ljubljana,https://dx.doi.org/10.1016/j.cmi.2021.03.009,5/20/2021,8/15/2023,Verified
210407_Slovenia_UniversityofLjubljana_SecondRound_Nov,"April 7, 2021",National,Slovenia,SVN,,,"October 17, 2020","November 10, 2020",Household and community samples,Multiple groups,1211,4.29%,3.18%,5.47%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mario Poljak ,University of Ljubljana,https://dx.doi.org/10.1016/j.cmi.2021.03.009,8/6/2021,3/2/2024,Verified
220715_Slovenia_NationalInstituteofPublicHealth_Overall,"July 15, 2022",National,Slovenia,SVN,,,"November 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),813,20.40%,,,Convenience,EUROIMMUN,ELISA,IgG,100.00%,97.70%,High,Journal Article (Peer-Reviewed),Maja Socan,National Laboratory for Health,https://dx.doi.org/10.13075/ijomeh.1896.01932,7/28/2022,3/2/2024,Unverified
230218_Ljubljana_NationalInstituteOfPublicHealth_Primary_AntiSorAntiN,"February 18, 2023",Local,Slovenia,SVN,,Ljubljana,"March 1, 2022","June 6, 2022",Residual sera,Multiple groups,2899,87.96%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Maja Socan,National Institute of Public Health,https://dx.doi.org/10.3390/ijerph20043665,4/12/2023,4/6/2024,Verified
211116_Bratislava_SlovakAcademyOfSciences,"November 16, 2021",Local,Slovakia,SVK,,Bratislava,"July 1, 2021","August 15, 2021",Non-essential workers and unemployed persons,Multiple groups,1928,84.13%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Kajanova,Slovak Academy Of Sciences,https://dx.doi.org/10.4149/av_2021_407,12/2/2021,3/2/2024,Unverified
220718_Trencin_SlovakAcademyofSciences_Overall,"July 18, 2022",Local,Slovakia,SVK,,Trencin,"January 20, 2022","March 2, 2022",Household and community samples,Multiple groups,3013,74.48%,,,Self-referral,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Preprint,Ivana Kajanova,Slovak Academy of Sciences,https://dx.doi.org/10.4149/av_2022_301,7/28/2022,3/2/2024,Unverified
200429_Singapore_NCID_GeneralPopulation,"April 29, 2020",Local,Singapore,SGP,,Singapore,"February 15, 2020","April 15, 2020",Household and community samples,Multiple groups,774,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,7/17/2022,Verified
200429_Singapore_Singapore_NCID_HCW,"April 29, 2020",Local,Singapore,SGP,,Singapore,"February 15, 2020","April 15, 2020",Health care workers and caregivers,Multiple groups,1096,0.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Rei Kurohi,Singapore National Centre for Infectious Diseases,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,7/17/2022,Verified
210209_Singapore_MinistryOfHealthSingapore,"February 9, 2021",Local,Singapore,SGP,Singapore,Singapore,"March 25, 2020","July 25, 2020",Multiple populations,Adults (18-64 years),135760,60.10%,,,Convenience,"Siemens,Abbott Laboratories,Roche Diagnostics",Multiple Types,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Iain Tan,Ministry of Health Singapore,https://dx.doi.org/10.1001/jama.2020.24071,3/6/2021,3/2/2024,Verified
201102_Singapore_NationalCentreForInfectiousDiseases_overall,"November 2, 2020",National,Singapore,SGP,,,"January 23, 2020","April 3, 2020",Contacts of COVID patients,Multiple groups,1150,3.80%,,,Entire sample,NA,Neutralization,Neutralizing ,98.90%,100.00%,Moderate,Journal Article (Peer-Reviewed),Oon Tek Ng,"National Centre for Infectious Diseases, Singapore",https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email,3/13/2021,7/17/2022,Verified
210420_Singapore_NationalUniversityOfSingapore_MigrantWorkers_TestAdj,"April 20, 2021",Local,Singapore,SGP,,,"May 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),478,63.80%,57.90%,70.30%,Simplified probability,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,High,Preprint, Hannah E Clapham,National University of Singapore,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194,5/20/2021,8/15/2023,Verified
210420_Singapore_NationalUniversityOfSingapore_Community_TestAdj,"April 20, 2021",National,Singapore,SGP,,,"November 15, 2020","December 15, 2020",Household and community samples,Multiple groups,937,0.16%,0.01%,0.72%,Convenience,GenScript,Neutralization,Neutralizing ,80.30%,99.30%,High,Preprint, Hannah E Clapham,National University of Singapore,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3826194,5/20/2021,8/15/2023,Verified
220216_Singapore_NationalUniversityofSingapore,"February 16, 2022",Local,Singapore,SGP,Central Region of Singapore,Queenstown,"March 16, 2020","June 19, 2020",Residual sera,Multiple groups,51,15.69%,,,Convenience,"GenScript,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gail Cross,National University of Singapore,https://dx.doi.org/10.1002/jmv.27656,2/25/2022,3/2/2024,Unverified
211111_SierraLeone_HarvardMedicalSchool_WeightedOverall,"November 11, 2021",National,Sierra Leone,SLE,,,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,1893,2.80%,2.10%,3.50%,Stratified probability,Hangzhou Biotest Biotech Co. Ltd,LFIA,"IgG,IgM",100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Mohamed Bailor Barrie,Harvard Medical School,https://gh.bmj.com/content/6/11/e007271,9/10/2022,3/2/2024,Unverified
230329_Kambia_InstituteNationalResearchBiomedical_M4_Overall,"March 29, 2023",Local,Sierra Leone,SLE,,,"July 1, 2021","July 31, 2021",Health care workers and caregivers,Adults (18-64 years),62,82.26%,,,Stratified probability,Luminex Corporation,Luminex,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Bolarinde Lawal,Institute National Research biomedical,https://dx.doi.org/10.1016/j.ijid.2023.03.049,4/1/2023,3/2/2024,Unverified
210709_Vojvodina_UniversityOfNoviSad_Unadj_April1_Overall,"July 9, 2021",Regional,Serbia,SRB,Vojvodina,,"April 17, 2020","April 30, 2020",Household and community samples,Multiple groups,1267,2.60%,1.80%,3.63%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/22/2021,3/2/2024,Verified
210709_Vojvodina_UniversityOfNoviSad_Unadj_May2_Overall,"July 9, 2021",Regional,Serbia,SRB,Vojvodina,,"May 18, 2020","May 31, 2020",Household and community samples,Multiple groups,1068,3.93%,2.85%,5.28%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/22/2021,3/2/2024,Verified
210709_Vojvodina_UniversityOfNoviSad_Unadj_June3_Overall,"July 9, 2021",Regional,Serbia,SRB,Vojvodina,,"June 17, 2020","June 30, 2020",Household and community samples,Multiple groups,1014,6.11%,4.72%,7.77%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/22/2021,3/2/2024,Verified
210709_Vojvodina_UniversityOfNoviSad_LFIA_September4_Overall,"July 9, 2021",Regional,Serbia,SRB,Vojvodina,,"September 17, 2020","September 30, 2020",Household and community samples,Multiple groups,1041,14.60%,12.51%,16.81%,Stratified probability,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Mioljub Ristic,University Of Novi Sad,https://dx.doi.org/10.1371/journal.pone.0254516,7/22/2021,3/2/2024,Verified
220324_UniversityOfBelgrade_Belgrade,"March 24, 2022",Local,Serbia,SRB,,Belgrade,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),575,18.30%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marija Zdravkovic,University of Belgrade,https://dx.doi.org/10.3390/vaccines10040500,4/23/2022,7/17/2022,Unverified
220525_Belgrade_UniversityofBelgrade_Overall_TestAdj,"May 25, 2022",Local,Serbia,SRB,Belgrade,Belgrade,"June 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),1580,16.80%,,,Convenience,NA,ELISA,IgG,99.00%,98.00%,High,Journal Article (Peer-Reviewed),Ljiljana Markovic-Denic,University of Belgrade,https://dx.doi.org/10.1016/j.jiph.2022.05.009,6/29/2022,7/17/2022,Verified
221216_Vojvodina_UniversityofNoviSad_Primary,"December 16, 2022",Regional,Serbia,SRB,Vojvodina,,"March 28, 2022","June 10, 2022",Health care workers and caregivers,Multiple groups,6936,92.96%,,,Unclear,"EUROIMMUN,DiaSorin",Multiple Types,IgG,,,,Journal Article (Peer-Reviewed),Mioljub Ristic,University of Novi Sad,https://dx.doi.org/10.3390/vaccines10122168,1/14/2023,3/2/2024,Unverified
210817_Senegal_UniversityGastonBerger_Primary,"August 17, 2021",National,Senegal,SEN,,,"June 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,303,21.20%,16.70%,26.10%,Simplified probability,Healgen,LFIA,"IgM,IgG",,,Moderate,Preprint,Sidy Mohamed Seck,University Gaston Berger,https://www.researchsquare.com/article/rs-660094/v1,8/25/2021,3/2/2024,Unverified
220305_Senegal_InstitutPasteurdeDakar_OverallTestPopAdj,"March 5, 2022",National,Senegal,SEN,,,"October 25, 2020","November 26, 2020",Household and community samples,Multiple groups,1422,28.40%,26.10%,30.80%,Simplified probability,"Generic Diagnostics Ltd,Beijing Wantai Biological",ELISA,"IgG,Total Antibody",,,Low,Journal Article (Peer-Reviewed),Cheikh Talla,Institut Pasteur de Dakar,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897837/,6/29/2022,8/15/2023,Unverified
211224_Senegal_InstitutDeRechercheEnSante_TestAdj_Overall,"December 24, 2021",National,Senegal,SEN,,"Dakar , Thiès, Ziguinchor, Saint-Louis, Kaolack, Kolda, Touba, Tambacounda, Louga, Bounkiling","June 15, 2020","October 15, 2020",Household and community samples,Multiple groups,3231,20.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Journal Article (Peer-Reviewed),Ambroise Ahouidi,Institut de Recherche en Sante,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702669/,6/30/2022,8/15/2023,Unverified
200906_Madinah_KingFahadGeneralHospital_HCWs_Overall,"September 6, 2020",Local,Saudi Arabia,SAU,Hejaz,Madinah,"April 18, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),330,24.24%,,,Unclear,Vircell S.L.,ELISA,"IgM,IgA,IgG",,,High,Journal Article (Peer-Reviewed),Suliman Alharbi,King Fahad General Hospital,https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf,9/29/2020,3/2/2024,Verified
201120_SaudiArabia_SaudiCDC_Overall,"November 20, 2020",National,Saudi Arabia,SAU,"Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Emirate of the Eastern Province, Aseer, Madinah, Makkah",,"May 20, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),12621,2.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Haleema Ali Alserehi,Saudi Center for Disease Prevention and Control,https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273,1/24/2021,3/2/2024,Verified
210112_Dammam_KingFahadSpecialistHospital_Overall,"January 12, 2021",Local,Saudi Arabia,SAU,Eastern Province,Dammam,"August 15, 2020","October 12, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),72,12.50%,,,Sequential,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,High,Preprint,Alanoud Alshami,King Fahad Specialist Hospital,https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf,2/5/2021,3/2/2024,Verified
210116_SaudiArabia_MinistryofHealth_overall,"January 16, 2021",National,Saudi Arabia,SAU,,,"May 20, 2020","May 25, 2020",Blood donors,Adults (18-64 years),837,1.40%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.80%,99.50%,High,Journal Article (Peer-Reviewed),Ayman Banjar,Ministry of Health (Saudi Arabia),https://dx.doi.org/10.1016/j.ijid.2021.01.028,2/8/2021,3/2/2024,Verified
210105_Jeddah_KingAbdulazizUniversity_overall,"January 5, 2021",Local,Saudi Arabia,SAU,,Jeddah,"January 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),956,1.50%,,,Sequential,NA,ELISA,IgG,100.00%,98.40%,High,Journal Article (Peer-Reviewed),Thamir Alandijany,King Abdulaziz University,https://dx.doi.org/10.3390/healthcare9010051,2/10/2021,7/17/2022,Verified
201206_Al-Madinah_TaibahUniversity_Overall,"December 11, 2020",Local,Saudi Arabia,SAU,,Al-Madinah,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1212,19.31%,17.12%,21.64%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed H Mahallawi,Taibah University,https://dx.doi.org/10.1016/j.sjbs.2020.12.009,2/18/2021,7/17/2022,Verified
210131_SaudiArabia_KingAbdullahInternationalMedicalResearchCenter_genpop_overall,"January 31, 2021",National,Saudi Arabia,SAU,"Riyadh, Jazan, Qassim, Hail, Al-Ahsa, Makkah",,"June 15, 2020","November 15, 2020",Multiple general populations,Multiple groups,11275,10.90%,10.30%,11.60%,Convenience,"EUROIMMUN,NA",ELISA,IgG,,,Moderate,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,3/5/2021,3/2/2024,Verified
210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall,"January 31, 2021",Local,Saudi Arabia,SAU,,Riyadh City,"June 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),400,7.50%,4.95%,10.16%,Unclear,NA,ELISA,IgG,,,High,Preprint,Naif Khalaf Alharbi,King Abdullah International Medical Research Center,https://www.medrxiv.org/content/10.1101/2021.01.28.21250598v1,3/5/2021,7/17/2022,Verified
210213_Makkah_KingAbdulazizUniversity_HCW,"February 13, 2021",Local,Saudi Arabia,SAU,Mecca Province,Makkah (Mecca),"June 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),204,6.30%,,,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Ahmed,King Abdulaziz University,https://www.sciencedirect.com/science/article/pii/S1018364721000276?via%3Dihub,3/29/2021,7/17/2022,Verified
210628_Jeddah_KingAbdulazizUniversity,"June 28, 2021",Local,Saudi Arabia,SAU,Mecca,Jeddah,"August 9, 2020","November 2, 2020",Health care workers and caregivers,Adults (18-64 years),319,12.20%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Farsi,King Abdulaziz University,https://dx.doi.org/10.15537/smj.2021.42.7.20210348,7/8/2021,7/17/2022,Verified
210720_Jeddah_KingAbdulazizUniversity_Overall,"July 20, 2021",Local,Saudi Arabia,SAU,,Jeddah,"June 29, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),693,32.20%,28.80%,35.80%,Convenience,NA,Multiple Types,"Neutralizing ,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Rowa Alhabbab,King Abdulaziz University,10.3390/v13071413,8/3/2021,7/17/2022,Verified
210801_Riyadh_KingSaudUniversity_Primary,"August 1, 2021",Local,Saudi Arabia,SAU,,Riyadh,"November 22, 2020","December 17, 2020",Blood donors,Adults (18-64 years),515,12.23%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Mohammed F. Alosaimi,King Saud University,https://dx.doi.org/10.15537/smj.2021.42.8.20210238,8/11/2021,3/2/2024,Verified
210802_Riyadh_KingSaudUniversity_Primary,"August 2, 2021",Local,Saudi Arabia,SAU,Riyadh Province,Riyadh,"November 22, 2020","December 17, 2020",Blood donors,Multiple groups,515,12.23%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Mohammed Alosaimi,King Saud University,http://dx.doi.org/10.15537/SMJ.2021.42.8.20210238,8/24/2021,3/2/2024,Verified
210901_Riyadh_KingSaudbinAbdulazizUniversity,"September 1, 2021",Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,"July 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),420,14.80%,11.50%,18.50%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Fayhan Alroqi,King Saudbin Abdulaziz University for Health Sciences,https://dx.doi.org/10.1016/j.jiph.2021.08.029,9/13/2021,3/2/2024,Unverified
210922_Madinah_TaibahUniversity_children1_primary,"September 22, 2021",Local,Saudi Arabia,SAU,, Madinah,"January 15, 2021","April 15, 2021",Residual sera,Children and Youth (0-17 years),332,58.73%,,,Convenience,BGI Genomics,ELISA,IgG,98.71%,98.38%,Moderate,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,http://dx.doi.org/10.3390/ijerph18199971,10/6/2021,3/2/2024,Verified
210922_Madinah_TaibahUniversity_women2,"September 22, 2021",Local,Saudi Arabia,SAU,, Madinah,"January 15, 2021","April 15, 2021",Residual sera,Adults (18-64 years),247,50.20%,,,Convenience,BGI Genomics,ELISA,IgG,98.71%,98.38%,Moderate,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,http://dx.doi.org/10.3390/ijerph18199971,10/6/2021,3/2/2024,Verified
211101_Riyadh_PrinceSultanMilitaryMedicalCity_Primary,"November 1, 2021",Local,Saudi Arabia,SAU,,,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),188,3.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Abeer M. Albaadani,Prince Sultan Military Medical City,https://dx.doi.org/10.15537/smj.2021.42.11.20210391,11/10/2021,3/2/2024,Unverified
211126_Jazan_JazanUniversity_Primary,"November 26, 2021",Regional,Saudi Arabia,SAU,Jazan province,,"August 25, 2020","December 30, 2020",Household and community samples,Multiple groups,594,25.75%,21.20%,30.00%,Self-referral,"Vircell S.L.,NA",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Abdulaziz Alhazmi,Jazan University,http://dx.doi.org/10.3390/ijerph182312451,12/7/2021,3/2/2024,Unverified
211208_SaudiArabia_JohnsHopkinsAramcoHealthcare_Primary,"December 8, 2021",Local,Saudi Arabia,SAU,,,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,5629,50.20%,48.80%,51.50%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sami Almudarra,Saudi Ministry of Health,https://dx.doi.org/10.1007/s15010-021-01726-2,12/14/2021,3/2/2024,Unverified
220131_Riyadh_KingSaudMedicalCity,"January 31, 2022",Local,Saudi Arabia,SAU,,Riyadh,"December 15, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),3644,26.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hala Amer,"""Prevention and Control of Infection Administration, King Saud Medical City""",https://dx.doi.org/10.1016/j.jiph.2022.01.018,2/22/2022,3/2/2024,Unverified
220407_Madinah_TaibahUniversity_Overall,"April 7, 2022",Local,Saudi Arabia,SAU,,Madinah,"December 15, 2020","April 30, 2021",Residual sera,Multiple groups,527,23.53%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Waleed Mahallawi,Taibah University,https://dx.doi.org/10.5144/0256-4947.2022.69,4/13/2022,7/17/2022,Unverified
220422_Riyadh_KingAbdullahInternationalMedicalResearchCenter_ResidualSera,"April 22, 2022",Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,"June 1, 2020","June 16, 2020",Residual sera,Multiple groups,432,9.25%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mohammed Alenazi,King Abdullah International Medical Research Center,https://dx.doi.org/10.1016/j.sjbs.2022.103282,5/5/2022,7/17/2022,Unverified
220422_Riyadh_KingAbdullahInternationalMedicalResearchCenter_BloodDonors,"April 22, 2022",Local,Saudi Arabia,SAU,Riyadh Province,Riyadh City,"June 1, 2020","June 16, 2020",Residual sera,Multiple groups,350,6.00%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mohammed Alenazi,King Abdullah International Medical Research Center,https://dx.doi.org/10.1016/j.sjbs.2022.103282,5/5/2022,7/17/2022,Unverified
211123_Riyadh_KingFaisalHospitalAndResearchCentre,"November 23, 2021",Local,Saudi Arabia,SAU,Riyadh Province,Riyadh,"June 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),1076,24.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,71.90%,96.54%,High,Journal Article (Peer-Reviewed),Reem Almaghrabi,King Faisal Hospital and Research Centre,https://dx.doi.org/10.1016/j.ijregi.2021.11.009,6/29/2022,3/2/2024,Unverified
220602_Abha_KingKhalidUniversity_HCW_ELISA_IgGIgM_Primary,"June 2, 2022",Local,Saudi Arabia,SAU,'Asir,Abha,"October 15, 2020","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),186,16.12%,,,Simplified probability,Vircell S.L.,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ahmed M. Al-Hakami,King Khalid University,https://www.bahrainmedicalbulletin.com/JUNE_2022/BMB-22-204.pdf,8/20/2022,3/2/2024,Unverified
220810_Dhahran_JohnsHopkinsAramcoHealthcare,"August 10, 2022",Local,Saudi Arabia,SAU,Eastern Province,Dhahran,"June 15, 2020","April 30, 2021",Health care workers and caregivers,Adults (18-64 years),682,12.76%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hayat Mushcab,Johns Hopkins Aramco Healthcare,https://dx.doi.org/10.2147/IDR.S369755,8/23/2022,3/2/2024,Unverified
220812_Riyadh_KingFahadMedicalCity_Baseline,"August 12, 2022",Local,Saudi Arabia,SAU,,Riyadh,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Multiple groups,2523,10.80%,9.60%,12.10%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,99.00%,High,Journal Article (Peer-Reviewed),Faisal Alasmari,King Fahad Medical City,https://dx.doi.org/10.1371/journal.pone.0272818,8/24/2022,3/2/2024,Unverified
220808_Makkah_UmmAlQuraUniversity_Overall,"August 8, 2022",Local,Saudi Arabia,SAU,,Makkah,"August 1, 2020","December 30, 2020",Blood donors,Multiple groups,4368,51.50%,,,Unclear,BGI Genomics,ELISA,IgG,93.78%,97.12%,Moderate,Journal Article (Peer-Reviewed),Kamal H. Alzabeedi,Umm Al Qura University,https://dx.doi.org/10.3390/vaccines10081279,9/8/2022,3/2/2024,Unverified
220818_Abha_KingKhalidUniversity_TestAdj_Overall,"August 18, 2022",Local,Saudi Arabia,SAU,,Abha,"October 1, 2021","November 30, 2021",Residual sera,Children and Youth (0-17 years),413,33.00%,28.50%,37.40%,Convenience,Palex,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ali Asseri,King Khalid University,https://dx.doi.org/10.3390/vaccines10081344,9/8/2022,8/15/2023,Unverified
221222_Sakaka_JoufUniversity_IgG,"December 22, 2022",Local,Saudi Arabia,SAU,Aljouf,Sakaka City,"July 15, 2021","October 15, 2021",Blood donors,Multiple groups,400,57.70%,,,Sequential,"SunLong Biotech Co., LTD, Hangzhou, China",LFIA,IgG,,,,Journal Article (Peer-Reviewed),Ahmed E. Taha,Jouf University,https://dx.doi.org/10.3390/vaccines11010026,2/7/2023,3/22/2023,Unverified
221211_SaudiArabia_KingSaudBinAbdulazizUniversity_Overall,"December 11, 2022",National,Saudi Arabia,SAU,"Asir, Albaha, Najran, Jazan, Eastern Province, Makkah, Madinah",,"July 15, 2020","October 15, 2020",Household and community samples,Multiple groups,14118,19.10%,,,Stratified non-probability,BGI Genomics,ELISA,,99.00%,,,Journal Article (Peer-Reviewed),Lujain Alassaf,King Saud Bin Abdulaziz University for Health Sciences,https://dx.doi.org/10.7759/cureus.32419,2/8/2023,3/20/2023,Unverified
230317_UniversityOfTabuk_Tabuk,"March 17, 2023",Local,Saudi Arabia,SAU,,Tabuk,"September 1, 2020","December 31, 2020",Students and Daycares,Adults (18-64 years),175,38.90%,,,Unclear,Vircell S.L.,ELISA,"IgG,IgA",,,,Journal Article (Peer-Reviewed),Tarig M. S. Alnour,University of Tabuk,https://dx.doi.org/10.1371/journal.pone.0283197,4/12/2023,3/2/2024,Unverified
230915_Riyadh_KingSaudMedicalCity_Overall,"September 15, 2023",Local,Saudi Arabia,SAU,,Riyadh,"November 15, 2020","January 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,214,15.00%,,,Sequential,Siemens,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Sultan A. Almdallaleh,King Saud Medical City,https://dx.doi.org/10.15537/smj.2023.44.9.20230129,10/3/2023,3/2/2024,Unverified
200611_Russia_NationalCouncilCombatingCoronavirus_GenPop,"June 10, 2020",National,Russian Federation,RUS,,,"June 10, 2020","June 10, 2020",Household and community samples,Multiple groups,650000,14.00%,,,Unclear,NA,Not reported,Not reported,95.00%,98.00%,Moderate,News and Media,Sergei Kiselyov,Russian National Council for Combating Coronavirus,https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617,6/28/2020,12/13/2023,Verified
200626_Moscow_CityofMoscow,"June 26, 2020",Local,Russian Federation,RUS,Central Russia,Moscow,"June 5, 2020","June 18, 2020",Household and community samples,Multiple groups,90000,19.90%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Jonny Tickle,City of Moscow,https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA,8/1/2020,7/17/2022,Verified
201007_MinistryofHealthofRussianFederation_employees,"October 7, 2020",Local,Russian Federation,RUS,,Moscow,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),1589,8.90%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),LV Krechetova,Ministry of Health of Russia,http://dx.doi.org/10.18565/aig.2020.7.122-128,1/16/2021,7/17/2022,Verified
210205_Ekaterinburg_RussianAcademyOfSciences_overall,"February 5, 2021",Local,Russian Federation,RUS,,Ekaterinburg,"May 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),157,11.50%,,,Convenience,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),M Sarapultseva,Russian Academy of Sciences,https://dx.doi.org/10.1177/2380084421993099,2/21/2021,7/17/2022,Verified
200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall,"September 16, 2020",Regional,Russian Federation,RUS,Northwestern Federal District,,"June 23, 2020","June 26, 2020",Household and community samples,Multiple groups,3130,20.70%,,,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1371/1150#,3/12/2021,7/17/2022,Verified
201019_Irkutsk_SaintPetersburgPasteurResearchInstitute_Overall,"October 10, 2020",Regional,Russian Federation,RUS,Irkutsk Region,,"June 28, 2020","July 19, 2020",Household and community samples,Multiple groups,2674,5.80%,5.35%,6.25%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute,https://journal.microbe.ru/jour/article/view/1370/1149,3/15/2021,7/17/2022,Verified
200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall,"September 23, 2020",Local,Russian Federation,RUS,,Saint-Petersburg,"June 15, 2020","June 20, 2020",Household and community samples,Multiple groups,2713,26.00%,24.30%,27.70%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology,https://journal.microbe.ru/jour/article/view/1372/1151,3/20/2021,7/17/2022,Verified
201001_TyumenRegion_SaintPetersburgPasteurInstitute,"October 1, 2020",Regional,Russian Federation,RUS,Tyumen region,,"June 7, 2020","June 20, 2020",Household and community samples,Multiple groups,2758,24.50%,22.90%,26.10%,Simplified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/890/520,3/20/2021,7/17/2022,Verified
210119_Kaliningrad_RussianAcademyOfSciences_overall,"January 19, 2021",Regional,Russian Federation,RUS,Kaliningrad Region,,"August 3, 2020","August 7, 2020",Household and community samples,Multiple groups,2939,50.20%,49.03%,51.10%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),A Yu Popova,The Russian Academy of Sciences ,http://dx.doi.org/10.22625/2072-6732-2020-12-5-62-71,3/26/2021,7/17/2022,Verified
20201231_Moscow_MoscowResearchInstituteofEpidemiologyAndMicrobiology_Overall,"October 14, 2020",Regional,Russian Federation,RUS,Central Russia,Moscow Region,"June 22, 2020","July 11, 2020",Household and community samples,Multiple groups,2688,21.00%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),A Popova,Moscow Research Insistute of Epidemiology and Microbiology named after V.I G.N Gabrichevsky,http://dx.doi.org/10.20953/1729-9225-2020-4-17-26,4/27/2021,7/17/2022,Verified
210101_MurmanskRegion_StPetersburgPasteurInstitute_Overall,"January 1, 2021",Regional,Russian Federation,RUS,Murmansk Region,,"August 3, 2020","August 11, 2020",Household and community samples,Multiple groups,3117,31.20%,30.40%,32.00%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St. Petersburg Pasteur Institute,https://hiv.bmoc-spb.ru/jour/article/view/605#,5/6/2021,7/17/2022,Verified
201021_RepublicOfTartarstan_SaintPetersburgPasteurInstitute_overall,"October 21, 2020",Regional,Russian Federation,RUS,Republic of Tartarstan,,"September 20, 2020","September 27, 2020",Household and community samples,Multiple groups,2946,31.30%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Yu Popova,Saint Petersburg Pasteur Institute,https://microbiol.elpub.ru/jour/article/view/940?locale=en_US,5/19/2021,7/17/2022,Verified
201228_Moscow_SaintPetersburgPasteurInstitute_primary,"April 6, 2021",Local,Russian Federation,RUS,,Moscow,"July 1, 2020","July 30, 2020",Household and community samples,Multiple groups,2688,22.10%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Popova A Yu,Saint-Petersburg Pasteur Institute,http://dx.doi.org/10.20953/1729-9225-2020-4-8-16,5/20/2021,7/17/2022,Verified
210625_Ekaterinburg_DentalCollegeYamunanagar,"June 25, 2021",Local,Russian Federation,RUS,Ural,Ekaterinburg,"May 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),157,12.10%,,,Convenience,Vector BEST,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Neeraj Gugnani,Dental College Yamunanagar,https://dx.doi.org/10.1038/s41432-021-0171-5,7/6/2021,7/17/2022,Unverified
210629_StPetersburg_Saint-PetersburgStateUniversityHospital_overall,"June 29, 2021",Local,Russian Federation,RUS,,St. Petersburg,"May 27, 2020","March 19, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),180,15.56%,,,Unclear,EUROIMMUN,ELISA,IgA,,,Unclear,Journal Article (Peer-Reviewed),Andrei Ivanov,B.P.Konstantinov St Petersburg Nuclear Physics Institute,https://dx.doi.org/10.1002/jmv.27166,7/7/2021,3/2/2024,Verified
210609_Chelyabinsk_SouthUralStateUniversity_HighRisk_testadj,"June 9, 2021",Local,Russian Federation,RUS,,Chelyabinsk,"September 28, 2020","December 30, 2020",Health care workers and caregivers,Adults (18-64 years),1091,17.23%,17.17%,17.29%,Unclear,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alexandr Zurochka,South Ural State University,http://dx.doi.org/10.3390/vaccines9060627,7/7/2021,7/17/2022,Unverified
210819_RussianFederation_StPetersburgPasteurInstitute_Overall,"August 19, 2021",National,Russian Federation,RUS,,,"June 15, 2020","December 31, 2020",Household and community samples,Multiple groups,74158,19.20%,18.90%,19.50%,Unclear,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Anna Popova,Saint Petersburg Pasteur Institute,http://dx.doi.org/10.3390/v13081648,8/31/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_Overall,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Multiple groups,2728,9.10%,8.00%,10.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_1-6,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Children and Youth (0-17 years),55,10.90%,4.10%,16.90%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_7-13,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Children and Youth (0-17 years),151,8.60%,4.70%,14.30%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_14-17,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Children and Youth (0-17 years),182,17.60%,12.30%,23.90%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_18-29,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),399,5.50%,3.50%,8.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_30-39,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),388,4.90%,3.00%,8.00%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_40-49,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),391,9.70%,7.00%,13.10%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_50-59,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),409,7.60%,5.20%,10.60%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_60-69,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Multiple groups,376,8.00%,5.40%,11.20%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase1_70+,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Seniors (65+ years),377,14.80%,11.40%,18.80%,Stratified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
210831_Novosibirsk_StPetersburgPasteurInstitute_Phase2-Stage3_Overall,"August 31, 2021",Local,Russian Federation,RUS,,"Kochenyevsky, Krasnozyersky, Moshkovsky, Novosibirsk, Elitny Village, Toguchinsky Districts","June 28, 2020","July 15, 2020",Household and community samples,Multiple groups,1651,31.00%,28.80%,33.30%,Convenience,FBSI State scientific center for applied microbiology and biotechnology,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Popova,St Petersburg Pasteur Institute,https://dx.doi.org/10.36233/0507-4088-54,9/29/2021,7/17/2022,Unverified
211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_nonHCW,"October 31, 2021",Local,Russian Federation,RUS,Tatarstan,Kazan,"June 30, 2020","July 27, 2020",Essential non-healthcare workers,Adults (18-64 years),61,21.31%,,,Simplified probability,Vector BEST,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Irina Dmitrievna Reshetnikova,Scientific Research Institutes of Rospotrebnadzor,https://dx.doi.org/10.15789/2220-7619-SOT-1587,1/7/2022,7/17/2022,Unverified
211101_Kazan_ScientificResearchInstitutesofRospotrebnadzor_HCW,"October 31, 2021",Local,Russian Federation,RUS,Tatarstan,Kazan,"June 30, 2020","July 27, 2020",Health care workers and caregivers,Adults (18-64 years),60,46.67%,,,Simplified probability,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Irina Dmitrievna Reshetnikova,Scientific Research Institutes of Rospotrebnadzor,https://dx.doi.org/10.15789/2220-7619-SOT-1587,1/7/2022,7/17/2022,Unverified
210928_Moscow_RussianFederation,"September 28, 2021",Regional,Russian Federation,RUS,Central Russia,Moscow,"April 14, 2020","December 31, 2020",Health care workers and caregivers,Multiple groups,24373,22.10%,,,Unclear,Vector BEST,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,Russian Federation,https://dx.doi.org/10.20953/1729-9225-2021-3-5-13,1/23/2022,7/17/2022,Unverified
220122_Arkhangelsk_LondonSchoolofHygieneandTropicalMedicine_TestAdj,"January 22, 2022",Local,Russian Federation,RUS,,Arkhangelsk,"February 24, 2021","May 28, 2021",Household and community samples,Multiple groups,1067,72.60%,64.20%,83.10%,Convenience,Vector BEST,ELISA,IgG,89.00%,100.00%,High,Journal Article (Peer-Reviewed),Ekaterina Krieger,London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.3201/eid2802.211640,2/1/2022,7/17/2022,Unverified
220201_Moscow_InstituteofPreventiveMedicine_Overall,"February 1, 2022",Regional,Russian Federation,RUS,Central,Moscow,"August 1, 2019","August 31, 2021",Residual sera,Multiple groups,310,22.58%,,,Unclear,Mediagnost,ELISA,IgG,95.55%,98.36%,Unclear,Preprint,Nadezhda Gumanova,Institute of Preventive Medicine,https://www.researchsquare.com/article/rs-1308920/v1,2/11/2022,9/28/2022,Unverified
211227_Stavropol_StPetersburgResearchInstituteofEpidemiologyandMicrobiology_Round1_Overall,"December 27, 2021",Regional,Russian Federation,RUS,Stavropol Region,,"June 6, 2020","June 29, 2020",Household and community samples,Multiple groups,2683,9.80%,8.70%,10.90%,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),A Papova,Saint-Petersburg Research Institute of Epidemiology and Microbiology,https://dx.doi.org/10.22625/2072-6732-2021-13-4-79-89,2/11/2022,7/17/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_After1st_Primary,"February 12, 2022",Local,Russian Federation,RUS,,Moscow,"May 29, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),202,27.20%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,3/10/2022,7/17/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_2nd_Primary,"February 12, 2022",Local,Russian Federation,RUS,,Moscow,"October 1, 2020","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),202,17.80%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,3/10/2022,7/17/2022,Unverified
220212_Moscow_RussianMedicalAcademyOfContinuousProfessionalEducation_After2nd_Primary,"February 12, 2022",Local,Russian Federation,RUS,,Moscow,"February 1, 2021","May 30, 2021",Health care workers and caregivers,Adults (18-64 years),123,52.80%,,,Unclear,Vector BEST,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Vera S. Kichatova,Russian Medical Academy of Continuous Professional Education,https://dx.doi.org/10.3390/microorganisms10020429,3/10/2022,7/17/2022,Unverified
211227_Krasnodar_KubanStateMedicalUniversity_Round2_Overall_NeutAssay,"December 27, 2021",Local,Russian Federation,RUS,Krasnodar Kai,Krasnodar,"October 26, 2020","December 30, 2020",Household and community samples,Adults (18-64 years),806,35.50%,,,Convenience,Beckman Coulter,Neutralization,IgG,,,High,Journal Article (Peer-Reviewed),Vladimir Gorodin,Kuban State Medical University,https://dx.doi.org/10.20953/1729-9225-2021-4-98-102,4/22/2022,3/2/2024,Unverified
20220412_Moscow_MoscowInstituteofPhysicsandTechnology_Primary,"April 12, 2022",Local,Russian Federation,RUS,,"Moscow
","October 15, 2020","December 15, 2020",Blood donors,Multiple groups,5340,50.30%,,,Convenience,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,"IgG,IgM",,,High,Preprint,Ivan A. Molodtsov,Moscow Institute of Physics and Technology,https://dx.doi.org/10.1093/cid/ciac278,4/27/2022,7/17/2022,Unverified
220418_StPetersburg_SaintPetersburgPasteurInstitute_Stage5_antiRBD,"April 18, 2022",Local,Russian Federation,RUS,Saint Petersburg,Saint Petersburg,"August 30, 2021","September 3, 2021",Household and community samples,Multiple groups,1000,40.40%,37.30%,43.50%,Simplified probability,NA,ELISA,IgG,,,High,Preprint,Viacheslav Smirnov,Saint Petersburg Pasteur Institute,10.20944/preprints202204.0165.v1,4/28/2022,7/17/2022,Unverified
"221215_Saratov_RossiyskiyNauchno-Issledovatel'skiyProtivochumnyyInstitut""Mikrob""Rospotrebnadzora","February 28, 2022",Local,Russian Federation,RUS,Saratov Region,City of Saratov,"June 23, 2020","September 1, 2020",Residual sera,Multiple groups,129,63.60%,,,Convenience,Vector BEST,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Svetlana Portenko,Saratov City Clinical Hospital No. 10,https://dx.doi.org/10.15789/2220-7619-EPO-1747,6/4/2022,7/17/2022,Unverified
220530_SaintPetersburg_SaintPetersburgStateUniversityHospital,"May 30, 2022",Local,Russian Federation,RUS,Northwestern Federal District,St. Petersburg,"May 15, 2020","November 15, 2020",Household and community samples,Multiple groups,158283,16.70%,,,Sequential,"EUROIMMUN,Abbott Laboratories,Vector BEST,NA",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ekaterina V Parshina,Saint Petersburg State University Hospital,https://dx.doi.org/10.1007/s44197-022-00041-9,6/11/2022,3/2/2024,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round4_Overall_PopTestAdj,"June 15, 2022",Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,"February 15, 2021","April 4, 2021",Household and community samples,Multiple groups,1140,43.90%,39.70%,48.00%,Convenience,Genetico,ELISA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,6/30/2022,8/15/2023,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round2_Overall_PopTestAdj,"June 15, 2022",Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,"July 20, 2020","August 8, 2020",Household and community samples,Multiple groups,474,13.30%,9.90%,16.60%,Simplified probability,Genetico,ELISA,Total Antibody,92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,6/30/2022,8/15/2023,Unverified
220615_StPetersburg_SmorodintsevResearchInstituteofInfluenza_Round1_Overall_PopTestAdj,"June 15, 2022",Local,Russian Federation,RUS,Northwestern Region,Saint Petersburg,"May 25, 2020","June 28, 2020",Household and community samples,Multiple groups,988,9.70%,7.70%,11.70%,Simplified probability,Genetico,ELISA,Total Antibody,92.00%,100.00%,Low,Journal Article (Peer-Reviewed),Anton Barchuk,Smorodinova Research Institute of Influenza,https://dx.doi.org/10.1371/journal.pone.0266945,6/30/2022,8/15/2023,Unverified
220617_Russia_PasteurInstituteofEpidemiologyandMicrobiology_Overall_NorSProtein,"June 17, 2022",National,Russian Federation,RUS,"Astrakhan region, Belgorod region, Vladimir region
Irkutsk region, Krasnoyarsk region, Leningrad region, Moscow region, Nizhny Novgorod region, Novosibirsk region, Primorsky Krai, Republic of Crimea, Republic of Tatarstan, St. Petersburg, Saratov Region, Tula region, Khabarovsk region, Chelyabinsk region",,"December 1, 2021","December 31, 2021",Household and community samples,Children and Youth (0-17 years),3667,82.30%,,,Simplified probability,FBSI State scientific center for applied microbiology and biotechnology,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),A.Y. Popova,Pasteur Institute,https://dx.doi.org/10.24110/0031-403x-2022-101-3-85-97,8/25/2022,8/25/2022,Unverified
220926_SaintPetersburg_S.M.KirovMilitaryMedicalAcademy_Females,"September 26, 2022",Local,Russian Federation,RUS,,St Petersburg,"December 15, 2021","May 15, 2022",Students and Daycares,Children and Youth (0-17 years),75,62.30%,,,Stratified non-probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),E.V. Kryukov,S.M. Kirov Military Medical Academy,https://dx.doi.org/10.24110/0031-403X-2022-101-5-69-75,11/18/2022,11/18/2022,Unverified
220926_SaintPetersburg_S.M.KirovMilitaryMedicalAcademy_Males,"September 26, 2022",Local,Russian Federation,RUS,,St Petersburg,"December 15, 2021","May 15, 2022",Students and Daycares,Children and Youth (0-17 years),153,68.10%,,,Stratified non-probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),E.V. Kryukov,S.M. Kirov Military Medical Academy,https://dx.doi.org/10.24110/0031-403X-2022-101-5-69-75,11/18/2022,11/18/2022,Unverified
210504_Russia_FederalScientificResearchInstituteofEpidemiologyandMicrobiology_Phase3,"May 4, 2021",National,Russian Federation,RUS,,,"December 1, 2020","December 31, 2020",Household and community samples,Children and Youth (0-17 years),4838,47.42%,,,Stratified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),A.Y. Popova,Federal Scientific Research Institute of Epidemiology and Microbiology,https://dx.doi.org/10.24110/0031-403X-2021-100-3-97-106,12/17/2022,3/22/2023,Unverified
250315_Arkhangelsk_NorthernStateMedicalUniversity,"March 15, 2023",Local,Russian Federation,RUS,,Arkhangelsk,"February 24, 2021","June 30, 2021",Household and community samples,Multiple groups,1332,65.10%,62.50%,67.60%,Convenience,Vector BEST,ELISA,IgG,89.00%,100.00%,,Journal Article (Peer-Reviewed),Ekaterina Krieger,Northern State Medical University,https://dx.doi.org/10.1080/23744235.2023.2179660,4/12/2023,4/12/2023,Unverified
230101_Arkhangelsk_NorthernStateMedicalUniversity_2021May,"January 1, 2023",Regional,Russian Federation,RUS,Arkhangelsk,,"May 1, 2021","May 31, 2021",Health care workers and caregivers,Multiple groups,170,91.20%,,,Convenience,Vector BEST,ELISA,IgG,,,,Journal Article (Peer-Reviewed),E.A. Krieger,Northern State Medical University,https://dx.doi.org/10.22625/2072-6732-2023-15-2-93-104,9/19/2023,9/22/2023,Unverified
230101_Arkhangelsk_NorthernStateMedicalUniversity_2021Dec,"January 1, 2023",Regional,Russian Federation,RUS,Arkhangelsk,,"December 1, 2021","December 31, 2021",Health care workers and caregivers,Multiple groups,170,98.80%,,,Convenience,Vector BEST,ELISA,IgG,,,,Journal Article (Peer-Reviewed),E.A. Krieger,Northern State Medical University,https://dx.doi.org/10.22625/2072-6732-2023-15-2-93-104,9/22/2023,9/22/2023,Unverified
200424_Romania_MedLife_HCW,"April 24, 2020",National,Romania,ROU,"Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov","Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti","March 24, 2020","April 21, 2020",Health care workers and caregivers,Multiple groups,371,2.96%,,,Convenience,"Abbott Laboratories,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,Unclear,Institutional Report,MedLife,MedLife,https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a,6/28/2020,3/2/2024,Verified
210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj,"January 4, 2021",Local,Romania,ROU,,Bucharest,"May 17, 2020","December 1, 2020",Multiple populations,Adults (18-64 years),546,6.00%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",90.70%,98.60%,High,Preprint,Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://www.preprints.org/manuscript/202101.0024/v1,1/24/2021,3/2/2024,Verified
210107_Romania_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Romania,ROU,NR,NR,"May 14, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),124,0.81%,0.14%,4.30%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
210106_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall,"January 6, 2021",Local,Romania,ROU,,,"July 8, 2020","September 1, 2020",Blood donors,Adults (18-64 years),2115,1.51%,1.07%,2.13%,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Tudor Rares Olariu,Victor Babes University of Medicine and Pharmacy,http://dx.doi.org/10.1016/j.cmi.2020.12.027,3/19/2021,3/2/2024,Verified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_Patients_Unadj,"July 27, 2021",Local,Romania,ROU,,Bucharest,"May 17, 2020","December 1, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),516,6.80%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,8/3/2021,3/2/2024,Unverified
210727_Bucharest_CarolDavilaUniversityOfMedicineAndPharmacy_HCW_Unadj,"July 27, 2021",Local,Romania,ROU,,Bucharest,"May 17, 2020","December 1, 2020",Health care workers and caregivers,Adults (18-64 years),30,23.30%,,,Convenience,DiaSorin,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Corina Manolea,Carol Davila University of Medicine and Pharmacy,https://dx.doi.org/10.1093/hropen/hoab028,8/3/2021,3/2/2024,Unverified
211226_Timisoara_VictorBabesUniversityOfMedicineAndPharmacy_Overall,"December 26, 2021",Local,Romania,ROU,,,"March 10, 2021","June 10, 2021",Residual sera,Multiple groups,2443,45.60%,43.63%,47.58%,Sequential,Roche Diagnostics,Not reported,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Tudor Rares Olariu,Victor Babes University of Medicine and Pharmacy,https://dx.doi.org/10.3390/medicina58010035,2/3/2022,3/2/2024,Unverified
220211_TimisCounty_VictorBabesUniversityofMedicineandPharmacy_Overall,"February 11, 2022",Local,Romania,ROU,,,"July 2, 2021","September 2, 2021",Blood donors,Adults (18-64 years),2395,41.04%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Tudor Olariu,Victor Babes University of Medicine and Pharmacy,https://dx.doi.org/10.1080/23744235.2022.2036811,2/24/2022,3/2/2024,Verified
220406_TimisCounty_VictorBabesUniversityOfMedicineAndPharmacyTimisoara_Overall,"April 6, 2022",Local,Romania,ROU,,Timisoara,"March 10, 2021","June 10, 2021",Residual sera,Children and Youth (0-17 years),379,46.70%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Tudor Olariu,Victor Babes University of Medicine and Pharmacy Timisoara,https://dx.doi.org/10.1089/vbz.2022.0003,4/14/2022,3/2/2024,Verified
230517_Bucharest_CarolDavilaUniversity,"May 17, 2023",Local,Romania,ROU,,Bucharest,"April 1, 2021","April 30, 2022",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),158,23.30%,,,Convenience,NA,Not reported,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Anca Andreea Boboc,Carol Davila University,https://dx.doi.org/10.3390/ijms24108885,6/28/2023,7/4/2023,Unverified
200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total,"July 9, 2020",National,Republic of Korea,KOR,Korea,,"July 9, 2020","July 9, 2020",Household and community samples,Multiple groups,3055,0.03%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Ock Hyun-ju,Korea Centers for Disease Control and Prevention,https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw,8/1/2020,12/13/2023,Verified
200716_Daegu_DaeguCatholicUniversityHospital_Overall,"July 16, 2020",Local,Republic of Korea,KOR,North Gyeongsang,Daegu,"May 25, 2020","June 5, 2020",Multiple populations,Multiple groups,198,7.60%,,,Convenience,Shin Jin Medics Inc,LFIA,IgG,100.00%,92.00%,High,Journal Article (Peer-Reviewed),Suk-Kyoon Song,Daegu Catholic University Hospital,https://dx.doi.org/10.3346/jkms.2020.35.e269,9/26/2020,3/2/2024,Verified
200824_Seoul_KoreaUniversity_Overall,"August 24, 2020",Local,Republic of Korea,KOR,,Seoul,"May 25, 2020","May 29, 2020",Residual sera,Multiple groups,1500,0.07%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Ji Noh,Korea University,https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311,10/5/2020,3/2/2024,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1,"November 20, 2020",National,Republic of Korea,KOR,,,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),309,0.32%,,,Convenience,Vitrex Medical,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,3/2/2024,Verified
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1,"November 20, 2020",National,Republic of Korea,KOR,,,"April 26, 2020","May 9, 2020",Health care workers and caregivers,Adults (18-64 years),123,0.00%,,,Convenience,Vitrex Medical,ELISA,Total Antibody,98.20%,100.00%,High,Journal Article (Peer-Reviewed),Jae Hoon Ko,Sungkyunkwan University School of Medicine,https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,3/2/2024,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop,"November 23, 2020",National,Republic of Korea,KOR,,,"August 15, 2020","October 15, 2020",Household and community samples,Multiple groups,1379,0.22%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,7/17/2022,Verified
201123_Korea_KoreaDiseaseControlAndPreventionAgency_military,"November 23, 2020",National,Republic of Korea,KOR,,,"August 15, 2020","October 15, 2020",Essential non-healthcare workers,Adults (18-64 years),6900,0.36%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,KBS World,Korea Disease Control and Prevention Agency,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/8/2021,7/17/2022,Verified
210424_SouthKorea_KoreaAssociationofHealthPromotion_Primary,"April 24, 2021",National,Republic of Korea,KOR,N/A,"Seoul (Dongbu), Chuncheon, Chungju, Daegu (Dong-gu), Daegu (Buk-gu), Ulsan, Busan, Changwon, Kwangju, Jeonju, Daejeon, Suwon, Seoul (Kangnam), Incheon, Seoul (Seobu), Jeju ","September 24, 2020","December 9, 2020",Residual sera,Multiple groups,4085,0.39%,0.20%,0.58%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Eun Hee Nah,Korea Association of Health Promotion,https://bmjopen.bmj.com/content/11/4/e049837.abstract,5/18/2021,3/2/2024,Unverified
210428_ChungbukProvince_ChungbukNationalUniversity_NonEpicenter_OverallAdj,"April 28, 2021",Local,Republic of Korea,KOR,Chungbuk Province,,"May 1, 2020","July 17, 2020",Residual sera,Multiple groups,3981,0.91%,0.69%,1.13%,Simplified probability,NA,IFA,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/,5/18/2021,7/17/2022,Verified
210428_DaeguCity_ChungbukNationalUniversity_Epicenter_OverallAdj,"April 28, 2021",Local,Republic of Korea,KOR,North Gyeongsang Province,Daegu,"May 1, 2020","July 17, 2020",Residual sera,Multiple groups,3268,1.27%,1.01%,1.53%,Simplified probability,NA,IFA,IgG,99.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Hye Won Jeong,Chungbuk National University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079228/,5/18/2021,7/17/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_July1_overall,"May 24, 2021",National,Republic of Korea,KOR,,,"April 21, 2020","June 16, 2020",Residual sera,Multiple groups,1500,0.00%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/8/2021,7/17/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_November3_TestAdj,"May 24, 2021",National,Republic of Korea,KOR,,,"August 14, 2020","October 31, 2020",Residual sera,Multiple groups,1379,0.62%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/8/2021,7/17/2022,Verified
210524_SouthKorea_KoreaDiseaseControlAndPreventionAgency_September2,"May 24, 2021",National,Republic of Korea,KOR,,,"June 10, 2020","August 13, 2020",Residual sera,Multiple groups,1440,0.07%,,,Convenience,NA,Neutralization,Neutralizing ,93.30%,97.10%,High,Journal Article (Peer-Reviewed),Kwangmin Lee,Korea Disease Control and Prevention Agency,https://dx.doi.org/10.1007/s42952-021-00131-7,6/8/2021,7/17/2022,Verified
210630_Hwaseong_DongtanSacredHeartHospital,"June 30, 2021",Local,Republic of Korea,KOR,Gyeonggi,Hwaseong,"March 4, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),298,0.00%,,,Convenience,GenScript,Neutralization,"IgG,IgM,Neutralizing ",95.40%,90.80%,Moderate,Journal Article (Peer-Reviewed),Seri Jeong,Dongtan Sacred Heart Hospital,https://dx.doi.org/10.1128/JCM.01105-21,7/8/2021,3/2/2024,Unverified
211019_Daegu_KyungpookNationalUniversity_Overall,"October 19, 2021",Local,Republic of Korea,KOR,,Daegu,"January 18, 2021","February 26, 2021",Health care workers and caregivers,Multiple groups,2935,0.41%,,,Convenience,"Roche Diagnostics,NA,Abbott Laboratories,GenScript",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Yu Kim,Kyungpook National University,https://dx.doi.org/10.3346/jkms.2021.36.e294,11/16/2021,3/2/2024,Unverified
221230_Gyeonggi_HallymUniversityCollegeofMedicine_Overall,"December 30, 2021",Regional,Republic of Korea,KOR,Gyeonggi,,"March 1, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),228,0.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Seri Jeong,Hallym University College of Medicine,https://dx.doi.org/10.3390/diagnostics12010085,2/3/2022,3/2/2024,Unverified
220221_Korea_NationalInstituteofInfectiousDiseases_Overall,"February 21, 2022",National,Republic of Korea,KOR,,,"April 24, 2020","December 12, 2020",Residual sera,Multiple groups,5284,0.09%,,,Convenience,"Roche Diagnostics,Abbott Laboratories,Beckman Coulter,SG medical, Inc.,Sugentech, Inc.,NA",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Ah-Ra Kim,National Institute of Infectious Diseases,https://dx.doi.org/10.4178/epih.e2022028,3/8/2022,3/2/2024,Verified
220504_KoreanArmyTrainingCenter_InjeUniversity_Overall,"May 4, 2022",National,Republic of Korea,KOR,,,"September 1, 2020","November 30, 2020",Essential non-healthcare workers,Adults (18-64 years),9954,0.31%,,,Simplified probability,"Roche Diagnostics,Abbott Laboratories,Beckman Coulter,SG medical, Inc.,Sugentech, Inc.,NA",Multiple Types,"IgG,IgM,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Kwang Mun,Armed Force Medical Science Research Institute,https://dx.doi.org/10.12659/MSM.934926,5/11/2022,3/2/2024,Unverified
220923_Korea_KoreaCDC_Overall,"September 23, 2022",National,Republic of Korea,KOR,,,"August 8, 2022","September 6, 2022",Household and community samples,Multiple groups,9901,99.38%,,,Unclear,NA,Not reported,Not reported,,,High,Institutional Report,Korea Disease Control and Prevention Agency,Korea Centers for Disease Control and Prevention,http://ncov.kdca.go.kr/tcmBoardView.do?contSeq=372996,10/5/2022,10/5/2022,Unverified
220930_Seoul_SeoulNationalUniversity_overall_popadj,"September 30, 2022",Local,Republic of Korea,KOR,,"Gyeonggi-do, Seoul and Incheon","January 30, 2021","March 3, 2021",Residual sera,Multiple groups,4942,0.47%,0.31%,0.70%,Sequential,"GenScript,Roche Diagnostics",Multiple Types,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Kyuhyun Yoon,Seoul National University,https://dx.doi.org/10.4178/epih.e2022085,10/31/2022,4/15/2024,Verified
220906_Korea_TheCatholicUniversityofKorea,"September 6, 2022",National,Republic of Korea,KOR,,,"December 24, 2020","March 25, 2021",Household and community samples,Children and Youth (0-17 years),1866,0.11%,,,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Jin Lee, The Catholic University of Korea,https://dx.doi.org/10.3346/jkms.2022.37.e314,11/22/2022,4/11/2024,Verified
230817_SouthKorea_AjouUniviersitySchoolofMedicine_overall,"August 17, 2023",National,Republic of Korea,KOR,,,"August 12, 2022","September 5, 2022",Household and community samples,Multiple groups,9945,97.60%,97.20%,97.90%,Stratified probability,Roche Diagnostics,CLIA,Not reported,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jina Han,Ajou Univiersity School of Medicine,https://dx.doi.org/10.4178/epih.e2023075,9/21/2023,5/1/2024,Verified
201124_Qatar_MinistryofPublicHealth_Overall_popadj,"November 24, 2020",National,Qatar,QAT,,,"July 26, 2020","September 9, 2020",Non-essential workers and unemployed persons,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,95.00%,99.80%,Moderate,Preprint,Mohamed H Al Thani,Ministry of Public Health,https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1,1/24/2021,3/2/2024,Verified
210309_Qatar_HamadMedicalCorporation_MortuaryWorkers,"March 9, 2021",Local,Qatar,QAT,NR,NR,"September 17, 2020","September 17, 2020",Essential non-healthcare workers,Adults (18-64 years),32,25.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/16/2021,3/2/2024,Verified
210309_Qatar_HamadMedicalCorporation_CemetaryWorkers,"March 9, 2021",Local,Qatar,QAT,NR,NR,"September 1, 2020","September 1, 2020",Essential non-healthcare workers,Adults (18-64 years),64,34.38%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1016/j.ijid.2021.03.012,4/16/2021,3/2/2024,Verified
210501_Qatar_CornellUniversity,"May 1, 2021",National,Qatar,QAT,,,"June 21, 2020","September 9, 2020",Essential non-healthcare workers,Adults (18-64 years),4970,64.40%,63.00%,65.70%,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Andrew Jeremijenko,Cornell University ,https://wwwnc.cdc.gov/eid/article/27/5/20-4365_article,5/24/2021,3/2/2024,Unverified
210604_Qatar_CornellUniversity_Overall1,"June 4, 2021",National,Qatar,QAT,,,"July 26, 2020","September 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),394,46.50%,41.60%,51.40%,Convenience,"Shenzhen Mindray Bio-Medical Electronics Co.,Biomerieux,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Gheyath K Nasrallah,Cornell University,https://dx.doi.org/10.1038/s41598-021-91235-x,6/17/2021,3/2/2024,Verified
210502_Qatar_CornellUniversity_Primary,"May 2, 2021",National,Qatar,QAT,,,"July 26, 2020","September 9, 2020",Essential non-healthcare workers,Multiple groups,2641,55.30%,53.30%,57.30%,Stratified probability,Roche Diagnostics,CLIA,Not reported,,,Low,Journal Article (Peer-Reviewed),Mohamed Al-Thani,Cornell University,https://academic.oup.com/ofid/article/8/8/ofab221/6261968,9/8/2021,3/2/2024,Unverified
210930_Qatar_HamadMedicalCorporation_Primary,"September 30, 2021",National,Qatar,QAT,,,"March 1, 2020","October 31, 2020",Multiple populations,Multiple groups,12126,17.70%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,http://dx.doi.org/10.1371/journal.pone.0257845,10/14/2021,3/2/2024,Unverified
211019_Qatar_PrimaryHealthCareCorporation_Timepoint1,"October 19, 2021",National,Qatar,QAT,,,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,943,12.00%,,,Stratified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation (PHCC),https://journals.sagepub.com/doi/full/10.1177/21501327211050569,11/9/2021,7/17/2022,Verified
211019_Qatar_PrimaryHealthCareCorporation_Timepoint2,"October 19, 2021",National,Qatar,QAT,,,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,943,17.20%,,,Stratified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation (PHCC),https://journals.sagepub.com/doi/full/10.1177/21501327211050569,11/9/2021,7/17/2022,Verified
210523_Qatar_CornellUniversity_Overall_PopTestAdj,"May 23, 2021",National,Qatar,QAT,,,"May 12, 2020","September 9, 2020",Residual sera,Multiple groups,112941,14.80%,,,Sequential,Roche Diagnostics,CLIA,Not reported,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Peter Coyle,Cornell University,http://dx.doi.org/10.1016/j.isci.2021.102646,11/12/2021,8/15/2023,Verified
211111_Qatar_HamadMedicalCorporation_SchoolEnd,"November 11, 2021",Local,Qatar,QAT,,,"December 16, 2020","December 22, 2020",Essential non-healthcare workers,Adults (18-64 years),331,31.72%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,https://dx.doi.org/10.1186/s12889-021-12134-4,11/25/2021,3/2/2024,Unverified
220131_Qatar_CornellUniversity_RocheElecsys,"January 31, 2022",National,Qatar,QAT,,,"October 10, 2020","October 21, 2020",Residual sera,Multiple groups,709,71.93%,68.50%,75.20%,Convenience,Roche Diagnostics,CLIA,Not reported,89.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Peter Coyle,Cornell University,https://dx.doi.org/10.1371/journal.pone.0262897,2/11/2022,3/2/2024,Verified
220615_Qatar_PrimaryHealthCareCorporation_Primary,"June 15, 2022",National,Qatar,QAT,,,"July 1, 2020","July 31, 2020",Blood donors,Multiple groups,2044,9.05%,,,Simplified probability,Shenzhen Mindray Bio-Medical Electronics Co.,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mohamed Syed,Primary Health Care Corporation,https://dx.doi.org/10.1016/j.ijregi.2022.02.005,6/28/2022,7/17/2022,Unverified
220721_Qatar_HamadMedicalCorporation_Restricted_Overall,"July 21, 2022",National,Qatar,QAT,,,"March 17, 2020","September 10, 2020",Multiple populations,Adults (18-64 years),1636,5.13%,,,Sequential,Roche Diagnostics,CLIA,Not reported,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Moza Alishaq,Hamad Medical Corporation,https://dx.doi.org/10.2147/IDR.S360241,8/13/2022,8/26/2022,Unverified
201123_PuertoRico_PuertoRicoPublicHealthTrust_Primary,"November 23, 2020",National,Puerto Rico,PRI,,"Arecibo, Bayamón, Caguas, Fajardo,Mayagüez, Aguadilla, Metro / San Juan, Ponce","November 20, 2020","November 23, 2020",Household and community samples,Multiple groups,1816,2.80%,,,Stratified probability,NA,Not reported,"IgM,IgG",,,High,Institutional Report,Puerto Rico Public Health Trust,Puerto Rico Public Health Trust,https://sites.google.com/view/casperpr/análisis-y-resultados?authuser=0,5/22/2021,7/17/2022,Verified
200902_Lisbon_UniversityofLisbon_Overall,"September 2, 2020",Local,Portugal,PRT,Estremadura,Lisbon,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2571,1.50%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",94.74%,98.00%,Moderate,Preprint,Patricia Figueiredo Campos,University of Lisbon,https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1,10/20/2020,7/17/2022,Verified
201218_Lisbon_NovaUniversityofLisbon,"December 18, 2020",Local,Portugal,PRT,Lisboa Region,Lisbon,"June 15, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1636,3.05%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,Moderate,Journal Article (Peer-Reviewed),Juliana Goncalves,NOVA University of Lisbon,https://dx.doi.org/10.3389/fmed.2020.603996,1/24/2021,7/17/2022,Verified
210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj,"February 1, 2021",National,Portugal,PRT,"Norte Region, Centro Region, Lisboa Region, Alentejo Region, Algarve Region, Madeira, Azores",,"May 21, 2020","July 8, 2020",Residual sera,Multiple groups,2301,1.70%,0.00%,3.30%,Stratified non-probability,"EUROIMMUN,Beijing Wantai Biological",ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Irina Kislaya, Instituto Nacional de Saúde Doutor Ricardo Jorge,https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122,3/12/2021,8/15/2023,Verified
201021_UniversidadeDeLisboa_UniversidadeDeLisboa_overall,"October 21, 2020",Local,Portugal,PRT,,Lisbon,"May 13, 2020","July 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2715,2.60%,,,Convenience,NA,ELISA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Patricia Figueiredo Campos,Universidade de Lisboa,https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970,3/23/2021,7/17/2022,Verified
210426_Portugal_DepartmentofEpidemiologyandInfectiousDiseasesoftheNationalInstitutesofHealth,"April 26, 2021",National,Portugal,PRT,,,"February 2, 2021","March 31, 2021",Household and community samples,Multiple groups,8463,15.50%,,,Convenience,NA,Not reported,"IgG,IgM",,,Unclear,News and Media,Pedro Simas,Department of Epidemiology and Infectious Diseases of the National Institutes of Health (INSA),https://newsline.news/the-second-national-serological-survey-showed-that-15-5-of-the-portuguese-population-has-antibodies-against-sars-cov-2/,5/18/2021,7/17/2022,Verified
210428_Europe_SorbonneUniversité_3Centro,"April 28, 2021",Regional,Portugal,PRT,Região do Centro,,"July 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,526,1.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/31/2021,3/2/2024,Verified
210621_Portugal_LosAlamosNationalLaboratory_overall_PopAdj_TestAdj,"June 21, 2021",National,Portugal,PRT,,,"March 1, 2021","March 17, 2021",Household and community samples,Multiple groups,2435,17.30%,15.80%,18.80%,Stratified probability,Siemens,CLIA,Total Antibody,98.10%,99.90%,Moderate,Preprint,Luisa Canto e Castro,Los Alamos National Laboratory,https://europepmc.org/article/PPR/PPR359402,7/2/2021,8/15/2023,Verified
210630_Porto_UniversidadeDoPorto_primary,"June 30, 2021",Local,Portugal,PRT,Norte,Porto,"May 21, 2020","July 31, 2020",Essential non-healthcare workers,Multiple groups,4592,2.50%,0.10%,5.30%,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Paula Meireles, Universidade do Porto,https://dx.doi.org/10.1136/oemed-2021-107519,7/6/2021,8/15/2023,Verified
210616_Lisbon_ UniversidadeNOVAdeLisboa_primary,"June 16, 2021",Local,Portugal,PRT,,Lisbon,"June 15, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1624,3.10%,,,Convenience,NA,ELISA,IgG,94.74%,99.53%,High,Journal Article (Peer-Reviewed),David G. Lopes, Universidade NOVA de Lisboa,https://dx.doi.org/10.3389/fpubh.2021.689919,7/16/2021,7/17/2022,Unverified
211012_NortheastPortugal_FernandoPessoaUniversity_Overall,"October 12, 2021",National,Portugal,PRT,,,"April 15, 2020","February 15, 2021",Household and community samples,Multiple groups,358,30.45%,,,Self-referral,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mary Duro,Fernando Pessoa University,https://dx.doi.org/10.1007/s11845-021-02799-6,10/19/2021,3/2/2024,Verified
211018_Porto_UniversidadedoPorto,"October 18, 2021",Local,Portugal,PRT,Porto District,Porto,"November 27, 2020","January 29, 2021",Non-essential workers and unemployed persons,Multiple groups,1891,10.68%,,,Self-referral,SD Biosensor,Not reported,"IgG,IgM",94.50%,95.70%,Moderate,Preprint,Joana Costa,Universidade do Porto,10.1101/2021.10.14.21264980,10/28/2021,7/17/2022,Unverified
211130_Porto_CentroHospitalarUniversitáriodeSãoJoão,"November 30, 2021",Local,Portugal,PRT,Norte,Porto,"March 1, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),19,0.00%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Laura Leite-Almeida,Centro Hospitalar Universitário de São João,https://dx.doi.org/10.1080/2331205X.2021.2002558,1/18/2022,7/17/2022,Unverified
211130_SantaMariadaFeira_CHEDV,"November 30, 2021",Local,Portugal,PRT,Norte,Santa Maria da Feira,"April 1, 2020","May 31, 2021",Perinatal,Children and Youth (0-17 years),32,31.25%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Rosario Cunha,Centro Hospitalar de Entre Douro e Vouga,https://dx.doi.org/10.1080/2331205X.2021.2002558,1/18/2022,7/17/2022,Unverified
211217_Portugal_NationalInstituteofHealth_Primary,"December 17, 2021",National,Portugal,PRT,,,"September 28, 2021","November 19, 2021",Household and community samples,Multiple groups,4545,86.40%,85.20%,87.60%,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Institutional Report,ISN COVID-19 Group,National Institute of Health,http://repositorio.insa.pt/handle/10400.18/7828,1/27/2022,3/2/2024,Verified
220207_Porto_UniversidadedoPorto_FirstRound,"February 7, 2022",Local,Portugal,PRT,,Porto,"May 21, 2020","July 31, 2020",Non-essential workers and unemployed persons,Multiple groups,3628,4.10%,,,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,2/15/2022,3/2/2024,Unverified
220207_Porto_UniversidadedoPorto_SecondRound,"February 7, 2022",Local,Portugal,PRT,,Porto,"November 27, 2020","January 29, 2021",Non-essential workers and unemployed persons,Multiple groups,2661,13.20%,,,Convenience,SD Biosensor,IFA,"IgG,IgM",94.50%,95.70%,Moderate,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,2/15/2022,7/17/2022,Unverified
220207_Porto_UniversidadedoPorto_Cohort_Primary,"February 7, 2022",Local,Portugal,PRT,,Porto,"May 21, 2020","January 29, 2021",Non-essential workers and unemployed persons,Multiple groups,1891,10.70%,,,Convenience,SD Biosensor,Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Joana Costa,Universidade do Porto,https://dx.doi.org/10.1080/23744235.2022.2035429,2/15/2022,3/2/2024,Unverified
220207_PortoandMatosinhos_UniversityofPorto_Overall,"February 7, 2022",Local,Portugal,PRT,Norte,"Porto, Matosinhos","May 15, 2020","June 19, 2020",Essential non-healthcare workers,Adults (18-64 years),1696,2.95%,2.10%,3.70%,Convenience,SureScreen Diagnostics,Not reported,"IgG,IgM",96.60%,99.70%,Moderate,Journal Article (Peer-Reviewed),Nuno Ferreira,University of Porto,https://dx.doi.org/10.13075/ijomeh.1896.01878,2/18/2022,3/2/2024,Unverified
220221_Lisboa_HospitalDaLuzLisboa_Visit2_Overall,"February 21, 2022",Local,Portugal,PRT,,Lisbon,"June 6, 2020","July 14, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,72,2.78%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Goncalo Fernandes,Hospital da Luz Lisboa,https://www.cureus.com/articles/82283-sars-cov-2-antibody-seroprevalence-in-patients-with-cancer-on-systemic-antineoplastic-treatment-in-the-first-wave-of-the-covid-19-pandemic-in-portugal,3/9/2022,3/2/2024,Unverified
220511_CentroHospitalareUniversitáriodeCoimbra_UniversityofCoimbra,"May 11, 2022",Local,Portugal,PRT,Coimbra,Coimbra,"December 15, 2020","March 4, 2021",Health care workers and caregivers,Adults (18-64 years),2968,2.12%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.37%,99.55%,Moderate,Journal Article (Peer-Reviewed),Joana Oliveira-Silva,University of Coimbra,https://dx.doi.org/10.1016/j.ijid.2022.05.026,6/5/2022,3/2/2024,Unverified
220617_Portugal_CentroHospitalareUniversitariodeSaoJoao_Overall,"June 17, 2022",National,Portugal,PRT,,,"April 9, 2020","May 30, 2020",Health care workers and caregivers,Adults (18-64 years),1027,2.70%,,,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,Bio-rad",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Angelica Ramos,Centro Hospitalar e Universitario de Sao Joao,https://dx.doi.org/10.1097/j.pbj.0000000000000166,7/13/2022,3/2/2024,Unverified
220601_VilaNovadeGaia_OrdemdosMédicosPortugueses_Overall_PopAdj,"June 1, 2022",Local,Portugal,PRT,,,"June 23, 2020","July 17, 2020",Household and community samples,Multiple groups,2754,3.03%,2.37%,3.87%,Stratified non-probability,DiaSorin,CLIA,IgG,98.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Alvaro Carvalho,Ordem dos Médicos Portugueses,https://dx.doi.org/10.20344/amp.17676,7/26/2022,3/2/2024,Unverified
221020_UniversityofPorto_UniversityofPorto_Overall_TestAdj,"October 20, 2022",Local,Portugal,PRT,,Porto,"September 24, 2020","December 15, 2020",Students and Daycares,Multiple groups,6512,7.90%,4.90%,11.10%,Convenience,"SD Biosensor,Qingdao Hightop Biotech Co. Ltd ,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Paula Meireles,University of Porto,https://dx.doi.org/10.3389/ijph.2022.1604548,11/15/2022,8/15/2023,Unverified
230202_Portugal_InstitutoNacionaldeSaúdeDoutorRicardo,"February 2, 2023",National,Portugal,PRT,,,"April 27, 2022","June 8, 2022",Residual sera,Multiple groups,3825,95.80%,95.00%,96.40%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Irina Kislaya,Instituto Nacional de Saúde Doutor Ricardo,https://dx.doi.org/10.3201/eid2903.221546,3/9/2023,4/6/2024,Verified
221026_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Overall_Anti-S,"October 26, 2022",National,Portugal,PRT,,,"September 28, 2021","November 19, 2021",Residual sera,Multiple groups,4545,86.40%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Irina Kislaya,Instituto Nacional de Saúde Doutor Ricardo Jorge,https://dx.doi.org/10.20344/amp.18528,5/9/2023,3/2/2024,Unverified
201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall,"October 11, 2020",Regional,Poland,POL,Mazowieckie Province,,"June 22, 2020","July 8, 2020",Essential non-healthcare workers,Multiple groups,5082,4.30%,3.70%,4.90%,Stratified probability,Vircell S.L.,ELISA,IgG,97.00%,94.00%,Moderate,Journal Article (Peer-Reviewed),Mariusz Gujski,Medical University of Warsaw,http://dx.doi.org/10.3390/jcm9103245,1/30/2021,3/2/2024,Verified
210205_Poland_CentralClinicalHospital_IBDPatients_IgG,"February 5, 2021",National,Poland,POL,,,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,432,4.60%,,,Sequential,Vircell S.L.,ELISA,IgG,88.00%,99.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/23/2021,3/2/2024,Verified
210205_Poland_CentralClinicalHospital_HCWs_IgG,"February 5, 2021",National,Poland,POL,,,"May 1, 2020","June 15, 2020",Health care workers and caregivers,Multiple groups,432,1.60%,,,Stratified non-probability,Vircell S.L.,ELISA,IgG,85.00%,98.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,https://dx.doi.org/10.20452/pamw.15796,2/23/2021,3/2/2024,Verified
201222_Warsaw_CentralClinicalHospitalMSWiA,"December 22, 2020",Local,Poland,POL,,Warsaw,"April 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),61,16.39%,,,Sequential,Vircell S.L.,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Piotr Ciechanowicz,Central ClinicalHospital MSWiA,https://dx.doi.org/10.1080/09546634.2020.1861177,3/8/2021,3/2/2024,Verified
210401_Warsaw_Children’sMemorialHealthInstitute_HCW,"April 1, 2021",Local,Poland,POL,,Warsaw,"July 1, 2020","August 9, 2020",Health care workers and caregivers,Adults (18-64 years),1879,0.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Beata Kasztelewicz,Children’s Memorial Health Institute,https://dx.doi.org/10.1371/journal.pone.0249550,5/3/2021,3/2/2024,Unverified
210331_Poznań_PolishAcademyofSciences_Primary,"March 31, 2021",Local,Poland,POL,Greater Poland,Poznań,"July 15, 2020","September 15, 2020",Household and community samples,Multiple groups,1500,0.93%,0.56%,1.56%,Simplified probability,"EUROIMMUN,Polycheck",Multiple Types,IgG,,,Moderate,Preprint,Dagny Lorent,Polish Academy of Sciences,https://www.medrxiv.org/content/10.1101/2021.03.29.21254544v1.full,5/15/2021,3/2/2024,Verified
210317_SilesianVoivodeship_JanKochanowskiUniversity,"March 17, 2021",Regional,Poland,POL,Silesian Voivodeship,,"May 15, 2020","June 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),516,1.94%,,,Convenience,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Rafal Krygier, Jan Kochanowski University,https://dx.doi.org/10.13075/ijomeh.1896.01756,5/19/2021,3/1/2024,Verified
210419_Lublin_MedicalUniversityofLublin_JIA,"April 19, 2021",Local,Poland,POL,Lublin Voivodeship,Lublin,"June 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),62,4.80%,,,Sequential,EUROIMMUN,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,5/20/2021,3/2/2024,Verified
210419_Lublin_MedicalUniversityofLublin_HealthyControls,"April 19, 2021",Local,Poland,POL,Lublin Voivodeship,Lublin,"June 1, 2020","September 30, 2020",Household and community samples,Children and Youth (0-17 years),32,6.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,91.90%,High,Journal Article (Peer-Reviewed),Violetta Opoka Winiarska ,Medical University of Lublin,https://dx.doi.org/10.3390/jcm10081771,5/20/2021,3/2/2024,Verified
210420_Bytom1_UniversityofOpole,"April 20, 2021",Local,Poland,POL,Silesian,Bytom,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),90,10.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,3/2/2024,Unverified
210420_MiasteczkoSlaskie2_UniversityofOpole,"April 20, 2021",Local,Poland,POL,Silesian,Miasteczko Slaskie,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),25,4.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,3/2/2024,Unverified
210420_Opole3_UniversityofOpole,"April 20, 2021",Local,Poland,POL,Opole,Opole,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),84,1.19%,,,Convenience,EUROIMMUN,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Rafal Jakub Buldak,University of Opole,https://dx.doi.org/10.3390/ijerph18084376,5/21/2021,3/2/2024,Unverified
210415_Poland_MedicalUniversityOfSilesiaInKatowice_Overall,"April 21, 2021",Regional,Poland,POL,Silesian Voivodeship,"Katowice, Gliwice, Sosnowiec","October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,5479,22.90%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Małgorzata Kowalska,Medical University of SilesiaIn Katowice,https://dx.doi.org/10.3390/vaccines9050415,5/29/2021,3/2/2024,Verified
210608_Warsaw_CentralClinicalHospitalOfTheMinistryOfInterior,"June 8, 2021",Local,Poland,POL,Mazovia,Warsaw,"April 21, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),1572,22.70%,,,Convenience,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Radosław Rzeplinski,Central Clinical Hospital of the Ministry of Interior and Administration,https://dx.doi.org/10.20452/pamw.16025,6/20/2021,7/17/2022,Unverified
210820_Poland_CentralClinicalHospitaloftheMinistryoftheInteriorandAdministration,"August 20, 2021",National,Poland,POL,"Masovian Voivodeship, Greater Poland Voivodeship, Łódź Voivodeship","Warsaw, Poznań, Łódź","May 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,473,9.30%,,,Unclear,Vircell S.L.,ELISA,IgG,88.00%,99.00%,High,Journal Article (Peer-Reviewed),Michal Lodyga,Central Clinical Hospital of the Ministry of the Interior and Administration,http://dx.doi.org/10.3390/jcm10163689,9/1/2021,3/2/2024,Unverified
211109_Poland_SlaskiUniwersytetMedyczny_Primary,"November 9, 2021",Local,Poland,POL,,"Katowice, Gliwice and Sosnowiec","October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,1167,11.40%,9.50%,13.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jan Zejda,Slaski Uniwersytet Medyczny,https://dx.doi.org/10.13075/mp.5893.01179,11/19/2021,3/2/2024,Verified
210527_Krakow_JagiellonianUniversityMedicalCollege_Primary,"May 27, 2021",Local,Poland,POL,,Kraskow,"March 4, 2020","March 3, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),62,30.60%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ruth Sladek,Jagiellonian University Medical College,https://academic.oup.com/ecco-jcc/article/15/Supplement_1/S372/6286668,11/24/2021,3/2/2024,Unverified
211127_Bydgoszcz_NicolausCopernicusUniversity_OverallIgG,"November 27, 2021",Local,Poland,POL,Kuyavian-Pomeranian,Bydgoszcz,"July 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),120,0.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Joanna Kwiecinska-Pirog,Nicolaus Copernicus University,https://dx.doi.org/10.3390/vaccines9121402,1/4/2022,7/17/2022,Unverified
211130_Lublin_MedicalUniversityofLublin_JIA,"November 30, 2021",Local,Poland,POL,Lublin,Lublin,"January 10, 2021","May 30, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),65,29.20%,,,Convenience,NA,ELISA,IgA,,,High,Presentation or Conference,Izabela Morawska,Medical University of Lublin,https://dx.doi.org/10.1080/2331205X.2021.2002558,1/19/2022,7/17/2022,Unverified
211130_Lublin_MedicalUniversityofLublin_HC,"November 30, 2021",Local,Poland,POL,Lublin,Lublin,"January 10, 2021","May 30, 2021",Residual sera,Children and Youth (0-17 years),31,6.50%,,,Convenience,NA,ELISA,IgA,,,High,Presentation or Conference,Izabela Morawska,Medical University of Lublin,https://dx.doi.org/10.1080/2331205X.2021.2002558,1/19/2022,7/17/2022,Unverified
220110_Wrocław_WroclawMedicalUniversity,"January 10, 2022",Local,Poland,POL,Silesia,Wrocław,"March 15, 2021","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,93,25.00%,,,Convenience,Abbott Laboratories,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Maciej Majcherek ,Wroclaw Medical University ,https://dx.doi.org/10.3390/cancers14020325,1/20/2022,3/2/2024,Unverified
220217_Lublin_MedicalUniversityofLublin_May2020_Overall,"February 17, 2022",Local,Poland,POL,,Lublin,"May 5, 2020","May 25, 2020",Health care workers and caregivers,Multiple groups,208,7.20%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Izabela Korona-Głowniak,Medical University of Lublin,https://dx.doi.org/10.3390/ijerph19042319,3/3/2022,3/2/2024,Unverified
220217_Lublin_MedicalUniversityofLublin_Dec2020_Overall,"February 17, 2022",Local,Poland,POL,,Lublin,"December 4, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),179,48.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Izabela Korona-Głowniak,Medical University of Lublin,https://dx.doi.org/10.3390/ijerph19042319,3/3/2022,3/2/2024,Unverified
220210_Wroclaw_WroclawMedicalUniversity_Dentists,"February 10, 2022",Local,Poland,POL,,Wroclaw,"September 28, 2020","November 19, 2020",Health care workers and caregivers,Adults (18-64 years),67,6.00%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,3/15/2022,7/17/2022,Unverified
220210_Wroclaw_WroclawMedicalUniversity_ChairsideAssistants,"February 10, 2022",Local,Poland,POL,,Wroclaw,"September 28, 2020","November 19, 2020",Health care workers and caregivers,Adults (18-64 years),40,7.50%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,3/15/2022,7/17/2022,Unverified
220210_Wroclaw_WroclawMedicalUniversity_AdministrativeWorkers,"February 10, 2022",Local,Poland,POL,,Wroclaw,"September 28, 2020","November 19, 2020",Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,Demeditec,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Irena Dus-Ilnicka,Wroclaw Medical University,https://dx.doi.org/10.1016/j.identj.2022.02.003,3/15/2022,7/17/2022,Unverified
220317_Poland_NationalResearchInstitute_Primary,"March 17, 2022",National,Poland,POL,"Pomorskie voivodeship, Mazowieckie voivodeship, Wielkopolskie voivodeship","Gdańsk, Wejherowo, Warsaw, Grójec, Krotoszyn","December 1, 2020","December 23, 2020",Health care workers and caregivers,Multiple groups,1040,25.20%,22.60%,27.90%,Self-referral,"Nanjing Vazyme Medical Technology Co. Ltd,NovaTec Immundiagnostics GmbH",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Magdalena Rosiska,National Research Institute,https://dx.doi.org/10.13075/mp.5893.01216,3/30/2022,3/2/2024,Unverified
220323_Wroclaw_RegionalSpecializedHospitalinWroclaw_Overall,"March 23, 2022",Local,Poland,POL,Lower Silesian Voivodeship,Wroclaw,"December 11, 2021","December 11, 2021",Household and community samples,Multiple groups,38,28.95%,,,Convenience,TestLine Clinical Diagnostics,Not reported,IgG,,,High,Preprint,Alina Szewczyk-Dabrowska,Regional Specialized Hospital in Wroclaw,https://www.medrxiv.org/content/10.1101/2022.03.20.22272651v1.full-text,3/31/2022,7/17/2022,Unverified
220329_Krakow_UniversityHospitalinKrakow_Overall,"March 29, 2022",Local,Poland,POL,,Krakow,"January 4, 2021","January 19, 2021",Health care workers and caregivers,Adults (18-64 years),1221,42.67%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",89.50%,99.06%,High,Journal Article (Peer-Reviewed),Barbara Zoltowska,University Hospital in Krakow,https://dx.doi.org/10.3390/ijerph19074044,4/5/2022,3/2/2024,Unverified
220405_Silesia_MedicalUniversityofSilesia,"April 5, 2022",Regional,Poland,POL,Silesia,,"October 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),575,19.10%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marek Wojczyk,Medical University of Silesia,https://dx.doi.org/10.13075/mp.5893.01221,4/13/2022,3/2/2024,Unverified
220316_Zabrze_MedicalUniversityofSilesia_Overall,"March 16, 2022",Local,Poland,POL,Silesia,Zabrze,"February 15, 2021","September 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,371,73.60%,,,Sequential,Roche Diagnostics,CLIA,Not reported,84.00%,100.00%,High,Journal Article (Peer-Reviewed),Agnieszka Kuczaj,Medical University of Silesia,https://dx.doi.org/10.1016/j.transproceed.2022.02.044,4/22/2022,3/2/2024,Unverified
220430_Poland_WroclawMedicalUniversity_Primary,"April 30, 2022",Local,Poland,POL,,,"November 15, 2020","February 10, 2021",Health care workers and caregivers,Multiple groups,344,34.60%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Ewa Morgiel,Wroclaw Medical University,https://dx.doi.org/10.3390/vaccines10050710,6/6/2022,3/2/2024,Unverified
220701_Bydgoszcz_VoivodeshipInfectiousObservationHospital,"July 1, 2022",Local,Poland,POL,,Bydgoszcz,"June 1, 2021","April 30, 2022",Residual sera,Multiple groups,686,57.00%,,,Unclear,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Justyna Franczak,Voivodeship Infectious Observation Hospital,https://dx.doi.org/10.3390/jcm11133819,7/13/2022,3/2/2024,Unverified
220719_Lodz_PolishMother'sMemorialHospital,"July 19, 2022",Local,Poland,POL,,Lodz,"September 15, 2020","May 15, 2021",Residual sera,Multiple groups,38,55.00%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,Anna Mazurek Kula,"Cardiology Department, Polish Mother’s Memorial Hospital Research Institute",https://dx.doi.org/10.1017/S1047951122001950,10/19/2022,10/19/2022,Unverified
220920_Poland_InstituteofBioorganicChemistryPolishAcademyofSciences_Wave1,"September 20, 2022",Regional,Poland,POL,the Greater Poland Region,"Poznan, Wrzesnia","September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),90,0.00%,0.00%,4.09%,Self-referral,"EUROIMMUN,NA",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dagny Lorent,Institute of Bioorganic Chemistry Polish Academy of Sciences,https://dx.doi.org/10.3390/vaccines10101576,11/17/2022,3/2/2024,Unverified
221102_Wroclaw_SilesianCenterOfOncology_Overall,"November 2, 2022",Local,Poland,POL,,Wroclaw,"December 15, 2020","September 15, 2021",Residual sera,Multiple groups,83,46.99%,,,Convenience,NA,Not reported,IgG,,,,Presentation or Conference,E. Jaskula,Silesian Center of Oncology,https://dx.doi.org/10.1038/s41409-022-01798-0,12/14/2022,3/22/2023,Unverified
221124_Bialystok_MedicalUniversityofBialystok_GroupVisit1_IgG-s_Primary,"November 24, 2022",Local,Poland,POL,,Bialystok,"May 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),186,3.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Joanna Kulikowska,Medical University of Bialystok,https://dx.doi.org/10.5603/PJNNS.a2022.0067,12/16/2022,3/2/2024,Unverified
221124_Bialystok_MedicalUniversityofBialystok_GroupVisit2_IgG-s_Primary,"November 24, 2022",Local,Poland,POL,,Bialystok,"May 15, 2021","June 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),88,71.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Joanna Kulikowska,Medical University of Bialystok,https://dx.doi.org/10.5603/PJNNS.a2022.0067,12/16/2022,3/2/2024,Unverified
230105_Krakow_JagiellonianUniversityMedicalCollege,"January 5, 2023",Local,Poland,POL,,Krakow,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),676,41.10%,,,Convenience,Roche Diagnostics,CLIA,,,,,Journal Article (Peer-Reviewed),Izabella Owsianka,Jagiellonian University Medical College,https://dx.doi.org/10.3389/fimmu.2022.1071204,2/9/2023,3/2/2024,Unverified
230831_Poland_NIPHNIH–NRI_antiS,"August 31, 2023",National,Poland,POL,,,"March 19, 2021","May 14, 2021",Household and community samples,Multiple groups,5892,54.40%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Michał Czerwinski,National Institute of Public Health NIH–National Research Institute,https://dx.doi.org/10.2807/1560-7917.ES.2023.28.35.2200745,9/21/2023,5/1/2024,Verified
230831_Poland_NIPHNIH–NRI_antiN,"August 31, 2023",National,Poland,POL,,,"March 19, 2021","May 14, 2021",Household and community samples,Multiple groups,5892,31.60%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Michał Czerwinski,National Institute of Public Health NIH–National Research Institute,https://dx.doi.org/10.2807/1560-7917.ES.2023.28.35.2200745,9/21/2023,5/1/2024,Verified
220101_SanLazaroHospital_NagasakiUniversity_OverallTestAdjusted,"January 1, 2022",Regional,Philippines,PHL,National Capital Region,Manila,"March 8, 2021","April 24, 2021",Health care workers and caregivers,Multiple groups,525,36.00%,30.00%,38.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Nimfa Putong,Nagasaki University,https://dx.doi.org/10.1016/j.lanwpc.2021.100353,1/19/2022,8/15/2023,Unverified
220427_Manila_AteneoDeManilaUniversity_Overall,"April 27, 2022",Local,Philippines,PHL,,Manila,"June 15, 2021","December 15, 2021",Multiple populations,Multiple groups,1318,47.80%,,,Convenience,Roche Diagnostics,LFIA,IgG,92.00%,100.00%,High,Preprint,Lourdes Bernadette Sumpaico-Tanchanco,Ateneo de Manila University,https://dx.doi.org/10.1101/2022.04.25.22274280,9/16/2022,9/23/2022,Unverified
221011_Manila_NagasakiUniversity_Overall,"October 11, 2022",Local,Philippines,PHL,,Manila,"May 29, 2020","March 23, 2021",Residual sera,Multiple groups,615,39.35%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Greco Mark Malijan,Nagasaki University,https://dx.doi.org/10.1186/s41182-022-00468-7,10/21/2022,10/21/2022,Unverified
221109_Bohol_Gov.CelestinoGallaresMemorialHospital,"November 9, 2022",Local,Philippines,PHL,,Bohol,"July 1, 2020","May 31, 2021",Household and community samples,Multiple groups,4138,4.45%,,,Unclear,NA,CLIA,Not reported,,,,Journal Article (Peer-Reviewed),A L Salillas,Gov. Celestino Gallares Memorial Hospital,https://dx.doi.org/10.1093/ajcp/aqac126.304,2/10/2023,3/20/2023,Unverified
200726_Peru_NationalCenterforEpidemiology_Overall,"July 27, 2020",Local,Peru,PER,"Lima, Callao","Lima, Callao","June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3118,21.60%,18.70%,24.60%,Stratified probability,NA,LFIA,"IgG,IgM",40.00%,,High,News and Media,Peruvian Government,"National Center for Epidemiology, Prevention and Control of Diseases",https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/,10/21/2020,7/17/2022,Verified
210120_Iquitos_DIRESA_1monthFollowUp_overall_adj,"January 20, 2021",Local,Peru,PER,Loreto,Iquitos,"August 13, 2020","August 18, 2020",Household and community samples,Multiple groups,621,66.00%,62.00%,70.10%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Carlos Alvarez-Antonio,Universidad de Ingeniería y Tecnología,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/12/2021,7/5/2023,Verified
210331_Lima_PeruvianMinistryOfHealth_Overall_PopAdj_TestAdj,"March 31, 2021",Local,Peru,PER,Lima and Callao,Lima metropolitan area,"June 28, 2020","July 9, 2020",Household and community samples,Multiple groups,3212,20.80%,17.20%,23.50%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",96.94%,96.23%,Low,Journal Article (Peer-Reviewed),Mary F Reyes Vega,Peruvian Ministry of Health,https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00081-X/fulltext#%20,4/11/2021,8/15/2023,Verified
210312_Lima_InstitutoNacionalDeSalud_Overall,"March 12, 2021",Local,Peru,PER,,Lima,"April 23, 2020","May 2, 2020",Contacts of COVID patients,Multiple groups,236,53.00%,,,Stratified non-probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Yolanda Angulo Bazan,Instituto Nacional de Salud,https://dx.doi.org/10.1590/0102-311X00238720,5/12/2021,3/2/2024,Verified
200808_Lima_NationalMaternalPerinatalInstitute_overall,"August 8, 2020",Local,Peru,PER,Lima Province,Lima,"April 15, 2020","May 15, 2020",Pregnant or parturient women,Adults (18-64 years),2419,7.00%,6.10%,8.10%,Sequential,NA,LFIA,"IgG,IgM",97.60%,98.80%,Moderate,Journal Article (Peer-Reviewed),Enrique Guevara Rios,"National Maternal Perinatal
Institut",http://www.scielo.org.pe/scielo.php?pid=S2304-51322020000300002&script=sci_abstract&tlng=en,5/19/2021,7/17/2022,Verified
210406_Lambayeque_UniversidadParticulardeChiclayo_PopTestAdj,"April 6, 2021",Regional,Peru,PER,Lambayeque Province,,"June 24, 2020","July 10, 2020",Household and community samples,Multiple groups,2010,29.50%,27.60%,31.50%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",66.00%,97.00%,Low,Journal Article (Peer-Reviewed),Cristian Diaz Velez,Universidad Particular de Chiclayo,https://dx.doi.org/10.7717/peerj.11210,5/19/2021,8/15/2023,Verified
210421_Lima_HarvardMedicalSchool_Market1,"April 21, 2021",Local,Peru,PER,Lima Province,Lima,"June 5, 2020","July 18, 2020",Essential non-healthcare workers,Adults (18-64 years),1285,45.00%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,5/21/2021,3/2/2024,Unverified
210421_Lima_HarvardMedicalSchool_BusDepot2,"April 21, 2021",Local,Peru,PER,Lima Province,Lima,"June 5, 2020","July 18, 2020",Essential non-healthcare workers,Adults (18-64 years),477,36.33%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",90.00%,99.00%,High,Journal Article (Peer-Reviewed),Marco Tovar,Harvard Medical School,https://dx.doi.org/10.1093/cid/ciab323,5/21/2021,3/2/2024,Unverified
200901_Loreto_HospitalRegionaldeLoreto_primary,"September 1, 2020",Local,Peru,PER,,Loreto,"May 19, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),1147,58.30%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricci Alonso Chafloque Vasquez,Hospital Regional de Loreto,https://amp.cmp.org.pe/index.php/AMP/article/view/1050,5/22/2021,7/17/2022,Verified
210901_LimaPeru_HospitalNacionalDocenteMadreNinoSanBartolome_primary,"September 1, 2020",Local,Peru,PER,,Lima,"April 15, 2020","July 15, 2020",Pregnant or parturient women,Adults (18-64 years),1869,18.50%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Edy Martin Vera Loyola,Hospital Nacional Docente Madre Nino San Bartolome ,http://www.spog.org.pe/web/revista/index.php/RPGO/article/download/2265/pdf,6/7/2021,7/17/2022,Verified
210701_LaRinconada_GrenobleAlpesUniversity_overall,"July 1, 2021",Local,Peru,PER,Puno,La Riconanda,"October 11, 2020","October 18, 2020",Household and community samples,Multiple groups,159,48.40%,40.50%,56.40%,Sequential,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Benoit Champigneulle,Grenoble Alpes University,http://dx.doi.org/10.1089/ham.2021.0020,7/30/2021,3/2/2024,Verified
210920_Peru_UniversidadAndinadelCusco_OverallPopAdj,"September 20, 2021",Regional,Peru,PER,Cusco Region,,"September 12, 2020","September 27, 2020",Household and community samples,Multiple groups,1924,33.10%,30.10%,36.40%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,96.70%,98.60%,Low,Journal Article (Peer-Reviewed),Charles Huamani,Universidad Andina del Cusco,http://dx.doi.org/10.7717/peerj.12149,10/5/2021,3/2/2024,Verified
211023_Peru_GermanCentreforInfectionResearch_CLIAandNeutralization,"October 23, 2021",Regional,Peru,PER,San Martin,,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,563,58.97%,55.00%,63.00%,Simplified probability,"GenScript,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,Neutralizing ",,,Moderate,Preprint,Andres Moreira-Soto,German Centre for Infection Research,https://www.medrxiv.org/content/10.1101/2021.10.19.21265219v1.full-text,11/5/2021,3/2/2024,Verified
211215_Lima_InstitutoNacionalMaternoPerinatal,"December 15, 2021",Local,Peru,PER,,Lima,"June 1, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),4733,31.40%,,,Sequential,Celer Technologies Inc.,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Carmen Davila-Aliaga,Instituto Nacional Materno Perinatal,https://dx.doi.org/10.5867/medwave.2021.11.002141,12/23/2021,3/2/2024,Unverified
211223_Lima_UniversidadPeruanaCayetanoHeredia,"January 1, 2022",Local,Peru,PER,Lima,Lima,"August 1, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),440,37.50%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",,,High,Presentation or Conference,Arianna Portmann-Baracco,Universidad Peruana Cayetano Heredia,https://dx.doi.org/10.1016/j.ajog.2021.11.1178,1/11/2022,7/17/2022,Unverified
220119_Cantagallo_MINSA_Round1,"January 19, 2022",Local,Peru,PER,Lima,Cantagallo,"May 2, 2020","May 2, 2020",Household and community samples,Multiple groups,119,33.61%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,3/10/2022,7/17/2022,Unverified
220119_Cantagallo_MINSA_Round2,"January 19, 2022",Local,Peru,PER,Lima,Cantagallo,"May 12, 2020","May 12, 2020",Household and community samples,Multiple groups,475,73.26%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,3/10/2022,7/17/2022,Unverified
220119_Cantagallo_MINSA_Round3,"January 19, 2022",Local,Peru,PER,Lima,Cantagallo,"August 10, 2020","August 10, 2020",Household and community samples,Multiple groups,485,68.04%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luis Zavalaga,MINSA,https://dx.doi.org/10.20453/RMH.V32I4.4120,3/10/2022,7/17/2022,Unverified
211204_Lima_CentersForDiseaseControlAndPrevention,"December 4, 2021",Local,Peru,PER,,Lima,"August 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),667,32.08%,,,Convenience,NA,ELISA,Not reported,,,High,Presentation or Conference,Matthew Westercamp,Centers for Disease Control and Prevention,https://dx.doi.org/10.1093/ofid/ofab466.576,3/22/2022,7/17/2022,Unverified
220325_Pucallpa_NationalUniversityofJaén_IgGorIgM,"March 25, 2022",Local,Peru,PER,Coronel Portillo,Pucallpa,"June 25, 2020","July 24, 2020",Persons who are incarcerated,Adults (18-64 years),325,57.85%,,,Simplified probability,NA,CLIA,"IgG,IgM",,,Unclear,Preprint,Arturo Rafael-Heredia,National University of Jaén,https://preprints.scielo.org/index.php/scielo/preprint/view/3828,4/6/2022,7/17/2022,Unverified
220408_Peru_UniversidadPeruanadeCienciasAplicadas_IgM,"April 8, 2022",Local,Peru,PER,Jaen,Jaen,"April 15, 2020","March 15, 2021",Representative patient population,Multiple groups,464,35.80%,,,Sequential,ImmunoDiagnostics,ELISA,IgM,88.20%,92.00%,High,Journal Article (Peer-Reviewed),Yordi Tarazona-Castro,Universidad Peruana de Ciencias Aplicadas,https://dx.doi.org/10.1371/journal.pone.0265820,4/22/2022,3/2/2024,Unverified
221227_SanJuandeLurigancho_VanderbiltUniversity_FollowUp,"December 27, 2021",Local,Peru,PER,Lima,Lima,"January 15, 2021","March 19, 2021",Household and community samples,Multiple groups,111,53.15%,43.45%,62.69%,Convenience,SD Biosensor,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Claudio Lanata,Vanderbilt University,https://dx.doi.org/10.1111/irv.12952,5/4/2022,7/17/2022,Unverified
221227_SanJuandeLurigancho_VanderbiltUniversity_Baseline,"December 27, 2021",Local,Peru,PER,Lima,Lima,"December 9, 2020","January 15, 2021",Household and community samples,Multiple groups,128,46.09%,37.25%,55.12%,Convenience,SD Biosensor,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Claudio Lanata,Vanderbilt University,https://dx.doi.org/10.1111/irv.12952,5/4/2022,7/17/2022,Unverified
230628_PuertoPizarro_HospitalAmistadPeruCoreaSantaRosa_TestAdj_Overall,"June 28, 2023",Local,Peru,PER,Tumbes,Puerto Pizarro,"November 11, 2020","November 30, 2020",Household and community samples,Multiple groups,1391,24.72%,,,Simplified probability,SD Biosensor,LFIA,"IgG,IgM",99.03%,98.65%,Moderate,Journal Article (Peer-Reviewed),Luz M. Moyano,Hospital Amistad Peru Corea Santa Rosa,https://dx.doi.org/10.1371/journal.pntd.0010794,9/21/2022,7/29/2023,Unverified
230424_Iquitos_UniversidadCientıficadelSur_overall,"April 24, 2023",Local,Peru,PER,,"Iquitos
","July 13, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),326,78.00%,73.00%,82.60%,Stratified non-probability,"CTK Biotech, Inc.,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Maria Pons,Universidad Cientıfica del Sur,https://dx.doi.org/10.4269/ajtmh.22-0539,6/1/2023,4/28/2024,Verified
230424_Iquitos_UniversidadCientıficadelSur_Punchana,"April 24, 2023",Local,Peru,PER,,,"July 13, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),59,78.00%,64.00%,88.00%,Stratified non-probability,"CTK Biotech, Inc.,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Maria Pons,Universidad Cientıfica del Sur,https://dx.doi.org/10.4269/ajtmh.22-0539,6/1/2023,4/28/2024,Verified
230424_Iquitos_UniversidadCientıficadelSur_San Juan,"April 24, 2023",Local,Peru,PER,,,"July 13, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),126,82.00%,74.00%,88.10%,Stratified non-probability,"CTK Biotech, Inc.,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Maria Pons,Universidad Cientıfica del Sur,https://dx.doi.org/10.4269/ajtmh.22-0539,6/1/2023,4/28/2024,Verified
230424_Iquitos_UniversidadCientıficadelSur_Belen,"April 24, 2023",Local,Peru,PER,,,"July 13, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),34,82.00%,65.00%,93.20%,Stratified non-probability,"CTK Biotech, Inc.,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Maria Pons,Universidad Cientıfica del Sur,https://dx.doi.org/10.4269/ajtmh.22-0539,6/1/2023,4/28/2024,Verified
230424_Iquitos_UniversidadCientıficadelSur_Iquitos,"April 24, 2023",Local,Peru,PER,,,"July 13, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),107,73.00%,63.00%,81.00%,Stratified non-probability,"CTK Biotech, Inc.,EUROIMMUN",LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Maria Pons,Universidad Cientıfica del Sur,https://dx.doi.org/10.4269/ajtmh.22-0539,6/1/2023,4/28/2024,Verified
201215_CiudaddelEste_MinisteriodeSaludPública_primary,"December 15, 2020",Local,Paraguay,PRY,,Ciudad del Este,"November 29, 2020","December 15, 2020",Household and community samples,Multiple groups,1675,30.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Not reported,Ministerio de Salud Pública,https://www.ultimahora.com/el-30-testeados-el-este-tuvieron-covid-n2918654.html,4/23/2021,7/17/2022,Verified
220615_Paraguay_MinisteriodeSaludPublicayBienestarSocial_Overall,"June 15, 2022",Local,Paraguay,PRY,Central Department,Asunción,"December 22, 2020","March 15, 2021",Household and community samples,Multiple groups,1699,26.90%,24.80%,29.10%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",84.00%,87.00%,Moderate,Journal Article (Peer-Reviewed),Agueda Cabello,Ministerio de Salud Pública y Bienestar Social ,https://dx.doi.org/10.4067/s0716-10182022000200238,10/21/2022,4/18/2024,Verified
221215_Paraguay_UniversidadDelPacífico_Children_IgM/IgG,"December 15, 2022",Local,Paraguay,PRY,,,"October 25, 2021","November 5, 2021",Students and Daycares,Children and Youth (0-17 years),966,37.70%,,,Unclear,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Margarita Samudio,Universidad del Pacífico,https://dx.doi.org/10.4067/S0716-10182022000600675,5/30/2023,3/2/2024,Unverified
221215_Paraguay_UniversidadDelPacífico_Teachers_IgM/IgG,"December 15, 2022",Local,Paraguay,PRY,,,"October 25, 2021","November 5, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),148,91.90%,,,Unclear,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Margarita Samudio,Universidad del Pacífico,https://dx.doi.org/10.4067/S0716-10182022000600675,5/30/2023,3/2/2024,Unverified
230326_CiudadDelEste_MinisterioDeSaludPublica,"March 26, 2023",Local,Paraguay,PRY,Alto Paraná department,Ciudad del Este,"October 27, 2020","November 21, 2020",Household and community samples,Multiple groups,1978,29.88%,,,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",84.00%,87.00%,,Journal Article (Peer-Reviewed),Agueda Cabello,Ministerio de Salud Pública,https://revsaludpublica.sld.cu/index.php/spu/article/view/3850,5/31/2023,4/24/2024,Verified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_BloodDonors,"March 2, 2021",Local,Panama,PAN,,"Panama City,
Colon","April 30, 2020","July 7, 2020",Blood donors,Multiple groups,255,13.33%,,,Convenience,NA,LFIA,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,"Instituto de Investigaciones Científicas y
Servicios de Alta Tecnología",https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,7/17/2022,Verified
210302_Panama_InstitutodeInvestigacionesCientíficasyServiciosdeAltaTecnología_HCWs,"March 2, 2021",Local,Panama,PAN,,"Panama City,
Colon","April 30, 2020","July 7, 2020",Health care workers and caregivers,Multiple groups,351,12.82%,,,Unclear,NA,LFIA,"IgG,IgM",87.01%,98.89%,High,Journal Article (Peer-Reviewed),Alcibiades Villarreal,"Instituto de Investigaciones Científicas y
Servicios de Alta Tecnología",https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full,4/7/2021,7/17/2022,Verified
200720_Lahore_ChughtaiInstituteofPathology_Overall,"August 19, 2020",Local,Pakistan,PAK,,Lahore,"May 20, 2020","May 30, 2020",Essential non-healthcare workers,Adults (18-64 years),154,15.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.77%,99.00%,High,Journal Article (Peer-Reviewed),Omar Chughtai,Chughtai Institute of Pathology,https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan,10/4/2020,3/2/2024,Verified
200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall,"August 24, 2020",Local,Pakistan,PAK,Sindh,Karachi,"May 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),370,34.60%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",,,High,Journal Article (Peer-Reviewed),Amber Younas,National Institute of Blood Diseases & Bone Marrow Transplantation,https://dx.doi.org/10.1016/j.transci.2020.102923,10/21/2020,3/2/2024,Verified
201109_ Peshawar_HayatabadMedicalComplex_Overall,"November 9, 2020",Local,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar,"July 13, 2020","July 15, 2020",Health care workers and caregivers,Multiple groups,1011,30.76%,,,Stratified probability,Roche Diagnostics,Not reported,"IgG,IgM",87.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Noor,Hayatabad Medical Complex,https://dx.doi.org/10.7759/cureus.11389,1/18/2021,3/2/2024,Verified
200930_PeshawarCity_RiphahInternationalUniversity_Overall,"September 30, 2020",Local,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar City,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),1011,30.70%,27.80%,33.60%,Stratified non-probability,Roche Diagnostics,Not reported,Total Antibody,98.80%,100.00%,Moderate,Preprint,Mohsina Haq,Riphah International University,https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1,1/20/2021,3/2/2024,Verified
210103_Pakistan_LiaquatUniversity_primary,"January 3, 2021",Local,Pakistan,PAK,NR,NR,"June 15, 2020","August 15, 2020",Residual sera,Multiple groups,728,10.80%,,,Convenience,NA,ELISA,Not reported,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Sheeba Ansari,Liaquat University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/,2/20/2021,7/5/2023,Verified
210101_Pakistan_ColSultan’sLab_Overall,"January 1, 2021",Local,Pakistan,PAK,NR,NR,"June 13, 2020","July 8, 2020",Residual sera,Multiple groups,453,63.80%,,,Self-referral,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Sidra Ghazanfer,Col Sultan’s Lab,https://dx.doi.org/10.29271/jcpsp.2021.01.S55,4/11/2021,3/2/2024,Verified
200814_Pakistan_GetzPharma_Overall,"August 14, 2020",Regional,Pakistan,PAK,NR,"Karachi, Lahore, Multan, Peshawar and Quetta","July 6, 2020","July 6, 2020",Household and community samples,Adults (18-64 years),24210,17.50%,,,Simplified probability,Getz Pharma,LFIA,"IgG,IgM",,,Moderate,Preprint,Wajiha Javed,Getz Pharma,https://www.medrxiv.org/content/10.1101/2020.08.13.20173914v1,5/17/2021,3/2/2024,Verified
210321_Karachi_AgaKhanUniversity_Phase1Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District Malir,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.20%,0.00%,0.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210321_Karachi_AgaKhanUniversity_Phase1East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District East,"April 15, 2020","April 25, 2020",Household and community samples,Multiple groups,500,0.40%,0.00%,1.30%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210321_Karachi_AgaKhanUniversity_Phase2Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District Malir,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,504,8.70%,5.10%,13.10%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210321_Karachi_AgaKhanUniversity_Phase2East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District East ,"June 25, 2020","July 11, 2020",Household and community samples,Multiple groups,500,15.10%,9.40%,21.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210321_Karachi_AgaKhanUniversity_Phase3Malir_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District Malir,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,501,12.80%,8.30%,17.70%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210321_Karachi_AgaKhanUniversity_Phase3East_PopAdj_TestAdj,"March 15, 2021",Local,Pakistan,PAK,Karachi,District East ,"August 17, 2020","August 22, 2020",Household and community samples,Multiple groups,500,21.50%,15.60%,28.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Muhammed Imran Nisar,Aga Khan University,http://dx.doi.org/10.1016/j.ijid.2021.03.040,5/18/2021,8/15/2023,Verified
210421_Pakistan_MemorialCancerHospitalandResearchCenter_overall,"April 21, 2021",Local,Pakistan,PAK,Punjab,Lahore,"July 29, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),2162,39.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Salma Abbas,Shaukat Khanum Memorial Cancer Hospital and Research Centre,https://dx.doi.org/10.1177/10105395211011010,5/19/2021,3/2/2024,Verified
200930_Karachi_NationalInstituteOfBloodDiseasesAndBoneMarrowTransplantation,"September 30, 2020",Local,Pakistan,PAK,Sindh,Kararchi,"August 30, 2020","September 12, 2020",Household and community samples,Adults (18-64 years),2404,55.00%,,,Convenience,NA,CLIA,"IgG,IgM,IgA",,,High,Preprint,Faiza Rezwan,National Institute of Blood Diseases and Bone Marrow Transplantation,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3700931,5/20/2021,7/17/2022,Unverified
210525_Pakistan_RiphahInternationalUniversity,"May 25, 2021",National,Pakistan,PAK,,,"July 15, 2020","July 31, 2020",Household and community samples,Multiple groups,15390,42.40%,41.50%,43.14%,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mohsina Haq,Riphah International University ,https://dx.doi.org/10.1007/s15010-021-01629-2,6/7/2021,3/2/2024,Verified
210529_Pakistan_CombinedMilitaryHospitalKharianMedicalCollege,"May 29, 2021",National,Pakistan,PAK,,,"September 1, 2020","September 30, 2020",Non-essential workers and unemployed persons,Multiple groups,442,16.96%,,,Convenience,Boditech Med Inc.,LFIA,IgG,95.80%,96.70%,High,Journal Article (Peer-Reviewed),Iffat Naiyar,Combined Military Hospital Kharian Medical College,https://dx.doi.org/10.1016/j.jtumed.2021.04.004,6/18/2021,3/2/2024,Unverified
210816_Pakistan_ChughtaiInstituteofPathology_Primary,"August 16, 2021",National,Pakistan,PAK,,,"July 1, 2021","July 20, 2021",Health care workers and caregivers,Adults (18-64 years),15000,33.00%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.60%,96.70%,Moderate,Journal Article (Peer-Reviewed),Hijab Batool,Chughtai Institute of Pathology,https://dx.doi.org/10.1136/bmjopen-2020-046276,8/24/2021,3/2/2024,Unverified
210929_Islamabad_NationalInstituteofHealth_Overall,"September 29, 2021",Local,Pakistan,PAK,Islamabad Capital Territory,Islamabad,"June 1, 2020","June 30, 2020",Household and community samples,Multiple groups,6333,16.30%,,,Stratified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,Moderate,Preprint,Mirza Amir Baig,National Institute of Health,https://www.medrxiv.org/content/10.1101/2021.09.27.21264003v1.article-info,10/6/2021,3/2/2024,Verified
210927_Karachi_AgaKhanUniversityandHospital_primary,"September 27, 2021",Local,Pakistan,PAK,,Karachi,"December 15, 2020","February 14, 2021",Blood donors,Multiple groups,558,53.40%,,,Convenience,NA,ELISA,IgG,,,High,Preprint,Muhammad Hasan,The Aga Khan University and Hospital,https://www.researchsquare.com/article/rs-941908/v1,10/14/2021,7/17/2022,Verified
211213_Sindh_ShaheedMohtarmaBenazirBhuttoMedicalUniversity_Primary,"December 13, 2021",Regional,Pakistan,PAK,Sindh,Hyderabad,"August 1, 2020","November 30, 2020",Residual sera,Adults (18-64 years),1229,16.76%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Shahzad Rasheed Qureshi,"Liaquat University of Medical and Health
Sciences ",http://libraryaplos.com/xmlui/handle/123456789/8719,1/11/2022,3/2/2024,Unverified
220310_PeshawarCity_RiphahInternationalUniversity_OverallCrude,"March 10, 2022",Local,Pakistan,PAK,,Peshawar,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),987,31.41%,28.50%,34.40%,Simplified probability,Roche Diagnostics,Not reported,Not reported,10.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Mohsina Haq,Riphah International University,https://dx.doi.org/10.1177/25151355221080724,3/22/2022,7/17/2022,Unverified
220406_Pakistan_MinistryofNationalHealthServicesRegulationsandCoordination_Overall,"April 6, 2022",National,Pakistan,PAK,"Punjab, Sindh, Baluchistan, Khyber Pakhtunkhwa, Azad Jammu & Kashmir, Gilgit Baltistan",,"October 21, 2020","November 8, 2020",Household and community samples,Multiple groups,4998,7.02%,,,Stratified probability,Bioperfectus,LFIA,"IgG,IgM",,95.00%,Moderate,Journal Article (Peer-Reviewed),Ahsan Ahmad,Ministry of National Health Services Regulations and Coordination,https://bmjopen.bmj.com/content/12/4/e055381.abstract,4/13/2022,3/2/2024,Verified
220520_Pakistan_GetzPharma_IgGorIgM,"May 20, 2022",National,Pakistan,PAK,Sindh; Punjab; Khyber Pakhtunkhwa; Balochistan.,Karachi; Lahore; Multan; Peshawar; and Quetta.,"April 15, 2020","September 15, 2020",Multiple populations,Adults (18-64 years),17764,15.82%,,,Convenience,Getz Pharma,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Wajiha Javed,Getz Pharma,https://doi.org/10.1186/s12879-022-07461-9,5/31/2022,3/2/2024,Unverified
220524_KhyberPakhtunkhwa_KhyberMedicalUniversity_SecondWave,"May 24, 2022",Local,Pakistan,PAK,Khyber Pakhtunkhw,Peshawar,"November 1, 2020","January 1, 2021",Blood donors,Adults (18-64 years),2100,56.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,,Journal Article (Peer-Reviewed),M. Khan,Khyber Medical University,https://dx.doi.org/10.1111/vox.13285,7/7/2022,3/2/2024,Unverified
220620_Peshawar_RegionalBloodCentre_Overall,"June 20, 2022",Regional,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar,"November 15, 2020","June 15, 2021",Residual sera,Multiple groups,4047,59.00%,,,Sequential,Roche Diagnostics,CLIA,Not reported,100.00%,99.50%,High,Journal Article (Peer-Reviewed),Muhammad Nisar Khan,Regional Blood Centre,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301020/,8/4/2022,3/30/2024,Verified
220920_Peshawar_PeshawarDentalCollege_overall,"September 20, 2022",Local,Pakistan,PAK,Khyber Pakhtunkhwa,Peshawar,"January 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),133,33.08%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shawana Iqbal,Peshawar Dental College,https://dx.doi.org/10.53350/pjmhs22168335,10/18/2022,10/21/2022,Unverified
221212_USA_RTIInternational_Pakistan,"December 12, 2022",National,Pakistan,PAK,,,"October 1, 2020","October 31, 2020",Pregnant or parturient women,Adults (18-64 years),2031,20.50%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221217_IbrahimHyderi_AgaKhanUniversity_Women_Follow-up_Primary,"December 17, 2022",Local,Pakistan,PAK,,Karachi,"September 15, 2021","December 15, 2021",Pregnant or parturient women,Adults (18-64 years),1142,82.30%,79.90%,84.40%,Unclear,Roche Diagnostics,Not reported,Total Antibody,88.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nadia Ansari,Aga Khan University,https://dx.doi.org/10.7189/jogh.12.95955,1/13/2023,4/11/2024,Verified
221217_IbrahimHyderi_AgaKhanUniversity_Children_Follow-up_Primary,"December 17, 2022",Local,Pakistan,PAK,,Karachi,"September 15, 2021","December 15, 2021",Household and community samples,Children and Youth (0-17 years),1063,57.40%,54.30%,60.30%,Unclear,Roche Diagnostics,Not reported,Total Antibody,88.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nadia Ansari,Aga Khan University,https://dx.doi.org/10.7189/jogh.12.95955,1/13/2023,4/11/2024,Verified
230215_Pakistan_DrZiauddinHospital_Primary,"February 15, 2023",Local,Pakistan,PAK,,Karachi,"October 15, 2020","April 15, 2021",Residual sera,Multiple groups,207,11.50%,,,Sequential,Genrui Biotech,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Abeer Altaf,Dr. Ziauddin Hospital,https://dx.doi.org/10.12669/pjms.39.2.5659,3/7/2023,3/2/2024,Unverified
230303_Karachi_DowInternationalMedicalCollege,"March 3, 2023",Local,Pakistan,PAK,,Karachi,"August 1, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,5247,46.20%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.50%,,Journal Article (Peer-Reviewed),Ambreen Fatima,Dow International Medical Colleg,https://www.rmj.org.pk/fulltext/27-1662180772.pdf,4/5/2023,3/2/2024,Unverified
230720_Pakistan_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Pakistan,PAK,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2892,26.80%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
230727_Karachi_AgaKhanUniversity_Dec2021_adj,"July 27, 2023",Regional,Pakistan,PAK,Karachi,,"December 1, 2021","December 31, 2021",Household and community samples,Multiple groups,506,84.90%,78.50%,92.30%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Muhammad Imran Nisar,Aga Khan University,https://www.joghr.org/article/84241-community-based-seroprevalence-of-sars-cov-2-in-an-urban-district-of-karachi-pakistan,8/24/2023,8/26/2023,Unverified
230301_Baqai_BaqaiMedicalUniversity,"March 1, 2023",Local,Pakistan,PAK,Karachi,Baqai,"June 15, 2021","November 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),300,19.00%,,,Convenience,NA,,,,,,Presentation or Conference,A. Fawwad,Baqai Medical University,https://dx.doi.org/10.1016/j.diabres.2023.110510,10/5/2023,10/6/2023,Unverified
210427_Oman_Directorate-GeneralforDiseasesSurveillanceandControl_Primary,"April 27, 2021",Regional,Oman,OMN,"Al Dakhilia, North Batinah, and South Batinah goveronates",,"September 14, 2020","September 28, 2020",Health care workers and caregivers,Adults (18-64 years),1078,21.00%,,,Stratified probability,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Amal Al Maani,Directorate-General for Diseases Surveillance and Control,https://dx.doi.org/10.1016/j.ijid.2021.04.071,6/1/2021,3/2/2024,Verified
210930_Oman_MinistryOfHealth_Cycle1_PrimaryEstimate,"September 30, 2021",National,Oman,OMN,,,"July 12, 2020","July 23, 2020",Household and community samples,Multiple groups,4210,5.50%,4.80%,6.20%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,10/15/2021,3/2/2024,Verified
210930_Oman_MinistryOfHealth_Cycle2_PrimaryEstimate,"September 30, 2021",National,Oman,OMN,,,"August 16, 2020","August 27, 2020",Household and community samples,Multiple groups,4403,9.70%,8.50%,11.00%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,10/15/2021,3/2/2024,Verified
210930_Oman_MinistryOfHealth_Cycle3_PrimaryEstimate,"September 30, 2021",National,Oman,OMN,,,"September 13, 2020","September 24, 2020",Household and community samples,Multiple groups,4780,16.40%,14.50%,18.40%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,10/15/2021,3/2/2024,Verified
210930_Oman_MinistryOfHealth_Cycle4_PrimaryEstimate,"September 30, 2021",National,Oman,OMN,,,"November 8, 2020","November 19, 2020",Household and community samples,Multiple groups,4064,22.00%,19.60%,24.60%,Stratified probability,DiaSorin,CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Seif Al-Abri,Ministry of Health (Oman),https://dx.doi.org/10.1016/j.ijid.2021.09.062,10/15/2021,3/2/2024,Verified
210915_Oman_ArmedForcesHospital_HCW_overall,"September 15, 2021",Local,Oman,OMN,,Muscat,"December 9, 2020","December 24, 2020",Health care workers and caregivers,Adults (18-64 years),1111,33.60%,,,Convenience,Roche Diagnostics,Not reported,Total Antibody,98.80%,99.98%,High,Journal Article (Peer-Reviewed),Khalid Al-Naamani,Armed Forces Hospital,https://dx.doi.org/10.1016/j.jiph.2021.09.006,11/3/2021,3/2/2024,Unverified
220705_Muscat_RoyalHospital_Baseline,"July 5, 2022",Local,Oman,OMN,,"Muscat
","May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),328,1.20%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Amal Altai,The Royal Hospital,https://dx.doi.org/10.5001/omj.2022.74,8/20/2022,8/20/2022,Unverified
220705_Muscat_RoyalHospital_Follow-up,"July 5, 2022",Local,Oman,OMN,,Muscat,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),328,3.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Amal Altai,The Royal Hospital,https://dx.doi.org/10.5001/omj.2022.74,8/20/2022,8/20/2022,Unverified
210107_WestBank_ArabAmericanUniversity_Households_overall_adj,"January 7, 2021",Local,occupied Palestinian territory - including east Jerusalem,PSE,,West Bank,"June 15, 2020","June 30, 2020",Household and community samples,Multiple groups,1355,0.00%,0.00%,0.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,83.87%,100.00%,Low,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://bmjopen.bmj.com/content/11/2/e044552,2/19/2021,7/5/2023,Verified
210107_WestBank_ArabAmericanUniversity_LabReferrals_overall_adj,"January 7, 2021",Local,occupied Palestinian territory - including east Jerusalem,PSE,,West Bank,"May 1, 2020","July 9, 2020",Residual sera,Multiple groups,1136,0.35%,0.13%,1.16%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,83.87%,High,Journal Article (Peer-Reviewed),Nouar Qutob,Arab American University ,https://bmjopen.bmj.com/content/11/2/e044552,2/19/2021,7/5/2023,Verified
211007_Palestine_PalestinianNationalInstituteofPublicHealth_WestBank_Overall,"October 7, 2021",Regional,occupied Palestinian territory - including east Jerusalem,PSE,West Bank,N/A,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,4356,38.00%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,98.80%,99.98%,Moderate,Preprint,I Rayan,Palestinian National Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1,10/14/2021,3/2/2024,Verified
211007_Palestine_PalestinianNationalInstituteofPublicHealth_Gaza_Overall,"October 7, 2021",Regional,occupied Palestinian territory - including east Jerusalem,PSE,Gaza,N/A,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,2904,40.00%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,98.80%,99.98%,Moderate,Preprint,I Rayan,Palestinian National Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.10.04.21263131v1,10/14/2021,3/2/2024,Verified
211008_Palestine_An-NajahNationalUniversity_Overall,"October 8, 2021",Regional,occupied Palestinian territory - including east Jerusalem,PSE,West Bank,,"November 1, 2020","December 31, 2020",Residual sera,Multiple groups,1269,24.03%,21.70%,26.50%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Beesan Maraqa,An-Najah National University,https://dx.doi.org/10.1371/journal.pone.0258255,10/20/2021,3/2/2024,Verified
220817_WestBank_ArabAmericanUniversityofPalestine_Overall_TotalAntibodies_Primary,"August 17, 2022",Regional,occupied Palestinian territory - including east Jerusalem,PSE,"""11 governorates in West Bank, Palestine""",,"September 14, 2021","October 21, 2021",Household and community samples,Multiple groups,910,75.90%,,,Stratified probability,Roche Diagnostics,Not reported,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Faisal Awartani,Arab American University of Palestine,https://dx.doi.org/10.3390/vaccines10081332,9/12/2022,4/30/2024,Verified
200615_Bergen_UniversityofBergen_HouseholdMembers,"June 15, 2020",Local,Norway,NOR,Western Norway,Bergen,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Multiple groups,77,31.17%,,,Convenience,NA,ELISA,"IgM,IgG,IgA",,,High,Journal Article (Peer-Reviewed),Rebecca Cox,University of Bergen,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/,7/19/2020,7/17/2022,Verified
201128_Bergen_UniversityofBergen_primaryest_HCW,"November 28, 2020",Local,Norway,NOR,Midhordland,Bergen,"March 6, 2020","April 9, 2020",Health care workers and caregivers,Multiple groups,607,5.27%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mai Chi Trieu,University of Bergen,https://dx.doi.org/10.1093/infdis/jiaa737,1/30/2021,7/17/2022,Verified
210115_Norway_NorwegianArmedForcesJointMedicalServices_primary,"January 15, 2021",National,Norway,NOR,,,"April 19, 2020","April 27, 2020",Essential non-healthcare workers,Adults (18-64 years),1170,0.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Einar Kristian Borud,Norwegian Armed Forces Joint Medical Services,https://dx.doi.org/10.1002/hsr2.233,2/28/2021,3/2/2024,Verified
210223_Lorenskog_AkershusUniversityHospital_Overall,"February 23, 2021",Local,Norway,NOR,,Lorenskog,"May 11, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),360,3.30%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nina Handal,Akershus University Hospital,https://dx.doi.org/10.1080/23744235.2021.1885734,3/24/2021,3/2/2024,Verified
210331_Bergen_UniversityOfBergen_overall_unadj,"March 31, 2021",Local,Norway,NOR,,Bergen,"February 28, 2020","April 4, 2020",Contacts of COVID patients,Multiple groups,179,45.00%,38.00%,53.00%,Convenience,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Kanika Kuwelker,University of Bergen ,https://dx.doi.org/10.1016/j.lanepe.2020.100014,5/18/2021,7/17/2022,Verified
210326_Norway_ArcticUniversityOfNorway_PopAdj_TestAdj,"March 26, 2021",National,Norway,NOR,,,"November 25, 2020","February 15, 2021",Household and community samples,Multiple groups,27700,0.90%,0.70%,1.00%,Stratified probability,"EUROIMMUN,NA",Multiple Types,IgG,,,Low,Preprint,Erik Anda,Arctic University of Norway,https://www.medrxiv.org/content/10.1101/2021.03.23.21253730v1,5/19/2021,8/15/2023,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time1_PopTestAdj,"November 9, 2021",National,Norway,NOR,,,"April 19, 2020","May 16, 2020",Residual sera,Multiple groups,900,1.00%,0.10%,2.40%,Convenience,NA,Other,IgG,86.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,11/18/2021,7/17/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time2_PopTestAdj,"November 9, 2021",National,Norway,NOR,,,"July 19, 2020","September 12, 2020",Residual sera,Multiple groups,1812,0.60%,0.20%,1.20%,Convenience,NA,Other,IgG,86.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,11/18/2021,7/17/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time3_PopTestAdj,"November 9, 2021",National,Norway,NOR,,,"December 27, 2020","February 13, 2021",Residual sera,Multiple groups,1912,3.20%,2.30%,4.20%,Convenience,NA,Other,IgG,96.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,11/18/2021,7/17/2022,Verified
211109_Norway_NorwegianInstituteofPublicHealth_Time4_Primary,"November 9, 2021",National,Norway,NOR,,,"August 1, 2019","August 31, 2019",Residual sera,Multiple groups,216,0.00%,,,Convenience,NA,Other,IgG,,,Unclear,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.12932,11/18/2021,7/17/2022,Verified
211117_Norway_OsloUniversityHospital_KidneyTransplantRecipient,"November 17, 2021",National,Norway,NOR,,,"June 15, 2020","October 31, 2020",Representative patient population,Multiple groups,815,0.00%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,IgG,,,High,Preprint,Kjersti B. Blom,Oslo University Hospital,https://dx.doi.org/10.1016/j.xkme.2021.09.006,12/2/2021,3/2/2024,Unverified
220113_Lorenskog_UniversityofOslo_Overall_TestAdj,"January 13, 2022",Local,Norway,NOR,Akershus,Lorenskog,"December 1, 2019","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),6520,1.70%,,,Sequential,"Roche Diagnostics,DiaSorin",CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Anne Eskild,University of Oslo,https://dx.doi.org/10.1017/S0950268822000073,1/19/2022,8/15/2023,Verified
220331_Norway_TheArcticUniversityofNorway_Popadj,"March 31, 2022",National,Norway,NOR,,,"November 15, 2020","February 15, 2021",Household and community samples,Multiple groups,27700,0.90%,0.70%,1.00%,Convenience,"EUROIMMUN,NA",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Erik Eik Anda,The Arctic University of Norway,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.13.2100376,4/14/2022,3/2/2024,Unverified
220630_Oslo_NationalInstituteofOccupationalHealth_Followup,"June 30, 2022",Local,Norway,NOR,,Oslo,"January 7, 2021","March 17, 2021",Essential non-healthcare workers,Multiple groups,158,6.96%,,,Convenience,Luminex Corporation,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anne-Mari Moe,National Institute of Occupational Health,https://dx.doi.org/10.13075/ijomeh.1896.01942,7/13/2022,3/2/2024,Unverified
220630_Norway_NorwegianInstituteofPublicHealth_Overall_PopTestAdj,"June 30, 2022",National,Norway,NOR,,,"July 19, 2021","September 12, 2021",Residual sera,Multiple groups,1926,62.60%,60.10%,65.20%,Sequential,NA,Other,IgG,97.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Gro Tunheim,Norwegian Institute of Public Health,https://dx.doi.org/10.1111/irv.13024,7/26/2022,7/26/2022,Unverified
230522_Oslo_OsloUniversityHospital,"May 22, 2023",Local,Norway,NOR,,Oslo,"November 1, 2020","November 30, 2020",Persons experiencing homelessness,Multiple groups,99,96.00%,,,Convenience,NA,,,94.00%,99.50%,,Preprint,Linda Wusthoff,Oslo University Hospital,https://doi.org/10.21203/rs.3.rs-2939683/v1,6/30/2023,7/4/2023,Unverified
230721_WesternNorway_UniversityOfBergen_Overall,"July 21, 2023",Regional,Norway,NOR,Western Norway,,"March 6, 2020","December 9, 2020",Health care workers and caregivers,Multiple groups,1214,10.00%,8.40%,11.90%,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Amit Bansal,University of Bergen,https://dx.doi.org/10.3389/fpubh.2023.1164326,8/22/2023,8/23/2023,Unverified
210531_Skopje_InstituteForTransfusionMedicine,"May 31, 2021",Local,North Macedonia,MKD,Skopje,Skopje,"November 15, 2020","March 15, 2021",Blood donors,Multiple groups,9773,25.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Tatjana Makarovska Bojadjieva, Institute for Transfusion Medicine,http://dx.doi.org/10.1111/vox.13117,7/1/2021,3/2/2024,Verified
200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1,"July 24, 2020",Local,Nigeria,NGA,Cross River State,Calabar,"June 17, 2020","June 24, 2020",Multiple populations,Adults (18-64 years),66,26.00%,,,Unclear,Healgen,LFIA,IgG,,,High,Preprint,Marcus Inyama Asuquo,Joseph Ukpo Hospitals and Research Institutes,https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2,9/27/2020,3/2/2024,Verified
200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj,"August 5, 2020",Regional,Nigeria,NGA,Niger State,,"June 26, 2020","June 30, 2020",Household and community samples,Multiple groups,185,25.41%,,,Stratified probability,Cambridge Network,LFIA,IgG,100.00%,100.00%,Moderate,Preprint,Hussaini Majiya,Ibrahim Badamasi Babangida University,https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf,10/15/2020,3/2/2024,Verified
210121_Abuja_MolecularPathologyInstituteEnugu,"January 21, 2021",Local,Nigeria,NGA,NR,"Abuja, Enugu","August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),113,42.00%,34.00%,52.00%,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,100.00%,100.00%,High,Preprint,Ijeoma Ifeorah,Molecular Pathology Institute,https://www.researchsquare.com/article/rs-151037/v1,5/22/2021,3/2/2024,Unverified
210719_AnambraState_StateMinistryOfHealth_testadj,"July 19, 2021",Regional,Nigeria,NGA,Anambra State,,"December 8, 2020","December 15, 2020",Household and community samples,Multiple groups,3142,16.07%,,,Stratified probability,Hangzhou Realy Tech Co. Ltd,LFIA,"IgG,IgM",98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),OgoChukwu Vincent Okpala,Anambra State Ministry of Health,https://www.sciencedirect.com/science/article/pii/S1201971221005968,8/4/2021,8/15/2023,Verified
220628_Kaduna_UniversityofGlasgow_Overall,"June 30, 2022",Regional,Nigeria,NGA,Kaduna,"Kaduna City, Kofar-Gayan","October 11, 2021","November 8, 2021",Residual sera,Multiple groups,802,43.70%,,,Convenience,Biopanda,LFIA,"IgG,IgM",99.00%,98.60%,High,Journal Article (Peer-Reviewed),Gloria Chechet,University of Glasgow,https://dx.doi.org/10.1093/ije/dyac141,7/7/2022,3/30/2024,Verified
221011_Nigeria_UniversityofIlorin_Primary,"October 11, 2022",National,Nigeria,NGA,"Abuja, Kwara, Kaduna, Sokoto, Akwa-Ibom, Lagos, Ondo, Enugu, Imo, Borno, Yobe",,"June 29, 2021","August 21, 2021",Household and community samples,Multiple groups,4904,78.90%,,,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM",96.70%,97.50%,High,Journal Article (Peer-Reviewed),Olatunji Matthew Kolawole,Federal Ministry of Health,https://dx.doi.org/10.1001/jamanetworkopen.2022.36053,10/19/2022,4/17/2024,Verified
221017_Lagos_CITIID_Primary,"October 17, 2022",Local,Nigeria,NGA,,Lagos,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),140,59.29%,,,Convenience,NA,Luminex,IgG,,,High,Journal Article (Peer-Reviewed),Adam Abdullahi,Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID),https://doi.org/10.1038/s41467-022-33792-x,10/25/2022,10/25/2022,Unverified
230117_Nigeria_UniversityofAbuja_baseline,"January 17, 2023",National,Nigeria,NGA,,,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),490,31.00%,27.00%,35.00%,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Dike B. Ojji,University of Abuja,https://dx.doi.org/10.1371/journal.pgph.0000549,5/4/2023,5/9/2023,Unverified
220617_Nigeria_NigerianInstituteofMedicalResearch,"June 17, 2022",National,Nigeria,NGA,"Enugu, Gombe, Nasarawa, Lago",,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,10628,18.20%,,,Convenience,"Abbott Laboratories,EUROIMMUN,Luminex Corporation",Multiple Types,,,,,Journal Article (Peer-Reviewed),Rosemary Audu,Nigerian Institute of Medical Research,https://dx.doi.org/10.1371/journal.pgph.0000363,5/4/2023,3/2/2024,Unverified
230619_Lagos_UniversityofLagos_HCW,"June 19, 2023",Local,Nigeria,NGA,,Lagos,"March 15, 2021","October 15, 2021",Health care workers and caregivers,Adults (18-64 years),134,70.00%,,,Convenience,NA,Other,Not reported,,,,Journal Article (Peer-Reviewed),Sulaimon Akanmu,University of Lagos,https://dx.doi.org/10.1016/j.jcvp.2023.100156,7/30/2023,8/15/2023,Unverified
230619_Lagos_UniversityofLagos_GenPop,"June 19, 2023",Local,Nigeria,NGA,,Lagos,"March 15, 2021","July 15, 2021",Household and community samples,Adults (18-64 years),116,59.00%,,,Convenience,NA,Other,Not reported,,,,Journal Article (Peer-Reviewed),Sulaimon Akanmu,University of Lagos,https://dx.doi.org/10.1016/j.jcvp.2023.100156,7/30/2023,8/15/2023,Unverified
210819_Managua_UniversityOfMichiganAnnArbor_Primary_PopAdj,"August 19, 2021",Local,Nicaragua,NIC,,Managua,"October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,1995,57.50%,,,Self-referral,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hannah E. Maier,"University of Michigan, Ann Arbor ",http://dx.doi.org/10.1093/cid/ciab717,9/22/2021,7/17/2022,Verified
211020_Leon_NationalAutonomousUniversityofNicaraguaatLeon_FebMar2021_TestAdj,"October 20, 2021",Local,Nicaragua,NIC,, León,"February 15, 2021","March 15, 2021",Household and community samples,Multiple groups,1243,34.70%,31.20%,38.20%,Convenience,NA,ELISA,Total Antibody,95.20%,96.70%,Moderate,Journal Article (Peer-Reviewed),Fredman Gonzalez,The National Autonomous University of Nicaragua at León,10.1017/s0950268821002144,1/2/2022,7/17/2022,Unverified
220105_Managua_UniversityofMichigan,"January 5, 2022",Local,Nicaragua,NIC,Managua,Managua,"March 1, 2020","October 15, 2021",Household and community samples,Children and Youth (0-17 years),1824,49.80%,,,Unclear,NA,ELISA,Not reported,,,Moderate,Preprint,John Kubale,University of Michigan,https://www.medrxiv.org/content/10.1101/2022.01.03.22268684v1.full-text,1/19/2022,7/17/2022,Unverified
220105_Nicaragua_MountAuburnHospital_Overall,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Multiple groups,502,38.00%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_0-18,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Children and Youth (0-17 years),78,15.38%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_19-39,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Adults (18-64 years),208,43.75%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_40-59,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Adults (18-64 years),156,42.31%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Ages_60+,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Seniors (65+ years),60,36.67%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Sex_Female,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Multiple groups,274,37.59%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_Sex_Male,"January 5, 2022",National,Nicaragua,NIC,,,"February 22, 2021","March 19, 2021",Household and community samples,Multiple groups,228,38.60%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_City_Managua,"January 5, 2022",National,Nicaragua,NIC,,Managua,"February 22, 2021","March 19, 2021",Household and community samples,Multiple groups,451,38.36%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220105_Nicaragua_MountAuburnHospital_CIty_Leon_Masaya,"January 5, 2022",National,Nicaragua,NIC,,"Leon, Masaya","February 22, 2021","March 19, 2021",Household and community samples,Multiple groups,51,35.29%,,,Convenience,SafeCare Bio-Tech,LFIA,"IgG,IgM",91.00%,96.00%,High,Journal Article (Peer-Reviewed),Jorge Huete-Perez,Mount Auburn Hospital,https://dx.doi.org/10.1016/j.ijregi.2021.12.013,6/29/2022,3/2/2024,Unverified
220525_Managua_UniversityofMichigan_2020,"May 25, 2022",Local,Nicaragua,NIC,,Managua,"March 1, 2020","September 30, 2021",Residual sera,Children and Youth (0-17 years),1455,1.60%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Aaron Frutos,"University of Michigan
",https://dx.doi.org/10.1371/journal.pgph.0000414,7/14/2022,7/26/2022,Unverified
220525_Managua_ UniversityofMichigan_2021,"May 25, 2022",Local,Nicaragua,NIC,,Managua,"March 1, 2020","September 30, 2021",Residual sera,Children and Youth (0-17 years),1743,49.00%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Aaron Frutos,"University of Michigan
",https://dx.doi.org/10.1371/journal.pgph.0000414,7/14/2022,7/26/2022,Unverified
220627_Nicarugua_UniversityOfMichiganSchoolOfPublicHealth,"June 27, 2022",National,Nicaragua,NIC,,,"March 1, 2020","October 15, 2021",Household and community samples,Children and Youth (0-17 years),1824,49.80%,47.50%,52.10%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),John Kubale,University of Michigan School of Public Health,https://dx.doi.org/10.1001/jamanetworkopen.2022.18794,7/26/2022,7/26/2022,Unverified
221201_Nicaragua_UniversityOfMichigan_Primary,"December 1, 2022",Local,Nicaragua,NIC,,Managua,"May 15, 2020","March 15, 2022",Household and community samples,Multiple groups,745,59.50%,,,Convenience,NA,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),Hannah E. Maier,University of Michigan,https://dx.doi.org/10.1111/irv.13074,2/21/2023,3/22/2023,Unverified
210419_NewZealand_UniversityOfAuckland_BloodDonors,"April 19, 2021",National,New Zealand,NZL,,,"December 3, 2020","January 6, 2021",Blood donors,Adults (18-64 years),9806,0.10%,0.09%,0.12%,Sequential,"EUROIMMUN,GenScript",Multiple Types,IgG,81.70%,100.00%,Moderate,Preprint,Lauren Carlton,University of Auckland,https://www.medrxiv.org/content/10.1101/2021.04.12.21255282v1,5/21/2021,8/15/2023,Verified
210518_NewZealand_SouthernCommunityLaboratories_MostAdj,"May 18, 2021",Regional,New Zealand,NZL,Southern Region,,"June 4, 2020","August 4, 2020",Contacts of COVID patients,Multiple groups,1127,0.80%,0.40%,1.50%,Convenience,"Abbott Laboratories,Beijing Wantai Biological,EUROIMMUN,GenScript,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Alyson Craigie,Southern Community Laboratories,https://dx.doi.org/10.1016/j.pathol.2021.04.001,6/20/2021,8/15/2023,Verified
201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,"November 12, 2020",National,Netherlands,NLD,,,"April 1, 2020","April 15, 2020",Blood donors,Multiple groups,7361,3.40%,,,Sequential,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",100.00%,99.10%,Moderate,Journal Article (Peer-Reviewed),Ed Slot,Amsterdam UMC,https://www.nature.com/articles/s41467-020-19481-7,5/26/2020,3/2/2024,Verified
200824_Rotterdam_ErasmusMedicalCentre_1_March,"August 24, 2020",Local,Netherlands,NLD,,Rotterdam,"March 2, 2020","March 6, 2020",Residual sera,Multiple groups,879,0.20%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,7/17/2022,Verified
200824_Rotterdam_ErasmusMedicalCentre_2_April,"August 24, 2020",Local,Netherlands,NLD,,Rotterdam,"April 3, 2020","April 7, 2020",Residual sera,Multiple groups,729,2.50%,,,Convenience,NA,Not reported,IgG,,100.00%,High,Preprint,Brenda Westerhuis,Erasmus Medical Centre,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,7/17/2022,Verified
201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall,"November 28, 2020",National,Netherlands,NLD,,,"March 31, 2020","May 11, 2020",Household and community samples,Multiple groups,570,2.90%,1.40%,6.30%,Stratified probability,NA,ELISA,IgG,84.40%,99.00%,Low,Journal Article (Peer-Reviewed),Eric Vos,Centre for Infectious Disease Control,https://dx.doi.org/10.1136/jech-2020-215678,1/25/2021,7/17/2022,Verified
210316_Netherlands_SanquinResearch_blooddonors,"March 16, 2021",National,Netherlands,NLD,,,"May 11, 2020","May 18, 2020",Blood donors,Multiple groups,3676,6.50%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,98.70%,99.60%,Moderate,Journal Article (Peer-Reviewed),Katj van den HUrk,Sanquin Research,https://dx.doi.org/10.1016/j.xcrm.2021.100222,5/10/2021,3/2/2024,Verified
210430_Amsterdam_AmsterdamUniversityMedicalCenter,"April 30, 2021",Local,Netherlands,NLD,North Holland,Amsterdam,"July 31, 2020","December 18, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),546,11.70%,,,Convenience,NA,Not reported,Not reported,98.10%,99.50%,High,Journal Article (Peer-Reviewed),Zoe van Kempen,Amsterdam University Medical Center,https://dx.doi.org/10.1001/jamaneurol.2021.1364,5/26/2021,7/17/2022,Unverified
210323_Budel_MaastrichtUniversity_Overall,"March 23, 2021",Local,Netherlands,NLD,North Brabant,Budel,"June 4, 2020","June 16, 2020",Health care workers and caregivers,Adults (18-64 years),240,39.17%,,,Convenience,Beijing Wantai Biological,Not reported,"IgA,IgG,IgM",96.10%,98.00%,High,Journal Article (Peer-Reviewed),Joyce Heffels,Maastricht University,https://dx.doi.org/10.36613/tgg.1875-6832/2021.01.01,6/8/2021,3/2/2024,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_COVIDCare3,"July 28, 2021",Local,Netherlands,NLD,,Amsterdam,"March 23, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),439,13.20%,9.90%,16.40%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/3/2021,3/2/2024,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NonCOVIDCare2,"July 28, 2021",Local,Netherlands,NLD,,Amsterdam,"June 25, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),164,6.70%,2.80%,10.50%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/3/2021,3/2/2024,Verified
210728_Amsterdam_AmsterdamUniversityMedicalCenters_NoPatientCare1,"July 28, 2021",Local,Netherlands,NLD,,Amsterdam,"March 23, 2020","June 25, 2020",Health care workers and caregivers,Adults (18-64 years),198,3.60%,0.90%,6.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,85.20%,99.30%,High,Journal Article (Peer-Reviewed),Jonne Sikkens,Amsterdam University Medical Centers ,https://dx.doi.org/10.1001/jamanetworkopen.2021.18554,8/3/2021,3/2/2024,Verified
210915_Netherlands_UniversityofAmsterdam_Wantai_Overall,"September 15, 2021",Local,Netherlands,NLD,North Holland,Amsterdam,"April 12, 2020","October 2, 2020",Residual sera,Children and Youth (0-17 years),487,3.29%,1.90%,5.30%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,High,Journal Article (Peer-Reviewed),Maya Keuning,University of Amsterdam,https://dx.doi.org/10.1128/Spectrum.00731-21,9/22/2021,3/2/2024,Verified
211008_NorthBrabant_RegionalPublicHealthServiceofWestBrabant_Overall,"October 8, 2021",Regional,Netherlands,NLD,North Brabant,,"June 1, 2020","July 14, 2020",Non-essential workers and unemployed persons,Multiple groups,497,11.30%,,,Convenience,Beijing Wantai Biological,ELISA,"IgA,IgM,IgG",96.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Dymphie Mioch,Regional Public Health Service of West-Brabant,https://dx.doi.org/10.1016/j.pmedr.2021.101594,10/20/2021,3/2/2024,Unverified
211018_Venlo_VieCuriMedicalCentre_Overall,"October 18, 2021",Local,Netherlands,NLD,Limburg,Venlo,"June 22, 2020","July 3, 2020",Health care workers and caregivers,Multiple groups,2507,21.10%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,97.50%,99.60%,Moderate,Journal Article (Peer-Reviewed),Maud Bouwman,VieCuri Medical Centre,http://dx.doi.org/10.1136/bmjopen-2021-051573,11/5/2021,3/2/2024,Unverified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_SepOct2020,"October 27, 2021",Local,Netherlands,NLD,,Amsterdam,"September 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,236,5.50%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,12/15/2021,3/2/2024,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_SepOct2020,"October 27, 2021",Local,Netherlands,NLD,,Amsterdam,"September 1, 2020","October 31, 2020",Multiple populations,Multiple groups,312,6.70%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,12/15/2021,3/2/2024,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVpos_MarApr2021,"October 27, 2021",Local,Netherlands,NLD,,Amsterdam,"March 1, 2021","April 30, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,202,12.90%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,12/15/2021,3/2/2024,Verified
211027_Amsterdam_AmsterdamUniversityMedicalCenters_HIVneg_MarApr2021,"October 27, 2021",Local,Netherlands,NLD,,Amsterdam,"March 1, 2021","April 30, 2021",Multiple populations,Multiple groups,288,12.20%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,100.00%,98.20%,High,Presentation or Conference,Myrthe L Verburgh,Amsterdam University Medical Centers,http://dx.doi.org/10.1111/hiv.13183,12/15/2021,3/2/2024,Verified
211220_Amsterdam_AmsterdamInfectionandImmunityInstitute_Overall,"December 20, 2021",Local,Netherlands,NLD,North Holland,Amsterdam,"September 15, 2020","April 15, 2021",Multiple populations,Multiple groups,563,10.83%,,,Convenience,Eurofins Ingenasa,Not reported,Total Antibody,100.00%,98.20%,High,Journal Article (Peer-Reviewed),Myrthe Verburgh,Amsterdam Infection and Immunity Institute,https://dx.doi.org/10.1093/infdis/jiab616,1/10/2022,3/2/2024,Verified
211214_Amsterdam_UniversityofAmsterdam_Visit2,"December 14, 2021",Local,Netherlands,NLD,North Holland,Amsterdam,"November 23, 2020","June 4, 2021",Household and community samples,Multiple groups,2075,23.61%,,,Convenience,Beijing Wantai Biological,ELISA,"IgA,IgG,IgM",94.00%,,High,Journal Article (Peer-Reviewed),Liza Coyer,University of Amsterdam,https://dx.doi.org/10.1016/j.lanepe.2021.100284,1/12/2022,3/2/2024,Verified
211009_Rotterdam_FranciscusGasthuisandVlietland_Period1_Overall,"December 1, 2021",Local,Netherlands,NLD,South Holland,Rotterdam,"July 19, 2020","September 19, 2020",Residual sera,Children and Youth (0-17 years),209,4.10%,1.10%,7.10%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),I.L.M. Rotee,Franciscus Gasthuis & Vlietland,https://dx.doi.org/10.1016/j.jcvp.2021.100045,3/16/2022,3/2/2024,Verified
211009_Rotterdam_FranciscusGasthuisandVlietland_Period2_Overall,"December 1, 2021",Local,Netherlands,NLD,South Holland,Rotterdam,"October 19, 2020","December 19, 2020",Residual sera,Children and Youth (0-17 years),240,13.80%,9.00%,18.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),I.L.M. Rotee, Franciscus Gasthuis & Vlietland,https://dx.doi.org/10.1016/j.jcvp.2021.100045,3/16/2022,3/2/2024,Verified
220810_Limburg_SouthLimburgPublicHealthService_Overall,"August 10, 2022",Regional,Netherlands,NLD,Limburg,,"October 28, 2020","December 23, 2020",Household and community samples,Multiple groups,9715,17.70%,16.90%,18.50%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Demi Pagen,South Limburg Public Health Service,https://dx.doi.org/10.1017/S0950268822001339,9/13/2022,3/2/2024,Unverified
220909_Netherlands_AmsterdamUniversityMedicalCenters,"September 8, 2022",Regional,Netherlands,NLD,,,"May 10, 2021","October 15, 2021",Residual sera,Children and Youth (0-17 years),209,36.00%,29.00%,43.00%,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Maya W Keuning,Amsterdam University Medical Centers,https://dx.doi.org/10.3389/fimmu.2022.976382,10/20/2022,4/11/2024,Verified
221215_Netherland_BravisHospital_Overall,"December 15, 2022",National,Netherlands,NLD,,"Roosendaal, Nijmegen, Arnhem","April 12, 2021","October 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,482,6.40%,,,Convenience,"Luminex Corporation,Beijing Wantai Biological",Multiple Types,"IgA,IgG,IgM",,,,Journal Article (Peer-Reviewed),K.V. Kwee,Bravis Hospital,https://dx.doi.org/10.1080/09546634.2022.2161297,1/11/2023,3/2/2024,Unverified
220109_Netherlands_NationalInstituteforPublicHealthandtheEnvironment_antiNp,"January 9, 2023",National,Netherlands,NLD,,,"January 10, 2022","September 1, 2022",Household and community samples,Multiple groups,43257,5.08%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Preprint,Brechje de Gier,National Institute for Public Health and the Environment,10.1101/2023.01.09.23284334,1/25/2023,4/18/2024,Verified
230725_Amsterdam_PublicHealthServiceOfAmsterdam_Visitors_Overall,"July 25, 2023",Local,Netherlands,NLD,,Amsterdam,"May 3, 2021","May 21, 2021",Persons experiencing homelessness,Multiple groups,134,3.00%,0.80%,7.50%,Convenience,Biozek,LFIA,"IgG,IgM",85.70%,,,Journal Article (Peer-Reviewed),Ellen Generaal,Public Health Service of Amsterdam,https://dx.doi.org/10.1371/journal.pone.0288610,8/22/2023,3/2/2024,Unverified
230725_Amsterdam_PublicHealthServiceOfAmsterdam_Staff_Overall,"July 25, 2023",Local,Netherlands,NLD,,Amsterdam,"May 3, 2021","May 21, 2021",Non-essential workers and unemployed persons,Multiple groups,53,11.30%,4.30%,23.00%,Convenience,Biozek,LFIA,"IgG,IgM",85.70%,,,Journal Article (Peer-Reviewed),Ellen Generaal,Public Health Service of Amsterdam,https://dx.doi.org/10.1371/journal.pone.0288610,8/22/2023,3/2/2024,Unverified
230802_Netherland_AmsterdamUMClocationVrijeUniversiteitAmsterdam_Overall,"August 2, 2023",Local,Netherlands,NLD,,Amsterdam,"March 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),219,15.50%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.40%,99.60%,,Journal Article (Peer-Reviewed),A. H. Ayesha Lavell,Amsterdam UMC location Vrije Universiteit Amsterdam,https://dx.doi.org/10.1371/journal.pone.0288352,8/23/2023,3/2/2024,Unverified
230801_Netherlands_EmmaChildren’sHospital,"August 1, 2023",National,Netherlands,NLD,,,"October 12, 2020","February 24, 2021",Residual sera,Adults (18-64 years),2312,15.40%,,,Convenience,NA,ELISA,"IgA,IgG",67.90%,99.00%,,Journal Article (Peer-Reviewed),Hannah G. Juncker,Emma Children’s Hospital,https://dx.doi.org/10.1016/j.heliyon.2023.e19218,9/22/2023,9/22/2023,Unverified
210404_Nepal_GovernmentOfNepal_overall_PopAdj,"April 4, 2021",National,Nepal,NPL,,,"October 9, 2020","October 22, 2020",Household and community samples,Multiple groups,3040,14.40%,11.80%,17.00%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Low,Institutional Report,Government of Nepal,Government of Nepal,https://mohp.gov.np/attachments/article/708/First%20Sero-prevalence_final_report_04-04-2021.pdf,5/23/2021,3/2/2024,Verified
210623_KathmanduValley_NepalHealthResearchCouncil_TestAdj,"June 23, 2021",Regional,Nepal,NPL,Bagmati Pradesh Province,Kathmandu Valley,"December 3, 2020","December 25, 2020",Health care workers and caregivers,Adults (18-64 years),800,38.99%,29.08%,43.91%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,89.30%,99.20%,Moderate,Preprint,Kiran Raj Pandey,Nepal Health Research Council,10.21203/rs.3.rs-626260/v1,7/6/2021,8/15/2023,Unverified
210706_Kathmandu_ManmohanMemorialMedicalCollege_primary,"July 6, 2021",Local,Nepal,NPL,,Kathmandu,"November 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),185,22.20%,,,Convenience,Zybio Inc.,Other,"IgM,IgG",,,High,Preprint,Suraj Aryal,Manmohan Memorial Medical College,https://www.medrxiv.org/content/10.1101/2021.07.01.21259884v1.full-text,7/14/2021,3/2/2024,Verified
210830_Nepal_MinistryofHealthandPopulation_Overall,"August 30, 2021",National,Nepal,NPL,,,"July 5, 2021","August 14, 2021",Household and community samples,Multiple groups,13161,68.60%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Shuvam Dhungana,Ministry of Health and Population,https://kathmandupost.com/health/2021/08/30/over-two-thirds-population-has-covid-19-antibodies-seroprevalence-study-shows,9/7/2021,7/17/2022,Verified
220201_Kathmandu_ManmohanMemorialMedicalCollegeAndTeachingHospital_Overall,"February 1, 2022",Local,Nepal,NPL,,Kathmandu,"November 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),185,22.16%,,,Convenience,Zybio Inc.,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Suraj Aryal,Manmohan Memorial Medical College and Teaching Hospital,https://dx.doi.org/10.1155/2022/8515051,2/21/2022,3/2/2024,Unverified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Household and community samples,Multiple groups,9756,1.40%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,5/21/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Genpop_Primary,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Household and community samples,Multiple groups,1577,7.40%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,5/22/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_Genpop_Primary,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Household and community samples,Multiple groups,3974,5.50%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,5/22/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop_Primary,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Household and community samples,Multiple groups,1769,5.00%,4.00%,6.00%,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,5/22/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Household and community samples,Multiple groups,4940,5.20%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,5/22/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Household and community samples,Multiple groups,1946,0.70%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,5/22/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Household and community samples,Multiple groups,5394,3.56%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,5/22/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Genpop,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Household and community samples,Multiple groups,1635,0.30%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,5/22/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_Genpop_Primary,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Household and community samples,Multiple groups,4932,3.70%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,5/22/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_Genpop_Primary,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Household and community samples,Multiple groups,2451,5.30%,,,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",,,Moderate,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,5/22/2021,3/2/2024,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_Fishermen,"July 27, 2020",Local,Mozambique,MOZ,Cabo Delgado,Pemba,"July 6, 2020","July 13, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),80,5.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,3/2/2024,Verified
201727_Pemba_RepúblicaDeMoçambiqueMinistérioDaSaúde_DisplacedPeople,"July 27, 2020",Local,Mozambique,MOZ,Cabo Delgado,Pemba,"July 6, 2020","July 13, 2020",Persons experiencing homelessness,Multiple groups,66,6.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,República de Moçambique Ministério da Saúde,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inquerito-SARS-CoV-2-PEMBA_-RESULTADOS-PRELIMINARES_FINAL_3_27.07.2020.pdf,6/25/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Non-essential workers and unemployed persons,Multiple groups,188,6.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Essential non-healthcare workers,Multiple groups,324,2.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Health care workers and caregivers,Multiple groups,787,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Essential non-healthcare workers,Multiple groups,473,8.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,3/2/2024,Verified
201015_Beira_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 15, 2020",Local,Mozambique,MOZ,Sofala,Beira,"September 21, 2020","October 2, 2020",Non-essential workers and unemployed persons,Multiple groups,1585,8.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Nedio Mabunda,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/InCOVID-2020_-BEIRA_-RESULTADOS-PRELIMINARES.pdf,7/9/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Refugees,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Persons experiencing homelessness,Multiple groups,221,6.00%,2.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),250,5.00%,2.00%,7.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),564,6.00%,4.00%,8.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1427,7.00%,6.00%,9.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),554,3.00%,1.00%,4.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
200701_NampulaCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_MerchantsVendors,"July 7, 2020",Local,Mozambique,MOZ,Nampula,Nampula,"June 17, 2020","June 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1493,10.00%,8.00%,11.00%,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Presentation or Conference,Eduardo Samo Gudo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-SARS-CoV-2-NAMPULA_vfinal.pdf,7/12/2021,3/2/2024,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Essential non-healthcare workers,Adults (18-64 years),287,1.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,3/2/2024,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Health care workers and caregivers,Adults (18-64 years),380,1.30%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,3/2/2024,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_DefenceForces,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Essential non-healthcare workers,Adults (18-64 years),407,4.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,3/2/2024,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),172,4.70%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,3/2/2024,Verified
201127_Chimoio_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"November 27, 2020",Local,Mozambique,MOZ,Manica Province,Chimoio,"November 2, 2020","November 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),643,1.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Arlete Mahumane,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/11/Inqueirito-SE-SARS-CoV-2-de-Cidade-de-Chimoio-Resultados-preliminares-27-Nov-2020-V_1.1_corrigido-I_JANI_FINAL1.pdf,7/12/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),871,0.20%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/18/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Essential non-healthcare workers,Adults (18-64 years),230,0.40%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/18/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Health care workers and caregivers,Adults (18-64 years),454,1.80%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/18/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Essential non-healthcare workers,Adults (18-64 years),471,1.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/18/2021,3/2/2024,Verified
201019_Lichinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 19, 2020",Local,Mozambique,MOZ,Niassa,Lichinga,"September 28, 2020","October 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),122,0.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Jeronimo Langa,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inquerito-SE-SARS-CoV-2-Lichinga_19-10-020.pdf,7/18/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Essential non-healthcare workers,Adults (18-64 years),554,2.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/18/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransporationWorkers,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Essential non-healthcare workers,Adults (18-64 years),334,1.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/18/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1556,0.80%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/18/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCW,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Health care workers and caregivers,Adults (18-64 years),569,0.70%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/18/2021,3/2/2024,Verified
200924_TeteCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"September 24, 2020",Local,Mozambique,MOZ,Tete,Tete,"August 31, 2020","October 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),404,0.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/09/Inque%CC%81rito-SE-SARS-CoV-2_Cidade-de-Tete_resultados.pdf,7/18/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_CommercialEstablishments,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),323,5.88%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_VendorsMerchants,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1288,4.97%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_PoliceForces,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),456,4.39%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_HCWs,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),793,3.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,3/2/2024,Verified
201021_Matola_RepúblicaDeMoçambiqueMinistérioDaSaúde_TransportationWorkers,"October 21, 2020",Local,Mozambique,MOZ,Maputo,Matolo,"September 14, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),282,3.19%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Ivalda Macicame,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/10/Inque%CC%81rito-Provincia-de-Maputo_resultados-preliminares_21Out2020-versao-final.pdf,7/18/2021,3/2/2024,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Police,"August 31, 2020",Local,Mozambique,MOZ,,Maputo,"August 3, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),559,3.94%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,3/2/2024,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_Airport&PortWorkers,"August 31, 2020",Local,Mozambique,MOZ,,Maputo,"August 3, 2020","August 21, 2020",Essential non-healthcare workers,Adults (18-64 years),362,3.31%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,3/2/2024,Verified
200831_MaputoCity_RepúblicaDeMoçambiqueMinistérioDaSaúde_NursingHomeWorkers,"August 31, 2020",Local,Mozambique,MOZ,,Maputo,"August 3, 2020","August 21, 2020",Health care workers and caregivers,Adults (18-64 years),85,1.18%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Edna Viegas,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/08/Inqu%C3%A9rito-SE-SARS-CoV-2_Cidade-de-Maputo_resultados_31Ago2020.pdf,7/18/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_DefenceForcesy,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Essential non-healthcare workers,Multiple groups,174,9.20%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_TransportationWorkers,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),153,4.60%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_VendorsMerchants,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1001,4.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_CommercialEstablishments,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),255,3.50%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Maxixe&Massinga_RepúblicaDeMoçambiqueMinistérioDaSaúde_Maxixe1_HCW,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Maxixe,"November 7, 2020","November 21, 2020",Health care workers and caregivers,Adults (18-64 years),342,2.00%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_DefenceForces,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Essential non-healthcare workers,Adults (18-64 years),116,18.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_TransportationWorkers,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Essential non-healthcare workers,Adults (18-64 years),34,5.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_Vendors/Merchants,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),517,8.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_CommercialEstablishments,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),128,10.90%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201216_Mozambique_RepúblicaDeMoçambiqueMinistérioDaSaúde_Massinga2_HCW,"December 16, 2020",Local,Mozambique,MOZ,Inhambane,Massinga,"November 26, 2020","December 3, 2020",Health care workers and caregivers,Adults (18-64 years),131,6.10%,,,Convenience,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,High,Presentation or Conference,Mussagy Mahomed,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/Inquerito-de-SARS-CoV-2_Maxixe-e-Massinga.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_VendorsMerchants,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),460,5.90%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_TransporationWorkers,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Essential non-healthcare workers,Adults (18-64 years),209,3.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_HCWs,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Health care workers and caregivers,Adults (18-64 years),281,5.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_DefenceForces,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Essential non-healthcare workers,Adults (18-64 years),116,1.70%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Xai-Xai1_CommercialEstablishments,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Xai-Xai,"November 2, 2020","November 12, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),272,3.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_VendorsMerchants,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),472,6.80%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_TransporationWorkers,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),112,16.10%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_HCWs,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Health care workers and caregivers,Adults (18-64 years),165,10.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_CommercialEstablishments,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),145,7.50%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
201208_Xai-Xai&Chokwe_RepúblicaDeMoçambiqueMinistérioDaSaúde_Chokwe2_DefenceForces,"December 8, 2020",Local,Mozambique,MOZ,Gaza,Chokwe,"November 16, 2020","November 21, 2020",Essential non-healthcare workers,Adults (18-64 years),67,10.40%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,,High,Presentation or Conference,Paulo Arnaldo,Republica de Mocambique Ministerio da Saude,https://covid19.ins.gov.mz/wp-content/uploads/2020/12/InCOVID-2020_-XAI-XAI-CHOKWE_-RESULTADOS-PRELIMINARES_08-12-2020.pdf,7/24/2021,3/2/2024,Verified
220624_MaputoCity_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdj_PopAdj,"June 24, 2022",Local,Mozambique,MOZ,Maputo,Maputo City,"August 4, 2020","August 24, 2020",Household and community samples,Multiple groups,4719,2.10%,1.20%,3.30%,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",83.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,7/7/2022,8/15/2023,Unverified
220624_Pemba_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdjPopAdj,"June 24, 2022",Local,Mozambique,MOZ,Cabo Delgado,Pemba,"July 6, 2020","July 13, 2020",Household and community samples,Multiple groups,1358,3.00%,1.00%,6.60%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",86.70%,98.70%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,7/12/2022,8/15/2023,Unverified
220624_Quelimane_InstitutoNacionaldeSaúde_GenPop_Overall_TestAdj_PopAdj,"June 24, 2022",Local,Mozambique,MOZ,Zambezia,Quelimane,"August 10, 2020","August 21, 2020",Household and community samples,Multiple groups,5066,0.90%,0.10%,1.90%,Stratified probability,Abbott Laboratories,LFIA,"IgG,IgM",83.30%,98.00%,Moderate,Journal Article (Peer-Reviewed),Paulo Arnaldo,Instituto Nacional de Saúde,https://dx.doi.org/10.1093/cid/ciac516,7/12/2022,8/15/2023,Unverified
221024_Manhica_BarcelonaInstituteforGlobalHealth,"October 26, 2022",Regional,Mozambique,MOZ,Maputo Province,Manhica District,"November 15, 2019","June 15, 2021",Pregnant or parturient women,Multiple groups,397,11.30%,8.40%,14.90%,Convenience,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Raquel Gonzalez,Barcelona Institute for Global Health,https://dx.doi.org/10.1097/QAI.0000000000003120,11/7/2022,3/16/2024,Verified
231226_Maputo_InstitutoNacionaldeSaude_unadj,"December 26, 2023",Local,Mozambique,MOZ,,Maputo,"December 15, 2020","July 31, 2021",Household and community samples,Multiple groups,1412,21.30%,,,Simplified probability,NA,Luminex,IgG,96.00%,99.00%,Moderate,Preprint,Brecht Ingelbeen,Instituto Nacional de Saúde,https://doi.org/10.1101/2023.12.22.23300474,5/15/2024,5/15/2024,Unverified
230410_Mongolia_MongolianNationalUniversityOfMedicalSciences_4thRound_PopAdj_TotalAb,"April 10, 2023",National,Mongolia,MNG,"Dornod, Khentii, Selenge, Umnugobi, Dornogobi, Bayankhongor, Bayan-Ulgii, Zavkhan
","Ulaanbaatar, Erdenet","September 3, 2021","December 9, 2021",Household and community samples,Multiple groups,4088,80.60%,77.80%,83.10%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,99.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Battogtokh Chimeddorj,Mongolian National University of Medical Sciences,https://dx.doi.org/10.1016/j.lanwpc.2023.100760,5/7/2023,4/28/2024,Verified
201021_VeracruzCity_UniversidadVeracruzana_unadj,"October 21, 2020",Local,Mexico,MEX,Veracruz,Veracruz City,"June 1, 2020","July 31, 2020",Residual sera,Multiple groups,2174,29.50%,27.59%,31.47%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Jose Maria Remes-Troche,Universidad Veracruzana,https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1,1/18/2021,3/2/2024,Verified
210624_NuevoLeon_AutonomousUniversityofNuevoLeon_primary,"June 24, 2021",Regional,Mexico,MEX,Nuevo Leon,,"January 1, 2020","December 15, 2020",Blood donors,Adults (18-64 years),2068,5.30%,,,Sequential,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Natalia Martinez-Acu a,Autonomous University of Nuevo Leon,https://dx.doi.org/10.3390/v13071225,2/5/2021,7/5/2023,Verified
210415_Mexico_InstitutodeSaludparaelBienestar_Overall,"April 15, 2021",National,Mexico,MEX,NR,NR,"February 10, 2020","December 31, 2020",Residual sera,Multiple groups,24273,15.90%,,,Stratified non-probability,"DiaSorin,GenScript",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Jose Munoz-Medina,Instituto de Salud para el Bienestar,https://dx.doi.org/10.3390/microorganisms9040850,5/20/2021,3/2/2024,Verified
210423_Monterrey_UniversidadAutónomaDeNuevoLeón,"April 23, 2021",Local,Mexico,MEX,Nuevo Leon,Monterrey,"May 22, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,154,11.70%,,,Sequential,Healgen,LFIA,"IgG,IgM",90.11%,98.46%,High,Journal Article (Peer-Reviewed),Giovanna Yazmin Arteaga Muller,Universidad Autónoma de Nuevo León,https://dx.doi.org/10.1007/s11255-021-02852-4,5/21/2021,3/2/2024,Unverified
201216_Mexico_GovernmentOfMexico_overall,"December 16, 2020",National,Mexico,MEX,,,"August 15, 2020","November 15, 2020",Household and community samples,Multiple groups,7098,25.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Secretaria de Salud ,Government of Mexico,https://www.gob.mx/salud/prensa/255-secretaria-de-salud-presenta-resultados-preliminares-de-la-encuesta-nacional-de-salud-y-nutricion-covid-19?idiom=es,6/6/2021,7/17/2022,Verified
210607_NuevoLeon_HealthServicesOfTheStateOfNuevoLeon_Overall,"June 7, 2021",Regional,Mexico,MEX,Nuevo Leon,,"August 15, 2020","November 15, 2020",Household and community samples,Multiple groups,4495,27.10%,25.80%,28.40%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Edgar Rodriguez-Vidales,Health Services of the State of Nuevo Leon,https://dx.doi.org/10.1002/jmv.27131,6/23/2021,3/2/2024,Verified
210812_MexicoCity_InstitutoNacionaldeRehabilitacion_Overall,"August 12, 2021",Local,Mexico,MEX,,Mexico City,"August 10, 2020","September 9, 2020",Health care workers and caregivers,Multiple groups,299,13.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esteban Cruz-Arenas,Nacional de Rehabilitacion hospital,http://dx.doi.org/10.1371/journal.pone.0255916,8/30/2021,3/2/2024,Unverified
210819_CityofGuadalupe_UniversidadAutónomadeNuevoLeón_Overall,"August 19, 2021",Local,Mexico,MEX,Nuevo Leon,Guadalupe,"July 9, 2020","July 23, 2020",Multiple populations,Multiple groups,3268,5.90%,5.10%,6.80%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Cristina Diaz‑Salazar,Universidad Autonoma de Nuevo Leon,https://dx.doi.org/10.1186/s12879-021-06550-5,9/1/2021,3/2/2024,Verified
210916_MexicoCity_UniversidadNacionalAutónomaDeMéxico_Primary,"September 16, 2021",Local,Mexico,MEX,,Mexico City,"September 21, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),169,20.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Fatima Sofía Magana-Guerrero,Universidad Nacional Autónoma De México,https://dx.doi.org/10.1080/09286586.2021.1974493,9/29/2021,7/17/2022,Unverified
211109_Nayarit_AutonomousUniversityofNayarit_overall,"November 9, 2021",Local,Mexico,MEX,Nayarit,Ciudad de Tepic,"June 28, 2021","June 28, 2021",Household and community samples,Children and Youth (0-17 years),134,17.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Gladys Alejandra Toledo-Ibarra,Autonomous University of Nayarit,https://saludpublica.mx/index.php/spm/article/view/13128/12175,12/1/2021,7/17/2022,Unverified
211105_Mexico_InstitutoNacionaldeSaludPublica_Children_Primary,"November 5, 2021",National,Mexico,MEX,,,"August 15, 2020","November 15, 2020",Household and community samples,Children and Youth (0-17 years),858,26.70%,22.10%,31.30%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.00%,99.50%,Low,Journal Article (Peer-Reviewed),Francisco Canto-Osorio,Instituto Nacional de Salud Públic,https://saludpublica.mx/index.php/spm/article/view/12847,12/2/2021,8/15/2023,Verified
211105_Mexico_InstitutoNacionaldeSaludPublica_Adolescent_Primary,"November 5, 2021",National,Mexico,MEX,,,"August 15, 2020","November 15, 2020",Household and community samples,Children and Youth (0-17 years),944,18.70%,14.90%,22.50%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.00%,99.50%,Low,Journal Article (Peer-Reviewed),Francisco Canto-Osorio,Instituto Nacional de Salud Públic,https://saludpublica.mx/index.php/spm/article/view/12847,12/2/2021,8/15/2023,Verified
211213_MexicoCity_INCMNSZ_FollowUp,"December 13, 2021",Local,Mexico,MEX,,Mexico City,"August 15, 2020","September 30, 2020",Multiple populations,Multiple groups,97,7.20%,,,Unclear,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Monica Meneses-Medina,The National Institute of Medical Sciences and Nutrition Salvador Zubirán,https://dx.doi.org/10.1200/GO.21.00207,1/5/2022,3/2/2024,Unverified
220201_Mexico_NationalInstituteofPublicHealth_Overall,"February 1, 2022",National,Mexico,MEX,,,"August 15, 2020","November 15, 2020",Household and community samples,Multiple groups,9463,24.90%,22.20%,26.70%,Stratified probability,Roche Diagnostics,CLIA,IgG,92.02%,99.52%,Moderate,Journal Article (Peer-Reviewed),Ana Basto-Abreu,National Institute of Public Health,https://dx.doi.org/10.1038/s41467-022-28232-9,2/8/2022,8/15/2023,Unverified
220127_Campeche_UniversidadAutonomaCampeche_Overall,"January 27, 2022",Regional,Mexico,MEX,Campeche,,"August 15, 2021","September 15, 2021",Blood donors,Multiple groups,479,69.10%,,,Sequential,NA,ELISA,IgG,94.00%,100.00%,High,Journal Article (Peer-Reviewed),Victor Monteon,Universidad Autonoma Campeche,https://dx.doi.org/10.1016/j.transci.2022.103374,2/10/2022,7/17/2022,Verified
220311_Tijuana_UniversityofCaliforniaSanFrancisco_2020NovDec,"March 11, 2022",Local,Mexico,MEX,Baja California,Tijuana,"February 15, 2021","April 15, 2021",Persons experiencing homelessness,Adults (18-64 years),84,46.30%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ietza Bojorquez-Chapela,University of California San Francisco,https://dx.doi.org/10.1136/bmjgh-2021-007202,3/23/2022,7/17/2022,Unverified
220311_Tijuana_UniversityofCaliforniaSanFrancisco_2021FebApr,"March 11, 2022",Local,Mexico,MEX,Baja California,Tijuana,"November 15, 2020","December 15, 2020",Persons experiencing homelessness,Adults (18-64 years),397,54.50%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ietza Bojorquez-Chapela,University of California San Francisco,https://dx.doi.org/10.1136/bmjgh-2021-007202,3/23/2022,7/17/2022,Unverified
220328_Mexico_SaludDignaAC_PopAdj_Overall,"March 28, 2022",National,Mexico,MEX,"Aguascalientes,Baja California,Baja California Sur,Campeche,Chiapas,Chihuahua,Ciudad de México,Coahuila,Colima,Durango,Estado de México,Guanajuato,Guerrero,Hidalgo,Jalisco,Michoacán,Morelos,Nayarit,Nuevo León,Oaxaca,Puebla,Querétaro,Quintana Roo,San Luis Potosí,Sinaloa,Sonora,Tabasco,Tamaulipas,Tlaxcala,Veracruz,Yucatán,Zacatecas",,"July 5, 2020","December 31, 2020",Residual sera,Multiple groups,522690,32.80%,32.10%,33.50%,Sequential,Roche Diagnostics,CLIA,"IgG,IgM",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Miguel Fernández-Rojas,Salud Digna A.C.,https://dx.doi.org/10.1038/s41598-022-09395-3,4/6/2022,7/17/2022,Verified
220317_MexicoCity_NationalInstituteofRespiratoryDiseases_Overall_TestAdj,"March 17, 2022",Local,Mexico,MEX,Mexico City,Mexico City,"October 15, 2020","June 15, 2021",Health care workers and caregivers,Adults (18-64 years),883,33.50%,,,Convenience,Roche Diagnostics,CLIA,Not reported,97.92%,99.95%,Moderate,Journal Article (Peer-Reviewed),Vanessa Davila-Conn,National Institute of Respiratory Diseases,https://dx.doi.org/10.1371/journal.pone.0264964,4/7/2022,8/15/2023,Unverified
220512_MexicoCity_GeneralHospitalofMexico_Overall,"May 12, 2022",Local,Mexico,MEX,,Mexico City,"August 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),109,58.72%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Nallely Bueno-Hernandez,General Hospital of Mexico,https://dx.doi.org/10.3390/healthcare10050896,6/10/2022,7/17/2022,Unverified
220605_Sinaloa_UniversityofSinaloa_PregnantWomen1,"June 5, 2022",Regional,Mexico,MEX,Sinaloa State,,"August 15, 2020","December 15, 2020",Pregnant or parturient women,Multiple groups,116,11.20%,,,Unclear,Roche Diagnostics,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Nidia Leon-Sicairos,University of Sinaloa,https://dx.doi.org/10.1111/aji.13583,6/22/2022,7/17/2022,Unverified
220605_Sinaloa_UniversityofSinaloa_Neonates2,"June 5, 2022",Regional,Mexico,MEX,Sinaloa State,,"August 15, 2020","December 15, 2020",Perinatal,Children and Youth (0-17 years),84,35.70%,,,Unclear,Roche Diagnostics,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Nidia Leon-Sicairos,University of Sinaloa,https://dx.doi.org/10.1111/aji.13583,6/24/2022,7/17/2022,Unverified
220708_Mexico_InstitutoNacionaldeSaludPública_Overall,"July 8, 2022",Local,Mexico,MEX,Morelos,,"January 14, 2021","January 21, 2021",Health care workers and caregivers,Adults (18-64 years),381,31.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Antonia Herrera-Ortiz,Instituto Nacional de Salud Pública,https://dx.doi.org/10.21149/13677,9/28/2022,3/2/2024,Unverified
220602_Mexico_InstitutoNacionaldeNeurologíayNeurocirugía_Prepandemic,"June 6, 2022",Local,Mexico,MEX,,,"January 1, 2018","December 31, 2019",Blood donors,Multiple groups,538,0.60%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,96.30%,High,Journal Article (Peer-Reviewed),Lucinda Aguirre-Cruz,Instituto Nacional de Neurología y Neurocirugía,https://dx.doi.org/10.21149/12930,10/1/2022,3/2/2024,Unverified
220602_Mexico_InstitutoNacionaldeNeurologíayNeurocirugía_PandemicDonors,"June 6, 2022",Local,Mexico,MEX,,,"October 1, 2020","December 31, 2020",Blood donors,Multiple groups,243,29.60%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,96.30%,High,Journal Article (Peer-Reviewed),Lucinda Aguirre-Cruz,Instituto Nacional de Neurología y Neurocirugía,https://dx.doi.org/10.21149/12930,10/2/2022,3/2/2024,Unverified
220602_Mexico_InstitutoNacionaldeNeurologíayNeurocirugía_PandemicPatients,"June 6, 2022",Local,Mexico,MEX,,,"October 1, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,312,15.70%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,96.30%,High,Journal Article (Peer-Reviewed),Lucinda Aguirre-Cruz,Instituto Nacional de Neurología y Neurocirugía,https://dx.doi.org/10.21149/12930,10/2/2022,3/2/2024,Unverified
221117_Mexico_CarlosSlimFoundation,"November 17, 2022",National,Mexico,MEX,,,"June 26, 2020","December 16, 2020",Household and community samples,Adults (18-64 years),58277,4.10%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hector Gallardo-Rinco,Carlos Slim Foundation ,https://dx.doi.org/10.1371/journal.pone.0277014,12/9/2022,3/20/2023,Unverified
220615_Merida_EmoryUniversity_Overall,"June 15, 2022",Local,Mexico,MEX,Yucatan,Merida,"February 15, 2021","June 15, 2021",Household and community samples,Children and Youth (0-17 years),1005,25.50%,,,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Guadalupe Ayora-Talavera,Emory University,https://dx.doi.org/10.1371/journal.pgph.0000354,4/26/2023,3/2/2024,Unverified
220802_Baja_SecretariatofHealthofBajaCalifornia,"August 2, 2022",Regional,Mexico,MEX,Baja California,,"February 1, 2021","February 19, 2021",Household and community samples,Multiple groups,1126,21.10%,17.40%,25.20%,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Oscar Zazueta,Secretariat of Health of Baja California,https://dx.doi.org/10.1371/journal.pgph.0000820,5/4/2023,5/4/2023,Unverified
230413_Mexico_UniversidadAutónomaDeGuerrero_HCWs,"April 13, 2023",Local,Mexico,MEX,,Guerrero,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),253,42.70%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Karen Cortes-Sarabia,Universidad Autónoma de Guerrero,https://dx.doi.org/10.3390/v15040955,5/30/2023,5/30/2023,Unverified
230824_Mexico_NationalInstituteofPublicHealth_AntiS_Adj,"August 24, 2023",National,Mexico,MEX,,,"August 4, 2021","November 11, 2021",Household and community samples,Multiple groups,7236,84.10%,79.70%,88.30%,Stratified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Ana Basto-Abreu,National Institute of Public Health,https://dx.doi.org/10.1002/jmv.29038,9/16/2023,9/16/2023,Unverified
230809_StateofMexico_MexicanSocialSecurityInstitute_Overall,"August 9, 2023",Regional,Mexico,MEX,State of Mexico,,"May 14, 2021","July 27, 2021",Household and community samples,Multiple groups,980,46.02%,,,Convenience,GenScript,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Daniel Montes-Herrera,Mexican Social Security Institute,https://dx.doi.org/10.3390/diagnostics13162630,9/21/2023,4/26/2024,Verified
210118_Nouakchott_CentreHospitalierNationalDeNouakchott_Overall,"January 18, 2021",Local,Mauritania,MRT,,Nouakchott,"May 5, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),835,1.67%,,,Convenience,Xiamen Biotime Biotechnology Co. Ltd,LFIA,"IgG,IgM",96.40%,98.70%,High,Journal Article (Peer-Reviewed),Mohamed Lemine Ould Salem,Centre Hospitalier National de Nouakchott,http://dx.doi.org/10.11604/pamj.2021.38.55.24259,4/14/2021,3/2/2024,Verified
220107_Bamako_UniversityOfBamako,"January 7, 2022",Local,Mali,MLI,,Bamako,"November 15, 2020","June 15, 2021",Health care workers and caregivers,Adults (18-64 years),238,61.76%,,,Convenience,Enzo Life Sciences,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anou M. Somboro,University Of Bamako,https://dx.doi.org/10.3390/v14010102,1/21/2022,7/17/2022,Unverified
220216_Bamako_SorbonneUniversite_Overall,"February 16, 2022",Local,Mali,MLI,,Bamako,"March 16, 2021","July 15, 2021",Health care workers and caregivers,Adults (18-64 years),195,52.30%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",,94.00%,High,Preprint,Almoustapha Maiga,Sorbonne Universite,https://dx.doi.org/10.1016/j.cmi.2022.02.019,3/1/2022,3/2/2024,Unverified
210629_Mali_NationalInstitutesofHealth_1SotubaVisit2_OverallAdjusted,"June 29, 2021",Local,Mali,MLI,Bamako,Bamako,"December 21, 2020","January 26, 2021",Household and community samples,Multiple groups,528,70.40%,56.80%,84.10%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,3/9/2022,7/17/2022,Verified
210629_Mali_NationalInstitutesofHealth_2BancoumanaVisit2_OverallAdjusted,"June 29, 2021",Local,Mali,MLI,Koulikoro Region,Bancoumana,"December 28, 2020","January 29, 2021",Household and community samples,Multiple groups,904,52.10%,41.90%,62.30%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,3/9/2022,7/17/2022,Verified
210629_Mali_NationalInstitutesofHealth_3DoneguebougouVisit2_OverallAdjusted,"June 29, 2021",Local,Mali,MLI,Koulikoro Region,Doneguebougou,"December 14, 2020","January 15, 2021",Household and community samples,Multiple groups,1088,35.00%,27.90%,42.10%,Convenience,NA,ELISA,IgG,73.90%,99.40%,Moderate,Journal Article (Peer-Reviewed),Issaka Sagara,National Institutes of Health, https://doi.org/10.1093/cid/ciab589,3/9/2022,7/17/2022,Verified
220616_Kita_UniversityCollegeLondon_Community_Overall,"June 16, 2022",Local,Mali,MLI,,Kita,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,875,27.66%,,,Stratified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Dagmar Alber,Tampere University,https://dx.doi.org/10.1136/bmjopen-2021-060367,6/29/2022,4/1/2024,Unverified
220803_Mali_NationalInstituteofAllergyandInfectiousDiseases_Visit3_overall,"August 3, 2022",National,Mali,MLI,,,"July 1, 2021","July 31, 2021",Household and community samples,Multiple groups,787,30.60%,,,Sequential,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),John Woodford,National Institute of Allergy and Infectious Diseases,https://dx.doi.org/10.3389/fimmu.2022.959697,8/31/2022,9/1/2022,Unverified
230105_ Koutiala_MedecinsSansFrontières_overall,"January 5, 2023",Local,Mali,MLI,Sikasso,Koutiala,"December 1, 2020","June 30, 2021",Blood donors,Adults (18-64 years),927,24.60%,21.80%,27.40%,Sequential,NG Biotech Laboratoires,LFIA,"IgG,IgM",93.70%,99.20%,Moderate,Journal Article (Peer-Reviewed),Fara Wagbo Temessadouno,Medecins Sans Frontières,https://dx.doi.org/10.1371/journal.pgph.0001316,5/8/2023,4/12/2024,Verified
230420_Bamako_AixMarseilleUniversity_PopAdj_Overall,"April 20, 2023",Local,Mali,MLI,,Bamako,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,1327,16.40%,8.00%,24.90%,Stratified probability,BioMérieux,,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Mady Cissoko,Aix-Marseille University,https://dx.doi.org/10.1136/bmjopen-2022-067124,5/25/2023,4/24/2024,Verified
230510_Bamako_UniversityOfSciencesTechniquesAndTechnologiesOfBamako,"May 10, 2023",Local,Mali,MLI,,,"September 1, 2022","September 30, 2022",Household and community samples,Multiple groups,3601,98.00%,,,Stratified non-probability,NA,ELISA,IgG,73.90%,99.40%,Moderate,Preprint,Bourama Traore,"University of Sciences, Techniques and Technologies of Bamako",https://doi.org/10.22541/au.168369884.49641985/v1,5/31/2023,5/1/2024,Verified
211226_Male_MaldivesNationalUniversity_overall,"December 26, 2021",Local,Maldives,MDV,,Male',"October 15, 2020","November 16, 2020",Household and community samples,Multiple groups,1940,13.40%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Raheema Abdul-Raheem,Maldives National University,https://apjai-journal.org/wp-content/uploads/2022/01/AP-040721-1177.pdf,1/12/2022,3/2/2024,Verified
200813_Selangor_UniversityMalaya_OverallPopAdj,"August 13, 2020",Regional,Malaysia,MYS,Selangor,Kuala Lumpur,"January 29, 2020","June 6, 2020",Residual sera,Multiple groups,588,0.40%,0.00%,0.93%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),I Ching Sam,University Malaya,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426,10/3/2020,7/17/2022,Verified
210321_KlangValley_MalaysianMinistryofHealth_HCW,"March 21, 2021",Local,Malaysia,MYS,Klang Valley,,"April 13, 2020","May 12, 2020",Health care workers and caregivers,Adults (18-64 years),400,0.00%,0.00%,0.01%,Self-referral,GenScript,Neutralization,Not reported,91.30%,100.00%,High,Journal Article (Peer-Reviewed),Yuan Liang Woon,Malaysian Ministry of Health,https://dx.doi.org/10.1016/j.lanwpc.2021.100123,4/19/2021,3/2/2024,Verified
211110_Malaysia_UniversityofMalaya_PopAdjusted,"November 10, 2021",Regional,Malaysia,MYS,Selangor,Kuala Lumpur,"December 15, 2020","April 15, 2021",Residual sera,Multiple groups,653,3.00%,,,Convenience,Beijing Wantai Biological,ELISA,Not reported,96.70%,99.50%,High,Journal Article (Peer-Reviewed),I-Ching Sam,University of Malaya,https://dx.doi.org/10.1002/jmv.27441,11/19/2021,3/2/2024,Verified
220117_KlangValleyAndPerak_HealthyMalaysiaSociety_LocalWorkers_TestAndSeroReversionAdj,"January 17, 2022",Regional,Malaysia,MYS,Klang Valley; and Perak,,"July 15, 2021","September 15, 2021",Essential non-healthcare workers,Adults (18-64 years),204,12.10%,8.00%,16.20%,Convenience,ECO Diagnostica LTDA,LFIA,Not reported,83.00%,96.00%,High,Preprint,Noorliza Mohamad Noordin,Healthy Malaysia Society,https://doi.org/10.1101/2022.01.16.22269388,1/25/2022,8/15/2023,Unverified
220117_KlangValleyAndPerak_HealthyMalaysiaSociety_MigrantWorkers_TestAndSeroReversionAdj,"January 17, 2022",Regional,Malaysia,MYS,Klang Valley; and Perak,,"July 15, 2021","September 15, 2021",Essential non-healthcare workers,Adults (18-64 years),874,99.90%,96.70%,100.00%,Convenience,ECO Diagnostica LTDA,LFIA,Not reported,83.00%,96.00%,High,Preprint,Noorliza Mohamad Noordin,Healthy Malaysia Society,https://doi.org/10.1101/2022.01.16.22269388,1/25/2022,8/15/2023,Unverified
220301_KlangValley_UniversitiTeknologiMARA_Spike,"March 1, 2022",Regional,Malaysia,MYS,Klang Valley,,"February 15, 2021","March 15, 2021",Blood donors,Adults (18-64 years),806,4.59%,,,Sequential,Beijing Wantai Biological,ELISA,Not reported,,,High,Presentation or Conference,A.M.A. Shukri,Universiti Teknologi MARA,https://dx.doi.org/10.1016/j.ijid.2021.12.080,3/15/2022,3/2/2024,Verified
220602_UniversitiMalaysiaSabah_INTIInternationalUniversity_Overall,"June 2, 2022",Local,Malaysia,MYS,Sabah,Kota Kinabalu,"December 15, 2020","June 15, 2021",Multiple populations,Adults (18-64 years),168,8.33%,,,Convenience,SD Biosensor,Not reported,"IgG,IgM",100.00%,,High,Journal Article (Peer-Reviewed),Mohd Hijazi,INTI International University,https://dx.doi.org/10.3390/ijerph19116840,6/16/2022,7/17/2022,Unverified
220920_Malaysia_UniversitiSainsMalaysia_Overall,"September 20, 2022",Local,Malaysia,MYS,Penang,Gelugor,"August 24, 2020","March 9, 2021",Health care workers and caregivers,Multiple groups,617,0.00%,,,Self-referral,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Nik Mohd Noor Nik Zuraina,Universiti Sains Malaysia,https://dx.doi.org/10.3390/healthcare10101810,11/10/2022,3/2/2024,Unverified
230101_Malaysia_UniversitiPutraMalaysia_Pre-Vaccination,"January 1, 2023",Local,Malaysia,MYS,,,"May 15, 2020","June 15, 2021",Health care workers and caregivers,Adults (18-64 years),666,2.20%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,,Journal Article (Peer-Reviewed),Amrina Mohd Amin,Universiti Putra Malaysia,https://pubmed.ncbi.nlm.nih.gov/36715186/ ,2/27/2023,3/2/2024,Unverified
200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj,"August 5, 2020",National,Malawi,MWI,Southern Region Malawi,Blantyre,"May 22, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),500,12.30%,8.20%,16.50%,Convenience,Generic Diagnostics Ltd,ELISA,IgG,88.10%,93.20%,High,Preprint,Marah Chibwana,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf,8/8/2020,8/15/2023,Verified
211119_Malawi_Malawi-Liverpool-WellcomeTrustClinicalResearchProgramme_Primary,"November 19, 2021",National,Malawi,MWI,,,"January 15, 2020","July 15, 2021",Blood donors,Multiple groups,5085,27.60%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,97.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Jonathan Mandolo,Malawi-Liverpool-Wellcome Trust Clinical Research Programme,https://dx.doi.org/10.1186/s12916-021-02187-y,12/1/2021,3/2/2024,Verified
211217_Lilongwe_UniversitatsmedizinBerlin,"December 17, 2021",Local,Malawi,MWI,Central Region,Lilongwe,"August 24, 2020","September 3, 2020",Multiple populations,Multiple groups,914,7.99%,,,Convenience,"EUROIMMUN,GenScript",ELISA,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),C Meinus,University of Malawi ,https://dx.doi.org/10.1016/j.ijid.2021.12.336,1/12/2022,3/2/2024,Unverified
220803_Mzuzu_MzuzuUniversity,"August 3, 2022",Local,Malawi,MWI,,Mzuzu,"March 1, 2022","March 31, 2022",Students and Daycares,Multiple groups,166,78.00%,,,Convenience,Abbott Laboratories,LFIA,"IgG,IgM",96.20%,100.00%,High,Preprint,Saul Eric Mwale,Mzuzu University,https://assets.researchsquare.com/files/rs-1870665/v1/bacd0fb8-f35a-4ab7-a0a6-5671b4c46db8.pdf?c=1659971385,8/26/2022,3/2/2024,Unverified
220823_Malawi_PublicHealthInstituteofMalawi_TestAdj,"August 23, 2022",National,Malawi,MWI,,,"December 27, 2021","January 17, 2022",Household and community samples,Multiple groups,4619,86.50%,83.30%,89.20%,Stratified probability,"Beijing Wantai Biological,NA",ELISA,Total Antibody,94.00%,100.00%,Moderate,Preprint,Upendo Mseka,Public Health Institute of Malawi,https://www.medrxiv.org/content/10.1101/2022.08.22.22279060v1,8/31/2022,4/10/2024,Verified
220916_Blantyre_IstitutoSuperioreDiSanita_2020Feb-2021May_Overall,"September 16, 2022",Local,Malawi,MWI,,Blantyre,"February 1, 2020","May 15, 2021",Perinatal,Children and Youth (0-17 years),158,31.00%,23.70%,38.30%,Convenience,"The Binding Site,Kantaro Biosciences LLC",ELISA,"IgG,IgM,IgA",,100.00%,High,Journal Article (Peer-Reviewed),Silvia Baroncelli,Istituto Superiore di Sanità,https://dx.doi.org/10.1016/j.jcvp.2022.100110,9/28/2022,3/2/2024,Unverified
221017_Malawi_USCDC_Community1,"October 17, 2022",National,Malawi,MWI,,,"October 14, 2020","December 8, 2020",Household and community samples,Multiple groups,4261,7.80%,6.30%,9.60%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,,Journal Article (Peer-Reviewed),Joe Alex Theu,United States Centres for Disease Control,https://dx.doi.org/10.3201/eid2813.212348,12/23/2022,3/2/2024,Unverified
221017_Malawi_USCDC_HCW2,"October 17, 2022",National,Malawi,MWI,,,"October 14, 2020","December 8, 2020",Health care workers and caregivers,Multiple groups,970,9.70%,6.40%,14.50%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,,Journal Article (Peer-Reviewed),Joe Alex Theu,United States Centres for Disease Control,https://dx.doi.org/10.3201/eid2813.212348,1/13/2023,3/2/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey1_Overall_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,1001,26.30%,20.70%,32.10%,Stratified probability,Mount Sinai Laboratory (MSL),ELISA,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey1_Lessthan15_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Children and Youth (0-17 years),372,14.10%,8.80%,20.40%,Stratified probability,Mount Sinai Laboratory (MSL),ELISA,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey1_30plus_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,348,36.00%,31.60%,40.10%,Stratified probability,Mount Sinai Laboratory (MSL),ELISA,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey4_Overall_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,886,89.30%,85.40%,92.20%,Stratified probability,Mount Sinai Laboratory (MSL),ELISA,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey4_Lessthan15_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Children and Youth (0-17 years),338,85.20%,81.60%,88.30%,Stratified probability,Mount Sinai Laboratory (MSL),ELISA,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey4_15to29_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,234,95.40%,90.70%,98.20%,Unclear,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Karonga_MalawiEpidemiologyInterventionResearchUnit_Survey4_30plus_PopAdj,"October 28, 2023",Local,Malawi,MWI,,Karonga,"February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,314,89.90%,83.00%,94.30%,Unclear,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/30/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey1_Overall_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,948,46.40%,40.20%,53.00%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey1_Lessthan15_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Children and Youth (0-17 years),276,24.30%,17.40%,33.20%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey1_15to29_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,277,59.30%,48.50%,70.20%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey1_30plus_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,395,59.90%,55.50%,64.10%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey4_Overall_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,531,93.90%,90.60%,96.50%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey4_Lessthan15_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Children and Youth (0-17 years),165,91.40%,88.10%,94.60%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey4_15to29_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,125,96.70%,91.30%,99.00%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
20231028_Lilongwe_MalawiEpidemiologyInterventionResearchUnit_Survey4_30plus_PopAdj,"October 28, 2023",Local,Malawi,MWI,,"Lilongwe
","February 1, 2021","April 1, 2022",Household and community samples,Multiple groups,241,94.60%,89.30%,97.80%,Stratified probability,Mount Sinai Laboratory (MSL),,IgG,86.50%,98.80%,Low,Journal Article (Peer-Reviewed),Louis Banda,Malawi Epidemiology and Intervention Research Unit (MEIRU),https://doi.org/10.1016/j.ijid.2023.10.020,1/31/2024,2/1/2024,Unverified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMarch_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"March 1, 2020","March 30, 2020",Blood donors,Adults (18-64 years),496,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoApril_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),157,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoMay_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),598,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJune_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),308,2.80%,2.70%,2.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoJuly_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),428,35.40%,35.20%,35.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoAugust_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"August 1, 2020","August 30, 2020",Blood donors,Adults (18-64 years),432,41.30%,41.10%,41.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoSeptember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),481,43.50%,43.30%,43.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoOctober_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),495,43.20%,43.00%,43.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_AntananarivoNovember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Antananarivo,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),502,38.00%,37.90%,38.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJune_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),82,43.70%,43.10%,44.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaJuly_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),182,51.20%,50.80%,51.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaAugust_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),227,49.20%,48.90%,49.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaSeptember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),213,36.20%,35.90%,36.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaOctober_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),199,33.00%,32.60%,33.30%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToamasinaNovember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toamasina,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),282,23.30%,23.10%,23.50%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/17/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJune_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),129,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaJuly_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"July 1, 2020","July 30, 2020",Blood donors,Adults (18-64 years),142,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaAugust_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),120,10.40%,10.20%,10.60%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaSeptember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),173,21.90%,21.60%,22.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaOctober_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),152,18.70%,18.50%,18.90%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_FianarantsoaNovember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Fianarantsoa,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),172,16.20%,16.00%,16.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJune_Adj,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),50,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaJuly_Adj,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),98,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaAugust_Adj,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),107,44.50%,44.10%,44.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaSeptember_Adj ,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),53,26.00%,25.90%,26.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaOctober_Adj,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),26,29.60%,28.90%,30.20%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,7/17/2022,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_MahajangaNovember_Adj ,"June 4, 2021",Local,Madagascar,MDG,,Mahajanga,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),30,21.50%,20.90%,22.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJune_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),87,0.00%,0.00%,0.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraJuly_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"July 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),147,0.00%,0.00%,0.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraAugust_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"August 1, 2020","August 31, 2020",Blood donors,Adults (18-64 years),167,7.90%,7.70%,8.10%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraSeptember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),185,24.20%,23.90%,24.40%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraOctober_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),139,27.70%,27.30%,28.00%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
210604_Madagascar_InstitutPasteurDeMadagascar_ToliaraNovember_Adj,"June 4, 2021",Local,Madagascar,MDG,,Toliara,"November 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),199,23.50%,23.20%,23.80%,Convenience,ID.Vet,ELISA,IgG,92.60%,99.60%,High,Journal Article (Peer-Reviewed),Matthieu Schoenhals,Institut Pasteur de Madagascar,https://dx.doi.org/10.1016/j.ebiom.2021.103419,6/18/2021,8/15/2023,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_8May2021_AntiRBD,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"May 1, 2021","May 26, 2021",Blood donors,Adults (18-64 years),500,64.80%,56.10%,72.60%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/22/2021,3/2/2024,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_6March2021_AntiRBD,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"March 1, 2021","March 31, 2021",Blood donors,Adults (18-64 years),497,49.90%,45.50%,54.30%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/22/2021,3/2/2024,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_4January2021_AntiRBD,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"January 1, 2021","January 31, 2021",Blood donors,Adults (18-64 years),389,44.70%,39.90%,49.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/22/2021,3/2/2024,Verified
211001_Antananarivo_InstitutPasteurdeMadagascar_7April2021_AntiRBD,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"April 1, 2021","April 30, 2021",Blood donors,Adults (18-64 years),493,58.40%,54.00%,62.70%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/22/2021,3/2/2024,Unverified
211001_Antananarivo_InstitutPasteurdeMadagascar_5February2021_AntiRBD,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"February 1, 2021","February 28, 2021",Blood donors,Adults (18-64 years),319,50.50%,45.00%,55.90%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,94.36%,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/22/2021,3/2/2024,Unverified
211001_Antananarivo_InstitutPasteurdeMadagascar_3December2020,"September 14, 2021",Local,Madagascar,MDG,, Antananarivo,"December 1, 2020","December 31, 2020",Blood donors,Adults (18-64 years),177,22.00%,16.60%,28.70%,Sequential,ID.Vet,ELISA,IgG,,,High,Presentation or Conference,Solohery Razafimahatratra,Institut Pasteur de Madagascar,http://dx.doi.org/10.1016/S2214-109X%2821%2900361-2,9/23/2021,3/2/2024,Verified
220905_Germany_BernhardNochtInsituteForTropicalMedicine_Madagascar_Adj,"September 5, 2022",Local,Madagascar,MDG,Fianarantsoa,Fianarantsoa,"February 26, 2021","June 18, 2021",Household and community samples,Multiple groups,674,41.50%,36.50%,49.00%,Stratified probability,NA,ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Nicole S. Struck,Bernhard Nocht Insitute for Tropical Medicine,https://dx.doi.org/10.1186/s12889-022-13918-y,9/13/2022,9/13/2022,Unverified
230324_Ifanadiana_InstitutPasteurDeMadagascar_SpikeS2_Primary,"March 24, 2023",Local,Madagascar,MDG,Vatovavy,,"April 22, 2021","June 20, 2021",Household and community samples,Multiple groups,6496,43.80%,40.90%,46.70%,Stratified probability,Luminex Corporation,Luminex,IgG,,,Moderate,Preprint,Andres Garchitorena,Institut Pasteur de Madagascar,http://doi.org/10.1101/2023.03.24.23287674,5/7/2023,4/21/2024,Verified
200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,"May 18, 2020",National,Luxembourg,LUX,,,"April 15, 2020","May 5, 2020",Household and community samples,Multiple groups,1820,2.09%,1.37%,2.82%,Stratified probability,EUROIMMUN,ELISA,IgG,85.70%,97.80%,Moderate,Preprint,Chantal Snoeck,Luxembourg Institute of Health,https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1,7/13/2020,3/2/2024,Verified
210107_Lithuania_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Lithuania,LTU,NR,NR,"June 1, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),300,0.66%,0.18%,2.40%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIA,"February 6, 2021",Local,Lithuania,LTU,,Kaunas,"June 15, 2020","September 21, 2020",Health care workers and caregivers,Multiple groups,432,1.16%,,,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Laura Pereckaite,The Hospital of Lithuanian University of Health Sciences Kauno Klinikos,https://dx.doi.org/10.3390/medicina57020148,3/16/2021,3/2/2024,Verified
210118_Lithuania_210118_Lithuania_LithuanianUniversityofHealthSciences_TestAdj,"January 18, 2021",National,Lithuania,LTU,"Vilnius County, Kaunas county, Klaipėda County, Tauragė County, Utena county
","Vilnius, Kaunas, Klaipėda
","August 10, 2020","September 10, 2020",Household and community samples,Multiple groups,3089,1.40%,0.92%,1.99%,Simplified probability,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",92.00%,99.40%,Moderate,Journal Article (Peer-Reviewed),Kastytis Smigelskas, Lithuanian University of Health Sciences,https://www.journals.vu.lt/AML/article/view/22344,5/14/2021,8/15/2023,Verified
210212_Kaunas_LithuanianUniversityOfHealthSciences_HidradenitisSuppurativa,"February 12, 2021",Local,Lithuania,LTU,,Kaunas,"August 12, 2020","December 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,26,7.70%,2.13%,24.14%,Convenience,EUROIMMUN,ELISA,"IgG,IgM",,,High,Presentation or Conference,Vaiva Jariene,Lithuanian University of Health Sciences,https://www.researchgate.net/publication/349992124_SARS-CoV-2_Seroprevalence_in_Patients_with_Hidradenitis_Suppurativa_in_Lithuania,7/5/2021,3/2/2024,Verified
201209_Liechtenstein_KantonsspitalGraubunden_Overall,"December 9, 2020",National,Liechtenstein,LIE,,,"June 2, 2020","October 6, 2020",Multiple populations,Multiple groups,1159,7.80%,6.40%,9.50%,Convenience,"Roche Diagnostics,Abbott Laboratories,DiaSorin,EUROIMMUN,Epitope Diagnostics, Inc.,Sugentech, Inc.",Multiple Types,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Anna Schaffner,Kantonsspital Graunbunden,https://dx.doi.org/10.3390/jcm9123989,1/29/2021,3/2/2024,Verified
200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,"May 26, 2020",Local,Libya,LBY,Libya,Alzintan City,"April 2, 2020","May 18, 2020",Health care workers and caregivers,Multiple groups,77,0.00%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,3/2/2024,Verified
200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,"May 26, 2020",Local,Libya,LBY,Libya,Alzintan City,"April 2, 2020","May 18, 2020",Multiple populations,Multiple groups,142,4.23%,,,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",86.40%,99.60%,High,Preprint,Abdulwahab Kammon,Al-Zintan University,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,3/2/2024,Verified
200929_Benghazi_TheCenterOfInfectiousDiseases-Benghazi_overall,"September 29, 2020",Local,Libya,LBY,,Benghazi,"May 2, 2020","May 7, 2020",Household and community samples,Multiple groups,600,0.00%,,,Stratified probability,NA,LFIA,"IgG,IgM",81.70%,96.70%,Moderate,Journal Article (Peer-Reviewed),Amal A Elfakhri,The Center of Infectious Diseases- Benghazi,https://preventive-medicine.imedpub.com/populationbased-random-survey-for-detection-of-covid19-infection-and-seroprevalence-in-benghazi-libya-may2020.pdf,4/27/2021,7/17/2022,Verified
220727_Tobruk_UniversityOfTobruk,"July 27, 2022",Local,Libya,LBY,,,"January 15, 2021","February 15, 2021",Blood donors,Multiple groups,200,4.00%,,,Unclear,SD Biosensor,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Faisal Ismail,University of Tobruk,https://dx.doi.org/10.1017/dmp.2022.180,8/3/2022,8/3/2022,Unverified
230621_Lesotho_UniversityHospitalZurich,"June 1, 2023",National,Lesotho,LSO,,,"February 15, 2020","July 15, 2021",Residual sera,Multiple groups,3173,35.00%,,,Sequential,NA,ELISA,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Jennifer Brown,University Hospital Zurich,https://dx.doi.org/10.1093/infdis/jiad197,6/30/2023,7/4/2023,Unverified
220110_Lebanon_LebaneseUniversity_Overall_TestPopAdj,"January 10, 2022",National,Lebanon,LBN,"Beirut, Mount Lebanon, North Lebanon, Akkar, Baalbek El-Hermel, Bekaa, Nabatieh, and South Lebanon",,"December 7, 2020","January 15, 2021",Household and community samples,Multiple groups,2058,18.50%,16.80%,20.20%,Stratified probability,Technogenetics,LFIA,IgG,92.30%,100.00%,Low,Journal Article (Peer-Reviewed),Abbas Hoballah,Lebanese University,https://dx.doi.org/10.1186/s12879-022-07031-z,1/19/2022,8/15/2023,Verified
220521_Lebanon_HumanLink_Overall,"May 21, 2022",National,Lebanon,LBN,"Beirut, North, South, Akkar, Nabatiye, Bekaa, Baalbak-Hermel",,"October 15, 2020","April 15, 2021",Multiple populations,Multiple groups,2783,58.90%,,,Convenience,NA,Neutralization,Neutralizing ,,,High,Journal Article (Peer-Reviewed),Omar Bahlawan,Human Link,https://dx.doi.org/10.1007/s00705-022-05470-2,6/5/2022,7/17/2022,Unverified
220129_Lebanon_LebaneseAmericanUniversityMedicalCentre_TestAdj_Overall,"January 29, 2022",National,Lebanon,LBN,eight Lebanese governorates,138 Lebanese municipalities,"September 21, 2020","April 8, 2021",Household and community samples,Multiple groups,13755,24.60%,,,Stratified probability,Roche Diagnostics,CLIA,Not reported,99.50%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ahmad Mahdi,Lebanese American University Medical Centre,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800496/,6/29/2022,8/15/2023,Unverified
210107_Latvia_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Latvia,LVA,NR,NR,"May 19, 2020","June 20, 2020",Health care workers and caregivers,Adults (18-64 years),177,0.00%,0.00%,2.14%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
230210_Riga_RigaStradinsUniversity_Overall,"February 10, 2023",Local,Latvia,LVA,,Riga,"March 15, 2022","July 15, 2022",Residual sera,Children and Youth (0-17 years),200,86.50%,81.80%,91.20%,Simplified probability,Roche Diagnostics,,,,,,Journal Article (Peer-Reviewed),Krista Sapronova,Children Clinical University Hospital and Riga Stradins University,https://dx.doi.org/10.1097/MD.0000000000032795,3/8/2023,3/2/2024,Unverified
210713_LaoPDR_InstitutPasteurDuLaos_GeneralCommunity_Primary_Adjusted,"July 13, 2021",National,Lao People's Democratic Republic,LAO,"Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak",,"August 12, 2020","September 25, 2020",Household and community samples,Multiple groups,2433,5.20%,4.20%,6.50%,Stratified probability,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/17/2022,Verified
210713_LaoPDR_InstitutPasteurDuLaos_HCW_Primary_Adjusted,"July 13, 2021",National,Lao People's Democratic Republic,LAO,"Vientiane Prefecture, Oudomxay, Luangprabang, Savannakhet, Champassak",,"August 12, 2020","September 25, 2020",Health care workers and caregivers,Adults (18-64 years),666,1.95%,1.10%,3.30%,Convenience,NA,ELISA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/17/2022,Verified
210713_LaoPDR_InstitutPasteurDuLaos_WildlifeContacts_Primary,"July 13, 2021",Regional,Lao People's Democratic Republic,LAO,Vientiane Province,,"August 12, 2020","September 25, 2020",Non-essential workers and unemployed persons,Multiple groups,74,20.30%,12.60%,31.00%,Convenience,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),Siriphone Virachith,Institut Pasteur du Laos,https://dx.doi.org/10.1016/j.lanwpc.2021.100197,7/28/2021,7/17/2022,Verified
211209_Kyrgyzstan_SaintPetersburgPasteurInstitute_Overall,"December 9, 2021",National,Kyrgyzstan,KGZ,,,"June 28, 2021","July 3, 2021",Household and community samples,Multiple groups,9471,48.70%,47.70%,49.70%,Simplified probability,NA,ELISA,IgG,,,Moderate,Preprint,Anna Popova,Saint Petersburg Pasteur Institute,https://www.researchsquare.com/article/rs-1138128/v1,12/15/2021,7/17/2022,Verified
201205_Kuwait_KuwaitUniversity_Overall_unadj,"December 5, 2020",National,Kuwait,KWT,,,"May 23, 2020","June 26, 2020",Essential non-healthcare workers,Adults (18-64 years),525,38.10%,34.00%,42.30%,Stratified probability,Biozek,LFIA,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Walid Q Alali,University of Kuwait,https://dx.doi.org/10.1093/jtm/taaa223,1/24/2021,3/2/2024,Verified
210816_Kuwait_MinistryofHealth_primary,"August 16, 2021",National,Kuwait,KWT,,,"August 15, 2020","October 15, 2020",Health care workers and caregivers,Multiple groups,847,20.50%,,,Convenience,DiaSorin,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),SarahAl Youha,Ministry of Health,http://dx.doi.org/10.1016/j.jiph.2021.08.012,8/31/2021,3/2/2024,Unverified
210513_Kuwait_KuwaitUniversity_Overall,"May 3, 2021",National,Kuwait,KWT,"Ahmadi, Farwaniya, Hawali, Asma, Jahra, Mubarak Alkabeer","Jeleeb Al Shuyoukh, Mahboula","April 18, 2020","May 10, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),10256,5.90%,5.40%,6.30%,Simplified probability,Biozek,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Haya Altawalah,Institut Pasteur du Maroc,https://dx.doi.org/10.1016/j.jcvp.2021.100017,3/15/2022,3/2/2024,Unverified
230202_Kuwait_MinistryOfHealth_Overall,"February 2, 2023",National,Kuwait,KWT,,,"September 1, 2020","December 31, 2020",Residual sera,Multiple groups,19453,24.89%,24.29%,25.50%,Stratified probability,DiaSorin,,IgG,98.70%,99.50%,,Journal Article (Peer-Reviewed),Wadha Alfouzan,Ministry of Health,https://dx.doi.org/10.3390/vaccines11020336,4/12/2023,4/23/2024,Verified
211128_Prishtina_MunicipalityofPrishtina_Primary,"November 28, 2021",Local,Kosovo,XKX,,Prishtina,"October 1, 2020","November 30, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),418,21.05%,,,Convenience,"BioMérieux,NA",Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Bujar Gashi,Municipality of Prishtina,http://dx.doi.org/10.3390/ijerph182312545,12/8/2021,3/2/2024,Unverified
220116_Prishtina_PrishtinaStarts_IgMorIgG_Overall,"January 16, 2022",Local,Kosovo,XKX,,Prishtina,"October 14, 2020","December 17, 2020",Health care workers and caregivers,Adults (18-64 years),475,17.47%,,,Entire sample,Biomerieux,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Rrezart Halili,Prishtina Starts,https://dx.doi.org/10.1186/s12879-022-07038-6,1/27/2022,3/2/2024,Unverified
210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,"February 17, 2021",National,Kenya,KEN,,,"September 30, 2020","October 23, 2020",Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NA,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,E Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1,3/17/2021,7/17/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_Nairobi_Overall_TestAdj,"February 8, 2021",Local,Kenya,KEN,Nairobi,Nairobi,"July 30, 2020","August 25, 2020",Pregnant or parturient women,Adults (18-64 years),196,49.90%,42.70%,58.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,4/16/2021,7/17/2022,Verified
210421_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,"April 24, 2021",National,Kenya,KEN,"Central, Coastal, Western",,"July 30, 2020","December 4, 2020",Health care workers and caregivers,Adults (18-64 years),684,20.80%,17.50%,24.40%,Convenience,NA,ELISA,IgG,92.70%,99.00%,Moderate,Journal Article (Peer-Reviewed),Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1093/cid/ciab346,5/23/2021,7/17/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_KilifiOct_TestAdj,"February 8, 2021",Local,Kenya,KEN,NR,Kilifi,"October 1, 2020","October 31, 2020",Pregnant or parturient women,Adults (18-64 years),183,1.50%,0.07%,4.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,6/24/2021,7/17/2022,Verified
210208_Kenya_KEMRI-WellcomeTrust_KilifiSept_TestAdj,"February 8, 2021",Local,Kenya,KEN,,Kilifi,"September 18, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),82,1.30%,0.04%,4.70%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Moderate,Preprint,R Lucinde,KEMRI-Wellcome Trust,https://www.medrxiv.org/content/10.1101/2021.02.05.21250735v1.full-text,6/24/2021,7/17/2022,Verified
210625_Kenya_KEMRI-WellcomeTrustResearchProgramme_overall_adj,"June 25, 2021",National,Kenya,KEN,,,"April 30, 2020","September 30, 2020",Blood donors,Adults (18-64 years),9922,7.90%,6.70%,9.00%,Sequential,NA,ELISA,IgG,92.70%,99.00%,Low,Journal Article (Peer-Reviewed),Ifedayo M. O. Adetifa,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1038/s41467-021-24062-3,7/8/2021,7/17/2022,Verified
210726_Dagahaley_MédecinsSansFrontières_Patients_Overall,"July 26, 2021",Local,Kenya,KEN,NR,"Dagahaley camp, Daadab Refugee Complex","March 1, 2021","April 14, 2021",Multiple populations,Multiple groups,619,6.90%,,,Sequential,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,8/4/2021,3/2/2024,Unverified
210726_Dagahaley_MédecinsSansFrontières_FamilyMembers,"July 26, 2021",Local,Kenya,KEN,NR,"Dagahaley camp, Daadab Refugee Complex","March 1, 2021","April 14, 2021",Multiple populations,Multiple groups,587,9.20%,,,Convenience,Biosynex,LFIA,"IgG,IgM",95.80%,98.10%,Moderate,Preprint,Etienne Gignoux,Médicins Sans Frontières,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3893538,8/4/2021,3/2/2024,Unverified
210612_Kenya_KEMRI-WellcomeTrustResearchProgramme_PrimaryTestAdj,"June 12, 2021",Regional,Kenya,KEN,"Western Province, Coast Province ","Magarini, Busia, Malaba","September 30, 2020","October 23, 2020",Essential non-healthcare workers,Adults (18-64 years),830,42.30%,38.40%,46.30%,Convenience,NA,ELISA,IgG,93.00%,99.00%,High,Journal Article (Peer-Reviewed),Eunice Kagucia,KEMRI-Wellcome Trust Research Programme,http://dx.doi.org/10.1093/ofid/ofab314,8/24/2021,7/17/2022,Verified
210902_Kenya_KEMRI-WellcomeTrustResearchProgramme_OverallPopAndTestAdjusted,"September 2, 2021",National,Kenya,KEN,,,"January 3, 2021","March 15, 2021",Blood donors,Multiple groups,3018,48.50%,45.20%,52.10%,Convenience,NA,ELISA,IgG,92.70%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sophie Uyoga,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1001/jama.2021.15265,9/10/2021,7/17/2022,Verified
210902_Nairobi_WashingtonStateUniversity_TestAdjPopAdj,"September 2, 2021",Local,Kenya,KEN,,,"November 2, 2020","November 23, 2020",Household and community samples,Multiple groups,1164,34.70%,31.80%,37.60%,Simplified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Isaac Ngere,Washington State University,https://dx.doi.org/10.1016/j.ijid.2021.08.062,10/13/2021,8/15/2023,Verified
210826_Nairobi_KenyaMedicalResearchInstitute_Overall_PopAdjusted,"August 26, 2021",Local,Kenya,KEN,Nairobi,,"November 27, 2020","December 5, 2020",Household and community samples,Multiple groups,511,43.30%,37.40%,49.50%,Simplified probability,Beijing Wantai Biological,ELISA,"IgM,IgG",94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Patrick Munywoki,Kenya Medical Research Institute,https://f1000research.com/articles/10-853,11/4/2021,3/2/2024,Verified
211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_Aug2021_WANTAI,"December 27, 2021",National,Kenya,KEN,,,"August 1, 2021","August 31, 2021",Blood donors,Adults (18-64 years),176,83.00%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.30%,97.90%,High,Journal Article (Peer-Reviewed),James Nyagwange,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1016/j.jcv.2021.105061,1/9/2022,3/2/2024,Verified
211227_Kenya_KEMRI-WellcomeTrustResearchProgramme_BloodDonors_May2020_Wantai,"December 27, 2021",National,Kenya,KEN,,,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),176,2.27%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.30%,97.90%,High,Journal Article (Peer-Reviewed),James Nyagwange,KEMRI-Wellcome Trust Research Programme,https://dx.doi.org/10.1016/j.jcv.2021.105061,1/15/2022,3/2/2024,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Kisumu_OverallAdjusted,"February 9, 2022",Local,Kenya,KEN,,Kisumu,"February 1, 2021","May 31, 2021",Household and community samples,Multiple groups,853,38.10%,34.10%,42.40%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,2/22/2022,7/17/2022,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_OverallAdjusted,"February 9, 2022",Local,Kenya,KEN,,Nairobi,"January 1, 2021","May 31, 2021",Household and community samples,Multiple groups,850,40.40%,36.00%,45.00%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,2/22/2022,7/17/2022,Verified
220209_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_OverallAdjusted,"February 9, 2022",Local,Kenya,KEN,,Kilifi,"December 1, 2020","April 30, 2021",Household and community samples,Multiple groups,856,19.80%,16.80%,23.10%,Stratified probability,NA,ELISA,IgG,92.70%,99.00%,Low,Preprint,Anthony Etyang,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.02.07.22270012v1.full-text,2/22/2022,7/17/2022,Verified
220223_CoastalKenya_KenyaMedicalResearchInstitute_Overall,"February 23, 2022",Local,Kenya,KEN,,,"March 17, 2020","November 15, 2020",Blood donors,Multiple groups,2437,20.30%,,,Unclear,NA,ELISA,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),James Nyagwange,Kenya Medical Research Institute,https://wellcomeopenresearch.org/articles/7-69,3/10/2022,7/17/2022,Unverified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_20210907-20211019_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Nairobi,"September 7, 2021","October 19, 2021",Pregnant or parturient women,Adults (18-64 years),245,84.90%,78.30%,91.50%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Nairobi_20210127-20210311_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Nairobi,"January 27, 2021","March 11, 2021",Pregnant or parturient women,Adults (18-64 years),265,32.10%,26.20%,38.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Busia_20210415-20210521_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Busia,"April 15, 2021","May 21, 2021",Pregnant or parturient women,Adults (18-64 years),270,30.60%,24.70%,37.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Busia_20210920-20211022_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Busia,"September 20, 2021","October 22, 2021",Pregnant or parturient women,Adults (18-64 years),297,70.70%,64.10%,77.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_1NovDec2020_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Kilifi,"November 1, 2020","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),236,14.00%,9.40%,19.50%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_2MarApr2021_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Kilifi,"March 1, 2021","April 30, 2021",Pregnant or parturient women,Adults (18-64 years),260,22.20%,16.70%,28.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_3MayJun2021_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Kilifi,"May 1, 2021","June 30, 2021",Pregnant or parturient women,Adults (18-64 years),382,28.90%,23.90%,34.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_4JulAug2021_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Kilifi,"July 1, 2021","August 31, 2021",Pregnant or parturient women,Adults (18-64 years),260,61.20%,54.40%,68.40%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220306_Kenya_KEMRIWellcomeTrustResearchProgramme_Kilifi_5SepOct2021_OverallAdjusted,"March 6, 2022",Local,Kenya,KEN,,Kilifi,"September 1, 2021","October 31, 2021",Pregnant or parturient women,Adults (18-64 years),305,62.70%,56.20%,69.10%,Sequential,NA,ELISA,IgG,92.70%,99.00%,High,Preprint,R Lucinde,KEMRI-Wellcome Trust Research Programme,https://www.medrxiv.org/content/10.1101/2022.03.03.22271860v1.full-text,3/17/2022,7/17/2022,Verified
220315_Kenya_UniversityofWashington_Primary,"March 15, 2022",Local,Kenya,KEN,,,"April 15, 2021","July 15, 2021",Blood donors,Multiple groups,1000,30.90%,,,Unclear,Bio-rad,ELISA,Total Antibody,,,High,Presentation or Conference,Shradha J. Doshi,University of Washington,https://www.iasusa.org/tam/march-2022/,6/16/2022,3/20/2024,Verified
220729_Kenya_JaramogiOginga OdingaUniversityofScienceandTechnology,"July 29, 2022",Regional,Kenya,KEN,Kisumu County and Siaya County,,"December 15, 2021","February 15, 2022",Household and community samples,Multiple groups,98,76.50%,66.90%,84.50%,Self-referral,"InBios International, Inc.",ELISA,"IgG,IgM",,,High,Preprint,Shehu Shagari Awandu,Jaramogi Oginga Odinga University of Science and Technology,10.1101/2022.07.27.22278095,8/10/2022,3/2/2024,Unverified
220111_Kenya_KEMRI-WellcomeTrustResearchProgramme_Kilifi_PopAdjusted,"October 11, 2022",Local,Kenya,KEN,,,"February 15, 2022","May 8, 2022",Household and community samples,Multiple groups,852,69.10%,65.80%,72.30%,Stratified probability,NA,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,Eunice Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://doi.org/10.1101/2022.10.10.22280824,10/18/2022,4/17/2024,Verified
220111_Kenya_KEMRI-WellcomeTrustResearchProgramme_Nairobi_PopAdjusted,"October 11, 2022",Local,Kenya,KEN,,,"March 8, 2022","June 22, 2022",Household and community samples,Multiple groups,851,88.50%,86.10%,90.60%,Stratified probability,NA,ELISA,IgG,93.00%,99.00%,Moderate,Preprint,Eunice Wangeci Kagucia,KEMRI-Wellcome Trust Research Programme,https://doi.org/10.1101/2022.10.10.22280824,10/18/2022,4/17/2024,Verified
221017_ Nairobi_FredHutchinsonCancerCenter_overall,"October 17, 2022",Local,Kenya,KEN,,Nairobi,"January 1, 2020","December 1, 2020",Household and community samples,Multiple groups,352,13.40%,,,Sequential,"Mount Sinai Laboratory (MSL),Bio-rad",ELISA,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Carolyn Fish,Fred Hutchinson Cancer Center,https://dx.doi.org/10.1002/jmv.28221,10/27/2022,4/17/2024,Verified
221212_USA_RTIInternational_Kenya,"December 12, 2022",National,Kenya,KEN,,,"December 1, 2020","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),1794,24.20%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221228_Kenya_WashingtonStateUniversity_adj,"December 28, 2022",National,Kenya,KEN,,,"January 17, 2022","February 24, 2022",Household and community samples,Multiple groups,1537,90.20%,88.60%,91.20%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,99.00%,87.10%,Low,Journal Article (Peer-Reviewed),Carolyne Nasimiyu,Washington State University,https://dx.doi.org/10.3390/vaccines11010068,2/9/2023,4/12/2024,Verified
221215_Kenya_IcahnSchoolofMedicine_Overall,"December 15, 2022",Regional,Kenya,KEN,Western,"Eldoret, Kitale, Turbo, Webuye","February 15, 2021","September 15, 2021",Representative patient population,Children and Youth (0-17 years),241,29.00%,,,Unclear,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Mary Boyle,"Icahn School of Medicine at Mount Sinai, New York",https://dx.doi.org/10.1093/ofid/ofac492.939,2/9/2023,3/20/2023,Unverified
230223_Kenya_UniversityofWashington,"February 23, 2023",Regional,Kenya,KEN,Coast region,,"April 15, 2021","July 15, 2021",Multiple populations,Multiple groups,1000,30.90%,,,Convenience,Bio-rad,ELISA,Total Antibody,97.40%,94.90%,High,Journal Article (Peer-Reviewed),Shrada Doshi,University of Washington,https://dx.doi.org/10.1186/s12954-023-00754-5,3/20/2023,3/2/2024,Unverified
230704_Asembo_USCDCKenya_Round2_Overall_PopAdj,"July 4, 2023",Local,Kenya,KEN,,Asembo,"July 8, 2021","August 4, 2021",Household and community samples,Multiple groups,888,48.70%,44.30%,53.20%,Simplified probability,"InBios International, Inc.",ELISA,IgG,92.00%,99.00%,Low,Journal Article (Peer-Reviewed),Patrick Munywoki,U.S. Centers for Disease Control and Prevention (CDC)-Kenya,http://doi.org/10.12688/gatesopenres.14684.1,8/1/2023,5/2/2024,Verified
230704_Kibera_USCDCKenya_Round2_Overall_PopAdj,"July 4, 2023",Local,Kenya,KEN,,Kibera,"June 4, 2021","July 4, 2021",Household and community samples,Multiple groups,750,63.90%,59.60%,67.90%,Simplified probability,"InBios International, Inc.",ELISA,IgG,92.00%,99.00%,Low,Journal Article (Peer-Reviewed),Patrick Munywoki,U.S. Centers for Disease Control and Prevention (CDC)-Kenya,http://doi.org/10.12688/gatesopenres.14684.1,8/1/2023,5/2/2024,Verified
230720_Kenya_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Kenya,KEN,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2420,31.10%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
220217_Kazakhstan_NazarbayevUniversitySchoolofMedicine_Overall_IgG,"February 17, 2022",National,Kazakhstan,KAZ,,,"July 16, 2020","July 7, 2021",Residual sera,Multiple groups,85346,63.00%,62.70%,63.30%,Sequential,Vector BEST,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Yuliya Semenova,Nazarbayev University School of Medicine,https://dx.doi.org/10.3390/ijerph19042263,3/1/2022,7/17/2022,Unverified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Almaty_OverallPopAdj,"March 15, 2022",Local,Kazakhstan,KAZ,,Almaty,"October 24, 2020","January 11, 2021",Household and community samples,Multiple groups,4461,57.00%,56.90%,59.80%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,5/29/2022,3/2/2024,Verified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Oskemen_OverallPopAdj,"March 15, 2022",Local,Kazakhstan,KAZ,,Oskemen,"October 24, 2020","January 11, 2021",Household and community samples,Multiple groups,664,60.70%,57.90%,65.50%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,5/29/2022,3/2/2024,Verified
220315_Kazakhstan_KazakhNationalMedicalUniversity_Kostanay_OverallPopAdj,"March 15, 2022",Local,Kazakhstan,KAZ,,Kostanay,"October 24, 2020","January 11, 2021",Household and community samples,Multiple groups,614,39.40%,35.80%,43.70%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Manar Smagul,Kazakh National Medical University,https://dx.doi.org/10.1002/hsr2.562,5/29/2022,3/2/2024,Verified
220727_Karaganda_KaragandaMedicalUniversity_IgGorIgA_Primary,"July 27, 2022",Local,Kazakhstan,KAZ,Karaganda Region,Karaganda,"April 15, 2021","May 15, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),99,63.60%,53.40%,73.10%,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,100.00%,High,Journal Article (Peer-Reviewed),Irina Kadyrova,Karaganda Medical University,https://dx.doi.org/10.1371/journal.pone.0272008,8/26/2022,3/2/2024,Unverified
230706_Kazakhstan_SDAsfendiyarovKazakhNationalMedicalUniversity_Overall,"July 6, 2023",National,Kazakhstan,KAZ,"Akmola, Aktobe, Almaty, Atyrau, Western Kazakhstan, Zhambyl, Karaganda, Kostanai, Kyzylorda, Mangistau, Turkestan, Pavlodar, North Kazakhstan, Eastern Kazakhstan","Nur-Sultan, Almaty, Shymkent","October 15, 2021","May 15, 2022",Household and community samples,Adults (18-64 years),6720,43.78%,,,Stratified probability,Abbott Laboratories,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mukhtar Kulimbet,S.D. Asfendiyarov Kazakh National Medical University,https://dx.doi.org/10.1017/S0950268823001085,8/3/2023,4/30/2024,Verified
210416_Jordan_KingHusseinCancerCenter_Grp3_January_TestAdj,"April 19, 2021",National,Jordan,JOR,"North, Center, South",,"January 28, 2021","February 5, 2021",Blood donors,Adults (18-64 years),292,27.30%,22.50%,32.90%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,8/15/2023,Verified
210416_Jordan_KingHusseinCancerCenter_Grp2_September,"April 19, 2021",National,Jordan,JOR,"North, Center, South",,"September 1, 2020","September 15, 2020",Blood donors,Adults (18-64 years),348,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,3/2/2024,Verified
210416_Jordan_KingHusseinCancerCenter_Grp1_June,"April 19, 2021",National,Jordan,JOR,"North, Center, South",,"January 15, 2020","June 15, 2020",Blood donors,Adults (18-64 years),736,0.00%,0.00%,0.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Maher Sughayer,King Hussein Cancer Center,http://dx.doi.org/10.1016/j.ijid.2021.04.059,6/8/2021,3/2/2024,Verified
210710_Jordan_WorldHealthOrganization_August2020_,"July 10, 2021",National,Jordan,JOR,,,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,4704,0.30%,0.20%,0.40%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,3/2/2024,Verified
210710_Jordan_WorldHealthOrganization_October2020,"July 10, 2021",National,Jordan,JOR,,,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,5470,7.00%,6.80%,7.20%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,3/2/2024,Verified
210710_Jordan_WorldHealthOrganization_January2021,"July 10, 2021",National,Jordan,JOR,,,"December 27, 2020","January 6, 2021",Household and community samples,Multiple groups,5044,34.20%,33.80%,34.60%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Saverio Bellizzi,World Health Organization,http://dx.doi.org/10.1016/j.onehlt.2021.100292,7/29/2021,3/2/2024,Verified
210818_Jordan_KingHusseinCancerCenter_Primary,"August 18, 2021",National,Jordan,JOR,,,"June 1, 2021","June 30, 2021",Blood donors,Adults (18-64 years),536,74.40%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,100.00%,High,Preprint,Maher Sughayer,King Hussein Cancer Center,https://www.medrxiv.org/content/10.1101/2021.08.15.21261584v1.full-text,8/25/2021,3/2/2024,Verified
211015_JordanUniversityOfScienceAndTechnology_Primary,"October 15, 2021",Local,Jordan,JOR,,,"September 15, 2020","January 15, 2021",Blood donors,Adults (18-64 years),1000,14.50%,,,Self-referral,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Ziad Elnasser,Jordan University of Science and Technology,https://dx.doi.org/10.1097/MD.0000000000027537,11/9/2021,3/2/2024,Verified
220420_Amman_KingHusseinCancerCenter_Overall,"April 20, 2022",Local,Jordan,JOR,,Amman,"July 15, 2021","September 15, 2021",Health care workers and caregivers,Multiple groups,485,95.88%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,99.35%,99.60%,High,Journal Article (Peer-Reviewed),Lina Souan,King Hussein Cancer Center,https://dx.doi.org/10.3390/vaccines10050642,5/19/2022,3/2/2024,Unverified
220905_Jordan_JordanMinistryofHealth_overall,"September 5, 2022",National,Jordan,JOR,,,"June 27, 2021","August 5, 2021",Household and community samples,Multiple groups,8821,74.10%,73.10%,74.90%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Moderate,Journal Article (Peer-Reviewed),Sami Sheikh Ali,Jordan Ministry of Health,https://doi.org/10.2147/IJGM.S371711,9/22/2022,4/20/2024,Verified
200707_Jersey_StatisticsJersey_Round3_TestAdj_PopAdj,"July 7, 2020",National,Jersey,JEY,,,"June 21, 2020","June 27, 2020",Household and community samples,Multiple groups,1386,4.00%,2.80%,5.20%,Simplified probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,99.39%,Low,Institutional Report,Statistics Jersey,Statistics Jersey,https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200707%20SJ.pdf,5/1/2021,8/15/2023,Verified
210419_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj,"April 19, 2021",Local,Japan,JPN,Hyogo Prefecture,Kobe,"March 31, 2020","April 7, 2020",Residual sera,Multiple groups,1000,2.70%,1.80%,3.90%,Simplified probability,Kurabo Industries Ltd,LFIA,IgG,76.38%,100.00%,High,Journal Article (Peer-Reviewed),Asaka Doi,Kobe City Medical Center General Hospital,https://dx.doi.org/10.1016/j.cegh.2021.100747,5/2/2020,7/17/2022,Verified
200621_Japan_SoftBank_HCW,"June 21, 2020",Local,Japan,JPN,,,"May 12, 2020","May 18, 2020",Health care workers and caregivers,Multiple groups,5850,1.79%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Simon Denyer,SoftBank,https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw,6/28/2020,7/17/2022,Verified
200721_Tokyo_NavitasClinicTachikawa_Overall,"July 21, 2020",Regional,Japan,JPN,"Kantō, Chūbu ","Tokyo, Kangawa, Saitama, Chiba, Yamanashi","April 20, 2020","May 20, 2020",Household and community samples,Multiple groups,1071,3.83%,2.76%,5.16%,Self-referral,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,Journal Article (Peer-Reviewed),Morihito Takita,Navitas Clinic Tachikawa,https://dx.doi.org/10.1177/2150132720942695,7/17/2020,7/17/2022,Verified
210226_Iwate_IwatePrefecturalCentralHospital_HCW_Abbot&Roche,"February 26, 2021",Local,Japan,JPN,Honshu,Morioka,"May 18, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),1000,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics,Alfa Scientific Designs",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital,https://dx.doi.org/10.5387/fms.2020-21,7/17/2020,3/2/2024,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,"July 30, 2020",Local,Japan,JPN,Hokkaido,Sapporo,"May 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.00%,0.00%,0.00%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,3/2/2024,Verified
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,"July 30, 2020",Local,Japan,JPN,Hokkaido,Sapporo,"March 1, 2020","March 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.30%,0.00%,1.80%,Unclear,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Goki Suda,Hokkaido University Graduate School of Medicine,https://dx.doi.org/10.1111/hepr.13551,10/1/2020,3/2/2024,Verified
200911_Osaka_ToyonakaMunicipalHospital_Overall,"September 11, 2020",Local,Japan,JPN,Kansai,Osaka,"June 12, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Preprint,Tsutomu Nishida,Toyonaka Municipal Hospital,https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1,10/23/2020,3/2/2024,Verified
201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff,"October 8, 2020",Local,Japan,JPN,Kanagawa,Fujisawa,"June 1, 2020","July 30, 2020",Health care workers and caregivers,Adults (18-64 years),806,0.74%,0.27%,1.61%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Unclear,Journal Article (Peer-Reviewed),M Hibino,Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.1016/j.jhin.2020.10.001,11/25/2020,3/2/2024,Verified
201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter,"December 7, 2020",Local,Japan,JPN,Kansai,Kyoto,"April 10, 2020","April 20, 2020",Health care workers and caregivers,Adults (18-64 years),92,5.40%,,,Convenience,"CTK Biotech, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kohei Fujita,National Hospital Organization Kyoto Medical Center,https://dx.doi.org/10.3389/fpubh.2020.595348,2/2/2021,3/2/2024,Verified
201120_Japan_TokyoNationalHospital_overall,"November 20, 2020",Local,Japan,JPN,,Tokyo,"June 1, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),93,16.10%,,,Convenience,"GenBody Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Shomi Oka,Tokyo National Hospital,https://www.researchsquare.com/article/rs-112294/v1,2/7/2021,3/2/2024,Verified
210113_Wakayama_WakayamaMedicalUniversity_overall,"January 13, 2021",Local,Japan,JPN,,Wakayama,"July 7, 2020","September 15, 2020",Health care workers and caregivers,Multiple groups,1528,0.79%,0.34%,1.22%,Convenience,Kurabo Industries Ltd,LFIA,IgG,76.40%,100.00%,High,Preprint,Sadahiro Iwabuchi,Wakayama Medical University,https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1,2/8/2021,7/17/2022,Unverified
201230_Fukushima_ HirataCentralHospital_CLIA_IgG,"December 30, 2020",Local,Japan,JPN,Fukushima Prefecture,Hirata,"May 8, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,637,0.94%,,,Unclear,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Yurie Kobashi, Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2020.107360,2/16/2021,7/5/2023,Verified
210120_Japan_ResearchInstituteOfTuberculosis_GenPop,"January 20, 2021",National,Japan,JPN,,"Tokyo, Osaka, Miyagi","June 1, 2020","June 7, 2020",Household and community samples,Multiple groups,7950,0.10%,0.04%,0.20%,Stratified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"Total Antibody,IgG",,,Low,Journal Article (Peer-Reviewed),Takashi Yoshiyama,Government of Japan,https://dx.doi.org/10.3201/eid2702.204088,3/1/2021,3/2/2024,Verified
210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall,"January 29, 2021",Regional,Japan,JPN,Kansai,,"August 6, 2020","October 1, 2020",Residual sera,Multiple groups,10377,0.60%,,,Sequential,"Sysmex,Roche Diagnostics",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Koichi Furukawa,Kobe University Graduate School of Medicine,https://dx.doi.org/10.31662/jmaj.2020-0094,3/21/2021,3/2/2024,Verified
210206_YokohamaCity_YokohamaCityUniversity,"February 6, 2021",Local,Japan,JPN,Kanagawa Prefecture,Yokohama City,"June 1, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),432,3.90%,,,Sequential,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Shigeta Miyake,Yokohama City University,http://dx.doi.org/10.1111/den.13945,4/5/2021,7/17/2022,Verified
200920_Tokyo_NationalCenterForGlobalHealthAndMedicine_Overall,"September 9, 2020",Local,Japan,JPN,,Tokyo,"February 14, 2020","April 3, 2020",Health care workers and caregivers,Adults (18-64 years),49,0.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tetsuya Suzuki,National Center for Global Health and Medicine,http://dx.doi.org/10.1016/j.jiac.2020.09.006,4/11/2021,7/17/2022,Verified
210330_Tokyo_JapanMinistryOfHealth1_overall,"March 30, 2021",Regional,Japan,JPN,Tokyo Prefecture,,"December 14, 2020","December 26, 2020",Household and community samples,Multiple groups,3399,1.35%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/17/2022,Unverified
210330_Osaka_JapanMinistryOfHealth2_overall,"March 30, 2021",Regional,Japan,JPN,Osaka Prefecture,,"December 14, 2020","December 26, 2020",Household and community samples,Multiple groups,2746,0.69%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/17/2022,Unverified
210330_ Aichi_JapanMinistryOfHealth3_overall,"March 30, 2021",Regional,Japan,JPN,Aichi Prefecture,,"December 14, 2020","December 26, 2020",Household and community samples,Multiple groups,2960,0.71%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/17/2022,Unverified
210330_Miyagi_JapanMinistryOfHealth4_overall,"March 30, 2021",Regional,Japan,JPN,Miyagi Prefecture,,"December 14, 2020","December 26, 2020",Household and community samples,Multiple groups,2860,0.14%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/17/2022,Unverified
210330_ Fukuoka_JapanMinistryOfHealth5_overall,"March 30, 2021",Regional,Japan,JPN,Fukuoka Prefecture,,"December 14, 2020","December 26, 2020",Household and community samples,Multiple groups,3078,0.42%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,The Bharat Express News,Japan Ministry of Health,https://www.thebharatexpressnews.com/1-35-in-tokyo-have-antibodies-against-the-coronavirus/,4/11/2021,7/17/2022,Unverified
200727_Japan_HealthandWelfareDepartment_primary,"July 27, 2020",Regional,Japan,JPN,prefecture 3,,"June 15, 2020","June 28, 2020",Residual sera,Multiple groups,3000,0.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Okuda,Health and Welfare Department,http://wave.pref.wakayama.lg.jp/news/kensei/shiryo.php?sid=31587,4/23/2021,7/17/2022,Verified
210212_Hiroshima_HiroshimaUniversity_overall,"February 12, 2021",Regional,Japan,JPN,Hiroshima Prefecture,"Hiroshima, Fukuyama, Miyoshi, and Higashi-Hiroshima","October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,2396,0.25%,,,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Institutional Report,Prefecture of Hiroshima,Hiroshima University ,https://www.chugoku-np.co.jp/local/news/article.php?comment_id=726622&comment_sub_id=0&category_id=256,5/1/2021,3/2/2024,Verified
210315_FukuokaCity_KanenokumaHospital_Staff,"March 15, 2021",Local,Japan,JPN,,Fukuoka City,"April 23, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),40,0.00%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,5/14/2021,3/2/2024,Verified
201216_Utsunomiya_TokyoMedicalandDentalUniversity_PopAdj,"December 16, 2020",Regional,Japan,JPN,Tochigi Prefecture,Utsunomiya City,"June 14, 2020","July 5, 2020",Household and community samples,Multiple groups,742,1.23%,0.17%,2.28%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Nobutoshi Nawa,Tokyo Medical and Dental University,https://onlinelibrary.wiley.com/doi/full/10.1002/jgf2.408,5/14/2021,7/17/2022,Verified
210315_FukuokaCity_KanenokumaHospital_Residents,"March 15, 2021",Local,Japan,JPN,,Fukuoka City,"April 23, 2020","June 15, 2020",Assisted living and long-term care facilities,Seniors (65+ years),76,7.89%,,,Convenience,"NA,Hanghzhou AllTest Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Chong,Kanenokuma Hospital,https://dx.doi.org/10.1186/s12879-021-05972-5,5/14/2021,3/2/2024,Verified
210405_Japan_SOUSEIKAI_Overall,"April 5, 2021",Local,Japan,JPN,"Fukuoka, Kumamoto, Tokyo",,"August 15, 2020","October 15, 2020",Health care workers and caregivers,Multiple groups,2160,1.70%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Tatsuya Yoshihara,SOUSEIKAI Medical Group,http://dx.doi.org/10.3390/ijerph18073786,5/14/2021,3/2/2024,Verified
210324_Morioka_IwatePrefecturalCentralHospital_hcw,"March 24, 2021",Local,Japan,JPN,Tonoku,Morioka,"May 18, 2020","May 19, 2020",Health care workers and caregivers,Adults (18-64 years),1404,0.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Akihiro Nakamura,Iwate Prefectural Central Hospital ,https://onlinelibrary.wiley.com/doi/10.1002/jmv.26962,5/17/2021,3/2/2024,Verified
210416_Tokyo_JuntendoUniversity_HCW_Overall_testadj,"April 16, 2021",Local,Japan,JPN,Kantō,Tokyo,"July 6, 2020","August 21, 2020",Health care workers and caregivers,Multiple groups,4147,0.38%,0.22%,0.63%,Convenience,Roche Diagnostics,CLIA,"IgA,IgM,IgG",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Hiroshi Fukuda,Juntendo Univesity,https://dx.doi.org/10.1038/s41598-021-87688-9,5/23/2021,7/5/2023,Verified
210223_Osaka_KyotoUniversity_RLA_Overall,"February 23, 2021",Local,Japan,JPN,Honshu,Osaka,"July 8, 2020","July 22, 2020",Health care workers and caregivers,Adults (18-64 years),1000,0.40%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Hidenori Matsunaga,Kyoto University,https://www.mdpi.com/1999-4915/13/2/347,5/24/2021,7/17/2022,Verified
210417_Itami_ItamiCityHospital,"April 17, 2021",Local,Japan,JPN,Kansai,Itami,"May 15, 2020","November 20, 2020",Residual sera,Multiple groups,592,2.20%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tsuyoshi Nakai,Itami City Hospital,https://dx.doi.org/10.1016/j.jos.2021.02.017,5/26/2021,7/17/2022,Unverified
210430_Tokyo_NationalCenterForGlobalHealthAndMedicine_Primary,"April 30, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1228,0.08%,0.02%,0.45%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Shohei Yamamoto,National Center for Global Health and Medicine,https://dx.doi.org/10.35772/ghm.2021.01022,5/30/2021,3/2/2024,Verified
200515_Tokyo_UniversityOfTokyo,"May 15, 2020",Regional,Japan,JPN,Tokyo Prefecture,Tokyo,"May 1, 2020","May 2, 2020",Residual sera,Multiple groups,500,0.60%,,,Convenience,NA,CLIA,"IgG,IgM",,,High,Presentation or Conference,Tatsuhiko Kodama,University of Tokyo,https://www.rcast.u-tokyo.ac.jp/ja/news/release/20200515.html,6/3/2021,7/17/2022,Verified
20210524_NCGM_Japan_hcw,"May 24, 2021",Regional,Japan,JPN,,"Tokyo, Chiba","October 1, 2020","December 31, 2020",Essential non-healthcare workers,Adults (18-64 years),2563,0.70%,0.42%,1.11%,Convenience,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Unclear,Journal Article (Peer-Reviewed),Shohei Yamamoto,The National Center for Global Health and Medicine (NCGM),https://dx.doi.org/10.1016/j.jinf.2021.05.017,6/6/2021,3/2/2024,Unverified
210504_Okinawa_OkinawaInstituteOfScienceAndTechnology,"May 4, 2021",Local,Japan,JPN,Okinawa Prefecture,Okinawa,"August 1, 2020","August 31, 2020",Multiple populations,Adults (18-64 years),675,0.00%,,,Convenience,NA,ELISA,Not reported,92.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Melissa M Matthews,Okinawa Institute of Science and Technology,https://dx.doi.org/10.1038/s41598-021-88850-z,6/7/2021,2/2/2024,Verified
210528_Tokyo_NationalCancerCenterHospital_HCW_primary,"May 28, 2021",Local,Japan,JPN,,Tokyo,"September 1, 2020","October 30, 2020",Health care workers and caregivers,Multiple groups,1190,0.67%,0.29%,1.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,6/7/2021,7/17/2022,Unverified
210528_Tokyo_NationalCancerCenterHospital_patients_primary,"May 28, 2021",Local,Japan,JPN,,Tokyo,"August 3, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,500,1.00%,0.33%,2.32%,Convenience,Sysmex,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shu Yazaki,National Cancer Center Hospital,https://dx.doi.org/10.1001/jamaoncol.2021.2159,6/7/2021,7/17/2022,Unverified
210608_Tokyo_BostonChildrensHospital_May26-June9,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"May 26, 2020","June 9, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),51,5.88%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_June10-June23,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"June 10, 2020","June 23, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),119,5.00%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_June24-July7,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"June 24, 2020","July 7, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),187,25.67%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_July8-July21,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"July 8, 2020","July 21, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),256,37.10%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_July22-August4,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"July 22, 2020","August 4, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),175,38.86%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_August5-August18,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"August 5, 2020","August 18, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),115,41.74%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210608_Tokyo_BostonChildrensHospital_August19-September2,"June 8, 2021",Local,Japan,JPN,Tokyo Prefecture,Tokyo,"August 19, 2020","September 2, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),62,46.77%,,,Convenience,Aurora Biomed Inc,LFIA,"IgG,IgM",,,High,Preprint,Sawako Hibino,Medical Corporation Koshikai ,https://www.researchsquare.com/article/rs-564670/v1,6/21/2021,3/2/2024,Verified
210201_Yamagata_YamagataUniversity_Overall,"February 1, 2021",Local,Japan,JPN,Yamagata prefecture,Yamagata,"June 1, 2020","June 4, 2020",Residual sera,Multiple groups,1009,0.50%,0.06%,0.93%,Sequential,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Institutional Report,Keita Morikane,Yamagata University,https://dx.doi.org/10.5365/wpsar.2020.11.3.012,6/23/2021,3/2/2024,Verified
210625_Osaka_ ToyonakaMunicipalHospital_Overall,"June 25, 2021",Local,Japan,JPN,Osaka Prefecture,Osaka,"June 12, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),925,0.43%,0.17%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Tsutomu Nishida, Toyonaka Municipal Hospital,https://dx.doi.org/10.1097/MD.0000000000026433,6/30/2021,3/2/2024,Verified
210612_Tokyo_TheUniversityOfTokyo_overall,"June 12, 2021",Regional,Japan,JPN,,Tokyo,"June 11, 2020","October 28, 2020",Multiple populations,Multiple groups,6609,0.48%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihisa Mitani,The University of Tokyo,https://dx.doi.org/10.1016/j.jiac.2021.06.008,7/1/2021,7/17/2022,Verified
210619_Tokyo_KeioUniversityHealthCenter,"June 19, 2021",Local,Japan,JPN,,Tokyo,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),2320,0.86%,0.53%,1.33%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tomoyasu Nishimura,Keio University Health Center,https://dx.doi.org/10.2169/internalmedicine.7033-21,7/8/2021,7/17/2022,Verified
210614_Fukushima_HirataCentralHospital_May_CLIA_IgG,"June 14, 2021",Local,Japan,JPN,Fukushima,Ishikawa District,"May 8, 2020","May 28, 2020",Health care workers and caregivers,Multiple groups,515,0.97%,0.32%,2.25%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,7/20/2021,7/17/2022,Unverified
210614_Fukushima_HirataCentralHospital_Oct_CLIA_IgG,"June 14, 2021",Local,Japan,JPN,Fukushima,Ishikawa District,"October 5, 2020","October 23, 2020",Health care workers and caregivers,Multiple groups,515,0.39%,0.05%,1.40%,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.30%,96.30%,Low,Journal Article (Peer-Reviewed),Yurie Kobashi,Hirata Central Hospital,https://dx.doi.org/10.1016/j.intimp.2021.107884,7/20/2021,7/17/2022,Unverified
210719_Kanagawa_OsakaCityUniversity,"July 19, 2021",Local,Japan,JPN,Kanagawa,Yokohama City,"June 30, 2020","July 2, 2020",Health care workers and caregivers,Adults (18-64 years),377,7.16%,,,Convenience,"Abbott Laboratories,GenScript",Multiple Types,"IgG,Neutralizing ,IgM",,,High,Preprint,Yu Nakagama,Osaka City University,https://www.medrxiv.org/content/10.1101/2021.07.15.21260585v1.full-text,7/29/2021,3/2/2024,Unverified
210727_Tokyo_MusashinoRed CrossHospital_Baseline,"July 27, 2021",Regional,Japan,JPN,,Tokyo,"March 15, 2021","May 15, 2021",Essential non-healthcare workers,Multiple groups,59,0.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Shun Kaneko,Musashino Red Cross Hospital,https://dx.doi.org/10.1002/jmv.27231,8/4/2021,3/2/2024,Unverified
210529_Yokohama_YokohamaDai-ichiHospital,"May 29, 2021",Local,Japan,JPN,,Yokohama,"August 1, 2020","December 14, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,55,3.64%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Takayasu Taira,Yokohama Dai-ichi Hospital,http://dx.doi.org/10.1093/ndt/gfab098.0019,9/14/2021,3/2/2024,Unverified
211011_SaitamaCity_JichiMedicalUniversity_crosssectional_HCW,"October 11, 2021",Local,Japan,JPN,Saitama Prefecture,Saitama City,"July 5, 2020","July 19, 2020",Health care workers and caregivers,Adults (18-64 years),607,0.17%,0.01%,1.06%,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Hiroshi Hori,Jichi Medical University,https://dx.doi.org/10.1371/journal.pone.0257513,10/20/2021,3/2/2024,Unverified
211011_SaitamaCity_JichiMedicalUniversity_cohort_HCW_primary,"October 11, 2021",Local,Japan,JPN,Saitama Prefecture,Saitama City,"May 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),116,0.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,High,Journal Article (Peer-Reviewed),Hiroshi Hori,Jichi Medical University,https://dx.doi.org/10.1371/journal.pone.0257513,10/20/2021,3/2/2024,Unverified
211030_Aichi_NationalCenterforGeriatricsandGerontology_Primary,"October 30, 2021",Regional,Japan,JPN,Aichi Prefecture,,"June 1, 2021","June 30, 2021",Health care workers and caregivers,Adults (18-64 years),556,93.70%,,,Convenience,Sysmex,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihiko Nishikimi,National Center for Geriatrics and Gerontology,https://dx.doi.org/10.1016/j.jinf.2021.10.021,11/11/2021,7/17/2022,Unverified
211029_OsakaCity_OsakaCityGeneralHospital_Overall,"October 29, 2021",Local,Japan,JPN,Osaka Prefecture,Osaka City,"November 1, 2020","March 31, 2021",Residual sera,Multiple groups,94,6.40%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Yusuke Hanioka,Osaka City General Hospital,https://dx.doi.org/10.2147/IJGM.S330525,11/18/2021,3/2/2024,Unverified
211113_Tokyo_TokyoMetropolitanInstituteofMedicalScience_Overall,"November 13, 2021",Regional,Japan,JPN,,Tokyo,"September 1, 2020","March 31, 2021",Residual sera,Multiple groups,23234,1.83%,1.66%,2.01%,Simplified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,100.00%,Moderate,Journal Article (Peer-Reviewed),Takahiro Sanada,Tokyo Metropolitan Institute of Medical Science,https://dx.doi.org/10.2188/jea.JE20210324,11/23/2021,3/2/2024,Unverified
211205_Tokyo_UniversityofTokyo_iFlashIgG,"December 5, 2021",Regional,Japan,JPN,,Tokyo,"June 11, 2020","December 22, 2020",Multiple populations,Adults (18-64 years),10039,0.23%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Akihisa Mitani,University of Tokyo,https://dx.doi.org/10.1016/j.jiac.2021.11.020,1/4/2022,7/17/2022,Unverified
211119_IwateMedicalUniversity_IwateMedicalUniversity,"November 19, 2021",Local,Japan,JPN,Tohoku,Morioke,"March 15, 2021","May 31, 2021",Health care workers and caregivers,Adults (18-64 years),10,0.00%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,Hiromi Nagashima,Iwate Medical University,https://onlinelibrary.wiley.com/doi/full/10.1111/resp.14150_356,1/13/2022,7/17/2022,Unverified
211228_Kanagawa_ ShonanFujisawaTokushukaiHospital_AbbottIgG-S,"December 28, 2021",Local,Japan,JPN,,Kanagawa,"April 15, 2021","May 15, 2021",Health care workers and caregivers,Adults (18-64 years),100,5.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Makoto Hibino, Shonan Fujisawa Tokushukai Hospital,https://dx.doi.org/10.2169/internalmedicine.8704-21,1/14/2022,3/2/2024,Unverified
220112_KantohDistrict_EPSHoldingsInc,"January 12, 2022",Regional,Japan,JPN,,,"April 26, 2021","August 1, 2021",Household and community samples,Multiple groups,139,12.23%,7.29%,18.86%,Convenience,NA,ELISA,IgG,,,High,Preprint,Keiichi Tsukinoki,"EPS Holdings, Inc.",https://www.medrxiv.org/content/10.1101/2022.01.09.22268986v2.full-text,1/18/2022,7/17/2022,Unverified
200906_Kanagawa_KanagawaPhysiciansAssociation_HCWs_PopAdjust,"September 6, 2020",Regional,Japan,JPN,Kanagawa Prefecture,,"May 18, 2020","June 24, 2020",Health care workers and caregivers,Adults (18-64 years),504,2.10%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ikuro Matsuba,Kanagawa Physicians Association,https://www.sciencedirect.com/science/article/pii/S1341321X20303251,2/2/2022,7/17/2022,Unverified
200906_Kanagawa_KanagawaPhysiciansAssociation_Patients_PopAdjust,"September 6, 2020",Regional,Japan,JPN,Kanagawa Prefecture,,"May 18, 2020","June 24, 2020",Residual sera,Multiple groups,988,2.70%,,,Convenience,NA,ELISA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ikuro Matsuba,Kanagawa Physicians Association,https://www.sciencedirect.com/science/article/pii/S1341321X20303251,2/2/2022,7/17/2022,Unverified
220121_Hyogo_UniversityOfOxford,"January 21, 2022",Local,Japan,JPN,,Hyogo,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,339,2.36%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
121203_Tochigi_JichiMedicalUniversity_Apr-May2020,"December 3, 2021",Local,Japan,JPN,Shimotsuke,Tochigi,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),54,3.70%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,3/29/2022,3/2/2024,Unverified
121203_Tochigi_JichiMedicalUniversity_Jun-Nov2020,"December 3, 2021",Local,Japan,JPN,Shimotsuke,Tochigi,"June 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),349,1.43%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,3/29/2022,3/2/2024,Unverified
121203_Tochigi_JichiMedicalUniversity_Dec2020-Mar2021,"December 3, 2021",Local,Japan,JPN,Shimotsuke,Tochigi,"December 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),86,1.16%,,,Entire sample,"Innovita Biological Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,Abbott Laboratories",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Kouichi Miura,Jichi Medical University,https://dx.doi.org/10.1002/deo2.79,3/29/2022,3/2/2024,Unverified
220327_Yokohama_YokohamaCityUniversity_Popadj,"March 27, 2022",Local,Japan,JPN,Kanagawa Prefecture,Yokohama,"January 30, 2022","February 28, 2022",Household and community samples,Multiple groups,1277,94.20%,93.00%,95.40%,Simplified probability,TOSOH,CLIA,IgG,,,Moderate,Preprint,Atsushi Goto,Yokohama City University,https://www.medrxiv.org/content/10.1101/2022.03.26.22272766v1.full-text,4/6/2022,3/2/2024,Verified
220331_Maebashi_GunmaUniversityHospital_Overall,"March 31, 2022",Local,Japan,JPN,Gunma Prefecture,Maebashi,"March 1, 2021","March 31, 2021",Health care workers and caregivers,Multiple groups,771,0.39%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Suguru Hiramoto,Gunma University Hospital,https://dx.doi.org/10.1620/tjem.2022.J017,4/7/2022,3/2/2024,Unverified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_1stSurveyMain_Overall,"March 3, 2022",Local,Japan,JPN,Okinawa Prefecture,,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,392,0.00%,0.00%,0.90%,Convenience,NA,ELISA,IgG,92.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,4/8/2022,7/17/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_2ndSurveyMain_Overall,"March 3, 2022",Local,Japan,JPN,Okinawa Prefecture,,"October 1, 2020","December 31, 2020",Household and community samples,Multiple groups,1448,0.60%,0.20%,1.10%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,4/8/2022,7/17/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_3rdSurveyMain_Overall,"March 3, 2022",Local,Japan,JPN,Okinawa Prefecture,,"February 1, 2021","February 28, 2021",Household and community samples,Multiple groups,582,1.40%,0.20%,5.80%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,4/8/2022,7/17/2022,Verified
220405_Japan_KobeUniversity_Baseline_OverallAntiS,"April 5, 2022",Regional,Japan,JPN,Hyogo Prefecture,Kobe,"July 19, 2021","August 6, 2021",Residual sera,Adults (18-64 years),1000,38.70%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Zhenxiao Ren,Kobe Univesity,https://dx.doi.org/10.1371/journal.pone.0266270,4/23/2022,7/17/2022,Unverified
220405_Japan_KobeUniversity_FollowUp_OverallAntiS,"April 5, 2022",Regional,Japan,JPN,Hyogo Prefecture,Kobe,"November 22, 2021","December 8, 2021",Residual sera,Adults (18-64 years),1000,90.80%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Zhenxiao Ren,Kobe Univesity,https://dx.doi.org/10.1371/journal.pone.0266270,4/23/2022,7/17/2022,Unverified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_2ndSurveyRemote_Overall,"March 3, 2022",Local,Japan,JPN,Okinawa Prefecture,,"October 1, 2020","December 31, 2020",Household and community samples,Multiple groups,144,0.00%,,,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,5/19/2022,7/17/2022,Verified
220303_Okinawa_OkinawaPrefectureEpidemiologicalStatisticsAndAnalysisCommittee_3rdSurveyRemote_Overall,"March 3, 2022",Local,Japan,JPN,Okinawa Prefecture,,"February 1, 2021","February 28, 2021",Household and community samples,Multiple groups,123,1.60%,0.20%,5.80%,Convenience,NA,ELISA,IgG,92.50%,100.00%,High,Journal Article (Peer-Reviewed),Kenji Mizumoto,Okinawa Prefecture Epidemiological Statistics and Analysis Committee,https://www.medrxiv.org/content/10.1101/2022.03.02.22271759v1.full-text,5/19/2022,7/17/2022,Verified
210820_AichiPrefecture_FujitaHealthUniversity,"August 20, 2021",Local,Japan,JPN,Aichi Prefecture,Toyoake,"August 17, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,35,0.00%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Masataka Yoshinaga,Fujita Health University,https://dx.doi.org/10.20407/fmj.2020-032,5/25/2022,3/2/2024,Verified
220520_Tokyo_TokyoShinagawaHospital_RBD,"May 20, 2022",Local,Japan,JPN,,Tokyo,"March 15, 2021","April 15, 2021",Health care workers and caregivers,Adults (18-64 years),685,9.50%,,,Unclear,Abbott Laboratories,CLIA,IgG,96.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Masashi Nishimura,Tokyo Shinagawa Hospital,https://dx.doi.org/10.1371/journal.pone.0267566,6/3/2022,3/2/2024,Unverified
220524_Tokyo_JuntendoUniversity_PreVaccination2020_AntiS,"May 24, 2022",Local,Japan,JPN,,Tokyo,"July 6, 2020","August 21, 2020",Health care workers and caregivers,Multiple groups,2203,1.32%,,,Unclear,Roche Diagnostics,Not reported,Total Antibody,,99.98%,High,Journal Article (Peer-Reviewed),Gene Igawa,Juntendo University,https://dx.doi.org/10.1038/s41598-022-12809-x,6/5/2022,3/2/2024,Unverified
220524_Tokyo_JuntendoUniversity_PostVaccination2021_AntiN,"May 24, 2022",Local,Japan,JPN,,Tokyo,"June 1, 2021","June 30, 2021",Health care workers and caregivers,Multiple groups,2202,1.59%,,,Sequential,Roche Diagnostics,Not reported,Total Antibody,,,High,Journal Article (Peer-Reviewed),Gene Igawa,Juntendo University,https://dx.doi.org/10.1038/s41598-022-12809-x,6/5/2022,3/2/2024,Unverified
220524_Japan_KanagawaDentalUniversity_Primary,"May 24, 2022",Regional,Japan,JPN,Kantoh region,,"April 8, 2021","August 2, 2021",Multiple populations,Multiple groups,180,52.78%,45.21%,60.25%,Unclear,NA,ELISA,IgA,,,High,Journal Article (Peer-Reviewed),Keiichi Tsukinoki,Teikyo University,https://dx.doi.org/10.1111/1348-0421.13011,6/5/2022,7/17/2022,Unverified
220531_Toon_EhimeUniversity_HCWs_1stSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"June 11, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),743,0.00%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,6/8/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_Outpatients_1stSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"June 11, 2020","June 17, 2020",Residual sera,Multiple groups,1000,0.10%,0.02%,0.56%,Simplified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,6/8/2022,3/2/2024,Unverified
220530_Tokyo_KitasatoUniversitySchoolofMedicine,"May 30, 2022",Local,Japan,JPN,,Tokyo,"June 8, 2020","July 4, 2020",Health care workers and caregivers,Adults (18-64 years),3677,0.35%,0.19%,0.60%,Sequential,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Yoko Takayama,Kitasato University School of Medicine,https://dx.doi.org/10.1272/jnms.JNMS.2022_89-511,6/9/2022,3/2/2024,Unverified
220624_Shiga_ShigaUniversityofMedicalScience,"June 24, 2022",Regional,Japan,JPN,Shiga Prefecture,,"February 15, 2021","February 26, 2021",Health care workers and caregivers,Adults (18-64 years),1237,1.78%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tokuchiro Chano,Shiga University of Medical Science,https://dx.doi.org/10.1371/journal.pone.0270334,7/8/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_0to9,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Children and Youth (0-17 years),148,0.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_10to19,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Children and Youth (0-17 years),81,2.50%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_20to29,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Adults (18-64 years),134,8.20%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_30to39,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Adults (18-64 years),244,5.70%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_40to49,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Adults (18-64 years),213,2.80%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_50to59,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Adults (18-64 years),298,2.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_60to69,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Multiple groups,358,4.20%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_70to79,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Seniors (65+ years),554,4.00%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
220712_Japan_UniversityofTokyo_80plus,"July 12, 2022",Local,Japan,JPN,,Tokyo,"January 1, 2020","January 31, 2020",Hospital visitors,Seniors (65+ years),355,3.70%,,,Convenience,Zeus,ELISA,IgG,100.00%,99.50%,High,Preprint,Seiya Yamayoshi,University of Tokyo,https://doi.org/10.1101/2022.07.11.22277481,7/22/2022,3/2/2024,Unverified
20220707_Hiroshima_Hiroshima University_Jan-Feb2021_Overall,"July 7, 2022",Local,Japan,JPN,Chūgoku Region,"Hiroshima, Fukuyama, Higashi-Hiroshima, Miyoshi, and Kita-Hiroshima","January 1, 2021","February 28, 2021",Household and community samples,Multiple groups,2351,0.30%,0.08%,0.52%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,GenScript,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Aya Sugiyama,Hiroshima University,https://dx.doi.org/10.1265/ehpm.22-00016,7/27/2022,3/2/2024,Unverified
210126_Japan_ChubuUniversity,"August 21, 2022",Local,Japan,JPN,,,"January 26, 2021","January 26, 2021",Household and community samples,Adults (18-64 years),129,3.90%,,,Convenience,Roche Diagnostics,LFIA,"IgG,IgM",99.03%,98.65%,Moderate,Journal Article (Peer-Reviewed),Yukihiro Mori,Chubu University,https://dx.doi.org/10.5582/ddt.2022.01048,9/13/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_HCWs_2ndSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"December 8, 2020","December 11, 2020",Health care workers and caregivers,Adults (18-64 years),407,0.00%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_HCWs_3rdSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"July 10, 2021","July 16, 2021",Health care workers and caregivers,Adults (18-64 years),804,0.12%,0.02%,0.70%,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_HCWs_4thSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"December 7, 2021","December 10, 2021",Health care workers and caregivers,Adults (18-64 years),415,0.00%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_Outpatients_2ndSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"December 8, 2020","December 11, 2020",Residual sera,Multiple groups,1000,0.00%,,,Simplified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_Outpatients_3rdSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"July 10, 2021","July 16, 2021",Residual sera,Multiple groups,1000,0.00%,,,Simplified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
220531_Toon_EhimeUniversity_Outpatients_4thSurvey_TwoAssays,"May 31, 2022",Local,Japan,JPN,Ehime Prefecture,Toon,"December 7, 2021","December 10, 2021",Residual sera,Multiple groups,1000,0.00%,,,Simplified probability,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Koichiro Suemori,Ehime University,https://dx.doi.org/10.7883/yoken.JJID.2022.155,10/6/2022,3/2/2024,Unverified
221026_Kyoto_KyotoUniversity_Overall,"October 26, 2022",Local,Japan,JPN,,Kyoto,"June 15, 2021","October 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,18,0.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Yasufumi Goda,Kyoto University,https://dx.doi.org/10.1007/s11748-022-01887-3,11/3/2022,3/2/2024,Unverified
221121_Niigata_NiigataUniversity_Staff_AntiS,"November 21, 2022",Local,Japan,JPN,,Niigata,"April 1, 2021","April 30, 2021",Health care workers and caregivers,Adults (18-64 years),62,12.90%,,,Unclear,Abbott Laboratories,,,,,,Journal Article (Peer-Reviewed),Keita Wagatsuma,Niigata University,https://dx.doi.org/10.3390/v14112581,12/15/2022,3/2/2024,Unverified
221121_Niigata_NiigataUniversity_Residents_AntiS,"November 21, 2022",Local,Japan,JPN,,Niigata,"April 1, 2021","April 30, 2021",Assisted living and long-term care facilities,Seniors (65+ years),39,41.00%,,,Unclear,Abbott Laboratories,,,,,,Journal Article (Peer-Reviewed),Keita Wagatsuma,Niigata University,https://dx.doi.org/10.3390/v14112581,12/15/2022,3/2/2024,Unverified
221130_Japan_MinistryofHealthLabourandWelfare_Overall,"November 30, 2022",National,Japan,JPN,,,"November 6, 2022","November 13, 2022",Blood donors,Multiple groups,8260,26.50%,25.60%,27.50%,Simplified probability,NA,Not reported,,,,,Institutional Report,"Ministry of Health, Labour and Welfare of Japan",Ministry of Health Labour and Welfare,https://www.mhlw.go.jp/content/10900000/001018624.pdf,1/10/2023,3/20/2023,Unverified
230228_Japan_NationalInstituteofInfectiousDiseases,"February 28, 2023",National,Japan,JPN,,,"August 3, 2020","November 13, 2020",Health care workers and caregivers,Multiple groups,1899,8.50%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.50%,99.80%,,Journal Article (Peer-Reviewed),Reiko Shimbashi,National Institute of Infectious Diseases,https://dx.doi.org/10.35772/ghm.2022.01060,3/22/2023,3/2/2024,Unverified
230327_Tokyo_JuntendoUniversityFacultyofMedicine_Overall,"March 27, 2023",Local,Japan,JPN,,Tokyo,"June 8, 2022","June 20, 2022",Health care workers and caregivers,Adults (18-64 years),3788,17.70%,,,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,,Journal Article (Peer-Reviewed),Rie Kanamori,Juntendo University Faculty of Medicine,https://dx.doi.org/10.1038/s41598-023-32193-4,5/4/2023,3/2/2024,Unverified
230624_Japan_MountSinai,"June 24, 2023",National,Japan,JPN,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,339,2.95%,,,Convenience,Roche Diagnostics,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230717_Japan_JapaneseRedCrossSociety_overall_adj,"July 17, 2023",National,Japan,JPN,,,"November 6, 2022","November 13, 2022",Blood donors,Multiple groups,8260,28.60%,27.60%,29.60%,Sequential,Roche Diagnostics,CLIA,Not reported,,,,Institutional Report,Ryo Kinoshita,Japanese Red Cross Society,"https://wwwnc.cdc.gov/eid/article/29/9/23-0365_article#:~:text=A%20nationwide%20survey%20of%20SARS,CI%2027.6%25%E2%80%9329.6%25 ",8/24/2023,8/26/2023,Unverified
230201_Japan_NationalInstituteofInfectiousDiseases_February2022_AntiN_PopAdj,"February 1, 2023",Regional,Japan,JPN,"Miyagi, Tokyo, Aichi, Osaka, and Fukuoka prefectures",,"February 15, 2022","March 15, 2022",Household and community samples,Multiple groups,8147,1.40%,1.00%,2.10%,Stratified probability,Roche Diagnostics,CLIA,,99.40%,98.10%,Moderate,Journal Article (Peer-Reviewed),Takeshi Arashiro, National Institute of Infectious Diseases,https://dx.doi.org/10.1111/irv.13094,4/3/2024,4/3/2024,Verified
230201_Japan_NationalInstituteofInfectiousDiseases_February2022_AntiS_PopAdj,"February 1, 2023",Regional,Japan,JPN,"Miyagi, Tokyo, Aichi, Osaka, and Fukuoka prefectures",,"February 15, 2022","March 15, 2022",Household and community samples,Multiple groups,8147,96.70%,95.80%,97.50%,Stratified probability,Roche Diagnostics,CLIA,,97.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Takeshi Arashiro, National Institute of Infectious Diseases,https://dx.doi.org/10.1111/irv.13094,4/3/2024,4/3/2024,Verified
210211_Kingston_UniversityOfTheWestIndies_Overall,"February 11, 2021",Local,Jamaica,JAM,,Kingston,"March 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),249,14.86%,,,Sequential,Abbott Laboratories,CLIA,IgG,80.00%,96.15%,High,Preprint,TeAnne Chisolm,University of the West Indies,10.1101/2021.02.08.21251367,3/19/2021,3/2/2024,Verified
220921_Kingston_TheUniversityoftheWestIndies_STI_overall,"September 21, 2022",Local,Jamaica,JAM,,Kingston,"March 16, 2022","May 5, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,374,91.18%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Joshua Anzinger,The University of the West Indies,https://dx.doi.org/10.1101/2022.09.20.22280173,10/5/2022,3/2/2024,Unverified
220921_Kingston_TheUniversityoftheWestIndies_ANC_overall,"September 21, 2022",Local,Jamaica,JAM,,Kingston,"March 16, 2022","May 5, 2022",Residual sera,Adults (18-64 years),335,89.85%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Joshua Anzinger,The University of the West Indies,https://dx.doi.org/10.1101/2022.09.20.22280173,10/5/2022,3/2/2024,Unverified
220921_Kingston_TheUniversityoftheWestIndies_NCD_overall,"September 21, 2022",Local,Jamaica,JAM,,Kingston,"March 16, 2022","May 5, 2022",Residual sera,Multiple groups,831,86.64%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Joshua Anzinger,The University of the West Indies,https://dx.doi.org/10.1101/2022.09.20.22280173,10/5/2022,3/2/2024,Unverified
200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,"May 8, 2020",Local,Italy,ITA,Puglia,Bari,"March 26, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),606,0.33%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Preprint,Angelo Virgilio Paradiso,Istituto Tumori G. Paolo II,https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1,5/14/2020,3/2/2024,Verified
210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,"February 3, 2021",Local,Italy,ITA,Lombardy,Milan,"February 24, 2020","April 8, 2020",Blood donors,Adults (18-64 years),789,5.10%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti, Fondazione IRCCS Ca' Granda Ospedale Maggiore ,https://dx.doi.org/10.2450/2021.0324-20,5/21/2020,3/2/2024,Verified
200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1,"April 30, 2020",Local,Italy,ITA,Lombardy,"Alzano, Nembro","April 23, 2020","April 28, 2020",Household and community samples,Multiple groups,750,61.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,ATS Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,7/17/2022,Verified
200430_Bergamo_HospitalofBergamo_HCW,"April 30, 2020",Local,Italy,ITA,Lombardy,Bergamo,,"April 24, 2020",Health care workers and caregivers,Adults (18-64 years),3000,13.00%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Armando Di Landro,Hospital of Bergamo,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,7/17/2022,Verified
200609_Milan_UniMilan_OverallAb,"June 9, 2020",Local,Italy,ITA,Lombardy,Milan,"March 30, 2020","March 31, 2020",Household and community samples,Adults (18-64 years),197,10.15%,,,Self-referral,"Beijing Wantai Biological,EUROIMMUN",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf,6/24/2020,3/2/2024,Verified
200609_Bergamo_HealthAgency_GenPop,"June 9, 2020",Regional,Italy,ITA,Lombardy,,"April 23, 2020","June 3, 2020",Household and community samples,Multiple groups,9965,57.00%,,,Simplified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Angelo Amante,Bergamo Health Agency,https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw,7/6/2020,7/17/2022,Verified
200617_Italy_D.CotugnoHospital_HCW_IgG,"June 17, 2020",Local,Italy,ITA,Campania,Naples,"March 23, 2020","April 2, 2020",Health care workers and caregivers,Adults (18-64 years),115,1.74%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesco Fusco,D. Cotugno’ Hospital,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext,7/19/2020,3/2/2024,Verified
200619_Rome_UniversityofRome_IgG,"June 19, 2020",Local,Italy,ITA,Lazio,Rome,"April 7, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),1084,0.70%,,,Convenience,Medical Systems,CLIA,IgG,50.00%,99.10%,High,Journal Article (Peer-Reviewed),Edith Lahner,University of Rome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/,7/22/2020,7/17/2022,Verified
200707_Turin_University of Turin_PregnantWomen_IgGonly,"July 7, 2020",Local,Italy,ITA,Piedmont,Turin,"April 16, 2020","June 4, 2020",Pregnant or parturient women,Adults (18-64 years),138,5.80%,,,Sequential,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267,8/2/2020,3/2/2024,Verified
200808_Italy_UniversityofTurin_CLLPatients_Overall,"August 8, 2020",Local,Italy,ITA,Piedmont,"Turin, Novara, Alessandria, Verbania","March 8, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),24,12.50%,,,Convenience,"Medical Systems,DiaSorin,In3diagnostic",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Marco Denina ,University of Turin,http://dx.doi.org/10.1016/j.jaad.2020.08.021,9/26/2020,3/2/2024,Verified
200813_Foggia_UniversityofFoggia_OverallIgG/IgM,"August 13, 2020",Local,Italy,ITA, Apulia,Foggia,"May 1, 2020","May 31, 2020",Blood donors,Adults (18-64 years),904,0.99%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jose Ramon Fiore,University of Foggia,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425,9/27/2020,3/2/2024,Verified
200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall,"August 4, 2020",Regional,Italy,ITA,Tuscany,,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),17098,3.10%,,,Convenience,"Screen Italia S.R.L,Zhejiang Orient Gene Biotech",LFIA,"IgG,IgM",,,High,Preprint,Francesca Carozzi,Arezzo Hospital,https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1,9/28/2020,3/2/2024,Verified
200721_Arezzo_OspedaleSanDonato_Total,"July 21, 2020",Local,Italy,ITA,Tuscany,Arezzo,"March 17, 2020","March 21, 2020",Residual sera,Adults (18-64 years),516,13.00%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",37.00%,94.00%,High,Journal Article (Peer-Reviewed),Alessandro Pancrazzi,Ospedale San Donato,http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002,9/28/2020,3/2/2024,Verified
200728_Prato_SantoStefanoHospital_Overall,"July 28, 2020",Local,Italy,ITA,Tuscany,Prato,"April 4, 2020","May 16, 2020",Pregnant or parturient women,Adults (18-64 years),134,4.48%,,,Sequential,ACRO Biotech Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anna Cavaliere,Santo Stefano Hospital,http://dx.doi.org/10.1080/14767058.2020.1793317,9/29/2020,3/2/2024,Verified
200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,"July 29, 2020",Local,Italy,ITA,Lombardy,Milan,"April 2, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),202,7.40%,3.80%,11.00%,Convenience,"BioMedomics, Inc.",LFIA,IgG,88.70%,90.60%,High,Journal Article (Peer-Reviewed),Giovanni Sotgiu,Università degli Studi di Milano ,https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0,9/29/2020,3/2/2024,Verified
200803_Italy_ItalianMinistryOfHealth_Overall,"August 3, 2020",National,Italy,ITA,"Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, Friuli-Venezia Giulia, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, Trentino-Alto Adige, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto",,"May 25, 2020","July 15, 2020",Household and community samples,Multiple groups,64660,2.50%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,Unclear,Institutional Report,Instituto Nazionale di Statistica,Italian Ministry of Health,https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf,10/5/2020,3/2/2024,Verified
200907_Bari_PoliclinicoHospital_Overall,"September 7, 2020",Local,Italy,ITA, Apulia,Bari,"March 23, 2020","April 21, 2020",Residual sera,Multiple groups,819,8.55%,,,Sequential,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",35.10%,97.30%,High,Journal Article (Peer-Reviewed),Daniela Loconsole,Policlinico Hospital,https://dx.doi.org/10.3390/ijerph17186493,10/15/2020,3/2/2024,Verified
200823_Bergamo_HospitalPapaGiovanniXXIII_Overall,"August 26, 2020",Local,Italy,ITA,Lombardy,Bergamo,"March 4, 2020","July 10, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,90,21.10%,,,Convenience,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lorenzo Norsa,Papa Giovani XXII,http://dx.doi.org/10.1053/j.gastro.2020.08.046,10/15/2020,3/2/2024,Verified
200827_LiguriaLombardia_UniversityofGenoa_Overall,"August 27, 2020",Regional,Italy,ITA,"Lombardy, Liguria",,"March 1, 2020","April 30, 2020",Residual sera,Adults (18-64 years),3609,11.00%,10.00%,12.10%,Convenience,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Hangzhou Realy Tech Co. Ltd,Biosynex",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonio Vena,University of Genoa,https://dx.doi.org/10.3390/jcm9092780,10/16/2020,3/2/2024,Verified
200818_Brescia_UniversityofBrescia_Overall,"August 18, 2020",Local,Italy,ITA,Lombardy,Brescia,"April 27, 2020","April 27, 2020",Health care workers and caregivers,Adults (18-64 years),76,11.80%,,,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Alberto Dalla Volta,University of Brescia,http://dx.doi.org/10.3389/fonc.2020.01574,10/16/2020,3/2/2024,Verified
200806_Milan_UniversityofMilan_Overall,"August 6, 2020",Local,Italy,ITA,Lombardy,Milan,"April 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),663,5.13%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Antonella Amendola,University of Milan,http://dx.doi.org/10.1017/ice.2020.401,10/25/2020,3/2/2024,Verified
201006_Turin_UniversityofTorino_TotalHCWs,"October 6, 2020",Local,Italy,ITA,Piemonte,Torino (Turin),"April 17, 2020","May 20, 2020",Health care workers and caregivers,Adults (18-64 years),5444,6.90%,,,Convenience,DiaSorin,CLIA,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Calcagno,University of Torino,https://dx.doi.org/10.3201/eid2701.203027,12/10/2020,3/2/2024,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers,"September 15, 2020",Local,Italy,ITA,Campania,Naples,"April 3, 2020","May 29, 2020",Multiple populations,Multiple groups,1397,0.43%,,,Convenience,"VivaChek Biotech (Hangzhou) Co. Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/16/2020,3/2/2024,Verified
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW,"September 15, 2020",Local,Italy,ITA,Campania,Naples,"April 3, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),249,2.01%,,,Convenience,"VivaChek Biotech (Hangzhou) Co. Ltd,NA",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pio Stellato,Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon,http://dx.doi.org/10.1136/bmjpo-2020-000818,12/16/2020,3/2/2024,Verified
201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,"November 3, 2020",Local,Italy,ITA,Sardinia,Cagliari,"March 31, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),86,5.80%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabio Medas, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2020.11.006,1/10/2021,3/2/2024,Verified
201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG,"October 27, 2020",Local,Italy,ITA,Umbria,Perugia,"May 4, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,270,3.70%,,,Sequential,Screen Italia S.R.L,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,1/10/2021,3/2/2024,Verified
201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG,"October 31, 2020",Local,Italy,ITA,Lombardy,Milan,"March 15, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),40,5.00%,,,Convenience,"PRIMA Lab S.A.,DiaSorin",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Diana Canetti,San Raffaele Scientific Institute,https://pubmed.ncbi.nlm.nih.gov/33135083/,1/13/2021,3/2/2024,Verified
201021_Italy_IRCCS_Overall_IgG_unadj,"October 21, 2020",Regional,Italy,ITA,Lombardy,,"March 30, 2020","May 11, 2020",Multiple populations,Multiple groups,166,41.57%,,,Convenience,PRIMA Lab S.A.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Antonio Marra,Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS),https://dx.doi.org/10.1016/j.annonc.2020.10.473,1/16/2021,3/2/2024,Verified
201008_Udine_UniversityofUdine_SCTrecipients,"October 8, 2020",Local,Italy,ITA,Udine,Udine,"April 1, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,70,1.43%,,,Sequential,Cellex Inc.,LFIA,"IgG,IgM",93.75%,96.40%,High,Journal Article (Peer-Reviewed),Alessandra Sperotto,The University of Udine,https://dx.doi.org/10.1002/jmv.26586,1/18/2021,3/2/2024,Verified
200806_Lombardy_BrunoKesslerFoundation,"August 6, 2020",Regional,Italy,ITA,Lombardy,,"April 16, 2020","May 25, 2020",Contacts of COVID patients,Multiple groups,4120,53.10%,,,Stratified non-probability,DiaSorin,Not reported,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383,1/22/2021,3/2/2024,Verified
201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall,"October 31, 2020",Local,Italy,ITA,Abruzzo,Villa Caldari,"April 18, 2020","April 19, 2020",Household and community samples,Multiple groups,667,10.90%,8.80%,13.50%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Francesa Cito,Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale ,https://dx.doi.org/10.3390/microorganisms8111711,1/22/2021,3/2/2024,Verified
201222_Rome_EleemosynariaApostolica_overall,"December 22, 2020",Local,Italy,ITA,Lazio,Rome,"April 14, 2020","July 31, 2020",Multiple populations,Multiple groups,173,1.80%,,,Convenience,Biozek,LFIA,"IgG,IgM",96.00%,96.00%,High,Journal Article (Peer-Reviewed),Massimo Ralli,Eleemosynaria Apostolica,https://dx.doi.org/10.4081/jphr.2020.1986,1/24/2021,3/2/2024,Verified
201219_Tuscany_UniversityOfFlorence_Overall,"December 19, 2020",Regional,Italy,ITA,Prato,,"May 1, 2020","May 31, 2020",Multiple populations,Multiple groups,4656,3.00%,2.50%,3.50%,Convenience,Hangzhou Laihe Biotech Co. Ltd,LFIA,"IgG,IgM",100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Vieri Lastrucci,University of Florence,https://dx.doi.org/10.3390/vaccines8040778,1/24/2021,3/2/2024,Verified
201119_Italy_UniversityofCagliari_Milano1_IBDPatients,"November 19, 2020",Local,Italy,ITA,,"Milan, Cagliari, Erlangen","April 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,354,2.30%,0.80%,3.80%,Convenience,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/24/2021,7/17/2022,Verified
201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop,"November 19, 2020",Local,Italy,ITA,Lombardy,Milan,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,129,7.00%,4.40%,9.60%,Sequential,NA,ELISA,"IgG,IgA",97.64%,95.20%,High,Journal Article (Peer-Reviewed),Roberto Berte,University of Cagliari,https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/24/2021,7/17/2022,Verified
201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj,"November 27, 2020",Regional,Italy,ITA,Trento,,"May 5, 2020","May 15, 2020",Household and community samples,Multiple groups,6075,25.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,90.00%,100.00%,Low,Journal Article (Peer-Reviewed),Paola Stefanelli,Azienda Provinciale per i Servizi Sanitari,https://dx.doi.org/10.1016/j.cmi.2020.11.013,1/24/2021,7/5/2023,Verified
201109_Milan_UniversitadegliStudidiMilano_patients_antiN_S,"November 20, 2020",Local,Italy,ITA,Lombardy ,Milan,"May 11, 2020","July 5, 2020",Residual sera,Multiple groups,2753,3.34%,,,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Valeria Cento,Universita degli Studi di Milano,http://dx.doi.org/10.1371/journal.pone.0242765,1/24/2021,3/2/2024,Verified
201126_Naples_UniversityofNaples_MS,"November 26, 2020",Local,Italy,ITA,Campania,Naples,"May 11, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),310,2.90%,,,Sequential,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,7/5/2023,Verified
201126_Naples_UniversityofNaples_LowRisk,"November 26, 2020",Local,Italy,ITA,Campania, Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),862,1.30%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,Moderate,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,7/5/2023,Verified
201126_Naples_UniversityofNaples_HighRisk,"November 26, 2020",Local,Italy,ITA,Campania,Naples,"May 11, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),235,10.60%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgG,IgM",66.00%,96.60%,High,Journal Article (Peer-Reviewed),Nicola Capasso,University of Naples,https://dx.doi.org/10.3390/jcm9124066,1/31/2021,7/5/2023,Verified
210109_GiglioIsland_UniversitàdegliStudidiMilano,"January 9, 2021",Local,Italy,ITA,Tuscany,Giglio Island,"April 29, 2020","May 3, 2020",Household and community samples,Adults (18-64 years),723,0.41%,,,Self-referral,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,High,Preprint,Antonio Bognanni,Università degli Studi di Milano,https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1,1/31/2021,3/2/2024,Verified
201217_Naples_UniversityofCampania_ELISA,"December 17, 2020",Local,Italy,ITA,Campania,Naples,"March 27, 2020","August 30, 2020",Health care workers and caregivers,Adults (18-64 years),65,0.00%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Antonio Russo,University of Campania,https://dx.doi.org/10.2147/IDR.S282652,2/2/2021,3/2/2024,Verified
201223_Bergamo_OspedalePapaGiovanniXXIII_overall,"December 23, 2020",Local,Italy,ITA,Lombardy,Bergamo,"April 1, 2020","April 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,560,31.00%,,,Sequential,nal von minden GmbH,LFIA,"IgG,IgM",92.10%,99.20%,High,Journal Article (Peer-Reviewed),Alberto Zambelli,Ospedale Papa Giovanni XXIII,https://dx.doi.org/10.1002/onco.13654,2/3/2021,3/2/2024,Verified
210111_Pavia_University of Pavia_overall,"January 13, 2021",Local,Italy,ITA,,Pavia,"May 4, 2020","June 3, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),104,13.46%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Giulia Mallucci,University of Pavia,https://doi.org/10.1016/j.msard.2021.102754,2/4/2021,3/2/2024,Verified
201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW,"December 13, 2020",Local,Italy,ITA,"Apulia, Province of Foggia",Foggia,"March 17, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),3242,1.90%,1.40%,2.30%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",97.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Armando De Carlo,Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia,https://dx.doi.org/10.3390/ijerph17249324,2/6/2021,7/17/2022,Verified
201101_ Borgosesia_ASLVercelli_overall,"November 1, 2020",Local,Italy,ITA,Piedmont,Borgosesia,"May 23, 2020","May 24, 2020",Household and community samples,Multiple groups,4987,4.90%,4.33%,5.55%,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Daniela Alessi,ASL Vercelli,https://dx.doi.org/10.19191/EP20.5-6.S2.119,2/8/2021,3/2/2024,Verified
210306_Rome_UniversitaCattolicadelSacroCuore_VenousBloodTest_overall,"March 6, 2021",Local,Italy,ITA,,Rome,"June 4, 2020","July 3, 2020",Health care workers and caregivers,Multiple groups,4694,1.19%,,,Convenience,EUROIMMUN,ELISA,IgG,78.79%,99.36%,High,Journal Article (Peer-Reviewed),Giuseppe Vetrugno,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph18052650,2/9/2021,3/2/2024,Verified
210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall,"February 4, 2021",Local,Italy,ITA,,Mlilan,"March 4, 2020","March 12, 2020",Health care workers and caregivers,Adults (18-64 years),679,0.40%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,7/5/2023,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseIII,"February 4, 2021",Local,Italy,ITA,,Mlilan,"May 20, 2020","May 27, 2020",Health care workers and caregivers,Adults (18-64 years),629,4.60%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,7/5/2023,Unverified
210204_Milan_ASSTFatebenefratelliSacco_PhaseII,"February 4, 2021",Local,Italy,ITA,,Mlilan,"April 14, 2020","April 22, 2020",Health care workers and caregivers,Adults (18-64 years),608,4.20%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,78.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Laura Milazzo,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,7/5/2023,Unverified
201231_Modena_OspedaleCivileS.AgostinoEstense_overall,"December 31, 2020",Local,Italy,ITA,Emilia-Romagna Region,Modena,"March 30, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),7711,5.00%,,,Convenience,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Valentina Pecoraro,Ospedale Civile S.Agostino Estense,https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696,2/13/2021,7/17/2022,Verified
210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall,"January 5, 2021",Local,Italy,ITA,,San Giovanni Rotondo,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,245,0.88%,,,Convenience,"Shanghai Kehua Bio-engineering (KHB) Co. Ltd,Tecan",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fabrizio Bossa,Fondazione Casa Sollievo della Sofferenza,http://dx.doi.org/10.1016/j.dld.2020.12.120,2/14/2021,7/17/2022,Verified
210127_Merano_FranzTappeinerHospital_patients_primary,"January 27, 2021",Local,Italy,ITA,,Merano,"June 22, 2020","July 17, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,250,0.80%,,,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/24/2021,3/2/2024,Verified
210127_Merano_FranzTappeinerHospital_HCW_primary,"January 27, 2021",Local,Italy,ITA,,Merano,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),36,5.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Dominic Fong,Franz Tappeiner Hospital,https://dx.doi.org/10.1007/s00508-020-01807-6,2/24/2021,3/2/2024,Unverified
201027_Perugia_UniversityofPerugia_HIVNegative2_Overall,"October 27, 2020",Local,Italy,ITA,Umbria,Perugia,"May 4, 2020","May 31, 2020",Multiple populations,Multiple groups,2843,5.40%,,,Unclear,Screen Italia S.R.L,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Chiara Papalini,University of Perugia,https://dx.doi.org/10.4084/MJHID.2020.080,2/27/2021,3/2/2024,Verified
210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall,"January 12, 2021",Local,Italy,ITA,Province of Avellino in the Campania region,Ariano Irpino,"May 16, 2020","May 19, 2020",Household and community samples,Multiple groups,13218,5.60%,5.20%,6.00%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Pellegrino Cerino,The Zoo-Prophylactic Institute of Southern Italy,https://www.future-science.com/doi/10.2144/fsoa-2020-0203,3/5/2021,3/2/2024,Verified
210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj,"January 27, 2021",Local,Italy,ITA,Puglia,Bari,"April 8, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),2407,2.37%,,,Convenience,Abbott Laboratories,CLIA,IgG,50.00%,97.99%,High,Journal Article (Peer-Reviewed),Luigi Vimercati,University of Bari,https://dx.doi.org/10.1016/j.envres.2021.110793,3/11/2021,3/2/2024,Verified
210209_Catania_UniversityofCatania,"February 9, 2021",Local,Italy,ITA,Sicily,Catania,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),133,3.00%,,,Convenience,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Caterina Ledda ,University of Catania,https://dx.doi.org/10.3390/tropicalmed6010021,3/15/2021,3/2/2024,Verified
201031_Veneto_NationalAssociationofCompanyandCompetentDoctors,"October 31, 2020",Local,Italy,ITA,Veneto,,"April 11, 2020","April 29, 2020",Essential non-healthcare workers,Adults (18-64 years),1267,1.58%,,,Convenience,"NA,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Danilo Bontadi,National Association of Company and Competent Doctors,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/,3/17/2021,3/2/2024,Verified
210204_Milan_UniversityOfMilan_Overall,"February 4, 2021",Local,Italy,ITA,Lombardy,Milan,"June 13, 2020","August 6, 2020",Contacts of COVID patients,Children and Youth (0-17 years),49,16.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Marco Farronato ,University of Milan,https://dx.doi.org/10.3390/ijerph18041488,3/20/2021,3/2/2024,Verified
210302_Milan_FondazioneIRCCSIstitutoNazionaleDeiTumori_HCW_overall,"March 2, 2021",Local,Italy,ITA,,Milan,"April 9, 2020","September 9, 2020",Health care workers and caregivers,Adults (18-64 years),110,20.00%,,,Simplified probability,Diagnostic Bioprobes,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Chiara Maura Ciniselli,Fondazione IRCCS Istituto Nazionale dei Tumori (INT),http://dx.doi.org/10.3390/cancers13051035,3/24/2021,7/17/2022,Verified
210224_NortheastItaly_PaduaUniversityHospital_HCW,"February 24, 2021",Local,Italy,ITA,Veneto Region,Padua,"April 8, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),344,7.85%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",91.21%,97.30%,High,Preprint,F Barbaro,Padua University Hospital ,https://doi.org/10.1101/2021.02.23.21249481,3/26/2021,3/2/2024,Verified
201020_DipartimentoOncologicoAziendaUslToscanaCentroFirenze_Florence,"October 20, 2020",Local,Italy,ITA,Tuscany,Florence,"May 11, 2020","May 17, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1145,2.30%,,,Sequential,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Francesca Martella ,Azienda Usl Toscana Centro Oncology,http://dx.doi.org/10.1177/0300891620953388,3/27/2021,7/17/2022,Verified
201020_Milan_UniversitàdegliStudidiMilano_Patients1_Overall,"October 20, 2020",Local,Italy,ITA,Lombardy,Milan,"April 15, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,42,9.50%,,,Unclear,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,3/28/2021,7/17/2022,Verified
210220_Lazio_ UniversitàCattolicadelSacroCuore_Overall,"February 20, 2021",Local,Italy,ITA,Lazio,Rome,"May 25, 2020","August 10, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),202,1.50%,,,Convenience,Siemens,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Fabio Del Zompo,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.dld.2021.02.015,3/28/2021,3/2/2024,Verified
210303_Lodi_IRCCSPoliclinico_overall_CLIA,"March 3, 2021",Local,Italy,ITA,Lombardy region,Lodi,"March 18, 2020","June 24, 2020",Blood donors,Multiple groups,1922,19.70%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Irene Cassaniti,IRCCS Policlinico,https://dx.doi.org/10.1016/j.cmi.2021.01.030,4/1/2021,3/2/2024,Verified
210204_Milan_ FoundationIRCCS Ca'GrandaOspedaleMaggiorePoliclinico_overall_adj,"February 22, 2021",Local,Italy,ITA,Lombardy,Milan,"April 27, 2020","June 12, 2020",Health care workers and caregivers,Multiple groups,4055,6.40%,,,Convenience,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Andrea Lombardi,Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1136/bmjopen-2020-047216,4/3/2021,8/15/2023,Verified
201020_Sondrio_AltoLario-OncologiaMedicaSondrio_Overall,"October 20, 2020",Local,Italy,ITA,Lombardy,Sondrio,"March 1, 2020","October 19, 2020",Health care workers and caregivers,Adults (18-64 years),220,11.36%,,,Convenience,nal von minden GmbH,LFIA,"IgG,IgM",94.10%,99.20%,Unclear,Journal Article (Peer-Reviewed),G Caponigro ,"ASST della Valtellina 
Alto Lario-Oncologia Medica Sondrio",http://dx.doi.org/10.1177/0300891620953388,4/5/2021,3/2/2024,Verified
200826_Veneto_UniversityHospitalOfPadova,"August 26, 2020",Regional,Italy,ITA,Veneto,,"February 22, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),8285,4.60%,4.10%,5.00%,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",73.00%,98.00%,High,Journal Article (Peer-Reviewed),Mario Plebani,University Hospital Of Padova,https://www.degruyter.com/document/doi/10.1515/cclm-2020-1236/html,4/9/2021,3/2/2024,Verified
210324_NorthernItaly_UniversitàDegliStudiDelPiemonteOrientale_HCW,"March 24, 2021",Local,Italy,ITA,Piedmont,Vercelli,"May 8, 2020","June 3, 2020",Health care workers and caregivers,Adults (18-64 years),2250,17.11%,15.55%,18.67%,Convenience,DiaSorin,CLIA,IgG,97.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università degli Studi del Piemonte Orientale,http://dx.doi.org/10.3390/ijerph18073343,4/9/2021,3/2/2024,Verified
210226_Turin_UniversityofTurin_Pharmacists,"February 26, 2021",Regional,Italy,ITA,Turin,,"July 1, 2020","July 31, 2020",Essential non-healthcare workers,Adults (18-64 years),286,3.50%,,,Self-referral,PRIMA Lab S.A.,LFIA,"IgG,IgM",100.00%,98.00%,High,Journal Article (Peer-Reviewed),Francesca Baratta,University of Turin,https://dx.doi.org/10.3390/ijerph18052302,4/10/2021,3/2/2024,Verified
201105_Italy_UniversityofVerona_overall_unadj,"November 5, 2020",National,Italy,ITA,"Veneto, Lazio and Friuli-Venezia Giulia",,"May 18, 2020","July 29, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,339,1.47%,,,Sequential,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,http://dx.doi.org/10.1182/blood-2020-140032,4/12/2021,7/17/2022,Verified
210125_TerreRoveresche_UniversityOfUrbinoCarloBo_Overall,"January 25, 2021",Local,Italy,ITA,Le Marche Region,Municipality of Terre Roveresche,"March 15, 2020","June 15, 2020",Multiple populations,Multiple groups,341,14.40%,,,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Mauro De Santi,University of Urbino Carlo Bo,https://dx.doi.org/10.23750/abm.v92i1.10847,4/14/2021,7/17/2022,Verified
210225_Brescia_UniversityofBrescia_HCW,"February 25, 2021",Local,Italy,ITA,Lombardy,Brescia,"April 26, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1893,22.90%,,,Convenience,DiaSorin,CLIA,IgG,95.70%,98.50%,Moderate,Journal Article (Peer-Reviewed),Agnese Comelli,University of Brescia,https://dx.doi.org/10.3390/microorganisms9030488,4/16/2021,3/2/2024,Verified
210224_Castiglioned'Adda_UniversityofMilan_Overall,"February 24, 2021",Local,Italy,ITA,Lombardy,Castiglione D’Adda,"May 18, 2020","June 7, 2020",Household and community samples,Multiple groups,4143,22.20%,,,Entire sample,PRIMA Lab S.A.,LFIA,IgG,100.00%,96.00%,Low,Journal Article (Peer-Reviewed),Gabriele Pagani,University of Milan,https://dx.doi.org/10.1371/journal.pone.0246513,4/17/2021,3/2/2024,Verified
210226_UniversityOfTurin_Turin,"February 26, 2021",Local,Italy,ITA,Piedmont,Turin,"April 16, 2020","June 22, 2020",Pregnant or parturient women,Adults (18-64 years),164,9.70%,,,Convenience,Boditech Med Inc.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,https://dx.doi.org/10.3390/diagnostics11030398,4/17/2021,3/2/2024,Verified
201020_Milan_UniversitàdegliStudidiMilano_Physicians2_Overall,"October 20, 2020",Local,Italy,ITA,Lombardy,Milan,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,34,5.88%,,,Convenience,NA,CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Andrea Sartore Bianchi,Università degli Studi di Milano,http://dx.doi.org/10.1177/0300891620953388,4/21/2021,7/17/2022,Verified
200721_Lodi_A.S.S.T.Lodi_HCW_overall,"July 21, 2020",Local,Italy,ITA,Lombardy Region,,"April 23, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),2415,16.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T. Lodi ,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/21/2021,3/2/2024,Verified
200721_Lodi_A.S.S.T.Lodi_genpop,"July 21, 2020",Local,Italy,ITA,Lombardy region,Lodi,"April 23, 2020","May 5, 2020",Household and community samples,Multiple groups,1792,29.80%,,,Simplified probability,DiaSorin,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandro  Baracco,A.S.S.T.Lodi,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3650227,4/21/2021,3/2/2024,Verified
210309_Benevento_UniversitàdegliStudidelSannio_Overall,"March 9, 2021",Local,Italy,ITA,Campania,NR,"September 1, 2020","September 30, 2020",Household and community samples,Seniors (65+ years),1383,4.70%,,,Convenience,Beijing Lepu Medical Technology,LFIA,"IgG,IgM",98.60%,97.60%,Moderate,Journal Article (Peer-Reviewed),Immacolata Polvere,Università degli Studi del Sannio,https://dx.doi.org/10.3390/diagnostics11030483,4/22/2021,3/2/2024,Verified
210404_Marche_UniversitàPolitecnicadelleMarche_ConfirmationAssay,"April 4, 2021",Local,Italy,ITA,Marche,Ancona,"July 1, 2020","October 26, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,949,0.70%,,,Sequential,"Zhejiang Orient Gene Biotech,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Cantini,Università Politecnica delle Marche,http://dx.doi.org/10.3390/jcm10071503,4/22/2021,3/2/2024,Verified
210324_Milan_UniversityofMilan_UniversityEmployees,"March 24, 2021",Local,Italy,ITA,,Milan,"May 13, 2020","June 23, 2020",Non-essential workers and unemployed persons,Multiple groups,1826,11.30%,,,Convenience,NA,ELISA,IgG,85.70%,98.10%,High,Journal Article (Peer-Reviewed),Gregorio Milani,University of Milan,https://dx.doi.org/10.1136/bmjopen-2020-046800,4/24/2021,7/17/2022,Unverified
210331_Naples_IstitutoNazionaleTumori_CancerPatients,"March 31, 2021",Local,Italy,ITA,,"Naples
","March 30, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,885,5.42%,,,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,4/30/2021,3/2/2024,Verified
210331_Naples_IstitutoNazionaleTumori_HCWs,"March 31, 2021",Local,Italy,ITA,,Naples,"March 30, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1050,4.60%,3.30%,5.90%,Convenience,Beijing Lepu Medical Technology,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Maria Isgro,Istituto Nazionale Tumori,https://dx.doi.org/10.1186/s12967-021-02798-2,4/30/2021,3/2/2024,Verified
210402_Italy_FondazioneIstitutoStomatologicoItaliano_DentalStaff,"April 2, 2021",National,Italy,ITA,"Como, Lecco, Monza-Brianza, Sondrio, Varese, Bergamo, Brescia  Cremona, Lodi, Mantova, Pavia, Milan",,"May 28, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),499,10.80%,,,Convenience,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,LFIA,"IgM,IgG",95.10%,99.30%,Moderate,Journal Article (Peer-Reviewed),Silvano Gallus,Fondazione Istituto Stomatologico Italiano,http://dx.doi.org/10.3390/ijerph18073711,5/3/2021,7/17/2022,Unverified
210320_GardenaValley_HospitalOfBolzano_PopAdj_TestAdj,"March 20, 2021",Local,Italy,ITA,,"Gardena Valley ( Ortisei, Santa Cristina, and Selva, the main municipalities)","May 26, 2020","June 8, 2020",Household and community samples,Multiple groups,2106,26.90%,25.20%,28.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,96.90%,99.90%,Low,Preprint,Roberto Melotti,Hospital of Bolzano,10.1101/2021.03.19.21253883,5/13/2021,8/15/2023,Verified
210320_Cogne_UniversitàDiTorino_genpop_overall,"March 20, 2021",Local,Italy,ITA,Valle D'Aosta,Cogne,"June 4, 2020","June 5, 2020",Household and community samples,Multiple groups,857,3.38%,,,Entire sample,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,Low,Preprint,F Truc,Università di Torino,https://www.medrxiv.org/content/10.1101/2021.03.19.21253962v1.full-text,5/14/2021,7/17/2022,Verified
210317_Bolzano_HospitalofBolzano,"March 17, 2021",Local,Italy,ITA,Trentino-Alto Adige/Südtirol,Bolzano,"October 29, 2020","December 28, 2020",Residual sera,Multiple groups,3033,34.50%,,,Sequential,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Thomas Mueller,Hospital of Bolzano,https://dx.doi.org/10.1016/j.cca.2021.03.007,5/18/2021,3/2/2024,Verified
210312_Venice_TheVenetoEyeBankFoundation,"March 27, 2021",Local,Italy,ITA,Veneto region,Venice,"March 15, 2020","May 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,30,3.33%,,,Sequential,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Antonella Franch,The Veneto Eye Bank Foundation,https://dx.doi.org/10.1177/11206721211006565,5/19/2021,3/2/2024,Verified
201007_Turin_UniversityofTurin_primary,"April 1, 2021",Local,Italy,ITA,,Turin,"February 22, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),225,9.30%,,,Convenience,"Boditech Med Inc.,DiaSorin",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefano Cosma,University of Turin,http://dx.doi.org/10.1016/j.ajog.2020.10.005,5/19/2021,3/2/2024,Verified
210419_Turin_AziendaOspedalieraOrdineMauriziano_Primary,"April 19, 2021",Local,Italy,ITA,Piedmont,Turin,"May 8, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1562,9.80%,,,Convenience,DiaSorin,CLIA,IgG,84.10%,93.70%,High,Journal Article (Peer-Reviewed),Marco Daperno,Azienda Ospedaliera Ordine Mauriziano,https://onlinelibrary.wiley.com/doi/10.1111/imj.15201,5/20/2021,3/2/2024,Verified
210420_Foggia_UniversityOfFoggia,"April 20, 2021",Local,Italy,ITA,Apulia,Foggia,"March 15, 2020","June 15, 2020",Blood donors,Adults (18-64 years),1797,1.00%,,,Sequential,"Ortho Clinical Diagnostics Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Mariantonietta Di Stefano,University of Foggia,https://www.karger.com/Article/Abstract/515258,5/20/2021,3/2/2024,Verified
201221_Lombardy_ATSMilan_cohabitants,"December 21, 2020",Regional,Italy,ITA,Lombardy,,"April 1, 2020","April 30, 2020",Family of essential workers,Adults (18-64 years),755,24.40%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,5/21/2021,3/2/2024,Verified
201221_Lombardy_ATSMilan_staff,"December 21, 2020",Regional,Italy,ITA,Lombardy,,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),108,15.70%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,5/21/2021,3/2/2024,Verified
201221_Lombardy_ATSMilan_peds,"December 21, 2020",Regional,Italy,ITA,Lombardy,,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),377,14.90%,,,Convenience,ACRO Biotech Inc,LFIA,IgG,96.00%,79.20%,High,Journal Article (Peer-Reviewed),Rinaldo Missaglia,University of Milano-Bicocca,https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00950-0,5/21/2021,3/2/2024,Verified
210415_Campania_UniversityofNapoli,"April 15, 2021",Regional,Italy,ITA,Campania,,"May 11, 2020","May 18, 2020",Household and community samples,Multiple groups,388,1.80%,0.69%,2.91%,Simplified probability,NovaTec Immundiagnostics GmbH,ELISA,IgG,94.90%,96.20%,High,Journal Article (Peer-Reviewed),Valeria Caturano ,University of Napoli ,https://dx.doi.org/10.1186/s12879-021-06054-2,5/22/2021,3/2/2024,Verified
210324_UniversiteCatholiquedeLouvain_Piedmont_workers,"March 24, 2021",Regional,Italy,ITA,PIedmont,,"June 20, 2020","July 23, 2020",Multiple populations,Multiple groups,6033,4.80%,,,Convenience,"ZenTech, Angleur, Belgium",LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Omar Nyabi,Université Catholique de Louvain,http://dx.doi.org/10.3390/ijerph18073372,5/23/2021,3/2/2024,Verified
210429_SouthernItaly_UniversityofCampania,"April 29, 2021",Regional,Italy,ITA,Southern Italy,"Caserta, Naples","September 21, 2020","December 31, 2020",Multiple populations,Multiple groups,2394,5.85%,,,Convenience,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,DiaSorin",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Francesco Napolitano,University of Campania,https://www.mdpi.com/1660-4601/18/9/4761,5/23/2021,3/2/2024,Unverified
210501_Rome_SapienzaUniversity,"May 1, 2021",Local,Italy,ITA,Lazio,Rome,"May 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),17377,1.22%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Guido Antonelli,Sapienza University,https://dx.doi.org/10.1016/S2666-5247(21)00083-5,5/28/2021,3/2/2024,Verified
210504_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,"May 4, 2021",Local,Italy,ITA,Sardinia,Cagliari,"September 1, 2020","December 10, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,121,10.70%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Federico Cappellacci, University of Cagliari,https://dx.doi.org/10.1016/j.amsu.2021.102375,5/30/2021,3/2/2024,Verified
210428_Europe_SorbonneUniversité_5EmiliaRomagna,"April 28, 2021",Regional,Italy,ITA,Emilia Romagna,,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,522,1.50%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/31/2021,3/2/2024,Verified
210528_Bari_IRCCSIstitutoTumoriGiovanniPaoloII_Baseline,"May 28, 2021",Local,Italy,ITA,Puglia,Bari,"March 26, 2020","March 31, 2020",Health care workers and caregivers,Multiple groups,606,1.10%,,,Convenience,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Angelo Virgilio Paradiso,IRCCS Istituto Tumori “Giovanni Paolo II” ,https://dx.doi.org/10.3390/diagnostics11060975,6/8/2021,3/2/2024,Unverified
210614_Verona_UniversityofVerona,"June 14, 2021",Local,Italy,ITA,Province of Verona,Verona ,"April 28, 2020","July 20, 2020",Health care workers and caregivers,Adults (18-64 years),5299,6.00%,5.30%,6.60%,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Stefano Porru,University of Verona,http://dx.doi.org/10.3390/ijerph18126446,6/21/2021,3/2/2024,Unverified
210607_Italy_UniversityofMilan_Patients1,"June 7, 2021",National,Italy,ITA,,,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),178,1.70%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/21/2021,7/17/2022,Unverified
210610_Lombardy_HumanitasUniversity_HCW_overall,"June 10, 2021",Regional,Italy,ITA,Lombardy ,"Milan, Rozzano, Varese, Castellanza and Bergamo","April 28, 2020","May 16, 2020",Health care workers and caregivers,Multiple groups,3985,13.00%,,,Convenience,DiaSorin,CLIA,IgG,90.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Maria Teresa Sandri,Humanitas University,https://dx.doi.org/10.1038/s41598-021-91773-4,6/22/2021,3/2/2024,Verified
210607_Italy_UniversityofMilan_Siblings2,"June 7, 2021",National,Italy,ITA,,,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),90,7.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/22/2021,7/17/2022,Unverified
210607_Italy_UniversityofMilan_Cohabitants3,"June 7, 2021",National,Italy,ITA,,,"July 15, 2020","September 15, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),271,3.00%,,,Stratified probability,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),William Morello,University of Milan,https://dx.doi.org/10.2215/CJN.00330121,6/22/2021,7/17/2022,Unverified
210505_Trieste_ItalianNationalInstituteOfHealth,"June 5, 2021",Regional,Italy,ITA,NR,Trieste,"January 5, 2021","January 31, 2021",Blood donors,Children and Youth (0-17 years),169,9.50%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Manola Comar,Italian National Institute of Health,https://dx.doi.org/10.1186/s13052-021-01074-9,6/22/2021,3/2/2024,Unverified
210603_Italy_UniversityHospitalCittaDellaSalute_University,"June 3, 2021",Local,Italy,ITA,Piedmont,Turin,"June 29, 2020","July 29, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1185,3.30%,2.40%,4.50%,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,7/6/2021,3/2/2024,Unverified
210603_Italy_UniversityHospitalCittaDellaSalute_Healthcare,"June 3, 2021",Local,Italy,ITA,Piedmont,Turin,"May 4, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),8769,7.60%,7.10%,8.20%,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Gitana Scozzari,University Hospital Città Della Salute e Della Scienza di Torino,http://dx.doi.org/10.3390/v13061064,7/6/2021,3/2/2024,Unverified
210611_Padova_UniversityOfPadova_SpAPatients_Overall,"June 11, 2021",Local,Italy,ITA,Province of Padova,Padova,"June 1, 2020","August 7, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,200,12.50%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,7/6/2021,3/2/2024,Unverified
210611_Padova_UniversityOfPadova_HCW_Overall,"June 11, 2021",Local,Italy,ITA,Province of Padova,Padova,"June 1, 2020","August 7, 2020",Health care workers and caregivers,Multiple groups,95,8.40%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Augusta Ortolan,University of Padova,https://dx.doi.org/10.3389/fimmu.2021.682850,7/6/2021,3/2/2024,Unverified
210628_Lombardy_UniversityofPavia_patients_primary,"June 28, 2021",Local,Italy,ITA,,,"May 15, 2020","May 31, 2020",Assisted living and long-term care facilities,Adults (18-64 years),36,36.10%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,7/13/2021,7/17/2022,Unverified
210628_Lombardy_UniversityofPavia_staff_primary,"June 28, 2021",Local,Italy,ITA,,,"May 15, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),35,34.30%,,,Convenience,NA,ELISA,"IgA,IgG",97.00%,86.00%,High,Journal Article (Peer-Reviewed),Natascia Brondino ,University of Pavia,https://dx.doi.org/10.3390/brainsci11070860,7/13/2021,7/17/2022,Unverified
210703_Rome_FondazionePoliclinicoUniversitario_Primary,"July 3, 2021",Local,Italy,ITA,,Rome,"March 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1106,0.72%,,,Sequential,"Siemens,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Lombardi,Fondazione Policlinico Universitario,https://dx.doi.org/10.3390/diagnostics11071154,7/13/2021,3/2/2024,Unverified
210626_Torno_SaccoUniversityHospital_Residents1,"June 26, 2021",Local,Italy,ITA,Lombardy,Torno,"June 1, 2020","June 22, 2020",Assisted living and long-term care facilities,Seniors (65+ years),74,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,7/13/2021,7/17/2022,Unverified
210626_Torno_SaccoUniversityHospital_Staff2,"June 26, 2021",Local,Italy,ITA,Lombardy,Torno,"June 1, 2020","June 22, 2020",Health care workers and caregivers,Adults (18-64 years),51,0.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Mario Tagliabue,Sacco University Hospital,https://dx.doi.org/10.1016/j.pmedr.2021.101471,7/13/2021,7/17/2022,Unverified
210625_Emilia-Romagna_UniversityofMilan_primary,"June 25, 2021",Regional,Italy,ITA,"Calerno, Parma, Spilamberto",,"June 1, 2020","June 30, 2020",Essential non-healthcare workers,Adults (18-64 years),815,3.80%,,,Convenience,PRIMA Lab S.A.,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Susanna Esposito,University of Milan,https://dx.doi.org/10.3389/fpubh.2021.628098,7/20/2021,3/2/2024,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Residents1,"July 24, 2021",Local,Italy,ITA,Province of Brescia,Brescia,"May 19, 2020","June 30, 2020",Assisted living and long-term care facilities,Multiple groups,246,24.00%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,7/21/2021,3/2/2024,Unverified
210724_Brescia-Lombardy_UniversityOfBrescia_Staff2,"July 24, 2021",Local,Italy,ITA,Province of Brescia,Brescia,"April 23, 2020","May 14, 2020",Health care workers and caregivers,Multiple groups,286,16.78%,,,Convenience,Core Technology Co. Ltd,LFIA,"IgG,IgM",97.60%,100.00%,High,Journal Article (Peer-Reviewed),Antonella Savio,University Of Brescia,https://dx.doi.org/10.3389/fpubh.2021.649524,7/21/2021,3/2/2024,Unverified
210706_Lombardy_BrunoKesslerFoundation_HCW,"July 6, 2021",Regional,Italy,ITA,Lombardy region,,"April 1, 2020","June 26, 2020",Health care workers and caregivers,Multiple groups,82961,12.20%,12.00%,12.40%,Convenience,DiaSorin,CLIA,IgG,94.40%,98.30%,Moderate,Journal Article (Peer-Reviewed),Piero Poletti,Bruno Kessler Foundation,https://dx.doi.org/10.1001/jamanetworkopen.2021.15699,7/21/2021,3/2/2024,Unverified
210720_Italy_UniversityofGenoa,"July 20, 2021",National,Italy,ITA,,,"March 4, 2021","July 9, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1022,11.20%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Preprint,Maria Pia Sormani,University of Genoa,10.2139/ssrn.3886420,7/28/2021,3/2/2024,Unverified
210727_Modena_UniversityofModenaandReggioEmilia_Overall,"July 27, 2021",Regional,Italy,ITA,Modena,,"May 18, 2020","October 5, 2020",Essential non-healthcare workers,Adults (18-64 years),246608,0.45%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alberto Modenese,University of Modena and Reggio Emilia,http://dx.doi.org/10.3390/ijerph18157948,8/3/2021,7/17/2022,Unverified
210706_Italy_FondazioneIRCCSPoliclinicoSanMatteo_Primary,"July 6, 2021",Regional,Italy,ITA,"Pavia, Lecco, Piacenza",,"April 29, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),9610,15.20%,,,Unclear,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Rovida ,Fondazione IRCCS Policlinico San Matteo,http://dx.doi.org/10.1016/j.ijid.2021.07.003,8/11/2021,3/2/2024,Verified
210726_Florence_MeyerChildren'sUniversityHospital,"July 26, 2021",Local,Italy,ITA,"Tuscany
",Florence,"April 2, 2020","May 6, 2020",Health care workers and caregivers,Adults (18-64 years),1502,2.80%,,,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Valentina Guarnieri,Meyer Children's University Hospital,https://dx.doi.org/10.3389/fpubh.2021.644702,8/17/2021,3/2/2024,Unverified
210808_North-WesternItaly_UniversitàDelPiemonteOrientale,"August 8, 2021",Regional,Italy,ITA,,"Torino, Biella, Cuneo, Novara","April 28, 2020","August 7, 2020",Essential non-healthcare workers,Multiple groups,23568,4.97%,4.69%,5.25%,Convenience,Zeus,ELISA,IgG,93.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Chiara Airoldi,Università del Piemonte Orientale,https://dx.doi.org/10.1093/annweh/wxab062,8/18/2021,3/2/2024,Unverified
210519_Lombardy_ASSTGaetanoPini-CTOInstitute,"May 19, 2021",Regional,Italy,ITA,Lombardy,,"May 4, 2020","June 16, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),300,18.60%,14.60%,23.40%,Unclear,NA,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ennio Giulio Favalli,"The ASST Gaetano Pini-CTO
Institute",http://dx.doi.org/10.1136/annrheumdis-2021-eular.594,8/24/2021,7/17/2022,Verified
210831_Italy_UniversityofVerona_Overall,"August 31, 2021",National,Italy,ITA,"Veneto, Friuli-Venezia Giulia, and Lazio",,"May 18, 2020","November 3, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,564,1.95%,1.09%,3.46%,Sequential,Menarini Diagnostics,LFIA,"IgM,IgG",,100.00%,Moderate,Journal Article (Peer-Reviewed),Massimiliano Bonifacio,University of Verona,https://dx.doi.org/10.1002/cam4.4179,9/7/2021,3/2/2024,Unverified
210719_Vo_UniversityOfPadova_Overall_Adj,"July 19, 2021",Local,Italy,ITA,Padova,Vo,"May 1, 2020","May 31, 2020",Household and community samples,Multiple groups,2602,3.50%,2.80%,4.30%,Entire sample,"Abbott Laboratories,Roche Diagnostics,DiaSorin",CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Ilaria Dorigatti,University of Padova,https://dx.doi.org/10.1038/s41467-021-24622-7,9/9/2021,8/15/2023,Verified
210827_Italy_AOUCittàdellaSaluteedellaScienzadiTorino,"August 27, 2021",Local,Italy,ITA,Piedmont,Turin,"November 25, 2020","February 12, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,98,22.40%,,,Convenience,DiaSorin,Not reported,IgG,,,Moderate,Presentation or Conference,Margherita Saracco,AOU Citta della Salute e della Scienza di Torino,https://onlinelibrary.wiley.com/doi/10.1111/tri.13944,9/14/2021,3/2/2024,Unverified
210902_Milan_UniversityofMilan_September2020_Overall,"September 2, 2021",Local,Italy,ITA,Lombardy,Milan,"September 7, 2020","September 14, 2020",Students and Daycares,Children and Youth (0-17 years),1109,2.80%,1.90%,3.90%,Convenience,PerkinElmer,Other,IgG,96.00%,100.00%,High,Journal Article (Peer-Reviewed),Lucia Barcellini,University of Milan,http://dx.doi.org/10.1371/journal.pone.0257046,9/15/2021,3/2/2024,Unverified
210902_Milan_UniversityofMilan_January2021_Overall,"September 2, 2021",Local,Italy,ITA,Lombardy,Milan,"January 15, 2021","January 29, 2021",Students and Daycares,Children and Youth (0-17 years),1109,12.50%,10.60%,14.60%,Convenience,PerkinElmer,Other,IgG,96.00%,100.00%,High,Journal Article (Peer-Reviewed),Lucia Barcellini,University of Milan,http://dx.doi.org/10.1371/journal.pone.0257046,9/15/2021,3/2/2024,Unverified
210827_Modena_UniversityofModenaandReggioEmilia_Overall,"August 27, 2021",Local,Italy,ITA,Province of Modena,Modena,"June 1, 2020","September 25, 2020",Multiple populations,Multiple groups,7561,4.70%,4.20%,5.20%,Self-referral,"Roche Diagnostics,Shanghai Kehua Bio-engineering (KHB) Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Nausicaa Berselli,University of Modena and Reggio Emilia,https://dx.doi.org/10.13075/ijomeh.1896.01826,9/21/2021,3/2/2024,Unverified
210908_Italy_UniversityofFlorence_Players,"September 8, 2021",Local,Italy,ITA,,,"May 14, 2020","May 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),27,67.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Michele Spinicci,University of Florence,http://dx.doi.org/10.1017/S0950268821002065,9/28/2021,7/17/2022,Unverified
210908_Italy_UniversityofFlorence_Staff,"September 8, 2021",Local,Italy,ITA,,,"May 14, 2020","May 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),26,65.00%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Michele Spinicci,University of Florence,http://dx.doi.org/10.1017/S0950268821002065,9/28/2021,7/17/2022,Unverified
210920_Genoa_UniversitàdegliStudidiGenova_overall,"September 20, 2021",Local,Italy,ITA,Liguria,Genoa,"April 14, 2020","August 23, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,446,3.14%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Preprint,Francesco Ravera,Università degli Studi di Genova,https://www.researchsquare.com/article/rs-864803/v1,9/29/2021,7/17/2022,Unverified
210917_Gussago_FondazionePoliambulanzaHospital,"September 17, 2021",Local,Italy,ITA,Brescia,Gussago ,"January 1, 2021","April 1, 2021",Health care workers and caregivers,Adults (18-64 years),337,37.98%,,,Unclear,NA,Not reported,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Marcello Salvaggio,Fondazione Poliambulanza Hospital,http://dx.doi.org/10.3390/jcm10184204,9/29/2021,7/17/2022,Unverified
210909_Milan_FondazioneIRCCSCa’GrandaOspedaleMaggiorePoliclinico,"September 9, 2021",Local,Italy,ITA,,Milan,"April 20, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,109,18.35%,,,Convenience,NA,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Luca Elli,Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,https://dx.doi.org/10.1016/j.dld.2021.08.027,10/6/2021,7/17/2022,Unverified
210929_CasolaDiNapoli_UniversityOfSalerno_Overall,"September 29, 2021",Local,Italy,ITA,Naples,City of Napoli,"June 25, 2020","July 12, 2020",Household and community samples,Multiple groups,2738,1.40%,,,Self-referral,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Carmine Coppola,University of Salerno,https://dx.doi.org/10.1111/jvh.13623,10/6/2021,3/2/2024,Verified
211004_Lombardy_UniversityOfPavia,"October 4, 2021",Regional,Italy,ITA,Lombardy,,"June 15, 2020","May 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,93,13.00%,,,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Syed M A Ahmed,University Of Pavia,https://dx.doi.org/10.1111/jdv.17721,10/12/2021,7/17/2022,Unverified
211006_Italy_IRCCSOrthopedicInstituteGaleazzi_IOG-CSS,"October 6, 2021",National,Italy,ITA,"Lombardy, Apulia","Milan, San Giovanni Rotondo","January 4, 2021","February 12, 2021",Health care workers and caregivers,Multiple groups,950,18.42%,,,Unclear,Siemens,CLIA,IgG,100.00%,99.90%,Moderate,Journal Article (Peer-Reviewed),Davide Ferrari,IRCCS Orthopedic Institute Galeazzi,https://dx.doi.org/10.1515/cclm-2021-0364,10/14/2021,3/2/2024,Unverified
211006_Italy_IRCCSOrthopedicInstituteGaleazzi_OSR,"October 6, 2021",Local,Italy,ITA,Lombardy,Milan,"January 4, 2021","February 12, 2021",Health care workers and caregivers,Multiple groups,3340,9.13%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Davide Ferrari,IRCCS Orthopedic Institute Galeazzi,https://dx.doi.org/10.1515/cclm-2021-0364,10/14/2021,3/2/2024,Unverified
211011_SanSiro_ASSTFatebenefratelliSacco_primary,"October 11, 2021",Local,Italy,ITA,Lombardy,Milan,"December 23, 2020","February 19, 2021",Household and community samples,Multiple groups,2044,11.20%,,,Self-referral,Technogenetics,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Gabriele Pagani,ASST Fatebenefratelli Sacco,http://dx.doi.org/10.3390/ijerph182010621,10/20/2021,7/17/2022,Unverified
211014_Milan_UniversitàdegliStudidiMilano_Primary,"October 14, 2021",Local,Italy,ITA,,Milan,"July 1, 2020","February 23, 2021",Blood donors,Multiple groups,10680,5.90%,,,Sequential,"PRIMA Lab S.A.,DiaSorin",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Luca Valenti,Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano,https://dx.doi.org/10.1111/trf.16693,10/21/2021,3/2/2024,Verified
211001_Italy_UniversityofUrbino,"October 1, 2021",Regional,Italy,ITA,Marche,,"May 15, 2020","April 15, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),10000,5.19%,,,Convenience,NA,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Chiara Orlandi,University of Urbino,http://dx.doi.org/10.23750/abm.v92iS6.12238,10/27/2021,7/17/2022,Unverified
211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_IBDpatients,"October 1, 2021",Local,Italy,ITA,Verona,Negrar di Valpolicella,"December 7, 2020","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),386,10.40%,,,Convenience,DiaSorin,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Mirko Di Ruscio,IRCCS Sacro Cuore Don Calabria Hospital,https://dx.doi.org/10.3390/medicina57101048,11/3/2021,3/2/2024,Unverified
211001_Verona_IRCCSSacroCuoreDonCalabriaHospital_HCW_overall,"October 1, 2021",Local,Italy,ITA,Verona,Negrar di Valpolicella,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),2209,13.00%,,,Convenience,DiaSorin,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Mirko Di Ruscio,IRCCS Sacro Cuore Don Calabria Hospital,https://dx.doi.org/10.3390/medicina57101048,11/3/2021,3/2/2024,Unverified
210804_Italy_UniversityofCampania_Primary,"August 4, 2021",Regional,Italy,ITA,Campania (Southern Italy),,"April 21, 2020","June 10, 2020",Blood donors,Multiple groups,1808,0.83%,,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Federica Calo,University of Campania,https://dx.doi.org/10.2450/2021.0196-21,11/4/2021,3/2/2024,Verified
211028_UniversityHospitalofTrieste_University of Trieste,"October 28, 2021",Local,Italy,ITA,Northeast Italy,Trieste,"May 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),389,34.70%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Francesca Filon,University of Trieste,https://dx.doi.org/10.23749/mdl.v112i5.11798,11/9/2021,3/2/2024,Unverified
211028_Italy_FondazioneIRCCS_STest,"October 28, 2021",Local,Italy,ITA,,Pavia,"June 15, 2020","December 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,201,14.40%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna Lia Asti,IRCCS San Matteo Hospital ,https://pubmed.ncbi.nlm.nih.gov/34783351/,11/23/2021,3/2/2024,Unverified
210930_Novara_UniversityofPiemonteOrientale_pregnant_overall,"September 30, 2021",Local,Italy,ITA,Novara,Novara City,"April 27, 2020","July 1, 2020",Pregnant or parturient women,Adults (18-64 years),344,2.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Viviana Piccirllo,University of Piemonte Orientale,http://dx.doi.org/10.1080/14767058.2021.1962370,11/24/2021,7/17/2022,Unverified
210930_Novara_UniversityofPiemonteOrientale_nonpregnant_overall,"September 30, 2021",Local,Italy,ITA,"Novara
",Novara City,"April 27, 2020","July 1, 2020",Household and community samples,Adults (18-64 years),588,12.80%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Viviana Piccirllo,University of Piemonte Orientale,http://dx.doi.org/10.1080/14767058.2021.1962370,11/24/2021,7/17/2022,Unverified
211116_Italy_BambinoGesuChildrensHospital,"November 16, 2021",Local,Italy,ITA,,Rome,"May 1, 2020","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,85,5.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Casamento Tumeo,Bambino Gesù Children’s Hospital,https://www.researchsquare.com/article/rs-1061389/v1,11/25/2021,3/2/2024,Unverified
211115_Foggia_UniversityHospital“Ospedali Riuniti”Foggia_general_primary,"November 16, 2021",Local,Italy,ITA,,Foggia,"May 15, 2020","March 15, 2021",Blood donors,Multiple groups,8183,6.30%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Francescopaolo Antonucci,University Hospital “Ospedali Riuniti” Foggia,https://dx.doi.org/10.1080/23744235.2021.2003856,11/26/2021,3/2/2024,Verified
211120_Italy_UniversitàCattolicadelSacroCuore_Primary,"November 21, 2021",National,Italy,ITA,,,"April 15, 2020","July 15, 2020",Essential non-healthcare workers,Multiple groups,10535,4.80%,4.40%,5.30%,Self-referral,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,100.00%,Low,Journal Article (Peer-Reviewed),Sergio Garbarino,Università Cattolica del Sacro Cuore,http://dx.doi.org/10.3390/ijerph182212201,11/30/2021,3/2/2024,Unverified
211027_SicilianRegion_UniversityOfCatania_Primary,"October 27, 2021",Local,Italy,ITA,Sicilian,,"April 1, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,328,0.03%,,,Entire sample,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ermanno Vitale,University of Catania ,https://www.mdpi.com/2076-3417/11/21/10051/htm,12/1/2021,7/17/2022,Unverified
211201_Veneto_MonastierDiTrevisoHospital_Primary,"December 1, 2021",Local,Italy,ITA,Veneto,,"May 4, 2020","July 15, 2020",Household and community samples,Multiple groups,922,2.10%,,,Stratified probability,NA,Other,IgG,,,Moderate,Journal Article (Peer-Reviewed),Marco Bassanello,Monastier di Treviso Hospital,https://dx.doi.org/10.1038/s41598-021-02654-9,12/7/2021,7/17/2022,Unverified
211110_Modena_UniversityofModenaandReggioEmilia,"November 10, 2021",Local,Italy,ITA,,Modena,"January 15, 2021","June 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),85,15.29%,,,Unclear,NA,CLIA,IgG,,,Unclear,Presentation or Conference,B Predieri,University of Modena and Reggio Emilia,http://dx.doi.org/10.1111/pedi.13269,12/14/2021,7/17/2022,Unverified
211111_Verona_UniversityofVerona,"November 11, 2021",Local,Italy,ITA,Veneto,Verona,"January 1, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,49,18.40%,,,Convenience,"EUROIMMUN,DiaSorin,Beckman Coulter",Multiple Types,"IgG,IgA",,,High,Presentation or Conference,M Trentinaglia,University of Verona,http://dx.doi.org/10.1111/jns.12472,12/16/2021,3/2/2024,Unverified
211025_Piacenza_1AUSLPiacenza,"October 25, 2021",Local,Italy,ITA,Emilia-Romagna,Piacenza,"March 20, 2021","May 29, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,293,7.17%,,,Convenience,NA,Not reported,IgG,,,High,Presentation or Conference,Biasini C,Azienda Unita Sanitaria Locale di Piacenza,http://dx.doi.org/10.1177/03008916211041664,12/16/2021,7/17/2022,Unverified
211210_Rome_UniversityofRomeTorVergata,"December 10, 2021",Local,Italy,ITA,,Rome,"March 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),918,2.10%,,,Convenience,NA,CLIA,IgG,98.60%,99.50%,High,Journal Article (Peer-Reviewed),Luca Coppeta,University of Rome Tor Vergata,https://dx.doi.org/10.3390/ijerph182413053,1/3/2022,7/17/2022,Unverified
211207_Milan_SanGiuseppeHospital_Total1stWave,"December 17, 2021",Local,Italy,ITA,,Milan,"March 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),25,4.00%,,,Self-referral,Technogenetics,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Matteo Sacchi,San Giuseppe Hospital,https://dx.doi.org/10.1097/MD.0000000000028192,1/9/2022,7/17/2022,Unverified
211212_Italy_UniversitàdegliStudidiMilano_Overall,"December 12, 2021",Regional,Italy,ITA,Northern Italy,,"March 15, 2021","June 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,434,14.75%,11.50%,18.40%,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,100.00%,High,Journal Article (Peer-Reviewed),Gianfranco Alicandro,Università degli Studi di Milano,https://dx.doi.org/10.1016/j.jcf.2021.12.011,1/11/2022,3/2/2024,Unverified
211218_Italy_SanRaffaeleUniversity_Overall,"December 18, 2021",Local,Italy,ITA,Milan,Milan,"February 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,291,10.31%,,,Convenience,NA,CLIA,IgG,97.00%,100.00%,High,Journal Article (Peer-Reviewed),Rossana Caldara,Vita-Salute San Raffaele University,https://dx.doi.org/10.3390/biology10121349,1/14/2022,7/17/2022,Unverified
210730_Abruzzo_GDannunzioUniversity,"July 30, 2021",Regional,Italy,ITA,Abruzzo,,"August 1, 2020","October 20, 2020",Essential non-healthcare workers,Adults (18-64 years),216,5.09%,,,Unclear,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,91.21%,97.30%,High,Journal Article (Peer-Reviewed),E Toniato,G. D'Annunzio University,https://www.biolifesas.org/biolife/wp-content/uploads/2021/07/S3-Toniato-15.pdf,1/19/2022,3/2/2024,Unverified
220111_Rome_GemelliUniversityHospital,"January 11, 2022",Local,Italy,ITA,Lazio,Rome,"March 1, 2020","April 30, 2021",Perinatal,Children and Youth (0-17 years),59,15.25%,,,Convenience,Vircell S.L.,ELISA,IgG,85.00%,98.00%,High,Journal Article (Peer-Reviewed),Danilo Buonsenso,Gemelli University,https://dx.doi.org/10.1007/s00431-021-04319-1,1/27/2022,3/2/2024,Unverified
220202_Friuli-VeneziaGiulia_SantaMariadellaMisericordiaHospital_Overall,"February 2, 2022",Regional,Italy,ITA,Friuli-Venezia Giulia,,"May 1, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,860,1.62%,,,Sequential,Cellex Inc.,LFIA,"IgG,IgM",98.40%,96.40%,High,Journal Article (Peer-Reviewed),Anna Candoni,Santa Maria della Misericordia Hospital,https://dx.doi.org/10.1371/journal.pone.0262784,2/10/2022,3/2/2024,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period1_Overall,"February 12, 2022",Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,"January 1, 2021","February 28, 2021",Students and Daycares,Children and Youth (0-17 years),217,11.10%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,3/8/2022,3/2/2024,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period2_Overall,"February 12, 2022",Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,"April 1, 2021","May 31, 2021",Students and Daycares,Children and Youth (0-17 years),208,15.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,3/8/2022,3/2/2024,Unverified
220212_Friuli-VeneziaGiulia_UniversityofTrieste_Period3_Overall,"February 12, 2022",Regional,Italy,ITA,"Friuli-Venezia Giulia
Region",,"June 1, 2021","July 31, 2021",Students and Daycares,Children and Youth (0-17 years),169,11.80%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marzia Lazzerini,IRCCS “Burlo Garofolo”,https://dx.doi.org/10.3390/children9020246,3/8/2022,3/2/2024,Unverified
220227_Verona_UniversityofVerona_Patients_Overall,"February 27, 2022",Local,Italy,ITA,,Verona,"August 1, 2020","May 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,30,40.00%,,,Sequential,"EUROIMMUN,DiaSorin,Beckman Coulter,Roche Diagnostics",Multiple Types,"IgG,IgA,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sara Mariotto,University of Verona,https://dx.doi.org/10.1111/ene.15304,3/9/2022,3/2/2024,Unverified
220227_Verona_UniversityofVerona_Controls_Overall,"February 27, 2022",Local,Italy,ITA,,Verona,"August 1, 2020","May 31, 2021",Residual sera,Multiple groups,30,20.00%,,,Convenience,"EUROIMMUN,DiaSorin,Beckman Coulter,Roche Diagnostics",Multiple Types,"IgG,IgA,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sara Mariotto,University of Verona,https://dx.doi.org/10.1111/ene.15304,3/9/2022,3/2/2024,Unverified
220121_NorthItaly_UniversityofPiemonteOrientale,"January 21, 2022",Regional,Italy,ITA,North Italy,,"April 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,238,4.20%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,L Pisani,University of Piemonte Orientale,https://dx.doi.org/10.1093/ecco-jcc/jjab232.060,3/9/2022,7/17/2022,Unverified
220224_Piedmont_UniversityOfTurin_HCWs,"February 24, 2022",Regional,Italy,ITA,Region of Piedmont,"Alessandria, Cuneo, Turin","January 1, 2021","January 31, 2021",Health care workers and caregivers,Multiple groups,495,53.13%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Valerio Bordino,University of Turin,https://dx.doi.org/10.1002/jmv.27670,3/9/2022,3/2/2024,Unverified
211106_Milan_PoliclinicoSMatteoUniversity_Overall,"November 6, 2021",Regional,Italy,ITA,Lombardy,,"May 4, 2020","June 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,300,18.67%,14.60%,23.40%,Sequential,NA,ELISA,"IgG,IgM,IgA",,,High,Presentation or Conference,Gabriella Maioli,Policlinico S. Matteo University,https://acrabstracts.org/abstract/the-true-prevalence-of-sars-cov-2-infection-in-an-italian-cohort-of-patients-with-inflammatory-arthritis-a-seroepidemiological-study/,3/10/2022,7/17/2022,Unverified
220224_Piedmont_UniversityOfTurin_LTCFsResidents,"February 24, 2022",Regional,Italy,ITA,Region of Piedmont,"Alessandria, Cuneo, Turin","January 1, 2021","January 31, 2021",Assisted living and long-term care facilities,Multiple groups,163,65.03%,,,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,High,Journal Article (Peer-Reviewed),Valerio Bordino,University of Turin,https://dx.doi.org/10.1002/jmv.27670,3/10/2022,3/2/2024,Unverified
211011_Italy_AziendaUSLofModena_Overall,"October 11, 2021",National,Italy,ITA,,,"March 11, 2020","September 30, 2020",Residual sera,Multiple groups,42911,5.50%,,,Convenience,NA,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Valentina Pecoraro,University-Hospital of Padova,https://doi.org/10.1515/cclm-2021-1071,3/16/2022,7/17/2022,Unverified
220228_Italy_FedericoIIUniversityOfNaples_ECLIA,"February 28, 2022",Local,Italy,ITA,Naples,,"May 15, 2020","October 9, 2020",Blood donors,Multiple groups,1100,1.00%,,,Self-referral,Roche Diagnostics,CLIA,IgG,,99.00%,Moderate,Journal Article (Peer-Reviewed),Giovanni Dell’Aversana Orabona,Federico II University of Naples,https://dx.doi.org/10.3855/jidc.15144,4/8/2022,3/2/2024,Unverified
220311_Lombardy_UniversitàdegliStudidiMilano_Overall,"March 11, 2022",Regional,Italy,ITA,Lombardy,,"May 4, 2020","June 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,358,18.44%,14.00%,23.20%,Convenience,Diagnostic Bioprobes,ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Ennio Favalli,Università degli Studi di Milano,https://dx.doi.org/10.3389/fmed.2022.850858,4/12/2022,7/17/2022,Unverified
220316_Cremona_ASSTCremona_Overall,"March 16, 2022",Local,Italy,ITA,,Cremona,"April 22, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,103,18.40%,,,Sequential,DiaSorin,CLIA,IgG,97.10%,88.90%,High,Journal Article (Peer-Reviewed),Clara Conti,ASST Cremona,https://dx.doi.org/10.4253/wjge.v14.i3.153,4/27/2022,3/2/2024,Unverified
220512_Milan_UniversityofMilan,"May 12, 2022",Regional,Italy,ITA,Milan,,"February 16, 2022","February 28, 2022",Students and Daycares,Children and Youth (0-17 years),665,56.69%,,,Unclear,PerkinElmer,Not reported,IgG,,,Moderate,Journal Article (Peer-Reviewed),Alessandra Mari,University of Milan,https://dx.doi.org/10.1097/INF.0000000000003583,6/8/2022,3/2/2024,Unverified
220501_TorVergataUniversityHospital_UniversityofRome_Overall,"May 1, 2022",Local,Italy,ITA,,Rome,"November 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),85,9.41%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),M Mossa,Tor Vergata University of Rome,https://dx.doi.org/10.26355/eurrev_202205_28875,6/8/2022,7/17/2022,Unverified
220512_Milan_ MaggiorePoliclinicoHospital,"May 12, 2022",Local,Italy,ITA,Lombardy,Milan,"August 10, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,302,20.53%,,,Convenience,NA,Other,"IgG,IgM",86.10%,98.90%,High,Journal Article (Peer-Reviewed),Mariana Siddi,Maggiore Policlinico Hospital,https://dx.doi.org/10.3390/pathogens11050572,6/10/2022,7/17/2022,Unverified
220602_Milan_UniversityVita-SaluteSanRaffaele,"June 6, 2022",Local,Italy,ITA,Lombardy,Milan,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),1172,8.12%,,,Unclear,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Davide Ferrari,University Vita-Salute San Raffaele,https://dx.doi.org/10.1016/j.jim.2022.113293,6/20/2022,3/2/2024,Unverified
220627_EmiliaRomagnaRegion_UniversityOfModenaAndReggioEmilia_Overall,"June 27, 2022",Regional,Italy,ITA,"Emilia-Romagna Region; including provinces of Modena, Reggio Emilia, Parma, Bologna, and other provinces.",,"September 26, 2020","March 26, 2021",Multiple populations,Multiple groups,5128,11.31%,,,Self-referral,"Roche Diagnostics,Shanghai Kehua Bio-engineering (KHB) Co. Ltd",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stefania Paduano,University of Modena and Reggio Emilia,https://dx.doi.org/10.3390/ijerph19137882,7/5/2022,7/29/2022,Unverified
220630_Udine_UniversityofUdine,"June 30, 2022",Local,Italy,ITA,Friuli Venezia Giulia region,Udine,"March 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),143,0.70%,,,Sequential,"Siemens,Shenzhen Yhlo Biotech Co. Ltd",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pierluigi Toniutto,University of Udine,https://dx.doi.org/10.1007/s12664-022-01241-8,7/8/2022,3/2/2024,Unverified
220630_Tuscany_UniversityofSiena,"June 30, 2022",Regional,Italy,ITA,Tuscany,,"January 28, 2020","December 31, 2020",Residual sera,Multiple groups,2480,3.15%,,,Sequential,"Diesse,NA",ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Serena Marchi,University of Siena,https://dx.doi.org/10.3390/v14071441,7/22/2022,3/2/2024,Unverified
220614_Rome_HospitalPhysiotherapyInstitutes,"June 14, 2022",Local,Italy,ITA,Lazio,Rome,"March 15, 2020","October 15, 2021",Persons experiencing homelessness,Multiple groups,632,50.31%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aldo Morrone,Hospital Physiotherapy Institutes,https://dx.doi.org/10.3389/ijph.2022.1604851,7/26/2022,3/2/2024,Unverified
220622_Lombardy_VittoreBuzziChildren'sHospital,"June 22, 2022",Regional,Italy,ITA,Lombardy,,"January 15, 2021","May 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),29,17.20%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,L. Gianolio,Vittore Buzzi Children's Hospital,https://dx.doi.org/10.1097/MPG.0000000000003446,8/4/2022,8/26/2022,Unverified
220811_Veneto_UniversityHospitalOfPadova_2020Aug_Overall,"August 11, 2022",Regional,Italy,ITA,Veneto,,"August 1, 2020","August 15, 2020",Residual sera,Multiple groups,84,0.00%,,,Sequential,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Sabbadin,University-Hospital of Padova,https://dx.doi.org/10.2174/1871530322666220811103755,8/23/2022,12/13/2023,Unverified
220811_Veneto_UniversityHospitalOfPadova_2021MarApr_Overall,"August 11, 2022",Regional,Italy,ITA,Veneto,,"March 15, 2021","April 15, 2021",Residual sera,Multiple groups,84,9.52%,,,Sequential,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chiara Sabbadin,University-Hospital of Padova,https://dx.doi.org/10.2174/1871530322666220811103755,8/23/2022,8/23/2022,Unverified
220420_Italy_SanAgostinoEstenseCivilHospital,"April 20, 2022",Local,Italy,ITA,Modena,Modena,"March 11, 2020","September 30, 2020",Multiple populations,Multiple groups,533,15.90%,,,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,Technogenetics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Valentina Pecoraro,San'Agostino Estense Civil Hospital,https://dx.doi.org/10.19186/BC_2022.014,8/23/2022,3/2/2024,Unverified
220728_Italy_CittàdellaSaluteedellaScienzadiTorino_Primary,"July 28, 2022",Local,Italy,ITA,,Turin,"October 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),39,23.00%,,,Sequential,In3diagnostic,ELISA,IgG,96.00%,,High,Journal Article (Peer-Reviewed),Marco Denina,Città della Salute e della Scienza di Torino,https://dx.doi.org/10.3389/fmed.2022.927099,8/25/2022,3/2/2024,Unverified
220504_Italy_IRCCS,"May 4, 2022",Regional,Italy,ITA,NR (North Italy area),,"April 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,238,6.72%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),L.F. Pisani ,IRCCS Policlinico San Donato,https://dx.doi.org/10.1016/S1590-8658%2822%2900327-9,8/31/2022,9/23/2022,Unverified
220915_Turin_UniversityofTurin_Survey1,"September 15, 2022",Local,Italy,ITA,Piedmont,Turin,"October 15, 2019","November 15, 2019",Residual sera,Multiple groups,353,1.41%,,,Sequential,"EUROIMMUN,Bio-rad",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Constanza Vicentini,University of Turin,https://dx.doi.org/10.1016/j.ijid.2022.09.017,9/29/2022,3/2/2024,Unverified
220915_Turin_UniversityofTurin_Survey2,"September 15, 2022",Local,Italy,ITA,Piedmont,Turin,"September 15, 2021","October 15, 2021",Residual sera,Multiple groups,363,80.70%,,,Sequential,"EUROIMMUN,Bio-rad",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Constanza Vicentini,University of Turin,https://dx.doi.org/10.1016/j.ijid.2022.09.017,9/29/2022,3/2/2024,Unverified
221026_TrentinoAltoAdige_UniversityofPadova_overall,"October 26, 2022",Regional,Italy,ITA,Trentino,,"January 1, 2020","December 31, 2021",Residual sera,Children and Youth (0-17 years),2400,11.46%,,,Sequential,EUROIMMUN,ELISA,IgG,93.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Luisa Galla,University of Padova,https://dx.doi.org/10.1515/cclm-2022-0948,11/3/2022,4/18/2024,Verified
221009_Lombardy_IRCCSPoliclinicoSanDonato,"October 9, 2022",Regional,Italy,ITA,Lombardy,,"April 15, 2020","April 15, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,238,9.24%,,,Convenience,Bio-rad,Not reported,IgG,,,High,Presentation or Conference,L.F. Pisani,IRCCS Policlinico San Donato,https://dx.doi.org/10.1002/ueg2.12294,11/22/2022,3/2/2024,Unverified
221229_TurinAndMilan_UniversityOfTurin,"December 29, 2022",Local,Italy,ITA,,"Turin, Milan","January 15, 2021","April 15, 2021",Residual sera,Multiple groups,106,28.30%,,,Convenience,DiaSorin,,,,,,Journal Article (Peer-Reviewed),Amedeo De Nicolo,University of Turin,https://dx.doi.org/10.3390/nu15010169,1/24/2023,3/2/2024,Unverified
230112_Rome_UniversitàdegliStudiNiccolòCusano,"January 12, 2023",Local,Italy,ITA,,Rome,"September 15, 2020","July 15, 2021",Students and Daycares,Adults (18-64 years),2423,2.60%,2.00%,3.30%,Convenience,NA,Multiple Types,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Alessandra Ulivieri,Università degli Studi Niccolò Cusano,https://dx.doi.org/10.19191/EP22.5-6.A461.088,2/11/2023,3/20/2023,Unverified
230204_Apulia_UniversityofSiena_Primary,"February 4, 2023",Local,Italy,ITA,Apulia Region,Bari,"January 1, 2020","December 31, 2020",Residual sera,Multiple groups,1325,6.60%,,,Simplified probability,Diesse,ELISA,IgG,92.50%,95.80%,,Journal Article (Peer-Reviewed),Serena Marchi,University of Siena,https://dx.doi.org/10.1007/s10389-023-01834-3,3/10/2023,3/2/2024,Unverified
230404_Verona_InstitutoDiRicoveroECuraACaratterre_April-May2020_Primary,"April 4, 2023",Local,Italy,ITA,Veneto,Verona,"April 25, 2020","May 8, 2020",Household and community samples,Multiple groups,1515,2.70%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Zeno Bisoffi,Instituto di Ricovero e Cura A Caratterre,https://dx.doi.org/10.3201/eid2904.221268,4/4/2023,5/1/2024,Verified
230404_Verona_InstitutoDiRicoveroECuraACaratterre_November2021_Nucleocapsid_Primary,"April 4, 2023",Local,Italy,ITA,Veneto,Verona,"November 1, 2021","November 30, 2021",Household and community samples,Multiple groups,897,17.80%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Zeno Bisoffi,Instituto di Ricovero e Cura A Caratterre,https://dx.doi.org/10.3201/eid2904.221268,4/4/2023,5/1/2024,Verified
230422_Brescia_UniversityOfBrescia,"April 22, 2023",Local,Italy,ITA,,Brescia,"December 27, 2020","May 6, 2021",Health care workers and caregivers,Adults (18-64 years),6862,31.77%,,,Convenience,NA,Not reported,Total Antibody,,,,Journal Article (Peer-Reviewed),Stefania Arsuffi,University of Brescia,https://dx.doi.org/10.1016/j.isci.2023.106716,5/31/2023,5/31/2023,Unverified
230512_Verona_UniversityOfVerona_wConfirmatoryTest_Overall,"May 12, 2023",Local,Italy,ITA,,Verona,"March 1, 2020","August 31, 2020",Residual sera,Multiple groups,339,4.72%,,,Sequential,"EUROIMMUN,DiaSorin,Beckman Coulter,Roche Diagnostics",,"IgG,IgA,Total Antibody",,,,Journal Article (Peer-Reviewed),Cecilia Zivelonghi,University of Verona,https://dx.doi.org/10.1007/s12026-023-09384-2,6/1/2023,3/2/2024,Unverified
230530_Modena_UniversityOfModenaAndReggioEmilia_antiS_Primary,"May 30, 2023",Local,Italy,ITA,,Modena,"July 15, 2020","December 15, 2020",Blood donors,Multiple groups,25657,0.02%,,,Sequential,Abbott Laboratories,CLIA,IgM,,,,Journal Article (Peer-Reviewed),Martina Ferrari,University of Modena and Reggio Emilia,https://dx.doi.org/10.3201/eid2907.221745,6/29/2023,3/2/2024,Unverified
230609_Tuscany_NorthWesternTuscanyBloodBank,"June 9, 2023",Local,Italy,ITA,,Tuscany,"November 15, 2022","February 15, 2023",Blood donors,Adults (18-64 years),599,97.80%,,,Sequential,Abbott Laboratories,CLIA,IgG,100.00%,99.00%,High,Journal Article (Peer-Reviewed),Daniele Focosi,North-Western Tuscany Blood Bank,https://dx.doi.org/10.1111/vox.13498,8/24/2023,3/2/2024,Unverified
230713_Puglia_VitoFazziHospital,"July 13, 2023",Regional,Italy,ITA,Apulia,,"September 1, 2020","February 28, 2021",Blood donors,Adults (18-64 years),35709,6.80%,,,Sequential,Abbott Laboratories,CLIA,IgG,97.90%,99.60%,,Journal Article (Peer-Reviewed),Alessia Damiani,Vito Fazzi Hospital,https://dx.doi.org/10.1007/s00277-023-05331-1,8/24/2023,4/22/2024,Verified
200601_Israel_PandemicTaskForce_GenPop,"June 2, 2020",National,Israel,ISR,Israel,,"June 1, 2020","June 2, 2020",Household and community samples,Multiple groups,1700,2.50%,,,Stratified probability,NA,Not reported,IgG,,,Moderate,News and Media,Michael Bachner,Israeli Pandemic Task Force,https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg,6/3/2020,12/13/2023,Verified
201008_BneiBrak_CentralBureauofStatistics_primary,"October 8, 2020",Local,Israel,ISR,,Bnei Brak,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,3500,14.60%,,,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Aaron Rabinowitz,The Central Bureau of Statistics ,https://www.haaretz.com/israel-news/.premium-antibody-tests-30-percent-of-bnei-brak-residents-have-been-infected-with-covid-1.9217689,4/23/2021,7/17/2022,Verified
210421_Israel_MinistryofHealth_genpop_primary,"April 21, 2021",National,Israel,ISR,,,"June 28, 2020","September 14, 2020",Household and community samples,Multiple groups,54357,4.60%,4.40%,4.80%,Convenience,"Abbott Laboratories,DiaSorin",ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Shay Reicher,Ministry of Health,https://dx.doi.org/10.1007/s10654-021-00749-1,5/20/2021,3/2/2024,Verified
210412_TelAviv_TelAvivUniversity,"April 12, 2021",Local,Israel,ISR,,Tel Aviv,"May 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,242,2.07%,,,Sequential,EUROIMMUN,ELISA,"IgG,IgA",100.00%,98.50%,High,Journal Article (Peer-Reviewed),Tali Eviatar ,Tel Aviv University,https://dx.doi.org/10.1111/imj.15202,5/22/2021,3/2/2024,Verified
210416_Safed_ZivMedicalCentre_overall_unadj,"April 16, 2021",Local,Israel,ISR,,Safed,"December 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),725,3.45%,,,Convenience,"Abbott Laboratories,DiaSorin",Not reported,IgG,,,High,Preprint,Kamal Abu Jabal,Ziv Medical Centre,10.1101/2021.04.11.21255273,5/23/2021,3/2/2024,Verified
210624_Modiin_IsraelMinistryOfHealth_Primary,"June 24, 2021",Local,Israel,ISR,,Modiin,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,283,16.61%,,,Convenience,"Abbott Laboratories,DiaSorin,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Yael Gozlan,Israel Ministry of Health,http://dx.doi.org/10.1017/S0950268821001369,7/14/2021,3/2/2024,Verified
210624_Israel_TelAvivUniversity_overall,"June 24, 2021",National,Israel,ISR,,,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),874,1.10%,0.60%,2.10%,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Khitam Muhsen,Tel Aviv University,https://dx.doi.org/10.3389/fmed.2021.689994,7/21/2021,3/2/2024,Verified
210715_Israel_ShaareZedekMedicalCenter_Primary,"July 15, 2021",Local,Israel,ISR,,Jerusalem,"October 18, 2020","January 12, 2021",Residual sera,Children and Youth (0-17 years),1138,10.00%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Adin Breuer,Shaare Zedek Medical Center,http://dx.doi.org/10.1111/apa.16031,8/4/2021,3/2/2024,Verified
210924_BneiBrak_MayaneiHayeshuaMedicalCenter_primary,"September 24, 2021",Local,Israel,ISR,Tel Aviv District,Bnei Brak,"February 28, 2021","March 8, 2021",Pregnant or parturient women,Adults (18-64 years),21,0.00%,,,Convenience,Roche Diagnostics,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lior Kashani-Ligumsky,Mayanei Hayeshua Medical Center,https://dx.doi.org/10.1038/s41372-021-01216-1,10/6/2021,3/2/2024,Unverified
211006_Israel_IsraelInstituteforBiologicalResearch,"October 6, 2021",National,Israel,ISR,,,"April 24, 2020","April 24, 2020",Household and community samples,Multiple groups,146,0.00%,,,Convenience,NA,Not reported,IgG,98.20%,100.00%,Unclear,Journal Article (Peer-Reviewed),Morly Fisher,Israel Institute for Biological Research,https://dx.doi.org/10.1128/Spectrum.00870-21,10/13/2021,7/17/2022,Verified
211015_Jerusalem_ShaareZedekMedicalCenter,"October 15, 2021",Local,Israel,ISR,Jerusalem District,Jerusalem,"December 1, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,249,18.07%,,,Entire sample,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Low,Journal Article (Peer-Reviewed),Jenny Weinbrand-Goichberg,Shaare Zedek Medical Centre (SZMC),https://dx.doi.org/10.1007/s40620-021-01171-2,10/26/2021,3/2/2024,Unverified
211001_Israel_MaccabiHealthcareServices_Overall_TestAdjusted,"October 1, 2021",National,Israel,ISR,,,"June 28, 2020","July 27, 2020",Residual sera,Multiple groups,15459,1.91%,,,Convenience,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anat Ekka Zohar,Maccabi Healthcare Services,https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=10&page=611,12/1/2021,8/15/2023,Verified
211202_Israel_Tel-AvivUniversity,"December 2, 2021",Local,Israel,ISR,Tel Aviv District,Ramat Gan,"April 4, 2020","July 13, 2020",Health care workers and caregivers,Adults (18-64 years),428,0.70%,0.24%,2.00%,Self-referral,EUROIMMUN,ELISA,IgG,81.80%,98.00%,High,Journal Article (Peer-Reviewed),Yaniv Lustig,Tel-Aviv University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001690,12/14/2021,3/2/2024,Unverified
211202_Israel_TelAvivUniversity_Overall,"December 2, 2021",National,Israel,ISR,,,"January 1, 2020","March 31, 2021",Residual sera,Children and Youth (0-17 years),2765,5.64%,4.80%,6.60%,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Victoria Indenbaum,Tel Aviv University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2101040,12/15/2021,7/17/2022,Verified
220426_NorthernIsrael_RambamHealthCareCampus_Overall,"April 26, 2022",Regional,Israel,ISR,Northern Israel,,"November 15, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),4519,4.60%,,,Convenience,"NA,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Khetam Hussein,Rambam Health Care Campus,https://dx.doi.org/10.5041/RMMJ.10469,5/5/2022,3/2/2024,Unverified
220524_EmekMedicalCenter_EmekMedicalCenter_Overall,"May 24, 2022",Local,Israel,ISR,Northern District,Afula,"April 1, 2020","April 15, 2021",Health care workers and caregivers,Adults (18-64 years),101,9.90%,,,Convenience,"Abbott Laboratories,DiaSorin",Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Carmel Kasher,Emek Medical Center,https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2022&month=05&page=284,6/5/2022,3/2/2024,Unverified
210907_TelAviv_TelAvivUniversity_Overall,"September 7, 2021",Local,Israel,ISR,,Tel Aviv,"September 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,572,5.24%,,,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tali Eviatar,Tel Aviv University,https://dx.doi.org/10.55563/clinexprheumatol/ykin5p,7/25/2022,3/2/2024,Unverified
220716_Israel_ BaruchPadehMedicalCenter_Overall,"July 16, 2022",Local,Israel,ISR,North District,"Tiberias, Afula","July 14, 2020","February 3, 2021",Multiple populations,Adults (18-64 years),297,3.40%,,,Convenience,"Abbott Laboratories,DiaSorin",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Enav Yefet,Emek Medical Centre,https://dx.doi.org/10.1002/ijgo.14359,7/28/2022,3/2/2024,Unverified
221005_Israel_ChaimShebaMedicalCenter_Primary,"October 5, 2022",National,Israel,ISR,,,"January 15, 2020","July 15, 2021",Residual sera,Multiple groups,9517,28.32%,,,Entire sample,NA,ELISA,IgG,88.00%,98.00%,Low,Journal Article (Peer-Reviewed),Ravit Bassal,Chaim Sheba Medical Centre,https://dx.doi.org/10.3390/vaccines10101663,11/4/2022,2/3/2023,Unverified
210212_Dublin_RotundaHospital,"February 12, 2021",Local,Ireland,IRL,Leinster,Dublin,"May 12, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),51,4.00%,,,Convenience,Trinity Biotech,ELISA,IgG,95.92%,100.00%,High,Preprint,Joanna Griffin,Rotunda Hospital,https://www.medrxiv.org/content/10.1101/2021.02.10.20248323v1.full-text,3/26/2021,3/2/2024,Verified
210602_Dublin_UniversityCollegeDublin_overall_Unadj,"June 2, 2021",Local,Ireland,IRL,Leinster,Dublin,"June 15, 2020","September 15, 2020",Multiple populations,Adults (18-64 years),109,0.92%,,,Unclear,"EUROIMMUN,Fortress Diagnostics,Roche Diagnostics,DiaSorin",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Emma Heffernan,University College Dublin,https://dx.doi.org/10.1177/00045632211012728,5/22/2021,3/2/2024,Verified
210518_Mid-WestIreland_UniversityofLimerick_Staff1,"May 18, 2021",Regional,Ireland,IRL,Munster,,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,172,11.10%,4.00%,19.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,6/2/2021,7/17/2022,Unverified
210518_Mid-WestIreland_UniversityofLimerick_Patients2,"May 18, 2021",Regional,Ireland,IRL,Munster,,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,799,12.60%,8.00%,17.00%,Convenience,Maccura Biotechnology Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Edmund O'Callaghan,University of Limerick,https://dx.doi.org/10.3399/BJGPO.2021.0038,6/3/2021,7/17/2022,Unverified
210526_Ireland_TrinityCollege,"May 26, 2021",Regional,Ireland,IRL,,,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),5787,9.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Niamh Allen,"Trinity College, University of Dublin",https://europepmc.org/article/PPR/PPR347943,6/8/2021,3/2/2024,Unverified
210608_SouthWestOfIreland_CorkUniversityHospital,"June 8, 2021",Regional,Ireland,IRL,Munster,Cork,"May 27, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),404,1.49%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eamonn Faller,Cork University Hospital,http://dx.doi.org/10.1136/bmjopen-2021-051415,7/1/2021,3/2/2024,Unverified
210630_Dublin_TrinityCollegeDublin_Overall,"June 30, 2021",Local,Ireland,IRL,,Dublin,"July 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),1176,17.90%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,86.10%,100.00%,High,Journal Article (Peer-Reviewed),Ann Leonard,Trinity College Dublin,https://dx.doi.org/10.1007/s11845-021-02690-4,7/6/2021,3/2/2024,Verified
210707_Dublin_StJames'sHospital,"July 7, 2021",Local,Ireland,IRL,Leinster,Dublin,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),49,29.00%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Colm Kerr,St. James’s Hospital,https://dx.doi.org/10.1007/s11845-021-02700-5,7/14/2021,3/2/2024,Unverified
210709_Dublin_HSENationalDrugTreatmentCentre_overall,"July 9, 2021",Local,Ireland,IRL,,Dublin,"July 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),103,1.90%,,,Convenience,"Abbott Laboratories,DiaSorin,Fortress Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Fiona Fenton,HSE National Drug Treatment Centre,https://dx.doi.org/10.1007/s11845-021-02660-w,7/19/2021,3/2/2024,Unverified
210826_Dublin_MaterMisericordiaeUniversityHospital,"August 26, 2021",Local,Ireland,IRL,,Dublin,"June 24, 2020","July 6, 2020",Multiple populations,Multiple groups,157,6.40%,,,Unclear,"Superbio Biomedical Company ,Abbott Laboratories,Roche Diagnostics",Neutralization,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Brendan O'Kelly,Mater Misericordiae University Hospital,https://dx.doi.org/10.3389/fmed.2021.642318,9/25/2021,3/2/2024,Unverified
210824_Ireland_UniversityofLimerick_HCW_TestAdjusted,"August 24, 2021",Regional,Ireland,IRL,Midwest Region,,"June 15, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),171,11.10%,4.20%,18.60%,Stratified non-probability,Maccura Biotechnology Ltd,LFIA,IgG,71.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michael O'Callaghan,University of Limerick,http://dx.doi.org/10.3399/BJGPO.2021.0038,10/21/2021,7/17/2022,Verified
210824_Ireland_UniversityofLimerick_Patients_TestAdjusted,"August 24, 2021",Regional,Ireland,IRL,Midwest Region,,"June 15, 2020","July 10, 2020",Residual sera,Multiple groups,796,12.60%,7.50%,16.60%,Stratified non-probability,Maccura Biotechnology Ltd,LFIA,IgG,71.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michael O'Callaghan,University of Limerick,http://dx.doi.org/10.3399/BJGPO.2021.0038,10/21/2021,7/17/2022,Verified
211125_Ireland_IrishBloodTransfusionService_Primary,"November 25, 2021",National,Ireland,IRL,,,"February 15, 2020","September 15, 2020",Blood donors,Multiple groups,8509,2.41%,2.09%,2.76%,Simplified probability,"Abbott Laboratories,NA,Fortress Diagnostics",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Dearbhla Butler,Irish Blood Transfusion Service,https://dx.doi.org/10.1016/j.jcv.2021.105045,12/14/2021,3/2/2024,Unverified
211115_Ireland_RoyalCollegeofSurgeonsinIreland,"November 15, 2021",National,Ireland,IRL,,,"March 15, 2020","May 15, 2020",Perinatal,Children and Youth (0-17 years),200,1.50%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Marguerite Lawler,Royal College of Surgeons in Ireland,http://dx.doi.org/10.1111/all.15095,12/14/2021,7/17/2022,Unverified
211202_Ireland_HealthProtectionSurveillanceCentre_Dublin_OverallWeighted,"December 2, 2021",Local,Ireland,IRL,,,"June 22, 2020","July 16, 2020",Household and community samples,Multiple groups,913,3.12%,2.05%,4.53%,Simplified probability,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Laura Heavey,Health Protection Surveillance Centre,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741,12/16/2021,3/2/2024,Verified
211202_Ireland_HealthProtectionSurveillanceCentre_Sligo_OverallWeighted,"December 2, 2021",Local,Ireland,IRL,,,"June 22, 2020","July 16, 2020",Household and community samples,Multiple groups,820,0.58%,0.18%,1.38%,Simplified probability,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Laura Heavey,Health Protection Surveillance Centre,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.48.2001741,12/16/2021,3/2/2024,Verified
220414_Ireland_HealthProtectionSurveillanceCentre_AntiS_Adj,"April 14, 2022",Local,Ireland,IRL,,"Dublin, Cork","October 17, 2021","January 14, 2022",Blood donors,Multiple groups,5226,98.40%,98.00%,99.00%,Sequential,Abbott Laboratories,Not reported,IgG,98.70%,99.60%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/SEU%20IBTS%2012%20week%20surveillance%20report.pdf,7/26/2022,5/3/2024,Verified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),170,38.40%,31.30%,46.00%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,8/15/2023,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Adult_antiS_Adj,"June 3, 2022",National,Ireland,IRL,,,"January 30, 2022","February 19, 2022",Residual sera,Multiple groups,1410,96.50%,95.20%,97.50%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Verified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_UnAdj,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),170,38.20%,31.30%,45.70%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj_Age1to4,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),59,28.80%,18.70%,41.60%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj_Age5to12,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),111,43.50%,34.50%,53.00%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj_Female,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),84,40.70%,30.70%,51.60%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS_Adj_Male,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),86,36.20%,26.70%,46.90%,Convenience,Abbott Laboratories,Not reported,IgG,98.75%,99.55%,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
220603_Ireland_HealthProtectionSurveillanceCentre_Children_antiS-N_Adj_Age5to12,"June 3, 2022",Local,Ireland,IRL,,Dublin,"January 30, 2022","February 18, 2022",Residual sera,Children and Youth (0-17 years),111,37.90%,29.40%,47.30%,Convenience,"Abbott Laboratories,Roche Diagnostics",Not reported,IgG,,,Moderate,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/NSP%20combined%20adult%20paeds%20cycle%201%20report_final.pdf,7/26/2022,5/4/2024,Unverified
221004_Ireland_HealthProtectionSurveillanceCentre_2022Jan_TestAdj_Overall,"October 4, 2022",National,Ireland,IRL,,,"December 20, 2021","January 20, 2022",Residual sera,Children and Youth (0-17 years),170,38.40%,31.30%,46.00%,Unclear,Abbott Laboratories,CLIA,IgG,98.75%,99.55%,High,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/LSN_paediatric_SCreport.html,10/6/2022,4/17/2024,Verified
221004_Ireland_HealthProtectionSurveillanceCentre_2022Jun_TestAdj_Overall,"October 4, 2022",National,Ireland,IRL,,,"May 30, 2022","June 10, 2022",Residual sera,Children and Youth (0-17 years),207,82.50%,76.60%,87.30%,Unclear,Abbott Laboratories,CLIA,IgG,98.75%,99.55%,High,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/LSN_paediatric_SCreport.html,10/8/2022,4/17/2024,Verified
221004_Ireland_HealthProtectionSurveillanceCentre_2022Jul_TestAdj_Overall,"October 4, 2022",National,Ireland,IRL,,,"July 4, 2022","July 16, 2022",Residual sera,Children and Youth (0-17 years),72,85.70%,75.50%,92.30%,Unclear,Abbott Laboratories,CLIA,IgG,98.75%,99.55%,High,Institutional Report,Health Protection Surveillance Centre,Health Protection Surveillance Centre,https://www.hpsc.ie/a-z/nationalserosurveillanceprogramme/reports/LSN_paediatric_SCreport.html,10/8/2022,4/17/2024,Verified
230126_Ireland_StJamesHospital_Primary,"January 26, 2023",National,Ireland,IRL,,Dublin city and Galway city,"November 10, 2021","November 23, 2021",Health care workers and caregivers,Adults (18-64 years),2344,23.40%,21.70%,25.10%,Convenience,Roche Diagnostics,,,,,,Journal Article (Peer-Reviewed),Jonathan McGrath,St. James’s Hospital,https://dx.doi.org/10.3389/fmed.2023.1078022,3/3/2023,3/2/2024,Unverified
230424_Ireland_NationalBloodCentre_wave3_overall_adj,"April 24, 2023",National,Ireland,IRL,,,"February 15, 2021","March 15, 2021",Blood donors,Adults (18-64 years),1009,10.76%,8.87%,13.03%,Convenience,Abbott Laboratories,CLIA,"Total Antibody,IgG",,,Moderate,Journal Article (Peer-Reviewed),Dermot Coyne,"National Blood Centre
",https://dx.doi.org/10.1016/j.gloepi.2023.100108,6/2/2023,5/1/2024,Verified
220411_Babylon_UniversityofBabylon_IgG,"April 11, 2022",Regional,Iraq,IRQ,Babylon Province,,"January 15, 2021","March 22, 2021",Residual sera,Multiple groups,553,37.79%,,,Unclear,Biozek,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Dalia Al-Saray,Department of Clinical Laboratory Sciences,https://dx.doi.org/10.3889/oamjms.2022.9372,6/15/2022,3/2/2024,Unverified
220728_Zakho_GeneralDirectorateofDuhokEducation_Overall,"July 28, 2022",Local,Iraq,IRQ,Duhok,Zakho,"July 15, 2020","September 15, 2020",Residual sera,Multiple groups,489,26.58%,,,Convenience,BioMérieux,IFA,IgG,96.60%,99.90%,High,Journal Article (Peer-Reviewed),Ali Saeed,General Directorate of Duhok Education,https://dx.doi.org/10.3855/jidc.15825,8/9/2022,4/3/2024,Verified
230727_DuhokGovernorate_UniversityOfDuhok_Overall,"July 27, 2023",Regional,Iraq,IRQ,Duhok Governorate,,"January 10, 2021","December 30, 2021",Residual sera,Multiple groups,743,62.58%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,,Journal Article (Peer-Reviewed),Nawfal Hussein,University of Duhok,https://dx.doi.org/10.3855/jidc.17518,8/22/2023,3/2/2024,Unverified
201221_Guilan_TehranUniversityofMedicalSciences_overall,"December 21, 2020",Regional,Iran (Islamic Republic of),IRN,Guilan,,"April 11, 2020","April 19, 2020",Household and community samples,Multiple groups,528,22.20%,16.40%,28.50%,Stratified probability,VivaChek Biotech (Hangzhou) Co. Ltd,LFIA,"IgG,IgM",83.30%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maryam Shakiba,Tehran University of Medical Sciences,https://dx.doi.org/10.3201/eid2702.201960,1/24/2021,7/5/2023,Verified
201110_Tehran_TehranUniversityofMedicalSciences_unadj,"November 10, 2020",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"March 20, 2020","May 20, 2020",Essential non-healthcare workers,Adults (18-64 years),243,41.56%,,,Convenience,Karma Azma Andish Co.,LFIA,"IgM,IgG",71.10%,58.70%,High,Journal Article (Peer-Reviewed),Peyman Saberian,Tehran University of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/,1/24/2021,7/17/2022,Verified
201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine,"December 6, 2020",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"April 20, 2020","May 5, 2020",Health care workers and caregivers,Adults (18-64 years),475,29.40%,,,Convenience,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",99.90%,98.00%,High,Journal Article (Peer-Reviewed),Shahnaz Armin,High Institute for Research and Education in Transfusion Medicine,https://sites.kowsarpub.com/jjm/articles/108592.html,1/27/2021,3/2/2024,Verified
201223_RafsanjanCounty_UniversityofPecs,"December 23, 2020",Local,Iran (Islamic Republic of),IRN,Kerman,,"March 1, 2020","April 30, 2020",Contacts of COVID patients,Multiple groups,238,15.55%,,,Sequential,NA,Not reported,"IgG,IgM",,,High,Preprint,Reza Vazirinejad,University of Pecs,https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-,2/3/2021,7/17/2022,Verified
201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj,"December 15, 2020",National,Iran (Islamic Republic of),IRN,,"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan","April 17, 2020","June 2, 2020",Household and community samples,Multiple groups,3530,17.10%,14.60%,19.50%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,8/15/2023,Verified
201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj ,"December 15, 2020",National,Iran (Islamic Republic of),IRN,,"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan","April 17, 2020","June 2, 2020",Multiple populations,Multiple groups,5372,20.00%,18.50%,21.70%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Hossein Poustchi,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/7/2021,8/15/2023,Verified
2101_Zahedan_TehranUniversityofMedicalSciences,"January 1, 2021",Local,Iran (Islamic Republic of),IRN,Sistan and Balouchestan,Zahedan,"July 1, 2020","July 31, 2020",Persons experiencing homelessness,Adults (18-64 years),167,9.70%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,3/15/2021,3/2/2024,Verified
2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers,"January 1, 2021",Local,Iran (Islamic Republic of),IRN,Sistan and Balouchestan,Zahedan,"July 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),134,4.80%,,,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Zahra Mohammadi,Tehran University of Medical Sciences,http://dx.doi.org/10.34172/mejdd.2021.206a,3/15/2021,3/2/2024,Verified
210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj,"January 5, 2021",Regional,Iran (Islamic Republic of),IRN,Mazandaran,,"March 15, 2020","May 15, 2020",Household and community samples,Multiple groups,1588,17.29%,14.84%,17.79%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",59.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Seyed Abbas Mousavi,Mazandaran University of Medical Sciences,https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi,3/18/2021,3/2/2024,Verified
210217_Shiraz_ShirazUniversityOfMedicalSciences_Overall,"February 17, 2021",Local,Iran (Islamic Republic of),IRN,Fars,Shiraz City,"July 13, 2020","August 5, 2020",Health care workers and caregivers,Multiple groups,494,5.90%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kamran Bagheri Lankarani,Shiraz University of Medical Sciences,http://dx.doi.org/10.5812/semj.112681 ,4/16/2021,3/2/2024,Verified
210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_NonHCWs_Overall,"March 1, 2021",Local,Iran (Islamic Republic of),IRN,Tehran Province,Tehran,"April 4, 2020","April 6, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),2021,17.76%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sahar Mortezagholi,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.22034/iji.2021.88168.1851,4/28/2021,3/2/2024,Unverified
210413_Tabriz_TabrizUniversityOfMedicalSciences_overall_unadj_IgG_anti-S,"April 13, 2021",Local,Iran (Islamic Republic of),IRN,,Tabriz,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),609,6.07%,,,Unclear,NA,ELISA,"IgG,IgM",93.75%,98.00%,Moderate,Journal Article (Peer-Reviewed),Mohammad Sadegh Soltani Zangbar,Tabriz University of Medical Sciences,https://dx.doi.org/10.1016/j.genrep.2021.101140,5/20/2021,7/17/2022,Verified
210323_Tabriz_TabrizUniversityofMedicalSciences,"March 23, 2021",Local,Iran (Islamic Republic of),IRN,East Azerbaijan Province,Tabriz,"June 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,288,10.10%,,,Sequential,NA,ELISA,"IgG,IgM",93.00%,98.00%,High,Journal Article (Peer-Reviewed),Jalal Etemadi,Tabriz University of Medical Sciences,https://dx.doi.org/10.1080/08820139.2021.1899202,5/22/2021,7/17/2022,Verified
210420_Iran_TehranUniversityOfMedicalSciences,"April 20, 2021",National,Iran (Islamic Republic of),IRN,,,"September 15, 2020","October 15, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1243,17.90%,15.80%,20.10%,Entire sample,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",79.40%,97.30%,Moderate,Journal Article (Peer-Reviewed),Bahar Hassanmirzaei,Tehran University of Medical Sciences,https://dx.doi.org/10.1136/postgradmedj-2021-140176,5/28/2021,3/2/2024,Verified
210605_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_Overall,"June 5, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"June 15, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,168,17.26%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",100.00%,,High,Journal Article (Peer-Reviewed),Maliheh Arab,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.31557/APJCP.2021.22.6.1667,7/7/2021,3/2/2024,Unverified
210607_Iran_TehranUniversityofMedicalSciences_Primary,"June 7, 2021",National,Iran (Islamic Republic of),IRN,,,"August 3, 2020","October 31, 2020",Household and community samples,Multiple groups,11256,14.20%,13.30%,15.20%,Stratified probability,Pishtaz Diagnostics Iran,ELISA,IgG,74.00%,98.00%,Low,Journal Article (Peer-Reviewed),Kazem Khalagi ,Tehran University of Medical Sciences,http://dx.doi.org/10.1016/j.cmi.2021.06.002,7/8/2021,8/15/2023,Verified
210714_Iran_TarbiatModaresUniversity_primary,"July 14, 2021",National,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad","May 30, 2020","June 17, 2020",Multiple populations,Multiple groups,716,17.30%,8.80%,25.80%,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Preprint,Nazila Hajiahmadi,Tarbiat Modares University,10.1101/2021.07.11.21260336,7/21/2021,8/15/2023,Unverified
210816_Iran_HighInstituteForResearchEducationInTransfusionMedicine_Primary,"August 21, 2021",National,Iran (Islamic Republic of),IRN,,,"May 18, 2020","May 27, 2020",Blood donors,Multiple groups,1339,12.09%,10.34%,13.84%,Stratified non-probability,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgM,IgG",85.00%,100.00%,Moderate,Preprint,Ali Arabkhazaeli,High Institute for Research and Education in Transfusion Medicine ,https://dx.doi.org/10.1016/j.tracli.2021.08.008,8/31/2021,8/15/2023,Verified
210827_Birjand_BirjandUniversityOfMedicalSciences,"August 27, 2021",Local,Iran (Islamic Republic of),IRN,South Khorasan Province,Birjand,"July 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),137,5.10%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Malihe Zangoue,Birjand University Of MedicalSciences,https://dx.doi.org/10.3233/WOR-210634,9/1/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-05_to_2020-06_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"May 1, 2020","June 30, 2020",Household and community samples,Multiple groups,573,9.77%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-07_to_2020-08_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"July 1, 2020","August 31, 2020",Household and community samples,Multiple groups,1221,20.39%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-09_to_2020-10_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"September 1, 2020","October 31, 2020",Household and community samples,Multiple groups,1387,33.67%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2020-11_to_2020-12_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"November 1, 2020","December 31, 2020",Household and community samples,Multiple groups,1074,45.81%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2021-01_to_2021-02_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"January 1, 2021","February 28, 2021",Household and community samples,Multiple groups,294,36.05%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
210930_Tehran_TehranUniversityofMedicalSciences_2021-03_to_2021-04_Overall,"September 30, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"March 1, 2021","April 30, 2021",Household and community samples,Multiple groups,367,25.07%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Zahra Heydarifard,Tehran University of Medical Sciences,https://dx.doi.org/10.1007/s12250-021-00446-z,10/5/2021,3/2/2024,Verified
211026_Iran_NeyshaburUniversityofMedicalSciences_Overall,"October 26, 2021",National,Iran (Islamic Republic of),IRN,"Razavi Khorasan Province, Mazandaran Province","Neyshabur, Sabzevar, Babol","April 1, 2021","June 30, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,270,29.30%,,,Sequential,Pishtaz Diagnostics Iran,ELISA,IgG,94.10%,98.30%,High,Journal Article (Peer-Reviewed),Seyed Alireza Javadinia,Neyshabur University of Medical Sciences,https://dx.doi.org/10.1080/07357907.2021.1995742,11/2/2021,3/2/2024,Unverified
211022_Guilan_GuilanUniversityofMedical Sciences,"October 22, 2021",Local,Iran (Islamic Republic of),IRN,Guilan,Rasht,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,503,39.00%,34.80%,43.30%,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,,Low,Journal Article (Peer-Reviewed),Heydar Balou,Guilan University of Medical Sciences,https://dx.doi.org/10.1155/2021/9081491,11/2/2021,3/2/2024,Unverified
211202_Tehran_ImamHosseinHospital,"December 2, 2021",Local,Iran (Islamic Republic of),IRN,Tehran,Tehran,"August 1, 2020","October 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,107,14.02%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ali Motlagh,Imam Hossein Hospital,https://dx.doi.org/10.1038/s41598-021-02692-3,12/14/2021,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Overall,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,1106,28.70%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Male,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,823,27.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Female,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,278,31.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Married,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,883,28.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_Single,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,219,30.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityYes,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,159,27.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_ComorbidityNo,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,947,28.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionSanandaj,"October 7, 2021",Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Sanandaj,"November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,406,32.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionKermanshah,"October 7, 2021",Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Kermanshah,"November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,362,27.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_RegionHamedan,"October 7, 2021",Local,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.",Hamedan,"November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,338,26.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationPrimary,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,53,26.40%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationSomeSecondary,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,73,24.70%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationCompletedSecondary,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,258,29.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationBachelor,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,422,29.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_EducationMastersOrHigher,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,300,27.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationTaxiDriver,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,72,33.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationShopOwner,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,168,26.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationGovernmentEmployee,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,682,28.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
211007_WestOfIran_KurdistanUniversityOfMedicalSciences_OccupationPrivateSectorEmployee,"October 7, 2021",Regional,Iran (Islamic Republic of),IRN,"Three provinces of Kurdistan, Kermanshah, and Hamedan.","Three cities of Sanandaj, Kermanshah, and Hamedan.","November 5, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,184,29.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Ghobad Moradi,Kurdistan University of Medical Sciences,http://jmums.mazums.ac.ir/article-1-16926-en.html,1/14/2022,3/2/2024,Unverified
220225_Qom_TehranUniversityOfMedicalSciences,"February 25, 2022",Regional,Iran (Islamic Republic of),IRN,Qom Province,,"June 1, 2020","August 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,202,12.87%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Sepideh Paybast,Tehran University of Medical Sciences,https://dx.doi.org/10.1016/j.msard.2022.103712,3/17/2022,7/17/2022,Unverified
220208_Ardabil_ArdabilUniversityOfMedicalSciences_IgGIgM,"February 8, 2022",Local,Iran (Islamic Republic of),IRN,Ardabil,Ardabil,"May 20, 2020","June 7, 2020",Household and community samples,Multiple groups,1013,12.11%,,,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,Moderate,Journal Article (Peer-Reviewed),Hamed Zandian,Ardabil University of Medical Sciences,https://dx.doi.org/10.2174/18749445-v15-e2201140,4/22/2022,3/2/2024,Verified
220324_Tehran_TehranUniversityofMedicalSciences_Overall_TestAdjusted,"March 24, 2022",Local,Iran (Islamic Republic of),IRN,,Tehran,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Multiple groups,2065,22.60%,20.20%,25.10%,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Moderate,Journal Article (Peer-Reviewed),Maryam Darvishian,Tehran University of Medical Sciences,https://dx.doi.org/10.3389/fpubh.2022.832003,4/22/2022,8/15/2023,Unverified
220306_Tehran_IranUniversity,"March 6, 2022",Local,Iran (Islamic Republic of),IRN,Tehran Province,Tehran,"June 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,155,6.50%,,,Sequential,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),"Saba Garshasbi
",Iran University,https://dx.doi.org/10.5812/JJM.121929,5/3/2022,3/2/2024,Unverified
220523_Iran_TehranUniversityofMedicalSciences_OverallPopTestAdjust,"May 23, 2022",National,Iran (Islamic Republic of),IRN,,"Ahvaz,Ardabil,Babol,Gorgan,Hamedan,Kerman,Kermanshah,Mashhad,Qom,Sanandaj,Sari,Shiraz,Tabriz,Tehran,Urmia,Zahedan","January 15, 2021","March 15, 2021",Household and community samples,Multiple groups,7411,34.20%,31.00%,37.30%,Simplified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",66.90%,98.20%,Low,Journal Article (Peer-Reviewed),Mohammad Zamani,Tehran University of Medical Sciences,https://dx.doi.org/10.1186/s12889-022-13464-7,6/4/2022,8/15/2023,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_UC1,"May 26, 2022",Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas","June 15, 2020","November 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,381,19.16%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,6/9/2022,3/2/2024,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_CD2,"May 26, 2022",Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas","June 15, 2020","November 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,153,23.53%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,6/9/2022,3/2/2024,Unverified
220526_Iran_ShahidBeheshtiUniversityOfMedicalSciences_NonIBD3,"May 26, 2022",Local,Iran (Islamic Republic of),IRN,,"Tehran, Mashhad, Qazvin, Karaj, Isfahan, and Bandar Abbas","June 15, 2020","November 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,46,73.91%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,High,Journal Article (Peer-Reviewed),Shabnam Shahrokh,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.1080/13813455.2022.2080228,6/9/2022,3/2/2024,Unverified
220906_Iran_HIRETM_Overall,"September 6, 2022",National,Iran (Islamic Republic of),IRN,,,"September 1, 2020","November 30, 2020",Blood donors,Adults (18-64 years),10352,24.89%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,98.97%,99.42%,,Preprint,Fahimeh Ranjbar Kermani,High Institute for Research and Education in Transfusion Medicine,https://dx.doi.org/10.1016/j.tracli.2022.09.003,9/20/2022,3/2/2024,Unverified
220123_Shiraz_ShirazUniversityOfMedicalSciences,"January 23, 2022",Local,Iran (Islamic Republic of),IRN,Fars Province,Shiraz,"July 15, 2020","September 15, 2020",Household and community samples,Multiple groups,366,33.34%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Nasrin Aliabadi,Shiraz University of Medical Sciences,https://dx.doi.org/10.5812/jjm-126975,10/5/2022,10/5/2022,Unverified
210301_Tehran_ShahidBeheshtiUniversityOfMedicalSciences_HCWs_Overall,"March 1, 2021",Local,Iran (Islamic Republic of),IRN,Tehran Province,Tehran,"April 4, 2020","April 6, 2020",Health care workers and caregivers,Adults (18-64 years),72,31.94%,,,Unclear,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sahar Mortezagholi,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.22034/iji.2021.88168.1851,10/6/2022,3/2/2024,Unverified
221223_ Isfahan_IsfahanUniversityofMedicalSciences_overall,"December 23, 2022",Local,Iran (Islamic Republic of),IRN,,Isfahan,"October 19, 2020","February 17, 2021",Health care workers and caregivers,Adults (18-64 years),300,37.00%,,,Convenience,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,,Journal Article (Peer-Reviewed),Atefeh Vaezi ,Isfahan University of Medical Sciences,https://dx.doi.org/10.3390/antib12010002,2/10/2023,3/2/2024,Unverified
230320_Tabriz_TabrizUniversityOfMedicalSciences_Primary,"March 20, 2023",Local,Iran (Islamic Republic of),IRN,,Tabriz,"July 10, 2021","July 20, 2021",Residual sera,Multiple groups,104,43.27%,,,Convenience,NA,ELISA,IgG,93.75%,98.00%,,Journal Article (Peer-Reviewed),Jalal Etemadi,Tabriz University of Medical Sciences,https://dx.doi.org/10.1002/jcla.24863,4/11/2023,4/12/2023,Unverified
220901_Ravansar_KermanshahUniversityofMedicalSciences,"September 1, 2022",Local,Iran (Islamic Republic of),IRN,,Ravansar,"October 22, 2020","November 18, 2020",Household and community samples,Adults (18-64 years),716,35.16%,31.64%,38.79%,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Maryam Aghajarinezhad,Kermanshah University of Medical Sciences,https://irje.tums.ac.ir/browse.php?a_id=6920&sid=1&slc_lang=en,5/4/2023,4/10/2024,Verified
230225_Isfahan_IsfahanUniversityofMedical Sciences_overall,"February 23, 2023",Local,Iran (Islamic Republic of),IRN,,Isfahan,"October 23, 2020","December 21, 2020",Health care workers and caregivers,Adults (18-64 years),200,38.50%,,,Stratified non-probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,,Journal Article (Peer-Reviewed),Soodabeh Rostami,Isfahan University of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086646/ ,5/4/2023,3/2/2024,Unverified
230329_Kermanshah_KermanshahUniversityofMedicalSciences_IgG/IgM,"March 29, 2023",Regional,Iran (Islamic Republic of),IRN,Kermanshah,,"November 15, 2020","December 20, 2020",Household and community samples,Multiple groups,1967,20.20%,,,Stratified probability,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",94.10%,98.30%,Moderate,Journal Article (Peer-Reviewed),Fatemeh Khosravi Shadmani,Kermanshah University of Medical Sciences,https://dx.doi.org/10.2174/18749445-v16-230303-2022-92,5/30/2023,4/23/2024,Verified
230530_Iran_HighInstituteForResearchAndEducationInTransfusionMedicine_PopTestAdj,"May 30, 2023",National,Iran (Islamic Republic of),IRN,,,"August 25, 2021","September 15, 2021",Blood donors,Adults (18-64 years),3339,52.67%,50.14%,55.21%,Stratified non-probability,EUROIMMUN,ELISA,IgG,98.97%,99.42%,,Journal Article (Peer-Reviewed),Fahimeh Ranjbar Kermani,High Institute for Research and Education in Transfusion Medicine,https://dx.doi.org/10.5812/jjm-135768,6/29/2023,7/4/2023,Unverified
221219_Iran_UniversityTehran_Overall,"December 19, 2022",Local,Iran (Islamic Republic of),IRN,"Razavi Khorasan, Tehran","Mashhad, Tehran","May 30, 2020","June 17, 2020",Household and community samples,Multiple groups,716,17.70%,,,Self-referral,Pishtaz Diagnostics Iran,ELISA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Nazila Hajiahmadi,"University, Tehran",https://dx.doi.org/10.52547/iem.8.4.357,6/30/2023,3/2/2024,Unverified
230627_Tehran_ShahidBeheshtiUniversityofMedicalSciences,"June 27, 2023",Local,Iran (Islamic Republic of),IRN,,Tehran,"September 19, 2020","June 21, 2021",Household and community samples,Children and Youth (0-17 years),1517,33.20%,,,Convenience,EUROIMMUN,,IgG,,,,Journal Article (Peer-Reviewed),Roxana Mansour Ghanaie,Shahid Beheshti University of Medical Sciences,https://dx.doi.org/10.3390/microorganisms11071672,8/24/2023,4/22/2024,Verified
230825_Iran_TehranUniversityofMedicalSciences_overall,"August 25, 2023",National,Iran (Islamic Republic of),IRN,,,"February 15, 2021","April 15, 2021",Household and community samples,Multiple groups,16610,21.70%,,,Convenience,NA,ELISA,IgG,94.10%,98.30%,Moderate,Preprint,Mohammadreza Azangou-Khyavy,Tehran University of Medical Sciences,https://doi.org/10.21203/rs.3.rs-3143444/v1,9/22/2023,4/30/2024,Verified
210506_EastJava_KobeUniversity,"May 6, 2021",Regional,Indonesia,IDN,East Java,"Surabaya, Jombang","June 15, 2020","December 15, 2020",Household and community samples,Multiple groups,1819,11.40%,,,Convenience,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,IgG,91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Ni Luh Ayu Megasari,Kobe University,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251234,5/19/2021,3/2/2024,Verified
211223_TanjungPriok_CenterforIndonesia’sStrategicDevelopmentInitiatives_Primary,"December 23, 2021",Local,Indonesia,IDN,,Jakarta,"November 23, 2020","February 19, 2021",Household and community samples,Adults (18-64 years),3196,28.52%,25.44%,31.81%,Simplified probability,NA,CLIA,Not reported,,99.81%,Moderate,Journal Article (Peer-Reviewed),Olivia Herlinda,"World Health Organization, Geneva, Switzerland",https://dx.doi.org/10.1371/journal.pone.0261931,1/10/2022,7/17/2022,Unverified
220110_Surabaya_AirlanggaUniversity,"January 10, 2022",Local,Indonesia,IDN,East Java,Surabaya,"May 15, 2020","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),45,28.90%,,,Unclear,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",91.54%,97.02%,High,Journal Article (Peer-Reviewed),Maria Lusida,Airlangga University,https://dx.doi.org/10.1111/1348-0421.12962,1/19/2022,3/2/2024,Unverified
220609_Indonesia_UniversitasGadjahMada_Primary,"June 9, 2022",Local,Indonesia,IDN,Yogyakarta,,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,425,31.10%,,,Stratified probability,FineTest,ELISA,IgG,70.00%,83.00%,Moderate,Preprint,Riris Andono Ahmad,Universitas Gadjah Mada,10.1101/2022.06.07.22276128,6/16/2022,7/17/2022,Unverified
220831_Bali_UniversitasUdayana_Round1_Weighted,"August 31, 2022",Regional,Indonesia,IDN,Bali,,"October 14, 2020","November 14, 2020",Household and community samples,Multiple groups,1154,18.04%,9.98%,26.10%,Stratified probability,NA,Luminex,IgG,,,,Journal Article (Peer-Reviewed),Anak A. S. Sawitri,Universitas Udayana,https://dx.doi.org/10.1371/journal.pgph.0000727,4/26/2023,4/26/2023,Unverified
220831_Bali_UniversitasUdayana_Round2_Weighted,"August 31, 2022",Regional,Indonesia,IDN,Bali,,"November 15, 2020","December 24, 2020",Household and community samples,Multiple groups,1391,15.71%,11.15%,20.28%,Stratified probability,NA,Luminex,IgG,,,,Journal Article (Peer-Reviewed),Anak A. S. Sawitri,Universitas Udayana,https://dx.doi.org/10.1371/journal.pgph.0000727,4/26/2023,4/26/2023,Unverified
220101_Bali_SanjiwaniHospital,"January 1, 2022",National,Indonesia,IDN,,,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,510,37.30%,,,Convenience,Roche Diagnostics,CLIA,IgG,98.80%,100.00%,High,Journal Article (Peer-Reviewed),A.G. Budhitresna,Sanjiwani Hospital,http://www.researchtrends.net/tia/abstract.asp?in=0&vn=23&tid=36&aid=7026&pub=2022&type=3,8/1/2023,3/2/2024,Unverified
230626_Yogyakarta_NursingUniversitasGadjahMada,"June 26, 2023",Local,Indonesia,IDN,,Yogyakarta,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,425,31.10%,,,Stratified probability,FineTest,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Riris Andono Ahmad,Nursing Universitas Gadjah Mada,https://dx.doi.org/10.1371/journal.pgph.0000698,8/3/2023,8/15/2023,Unverified
200606_Bengaluru_SJICSR_Staff,"June 6, 2020",Local,India,IND,Karnataka,Bengaluru,"May 23, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),1000,1.00%,,,Convenience,NA,Not reported,IgG,,,Unclear,News and Media,Sunitha Rao,Sri Jayadeva Institute of Cardiovascular Sciences and Research,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q,6/28/2020,7/17/2022,Verified
200614_Thiruvananthapuram_HealthDepartment_GenPop,"June 14, 2020",Local,India,IND,Kerala,Thiruvananthapuram,"June 9, 2020","June 12, 2020",Household and community samples,Multiple groups,450,2.67%,,,Unclear,NA,Not reported,"IgM,IgG",,,Unclear,News and Media,Aswin Kumar,Thiruvanathapuram Health Department,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg,7/6/2020,7/17/2022,Verified
200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop,"July 21, 2020",Regional,India,IND,Haryana,"Gurugram, Faridabad, Ambala, Panchkula, Sonipat","June 21, 2020","July 15, 2020",Household and community samples,Adults (18-64 years),1544,12.00%,,,Stratified probability,NA,ELISA,IgG,,,High,News and Media,Prayag Arora Desai,Haryana Health Department,https://www.hindustantimes.com/gurugram/pvt-lab-says-16-20-sero-prevalence-in-gurugram-health-dept-distances-itself-from-data/story-265qYKX4XhRPeMVc5HrKEO.html,7/31/2020,7/17/2022,Verified
200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors,"July 19, 2020",Local,India,IND,Uttar Pradesh,Lucknow,"July 5, 2020","July 19, 2020",Blood donors,Multiple groups,1235,3.70%,,,Convenience,NA,Not reported,IgG,,,High,News and Media,Yusra Husain,King George's Medical University,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA,8/2/2020,7/17/2022,Verified
200723_Delhi_IndianCentreforDiseaseControl_GenPop,"July 21, 2020",Regional,India,IND,NCT Delhi,,"June 27, 2020","July 10, 2020",Household and community samples,Multiple groups,21387,23.48%,,,Stratified probability,Zydus Diagnostics,ELISA,IgG,98.70%,100.00%,Moderate,Institutional Report,Ministry of Health and Family Welfare,Indian Center for Disease Control,https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137,8/2/2020,3/2/2024,Verified
200723_India_Thyrocare_GenPop,"July 23, 2020",National,India,IND,,,"June 28, 2020","July 19, 2020",Household and community samples,Multiple groups,53000,15.00%,,,Simplified probability,NA,Multiple Types,Not reported,,,High,News and Media,India com News Desk,Thyrocare,https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q,8/4/2020,7/17/2022,Verified
200914_PaschimMedinipur_MedicalCollegeKolkata_Overall,"September 14, 2020",Regional,India,IND,West Bengal,,"July 26, 2020","August 8, 2020",Household and community samples,Multiple groups,458,4.15%,2.52%,6.40%,Stratified probability,Calbiotech Inc.,ELISA,IgG,98.30%,98.10%,Moderate,Preprint,Parthasarathi Satpati,Medical College Kolkata,https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1,11/6/2020,3/2/2024,Verified
200903_NewDelhi_MaxSuperSpecialtyHospital_Overall,"September 3, 2020",Local,India,IND,NCT Delhi,New Delhi,"April 15, 2020","August 15, 2020",Multiple populations,Multiple groups,780,19.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,94.50%,99.40%,High,Preprint,Samreen Siddiqui,Max Super Specialty Hospital,https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1,11/7/2020,3/2/2024,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj,"September 22, 2020",Local,India,IND,NCT Delhi,New Delhi,"June 26, 2020","July 10, 2020",Household and community samples,Multiple groups,21387,23.48%,22.96%,24.01%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/19/2020,3/2/2024,Verified
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj,"September 22, 2020",Local,India,IND,NCT Delhi,New Delhi,"August 1, 2020","August 7, 2020",Household and community samples,Multiple groups,15311,29.10%,28.51%,29.95%,Unclear,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Unclear,Preprint,Smarajit Dey,National Centre for Disease Control,https://www.researchsquare.com/article/rs-80259/v1,11/19/2020,3/2/2024,Verified
200917_India_MinistryofHealth&FamilyWelfare_OverallPopTestAdj,"September 17, 2020",National,India,IND,,,"May 11, 2020","June 4, 2020",Household and community samples,Multiple groups,28000,0.73%,0.34%,1.13%,Stratified probability,"Zydus Diagnostics,EUROIMMUN",ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.4103/ijmr.IJMR_3290_20,11/27/2020,8/15/2023,Verified
201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest,"December 7, 2020",Local,India,IND,Maharashtra,Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),208,12.50%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Tanu Singhal,Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute,https://dx.doi.org/10.4103/ijmm.IJMM_20_308,1/13/2021,3/2/2024,Verified
201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall,"November 9, 2020",Local,India,IND,West Bengal,Kolkata,"July 12, 2020","August 23, 2020",Health care workers and caregivers,Adults (18-64 years),1122,11.94%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india,1/18/2021,3/2/2024,Verified
201104_India_HindujaHospital_GenPop,"November 4, 2020",Local,India,IND,Maharashtra,Mumbai,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,801,11.10%,9.10%,13.50%,Unclear,Roche Diagnostics,Not reported,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Nishant Kumar,Postgraduate Institute of Medical Education and Research,https://dx.doi.org/10.1016/j.vaccine.2020.10.094,1/19/2021,3/2/2024,Verified
201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall,"November 9, 2020",Local,India,IND,West Bengal,Kolkata,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Mahesh Goenka,Apollo Gleneagles Hospitals,http://dx.doi.org/10.1002/jgh3.12447,1/31/2021,3/2/2024,Verified
201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary,"December 14, 2020",Local,India,IND,Gujarat,Ahmedabad,"June 16, 2020","July 7, 2020",Residual sera,Multiple groups,29891,17.61%,17.18%,18.04%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash, Municipal Medical College ,https://dx.doi.org/10.1136/bmjopen-2020-044101,2/3/2021,3/2/2024,Verified
210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall,"January 4, 2021",Local,India,IND,Tamil Nadu,Chennai,"July 30, 2020","August 7, 2020",Health care workers and caregivers,Adults (18-64 years),95,16.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Manoj Madhusudan,"Kanchi Kamakoti CHILDS Trust Hospital,",https://pubmed.ncbi.nlm.nih.gov/33408287/,2/5/2021,7/5/2023,Unverified
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre,"September 16, 2020",Local,India,IND,Kerala,,"July 11, 2020","July 24, 2020",Health care workers and caregivers,Multiple groups,635,0.00%,,,Convenience,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Anil Kumar,Amrita Institute of Medical Sciences & Research Centre,http://dx.doi.org/10.1016/j.cmi.2020.09.013,2/7/2021,3/2/2024,Verified
211104_Karnataka_Mapmygenome_primary_adj,"February 4, 2021",Regional,India,IND,Karnataka,,"June 15, 2020","August 29, 2020",Household and community samples,Multiple groups,1197,46.70%,43.30%,50.00%,Stratified probability,NA,ELISA,IgG,84.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Mohanan,Mapmygenome,https://dx.doi.org/10.1001/jama.2021.0332,2/9/2021,7/17/2022,Verified
201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj,"November 30, 2020",Local,India,IND,Maharashtra,Pune,"July 20, 2020","August 5, 2020",Household and community samples,Multiple groups,1659,51.30%,39.90%,62.40%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Aurnab Ghose,Indian Institute of Science Education and Research,https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text,2/12/2021,7/17/2022,Verified
210114_Puducherry_JawaharlalInstitute_August_primary,"January 14, 2021",Regional,India,IND,Puducherry,,"August 11, 2020","August 16, 2020",Household and community samples,Multiple groups,869,4.90%,3.50%,6.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/17/2021,3/2/2024,Verified
210114_Puducherry_JawaharlalInstitute_Sep_primary,"January 14, 2021",Regional,India,IND,Puducherry,,"September 10, 2020","September 16, 2020",Household and community samples,Multiple groups,898,20.70%,18.00%,23.30%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/17/2021,3/2/2024,Verified
210114_Puducherry_JawaharlalInstitute_Oct_primary,"January 14, 2021",Regional,India,IND,Puducherry,,"October 12, 2020","October 16, 2020",Household and community samples,Multiple groups,900,34.50%,31.50%,37.70%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sitanshu Sekhar Kar,Jawaharlal Institute,https://dx.doi.org/10.3201/2702.204480,2/17/2021,3/2/2024,Verified
210120_Chennai_NationalInstituteOfEpidemiology_primary_adj,"January 20, 2021",Local,India,IND,,Chennai,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,12405,18.40%,14.80%,22.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Sriram Selvaraju,National Institute of Epidemiology,https://dx.doi.org/10.3201/eid2702.203938,2/21/2021,7/5/2023,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj,"November 13, 2020",Local,India,IND,Maharashtra,Mumbai,"June 29, 2020","July 19, 2020",Persons living in slums,Multiple groups,4202,58.30%,56.80%,59.90%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,7/5/2023,Verified
201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj,"November 13, 2020",Local,India,IND,Maharashtra,Mumbai,"June 29, 2020","July 19, 2020",Household and community samples,Multiple groups,2702,17.10%,15.80%,18.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anup Malani,Tata Institute for Fundamental Research,http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,7/5/2023,Verified
210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG,"February 1, 2021",Local,India,IND,Tamil Nadu,Chennai,"June 1, 2020","September 30, 2020",Residual sera,Children and Youth (0-17 years),463,19.60%,15.40%,22.50%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Preprint,Aishwarya Venkataraman,Bristol Royal Hospital for Children,https://www.medrxiv.org/content/10.1101/2021.01.29.21250660v1,3/4/2021,7/5/2023,Verified
201031_Bhubaneswar_RegionalMedicalResearchCentre_overall,"October 31, 2020",Local,India,IND,,Bhubaneswar,"October 16, 2020","October 18, 2020",Household and community samples,Multiple groups,1403,50.00%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Riyan Ramanath,The Regional Medical Research Centre in Bhubaneswar,https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms,3/8/2021,7/17/2022,Verified
201027_DistrictSrinagar_GovernmentMedicalCollege_Overall,"October 27, 2020",Local,India,IND,Kashmir,,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),2905,2.50%,2.00%,3.10%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,,Moderate,Preprint,Muhammad Salim Khan,Government Medical College,https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text,3/17/2021,3/2/2024,Verified
210127_India_ICRM_overall_adj,"January 27, 2021",National,India,IND,,,"August 18, 2020","September 20, 2020",Household and community samples,Multiple groups,29082,6.60%,5.80%,7.40%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,The Indian Council of Medical Research (ICMR),https://dx.doi.org/10.1016/S2214-109X(20)30544-1,3/18/2021,7/5/2023,Verified
210205_India_ICRM_overall,"February 5, 2021",National,India,IND,,,"December 17, 2020","January 8, 2021",Household and community samples,Multiple groups,28589,21.50%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,BBC News,The Indian Council of Medical Research (ICMR),https://www.bbc.com/news/world-asia-india-55945382,3/18/2021,7/17/2022,Verified
210301_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,"March 1, 2021",Local,India,IND,NCT Delhi,New Delhi,"June 22, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),3739,13.02%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ritu Gupta,All India Institute of Medical Sciences,https://pubmed.ncbi.nlm.nih.gov/33642348/,3/24/2021,3/2/2024,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey1_overall,"March 11, 2021",Local,India,IND,Tamil Nadu,,"July 6, 2020","August 20, 2020",Household and community samples,Multiple groups,501,2.20%,0.80%,3.40%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/31/2021,3/2/2024,Verified
210311_Vellore_UniversityOfEdinburgh_CommunitySurvey2_overall ,"March 11, 2021",Local,India,IND,Tamil Nadu,,"November 6, 2020","November 20, 2020",Household and community samples,Multiple groups,200,22.00%,16.30%,27.70%,Simplified probability,"Siemens,Roche Diagnostics",CLIA,IgG,,,Moderate,Preprint,Rita Isaac,University of Edinburgh,https://www.researchsquare.com/article/rs-289385/v1,3/31/2021,3/2/2024,Verified
201111_Srinagar_GovernmentMedicalCollegeSrinagar,"November 11, 2020",Regional,India,IND,Srinagar,District Srinagar,"July 1, 2020","July 15, 2020",Residual sera,Multiple groups,2906,3.60%,2.90%,4.30%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),S Muhammad Salim Khan,Government Medical College Srinagar,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239303,4/9/2021,3/2/2024,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_September_AnaesthesiaHCW,"March 26, 2021",Local,India,IND,,Bhubaneswar,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),128,12.50%,7.30%,19.50%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,4/10/2021,3/2/2024,Verified
210326_Bhubaneswar_ICMRRegionalMedicalResearchCentre_December_AnaesthesiaHCW,"March 26, 2021",Local,India,IND,,Bhubaneswar,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),164,38.40%,30.90%,46.30%,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,High,Preprint,Debaprasad Parai,ICMR-Regional Medical Research Centre (Government of India),https://www.medrxiv.org/content/10.1101/2021.03.20.21253819v2,4/10/2021,3/2/2024,Verified
210411_India_BanarasHinduUniversity_Overall,"April 11, 2021",National,India,IND,,,"September 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),2301,30.55%,28.70%,32.50%,Simplified probability,"Biosense Technologies, India",Not reported,"IgM,IgA,IgG,Total Antibody",100.00%,99.00%,Moderate,Preprint,Prajjval Singh,Banaras Hindu University,https://www.medrxiv.org/content/10.1101/2021.02.05.21251118v2,4/15/2021,3/2/2024,Unverified
210202_Delhi_DelhiGovernment,"February 2, 2021",Local,India,IND,,Delhi,"January 15, 2021","January 23, 2021",Household and community samples,Multiple groups,28000,56.13%,,,Unclear,NA,CLIA,Not reported,,,Unclear,News and Media,Mallika Soni,Delhi Government,https://www.hindustantimes.com/india-news/after-5th-serosurvey-health-minister-jain-says-don-t-let-your-guard-down-101612264692531.html,4/15/2021,7/17/2022,Verified
210215_Patna_AllIndiaInstituteOfMedicalSciences_Overall,"February 15, 2021",Local,India,IND,Bihar,Patna,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),919,13.30%,11.20%,15.60%,Convenience,Siemens,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Mala Mahto,All India Institute of Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010601/,4/16/2021,3/2/2024,Verified
210301_Ahmedabad_SmtNHLMunicipalMedicalCollege_Overall,"March 1, 2021",Local,India,IND,Gujarat,Ahmedabad,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1333,27.76%,,,Unclear,Siemens,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Jemil Makadia,Smt NHL Municipal Medical College,http://dx.doi.org/10.7860/JCDR/2021/46817.14599,4/17/2021,3/2/2024,Verified
210311_NewDelhi_AllIndiaInstituteOfMedicalSciences_Overall,"March 11, 2021",Local,India,IND,,,"April 15, 2020","July 15, 2020",Blood donors,Adults (18-64 years),1191,9.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hem Chandra Pandey,All India Institute of Medical Sciences ,https://dx.doi.org/10.1016/j.transci.2021.103118,4/18/2021,3/2/2024,Verified
201103_Haryan_TheHindu_primary,"November 3, 2020",Regional,India,IND,Haryan,,"October 18, 2020","October 24, 2020",Household and community samples,Multiple groups,16477,14.76%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ashok Kumar,Unclear,https://www.thehindu.com/news/cities/Delhi/6-rise-in-seropositivity-among-delhis-neighbours/article33006634.ece,4/23/2021,7/17/2022,Verified
201017_Ujjain_TheTimesOfIndia_primary,"September 17, 2020",Regional,India,IND,Madhya Pradesh,,"August 27, 2020","August 30, 2020",Household and community samples,Multiple groups,3000,11.90%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Amarjeet Singh,The Times of India,https://timesofindia.indiatimes.com/city/bhopal/11-9-seroprevalence-in-ujjain-finds-survey/articleshow/78159395.cms,4/23/2021,7/17/2022,Verified
200820_Punjab_PunjabSeroSurvey_genpop,"August 20, 2020",Regional,India,IND,Punjab,,"August 1, 2020","August 17, 2020",Household and community samples,Multiple groups,1250,27.70%,,,Simplified probability,NA,LFIA,"IgM,IgG",,,Unclear,News and Media,Express News Service,NR,https://indianexpress.com/article/india/punjab-sero-survey-report-27-7-people-in-containment-zones-have-antibodies-against-covid-6563226/,4/26/2021,7/17/2022,Verified
200901_Aurangabad_GovernmentMedicalSchool_overall,"September 1, 2020",Local,India,IND,Maharashtra,,"August 10, 2020","August 19, 2020",Household and community samples,Multiple groups,6571,5.80%,,,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),J V Dixit,"Government Medical School, Aurangabad",https://ijcrt.org/papers/IJCRT2009467.pdf,4/27/2021,7/17/2022,Verified
20210406_Kashmir_GovernmentMedicalCollegeSringar_PopTestAdj,"April 6, 2021",Regional,India,IND,Kashmir,,"October 17, 2020","November 4, 2020",Household and community samples,Adults (18-64 years),6230,36.70%,34.30%,39.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Low,Preprint,Muhammad Khan,Government Medical College Sringar,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3820632,4/27/2021,2/3/2024,Verified
210303_Jabalpur_NationalCentreForDiseaseControl_TestPopAdj,"March 31, 2021",Local,India,IND,Madya Pradesh,Jabalpur,"December 11, 2020","December 21, 2020",Household and community samples,Multiple groups,9279,29.42%,28.41%,30.42%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Sudarshan Ramaswamy,National Centre for Disease Control,https://web.archive.org/web/20210410213821/http://medical.advancedresearchpublications.com/index.php/Journal-CommunicableDiseases/article/view/536,4/28/2021,8/15/2023,Verified
200831_Mumbai_NITI-Aayog_Slums_overall,"August 31, 2020",Local,India,IND,,Mumbai,"August 16, 2020","August 29, 2020",Persons living in slums,Multiple groups,3024,44.90%,43.20%,46.70%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/7/2021,3/2/2024,Verified
200831_Mumbai_NITI-Aayog_Non-Slum_overall,"August 31, 2020",Local,India,IND,,Mumbai,"August 16, 2020","August 29, 2020",Household and community samples,Multiple groups,2176,17.50%,15.90%,19.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Low,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/7/2021,3/2/2024,Verified
200831_Mumbai_NITI-Aayog_HCW,"August 31, 2020",Local,India,IND,,Mumbai,"August 16, 2020","August 29, 2020",Health care workers and caregivers,Adults (18-64 years),728,27.30%,24.10%,30.60%,Unclear,Abbott Laboratories,CLIA,IgG,93.00%,100.00%,Unclear,Institutional Report,Ullas Kolthur Seetharam,NITI-Aayog,https://www.tifr.res.in/TSN/article/Mumbai-Serosurvey%20Technical%20report-NITI_BMC-Round-2%20for%20TIFR%20website.pdf,5/7/2021,3/2/2024,Verified
210427_Bhubaneswar_IndianCouncilOfMedicalResearch_overall,"April 27, 2021",Local,India,IND,Odisha,Bhubaneswar,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,1403,49.04%,46.39%,51.68%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,Indian Council of Medical Research,https://www.cambridge.org/core/journals/epidemiology-and-infection/article/seroprevalence-of-sarscov2-in-bhubaneswar-india-findings-from-3-rounds-of-community-surveys/29A7905F297A1EFA68749AC3C6383300,5/14/2021,3/2/2024,Verified
201011_Assam_Srijanasom_overall,"October 11, 2020",Regional,India,IND,Assam,,"August 23, 2020","September 26, 2020",Household and community samples,Multiple groups,2390,23.70%,,,Unclear,NA,CLIA,IgG,,,Unclear,News and Media,Bikash Singh,Srijanasom,https://economictimes.indiatimes.com/news/politics-and-nation/assams-sero-survey-found-23-7-per-cent-seroprevalence-in-the-state/articleshow/78606153.cms,5/14/2021,7/17/2022,Verified
210320_Ahmedabad_AMCMETMedicalCollege_Overall,"March 20, 2021",Local,India,IND,Gujarat,Ahmedabad,"August 17, 2020","August 31, 2020",Contacts of COVID patients,Multiple groups,3973,31.92%,30.48%,33.38%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,https://pubmed.ncbi.nlm.nih.gov/33753682/,5/19/2021,3/2/2024,Verified
210401_Srinagar_GovernmentMedicalCollegeSrinagar_Primary,"April 1, 2021",Local,India,IND,Kashmir,Srinagar,"October 17, 2020","October 20, 2020",Household and community samples,Multiple groups,2418,40.60%,38.70%,42.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Taha Ayub,Government Medical College Srinagar,https://www.ijcmph.com/index.php/ijcmph/article/view/7827,5/19/2021,3/2/2024,Verified
200930_Kerala_GovernmentOfKerala_August,"September 30, 2020",Regional,India,IND,Kerala,"Ernakulam, Palakkad, Thrissur","August 24, 2020","August 26, 2020",Household and community samples,Multiple groups,1281,0.80%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,5/21/2021,7/17/2022,Verified
200930_Kerala_GovernmentOfKerala_May,"September 30, 2020",Regional,India,IND,Kerala,"Ernakulam, Palakkad, Thrissur","May 18, 2020","May 23, 2020",Household and community samples,Multiple groups,1193,0.33%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Institutional Report,Government of Kerala,Indian Medical Research Council,https://arogyakeralam.gov.in/wp-content/uploads/2020/03/Technical-Paper-COVID-19-ICMR-Sero-Surveillance-Study.docx.pdf,5/21/2021,7/17/2022,Verified
210321_Jamshedpur_TataMainHospital_OverallHCW,"March 21, 2021",Local,India,IND,Jharkhand,Jamshedpur,"October 7, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),2110,43.80%,,,Convenience,Beckman Coulter,CLIA,IgG,100.00%,98.60%,Moderate,Journal Article (Peer-Reviewed),Minakshi Mishra,Tata Main Hospital,https://pubmed.ncbi.nlm.nih.gov/33898113/,5/22/2021,3/2/2024,Verified
210501_Ahmedabad_MunicipalMedicalCollege_Genpop_primary,"May 1, 2021",Local,India,IND,,Ahmedabad,"October 15, 2020","October 31, 2020",Household and community samples,Multiple groups,17009,24.20%,23.57%,24.85%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,5/23/2021,3/2/2024,Verified
210324_India_UniversityofToronto_genpop_overall_unadj,"March 24, 2021",National,India,IND,"Maharashtra, West Bengal, Tamil Nadu, Karnataka, Gujarat, Rajasthan, Bihar, Andhra Pradesh","Mumbia, Delhi, Kolkata, Chennai, Bangalore, Ahmedabad, Pune, Surat, Jaipur, Nagpur, Coimbatore, Visakhapatnam","June 12, 2020","December 31, 2020",Household and community samples,Multiple groups,448518,31.00%,,,Self-referral,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Preprint,Arokiaswamy Velumani,University of Toronto ,10.1101/2021.03.19.21253429,5/23/2021,3/2/2024,Verified
210418_Delhi_CouncilofScientificandIndustrialResearchInstituteofGenomicsandIntegrativeBiology_HCW,"April 18, 2021",Regional,India,IND,Delhi,,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),307,42.00%,,,Convenience,Roche Diagnostics,Not reported,Not reported,,,High,Preprint,Rajat Ujjainia,Council of Scientific and Industrial Research Institute of Genomics and Integrative Biology,https://www.medrxiv.org/content/10.1101/2021.02.28.21252621v3,5/23/2021,3/2/2024,Unverified
210420_Kashmir_GovernmentMedicalCollege,"April 20, 2021",Regional,India,IND,Kashmir,,"June 15, 2020","June 29, 2020",Health care workers and caregivers,Multiple groups,2905,2.50%,2.00%,3.10%,Convenience,NA,ELISA,IgG,100.00%,99.00%,High,Journal Article (Peer-Reviewed),Muhammad Salim Khan,Government Medical College,https://dx.doi.org/10.12788/jhm.3609,5/27/2021,7/17/2022,Unverified
210521_Bengaluru_BangaloreMedicalCollege,"May 21, 2021",Local,India,IND,Karnataka,Bangalore,"April 15, 2021","April 22, 2021",Persons living in slums,Multiple groups,728,20.30%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Ranganath TS,Bangalore Medical College and Research Institute,https://timesofindia.indiatimes.com/city/bengaluru/one-in-five-has-antibodies-against-covid-in-slums-in-bengaluru-study/articleshow/82825325.cms,5/27/2021,7/17/2022,Unverified
210409_NewDelhi_MaulanaAzadMedicalCollege,"April 9, 2021",Local,India,IND,National Capital Territory of Delhi,New Delhi,"August 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),1401,12.10%,10.40%,13.80%,Convenience,Zydus Diagnostics,ELISA,IgG,92.40%,97.90%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2021.12.2.06,6/1/2021,3/2/2024,Verified
210508_Ahmedabad_GujaratUniversity,"May 8, 2021",Local,India,IND,Gujarat,Ahmedabad,"August 15, 2020","August 31, 2020",Health care workers and caregivers,Multiple groups,1710,23.65%,21.70%,25.73%,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,"Smt. Nathiba Hargovandas Lakhmichand (NHL) Municipal Medical College, Gujarat University",https://dx.doi.org/10.1016/j.cegh.2021.100766,6/4/2021,3/2/2024,Unverified
210408_Malegaon_MunicipalCorporationofMalegaon_genpop_overall,"April 8, 2021",Local,India,IND,,Malegaon,"July 25, 2020","August 20, 2020",Household and community samples,Multiple groups,336,40.00%,35.00%,45.00%,Stratified non-probability,NA,ELISA,IgG,93.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pallavi Saple,The Municipality of Malegaon ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140273/,6/6/2021,7/17/2022,Verified
220615_SouthEastAsia_MaulanaAzadMedicalCollege,"June 15, 2022",Local,India,IND,,New Delhi,"June 22, 2020","December 22, 2020",Contacts of COVID patients,Multiple groups,166,37.30%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Govind Mawar,Maulana Azad Medical College,,6/8/2021,3/2/2024,Unverified
210408_Indore_NationalCentreforDiseaseControl_Primary,"April 8, 2021",Local,India,IND,Madhya Pradesh,Indore,"August 11, 2020","August 23, 2020",Household and community samples,Multiple groups,7103,7.75%,7.14%,8.36%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Salil Sakalle,National Centre for Disease Control,https://dx.doi.org/10.4103/jfmpc.jfmpc_2015_20,6/8/2021,8/15/2023,Unverified
210521_Karnataka_IndianInstituteOfPublicHealth_Primary,"May 21, 2021",Regional,India,IND,Karnataka,,"September 3, 2020","September 16, 2020",Household and community samples,Multiple groups,15624,16.80%,15.50%,18.10%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Giridhara Babu,Indian Institute of Public Health,http://dx.doi.org/10.1016/j.ijid.2021.05.043,6/8/2021,2/2/2024,Verified
201708_Pune_AshokaUniversity_primary,"August 17, 2020",Local,India,IND,Maharashtra,Pune,"July 20, 2020","August 5, 2020",Household and community samples,Multiple groups,1664,51.50%,,,Stratified probability,NA,Not reported,IgG,,,Unclear,News and Media,Anuradha Mascarenhas,Ashoka University,https://indianexpress.com/article/cities/pune/first-sero-survey-shows-extensive-spread-of-covid-19-from-36-1-to-65-4-in-selected-areas-sampled-in-pune-6558853/,6/18/2021,7/17/2022,Unverified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiUrban1,"June 16, 2021",Local,India,IND,National Capital Territory of Delhi,New Delhi,"March 15, 2021","March 31, 2021",Household and community samples,Multiple groups,1001,74.70%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/23/2021,3/2/2024,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_DelhiRural2,"June 16, 2021",Local,India,IND,"Haryana
","Faridabad
","April 12, 2021","May 22, 2021",Household and community samples,Multiple groups,1059,59.30%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/23/2021,3/2/2024,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Bhubaneswar3,"June 16, 2021",Local,India,IND,Odisha,Bhubaneswar,"March 22, 2021","May 7, 2021",Household and community samples,Multiple groups,1000,52.60%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/23/2021,3/2/2024,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Gorakhpur4,"June 16, 2021",Local,India,IND,Uttar Pradesh,Gorakhpur,"April 22, 2021","June 10, 2021",Household and community samples,Multiple groups,448,87.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/23/2021,3/2/2024,Verified
210616_India_AllIndiaInstituteOfMedicalSciences_Agartala5,"June 16, 2021",Local,India,IND,Tripura,Agartala,"March 26, 2021","June 1, 2021",Household and community samples,Multiple groups,1001,51.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Preprint,Puneet Misra,All India Institute of Medical Sciences,https://europepmc.org/article/PPR/PPR357490,6/23/2021,3/2/2024,Verified
200826_Andhra_CollegeOfVeterinarySciences_Krishna1,"August 26, 2020",Regional,India,IND,Andhra,,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,21.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/17/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Anantapur2,"August 26, 2020",Regional,India,IND,Andhra,,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,16.70%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/17/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_EastGodavari3,"August 26, 2020",Regional,India,IND,Andhra,,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,14.40%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/17/2022,Unverified
200826_Andhra_CollegeOfVeterinary Sciences_Nellore4,"August 26, 2020",Regional,India,IND,Andhra,,"August 7, 2020","August 12, 2020",Household and community samples,Multiple groups,3750,8.20%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Dr K Rambabu,College of Veterinary Sciences,https://theprint.in/health/andhras-second-sero-survey-begins-today-45000-samples-to-be-collected-from-9-districts/489208/,6/23/2021,7/17/2022,Unverified
200903_Ahmedabad_AhmedabadMunicipalCorporation,"September 3, 2020",Local,India,IND,Gujarat,Ahmedabad,"August 15, 2020","August 29, 2020",Household and community samples,Multiple groups,10310,23.24%,,,Unclear,NA,Not reported,Not reported,,,High,News and Media,Express News Service ,Ahmedabad Municipal Corporation,https://indianexpress.com/article/cities/ahmedabad/second-survey-in-ahmedabad-sero-positivity-up-by-5-6-per-cent-since-june-no-herd-immunity-yet-6580951/,6/23/2021,7/17/2022,Unverified
210601_Chennai_GovernmentKilpaukMedicalCollege,"June 1, 2021",Local,India,IND,Tamil Nadu,Chennai,"April 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),45,26.66%,,,Convenience,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Therese Dhason,Government Kilpauk Medical College,http://dx.doi.org/10.7860/JCDR/2021/48889.14995,6/30/2021,3/2/2024,Unverified
210620_Delhi_AllIndiaInstituteOfMedicalScience,"June 20, 2021",Local,India,IND,,New Delhi,"September 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,164,14.00%,9.10%,20.30%,Convenience,Abbott Laboratories,CLIA,IgG,94.00%,100.00%,High,Preprint,Shivdas Rajaram Naik,All India Institute Of Medical Science,https://www.medrxiv.org/content/10.1101/2021.06.17.21259066v1.full-text,6/30/2021,3/2/2024,Verified
210710_SouthIndia_AravindEyeHospital_Primary,"July 10, 2021",Regional,India,IND,South India,,"August 19, 2020","August 28, 2020",Health care workers and caregivers,Multiple groups,1313,15.80%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.10%,99.70%,Moderate,Journal Article (Peer-Reviewed),Rajapandian Karthikeyan,Aravind Eye Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.06.014,7/20/2021,3/2/2024,Unverified
210721_India_IndianCouncilOfMedicalResearch_genpop_overall,"July 21, 2021",National,India,IND,,,"June 20, 2021","July 10, 2021",Household and community samples,Multiple groups,28975,67.60%,,,Simplified probability,NA,Not reported,IgG,,,Unclear,News and Media,Rhythma Kaul,Indian Council of Medical Research,https://www.hindustantimes.com/india-news/antibodies-in-68-indians-101626804217418.html,7/27/2021,7/17/2022,Verified
210722_Kolkata_IndianStatisticalInstitute_Primary,"July 22, 2021",Local,India,IND,West Bengal,Kolkata,"November 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),313,40.00%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,,,Moderate,Preprint,Soma Sarkar,Indian Statistical Institute,10.1101/2021.07.20.21260278,7/29/2021,3/2/2024,Verified
210722_Kerala_GovernmentMedicalCollegeThiruvananthapuram_TestAdj,"July 22, 2021",Local,India,IND,Kerala,Thiruvananthapuram,"January 8, 2021","January 19, 2021",Health care workers and caregivers,Adults (18-64 years),940,21.20%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Preprint,S J Jessy,Government Medical College Thiruvananthapuram,10.1101/2021.07.19.21260792,7/29/2021,8/15/2023,Unverified
210702_Ahmedabad_AMC-MET-MedicalCollege_Primary,"July 2, 2021",Local,India,IND,Gujarat,Ahmedabad,"August 15, 2020","August 31, 2020",Household and community samples,Multiple groups,10310,23.24%,22.43%,24.06%,Stratified probability,Zydus Diagnostics,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_2062_20,8/5/2021,3/2/2024,Verified
210702_Jodhpur_AllIndiaInstituteOfMedicalSciences_1,"July 2, 2021",Local,India,IND,Rajasthan,Jodhpur,"July 28, 2020","July 28, 2020",Essential non-healthcare workers,Adults (18-64 years),22,2.44%,,,Unclear,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,8/5/2021,3/2/2024,Unverified
210702_Jaipur_AllIndiaInstituteOfMedicalSciences_2,"July 2, 2021",Local,India,IND,Rajasthan,Jaipur,"August 4, 2020","August 4, 2020",Essential non-healthcare workers,Adults (18-64 years),41,13.64%,,,Unclear,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute Of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2381_20,8/5/2021,3/2/2024,Unverified
210721_Pune_ArmedForcesMedicalCollege,"July 27, 2021",Local,India,IND,Maharashtra,Pune,"June 16, 2020","August 16, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),413,7.50%,5.30%,10.40%,Convenience,Calbiotech Inc.,ELISA,IgG,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Sourav Sen,Armed Forces Medical College,https://dx.doi.org/10.1016/j.mjafi.2021.02.008,8/12/2021,3/2/2024,Unverified
210701_Kerala_ JubileeMissionMedicalCollegeandResearchInstitute_primary,"July 1, 2021",Local,India,IND,,Kerala,"December 20, 2020","December 30, 2020",Health care workers and caregivers,Adults (18-64 years),423,8.75%,6.23%,11.86%,Stratified non-probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Aboobacker Mohamed Rafi, Jubilee Mission Medical College and Research Institute,https://www.jcdr.net/articles/PDF/15154/48703_CE[Ra1]_F(SL)_PF1(AG_OM)_PFA(KM_AnK)%20PB(AG_AnK)_PN(KM).pdf,8/13/2021,3/2/2024,Unverified
210726_India_ArmedForcesMedicalCollege,"July 26, 2021",National,India,IND,,"Jaipur, Pune, Ahmedabad, Kolkata, Delhi, Jammu, Mumbai, Bangalore","August 21, 2020","November 20, 2020",Health care workers and caregivers,Adults (18-64 years),3253,19.70%,18.50%,21.70%,Simplified probability,Zydus Diagnostics,ELISA,IgG,92.40%,97.90%,High,Journal Article (Peer-Reviewed),Subhadeep Ghosh,Armed Forces Medical College,https://dx.doi.org/10.1016/j.mjafi.2021.03.020,8/13/2021,3/2/2024,Unverified
210501_Ahmedabad_MunicipalMedicalCollege_HCW,"May 1, 2021",Local,India,IND,,Ahmedabad,"October 15, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),1737,20.84%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,8/13/2021,3/2/2024,Verified
210501_Ahmedabad_MunicipalMedicalCollege_ContactCases,"May 1, 2021",Local,India,IND,,Ahmedabad,"October 15, 2020","October 31, 2020",Contacts of COVID patients,Multiple groups,2038,26.05%,,,Convenience,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,High,Journal Article (Peer-Reviewed),Om Prakash,Municipal Medical College,https://www.nepjol.info/index.php/AJMS/article/view/35099,8/13/2021,3/2/2024,Verified
210810_Odisha_IndianCouncilofMedicalResearch_primary,"August 10, 2021",Regional,India,IND,Odisha,,"July 15, 2020","November 15, 2020",Multiple populations,Multiple groups,5434,34.90%,33.60%,36.20%,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Preprint,Srikanta Kanungo,Indian Council of Medical Research,https://www.researchsquare.com/article/rs-664559/v1,8/17/2021,3/2/2024,Verified
210811_Karnataka_IndianInstituteofPublicHealth_Overall_PopTestAdj,"August 11, 2021",Regional,India,IND,Karnataka,,"January 25, 2021","February 18, 2021",Multiple populations,Multiple groups,41228,15.60%,14.90%,16.30%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Preprint,Rajagopal Padma,Indian Institute of Public Health,https://www.medrxiv.org/content/10.1101/2021.08.10.21261842v1,8/18/2021,8/15/2023,Unverified
210813_Madurai_UniversityOfCaliforniaBerkeley_Primary,"August 13, 2021",Local,India,IND,Tami Nadu,Madurai,"October 19, 2020","November 5, 2020",Household and community samples,Multiple groups,1140,40.20%,35.90%,44.70%,Stratified probability,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,93.00%,92.90%,Moderate,Journal Article (Peer-Reviewed),Ramanan Laxminarayan,University of California Berkeley,https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00393-5/fulltext,9/1/2021,7/17/2022,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_BAM_GenderAdj,"May 18, 2021",Local,India,IND,Odisha,Berhampur,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,1375,31.14%,28.69%,33.66%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,9/5/2021,3/2/2024,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_BBS_GenderAdj,"May 18, 2021",Local,India,IND,Odisha,Bhubaneswar,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,1319,5.24%,4.10%,6.58%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,9/5/2021,3/2/2024,Verified
210518_Odisha_ICMR-RegionalMedicalResearchCentre_RKL_GenderADj,"May 18, 2021",Local,India,IND,Odisha,Rourkela,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,1452,24.59%,22.39%,26.88%,Simplified probability,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jaya Singh Kshatri,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1038/s41598-021-89877-y,9/5/2021,3/2/2024,Verified
210829_Delhi_CouncilOfScientificAndIndustrialResearch_overall,"August 29, 2021",Local,India,IND,,Delhi,"May 15, 2021","June 15, 2021",Multiple populations,Multiple groups,846,87.00%,,,Convenience,NA,Not reported,Not reported,,,Unclear,News and Media,Anonna Dutt,Council Of Scientific And Industrial Research (CSIR),https://www.hindustantimes.com/india-news/covid-crisis-one-in-four-patients-in-delhi-were-reinfected-during-the-second-wave-says-preprint-study-101630175376759-amp.html,9/6/2021,7/17/2022,Unverified
210701_India_IndianCouncilOfMedicalResearch_GenPop_TestPopAdj,"July 1, 2021",National,India,IND,,,"December 18, 2020","January 6, 2021",Household and community samples,Multiple groups,28598,24.10%,23.00%,25.30%,Stratified probability,"Siemens,Abbott Laboratories",Multiple Types,IgG,,,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.1016/j.ijid.2021.05.040,9/13/2021,8/15/2023,Verified
210701_India_IndianCouncilOfMedicalResearch_HCWs_TestPopAdj,"July 1, 2021",National,India,IND,,,"December 18, 2020","January 6, 2021",Health care workers and caregivers,Multiple groups,7385,25.60%,23.50%,27.80%,Stratified probability,Siemens,CLIA,IgG,100.00%,99.90%,Low,Journal Article (Peer-Reviewed),Manoj V Murhekar,Indian Council of Medical Research,http://dx.doi.org/10.1016/j.ijid.2021.05.040,9/13/2021,8/15/2023,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Aug1_PopTestAdj,"August 2, 2021",Regional,India,IND,NCT Delhi,,"August 1, 2020","August 7, 2020",Household and community samples,Multiple groups,14779,28.39%,27.65%,29.14%,Stratified probability,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,92.10%,97.70%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,9/15/2021,8/15/2023,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Oct3_PopTestAdj,"August 2, 2021",Regional,India,IND,NCT Delhi,,"October 15, 2020","October 21, 2020",Household and community samples,Multiple groups,14905,24.71%,24.01%,25.42%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,9/15/2021,8/15/2023,Verified
210802_Delhi_ DirectorateGeneralHealthServices_Sept2_PopTestAdj,"August 2, 2021",Regional,India,IND,NCT Delhi,,"September 1, 2020","September 7, 2020",Household and community samples,Multiple groups,16953,24.08%,23.43%,24.74%,Stratified probability,Calbiotech Inc.,ELISA,IgG,99.12%,99.33%,Low,Journal Article (Peer-Reviewed),Nandini Sharma,Government of National Capital Territory of Delhi,https://dx.doi.org/10.1093/trstmh/trab109,9/15/2021,8/15/2023,Verified
210801_India_SevenHillsDedicatedCovidHospital,"August 1, 2021",Local,India,IND,Maharashtra,Mumbai,"December 15, 2020","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),1005,12.30%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Chavhan Santosh,Seven Hills Dedicated Covid Hospital,https://europepmc.org/article/med/34472805,9/15/2021,7/17/2022,Unverified
210913_Delhi_MaulanaAzadMedicalCollege_PopTestAdj,"September 13, 2021",Regional,India,IND,Delhi,,"January 11, 2021","January 22, 2021",Household and community samples,Multiple groups,27436,56.13%,55.49%,56.77%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Low,Preprint,Nandini Sharma,Maulana Azad Medical College,10.1101/2021.09.09.21263331,9/21/2021,8/15/2023,Verified
210903_Maharashtra_ICMR-NationalInstituteOfImmunohematology,"September 3, 2021",Regional,India,IND,Maharashtra,Dombivli,"July 21, 2020","August 3, 2020",Health care workers and caregivers,Adults (18-64 years),500,11.00%,,,Convenience,Zydus Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Reetika Malik Yadav,ICMR-National Institute of Immunohematology,https://dx.doi.org/10.2991/jegh.k.210518.001,9/25/2021,3/2/2024,Unverified
210918_Chandigarh_GovernmentMedicalCollegeandHospital_overall,"September 18, 2021",Local,India,IND,Punjab,Chandigarh,"July 1, 2021","July 31, 2021",Household and community samples,Adults (18-64 years),1200,80.20%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Hindustan Times Correspondent,Government Medical College and Hospital,https://www.hindustantimes.com/cities/chandigarh-news/sero-survey-80-of-chandigarh-s-adults-have-covid-antibodies-101631914347989.html,9/25/2021,7/17/2022,Verified
210922_PimpriChinchwad_DrDYPatilVidyapeeth_Overall,"September 22, 2021",Local,India,IND,Maharashtra,Pimpri-Chinchwad,"October 7, 2020","October 17, 2020",Household and community samples,Multiple groups,5000,34.04%,31.30%,36.80%,Stratified probability,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Low,Journal Article (Peer-Reviewed),Amitav Banerjee,"Dr. D. Y. Patil Medical College, Hospital and Research Centre",https://www.ijph.in/article.asp?issn=0019-557X;year=2021;volume=65;issue=3;spage=256;epage=260;aulast=Banerjee,10/6/2021,8/15/2023,Verified
210923_Kashmir_GovernmentMedicalCollegeSrinagar_PopAndTestAdjusted,"September 23, 2021",Regional,India,IND,Kashmir,,"October 17, 2020","November 4, 2020",Household and community samples,Multiple groups,6230,36.70%,34.30%,39.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Low,Journal Article (Peer-Reviewed),Muhammad Khan,Government Medical College Srinagar,https://dx.doi.org/10.1136/bmjopen-2021-053791,10/6/2021,8/15/2023,Verified
210919_India_TataMainHospital_Jul2021_Primary,"September 19, 2021",Local,India,IND,Jharkhand,,"July 1, 2021","July 31, 2021",Multiple populations,Multiple groups,4575,75.00%,,,Unclear,Beckman Coulter,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Deb Sanjay Nag,Tata Main Hospital,https://dx.doi.org/10.7759/cureus.18097,10/6/2021,3/2/2024,Verified
211005_NewDelhi_AllIndiaInstituteofMedicalSciences_Overall,"October 5, 2021",Local,India,IND,Delhi,New Delhi,"January 1, 2020","February 26, 2021",Household and community samples,Adults (18-64 years),352,45.20%,,,Unclear,DiaSorin,CLIA,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institute of Medical Sciences,https://dx.doi.org/10.1007/s13300-021-01158-z,10/13/2021,3/2/2024,Unverified
210901_Potheri_SRMInstituteofScienceandTechnology_Group1_Overall,"September 1, 2021",Local,India,IND,Tamil Nadu,Potheri,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),82,9.76%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Bhuvanamha Ramamurthy,SRM Institute of Science and Technology,https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422,10/13/2021,7/17/2022,Unverified
210901_Potheri_SRMInstituteofScienceandTechnology_Group2_Overall,"September 1, 2021",Local,India,IND,Tamil Nadu,Potheri,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),46,13.04%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Bhuvanamha Ramamurthy,SRM Institute of Science and Technology,https://www.jcdr.net/article_fulltext.asp?issn=0973-709x&year=2021&volume=15&issue=9&page=EC29&issn=0973-709x&id=15422,10/13/2021,7/17/2022,Unverified
211011_Kerala_KeralaGovernment_Primary,"October 11, 2021",Regional,India,IND,Kerala,,"July 4, 2021","August 7, 2021",Household and community samples,Multiple groups,13000,82.60%,,,Unclear,NA,Not reported,Not reported,,,Unclear,News and Media,Hindustan Times,Kerala Government,https://www.hindustantimes.com/india-news/82-adults-in-state-have-covid-19-antibodies-says-latest-serosurvey-in-kerala-101633964468707.html,10/20/2021,7/17/2022,Verified
210827_Bhubaneswar_AllIndiaInstituteOfMedicalSciences_Primary,"August 27, 2021",Local,India,IND,Odisha,Bhubaneswar,"August 1, 2020","August 8, 2020",Health care workers and caregivers,Adults (18-64 years),821,3.90%,2.60%,5.10%,Simplified probability,SD Biosensor,LFIA,"IgG,IgM",99.10%,95.09%,Moderate,Journal Article (Peer-Reviewed),Mishra Baijayantimala,All India Institute of Medical Sciences (AIIMS),https://dx.doi.org/10.4103/jfmpc.jfmpc_2486_20,10/26/2021,3/2/2024,Unverified
211013_Odisha_GovernmentofIndia_Primary,"October 13, 2021",Regional,India,IND,Odisha,,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),134,41.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Debaprasad Parai,Government of India,https://dx.doi.org/10.1016/j.tmaid.2021.102170,10/26/2021,3/2/2024,Unverified
211013_Cuttack_SriramChandraBhanjaMedicalCollegeandHospital_Primary,"October 13, 2021",Local,India,IND,"Odisha
",Cuttack,"November 1, 2020","January 31, 2021",Blood donors,Adults (18-64 years),1032,35.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Smita Mahapatra,Sriram Chandra Bhanja Medical College and Hospital,https://dx.doi.org/10.1016/j.tracli.2021.10.004,10/27/2021,3/2/2024,Verified
210906_NashikCity_GovernmentMedicalCollege_NonSlums_Overall,"September 6, 2021",Local,India,IND,Maharashtra ,Nashik,"January 9, 2021","January 11, 2021",Household and community samples,Multiple groups,1629,38.12%,35.76%,40.53%,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bapusaheb Nagargoje,Government Medical College,https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html,11/3/2021,7/17/2022,Verified
210906_NashikCity_GovernmentMedicalCollege_Slums_Overall,"September 6, 2021",Local,India,IND,Maharashtra ,Nashik,"January 9, 2021","January 11, 2021",Household and community samples,Multiple groups,726,42.70%,39.07%,46.39%,Stratified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bapusaheb Nagargoje,Government Medical College,https://www.jrmds.in/articles/seroprevalence-of-covid19-in-a-city-in-india-a-communitybased-crosssectional-study-83821.html,11/3/2021,7/17/2022,Verified
211020_NewDelhi_ SirGangaRamHospital_Overall,"October 20, 2021",Local,India,IND,,New Delhi,"September 18, 2020","September 24, 2020",Health care workers and caregivers,Multiple groups,1033,25.85%,,,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Chand Wattal, Sir Ganga Ram Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.09.011,11/5/2021,3/2/2024,Unverified
211014_Delhi_InstituteofLiverandBiliarySciences_Primary,"October 14, 2021",Local,India,IND,,"Delhi
","September 24, 2020","October 31, 2020",Blood donors,Adults (18-64 years),1066,27.57%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pratibha Kale,Institute of Liver and Biliary Sciences,https://dx.doi.org/10.1016/j.transci.2021.103293,11/6/2021,3/2/2024,Verified
211029_Delhi_MaulanaAzadMedicalCollege,"October 29, 2021",Local,India,IND,,Delhi,"September 24, 2020","October 9, 2021",Household and community samples,Multiple groups,28000,97.00%,,,Stratified probability,NA,CLIA,Not reported,,,Moderate,News and Media,The Times of India,Maulana Azad Medical College,https://timesofindia.indiatimes.com/city/delhi/covid-antibodies-found-in-97-of-delhi-residents/articleshow/87350053.cms,11/9/2021,7/17/2022,Unverified
211029_Jatni_ICMRRegionalMedicalResearchCentre,"October 29, 2021",Local,India,IND,Odisha,Jatni,"January 15, 2021","February 15, 2021",Household and community samples,Multiple groups,174,42.53%,,,Simplified probability,Diagnostic Bioprobes,ELISA,IgG,98.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Abhinav Sinha,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.1080/21645515.2021.1989925,11/11/2021,7/17/2022,Unverified
211026_UttarPrasesh_GovernmentofUttarPradesh_primary,"October 26, 2021",Regional,India,IND,Uttar Pradesh,,"September 4, 2020","September 10, 2020",Household and community samples,Multiple groups,16012,22.20%,21.50%,22.90%,Stratified probability,Zydus Diagnostics,LFIA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Vasanthakumar Namasivayam,Government of Uttar Pradesh,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546397/,11/12/2021,8/15/2023,Verified
210601_Kerala_GovernmentofKerala,"June 1, 2021",National,India,IND,,,"May 1, 2021","May 31, 2021",Household and community samples,Multiple groups,28975,67.60%,,,Unclear,NA,Not reported,IgG,,,Unclear,Institutional Report,Government of Kerala,Government of Kerala Department of Health & Family Welfare,https://health.kerala.gov.in/pdf/Technical_paper_COVID_19_Sero_Surveillance_Round_4_ICMR.pdf,11/18/2021,7/17/2022,Unverified
210101_Kerala_GovernmentofKerala,"January 1, 2021",Regional,India,IND,Kerala,,"December 20, 2020","December 30, 2020",Household and community samples,Multiple groups,1246,11.60%,9.91%,13.50%,Unclear,NA,Not reported,IgG,,,Unclear,Institutional Report,Government of Kerala,Government of Kerala Department of Health & Family Welfare,https://health.kerala.gov.in/pdf/Technical-paper-COVID-19-Sero-Surveillance-Round-3-ICMR.pdf,11/18/2021,7/17/2022,Unverified
210930_Kerala_GovernmentOfKerala_GenPop_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"September 1, 2021","September 30, 2021",Household and community samples,Multiple groups,4429,82.61%,81.50%,83.73%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
210930_Kerala_GovernmentOfKerala_Antenatal_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"August 15, 2021","September 15, 2021",Pregnant or parturient women,Adults (18-64 years),2274,65.40%,63.40%,67.40%,Convenience,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
210930_Kerala_GovernmentOfKerala_Children_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"September 1, 2021","September 30, 2021",Household and community samples,Children and Youth (0-17 years),1459,40.20%,,,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
210930_Kerala_GovernmentOfKerala_Tribal_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"September 1, 2021","September 30, 2021",Household and community samples,Multiple groups,1521,78.20%,,,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
210930_Kerala_GovernmentOfKerala_Coastal_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"September 1, 2021","September 30, 2021",Household and community samples,Multiple groups,1476,87.70%,86.00%,89.30%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
210930_Kerala_GovernmentOfKerala_Slum_Primary,"September 30, 2021",Regional,India,IND,Kerala,,"September 1, 2021","September 30, 2021",Persons living in slums,Multiple groups,1706,85.30%,83.63%,86.97%,Stratified probability,"Siemens,Abbott Laboratories",CLIA,IgG,,,Moderate,Institutional Report,Government of Kerala,Government of Kerala Department of Health,https://health.kerala.gov.in/pdf/Sero_Surveillance_Report_aug_sep.pdf,11/20/2021,3/2/2024,Verified
211115_TamilNadu_GovernmentofTamilNadu_Round1_Primary,"November 15, 2021",Regional,India,IND,Tamil Nadu,,"October 19, 2020","November 30, 2020",Household and community samples,Multiple groups,26135,31.60%,30.30%,32.70%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,11/24/2021,3/2/2024,Unverified
211115_TamilNadu_GovernmentofTamilNadu_Round2_Primary,"November 15, 2021",Regional,India,IND,Tamil Nadu,,"April 7, 2021","April 30, 2021",Household and community samples,Multiple groups,21992,22.90%,21.80%,23.90%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,11/24/2021,3/2/2024,Unverified
211115_TamilNadu_GovernmentofTamilNadu_Round3_Primary,"November 15, 2021",Regional,India,IND,Tamil Nadu,,"June 28, 2021","July 7, 2021",Household and community samples,Multiple groups,26592,67.10%,65.90%,68.30%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T S Selvavinayagam,Government of Tamil Nadu,https://www.medrxiv.org/content/10.1101/2021.11.14.21265758v1.full-text,11/24/2021,3/2/2024,Unverified
211110_Bangalore_BangaloreBaptistHospital_Phase1_HCW_overall,"November 10, 2021",Local,India,IND,Karnataka,Bangalore,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),211,0.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,11/24/2021,3/2/2024,Verified
211110_Bangalore_BangaloreBaptistHospital_Phase2_HCW_overall,"November 10, 2021",Local,India,IND,Karnataka,Bangalore,"September 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),206,9.20%,8.60%,9.40%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,11/24/2021,3/2/2024,Verified
211110_Karnataka_BangaloreBaptistHospital_Phase1_BloodDonors_overall,"November 10, 2021",Regional,India,IND,Karnataka,,"May 15, 2020","June 15, 2020",Blood donors,Multiple groups,210,0.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",97.20%,99.80%,High,Journal Article (Peer-Reviewed),Sindhulina Chandrasingh,Bangalore Baptist Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.10.006,11/24/2021,3/2/2024,Verified
211118_Delhi_RajivGandhiSuperSpecialityHospital,"November 18, 2021",Local,India,IND,,Delhi,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),305,21.96%,,,Unclear,Calbiotech Inc.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),B.L. Sherwal,Rajiv Gandhi Super Speciality Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.11.006,11/30/2021,3/2/2024,Unverified
210914_Chennai_NationalInstituteofEpidemiology_Overall_PopandTestAdjusted,"September 14, 2021",Local,India,IND,Tamil Nadu,Chennai,"October 8, 2020","October 15, 2020",Household and community samples,Multiple groups,6366,30.10%,24.70%,36.10%,Stratified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Muthusamy Kumar,National Institute of Epidemiology,https://academic.oup.com/trstmh/article/115/11/1350/6370308?login=true,12/1/2021,8/15/2023,Verified
211119_Kashmir_GovernmentMedicalCollegeSrinagarJammuKashmir_Primary,"November 19, 2021",Regional,India,IND,Kashmir,,"January 14, 2021","January 17, 2021",Health care workers and caregivers,Adults (18-64 years),2003,26.80%,24.80%,28.80%,Convenience,NA,CLIA,IgG,100.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Inaamul Haq,"Government Medical College Srinagar, Jammu and Kashmir",https://dx.doi.org/10.1371/journal.pone.0259893,12/2/2021,7/17/2022,Unverified
211029_Maharashtra_ArmedForcesMedicalCollege_Primary,"October 29, 2021",Regional,India,IND,Maharashtra,,"August 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),117,32.48%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Harish Kumur,Armed Forces Medical College,https://www.journaljpri.com/index.php/JPRI/article/view/33074,12/8/2021,7/17/2022,Unverified
211210_India_ICMR_GenPop_OverallTestAdjust,"December 10, 2021",National,India,IND,"Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal",,"June 14, 2021","July 6, 2021",Household and community samples,Multiple groups,28975,66.80%,65.50%,68.00%,Stratified probability,Siemens,CLIA,IgG,80.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,https://dx.doi.org/10.1371/journal.pmed.1003877,12/30/2021,8/15/2023,Unverified
211210_India_ICMR_HCW_OverallTestAdjust,"December 10, 2021",National,India,IND,"Andhra Pradesh,Assam,Bihar,Chhattisgarh,Gujarat,Haryana,Himachal Pradesh,Jammu & Kashmir,Jharkhand,Karnataka,Kerala,Madhya Pradesh,Maharashtra,Odisha,Punjab,Rajasthan,Tamil Nadu,Telangana,Uttar Pradesh,Uttarakhand,West Bengal",,"June 14, 2021","July 6, 2021",Health care workers and caregivers,Multiple groups,7252,87.40%,85.60%,89.10%,Convenience,Siemens,CLIA,IgG,80.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Manoj Murhekar,Indian Council of Medical Research,https://dx.doi.org/10.1371/journal.pmed.1003877,12/30/2021,8/15/2023,Unverified
211107_India_ESICMedicalCollegeAndHospital_OverallCrude,"November 7, 2021",Local,India,IND,Telangana,Hyderabad,"October 15, 2020","January 15, 2021",Health care workers and caregivers,Multiple groups,190,25.26%,,,Unclear,Ortho Clinical Diagnostics Inc.,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lakshmi Tadi,ESIC Medical College & Hospital,https://dx.doi.org/10.7759/cureus.19341,1/4/2022,3/2/2024,Unverified
211205_Jaipur_MahatmaGandhiMedicalCollege&Hospital_Overall,"December 5, 2021",Local,India,IND,Rajasthan,Jaipur,"December 15, 2020","January 15, 2021",Blood donors,Adults (18-64 years),534,42.88%,,,Sequential,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ram Jaiswal,Mahatma Gandhi Medical College & Hospital,https://dx.doi.org/10.1016/j.transci.2021.103338,1/9/2022,3/2/2024,Unverified
211227_Vellore_ChristianMedicalCollege_Jan2021_PopAdj,"December 27, 2021",Local,India,IND,,Vellore,"January 1, 2021","January 31, 2021",Household and community samples,Multiple groups,1228,28.50%,22.30%,33.70%,Stratified probability,"InBios International, Inc.",ELISA,IgG,,97.60%,Moderate,Journal Article (Peer-Reviewed),Divya Dayanand,Christian Medical College,https://dx.doi.org/10.1016/j.ijid.2021.12.356,1/9/2022,3/2/2024,Verified
211227_Vellore_ChristianMedicalCollege_July2021_PopAdj,"December 27, 2021",Local,India,IND,,Vellore,"July 1, 2021","July 31, 2021",Household and community samples,Multiple groups,1205,71.60%,62.80%,80.50%,Stratified probability,"InBios International, Inc.",ELISA,IgG,,97.60%,Moderate,Journal Article (Peer-Reviewed),Divya Dayanand,Christian Medical College,https://dx.doi.org/10.1016/j.ijid.2021.12.356,1/9/2022,3/2/2024,Verified
210921_Mumbai_UniversityofPittsburghMedicalCenter_Patients_Overall,"September 21, 2021",Local,India,IND,Maharashtra,Mumbai,"March 24, 2020","May 17, 2020",Residual sera,Multiple groups,110,37.27%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Viswanath Billa,University of Pittsburgh Medical Center,https://dx.doi.org/10.4103/ijn.IJN_361_20,1/9/2022,3/2/2024,Unverified
210921_Mumbai_UniversityofPittsburghMedicalCenter_Staff_Overall,"September 21, 2021",Local,India,IND,Maharashtra,Mumbai,"March 24, 2020","May 17, 2020",Health care workers and caregivers,Multiple groups,85,43.53%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Viswanath Billa,University of Pittsburgh Medical Center,https://dx.doi.org/10.4103/ijn.IJN_361_20,1/9/2022,3/2/2024,Unverified
211229_UttarPradesh_KingGeorgeMedicalUniversity_blooddonors_Overall,"December 29, 2021",Regional,India,IND,Uttar Pradesh,Lucknow,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),2163,1.90%,1.36%,2.52%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tulika Chandra,King George Medical University,https://dx.doi.org/10.1155/2021/2404170,1/12/2022,3/2/2024,Unverified
211229_Lucknow_KingGeorgeMedicalUniversity_HCWs,"December 29, 2021",Local,India,IND,Uttar Pradesh,Lucknow,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),560,2.30%,1.07%,3.57%,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Tulika Chandra,King George Medical University,https://dx.doi.org/10.1155/2021/2404170,1/12/2022,3/2/2024,Unverified
211214_NewDelhi_AllIndiaInstituteofMedicalSciences_overall,"December 14, 2021",Local,India,IND,National Capital Territory of Delhi,New Delhi,"October 1, 2020","February 27, 2021",Multiple populations,Multiple groups,643,50.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institute of Medical Sciences,https://dx.doi.org/10.1016/j.eprac.2021.12.009,1/12/2022,3/2/2024,Unverified
211229_Delhi_MaulanaAzadMedicalCollege_Overall_PopTestAdj,"December 29, 2021",Regional,India,IND,Delhi,Delhi,"September 24, 2021","October 14, 2021",Household and community samples,Multiple groups,27811,97.50%,97.00%,98.00%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Low,Preprint,Pragya Sharma,Maulana Azad Medical College,https://www.medrxiv.org/content/10.1101/2021.12.28.21268451v1,1/13/2022,8/15/2023,Verified
211231_Delhi_HamdardInstituteoMedicalSciencesandResearch,"December 31, 2021",Local,India,IND,,Delhi,"September 15, 2020","February 15, 2021",Contacts of COVID patients,Adults (18-64 years),407,28.90%,24.60%,33.60%,Convenience,Roche Diagnostics,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Ayan Kumar Das,Hamdard Institute of Medical Sciences & Research,https://dx.doi.org/10.1016/j.ijmmb.2021.12.012,1/19/2022,7/17/2022,Unverified
211229_Delhi_MaulanaAzadMedicalCollege_HCW,"December 29, 2021",Local,India,IND,,Delhi,"December 2, 2020","May 25, 2021",Health care workers and caregivers,Adults (18-64 years),625,51.36%,,,Convenience,Beijing Wantai Biological,ELISA,IgG,94.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://www.cureus.com/articles/80002-seroprevalence-of-sars-cov-2-and-risk-assessment-among-healthcare-workers-at-a-dedicated-tertiary-care-covid-19-hospital-in-delhi-india-a-cohort-study,1/21/2022,3/2/2024,Unverified
211201_Chennai_YRCCARE,"December 1, 2021",Local,India,IND,Tamil Nadu,Chennai,"December 15, 2020","May 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,393,10.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Presentation or Conference,RT Khan,YRGCARE,https://journals.sagepub.com/doi/abs/10.1177/13596535211063242?journalCode=avta,2/2/2022,3/2/2024,Unverified
220207_Pune_ICMRNARI,"February 7, 2022",Local,India,IND,Maharashtra,Pune,"March 15, 2021","June 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),405,54.60%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Manisha Ghate,Indian Council of Medical Research-NationalAIDS Research Institute (ICMR-NARI),https://dx.doi.org/10.1177/23259582221077943,2/18/2022,3/2/2024,Unverified
20220130_India_ESICMedicalCollegeHospital_Primary,"January 30, 2022",Local,India,IND,South India,,"September 15, 2020","March 15, 2021",Blood donors,Adults (18-64 years),1034,54.90%,51.50%,58.30%,Self-referral,Ortho Clinical Diagnostics Inc.,CLIA,IgG,96.30%,99.90%,High,Journal Article (Peer-Reviewed),Srinivasa Rao Chunchu,ESIC Medical College Hospital ,https://dx.doi.org/10.1007/s12288-021-01512-y,2/20/2022,8/15/2023,Unverified
220131_Ahmedabad_AMCMETMedicalCollege,"January 31, 2022",Local,India,IND,Gujarat,Ahmedabad,"October 15, 2020","October 31, 2020",Health care workers and caregivers,Multiple groups,1737,20.84%,19.00%,22.81%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Low,Journal Article (Peer-Reviewed),Om Prakash,AMC MET Medical College,10.4103/ijabmr.ijabmr_516_21,3/2/2022,3/2/2024,Unverified
220201_NewDelhi_InstituteOfMedicalSciences_Overall,"February 1, 2022",Local,India,IND,,New Delhi,"June 15, 2020","August 15, 2020",Health care workers and caregivers,Adults (18-64 years),800,16.75%,,,Convenience,Erba Manneim,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mala Chhabra,Institute of Medical Sciences,https://dx.doi.org/10.4103/jpsic.jpsic_15_21,3/2/2022,3/2/2024,Unverified
211007_NorthIndia_ArmyCollegeOfMedicalSciencesAndBaseHospitalDelhiCantt_HCWs_Overall,"October 7, 2021",Regional,India,IND,A Himalayan Region in North India,,"February 1, 2021","February 28, 2021",Health care workers and caregivers,Adults (18-64 years),570,39.30%,35.40%,43.30%,Stratified probability,Karwa Enterprises,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Inam Khan,Army College of Medical Sciences and Base Hospital Delhi Cantt,10.4103/jmms.jmms_73_21,3/3/2022,3/2/2024,Unverified
211007_NorthIndia_ArmyCollegeOfMedicalSciencesAndBaseHospitalDelhiCantt_ArmedForces_Overall,"October 7, 2021",Regional,India,IND,A Himalayan Region in North India,,"February 1, 2021","February 28, 2021",Essential non-healthcare workers,Adults (18-64 years),400,34.50%,30.00%,39.20%,Stratified probability,Karwa Enterprises,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Inam Khan,Army College of Medical Sciences and Base Hospital Delhi Cantt,10.4103/jmms.jmms_73_21,3/3/2022,3/2/2024,Unverified
220121_NewDelhi_AllIndiaInstituteOfMedicalSciences_IBD_Overall,"January 21, 2022",Local,India,IND,,New Delhi,"July 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,235,31.50%,,,Convenience,Siemens,CLIA,IgG,,,High,Presentation or Conference,B Kante,All India Institute of Medical Sciences,https://dx.doi.org/10.1093/ecco-jcc/jjab232.841,3/8/2022,3/2/2024,Unverified
220121_NewDelhi_AllIndiaInstituteOfMedicalSciences_NoIBD_Overall,"January 21, 2022",Local,India,IND,,New Delhi,"July 15, 2020","April 15, 2021",Household and community samples,Multiple groups,73,27.40%,,,Unclear,Siemens,CLIA,IgG,,,High,Presentation or Conference,B Kante,All India Institute of Medical Sciences,https://dx.doi.org/10.1093/ecco-jcc/jjab232.841,3/8/2022,3/2/2024,Unverified
220121_NewDelhi_UniversityOfOxford,"January 21, 2022",Local,India,IND,,New Delhi,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,171,57.90%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
210930_India_48FieldHealthOrganization_Primary,"September 30, 2021",Regional,India,IND,"Punjab, UP, Haryana, and Rajasthan",,"October 15, 2020","November 15, 2020",Non-essential workers and unemployed persons,Multiple groups,3680,16.57%,,,Stratified non-probability,"Zydus Diagnostics,SD Biosensor",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Vikram Grewal,48 Field Health Organization,https://www.marinemedicalsociety.in/article.asp?issn=0975-3605;year=2021;volume=23;issue=2;spage=171;epage=177;aulast=Grewal,3/9/2022,3/2/2024,Unverified
220201_Gurugram_MedantaTheMedicity,"February 1, 2022",Local,India,IND,Haryana,Gurugram,"June 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),230,25.70%,,,Self-referral,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Sonam Singla,Mendanta - The Medicity ,https://dx.doi.org/10.7860/JCDR/2022/51855.16011,3/10/2022,3/2/2024,Unverified
220303_Odisha_ICMR_Athagarh1_Overall_PopAdj,"March 3, 2022",Local,India,IND,Odisha,Athagar,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,887,60.29%,56.98%,63.53%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,3/11/2022,3/2/2024,Verified
220303_Odisha_ICMR_Badamba2_Overall_PopAdj,"March 3, 2022",Local,India,IND,Odisha,Badamba,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,862,55.47%,52.08%,58.83%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,3/11/2022,3/2/2024,Verified
220303_Odisha_ICMR_Narsinghpur3_Overall_PopAdj,"March 3, 2022",Local,India,IND,Odisha,Narsinghpur,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,988,39.79%,36.71%,42.93%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,3/11/2022,3/2/2024,Verified
220303_Odisha_ICMR_Tigiria4_Overall_PopAdj,"March 3, 2022",Local,India,IND,Odisha,Tigiria,"March 15, 2021","April 15, 2021",Household and community samples,Multiple groups,885,63.26%,59.98%,66.45%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Pujarini Dash,Indian Council of Medical Research–Regional Medical Research Centre,https://dx.doi.org/10.1017/S0950268822000346,3/11/2022,3/2/2024,Verified
220301_Ahmedabad_AhmedabadMunicipalCorporationMedicalEducationTrustMedicalCollege_Overall,"March 1, 2022",Local,India,IND,Gujarat,Ahmedabad,"February 22, 2021","March 1, 2021",Household and community samples,Multiple groups,10136,27.92%,27.06%,28.80%,Stratified non-probability,Zydus Diagnostics,ELISA,IgG,92.37%,97.90%,Moderate,Journal Article (Peer-Reviewed),Om Prakash,"Nathiba
Hargovandas Lakhmichand (NHL) Municipal Medical College",10.7759/cureus.22759,3/15/2022,3/2/2024,Verified
211116_Mumbai_BreachCandyHospital_Overall,"November 16, 2021",Local,India,IND,Maharashtra,Mumbai,"July 18, 2020","July 25, 2020",Health care workers and caregivers,Adults (18-64 years),474,31.22%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,"Total Antibody,IgG",,,High,Presentation or Conference,Seema Rohra,Breach Candy Hospital,https://dx.doi.org/10.1016/j.ijmmb.2021.08.251,3/15/2022,3/2/2024,Unverified
220223_Pondicherry_PondicherryInstituteOfMedicalSciences_1stPhase_Overall,"February 23, 2022",Local,India,IND,,Pondicherry,"July 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),382,3.40%,2.00%,5.70%,Stratified non-probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aneesh Basheer,Pondicherry Institute of Medical Sciences,https://doi.org/10.7759/cureus.22520,3/16/2022,3/2/2024,Unverified
220223_Pondicherry_PondicherryInstituteOfMedicalSciences_2ndPhase_Overall,"February 23, 2022",Local,India,IND,,Pondicherry,"February 15, 2021","April 15, 2021",Health care workers and caregivers,Adults (18-64 years),168,42.26%,,,Stratified non-probability,Roche Diagnostics,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Aneesh Basheer,Pondicherry Institute of Medical Sciences,https://doi.org/10.7759/cureus.22520,3/16/2022,3/2/2024,Unverified
211116_NewDelhi_MaulanaAzadMedicalCollege_Overall,"November 16, 2021",Local,India,IND,Delhi,New Delhi,"August 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),1401,12.10%,,,Unclear,Zydus Diagnostics,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Pradeep Kumar Bharti,Maulana Azad Medical College,https://dx.doi.org/10.1016/j.ijmmb.2021.08.233,3/18/2022,3/2/2024,Unverified
220303_Chandigarh_PostGraduateInstituteofMedicalEducationandResearch_Overall,"March 3, 2022",Local,India,IND,Chandigarh,Chandigarh,"April 15, 2021","August 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,46,39.00%,,,Convenience,Roche Diagnostics,CLIA,Not reported,98.80%,99.90%,High,Journal Article (Peer-Reviewed),Madhu Chopra,Post Graduate Institute of Medical Education and Research,https://dx.doi.org/10.1007/s12288-022-01528-y,3/18/2022,3/2/2024,Unverified
220310_Bangalore_BangaloreBaptistHospital_Primary,"March 10, 2022",Regional,India,IND,Karnataka,,"July 1, 2021","July 31, 2021",Household and community samples,Multiple groups,831,44.90%,42.50%,47.40%,Simplified probability,Roche Diagnostics,CLIA,IgG,84.00%,100.00%,Low,Journal Article (Peer-Reviewed),Carolin George,Bangalore Baptist Hospital,https://dx.doi.org/10.1371/journal.pone.0265236,3/22/2022,3/2/2024,Unverified
220301_Dibrugarh_AssamMedicalCollegeandHospital,"March 1, 2022",Local,India,IND,Assam,Dibrugarh,"October 15, 2020","December 14, 2020",Health care workers and caregivers,Adults (18-64 years),215,25.12%,,,Convenience,BioMérieux,Other,IgG,,,High,Journal Article (Peer-Reviewed),Mithu Medhi,Assam Medical College and Hospital,https://dx.doi.org/10.7860/JCDR/2022/51664.16066,3/22/2022,3/2/2024,Unverified
220308_KingGeorgesMedicalUniversity_KingGeorgesMedicalUniversity_Overall,"March 8, 2022",Local,India,IND,Uttar Pradesh,Lucknow,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),500,25.60%,,,Unclear,Trivitron Healthcare,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anuragani Verma,King George's Medical University,https://dx.doi.org/10.1016/j.ijmmb.2022.02.004,3/26/2022,3/2/2024,Unverified
220324_Ballabhgarh_AllIndiaInstituteMedicalSciences_TotalAb,"March 24, 2022",Local,India,IND,Haryana,Ballabhgarh,"April 15, 2021","August 15, 2021",Pregnant or parturient women,Adults (18-64 years),220,77.30%,,,Convenience,BioMérieux,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Aparna Sharma,All India Institute of Medical Sciences,https://dx.doi.org/10.1002/ijgo.14189,3/30/2022,3/2/2024,Unverified
220115_Jodhpur_AllIndiaInstituteofMedicalSciences_Primary,"January 15, 2022",Local,India,IND,Rajasthan,Jodhpur,"September 2, 2020","September 2, 2020",Health care workers and caregivers,Adults (18-64 years),39,10.30%,,,Entire sample,Karwa Enterprises,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Vidhi Jain,All India Institute of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_534_21,4/6/2022,3/2/2024,Unverified
220405_NewDelhi_AllIndiaInstituteofMedicalSciences,"April 5, 2022",Local,India,IND,,New Delhi,"August 15, 2020","February 15, 2021",Multiple general populations,Adults (18-64 years),240,45.40%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Alpesh Goyal,All India Institue of Medical Sciences,https://dx.doi.org/10.1111/cen.14731,4/14/2022,3/2/2024,Verified
220220_SouthAndaman_AndamanandNicobarIslandsInstituteofMedicalSciences_Overall,"February 20, 2022",Local,India,IND,Andaman and Nicobar Islands,South Andaman district,"December 15, 2020","February 14, 2021",Household and community samples,Multiple groups,4089,39.74%,,,Stratified probability,Erba Manneim,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Deepak Kumar,Andaman and Nicobar Islands Institute of Medical Sciences,https://dx.doi.org/10.7759/cureus.22398,4/14/2022,3/2/2024,Verified
220316_Mumbai_SethGSMedicalCollege,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,10197,36.30%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/17/2022,3/2/2024,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_<18,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,467,39.40%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_18-30,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,2691,32.96%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_31-40,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,1905,34.44%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
"220316_Mumbai_SethGSMedicalCollege_Age_41-50
","March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,1758,37.88%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_51-60,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,1673,45.53%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
220316_Mumbai_SethGSMedicalCollege_Age_>61,"March 16, 2022",Local,India,IND,Maharashtra,Mumbai,"March 1, 2021","March 31, 2021",Residual sera,Multiple groups,1691,37.85%,,,Convenience,"Abbott Laboratories,Siemens",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Gajanan Velhal,Seth GS Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_984_21,4/18/2022,3/2/2024,Unverified
220410_Mumbai_BEST_Primary,"April 10, 2022",Local,India,IND,Maharashtra,Mumbai,"March 28, 2022","March 30, 2022",Essential non-healthcare workers,Adults (18-64 years),776,100.00%,,,Convenience,NA,Not reported,Not reported,,,High,News and Media,Pratip Acharya,Brihanmumbai Electric Supply and Transport,https://www.hindustantimes.com/cities/mumbai-news/100-best-drivers-conductors-developed-antibodies-101649607686530.html,4/21/2022,7/17/2022,Unverified
220324_NewDelhi_AllIndiaInstituteofMedicalSciences_IgG,"March 24, 2022",Local,India,IND,National Capital Territory of Delhi,New Delhi,"April 15, 2021","August 15, 2021",Pregnant or parturient women,Adults (18-64 years),220,72.73%,66.80%,78.60%,Unclear,BioMérieux,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Kandala Sharma,All India Institute of Medical Sciences,https://dx.doi.org/10.1002/ijgo.14189,4/26/2022,3/2/2024,Unverified
220310_HimachalPradesh_DrRPGovernmentMedicalCollege_Overall,"March 10, 2022",Local,India,IND,Himachal Pradesh,,"September 15, 2020","January 15, 2021",Health care workers and caregivers,Adults (18-64 years),1279,12.67%,,,Convenience,Trivitron Healthcare,ELISA,IgG,98.00%,100.00%,High,Journal Article (Peer-Reviewed),Dinesh Kumar,Dr. Rajendra Prasad Government Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_288_21,5/10/2022,3/2/2024,Unverified
201203_Mumbai_MGMInstituteOfHealthSciences,"December 30, 2020",Local,India,IND,Maharashtra,Mumbai,"July 17, 2020","July 31, 2020",Essential non-healthcare workers,Multiple groups,2077,25.37%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Samant Parineeta,Mahatma Gandhi Mission Institute of Health Sciences,https://dx.doi.org/10.36848/PMR/2020/12100.50430,5/18/2022,7/17/2022,Unverified
220331_Chennai_BloombergSchoolofPublicHealth,"March 31, 2022",Local,India,IND,Tamil Nadu,Chennai,"January 15, 2021","May 15, 2021",Household and community samples,Multiple groups,4712,61.90%,60.50%,65.30%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Presentation or Conference,Eshan U. Patel,Bloomberg School of Public Health ,https://www.iasusa.org/tam/march-2022/,6/15/2022,3/20/2024,Verified
220531_Gurugram_SGTUniversity,"May 31, 2022",Local,India,IND,Haryana,Gurugram,"January 15, 2021","July 15, 2021",Health care workers and caregivers,Multiple groups,150,28.00%,,,Convenience,HiMedia Laboratories,ELISA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Leimapokpam Devi,SGT University,https://dx.doi.org/10.1155/2022/4729844,6/24/2022,3/2/2024,Unverified
211119_Hyderabad_CSIR-CentreForCellularAndMolecularBiology_Primary,"November 19, 2021",Local,India,IND,Telangana,Hyderabad,"January 8, 2021","January 24, 2021",Household and community samples,Multiple groups,9363,54.20%,53.20%,55.20%,Simplified probability,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Avula Laxmaiah,CSIR-CentreForCellularAndMolecularBiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603330/,6/29/2022,3/2/2024,Unverified
211030_Karnataka_IndianInstituteofPublicHealth_PopTestAdj_Overall,"October 30, 2021",Regional,India,IND,Karnataka,Including eight administrative zones of the Bengaluru metropolitan area,"January 25, 2021","February 18, 2021",Multiple populations,Multiple groups,40030,15.60%,14.90%,16.30%,Stratified probability,Zydus Diagnostics,ELISA,IgG,92.20%,97.70%,Low,Journal Article (Peer-Reviewed),Rajagopal Padma,Indian Institute of Public Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620812/,6/29/2022,8/15/2023,Unverified
220607_Mumbai_FortisMemorialResearchInstitute_Overall,"June 7, 2022",Local,India,IND,Maharashtra,Mumbai,"January 22, 2021","February 2, 2021",Essential non-healthcare workers,Adults (18-64 years),3077,74.10%,72.50%,75.60%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Shibal Bhartiya,Hindaju Hospital,https://dx.doi.org/10.1007/s13337-022-00766-y,6/30/2022,7/17/2022,Verified
220509_Uttarakhand_AllIndiaInstituteofMedicalSciences_Overall,"May 9, 2022",Regional,India,IND,Uttarakhand,,"July 15, 2020","August 14, 2020",Health care workers and caregivers,Adults (18-64 years),704,1.99%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Amit Saini,All India Institute of Medical Sciences,https://dx.doi.org/10.7759/cureus.24840,6/30/2022,7/17/2022,Verified
220615_Hyderabad_ESICMedicalCollegeAndHospitalSanathNagar_Overall,"June 15, 2022",Local,India,IND,,Hyderabad,"August 10, 2020","August 25, 2020",Health care workers and caregivers,Adults (18-64 years),875,24.91%,,,Convenience,J. Mitra & Co. Pvt. Ltd,ELISA,IgG,92.10%,97.70%,High,Journal Article (Peer-Reviewed),Pravin Pissude,ESIC Medical College & Hospital Sanath Nagar,https://seronjihou.files.wordpress.com/2022/06/293208.pdf,7/5/2022,3/2/2024,Unverified
20220524_ Thrissur_JubileeMissionMedicalCollegeandResearchInstitute_IgG,"May 24, 2022",Local,India,IND,Thrissur,NR,"March 16, 2021","July 10, 2021",Blood donors,Adults (18-64 years),300,15.30%,,,Sequential,Beckman Coulter,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),S. John, Jubilee Mission Medical College and Research Institute,https://dx.doi.org/10.1111/vox.13285,7/7/2022,3/2/2024,Unverified
220705_Jammu_GovernmentMedicalCollege_TestAdj_Overall,"July 5, 2022",Local,India,IND,Jammu and Kashmir,,"September 30, 2020","October 1, 2020",Household and community samples,Multiple groups,2000,8.80%,8.78%,8.82%,Stratified probability,Meril Diagnostics (Meril Life),ELISA,IgG,93.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Dinesh Kumar,Government Medical College,https://dx.doi.org/10.4103/ijmr.IJMR_4489_20,7/13/2022,2/12/2024,Verified
220610_Delhi_MaulanaAzadMedicalCollege_Time2_TestAdj,"June 10, 2022",Local,India,IND,,Delhi,"September 15, 2021","October 15, 2021",Household and community samples,Children and Youth (0-17 years),4211,90.80%,89.80%,91.70%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2022.0014,7/20/2022,3/25/2024,Verified
220610_Delhi_MaulanaAzadMedicalCollege_Time1_Overall,"June 10, 2022",Local,India,IND,,Delhi,"January 1, 2021","January 31, 2021",Household and community samples,Children and Youth (0-17 years),4338,52.80%,51.30%,54.30%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.24171/j.phrp.2022.0014,7/20/2022,3/25/2024,Verified
220822_India_AllIndiaInstituteofMedicalSciences_Overall,"August 22, 2022",National,India,IND,"Delhi, Uttar Pradesh, Haryana, Bihar, Rajasthan",,"June 9, 2020","April 27, 2021",Residual sera,Multiple groups,916,28.80%,,,Sequential,NA,ELISA,IgG,,,High,Preprint,Animesh Ray,All India Institute of Medical Sciences,10.1101/2022.08.19.22278876,9/7/2022,9/7/2022,Unverified
220711_India_ArmedForcesMedicalCollege,"July 11, 2022",National,India,IND,,,"August 21, 2020","November 20, 2020",Health care workers and caregivers,Adults (18-64 years),2224,18.20%,,,Stratified probability,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Arun Kumar Yadav,Armed Forces Medical College,https://dx.doi.org/10.4103/ijcm.ijcm_684_21,9/10/2022,9/11/2022,Unverified
220816_Delhi_AllIndiaInstituteofAyurveda_TrialGroup,"August 16, 2022",Regional,India,IND,National Capital Territory of Delhi,,"May 16, 2020","July 16, 2020",Essential non-healthcare workers,Adults (18-64 years),80,17.50%,,,Convenience,HiMedia Laboratories,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tanuja Nesari,All India Institute of Ayurveda,https://dx.doi.org/10.3389/fpubh.2022.920126,9/14/2022,3/2/2024,Unverified
220816_Delhi_AllIndiaInstituteofAyurveda_ControlGroup,"August 16, 2022",Regional,India,IND,National Capital Territory of Delhi,,"May 16, 2020","July 16, 2020",Essential non-healthcare workers,Adults (18-64 years),66,39.40%,,,Convenience,HiMedia Laboratories,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tanuja Nesari,All India Institute of Ayurveda,https://dx.doi.org/10.3389/fpubh.2022.920126,9/14/2022,3/2/2024,Unverified
220128_Delhi_MaulanaAzadMedicalCollege_PopAdj,"January 28, 2022",Local,India,IND,,Delhi,"September 24, 2021","October 14, 2021",Household and community samples,Multiple groups,27811,88.00%,87.60%,88.40%,Stratified probability,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pragya Sharma,Maulana Azad Medical College,https://dx.doi.org/10.7759/cureus.27428,9/20/2022,3/2/2024,Unverified
220725_TamilNadu_GovernmentofTamilNadu_Round4,"July 25, 2022",Regional,India,IND,Tamil Nadu,,"December 27, 2021","January 6, 2022",Household and community samples,Adults (18-64 years),32244,90.60%,90.10%,91.10%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T.S. Selvavinayagam,Government of Tamil Nadu,https://dx.doi.org/10.1101/2021.11.14.21265758,9/21/2022,3/2/2024,Unverified
220725_TamilNadu_GovernmentofTamilNadu_Round1,"July 25, 2022",Regional,India,IND,Tamil Nadu,,"October 19, 2020","November 30, 2020",Household and community samples,Adults (18-64 years),26135,32.40%,31.30%,33.60%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T.S. Selvavinayagam,Government of Tamil Nadu,https://dx.doi.org/10.1101/2021.11.14.21265758,9/23/2022,3/2/2024,Unverified
220725_TamilNadu_GovernmentofTamilNadu_Round2,"July 25, 2022",Regional,India,IND,Tamil Nadu,,"April 7, 2021","April 30, 2021",Household and community samples,Adults (18-64 years),21992,21.60%,20.60%,22.60%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T.S. Selvavinayagam,Government of Tamil Nadu,https://dx.doi.org/10.1101/2021.11.14.21265758,9/23/2022,3/2/2024,Unverified
220725_TamilNadu_GovernmentofTamilNadu_Round3,"July 25, 2022",Regional,India,IND,Tamil Nadu,,"June 28, 2021","July 7, 2021",Household and community samples,Adults (18-64 years),26392,69.20%,68.20%,70.20%,Stratified probability,"Ortho Clinical Diagnostics Inc.,Shenzhen Yhlo Biotech Co. Ltd",CLIA,IgG,,,Moderate,Preprint,T.S. Selvavinayagam,Government of Tamil Nadu,https://dx.doi.org/10.1101/2021.11.14.21265758,9/23/2022,3/2/2024,Unverified
220615_India_AllIndiaInstituteOfMedicalSciences_Adj,"June 15, 2022",National,India,IND,,,"March 15, 2021","June 10, 2021",Household and community samples,Multiple groups,4509,65.90%,64.60%,67.40%,Stratified non-probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Puneet Misra,All India Institute of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_2274_21,9/27/2022,8/15/2023,Unverified
220615_India_AIIMS_Overall,"June 15, 2022",Local,India,IND,Bihar,"Patna
","January 20, 2021","February 20, 2021",Persons living in slums,Adults (18-64 years),645,31.50%,27.90%,35.10%,Simplified probability,Siemens,CLIA,IgG,100.00%,99.80%,Low,Journal Article (Peer-Reviewed),Santosh K. Nirala,All India Institute of Medical Science,https://dx.doi.org/10.4103/jfmpc.jfmpc_2127_21,9/27/2022,4/1/2024,Unverified
2022_Srinagar_GovernmentMedicalCollegeSrinagar_PopAdj_Overall,"June 30, 2022",Local,India,IND,Jammu and Kashmir,,"September 3, 2020","January 21, 2021",Multiple populations,Multiple groups,2107,52.00%,,,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Rafiya Kousar,Government Medical College Srinagar,https://dx.doi.org/10.4103/jfmpc.jfmpc_2012_21,9/28/2022,3/2/2024,Unverified
220630_Maharashtra_YashwantraoChavanMemorialHospital,"June 30, 2022",Local,India,IND,Maharashtra,Pimpri Chinchwad Municipal Corporation Area,"June 16, 2021","June 26, 2021",Household and community samples,Multiple groups,10082,81.40%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Mukesh Bawa,Yashwantrao Chavan Memorial Hospital,https://dx.doi.org/10.4103/jfmpc.jfmpc_1869_21,9/30/2022,4/1/2024,Verified
220526_EasternIndia_ApolloGleneaglesHospitals_Adj,"May 26, 2022",Local,India,IND,West Bengal,Kolkata,"June 1, 2020","July 31, 2020",Blood donors,Adults (18-64 years),611,4.10%,3.40%,4.70%,Self-referral,Ortho Clinical Diagnostics Inc.,CLIA,IgG,90.00%,99.00%,High,Journal Article (Peer-Reviewed),Sudipta Sekhar Das,Apollo Gleneagles Hospitals,https://dx.doi.org/10.4103/ajts.ajts_123_20,10/12/2022,8/15/2023,Unverified
221006_Kashmir_GovernmentMedicalCollegeSrinagar_ImpOverall,"October 6, 2022",Regional,India,IND,Kashmir,,"July 5, 2021","July 15, 2021",Household and community samples,Multiple groups,4169,9.04%,,,Stratified probability,"Abbott Laboratories,NA",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Kouser Sideeq Lone,Government Medical College Srinagar,https://dx.doi.org/10.3389/fpubh.2022.967447,11/2/2022,3/2/2024,Unverified
220901_Srinagar_ChestDiseaseGovernmentHospitalSrinagar_Patients,"September 1, 2022",Local,India,IND,Kashmir,Srinagar,"September 15, 2020","September 15, 2021",Residual sera,Multiple groups,1645,52.10%,,,Convenience,NA,CLIA,Not reported,88.48%,100.00%,High,Journal Article (Peer-Reviewed),Aaliya Azad,"Chest Disease Government Hospital, Srinagar",https://dx.doi.org/10.7860/JCDR/2022/56230.16910,11/17/2022,11/18/2022,Unverified
221109_Jharkhand_ICMRRegionalMedicalResearchCentre_round2_overall,"November 9, 2022",Regional,India,IND,Jharkhand,,"February 1, 2021","February 28, 2021",Household and community samples,Multiple groups,3855,41.96%,40.16%,43.22%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Amarendra Mahapatra,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.4103/ijmr.ijmr_3040_21,11/18/2022,3/2/2024,Unverified
221109_Jharkhand_ICMRRegionalMedicalResearchCentre_round1_overall,"November 9, 2022",Regional,India,IND,Jharkhand,,"June 1, 2020","June 30, 2020",Household and community samples,Multiple groups,4761,0.54%,0.36%,0.80%,Stratified probability,Roche Diagnostics,CLIA,IgG,100.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Amarendra Mahapatra,ICMR-Regional Medical Research Centre,https://dx.doi.org/10.4103/ijmr.ijmr_3040_21,11/18/2022,3/2/2024,Unverified
221109_Odisha_ICMRRegionalMedicalResearchCentre_Primary,"November 9, 2022",Regional,India,IND,Odisha,,"August 30, 2021","September 16, 2021",Household and community samples,Multiple groups,2855,72.80%,70.10%,75.30%,Stratified probability,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Jaya Singh Kshatri,ICMR Regional Medical Research Centre,https://dx.doi.org/10.4103/ijmr.ijmr_3428_21,11/18/2022,11/18/2022,Unverified
221109_India_CouncilOfScientificAndIndustrialResearch_202008_TestAdjusted,"November 9, 2022",Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,"August 1, 2020","August 31, 2020",Household and community samples,Multiple groups,724,10.61%,8.37%,12.85%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Journal Article (Peer-Reviewed),Romi Wahengbam,Council of Scientific and Industrial Research,https://dx.doi.org/10.1016/j.ijmmb.2022.10.011,11/23/2022,3/2/2024,Unverified
221109_India_CouncilOfScientificAndIndustrialResearch_202102_TestAdjusted,"November 9, 2022",Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,"February 1, 2021","February 28, 2021",Household and community samples,Multiple groups,866,40.21%,36.95%,43.48%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Journal Article (Peer-Reviewed),Romi Wahengbam,Council of Scientific and Industrial Research,https://dx.doi.org/10.1016/j.ijmmb.2022.10.011,11/23/2022,3/2/2024,Unverified
221109_India_CouncilOfScientificAndIndustrialResearch_202106_TestAdjusted,"November 9, 2022",Regional,India,IND," Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim",,"June 1, 2021","June 30, 2021",Household and community samples,Multiple groups,436,46.23%,41.55%,50.91%,Unclear,Roche Diagnostics,Not reported,IgG,99.80%,100.00%,Unclear,Journal Article (Peer-Reviewed),Romi Wahengbam,Council of Scientific and Industrial Research,https://dx.doi.org/10.1016/j.ijmmb.2022.10.011,11/23/2022,3/2/2024,Unverified
221111_Ernakulam_AmritaInstituteOfMedicalSciences_Overall,"November 11, 2022",Local,India,IND,Kerala,Ernakulam,"September 15, 2021","November 15, 2021",Household and community samples,Children and Youth (0-17 years),349,47.80%,,,Unclear,Beijing Wantai Biological,LFIA,"IgG,IgM",100.00%,98.80%,High,Journal Article (Peer-Reviewed),Saanu Sidharthan,Amrita Institute of Medical Sciences,https://dx.doi.org/10.4103/ijph.ijph_1082_22,12/8/2022,3/2/2024,Unverified
221014_Kerala_GovernmentMedicalCollege,"October 14, 2022",Local,India,IND,Kerala,Thiruvananthapuram,"August 15, 2021","October 15, 2021",Household and community samples,Children and Youth (0-17 years),204,41.70%,34.90%,48.43%,Convenience,Beijing Wantai Biological,,,,,,Journal Article (Peer-Reviewed),Mini S.,Government Medical College,https://dx.doi.org/10.4103/jfmpc.jfmpc_2465_21,12/23/2022,3/2/2024,Unverified
221212_USA_RTIInternational_Belagavi,"December 12, 2022",Local,India,IND,,Belagavi,"December 1, 2020","December 31, 2020",Pregnant or parturient women,Adults (18-64 years),1639,39.10%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221212_USA_RTIInternational_Nagpur,"December 12, 2022",Local,India,IND,,Nagpur,"November 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),882,44.80%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221226_Delhi_AllIndiaInstituteofMedicalSciences_Wantai,"December 7, 2022",Regional,India,IND,Delhi,,"March 15, 2021","September 15, 2021",Household and community samples,Multiple groups,3491,78.10%,,,Stratified non-probability,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Puneet Misra,All India Institute of Medical Sciences,https://dx.doi.org/10.1186/s12879-022-07805-5,12/27/2022,4/19/2024,Verified
221031_Ranchi_RajendraInstituteofMedicalSciences,"October 31, 2022",Local,India,IND,Jharkhand,Ranchi,"February 6, 2021","April 20, 2021",Blood donors,Adults (18-64 years),5140,67.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.80%,99.50%,Moderate,Journal Article (Peer-Reviewed),Sushma Kumari,Rajendra Institute of Medical Sciences,https://dx.doi.org/10.4103/jfmpc.jfmpc_727_22,1/20/2023,3/25/2024,Verified
230120_NewDelhi_HamdardInstituteOfMedicalSciencesAndResearch_Followup_Overall,"January 20, 2023",Local,India,IND,,New Delhi,"January 12, 2021","June 15, 2021",Health care workers and caregivers,Adults (18-64 years),139,77.70%,,,Convenience,Beijing Wantai Biological,,,,,,Journal Article (Peer-Reviewed),Mridu Dudeja,Hamdard Institute of Medical Sciences and Research,https://dx.doi.org/10.1371/journal.pone.0265290,2/10/2023,3/2/2024,Unverified
230103_Gurugram_MedantaTheMedicity_Overall,"January 3, 2023",Local,India,IND,Haryana,Gurugram,"January 12, 2021","February 13, 2021",Health care workers and caregivers,Adults (18-64 years),3258,46.20%,44.40%,47.90%,Convenience,DiaSorin,,,,,,Journal Article (Peer-Reviewed),Sushila Kataria,Medanta–The Medicity,https://dx.doi.org/10.25259/NMJI_345_21,2/17/2023,3/2/2024,Unverified
221107_Bangalore_BangaloreBaptistHospital,"November 7, 2022",Local,India,IND,Karnataka,,"June 14, 2021","July 13, 2021",Household and community samples,Multiple groups,412,45.90%,41.00%,50.80%,Stratified probability,Roche Diagnostics,Not reported,Total Antibody,,,,Journal Article (Peer-Reviewed),Carolin Elizabeth George,Bangalore Baptist Hospital,https://dx.doi.org/10.3389/fped.2022.997684,3/10/2023,3/22/2023,Unverified
230101_HimachalPradesh_IGCM_Primary,"January 1, 2023",Local,India,IND,Himachal Pradesh,Shimla,"October 15, 2021","March 15, 2022",Residual sera,Children and Youth (0-17 years),500,18.60%,,,Convenience,Diagnostic Bioprobes,Not reported,"IgG,IgM",98.00%,98.00%,High,Journal Article (Peer-Reviewed),Pancham Kumar,Dr. Rajendra Prasad Government Medical College,https://dx.doi.org/10.7860/JCDR/2023/59945.17429,3/10/2023,3/27/2024,Verified
230204_India_AllIndiaInstituteofMedicalSciences,"February 4, 2023",Local,India,IND,,,"July 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),235,32.00%,,,Convenience,Siemens,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Bhaskar Kante,All India Institute of Medical Sciences,https://dx.doi.org/10.1007/s12664-022-01310-y,3/10/2023,3/2/2024,Unverified
221119_TamilNadu_PanimalarMedicalCollegeHospital,"November 19, 2022",Local,India,IND,Tamil Nadu,,"January 15, 2021","April 15, 2021",Health care workers and caregivers,Adults (18-64 years),157,38.20%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Divyaa Elangovan,Panimalar Medical College Hospital & Research Institute,https://dx.doi.org/10.3390/vaccines10111967,4/4/2023,3/2/2024,Unverified
230321_Hyderabad_NationalInstituteOfNutrition,"March 21, 2023",Local,India,IND,Telangana,Hyderabad,"August 15, 2021","November 15, 2021",Pregnant or parturient women,Adults (18-64 years),212,57.55%,,,Sequential,Zydus Diagnostics,ELISA,IgG,,,,Journal Article (Peer-Reviewed),M. V. Surekha,National Institute of Nutrition,https://dx.doi.org/10.3389/fendo.2023.1092104,5/6/2023,3/2/2024,Unverified
230421_Chennai_JohnsHopkinsBloombergSchoolofPublicHealth_AntiS_TestAdj_Overall,"April 21, 2023",Local,India,IND,Tamil Nadu,Chennai,"January 9, 2021","May 13, 2021",Household and community samples,Multiple groups,4629,65.70%,62.20%,70.60%,Stratified probability,Abbott Laboratories,CLIA,IgG,95.60%,99.00%,Moderate,Journal Article (Peer-Reviewed),Matt Hitchings,Johns Hopkins Bloomberg School of Public Health,https://dx.doi.org/10.1093/aje/kwad103,5/25/2023,4/23/2024,Verified
230423_WesternMaharashtra_KEMHospitalResearchCentre,"April 23, 2023",Regional,India,IND,Western Maharashtra,,"January 15, 2021","June 15, 2021",Household and community samples,Multiple groups,14274,45.00%,,,Stratified probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Dhiraj Agarwal,KEM Hospital Research Centre,https://dx.doi.org/10.7189/jogh.13.06011,6/3/2023,6/3/2023,Unverified
220630_Kerala_BelieversChurchMedicalCollege,"June 30, 2022",Local,India,IND,Kerala,Kottayam,"December 15, 2020","June 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,100,11.00%,4.80%,17.10%,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,IgG,100.00%,100.00%,,Journal Article (Peer-Reviewed),George Geomcy,Believers Church Medical College,https://journals.lww.com/crst/Fulltext/2022/05020/A_cross_sectional_study_on_the_seroprevalence_of.4.aspx,6/27/2023,3/2/2024,Unverified
230524_Kerala_JubileeMissionMedicalCollegeandResearchInstitute,"May 24, 2023",Local,India,IND,Kerala,,"March 15, 2021","July 15, 2021",Blood donors,Adults (18-64 years),300,15.30%,,,Sequential,"Beckman Coulter,Beckman coulter",CLIA,"IgG,IgM",,,,Preprint,Sherin John,Jubilee Mission Medical College and Research Institute,https://doi.org/10.22541/au.168493759.96200562/v1,6/29/2023,3/2/2024,Unverified
230323_ Itanagar_TomoRibaInstituteofHealthandMedicalSciences,"March 24, 2023",Local,India,IND,Arunachal Pradesh,Itanagar,"September 15, 2021","November 15, 2021",Household and community samples,Multiple groups,1031,92.24%,,,Stratified probability,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",94.00%,98.70%,Moderate,Journal Article (Peer-Reviewed),Hage Nobin,Tomo Riba Institute of Health and Medical Sciences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231152/,6/30/2023,4/23/2024,Verified
230619_India_AllIndiaInstituteofMedicalSciences_Round1_Overall,"June 19, 2023",National,India,IND,"state of Delhi, Odisha, Uttar Pradesh, Pondicherry, and Tripura",,"March 3, 2021","August 18, 2021",Household and community samples,Multiple groups,10110,73.90%,73.10%,74.80%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Preprint,Puneet Misra,All India Institute of Medical Sciences,10.1101/2023.06.15.23291475,7/29/2023,5/1/2024,Verified
230619_India_AllIndiaInstituteofMedicalSciences_Round2_Overall,"June 19, 2023",National,India,IND,"state of Delhi, Odisha, Uttar Pradesh, Pondicherry, and Tripura",,"May 27, 2021","December 10, 2021",Household and community samples,Multiple groups,6503,90.70%,89.90%,91.40%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Preprint,Puneet Misra,All India Institute of Medical Sciences,10.1101/2023.06.15.23291475,7/29/2023,5/1/2024,Verified
230619_India_AllIndiaInstituteofMedicalSciences_Round3_Overall,"June 19, 2023",National,India,IND,"state of Delhi, Odisha, Uttar Pradesh, Pondicherry, and Tripura",,"August 26, 2021","January 14, 2021",Household and community samples,Multiple groups,5564,92.90%,92.20%,93.60%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Preprint,Puneet Misra,All India Institute of Medical Sciences,10.1101/2023.06.15.23291475,7/29/2023,5/1/2024,Verified
230624_India_MountSinai,"June 24, 2023",National,India,IND,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,219,63.01%,,,Convenience,Roche Diagnostics,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230720_India_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,India,IND,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),3007,48.70%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
230515_India_LakshmiHospital_Overall,"May 15, 2023",Local,India,IND,Kerala,Palakkad,"November 15, 2020","July 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,177,20.30%,,,Sequential,NA,CLIA,"IgG,IgM",100.00%,99.81%,,Journal Article (Peer-Reviewed),Jayagopal Pallakshmi,Lakshmi Hospital,https://dx.doi.org/10.4103/jicc.jicc_40_22,8/23/2023,8/26/2023,Unverified
230911_Malegaon_ MaharashtraUniversityofHealthSciences,"September 11, 2023",Local,India,IND,Maharashtra,Malegaon,"January 12, 2022","January 18, 2022",Household and community samples,Multiple groups,2454,93.93%,,,Stratified probability,J. Mitra & Co. Pvt. Ltd,ELISA,"IgG,Neutralizing ",,,,Journal Article (Peer-Reviewed),Prashant Shivgunde,Maharashtra University of Health Sciences,https://dx.doi.org/10.1007/s12088-023-01096-3,10/5/2023,4/22/2024,Verified
200901_Iceland_deCODEGenetics_OverallPopAdj,"September 1, 2020",National,Iceland,ISL,,,"April 27, 2020","June 12, 2020",Household and community samples,Multiple groups,23452,0.30%,,,Convenience,"Roche Diagnostics,Beijing Wantai Biological",CLIA,"IgG,IgM,IgA",91.10%,,Moderate,Journal Article (Peer-Reviewed),Daniel Gudbjartsson,deCODE Genetics,http://dx.doi.org/10.1056/NEJMoa2026116,10/14/2020,3/2/2024,Verified
200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,"July 17, 2020",National,Hungary,HUN,,,"May 1, 2020","May 16, 2020",Household and community samples,Multiple groups,10474,0.68%,0.50%,0.86%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Bela Merkely,Semmelweis University,https://dx.doi.org/10.1007/s11357-020-00226-9,8/2/2020,3/2/2024,Verified
211215_Budapest_SemmelweisUniversity_Physicians,"December 15, 2021",Local,Hungary,HUN,Central Hungary,Budapest,"July 1, 2020","August 1, 2020",Health care workers and caregivers,Adults (18-64 years),1552,1.50%,0.90%,2.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,1/12/2022,3/2/2024,Unverified
211215_Budapest_SemmelweisUniversity_OtherHCW,"December 15, 2021",Local,Hungary,HUN,Central Hungary,Budapest,"July 1, 2020","August 1, 2020",Health care workers and caregivers,Adults (18-64 years),2926,1.80%,1.40%,2.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,1/12/2022,3/2/2024,Unverified
211215_Budapest_SemmelweisUniversity_IntStudents,"December 15, 2021",Local,Hungary,HUN,Central Hungary,Budapest,"July 1, 2020","August 1, 2020",Students and Daycares,Adults (18-64 years),1832,2.10%,1.40%,2.70%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,1/12/2022,3/2/2024,Unverified
211215_Budapest_SemmelweisUniversity_HungarianIntProgram,"December 15, 2021",Local,Hungary,HUN,Central Hungary,Budapest,"July 1, 2020","August 1, 2020",Students and Daycares,Adults (18-64 years),682,1.60%,0.70%,2.60%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,1/12/2022,3/2/2024,Unverified
211215_Budapest_SemmelweisUniversity_HungarianProgram,"December 15, 2021",Local,Hungary,HUN,Central Hungary,Budapest,"July 1, 2020","August 1, 2020",Students and Daycares,Adults (18-64 years),956,0.60%,0.00%,1.10%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Annamaria Kosztin,Semmelweis University,https://dx.doi.org/10.13075/ijomeh.1896.01804,1/12/2022,3/2/2024,Unverified
230329_Budapest_UniversityOfVeterinaryMedicineBudapest_1MultiplePop,"March 29, 2023",Local,Hungary,HUN,,Budapest,"April 15, 2020","March 15, 2021",Multiple populations,Multiple groups,3771,12.90%,11.89%,14.05%,Convenience,"Palex,NA",ELISA,IgG,,,,Journal Article (Peer-Reviewed),Istvan Jankovics,University of Veterinary Medicine Budapest,https://dx.doi.org/10.3390/tropicalmed8040204,5/31/2023,3/2/2024,Unverified
230329_Budapest_UniversityOfVeterinaryMedicineBudapest_2CovidContacts,"March 29, 2023",Local,Hungary,HUN,,Budapest,"April 15, 2020","March 15, 2021",Contacts of COVID patients,Multiple groups,571,10.60%,8.27%,13.51%,Convenience,"Palex,NA",ELISA,IgG,,,,Journal Article (Peer-Reviewed),Istvan Jankovics,University of Veterinary Medicine Budapest,https://dx.doi.org/10.3390/tropicalmed8040204,5/31/2023,3/2/2024,Unverified
201217_Honduras_ColegioMédico_OverallGenpop,"December 17, 2020",National,Honduras,HND,,,"June 16, 2020","June 23, 2020",Household and community samples,Multiple groups,792,6.20%,,,Stratified probability,NA,LFIA,"IgG,IgM",93.40%,97.70%,Moderate,Journal Article (Peer-Reviewed),Mario Rene Mejia Nunez ,Colegio Médico,https://revistas.ucr.ac.cr/index.php/psm/article/view/43261/46175,4/17/2021,7/17/2022,Verified
210203_VaticanCity_UniversitàCattolicadelSacroCuore_Overall,"February 3, 2021",National,Holy See,VAT,Vatican City State,Vatican City,"June 8, 2020","January 4, 2021",Household and community samples,Multiple groups,1539,4.35%,,,Convenience,Siemens,CLIA,Total Antibody,97.48%,99.80%,Moderate,Journal Article (Peer-Reviewed),Massimo Ralli,Università Cattolica del Sacro Cuore,https://dx.doi.org/10.1016/j.ejim.2021.01.029,3/24/2021,3/2/2024,Verified
220825_Haiti_UniversityOfFlorida_Overall,"August 25, 2022",Local,Haiti,HTI,Port-au-Prince Arrondissement,,"February 15, 2019","March 15, 2021",Residual sera,Children and Youth (0-17 years),257,16.70%,12.70%,21.80%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Rigan Louis,University of Florida,https://dx.doi.org/10.1371/journal.pone.0273482,8/31/2022,9/1/2022,Unverified
220804_Haiti_LomaLindaUniversity_male_testadj,"August 4, 2022",Local,Haiti,HTI,,Port-au-Prince,"December 17, 2020","July 3, 2021",Residual sera,Multiple groups,218,28.90%,23.10%,35.60%,Convenience,BioSys Laboratories,LFIA,"IgG,IgM",93.50%,100.00%,High,Journal Article (Peer-Reviewed),Robert Price ,Loma Linda University School of Medicine,https://dx.doi.org/10.7759/cureus.27690,9/17/2022,4/3/2024,Verified
211203_Bissau_UniversityofSouthernDenmark,"December 3, 2021",Local,Guinea-Bissau,GNB,,Bissau,"November 9, 2020","November 24, 2020",Health care workers and caregivers,Multiple groups,140,18.00%,,,Convenience,"CTK Biotech, Inc.",LFIA,IgG,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Christine Benn,University of Southern Denmark,https://dx.doi.org/10.1016/j.puhe.2021.11.013,1/19/2022,3/2/2024,Unverified
220601_Bissau_IndepthNetwork_Overall,"June 1, 2022",Local,Guinea-Bissau,GNB,,Bissau,"June 1, 2021","October 1, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,293,43.00%,,,Stratified non-probability,Hanghzhou AllTest Biotech Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),A. Dutschke,Indepth Network,https://dx.doi.org/10.1016/j.puhe.2022.05.017,7/13/2022,3/2/2024,Unverified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey1_Overall,"March 23, 2022",Local,Guinea,GIN,,Conakry,"December 2, 2020","December 26, 2020",Household and community samples,Multiple groups,535,17.30%,12.40%,23.80%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,5/13/2022,3/2/2024,Verified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey2_Overall,"March 23, 2022",Local,Guinea,GIN,,Conakry,"December 2, 2020","December 26, 2020",Household and community samples,Multiple groups,1195,28.90%,25.60%,32.40%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,5/13/2022,3/2/2024,Verified
220322_Conakry_UniversiteGamalAbdelNasserdeConakry_Survey3_Overall,"March 23, 2022",Local,Guinea,GIN,,Conakry,"December 2, 2020","December 26, 2020",Household and community samples,Multiple groups,1073,42.40%,39.50%,45.30%,Stratified non-probability,Luminex Corporation,Luminex,IgG,,99.70%,Moderate,Journal Article (Peer-Reviewed),Abou Soumah,Université Gamal Abdel Nasser de Conakry ,https://dx.doi.org/10.1093/ofid/ofac152,5/13/2022,3/2/2024,Verified
230420_Conakry_CentralHospitalofYaounde_PopAdj,"April 20, 2023",Local,Guinea,GIN,,Conakry,"May 15, 2022","June 15, 2022",Household and community samples,Multiple groups,1386,71.57%,67.48%,75.33%,Simplified probability,Luminex Corporation,Luminex,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mamadou Diallo,Central Hospital of Yaounde,https://dx.doi.org/10.1093/ofid/ofad216,6/3/2023,4/28/2024,Verified
211102_Guatemala_UnidadNacionaldeOftalmología_HCW,"November 2, 2021",Local,Guatemala,GTM,,Guatemala City,"November 25, 2020","November 25, 2020",Health care workers and caregivers,Adults (18-64 years),94,18.00%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",100.00%,99.81%,High,Journal Article (Peer-Reviewed),Pamela Davila Siliezar,Unidad Nacional de Oftalmología,https://dx.doi.org/10.1080/07853890.2021.1993325,11/10/2021,3/2/2024,Unverified
220224_Guatemala_ColoradoSchoolofPublicHealth_Overall,"February 24, 2022",National,Guatemala,GTM,,,"August 15, 2021","November 15, 2021",Essential non-healthcare workers,Adults (18-64 years),4343,29.40%,,,Convenience,SD Biosensor,LFIA,"IgG,IgM",,,High,Preprint,Diva Calvimontes,Colorado School of Public Health,10.1101/2022.02.22.22270907,3/2/2022,3/2/2024,Unverified
220721_Guatemala_CentersforDiseaseControlandPrevention_Overall,"July 21, 2022",Regional,Guatemala,GTM,"The southwestern
coastal lowlands",,"June 15, 2020","December 15, 2020",Essential non-healthcare workers,Adults (18-64 years),1334,46.20%,,,Convenience,Roche Diagnostics,CLIA,IgG,95.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Chelsea Iwamoto,Colorado School of Public Health,https://dx.doi.org/10.3390/vaccines10071160,8/4/2022,3/2/2024,Unverified
221212_USA_RTIInternational_Guatemala,"December 12, 2022",National,Guatemala,GTM,,,"November 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),2011,17.20%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
230720_Guatemala_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Guatemala,GTM,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2358,23.00%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
210929_PointAPitre_UniversityHospitalofGuadeloupe,"September 29, 2021",Local,Guadeloupe,GLP,Pointe-à-Pitre,Pointe-à-Pitre,"July 1, 2020","October 28, 2020",Health care workers and caregivers,Adults (18-64 years),892,5.00%,3.60%,6.50%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Vincenzo Palmeri, University Hospital of Guadeloupe,https://pubmed.ncbi.nlm.nih.gov/34625780/,10/20/2021,3/2/2024,Unverified
200806_Greece_UniversityofThessaly_Overall,"August 6, 2020",National,Greece,GRC,"Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus",,"March 1, 2020","April 30, 2020",Residual sera,Multiple groups,6586,0.36%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369,10/3/2020,3/2/2024,Verified
200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj,"September 21, 2020",Local,Greece,GRC,,Athens,"June 15, 2020","July 15, 2020",Non-essential workers and unemployed persons,Multiple groups,2500,0.93%,0.27%,2.09%,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Ourania Tsitsilonis ,National and Kapodistrian University of Athens,https://dx.doi.org/10.3390/life10090214,11/10/2020,8/15/2023,Verified
201027_Athens_NationalandKapodistrianUniversityofAthens_Overall,"October 27, 2020",Local,Greece,GRC,Attica,Athens,"April 25, 2020","May 10, 2020",Health care workers and caregivers,Adults (18-64 years),321,2.18%,,,Unclear,EUROIMMUN,ELISA,IgG,93.00%,100.00%,High,Journal Article (Peer-Reviewed),Panayiotis Vlachoyiannopoulosa,National and Kapodistrian University of Athens/Laiko University Hospital,http://dx.doi.org/10.1016/j.clim.2020.108619,1/12/2021,3/2/2024,Verified
201203_Athens_UniversityOfAthens_Overall_BothAdj,"December 3, 2020",Local,Greece,GRC,Attica,Athens,"April 13, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1495,1.26%,0.43%,3.26%,Convenience,GenBody Inc.,LFIA,"IgG,IgM",74.10%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mina Psichogiou,University of Athens,https://dx.doi.org/10.1371/journal.pone.0243025,2/8/2021,8/15/2023,Verified
210107_Greece_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Greece,GRC,NR,NR,"June 19, 2020","July 16, 2020",Health care workers and caregivers,Adults (18-64 years),77,1.30%,0.23%,7.00%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
210302_Athens_NationalandKapodistrianUniversityofAthens_PopTestAdj,"March 2, 2021",Local,Greece,GRC,Attica,Athens,"June 15, 2020","November 15, 2020",Multiple populations,Multiple groups,4996,1.60%,0.92%,2.54%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",100.00%,99.81%,Low,Journal Article (Peer-Reviewed),Ourania Tsitsilonis,National and Kapodistrian University of Athens,http://dx.doi.org/10.3390/vaccines9030207,5/15/2021,8/15/2023,Verified
210513_Greece_UniversityThessaly_TestPopAdj,"May 13, 2021",National,Greece,GRC,,,"May 1, 2020","August 31, 2020",Household and community samples,Multiple groups,20110,0.19%,0.08%,0.30%,Stratified probability,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Zacharoula Bogogiannidou,University of Thessaly,https://dx.doi.org/10.3390/vaccines9050504,6/8/2021,8/15/2023,Unverified
210430_AghiaSophiaChildrensHospital_Athens_HCW,"July 5, 2021",Local,Greece,GRC,Atica,Athens,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),1216,0.66%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Elizabeth‑Barbara Tatsi,"The ""Aghia Sophia"" Children's Hospital ",https://dx.doi.org/10.1007/s15010-021-01653-2,7/13/2021,3/2/2024,Verified
210731_Greece_NationalandKapodistrianUniversityofAthens_Primary,"July 31, 2021",National,Greece,GRC,,,"June 1, 2020","July 9, 2020",Health care workers and caregivers,Adults (18-64 years),57418,0.66%,,,Self-referral,Abbott Laboratories,Other,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Petros Galanis,National and Kapodistrian University of Athens,https://dx.doi.org/10.1016/j.puhe.2021.07.029,9/13/2021,8/15/2023,Unverified
211101_Thrace_UniversityGeneralHospitalOfAlexandroupolis_Primary,"November 1, 2021",Regional,Greece,GRC,Thrace,,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),1036,0.58%,,,Self-referral,"Epitope Diagnostics, Inc.,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Theocharis Konstantinidis,University General Hospital of Alexandroupolis,http://dx.doi.org/10.18683/germs.2021.1274,11/2/2021,3/2/2024,Unverified
211123_Athens_UniversityofAthens_March_Overall,"November 23, 2021",Local,Greece,GRC,Attica,Athens,"March 1, 2021","March 22, 2021",Residual sera,Multiple groups,764,11.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helena Maltezou,University of Athens,https://dx.doi.org/10.1002/jmv.27465,12/2/2021,3/2/2024,Verified
211123_Athens_UniversityofAthens_June_Overall,"November 23, 2021",Local,Greece,GRC,Attica,Athens,"June 1, 2021","June 22, 2021",Residual sera,Multiple groups,901,55.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Helena Maltezou,University of Athens,https://dx.doi.org/10.1002/jmv.27465,12/2/2021,3/2/2024,Verified
211231_Deskati_UniversityofThessaly_Overall,"December 31, 2021",Local,Greece,GRC,West Macedonia,Deskati ,"June 6, 2021","June 6, 2021",Household and community samples,Multiple groups,69,79.71%,,,Convenience,Abbott Laboratories,ELISA,IgG,99.90%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19010407,1/9/2022,3/2/2024,Verified
220121_Athens_NationalandKapodistrianUniversityofAthens_Overall,"January 21, 2022",Local,Greece,GRC,,Athens,"May 1, 2020","August 31, 2021",Residual sera,Children and Youth (0-17 years),3099,11.10%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Filippos Filippatos,National and Kapodistrian University of Athens,https://dx.doi.org/10.1002/jmv.27608,2/3/2022,7/17/2022,Unverified
220121_Athens_NationalandKapodistrianUniversityofAthens_1st_Overall,"January 21, 2022",Local,Greece,GRC,,Athens,"May 1, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),793,1.39%,,,Sequential,Roche Diagnostics,CLIA,"IgA,IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Filippos Filippatos,National and Kapodistrian University of Athens,https://dx.doi.org/10.1002/jmv.27608,2/19/2022,7/17/2022,Unverified
220125_Greece_UniversityofThessaly_Overall,"January 25, 2022",National,Greece,GRC,,,"March 1, 2020","December 31, 2020",Residual sera,Multiple groups,55947,1.26%,,,Stratified probability,Abbott Laboratories,CLIA,IgG,84.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Michalis Koureas,University of Thessaly,https://www.mdpi.com/2075-4418/12/2/295,5/28/2022,3/2/2024,Verified
220517_Greece_UniversityofThessaly_Malesina_Overall,"May 17, 2022",Local,Greece,GRC,Phthiotis,Malesina,"June 14, 2021","June 16, 2021",Household and community samples,Multiple groups,525,77.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19106110,6/3/2022,3/2/2024,Unverified
220517_Greece_UniversityofThessaly_Domokos_Overall,"May 17, 2022",Local,Greece,GRC,Phthiotis,Dokomos,"July 9, 2021","July 9, 2021",Household and community samples,Multiple groups,151,77.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Journal Article (Peer-Reviewed),Ourania Kotsiou,University of Thessaly,https://dx.doi.org/10.3390/ijerph19106110,6/3/2022,3/2/2024,Unverified
221019_Athens_NationalandKapodistrianUniversityofAthens_Overall,"October 19, 2022",Local,Greece,GRC,,Athens,"September 1, 2021","April 30, 2022",Blood donors,Children and Youth (0-17 years),1312,38.60%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Filippos Filippatos,Nationaland Kapodistrian University of Athens,https://dx.doi.org/10.1017/S0950268822001601,11/18/2022,3/2/2024,Unverified
221116_Greece_NationalandKapodistrianUniversityofAthens_Children,"November 16, 2022",National,Greece,GRC,,,"March 1, 2021","June 30, 2021",Residual sera,Children and Youth (0-17 years),427,13.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dimitra Dimopoulou,National and Kapodistrian University of Athens,https://dx.doi.org/10.1007/s00431-022-04681-8,11/30/2022,3/2/2024,Unverified
221116_Greece_NationalandKapodistrianUniversityofAthens_Parents,"November 16, 2022",National,Greece,GRC,,,"March 1, 2021","June 30, 2021",Residual sera,Adults (18-64 years),396,16.40%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dimitra Dimopoulou,National and Kapodistrian University of Athens,https://dx.doi.org/10.1007/s00431-022-04681-8,11/30/2022,3/2/2024,Unverified
210706_Ghana_UniversityOfGhana_Phase1_Overall,"July 6, 2021",National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region, Upper East Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","July 27, 2020","September 14, 2020",Multiple general populations,Multiple groups,1305,19.00%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/14/2021,3/2/2024,Unverified
210706_Ghana_UniversityOfGhana_Phase2_Overall,"July 6, 2021",National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","October 1, 2020","October 31, 2020",Multiple general populations,Multiple groups,395,15.20%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/14/2021,3/2/2024,Unverified
210706_Ghana_UniversityOfGhana_Phase3_Overall,"July 6, 2021",National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","December 1, 2020","December 31, 2020",Multiple general populations,Multiple groups,393,9.70%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/14/2021,3/2/2024,Unverified
210706_Ghana_UniversityOfGhana_Phase4_Overall,"July 6, 2021",National,Ghana,GHA,"Greater Acra Region, Central Region, Eastern Region","Accra, Kasoa, Cape Coast, Akropong, Navrongo, Bolgatanga","February 1, 2021","February 28, 2021",Multiple general populations,Multiple groups,636,22.80%,,,Convenience,Wuhan UNscience Biotechnology Co. Ltd,LFIA,"IgG,IgM",66.00%,94.00%,High,Journal Article (Peer-Reviewed),Peter Kojo Quashie,University of Ghana,https://wellcomeopenresearch.org/articles/6-173,7/14/2021,3/2/2024,Unverified
220905_Germany_BernhardNochtInsituteForTropicalMedicine_Ghana_Adj,"September 5, 2022",Local,Ghana,GHA,Ashanti,Kumasi,"February 17, 2021","May 10, 2021",Household and community samples,Multiple groups,340,41.20%,34.50%,49.00%,Stratified probability,NA,ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Nicole S. Struck,Bernhard Nocht Insitute for Tropical Medicine,https://dx.doi.org/10.1186/s12889-022-13918-y,9/13/2022,9/13/2022,Unverified
220919_Accra_NoguchiMemorialInstituteforMedicalResearch,"September 26, 2022",Local,Ghana,GHA,,Accra,"December 1, 2021","December 31, 2021",Household and community samples,Multiple groups,1027,86.80%,,,Stratified non-probability,Beijing Wantai Biological,ELISA,Total Antibody,,,High,Preprint,Irene Owusu Donkor,Noguchi Memorial Institute for Medical Research,10.20944/preprints202209.0390.v1,10/10/2022,4/15/2024,Verified
221017_Kumasi_CITIID_Primary,"October 17, 2022",Local,Ghana,GHA,,Kumasi,"March 3, 2021","March 11, 2021",Multiple populations,Adults (18-64 years),527,38.71%,,,Simplified probability,NA,Luminex,IgG,,,High,Journal Article (Peer-Reviewed),Adam Abdullahi,Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID),https://doi.org/10.1038/s41467-022-33792-x,10/25/2022,11/18/2022,Unverified
221214_Accra_UniversityOfGhana_November1,"December 14, 2022",Local,Ghana,GHA,,Accra,"November 1, 2020","November 30, 2020",Household and community samples,Multiple groups,1238,13.80%,11.90%,16.10%,Simplified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Benedicta Ayiedu Mensah,University of Ghana,https://dx.doi.org/10.1038/s41598-022-25598-0,1/13/2023,3/27/2024,Verified
221214_Accra_UniversityOfGhana_March2,"December 14, 2022",Local,Ghana,GHA,,Accra,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,1013,25.70%,22.40%,29.30%,Simplified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Benedicta Ayiedu Mensah,University of Ghana,https://dx.doi.org/10.1038/s41598-022-25598-0,1/13/2023,3/27/2024,Verified
221214_Accra_UniversityOfGhana_July3,"December 14, 2022",Local,Ghana,GHA,,Accra,"July 1, 2021","July 31, 2021",Household and community samples,Multiple groups,1346,39.60%,34.80%,44.60%,Simplified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Moderate,Journal Article (Peer-Reviewed),Benedicta Ayiedu Mensah,University of Ghana,https://dx.doi.org/10.1038/s41598-022-25598-0,1/13/2023,3/27/2024,Verified
230505_Ghana_UniversityofGhana_Overall_PopAdj,"May 5, 2023",National,Ghana,GHA,,,"February 15, 2021","December 15, 2021",Household and community samples,Multiple groups,5348,67.10%,65.64%,68.54%,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Irene Donkor,University of Ghana,https://dx.doi.org/10.1371/journal.pgph.0001851,6/3/2023,5/1/2024,Verified
200525_Frankfurt_Goethe-UniversityFrankfurt_Employees,"May 25, 2020",Local,Germany,DEU,Hesse,Frankfurt,"April 6, 2020","April 14, 2020",Essential non-healthcare workers,Adults (18-64 years),998,0.40%,0.16%,1.02%,Convenience,NA,ELISA,IgG,,99.20%,High,Preprint,Verena Kraehling, Goethe-University Frankfurt,https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1,5/27/2020,7/17/2022,Verified
200514_Saalfeld_Thuringia_IgG,"May 14, 2020",Local,Germany,DEU,Thuringia,Saalfeld,"April 16, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),18,0.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Igor Harsch,Thuringia Clinic,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf,6/19/2020,3/2/2024,Verified
200615_Germany_UniversityofHannover_hcw,"June 15, 2020",Local,Germany,DEU,Lower Saxony,Hannover,"April 20, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,385,2.86%,,,Convenience,EUROIMMUN,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Simone Schmidt,University of Hannover,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417,6/27/2020,3/2/2024,Verified
200717_Ilm-Kreis_JenaUniversityHospital_Overall,"July 17, 2020",Local,Germany,DEU,Thuringia,,"May 12, 2020","May 22, 2020",Household and community samples,Multiple groups,620,8.39%,,,Convenience,"Epitope Diagnostics, Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),DiaSorin,Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Preprint,Sebastian Weis ,Jena University Hospital,https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1,7/19/2020,3/2/2024,Verified
200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA,"June 22, 2020",Local,Germany,DEU,Mecklenburg-Westpomerania,Rostock,"April 20, 2020","April 22, 2020",Household and community samples,Adults (18-64 years),401,0.00%,,,Self-referral,"EUROIMMUN,NA",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Emil Reisinger ,Universitätsmedizin Rostock,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293,8/5/2020,3/2/2024,Verified
200807_Bavaria_UniversityHospitalMunich,"August 7, 2020",Regional,Germany,DEU,Bavaria,Dachau,"April 2, 2020","April 6, 2020",Health care workers and caregivers,Adults (18-64 years),151,2.60%,0.80%,7.10%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Korbinian Lackermair,University Hospital Munich,http://dx.doi.org/10.1093/fampra/cmaa078,9/25/2020,3/2/2024,Verified
200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG,"September 4, 2020",Local,Germany,DEU,Lower Saxony,Hannover,"March 23, 2020","April 17, 2020",Health care workers and caregivers,Adults (18-64 years),217,1.38%,,,Convenience,EUROIMMUN,ELISA,IgG,87.20%,99.30%,High,Journal Article (Peer-Reviewed),Georg Behrens, Hannover Medical School,https://link.springer.com/article/10.1007/s40121-020-00334-1,9/29/2020,3/2/2024,Verified
200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,"August 24, 2020",Local,Germany,DEU,Thuringia,Jena,"April 6, 2020","May 13, 2020",Pregnant or parturient women,Multiple groups,180,0.60%,0.00%,1.70%,Sequential,"Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Janine Zollkau,Universitätsklinikum Jena,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033,9/29/2020,3/2/2024,Verified
200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate,"July 16, 2020",Regional,Germany,DEU,"North Rhine-Westphalia, Lower Saxony, Hesse",,"March 9, 2020","June 3, 2020",Residual sera,Multiple groups,3186,0.91%,0.58%,1.24%,Sequential,"Abbott Laboratories,EUROIMMUN,DiaSorin",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bastian Fischer,Heart and Diabetes Center NRW,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,10/2/2020,3/2/2024,Verified
200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,"July 23, 2020",Local,Germany,DEU,Thuringia,Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),45,0.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/2/2020,3/2/2024,Verified
200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,"July 23, 2020",Local,Germany,DEU,Thuringia,Saalfeld,"June 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),20,5.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000353,10/2/2020,3/2/2024,Verified
200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,"June 29, 2020",Local,Germany,DEU,,Fulda,"April 9, 2020","April 16, 2020",Multiple populations,Multiple groups,1780,0.96%,0.56%,1.53%,Unclear,EUROIMMUN,ELISA,IgG,93.80%,99.00%,High,Journal Article (Peer-Reviewed),Peter Kern,Universitätsmedizin Marburg,http://dx.doi.org/10.1055/a-1198-1243,10/12/2020,3/2/2024,Verified
200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW,"September 29, 2020",Local,Germany,DEU,Brandenburg,Oberspreewald-Lausitz,"July 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),156,1.30%,,,Convenience,NA,CLIA,Total Antibody,99.50%,99.80%,High,Preprint,Stephanie Hoffmann,Brandenburg University of Technology Cottbus-Senftenberg,https://doi.org/10.21203/rs.3.rs-84703/v1,11/28/2020,7/17/2022,Verified
200806_Regensburg_UniversityofRegensburg_12Wks,"August 6, 2020",Local,Germany,DEU,Bavaria,Regensburg,"March 15, 2020","June 7, 2020",Health care workers and caregivers,Adults (18-64 years),139,0.00%,,,Convenience,"EUROIMMUN,Roche Diagnostics",ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Sara Malfertheiner,University of Regensburg,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf,12/3/2020,3/2/2024,Verified
200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall,"August 13, 2020",Regional,Germany,DEU,North Rhine-Westphalia,,"March 26, 2020","June 4, 2020",Residual sera,Multiple groups,415,1.20%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Herrmann,Internal medicine and laboratory medicine specialist practice and laboratory,http://dx.doi.org/10.1007/s15006-020-0750-y,1/6/2021,3/2/2024,Verified
201103_Germany_UniversityofWitten,"November 3, 2020",National,Germany,DEU,,,"June 15, 2020","September 1, 2020",Residual sera,Children and Youth (0-17 years),731,11.20%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,"IgG,IgA,IgM",,,High,Journal Article (Peer-Reviewed),Silke Schwarz,University of Witten,https://dx.doi.org/10.1007/s00112-020-01050-3,1/7/2021,3/2/2024,Verified
201023_Berlin_CharitéUniversity_primary,"October 23, 2020",Local,Germany,DEU,Berlin,Berlin,"March 19, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,223,7.10%,,,Unclear,EUROIMMUN,Multiple Types,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Mira Choi,Charité University,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690804/,1/14/2021,3/2/2024,Verified
201126_Germany_RobertKochInstitute_BloodDonors_TestAdj,"November 26, 2020",National,Germany,DEU,,,"April 15, 2020","November 5, 2020",Blood donors,Multiple groups,48976,1.35%,,,Simplified probability,NA,ELISA,IgG,,,Moderate,Institutional Report,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102,1/14/2021,7/17/2022,Verified
201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3,"November 30, 2020",Local,Germany,DEU,Hamburg,Hamburg,"June 22, 2020","July 17, 2020",Health care workers and caregivers,Adults (18-64 years),1253,1.80%,1.00%,2.50%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Thomas Brehm,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1016/j.ijheh.2020.113671,1/22/2021,3/2/2024,Verified
210103_Munich_LudwigMaximillianUniversityofMunich_Overall,"January 3, 2021",Local,Germany,DEU,,Munich,"March 24, 2020","July 7, 2020",Health care workers and caregivers,Adults (18-64 years),300,4.67%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Tobias Weinberger,Ludwig Maximillian University of Munich,https://dx.doi.org/10.1093/cid/ciaa1935,1/24/2021,3/2/2024,Verified
201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall,"November 19, 2020",Local,Germany,DEU,Thuringia,,"May 13, 2020","May 16, 2020",Household and community samples,Multiple groups,620,8.40%,,,Self-referral,"Epitope Diagnostics, Inc.,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),DiaSorin,Abbott Laboratories,EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Weis,Friedrich Schiller University,https://dx.doi.org/10.1016/j.cmi.2020.11.009,1/28/2021,3/2/2024,Verified
201203_Tirschenreuth_MunichClinic_HCW_Overall,"December 3, 2020",Local,Germany,DEU,Bavaria,"Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/28/2021,3/2/2024,Verified
201203_Tirschenreuth_MunichClinic_NMU_Overall,"December 3, 2020",Local,Germany,DEU,Bavaria,"Tirschenreuth, Wieden","June 29, 2020","July 29, 2020",Essential non-healthcare workers,Adults (18-64 years),986,3.70%,,,Convenience,Roche Diagnostics,Not reported,"IgM,IgG",99.50%,99.80%,High,Journal Article (Peer-Reviewed),T Finkenzeller,Munich Clinic,https://dx.doi.org/10.1007/s00063-020-00761-5,1/28/2021,3/2/2024,Verified
200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall,"October 16, 2020",Local,Germany,DEU,Schleswig-Holstein,Hamburg,"April 14, 2020","June 16, 2020",Health care workers and caregivers,Multiple groups,871,2.64%,,,Convenience,"Mikrogen GmbH,EUROIMMUN",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Jonas Herzberg,University Hospitals of the Ruhr‑University of Bochum,http://dx.doi.org/10.1016/j.ijid.2020.10.026,1/30/2021,3/2/2024,Verified
201204_Germany_SaarlandUniversity_overall,"December 4, 2020",National,Germany,DEU,,,"June 16, 2020","June 30, 2020",Non-essential workers and unemployed persons,Multiple groups,1007,2.09%,1.37%,3.17%,Self-referral,"EUROIMMUN,NA,Roche Diagnostics",Multiple Types,"IgG,Not reported",,,High,Journal Article (Peer-Reviewed),Dietrich Mack,Saarland University,https://dx.doi.org/10.1016/j.cmi.2020.11.033,1/31/2021,3/2/2024,Verified
201126_Kupferzell_RobertKochInstitute_OverallAdj,"November 26, 2020",Local,Germany,DEU,Baden-Württemberg,Kupferzell,"May 20, 2020","June 9, 2020",Household and community samples,Multiple groups,2203,12.00%,10.40%,14.00%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Claudia Santos Hovener,Robert Koch Institute,https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752,2/5/2021,7/5/2023,Verified
210102_Munich_MUCResearch,"January 2, 2021",Local,Germany,DEU,,Munich,"May 29, 2020","July 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),500,1.50%,0.70%,3.13%,Sequential,Mikrogen GmbH,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),S Noe,MUC Research,https://dx.doi.org/10.1007/s15010-020-01564-8,2/5/2021,7/5/2023,Unverified
201216_Germany_Ruhr-UniversityBochum_overall,"December 16, 2020",Local,Germany,DEU,,Bochum,"April 1, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,99,3.03%,,,Sequential,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Constantin J Thieme,Ruhr-University Bochum,https://dx.doi.org/10.1016/j.transproceed.2020.12.001,2/7/2021,3/2/2024,Verified
210129_Eschweiler_St.AntoniusHospitalEschweiler_IgG,"January 29, 2021",Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,"April 27, 2020","May 20, 2020",Health care workers and caregivers,Multiple groups,1212,3.30%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler,https://dx.doi.org/10.1055/a-1322-5355,2/14/2021,3/2/2024,Verified
210122_Germany_HeidelbergUniversity_Parents_Overall_unadj,"January 22, 2021",Regional,Germany,DEU,Baden-Württemberg,"Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",Household and community samples,Adults (18-64 years),2482,1.90%,,,Self-referral,"EUROIMMUN,Roche Diagnostics,NA",Multiple Types,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,3/2/2024,Verified
210122_Germany_HeidelbergUniversity_Children_Overall_unadj,"January 22, 2021",Regional,Germany,DEU,Baden-Württemberg,"Freiburg, Heidelberg, Tübingen, Ulm","April 22, 2020","May 15, 2020",Students and Daycares,Children and Youth (0-17 years),2482,0.90%,,,Self-referral,"EUROIMMUN,Roche Diagnostics,NA",Multiple Types,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Burkhard Tonshoff,Heidelberg University,https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,3/2/2024,Verified
210129_Berlin_UniversitätsmedizinBerlin_Students_Overall,"January 29, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Students and Daycares,Children and Youth (0-17 years),347,2.00%,0.80%,4.10%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,7/17/2022,Verified
210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall ,"January 29, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,7/17/2022,Verified
210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall,"January 29, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,NA,ELISA,IgG,,,Moderate,Preprint,Stefanie Theuring,Universitätsmedizin Berlin,https://www.medrxiv.org/content/10.1101/2021.01.27.21250517v1,2/22/2021,7/17/2022,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj,"February 3, 2021",Local,Germany,DEU,,Düsseldorf,"November 2, 2020","November 23, 2020",Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgA,IgM",90.00%,99.80%,Low,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/10/2021,7/5/2023,Verified
210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj,"February 3, 2021",Local,Germany,DEU,,Düsseldorf,"November 23, 2020","November 27, 2020",Essential non-healthcare workers,Adults (18-64 years),745,4.40%,3.10%,6.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",90.00%,99.80%,High,Institutional Report,Insa Backhaus,Institute Of Medical Sociology,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/10/2021,7/5/2023,Verified
200731_Bremen_UniversityOfBremen_IgG/IgA,"July 31, 2020",Local,Germany,DEU,,Bremen,"March 31, 2020","May 16, 2020",Multiple populations,Adults (18-64 years),281,2.13%,,,Unclear,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jan Neumann,University of Bremen,https://www.asu-arbeitsmedizin.com/node/153868/print,3/12/2021,3/2/2024,Verified
210219_Jena_JenaUniversityHospital_Overall,"February 19, 2021",Local,Germany,DEU,Thuringia,Jena,"May 19, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),660,2.70%,1.60%,4.30%,Convenience,"Epitope Diagnostics, Inc.,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christina Bahrs,Jena University Hospital,https://dx.doi.org/10.1111/tbed.14041,3/14/2021,3/2/2024,Verified
201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall,"October 1, 2020",Regional,Germany,DEU,Southwest,,"March 15, 2020","June 15, 2020",Blood donors,Multiple groups,3880,0.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Stefan Runkel,University Medical Center of The Johannes Gutenberg-University Mainz,https://pubmed.ncbi.nlm.nih.gov/33073955/,3/15/2021,3/2/2024,Verified
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall,"February 12, 2021",Regional,Germany,DEU,Bavaria,,"April 1, 2020","June 30, 2020",Pregnant or parturient women,Adults (18-64 years),1916,0.47%,,,Convenience,NA,Other,Total Antibody,97.30%,100.00%,High,Journal Article (Peer-Reviewed),Markus Hippich, German Research Center for Environmental Health,https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/19/2021,7/17/2022,Verified
201127_Germany_IfoInstitue_overall_PopAdj,"November 27, 2020",National,Germany,DEU,,,"October 26, 2020","November 18, 2020",Household and community samples,Multiple groups,9929,1.10%,0.92%,1.33%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,99.80%,Unclear,Institutional Report,Clemens Fuest,ifo Institute,https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona,3/22/2021,3/2/2024,Verified
201216_Heidelberg_UniversityHospitalHeidelberg_Overall,"December 16, 2020",Local,Germany,DEU,Baden-Württemberg,Heidelberg,"May 5, 2020","August 6, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,219,3.20%,,,Sequential,EUROIMMUN,ELISA,IgG,94.60%,99.80%,High,Journal Article (Peer-Reviewed),Conrad Rauber,University Hospital Heidelberg,https://www.sciencedirect.com/science/article/abs/pii/S0041134520329043?via%3Dihub,4/9/2021,3/2/2024,Verified
210203_HeinsbergDistrict_UniversityHospitalDusseldorf_NeutralizationAssay,"February 3, 2021",Local,Germany,DEU,,,"April 9, 2020","April 9, 2020",Contacts of COVID patients,Multiple groups,42,61.90%,,,Convenience,NA,Neutralization,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Lisa Muller,University Hospital Dusseldorf,https://dx.doi.org/10.1007/s10096-021-04169-7,4/10/2021,7/17/2022,Verified
210310_Bavaria_BrandenburgMedicalSchoolTheodorFontane,"March 10, 2021",Local,Germany,DEU,Bavaria,Wieden,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1838,15.10%,13.40%,16.70%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/16/2021,3/2/2024,Verified
210310_Brandenburg_BrandenburgMedicalSchoolTheodorFontane,"March 10, 2021",Local,Germany,DEU,Brandenburg,NR,"July 17, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),585,2.10%,1.20%,3.80%,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Thomas Finkenzeller,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.1055/a-1393-6668,4/16/2021,3/2/2024,Verified
210223_Regensberg_HospitalStHedwigOfTheOrderOfStJohn_IgG+,"February 23, 2021",Local,Germany,DEU,Bavaria,Regensberg,"April 9, 2020","April 30, 2020",Pregnant or parturient women,Adults (18-64 years),151,2.00%,,,Sequential,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sebastian Hausler,Hospital St Hedwig of the Order of St John,https://dx.doi.org/10.1515/jpm-2021-0001,4/19/2021,3/2/2024,Verified
210408_Germany_HeinrichHeineUniversityDuesseldorf_Physicians,"April 8, 2021",National,Germany,DEU,,,"June 16, 2020","July 2, 2020",Health care workers and caregivers,Adults (18-64 years),516,3.10%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Detlef Kindgen Milles,Heinrich-Heine University Duesseldorf,https://dx.doi.org/10.1371/journal.pone.0248813,4/24/2021,3/2/2024,Unverified
201211_BadFeilnbach_RobertKochInstitute_primary,"December 11, 2020",Local,Germany,DEU,,Bad Feilnbach,"June 23, 2020","July 4, 2020",Household and community samples,Multiple groups,2152,9.10%,,,Simplified probability,NA,Not reported,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Bad_Feilnbach.html,5/1/2021,7/17/2022,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_HCW,"March 31, 2021",Local,Germany,DEU,Schleswig-Holstein,,"April 14, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),268,0.75%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,5/3/2021,3/2/2024,Unverified
210302_Dresden_TechnischeUniversitätDresden,"March 2, 2021",Local,Germany,DEU,Saxony,Dresden,"June 15, 2020","January 15, 2021",Contacts of COVID patients,Multiple groups,248,34.27%,,,Sequential,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Preprint,Lukas Galow,Technische Universität Dresden,10.2139/ssrn.3790443,5/3/2021,3/2/2024,Unverified
210408_Germany_BundeswehrInstituteofMicrobiology_overall,"April 8, 2021",Local,Germany,DEU,,Offenburg,"April 2, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),198,3.50%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Katharina Muller,Bundeswehr Institute of Microbiology,http://dx.doi.org/10.3390/ijerph18083910,5/8/2021,3/2/2024,Verified
210427_Germany_HelmholtzCentreForInfectionResearch,"April 27, 2021",National,Germany,DEU,,,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,13405,2.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Daniela Gornyk,Helmholtz Centre for Infection Research,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3834300,5/11/2021,3/2/2024,Verified
210308_Berlin_UniversitatmedizinBerlin,"March 8, 2021",Local,Germany,DEU,,Berlin,"June 11, 2020","June 19, 2020",Multiple populations,Multiple groups,527,1.30%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Franziska Hommes,Universitatmedizin Berlin,http://dx.doi.org/10.3390/ijerph18052739,5/12/2021,3/2/2024,Unverified
210429_Munich_GermanResearchCenterForEnvironmentalHealth_overall_popadj_testadj,"April 29, 2021",Local,Germany,DEU,,Munich,"November 2, 2020","January 31, 2021",Household and community samples,Multiple groups,4433,3.60%,2.90%,4.30%,Simplified probability,Roche Diagnostics,CLIA,Not reported,99.20%,98.70%,Low,Preprint,Katja Radon,German Research Center for Environmental Health,https://www.medrxiv.org/content/10.1101/2021.04.27.21256133v1,5/15/2021,8/15/2023,Verified
210315_Thuringia_ThuringiaClinic_ICU_Overall,"March 15, 2021",Local,Germany,DEU,Thuringia,Saalfeld/Saale,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),50,0.00%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,5/15/2021,3/2/2024,Verified
210315_Thuringia_ThuringiaClinic_COVIDStaff_overall,"March 15, 2021",Local,Germany,DEU,Thuringia,Saalfeld/Saale,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),18,5.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,98.50%,High,Journal Article (Peer-Reviewed),Jorg Epstude,Thuringia Clinic,https://dx.doi.org/10.3205/dgkh000382,5/15/2021,3/2/2024,Verified
201215_Straubing_RobertKochInstitut_ELISA_poptestadj,"December 15, 2020",Local,Germany,DEU,Bavaria,Straubing,"September 8, 2020","September 26, 2020",Household and community samples,Multiple groups,2361,1.70%,,,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.40%,Moderate,News and Media,Robert Koch Institute,Robert Koch Institute,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Straubing.html,5/17/2021,8/15/2023,Verified
210220_Dresden_DresdenUniversityOfTechnology_December,"March 24, 2021",Local,Germany,DEU,Saxony,Dresden,"December 10, 2020","December 11, 2020",Students and Daycares,Multiple groups,237,6.80%,3.80%,10.10%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Jakob Armann,Dresden University of Technology ,http://dx.doi.org/10.1136/bmjpo-2021-001036,5/18/2021,3/2/2024,Unverified
210317_Bavaria_LudwigMaximiliansUniversityMunich_Overall,"March 17, 2021",Local,Germany,DEU,Bavaria,Wasserburg,"May 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),1342,8.80%,,,Convenience,NA,CLIA,Total Antibody,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),M Rentrop,Ludwig Maximilians University Munich,https://dx.doi.org/10.1007/s00115-021-01101-4,5/18/2021,7/17/2022,Verified
210217_Berlin-Mitte_RobertKochInstit_ELISA_testadj_popadj,"February 17, 2021",Local,Germany,DEU,Berlin,Berlin-Mitte,"November 17, 2020","December 5, 2020",Household and community samples,Multiple groups,2287,4.40%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,News and Media,Robert Koch Institut,Robert Koch Institut,https://www.rki.de/DE/Content/Gesundheitsmonitoring/Studien/cml-studie/Factsheet_Berlin-Mitte.html,5/18/2021,8/15/2023,Verified
210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_firstwave_primary,"April 2, 2021",Regional,Germany,DEU,Bavaria,,"January 15, 2020","August 15, 2020",Household and community samples,Children and Youth (0-17 years),15523,0.68%,0.56%,0.82%,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Markus Hippich,German Research Center for Environmental Health,https://dx.doi.org/10.1016/j.medj.2021.03.019,5/19/2021,7/17/2022,Verified
210402_Bavaria_GermanResearchCenterforEnvironmentalHealth_secondwave_primary,"April 2, 2021",Regional,Germany,DEU,Bavaria,,"September 15, 2020","February 15, 2021",Household and community samples,Children and Youth (0-17 years),11380,3.92%,3.57%,4.29%,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Markus Hippich,German Research Center for Environmental Health,https://dx.doi.org/10.1016/j.medj.2021.03.019,5/19/2021,7/17/2022,Verified
210403_Mainz_JohannesGutenbergUniversity_overall_unadj,"April 3, 2021",Local,Germany,DEU,Rhineland-Palatinate,Mainz,"January 1, 2020","February 28, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,248,5.24%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Simone C Boedecker,Johannes Gutenberg University,http://dx.doi.org/10.3390/pathogens10040429,5/20/2021,3/2/2024,Verified
210404_Tirschenreuth_ FriedrichAlexanderUniversity_primary,"April 4, 2021",Local,Germany,DEU,Bavaria,,"June 28, 2020","July 10, 2020",Household and community samples,Multiple groups,4201,8.64%,,,Simplified probability,"Shenzhen Yhlo Biotech Co. Ltd,Roche Diagnostics,NA",Multiple Types,IgG,,,Moderate,Preprint,Ralf Wagner,Friedrich-Alexander University,https://www.medrxiv.org/content/10.1101/2021.03.29.21254343v1,5/20/2021,3/2/2024,Verified
200515_Regensburg_UniversityOfRegensburg,"May 15, 2020",Local,Germany,DEU,Bavaria,Regensburg,"March 1, 2020","March 31, 2020",Health care workers and caregivers,Adults (18-64 years),201,20.40%,,,Convenience,EUROIMMUN,ELISA,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Susanne Brandstetter,University of Regensburg,https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13278?af=R,5/20/2021,3/2/2024,Unverified
210422_Brandenburg_MedicalSchoolTheodorFontane_followup_primary,"April 22, 2021",Regional,Germany,DEU,Brandenburg,"Brandenburg/Havel, Neuruppin","May 31, 2020","June 6, 2020",Health care workers and caregivers,Adults (18-64 years),811,2.20%,,,Convenience,EUROIMMUN,ELISA,IgG,95.00%,96.20%,High,Journal Article (Peer-Reviewed),Mark Reinwald ,Brandenburg Medical School Theodor Fontane,https://dx.doi.org/10.3390/healthcare9050498,5/21/2021,3/2/2024,Verified
210425_Essen_UniversityHospitalEssen,"April 25, 2021",Local,Germany,DEU,North Rhine-Westphalia,Essen,"October 1, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),315,5.10%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),Johannes Korth,University Hospital Essen,https://dx.doi.org/10.3390/ijerph18094540,5/21/2021,3/2/2024,Verified
210429_Germany_BoehringerIngelheim_primary,"April 29, 2021",National,Germany,DEU,,,"April 15, 2020","June 15, 2020",Essential non-healthcare workers,Adults (18-64 years),121,1.65%,,,Convenience,EUROIMMUN,ELISA,IgG,55.00%,100.00%,High,Journal Article (Peer-Reviewed),Petra C Moroni Zentgraf,Boehringer Ingelheim,https://dx.doi.org/10.1080/03007995.2021.1914943,5/23/2021,3/2/2024,Verified
210409_Bonn_UniversityOfBonn_RhinelandStudy1_overall_Unadj_ELISA,"April 9, 2021",Local,Germany,DEU,North Rhine-Westphalia,Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,4755,0.97%,0.72%,1.30%,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,5/23/2021,3/2/2024,Verified
210409_Bonn_UniversityOfBonn_Voluntary2_overall_Unadj_ELISA,"April 9, 2021",Local,Germany,DEU,North Rhine-Westphalia,Bonn,"April 24, 2020","June 30, 2020",Household and community samples,Multiple groups,360,1.94%,0.84%,4.42%,Self-referral,EUROIMMUN,ELISA,IgG,94.40%,99.60%,High,Journal Article (Peer-Reviewed),N Ahmad Aziz,University of Bonn,https://dx.doi.org/10.1038/s41467-021-22351-5,5/23/2021,3/2/2024,Verified
210331_SchleswigHolstein_RuhrUniversityBochum_NonHCW,"March 31, 2021",Local,Germany,DEU,Schleswig-Holstein,,"April 14, 2020","October 20, 2020",Health care workers and caregivers,Adults (18-64 years),138,0.72%,,,Convenience,"EUROIMMUN,DiaSorin,Abbott Laboratories",ELISA,IgG,,,High,Preprint,Jonas Herzberg,Ruhr University Bochum,https://www.medrxiv.org/content/10.1101/2021.03.29.21254538v1,5/24/2021,3/2/2024,Unverified
210506_Berlin_FreieUniversitätBerlin,"May 6, 2021",Local,Germany,DEU,Berlin,Berlin,"September 28, 2020","October 2, 2020",Students and Daycares,Multiple groups,720,0.14%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marlene Thielecke,Freie Universität Berlin,https://dx.doi.org/10.1093/eurpub/ckab079,5/29/2021,3/2/2024,Unverified
210513_Ulm_UlmUniversity_Overall,"May 13, 2021",Local,Germany,DEU,Baden-Württemberg,Ulm,"November 15, 2020","March 7, 2021",Multiple populations,Adults (18-64 years),818,14.50%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",98.80%,99.98%,Moderate,Preprint,Michael Schon,Ulm University,https://www.medrxiv.org/content/10.1101/2021.05.04.21256382v2.full-text,5/29/2021,3/2/2024,Unverified
210428_Europe_SorbonneUniversité_1Nordrhein-Westfalen,"April 28, 2021",Regional,Germany,DEU,Nordrhein-Westfalen,,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,624,0.80%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/31/2021,3/2/2024,Verified
210413_Tubingen_EberhardKarlsUniversitatTubingen,"April 13, 2021",Local,Germany,DEU,Baden-Württemberg,Tubingen,"May 1, 2020","May 1, 2020",Essential non-healthcare workers,Adults (18-64 years),318,2.80%,1.50%,5.30%,Convenience,"Siemens,EUROIMMUN,Roche Diagnostics",Multiple Types,Not reported,,,High,Journal Article (Peer-Reviewed),Focke Ziemssen,Eberhard Karls Universitat Tubingen,https://bmjophth.bmj.com/content/bmjophth/6/1/e000688.full.pdf,6/1/2021,3/2/2024,Unverified
210512_Lübeck_UniversityofLübeck_TotalStudy,"May 12, 2021",Local,Germany,DEU,,Lubeck,"May 6, 2020","February 1, 2021",Household and community samples,Multiple groups,3051,3.44%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Preprint,Christine Klein,University of Lübeck,https://www.medrxiv.org/content/10.1101/2021.05.10.21256966v1.full-text,6/3/2021,3/2/2024,Verified
201212_Europe_UniversityOfGlasgow_Germany2,"December 12, 2020",National,Germany,DEU,,"Berlin, Düsseldorf and Wiesbaden","April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),137,2.92%,1.14%,7.27%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,3/2/2024,Verified
210618_Bonn_BonnUniversityHospital_primary,"June 18, 2021",Local,Germany,DEU,,Bonn,"December 15, 2020","January 15, 2021",Health care workers and caregivers,Multiple groups,118,14.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.50%,High,Journal Article (Peer-Reviewed),Kathrin van Bremen,Bonn University Hospital,https://dx.doi.org/10.1007/s15010-021-01641-6,7/7/2021,3/2/2024,Unverified
210625_Germany_RobertKochInstitute_overall,"June 25, 2021",National,Germany,DEU,,,"October 15, 2020","February 15, 2021",Household and community samples,Multiple groups,15122,1.30%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,Jens Hoebel,German Institute for Economic Research,https://www.medrxiv.org/content/10.1101/2021.06.21.21259001v1.full-text,7/7/2021,3/2/2024,Verified
210701_Heilbronn_SLKClinicsHeilbronn_Primary,"July 1, 2021",Local,Germany,DEU,Baden-Württemberg,Heilbronn,"July 1, 2020","July 21, 2020",Health care workers and caregivers,Multiple groups,3066,3.10%,,,Convenience,"Siemens,Abbott Laboratories,DiaSorin,EUROIMMUN",Multiple Types,"IgG,IgM",100.00%,,Moderate,Journal Article (Peer-Reviewed),Lionel Larribere,SLK Clinics Heilbronn ,http://dx.doi.org/10.3390/ijerph18137057,7/14/2021,3/2/2024,Verified
210714_Baden-Württemberg_UlmUniversityHospital_Residents1_overall,"July 14, 2021",Local,Germany,DEU,Baden-Württemberg,Alb-Danube district and Ulm ,"July 27, 2020","August 25, 2020",Assisted living and long-term care facilities,Multiple groups,100,1.00%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,7/19/2021,7/17/2022,Unverified
210714_Baden-Württemberg_UlmUniversityHospital_Employees2_overall,"July 14, 2021",Local,Germany,DEU,Baden-Württemberg,Alb-Danube district and Ulm ,"July 27, 2020","August 25, 2020",Health care workers and caregivers,Adults (18-64 years),394,0.25%,,,Convenience,NA,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Lukas Perkhofer,Ulm University Hospital ,https://dx.doi.org/10.1007/s00391-021-01931-6,7/19/2021,7/17/2022,Unverified
210520_NorthRhine-Westphalia_RuhrUniversityBochum,"May 20, 2021",Local,Germany,DEU,North Rhine-Westphalia,,"July 1, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),907,1.43%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.00%,99.00%,High,Journal Article (Peer-Reviewed),Anke Hildebrandt ,Ruhr University Bochum,10.1016/j.ijheh.2021.113771,7/29/2021,3/2/2024,Unverified
210803_Mainz_UniversityMedicalCentreOfMainz_Adj,"August 3, 2021",Local,Germany,DEU,Rhineland-Palatinate,Mainz,"August 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),3664,1.89%,1.39%,2.47%,Convenience,NA,Not reported,"IgG,IgM",,,High,Preprint,Stephan Gehring,University Medical Centre of Mainz,https://www.researchsquare.com/article/rs-688656/v1,8/12/2021,7/17/2022,Unverified
210811_Munich_LudwigMaximiliansUniversitatMunich_overall,"August 11, 2021",Local,Germany,DEU,,Munich,"May 27, 2020","August 12, 2020",Health care workers and caregivers,Adults (18-64 years),7554,2.20%,1.89%,2.55%,Convenience,"Abbott Laboratories,EUROIMMUN,Roche Diagnostics,Mikrogen GmbH,NA",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Paul Wratil,Ludwig Maximilians UNiversitat Munich (LMU Munich),https://dx.doi.org/10.1007/s15010-021-01672-z,8/17/2021,3/2/2024,Unverified
210820_Hamburg_UniversitätHamburg_primary,"August 20, 2021",Local,Germany,DEU,,Hamburg,"August 19, 2020","September 18, 2020",Health care workers and caregivers,Multiple groups,619,0.33%,0.04%,1.17%,Stratified non-probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Marietta Neumann,Universität Hamburg,https://dx.doi.org/10.1007/s12519-021-00447-8,9/1/2021,3/2/2024,Verified
210901_Dusseldorf_HeinrichHeineUniversityDusseldorf,"September 1, 2021",Local,Germany,DEU,North Rhine-Westphalia,Dusseldorf,"December 17, 2020","February 19, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,39,25.60%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Benedikt Botticher,Heinrich Heine University ,https://dx.doi.org/10.1007/s00431-021-04242-5,9/7/2021,3/2/2024,Verified
210826_Berlin_UniversitätsmedizinBerlin_PrimaryStudent_Primary,"August 26, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Students and Daycares,Children and Youth (0-17 years),174,1.10%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,9/8/2021,3/2/2024,Verified
210826_Berlin_UniversitätsmedizinBerlin_SecondaryStudent_Primary,"August 26, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Students and Daycares,Children and Youth (0-17 years),173,2.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,9/8/2021,3/2/2024,Verified
210826_Berlin_UniversitätsmedizinBerlin_Staff_Primary,"August 26, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Essential non-healthcare workers,Adults (18-64 years),141,1.40%,0.20%,5.00%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,9/8/2021,3/2/2024,Verified
210826_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Primary,"August 26, 2021",Local,Germany,DEU,,Berlin,"November 2, 2020","November 16, 2020",Household and community samples,Multiple groups,576,1.40%,0.60%,2.70%,Stratified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Stefanie Theuring,Universitätsmedizin Berlin,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.34.2100184,9/8/2021,3/2/2024,Verified
210726_Dresden_TechnischeUniversitatDresden_200715-201115_Adults,"July 26, 2021",Local,Germany,DEU,Saxony,Dresden,"July 15, 2020","November 15, 2020",Multiple populations,Multiple groups,350,0.60%,,,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Luise Haag,Technische Universitat Dresden,http://dx.doi.org/10.1016/j.jpeds.2021.07.054,9/15/2021,3/2/2024,Unverified
210726_Dresden_TechnischeUniversitatDresden_201116-210131_Adults,"July 26, 2021",Local,Germany,DEU,Saxony,Dresden,"July 16, 2020","January 31, 2021",Multiple populations,Multiple groups,424,11.30%,,,Convenience,"DiaSorin,EUROIMMUN,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Luise Haag,Technische Universitat Dresden\,http://dx.doi.org/10.1016/j.jpeds.2021.07.054,9/15/2021,3/2/2024,Unverified
210916_Augsburg_UniversityHospitalofAugsburg_HCW,"September 16, 2021",Local,Germany,DEU,Bavaria,Augsburg,"December 24, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),43,2.30%,,,Convenience,nal von minden GmbH,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Stephan Zellmer,University Hospital of Augsburg,https://dx.doi.org/10.1055/a-1526-1169,9/29/2021,3/2/2024,Unverified
211005_Munich_LMUMunich_TestAdjusted,"October 5, 2021",Local,Germany,DEU,Bavaria,Munich,"May 14, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,509,1.27%,0.46%,2.44%,Convenience,"Roche Diagnostics,EUROIMMUN",Multiple Types,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Katharina Eisenhut,LMU Munich,https://dx.doi.org/10.1007/s00415-021-10818-w,10/14/2021,8/15/2023,Unverified
211011_NorthRhineWestphalia_UniversityofDuisburgEssen_Overall,"October 11, 2021",Regional,Germany,DEU,North Rhine-Westphalia,,"June 1, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,861,0.81%,,,Unclear,"Abbott Laboratories,DiaSorin,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Dorothea Dehnen,University of Duisburg-Essen,https://dx.doi.org/10.1002/jmv.27385,10/19/2021,3/2/2024,Unverified
211012_Germany_UniversitätWürzburg_Overall,"October 12, 2021",Local,Germany,DEU,Bavaria,Würzburg,"June 1, 2020","October 31, 2020",Household and community samples,Multiple groups,3034,1.10%,0.70%,1.50%,Stratified non-probability,Roche Diagnostics,CLIA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Felizitas Eichner,Universität Würzburg,https://dx.doi.org/10.1055/a-1630-7601,10/20/2021,3/2/2024,Verified
211012_Essen_EssenUniversityHospital_overall,"October 12, 2021",Local,Germany,DEU,,Essen,"May 28, 2020","May 29, 2020",Essential non-healthcare workers,Adults (18-64 years),729,0.82%,,,Convenience,EUROIMMUN,ELISA,IgG,,95.80%,High,Journal Article (Peer-Reviewed),Bastian Brune,Essen University Hospital,https://dx.doi.org/10.1007/s10049-021-00948-z,10/27/2021,3/2/2024,Unverified
211004_Bavaria_UniversityofRegensburg_ELISA-ELECSYS-Neutralization,"October 4, 2021",Regional,Germany,DEU,Bavaria,"Tirschenreuth, Regensburg city and county, and Oberbayern/ alpine region","May 22, 2020","July 22, 2020",Multiple general populations,Children and Youth (0-17 years),2832,4.77%,,,Simplified probability,"NA,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Otto Laub,University of Regensburg,http://dx.doi.org/10.3389/fped.2021.678937,11/2/2021,3/2/2024,Verified
211025_Baden-Württemberg_HeidelbergUniversityHospital_overall,"October 25, 2021",Regional,Germany,DEU,Baden-Württemberg,"Alb-Donau, Breisgau-Hochschwarzwald, Heidelberg/Rhein-Neckar, Karlsruhe, Mannheim, Neckar-Odenwald, Reutlingen, and Tübingen","May 11, 2020","August 1, 2020",Contacts of COVID patients,Multiple groups,1220,32.79%,,,Convenience,"Roche Diagnostics,Mikrogen GmbH,Siemens",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Maximilian Stich,Heidelberg University Hospital,https://wwwnc.cdc.gov/eid/article/27/12/21-0978_article,11/3/2021,3/2/2024,Unverified
211101_Germany_RuhrUniversityBochum,"November 1, 2021",Local,Germany,DEU,,Bochum,"August 15, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,110,9.09%,,,Convenience,Roche Diagnostics,Not reported,"IgG,IgM",99.50%,,High,Journal Article (Peer-Reviewed),Oliver Overheu,Ruhr-University Bochum,https://dx.doi.org/10.1159/000520572,11/11/2021,3/2/2024,Unverified
211124_Germany_RobertKochInstitute_Primary,"November 24, 2021",National,Germany,DEU,,,"October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,14781,1.30%,0.90%,1.70%,Stratified probability,EUROIMMUN,ELISA,IgG,81.10%,99.70%,Low,Preprint,Hannelore Neuhauser,Robert Koch Institute,10.1101/2021.11.22.21266711,12/1/2021,8/15/2023,Unverified
211122_Germany_SaarlandUniversity_PLWH_Primary,"November 22, 2021",Regional,Germany,DEU,South-west Germany,,"April 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,594,1.85%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Dominic Kaddu-Mulindwa,Saarland University,https://dx.doi.org/10.1111/hiv.13207,12/1/2021,3/2/2024,Unverified
211122_Germany_SaarlandUniversity_PEP/PrEP_Primary,"November 22, 2021",Regional,Germany,DEU,South-west Germany,,"April 1, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,50,6.00%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Dominic Kaddu-Mulindwa,Saarland University,https://dx.doi.org/10.1111/hiv.13207,12/1/2021,3/2/2024,Unverified
211112_Ruhr_RuhrUniversityBochum_Primary,"November 12, 2021",Regional,Germany,DEU,Ruhr,"Bochum, Gütersloh, Herne","June 15, 2020","February 15, 2021",Residual sera,Children and Youth (0-17 years),2145,2.56%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Folke Brinkmann,Ruhr University Bochum,https://dx.doi.org/10.3390/idr13040088,12/8/2021,3/2/2024,Verified
220104_Wuerzburg_UniversityHospitalWuerzburg_Children_BeforeStudy,"January 4, 2022",Local,Germany,DEU,Bavaria,Wuerzburg,"October 1, 2020","October 15, 2020",Students and Daycares,Children and Youth (0-17 years),381,0.30%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,1/11/2022,3/2/2024,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_Children_AfterStudy,"January 4, 2022",Local,Germany,DEU,Bavaria,Wuerzburg,"March 1, 2021","March 15, 2021",Students and Daycares,Children and Youth (0-17 years),338,2.37%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,1/11/2022,3/2/2024,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_BeforeStudy,"January 4, 2022",Local,Germany,DEU,Bavaria,Wuerzburg,"October 1, 2020","October 15, 2020",Essential non-healthcare workers,Multiple groups,139,0.70%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,1/11/2022,3/2/2024,Unverified
220104_Wuerzburg_UniversityHospitalWuerzburg_ChildcareWorkers_AfterStudy,"January 4, 2022",Local,Germany,DEU,Bavaria,Wuerzburg,"March 1, 2021","March 15, 2021",Essential non-healthcare workers,Multiple groups,109,4.59%,,,Convenience,"Abbott Laboratories,Institut Virion/Serion,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Johannes Forster,University Hospital Wuerzburg,https://dx.doi.org/10.1001/jamanetworkopen.2021.42057,1/11/2022,3/2/2024,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_Patients1_Overall,"December 23, 2021",Local,Germany,DEU,Bavaria,Erlangen,"December 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,2869,4.20%,,,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,1/12/2022,3/2/2024,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_GenPop3_Overall,"December 23, 2021",Local,Germany,DEU,Bavaria,Erlangen,"December 15, 2020","March 15, 2021",Household and community samples,Multiple groups,1184,7.09%,5.70%,8.71%,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,1/12/2022,3/2/2024,Unverified
211223_Friedrich-AlexanderUniversityErlangen-Nuremberg_Erlangen_HCW2_Overall,"December 23, 2021",Local,Germany,DEU,Bavaria,Erlangen,"December 15, 2020","March 15, 2021",Health care workers and caregivers,Multiple groups,455,11.21%,8.46%,14.47%,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),David Simon,Friedrich-Alexander University (FAU) Erlangen-Nuremberg,https://dx.doi.org/10.1002/art.42035,1/12/2022,3/2/2024,Unverified
220103_Regensburg_UniversityHospitalRegensburg,"January 3, 2022",Local,Germany,DEU,Bavaria,Regensburg,"March 15, 2020","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),205,5.10%,,,Convenience,"Roche Diagnostics,EUROIMMUN",ELISA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Julian Hupf,University Hospital Regensburg,https://dx.doi.org/10.1007/s00063-021-00890-5,1/12/2022,3/2/2024,Unverified
211113_Hannover_HannoverMedicalSchool_Overall_Roche+Neut,"November 23, 2021",Local,Germany,DEU,Lower Saxony,Hannover,"June 15, 2020","June 15, 2021",Students and Daycares,Children and Youth (0-17 years),667,1.65%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,"Total Antibody,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Mira Paulsen,Hannover Medical School,https://dx.doi.org/10.1016/j.jadohealth.2021.11.021,1/14/2022,7/17/2022,Unverified
211209_Dusseldorf_HeinrichHeineUniversityDusseldorf_TestAdj,"December 9, 2021",Local,Germany,DEU,,Düsseldorf,"November 27, 2020","December 4, 2020",Essential non-healthcare workers,Adults (18-64 years),745,4.00%,3.10%,6.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgA,IgM",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Insa Backhaus,Heinrich Heine University Düsseldorf,https://dx.doi.org/10.1093/occmed/kqab164,1/18/2022,8/15/2023,Unverified
220111_Germany_UniversityMedicineGreifswald_Overall,"January 11, 2022",National,Germany,DEU,"Berlin, Hamburg, Saxony, Baden-Württemberg, North Rhine-Westphalia","Berlin, Hamburg, Dresden, Stuttgart, Cologne","January 15, 2021","April 21, 2021",Health care workers and caregivers,Adults (18-64 years),2784,5.20%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Maria Mksoud,University Medicine Greifswald,https://dx.doi.org/10.1007/s00784-021-04363-z,1/19/2022,3/2/2024,Unverified
220121_Bavaria_LudwigMaximiliansUniversitat_Children_Overall,"January 21, 2022",Regional,Germany,DEU,Bavaria,,"June 15, 2021","July 15, 2021",Students and Daycares,Children and Youth (0-17 years),509,7.70%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Preprint,Anna Kern,Ludwig-Maximilians-Universitat,10.1101/2022.01.18.22269445,2/2/2022,3/2/2024,Unverified
220121_Bavaria_LudwigMaximiliansUniversitat_Teachers_Overall,"January 21, 2022",Regional,Germany,DEU,Bavaria,,"June 15, 2021","July 15, 2021",Essential non-healthcare workers,Adults (18-64 years),202,4.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Preprint,Anna Kern,Ludwig-Maximilians-Universitat,10.1101/2022.01.18.22269445,2/2/2022,3/2/2024,Unverified
220124_Berlin_RobertKochInstitute_MayJune2020_Overall,"January 24, 2022",Local,Germany,DEU,,Berlin,"May 18, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),1477,1.20%,,,Convenience,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Tomczyk,BG Klinikum Unfallkrankenhaus Berlin gGmbH,https://dx.doi.org/10.1186/s12879-022-07057-3,2/2/2022,3/2/2024,Unverified
220124_Berlin_RobertKochInstitute_Dec2020_TestAdj,"January 24, 2022",Local,Germany,DEU,,"Berlin
","December 8, 2020","December 20, 2020",Health care workers and caregivers,Adults (18-64 years),1223,4.60%,3.34%,6.11%,Convenience,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Sara Tomczyk,BG Klinikum Unfallkrankenhaus Berlin gGmbH,https://dx.doi.org/10.1186/s12879-022-07057-3,2/2/2022,8/15/2023,Unverified
230403_Gangelt_GermanCenterforInfectionResearch_Visit3,"April 3, 2023",Local,Germany,DEU,North Rhine-Westphalia,Gangelt,"April 1, 2021","April 30, 2021",Household and community samples,Multiple groups,406,35.90%,30.00%,42.00%,Simplified probability,EUROIMMUN,ELISA,IgG,90.90%,99.10%,Moderate,Journal Article (Peer-Reviewed),Enrico Richter,German Center for Infection Research,https://dx.doi.org/10.1038/s41598-023-32441-7,2/10/2022,4/29/2024,Verified
211215_Marburg_PhilippsUniversityMarburg_Overall,"December 15, 2021",Local,Germany,DEU,Hesse,Marburg,"May 28, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),3623,0.36%,,,Convenience,"EUROIMMUN,Roche Diagnostics,Beijing Wantai Biological,NA",Other,"IgG,Total Antibody,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Christian Keller,Philipps University Marburg,https://doi.org/10.1515/labmed-2021-0107,2/10/2022,3/2/2024,Unverified
211124_Cologne_UniversityHospitalOfCologne,"December 21, 2021",Local,Germany,DEU,North Rhine-Westphalia,Cologne,"April 15, 2020","April 15, 2021",Residual sera,Multiple groups,203,2.96%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Patrick Affeldt,University Hospital of Cologne,https://dx.doi.org/10.3390/microorganisms10010004,2/11/2022,3/2/2024,Unverified
220211_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_Primary,"February 11, 2022",Local,Germany,DEU,,Hamburg,"May 11, 2020","June 30, 2020",Household and community samples,Children and Youth (0-17 years),4657,1.44%,,,Convenience,"Roche Diagnostics,DiaSorin",CLIA,"Total Antibody,IgG",,,Moderate,Preprint,Gabor Dunay,University Medical Center Hamburg-Eppendorf,https://www.medrxiv.org/content/10.1101/2022.02.11.22270611v1.full-text,2/22/2022,3/2/2024,Unverified
210901_Saxony-Anhalt_OttoVonGuerickeUniversityMagdeburg,"September 1, 2021",Local,Germany,DEU,Saxony-Anhalt,Magdeburg,"January 21, 2021","April 21, 2021",Blood donors,Adults (18-64 years),2236,12.90%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Stephan Werner Kramer,Otto Von Guericke University Magdeburg,https://dx.doi.org/10.1159/000518751,2/23/2022,7/17/2022,Unverified
220216_LowerSaxony_LeibnizUniversityHannover_Overall,"February 16, 2022",Local,Germany,DEU,Lower Saxony,"Hannover, Goettingen","September 15, 2020","June 15, 2021",Multiple populations,Multiple groups,1883,6.16%,,,Convenience,"Roche Diagnostics,Viramed Biotech AG",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Rebecca Jonczyk,Leibniz University Hannover,https://dx.doi.org/10.1128/spectrum.01512-21,2/24/2022,3/2/2024,Unverified
221216_Germany_InstitutfurLaboratoriumsundTransfusionsmedizin_Overall_1test,"December 16, 2022",National,Germany,DEU,"North Rhine-Westphalia, Lower Saxony, Hesse",,"July 1, 2020","June 30, 2021",Blood donors,Adults (18-64 years),3759,26.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bastian Fischer,Institut fur Laboratoriums- und Transfusionsmedizin,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279195#sec008,2/25/2022,3/2/2024,Verified
220131_Munich_TechnicalUniversityofMunich_Overall,"January 31, 2022",Local,Germany,DEU,Bavaria,Munich,"April 14, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),4554,2.40%,1.90%,2.90%,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,EUROIMMUN,NA,Roche Diagnostics",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Johanna Erber,Technical University Munich,https://dx.doi.org/10.3201/eid2803.204436,3/4/2022,3/2/2024,Unverified
211125_NorthRhine-Westphalia_UniversitiyClinicsHamburgEppendorf_Apr2020_Overall,"November 25, 2021",Regional,Germany,DEU,North Rhine-Westphalia,,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),1212,2.20%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Albert Nienhaus,St. Antonius Hospital,10.1183/13993003.congress-2021.PA3187,3/4/2022,7/17/2022,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period1_Overall,"February 25, 2022",Local,Germany,DEU,"Bavaria
","Erlangen
","October 15, 2020","November 15, 2020",Residual sera,Children and Youth (0-17 years),872,1.40%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,3/8/2022,3/2/2024,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period2_Overall,"February 25, 2022",Local,Germany,DEU,"Bavaria
","Erlangen
","April 1, 2021","April 30, 2021",Residual sera,Children and Youth (0-17 years),808,9.20%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,3/8/2022,3/2/2024,Unverified
220225_Erlangen_FriedrichAlexanderUniversity_Period3_Overall,"February 25, 2022",Local,Germany,DEU,"Bavaria
","Erlangen
","June 15, 2021","July 15, 2021",Residual sera,Children and Youth (0-17 years),946,14.60%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Felix Wachter,Friedrich Alexander University,https://dx.doi.org/10.1515/cclm-2022-0037,3/8/2022,3/2/2024,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round1,"February 19, 2022",Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,"April 15, 2020","May 15, 2020",Health care workers and caregivers,Multiple groups,1211,3.30%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,3/8/2022,3/2/2024,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round2,"February 19, 2022",Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,"September 1, 2020","September 30, 2020",Health care workers and caregivers,Multiple groups,1023,3.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,3/9/2022,3/2/2024,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round3,"February 19, 2022",Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,"November 15, 2020","December 15, 2020",Health care workers and caregivers,Multiple groups,1074,5.20%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,3/9/2022,3/2/2024,Unverified
220219_Eschweiler_StAntoniusHospitalEschweiler_Round4,"February 19, 2022",Local,Germany,DEU,North Rhine-Westphalia,Eschweiler,"April 1, 2021","April 30, 2021",Health care workers and caregivers,Multiple groups,1040,9.90%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Martin Platten,St. Antonius Hospital Eschweiler ,https://dx.doi.org/10.3390/ijerph19042429,3/9/2022,3/2/2024,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Reutlingen1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Baden-Württemberg,Reutlingen,"July 1, 2020","July 28, 2020",Household and community samples,Multiple groups,2407,2.00%,1.00%,3.00%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/9/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Reutlingen2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Baden-Württemberg,Reutlingen,"October 14, 2020","November 10, 2020",Household and community samples,Multiple groups,2360,2.10%,1.20%,3.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Freiburg1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Baden-Württemberg,Freiburg,"August 5, 2020","September 1, 2020",Household and community samples,Multiple groups,2867,1.20%,0.50%,1.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Freiburg2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Baden-Württemberg,Freiburg,"November 18, 2020","December 15, 2020",Household and community samples,Multiple groups,2867,2.00%,1.00%,3.10%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Aachen1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,North Rhine-Westphalia,Aachen,"September 9, 2020","October 9, 2020",Household and community samples,Multiple groups,2023,2.00%,1.00%,2.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Aachen2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,North Rhine-Westphalia,Aachen,"January 27, 2021","February 23, 2021",Household and community samples,Multiple groups,1888,5.20%,3.60%,6.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Osnabruck1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Lower Saxony,Osnabruck,"October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,2923,1.10%,0.40%,1.70%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,3/2/2024,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Osnabruck2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Lower Saxony,Osnabruck,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,1611,3.70%,2.10%,5.20%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Magdeburg1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Saxony-Anhalt,Magdeburg,"November 18, 2020","December 15, 2020",Household and community samples,Multiple groups,2713,2.00%,1.10%,2.90%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Magdeburg2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Saxony-Anhalt,Magdeburg,"April 7, 2021","May 5, 2021",Household and community samples,Multiple groups,1118,9.20%,6.90%,11.60%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Chemnitz1_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Saxony,Chemnitz,"March 3, 2021","April 1, 2021",Household and community samples,Multiple groups,2702,14.30%,12.00%,16.50%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Chemnitz2_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Saxony,Chemnitz,"July 21, 2021","August 17, 2021",Household and community samples,Multiple groups,358,37.40%,31.50%,43.40%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
211203_Germany_HelmholtzCenterforInfectionResearch_Greifswald_Overall_PopTestAdj,"December 3, 2021",Local,Germany,DEU,Mecklenburg-Vorpommern,Greifswald,"June 8, 2021","June 8, 2021",Household and community samples,Multiple groups,954,13.60%,10.20%,17.10%,Simplified probability,EUROIMMUN,ELISA,IgG,88.30%,99.20%,Low,Journal Article (Peer-Reviewed),Daniela Gornyk,Helmholtz Center for Infection Research,https://dx.doi.org/10.3238/arztebl.m2021.0364,3/10/2022,8/15/2023,Unverified
220219_Germany_StVincenzHospital,"February 19, 2022",National,Germany,DEU,,,"June 15, 2020","June 15, 2021",Health care workers and caregivers,Multiple groups,1842,13.20%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.00%,99.00%,Low,Journal Article (Peer-Reviewed),Anke Hildebradnt,St. Vincenz Hospital,https://dx.doi.org/10.3390/ijerph19042402,3/10/2022,3/2/2024,Unverified
220308_UniversityMedicalCenterHamburgEppendorf_UniversityofHamburg,"March 8, 2022",Local,Germany,DEU,Hamburg,Hamburg,"January 17, 2022","January 31, 2022",Health care workers and caregivers,Adults (18-64 years),697,9.76%,,,Convenience,Roche Diagnostics,CLIA,"IgA,IgG,IgM",99.50%,99.80%,High,Preprint,Thomas Brehm,University of Hamburg,https://www.medrxiv.org/content/10.1101/2022.03.06.22271718v1.full-text,3/17/2022,3/2/2024,Unverified
220301_Wurselen_UniversityHospitalHamburgEppendorf_Overall,"March 1, 2022",Local,Germany,DEU,North Rhine-Westphalia,Würselen,"June 19, 2020","July 17, 2020",Health care workers and caregivers,Multiple groups,903,5.43%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Philipp Stuven,University Hospital Hamburg Eppendorf,https://dx.doi.org/10.3205/dgkh000407,3/25/2022,3/2/2024,Unverified
220220_Hamburg_UniversityHeartAndVascularCenter_overall,"February 20, 2022",Local,Germany,DEU,,Hamburg,"May 9, 2020","June 30, 2020",Household and community samples,Children and Youth (0-17 years),4657,1.30%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),J Olfe,University Heart and Vascular Center,https://dx.doi.org/10.1055/s-0042-1742988,3/25/2022,7/17/2022,Unverified
20220324_German_FriedrichSchillerUniversity_Primary,"March 24, 2022",Local,Germany,DEU,,Jena,"February 15, 2020","March 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,156,4.20%,1.70%,9.80%,Self-referral,"DiaSorin,Roche Diagnostics",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anke Jaudszus,Friedrich Schiller University,https://dx.doi.org/10.1186/s12890-022-01900-8,4/6/2022,8/15/2023,Unverified
220423_EasternSaxony_TechnischeUniversitatDresden_Students_JuneJuly21,"April 23, 2022",Regional,Germany,DEU,Eastern Saxony,,"June 15, 2021","July 15, 2021",Students and Daycares,Children and Youth (0-17 years),841,21.50%,18.80%,24.40%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1007/s15010-022-01824-9,5/5/2022,3/2/2024,Unverified
220423_EasternSaxony_TechnischeUniversitatDresden_Teachers_JuneJuly21,"April 23, 2022",Regional,Germany,DEU,Eastern Saxony,,"June 15, 2021","July 15, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),46,30.40%,17.40%,43.50%,Convenience,"DiaSorin,Abbott Laboratories,EUROIMMUN",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Carolin Kirsten,Technische Universität Dresden,https://dx.doi.org/10.1007/s15010-022-01824-9,5/5/2022,3/2/2024,Unverified
220415_GreaterLubeckArea_UniversityofLubeck_Overall,"April 15, 2022",Local,Germany,DEU,Schleswig-Holstein,Lubeck,"May 6, 2020","February 1, 2021",Household and community samples,Multiple groups,3051,2.80%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Christine Klein,University of Lubeck ,https://dx.doi.org/10.1126/sciadv.abm5016,5/18/2022,3/2/2024,Verified
220402_Germany_CharitéResearchOrganisationGmbH_June2020-July2020,"April 20, 2022",National,Germany,DEU,,,"June 29, 2020","July 3, 2020",Essential non-healthcare workers,Adults (18-64 years),1064,1.90%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,5/25/2022,3/2/2024,Unverified
220402_Germany_CharitéResearchOrganisationGmbH_Oct2020-Oct2020,"April 20, 2022",National,Germany,DEU,,,"October 26, 2020","October 30, 2020",Essential non-healthcare workers,Adults (18-64 years),1076,2.40%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,5/25/2022,3/2/2024,Unverified
220402_Germany_CharitéResearchOrganisationGmbH_Feb2021-Mar2021,"April 20, 2022",National,Germany,DEU,,,"February 24, 2021","March 2, 2021",Essential non-healthcare workers,Adults (18-64 years),1014,6.50%,,,Convenience,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),HyoungJin Kim,Deutsche Bahn AG,https://dx.doi.org/10.1017/S095026882200070X,5/25/2022,3/2/2024,Unverified
220323_Dusseldorf_HeinrichHeineUniversity_TestAdjusted,"March 23, 2022",Regional,Germany,DEU,North Rhine-Westphalia,Dusseldorf,"November 2, 2020","November 27, 2020",Household and community samples,Adults (18-64 years),2186,3.10%,2.40%,4.00%,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.50%,99.80%,Low,Journal Article (Peer-Reviewed),Insa Backhaus,Heinrich Heine University,https://dx.doi.org/10.1016/j.puhe.2022.03.009,5/28/2022,8/15/2023,Verified
220526_Germany_UniversitätsmedizinBerlin,"May 26, 2022",National,Germany,DEU,,,"January 1, 2021","January 31, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,119,7.56%,,,Sequential,NA,Neutralization,Not reported,,,High,Journal Article (Peer-Reviewed),Elisabeth Bluthner,Universitätsmedizin Berlin,https://dx.doi.org/10.1002/jpen.2410,5/31/2022,7/17/2022,Unverified
220518_Saarland_SaarlandUniversityMedicalCenter_PopTestAdj,"May 18, 2022",Regional,Germany,DEU,Saarland,,"July 22, 2020","October 15, 2020",Household and community samples,Multiple groups,2940,0.32%,,,Simplified probability,EUROIMMUN,ELISA,IgG,84.90%,99.30%,Moderate,Journal Article (Peer-Reviewed),Stefan Lohse,Saarland University Medical Center,https://dx.doi.org/10.1038/s43856-022-00100-z,6/2/2022,3/23/2024,Verified
220601_Stuttgart_UniversityofCologne_Primary(S-IgG),"June 1, 2022",Local,Germany,DEU,Baden-Württemberg,Stuttgart,"June 15, 2021","July 14, 2021",Household and community samples,Multiple groups,454,71.60%,,,Simplified probability,EUROIMMUN,ELISA,IgG,98.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Gregor Paul,University of Cologne,https://dx.doi.org/10.1007/s15010-022-01830-x,6/11/2022,3/24/2024,Verified
220606_Germany_Ludwig-MaximiliansUniversityofMunich_Overall,"June 6, 2022",National,Germany,DEU,,"Hamburg, Hannover, Berlin, Krefeld, Dusseldorf, Aachen, Gießen, Dresden, Wurzburg, Mannheim, Homburg (town), Freiburg, Munich","June 1, 2020","May 31, 2021",Residual sera,Children and Youth (0-17 years),10358,4.50%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Anna-Lisa Sorg,Heidelberg University,https://doi.org/10.1038/s41467-022-30482-6,6/15/2022,3/2/2024,Unverified
220527_Tirschenreuth_UniversityofRegensburg_FollowUp2,"May 27, 2022",Regional,Germany,DEU,Tirschenreuth District,,"April 1, 2021","April 30, 2021",Household and community samples,Multiple groups,3177,15.68%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Sebastian Einhauser,University of Regensburg,https://dx.doi.org/10.3390/v14061168,6/24/2022,3/2/2024,Unverified
220706_Bavaria_Ludwig-Maximilians-Universität_Children1,"July 6, 2022",Regional,Germany,DEU,Bavaria,,"June 1, 2021","July 31, 2021",Students and Daycares,Children and Youth (0-17 years),315,8.57%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anna Kern,Ludwig-Maximilians-Universität,https://dx.doi.org/10.3389/fped.2022.888498,8/18/2022,8/26/2022,Unverified
220706_Bavaria_Ludwig-Maximilians-Universität_Staff2,"July 6, 2022",Regional,Germany,DEU,Bavaria,,"June 1, 2021","July 31, 2021",Essential non-healthcare workers,Adults (18-64 years),123,4.88%,,,Convenience,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Anna Kern,Ludwig-Maximilians-Universität,https://dx.doi.org/10.3389/fped.2022.888498,8/18/2022,8/26/2022,Unverified
220811_Augsburg_UniversityofAugsburg_Children,"August 11, 2022",Local,Germany,DEU,,Ausburg,"December 15, 2020","August 15, 2021",Students and Daycares,Children and Youth (0-17 years),363,4.40%,2.60%,7.20%,Convenience,"nal von minden GmbH,EUROIMMUN,Roche Diagnostics,Mikrogen GmbH",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Vincenza Leona,University of Augsburg,https://dx.doi.org/10.1371/journal.pone.0272874,8/24/2022,3/2/2024,Unverified
220811_Augsburg_UniversityofAugsburg_Parents,"August 11, 2022",Local,Germany,DEU,,Ausburg,"December 15, 2020","August 15, 2021",Students and Daycares,Adults (18-64 years),81,4.90%,2.60%,12.80%,Convenience,"nal von minden GmbH,EUROIMMUN,Roche Diagnostics,Mikrogen GmbH",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Vincenza Leona,University of Augsburg,https://dx.doi.org/10.1371/journal.pone.0272874,8/24/2022,3/2/2024,Unverified
220811_Augsburg_UniversityofAugsburg_Educators,"August 11, 2022",Local,Germany,DEU,,Ausburg,"December 15, 2020","August 15, 2021",Students and Daycares,Adults (18-64 years),297,5.70%,3.50%,9.20%,Convenience,"nal von minden GmbH,EUROIMMUN,Roche Diagnostics,Mikrogen GmbH",LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Vincenza Leona,University of Augsburg,https://dx.doi.org/10.1371/journal.pone.0272874,8/24/2022,3/2/2024,Unverified
220917_Germany_LudwigMaximiliansUniversityMunich_Overall,"September 27, 2022",National,Germany,DEU,"Baden-Württember, Bavaria, Lower Saxony, Saxony, North Rhine-Westphalia","Mannheim, Freiburg, Munich, Würzburg, Hannover, Dresden, Krefeld, Aachen","May 1, 2021","October 31, 2021",Residual sera,Children and Youth (0-17 years),634,15.77%,,,Simplified probability,EUROIMMUN,ELISA,IgG,94.40%,,Moderate,Journal Article (Peer-Reviewed),Anna-Lisa Sorg,Ludwig-Maximilians-University Munich,https://dx.doi.org/10.1001/jamanetworkopen.2022.33454,10/6/2022,3/2/2024,Unverified
230215_Jena_JenaUniversityHospital_Primary,"February 15, 2023",Local,Germany,DEU,Thuringia,Jena,"April 26, 2021","June 22, 2021",Health care workers and caregivers,Adults (18-64 years),406,78.30%,,,Convenience,DiaSorin,CLIA,IgG,97.00%,97.00%,High,Journal Article (Peer-Reviewed),Christina Bahrs,Jena University Hospital ,https://dx.doi.org/10.1007/s15010-023-01995-z,10/18/2022,3/2/2024,Unverified
221019_BerlinBrandenburgArea_IMDBerlinPotsdam_nAb,"October 19, 2022",Local,Germany,DEU,Province of Brandenburg,Berlin-Brandenburg area,"April 1, 2021","August 30, 2021",Residual sera,Multiple groups,2994,78.89%,,,Sequential,GenScript,ELISA,Neutralizing ,97.30%,99.40%,High,Journal Article (Peer-Reviewed),Berthold Hocher,Institute of Clinical Chemistry (IMD) Berlin-Potsdam,https://dx.doi.org/10.3390/microorganisms10102067,11/4/2022,4/17/2024,Verified
220901_Germany_BielefeldUniversity_overall,"September 1, 2022",Local,Germany,DEU,,Bielefeld,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),382,1.57%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.80%,High,Journal Article (Peer-Reviewed),Anna Catharina Sellmeier,Bielefeld University,https://dx.doi.org/10.25122/jml-2022-0126,11/30/2022,3/20/2023,Unverified
221114_Gemany_RobertKochInstitute_TestAdj,"November 14, 2022",National,Germany,DEU,,,"October 6, 2020","February 28, 2021",Household and community samples,Multiple groups,14781,1.30%,0.90%,1.70%,Stratified probability,EUROIMMUN,,IgG,81.10%,99.70%,Moderate,Journal Article (Peer-Reviewed),Hannelore Neuhauser,Robert Koch Institute,https://dx.doi.org/10.1038/s41598-022-23821-6,12/15/2022,4/18/2024,Verified
221217_Germany_UniversityofRegensburg_Baseline,"December 17, 2022",Regional,Germany,DEU,Bavaria,,"June 28, 2020","July 13, 2020",Household and community samples,Multiple groups,4181,8.90%,,,Simplified probability,Roche Diagnostics,,,,,Low,Journal Article (Peer-Reviewed),Felix Gunther,University of Regensburg,https://dx.doi.org/10.3390/ijerph192416996,1/11/2023,4/21/2024,Verified
230109_Munich_UniversitatdeBarcelona_Month0,"January 9, 2023",Local,Germany,DEU,,Munich,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),218,61.00%,,,Unclear,NA,Luminex,"IgG,IgM,IgA",95.78%,100.00%,,Journal Article (Peer-Reviewed),Ruth Aguilar,"Universitat de Barcelona, Technical University of Munich",https://dx.doi.org/10.1128/spectrum.03165-22,1/25/2023,3/22/2023,Unverified
221111_Wurzburg_Unknown_AntiS,"November 11, 2022",Local,Germany,DEU,Bavaria,Wurzburg,"July 1, 2022","July 31, 2022",Students and Daycares,Children and Youth (0-17 years),277,69.60%,64.30%,75.10%,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,,Journal Article (Peer-Reviewed),G Engels,Unknown,https://dx.doi.org/10.3238/arztebl.m2022.0345,2/7/2023,3/2/2024,Unverified
221101_Bavaria_ GermanResearchCenterforEnvironmentalHealth_wave1,"November 1, 2022",Regional,Germany,DEU,Bavaria,,"March 15, 2020","April 15, 2020",Household and community samples,Children and Youth (0-17 years),2550,0.35%,,,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Raffael Ott, German Research Center for Environmental Health,https://dx.doi.org/10.3238/arztebl.m2022.0355,3/9/2023,3/20/2023,Unverified
221101_Bavaria_ GermanResearchCenterforEnvironmentalHealth_wave3,"November 1, 2022",Regional,Germany,DEU,Bavaria,,"February 15, 2021","May 15, 2021",Household and community samples,Children and Youth (0-17 years),10478,8.52%,,,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Raffael Ott, German Research Center for Environmental Health,https://dx.doi.org/10.3238/arztebl.m2022.0355,3/9/2023,3/20/2023,Unverified
221101_Bavaria_ GermanResearchCenterforEnvironmentalHealth_wave2,"November 1, 2022",Regional,Germany,DEU,Bavaria,,"September 15, 2020","January 15, 2021",Household and community samples,Children and Youth (0-17 years),10896,2.72%,,,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Raffael Ott, German Research Center for Environmental Health,https://dx.doi.org/10.3238/arztebl.m2022.0355,3/9/2023,3/20/2023,Unverified
221101_Bavaria_ GermanResearchCenterforEnvironmentalHealth_wave4,"November 1, 2022",Regional,Germany,DEU,Bavaria,,"August 15, 2021","December 15, 2021",Household and community samples,Children and Youth (0-17 years),9100,13.01%,,,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Raffael Ott, German Research Center for Environmental Health,https://dx.doi.org/10.3238/arztebl.m2022.0355,3/9/2023,3/20/2023,Unverified
221101_Bavaria_ GermanResearchCenterforEnvironmentalHealth_wave5,"November 1, 2022",Regional,Germany,DEU,Bavaria,,"January 15, 2022","May 1, 2022",Household and community samples,Children and Youth (0-17 years),9489,50.48%,,,Convenience,NA,Other,IgG,,,,Journal Article (Peer-Reviewed),Raffael Ott, German Research Center for Environmental Health,https://dx.doi.org/10.3238/arztebl.m2022.0355,3/9/2023,3/22/2023,Unverified
230319_Germany_RobertKochInstitute_2021Dec,"March 19, 2023",National,Germany,DEU,,,"December 1, 2021","December 31, 2021",Residual sera,Multiple groups,52,92.31%,,,Sequential,EUROIMMUN,,Not reported,,,,Presentation or Conference,Oliver Hohn,Robert Koch Institute,https://dx.doi.org/10.1111/hiv.13464,5/6/2023,3/2/2024,Unverified
230420_Hamburg_UniversityMedicalCentreHamburg-Eppendorf_Baseline,"April 20, 2023",Local,Germany,DEU,,Hamburg,"July 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),678,1.20%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,,,,,Journal Article (Peer-Reviewed),Anja Schablon,University Medical Centre Hamburg-Eppendorf ,https://dx.doi.org/10.3390/ijerph20085599,5/31/2023,3/2/2024,Unverified
230428_Germany_UniversityHospitalMagdeburg,"April 18, 2023",Local,Germany,DEU,Saxony-Anhalt,Magdeburg,"January 20, 2021","April 30, 2021",Blood donors,Multiple groups,2195,13.00%,,,Convenience,DiaSorin,CLIA,IgG,98.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Robert Pohl,University Hospital Magdeburg,https://dx.doi.org/10.1136/bmjopen-2022-068472,5/31/2023,4/23/2024,Verified
230420_Hamburg_UniversityMedicalCentreHamburg-Eppendorf_3months,"April 20, 2023",Local,Germany,DEU,,Hamburg,"October 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),581,1.50%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,,,,,Journal Article (Peer-Reviewed),Anja Schablon,University Medical Centre Hamburg-Eppendorf ,https://dx.doi.org/10.3390/ijerph20085599,5/31/2023,3/2/2024,Unverified
230420_Hamburg_UniversityMedicalCentreHamburg-Eppendorf_6months,"April 20, 2023",Local,Germany,DEU,,Hamburg,"January 15, 2021","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),483,36.40%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,,,,,Journal Article (Peer-Reviewed),Anja Schablon,University Medical Centre Hamburg-Eppendorf ,https://dx.doi.org/10.3390/ijerph20085599,5/31/2023,3/2/2024,Unverified
230420_Hamburg_UniversityMedicalCentreHamburg-Eppendorf_12months,"April 20, 2023",Local,Germany,DEU,,Hamburg,"July 15, 2021","October 15, 2021",Health care workers and caregivers,Adults (18-64 years),462,88.50%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,,,,,Journal Article (Peer-Reviewed),Anja Schablon,University Medical Centre Hamburg-Eppendorf ,https://dx.doi.org/10.3390/ijerph20085599,5/31/2023,3/2/2024,Unverified
230606_Germany_UniversityHospitalWürzburg,"June 6, 2023",National,Germany,DEU,,"Würzburg, Bochum, Dresden","July 1, 2022","October 15, 2022",Students and Daycares,Children and Youth (0-17 years),497,86.50%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,,Journal Article (Peer-Reviewed),Geraldine Engels,University Hospital Würzburg,https://dx.doi.org/10.1007/s15010-023-02052-5,6/30/2023,3/2/2024,Unverified
230624_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_Dec20,"June 24, 2023",Local,Germany,DEU,,Hamburg,"December 1, 2020","December 15, 2020",Essential non-healthcare workers,Adults (18-64 years),44,2.30%,,,Convenience,Roche Diagnostics,CLIA,"IgA,IgM,IgG",98.80%,100.00%,,Journal Article (Peer-Reviewed),Julia Schadler,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1007/s12024-023-00661-y,8/1/2023,3/2/2024,Unverified
230624_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_June2021,"June 24, 2023",Local,Germany,DEU,,Hamburg,"June 1, 2021","June 30, 2021",Essential non-healthcare workers,Adults (18-64 years),33,48.50%,,,Convenience,Roche Diagnostics,CLIA,"IgA,IgM,IgG",98.80%,100.00%,,Journal Article (Peer-Reviewed),Julia Schadler,University Medical Center Hamburg-Eppendorf,https://dx.doi.org/10.1007/s12024-023-00661-y,8/1/2023,3/2/2024,Unverified
230401_Germany_UniversitätsmedizinBerlin,"April 1, 2023",National,Germany,DEU,,,"January 15, 2021","January 15, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,119,7.60%,,,Convenience,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),E. Bluthner,Universitätsmedizin Berlin,https://dx.doi.org/10.1016/j.clnesp.2022.09.547,8/1/2023,8/15/2023,Unverified
230611_Berlin_Humboldt-UniversitätzuBerlin,"June 11, 2023",Local,Germany,DEU,,Berlin,"March 24, 2021","June 15, 2021",Residual sera,Multiple groups,954,25.10%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Ariadne Brandt,Humboldt-Universität zu Berlin,https://dx.doi.org/10.3389/fpubh.2023.1134546,8/2/2023,5/1/2024,Verified
230802_Germany_UniversityOfMunster_PopAdj_AntiS,"August 2, 2023",National,Germany,DEU,,,"June 15, 2022","November 30, 2022",Household and community samples,Multiple groups,31566,94.80%,94.20%,95.40%,Unclear,"Roche Diagnostics,EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Berit Lange,University of Münster,https://dx.doi.org/10.1007/s15010-023-02071-2,8/22/2023,3/2/2024,Unverified
230728_Rostock_RostockUniversityMedicalCenter,"July 28, 2023",Local,Germany,DEU,,Rostock,"January 15, 2021","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,94,2.90%,,,Sequential,NA,CLIA,Not reported,,,,Journal Article (Peer-Reviewed),Adrianna Dera,Rostock University Medical Center,https://dx.doi.org/10.1097/IAE.0000000000003907,8/24/2023,8/26/2023,Unverified
230717_Munich_TechnicalUniversityofMunich,"July 17, 2023",Local,Germany,DEU,,Munich,"May 15, 2020","September 15, 2021",Residual sera,Adults (18-64 years),124,7.30%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,93.80%,99.30%,High,Journal Article (Peer-Reviewed),Simon Weidlich,Technical University of Munich,https://dx.doi.org/10.1177/09564624231190419,8/24/2023,3/2/2024,Unverified
230713_Munich_GermanResearchCentreforEnvironmentalHealth_baseline,"July 13, 2023",Local,Germany,DEU,,Munich,"April 5, 2020","June 12, 2020",Household and community samples,Multiple groups,5313,1.60%,1.10%,2.10%,Simplified probability,Roche Diagnostics,CLIA,IgG,99.20%,98.70%,High,Journal Article (Peer-Reviewed),Ronan Le Gleut,German Research Centre for Environmental Health,https://dx.doi.org/10.1186/s12879-023-08435-1,8/24/2023,3/2/2024,Unverified
230821_Germany_RobertKochInstitute,"August 21, 2023",Local,Germany,DEU,,"Kupferzell, Bad Feilnbach, Straubing, Berlin-Mitte","May 15, 2020","December 15, 2020",Household and community samples,Multiple groups,4817,6.00%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Christin Heidemann,Robert Koch Institute,https://dx.doi.org/10.1186/s12889-023-16524-8,9/22/2023,3/2/2024,Unverified
230402_Germany_RobertKochInstitute_Overall,"April 2, 2023",Local,Germany,DEU,,Hamburg,"May 3, 2020","May 21, 2022",Blood donors,Adults (18-64 years),134510,17.30%,,,Convenience,"EUROIMMUN,Roche Diagnostics",Multiple Types,,,,,Journal Article (Peer-Reviewed),Ruth Offergeld,Robert Koch Institute,https://dx.doi.org/10.3390/pathogens12040551,3/30/2024,3/30/2024,Verified
200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj,"September 18, 2020",Local,Georgia,GEO,Tbilisi,Tbilisi,"May 18, 2020","May 27, 2020",Household and community samples,Multiple groups,1086,1.02%,0.38%,2.18%,Convenience,Zhejiang Orient Gene Biotech,LFIA,IgG,93.10%,99.20%,Moderate,Preprint,Tengiz Tsertsvadze,"Infectious Diseases, AIDS and Clinical Immunology Research Center",https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1,11/22/2020,7/5/2023,Verified
230612_TheGambia_TheGambiaattheLondonSchoolofHygieneandTropicalMedicine_Prepandemic1,"June 12, 2023",Local,Gambia,GMB,,"Farafenni, Illiasa, Ngayen Sanjal ","October 15, 2019","December 15, 2019",Pregnant or parturient women,Adults (18-64 years),112,0.90%,0.20%,4.90%,Convenience,"Beijing Wantai Biological,EUROIMMUN",,IgG,,,,Preprint,Ramatoulie Janha,The Gambia at the London School of Hygiene and Tropical Medicine ,10.1101/2023.06.09.23291201,6/29/2023,3/2/2024,Unverified
230612_TheGambia_TheGambiaattheLondonSchoolofHygieneandTropicalMedicine_Prepandemic2,"June 12, 2023",Local,Gambia,GMB,,"Farafenni, Illiasa, Ngayen Sanjal ","February 15, 2019","June 15, 2019",Pregnant or parturient women,Adults (18-64 years),73,4.10%,1.40%,11.40%,Convenience,"Beijing Wantai Biological,EUROIMMUN",,IgG,,,,Preprint,Ramatoulie Janha,The Gambia at the London School of Hygiene and Tropical Medicine ,10.1101/2023.06.09.23291201,6/29/2023,3/2/2024,Unverified
230612_TheGambia_TheGambiaattheLondonSchoolofHygieneandTropicalMedicine_Postwave1,"June 12, 2023",Local,Gambia,GMB,,"Farafenni, Illiasa, Ngayen Sanjal ","October 15, 2020","December 15, 2020",Pregnant or parturient women,Adults (18-64 years),209,31.10%,25.20%,37.70%,Convenience,"Beijing Wantai Biological,EUROIMMUN",,IgG,,,,Preprint,Ramatoulie Janha,The Gambia at the London School of Hygiene and Tropical Medicine ,10.1101/2023.06.09.23291201,6/29/2023,3/2/2024,Unverified
230612_TheGambia_TheGambiaattheLondonSchoolofHygieneandTropicalMedicine_Postwave2,"June 12, 2023",Local,Gambia,GMB,,"Farafenni, Illiasa, Ngayen Sanjal ","May 15, 2021","June 15, 2021",Pregnant or parturient women,Adults (18-64 years),208,62.50%,55.80%,68.80%,Convenience,"Beijing Wantai Biological,EUROIMMUN",,IgG,,,,Preprint,Ramatoulie Janha,The Gambia at the London School of Hygiene and Tropical Medicine ,10.1101/2023.06.09.23291201,6/29/2023,3/2/2024,Unverified
230612_TheGambia_TheGambiaattheLondonSchoolofHygieneandTropicalMedicine_Postwave3,"June 12, 2023",Local,Gambia,GMB,,"Farafenni, Illiasa, Ngayen Sanjal ","October 15, 2021","December 15, 2021",Pregnant or parturient women,Adults (18-64 years),201,90.00%,85.10%,93.50%,Convenience,"Beijing Wantai Biological,EUROIMMUN",,IgG,,,,Preprint,Ramatoulie Janha,The Gambia at the London School of Hygiene and Tropical Medicine ,10.1101/2023.06.09.23291201,6/29/2023,3/2/2024,Unverified
210420_Libreville_CentreHospitalierUniversitaire(CHU)‐Mère‐Enfant_overall_unadj,"April 20, 2021",Local,Gabon,GAB,,Libreville,"July 15, 2020","October 15, 2020",Residual sera,Multiple groups,1495,36.20%,,,Convenience,"Biomerieux,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,Centre Hospitalier Universitaire (CHU) ‐ Mère‐ Enfant,https://dx.doi.org/10.1186/s13104-021-05570-3,5/20/2021,3/2/2024,Verified
210506_Gabon_CHUMèreEnfantFondationJeanneEbori,"May 6, 2021",National,Gabon,GAB,,,"March 15, 2020","August 15, 2020",Contacts of COVID patients,Multiple groups,319,55.00%,,,Convenience,NA,LFIA,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Amandine Mveang Nzoghe,CHU Mère Enfant Fondation Jeanne Ebori,https://dx.doi.org/10.1038/s41598-021-87043-y,5/28/2021,7/17/2022,Verified
220909_Gabon_UniversiteDeMontpellier_IgGIgM,"September 9, 2022",National,Gabon,GAB,,Urban: Libreville and Port-Gentil; Rural: Oyem,"May 15, 2021","July 15, 2021",Household and community samples,Multiple groups,1600,13.10%,11.40%,14.80%,Unclear,Biosynex,LFIA,"IgG,IgM",95.00%,98.00%,High,Journal Article (Peer-Reviewed),Berthe A.Iroungou,Universite de Montpellier ,https://dx.doi.org/10.1016/j.ijregi.2022.08.006,9/13/2022,3/2/2024,Unverified
221221_Tahiti_InstitutLouisMalarde_Primary_PopAdj,"December 21, 2022",Regional,French Polynesia,PYF,Tahiti,,"November 22, 2021","December 11, 2021",Household and community samples,Multiple groups,673,95.90%,94.00%,97.70%,Stratified probability,Roche Diagnostics,,,,,Moderate,Preprint,Maite Aubry,Institut Louis Malardé,http://doi.org/10.20944/preprints202212.0386.v1,1/13/2023,3/2/2024,Unverified
211112_FrenchGuiana_InstitutPasteurinFrenchGuiana_Overall_PopAdjusted,"November 12, 2021",National,French Guiana,GUF,"Cayenne, Saint-Laurent-du-Maroni","Cayenne, Matoury, Mana, Apatou, Saint-Laurent-du-Maroni, Awala-Yalimapo, Iracoubo, Sinnamary, Kourou, Macouria, Cayenne, Rémire-Montjoly, Saint-Georges, Maripasoula, Papaïchton, Grand-Santi","July 15, 2020","July 23, 2020",Residual sera,Multiple groups,480,15.40%,9.30%,24.40%,Convenience,EUROIMMUN,ELISA,IgG,93.80%,99.60%,Moderate,Journal Article (Peer-Reviewed),Claude Flamand,Institut Pasteur in French Guiana,https://dx.doi.org/10.1371/journal.pntd.0009945,11/23/2021,3/2/2024,Verified
200902_Lille_InstitutPasteur_BloodDonors_ELISA-N,"September 2, 2020",Local,France,FRA,Hauts-de-France,"Clermont, Noyon, Lille","March 20, 2020","March 24, 2020",Blood donors,Multiple groups,200,0.00%,,,Sequential,NA,ELISA,"IgA,IgE,IgD,IgM,IgG,Total Antibody",,95.00%,High,Journal Article (Peer-Reviewed),Ludivine Grzelak,Institut Pasteur,https://stm.sciencemag.org/content/12/559/eabc3103,4/29/2020,7/17/2022,Verified
200501_France_ CentreLeonBerard_HCW,"May 1, 2020",Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,"March 1, 2020","April 16, 2020",Health care workers and caregivers,Adults (18-64 years),85,5.88%,,,Convenience,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,3/2/2024,Verified
200501_France_ CentreLeonBerard_CancerPatient,"May 1, 2020",Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,"March 1, 2020","April 16, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,244,5.33%,,,Sequential,TODA Pharma,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),M Solodky,Centre Leon Berard,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,3/2/2024,Verified
200715_France_UnitedesVirusEmergents_BloodDonors,"July 15, 2020",National,France,FRA,"Provence-Alpes-Côte d'Azur, Grand-Est, Hauts-de-France, Île-de-France",,"March 25, 2020","April 7, 2020",Blood donors,Adults (18-64 years),998,2.71%,,,Sequential,NA,Neutralization,Not reported,,100.00%,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unite des Virus Emergents,https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72,8/2/2020,7/17/2022,Verified
200722_France_PicardieUniversity_IBDPatients_Overall,"July 22, 2020",Local,France,FRA,Somme,Amiens,"March 25, 2020","May 11, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,146,4.80%,,,Convenience,DiaSorin,CLIA,IgG,97.40%,98.50%,High,Journal Article (Peer-Reviewed),Mathurin Fumery,Picardie University,https://dx.doi.org/10.1093/ecco-jcc/jjaa154,8/2/2020,3/2/2024,Verified
200827_Paris_RothschildFoundationHospital_HealthcareProfessionals,"August 27, 2020",Local,France,FRA,Paris,Paris,"June 8, 2020","June 22, 2020",Health care workers and caregivers,Adults (18-64 years),646,12.00%,,,Convenience,Roche Diagnostics,ELISA,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Malcie Mesnil,Rothschild Foundation Hospital,http://dx.doi.org/10.1016/j.accpm.2020.08.003,10/22/2020,3/2/2024,Verified
200903_Paris_HopitalEuropeenGeorgesPompidou_Overall,"September 3, 2020",Local,France,FRA, Île-de-France,Paris,"May 2, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),3569,11.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Helene Pere,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2020.104617,11/10/2020,3/2/2024,Verified
201015_Paris_ParisSaclayUniversity_unadj,"October 15, 2020",Local,France,FRA,Paris,Paris,"May 4, 2020","May 31, 2020",Pregnant or parturient women,Adults (18-64 years),249,8.00%,,,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Jeremie Mattern,Paris Saclay University,http://dx.doi.org/10.1371/journal.pone.0240782,1/16/2021,3/2/2024,Verified
201106_Lyon_UniversitéClaudeBernardLyon_Overall,"November 6, 2020",Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,"April 10, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Unclear,"Biomerieux,Beijing Wantai Biological",Multiple Types,"Total Antibody,IgG",,,High,Preprint,Antonin Bal,Université Claude Bernard Lyon,https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1,1/18/2021,3/2/2024,Verified
201105_Corsica_UniversitédeCorse_Totaladj,"November 5, 2020",Regional,France,FRA,Corsica,"Ajaccio
Corte","April 16, 2020","June 15, 2020",Residual sera,Multiple groups,1973,5.46%,4.51%,6.57%,Sequential,EUROIMMUN,ELISA,IgG,86.40%,96.20%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://www.mdpi.com/2077-0383/9/11/3569,1/18/2021,3/2/2024,Verified
210205_IledeFrance_Epicentre_Shelters,"February 5, 2021",Local,France,FRA,Ile de France,Paris,"June 23, 2020","July 2, 2020",Persons experiencing homelessness,Multiple groups,818,52.00%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Thomas Roederer,Médecins sans Frontières (Epicentre) ,https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3,1/24/2021,7/17/2022,Verified
201104_Paris_CochinAPHP_HCW,"November 4, 2020",Local,France,FRA,Île-de-France,Paris,"May 14, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),4607,11.50%,10.60%,12.40%,Convenience,Abbott Laboratories,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Chantal Delmas,Cochin APHP,https://dx.doi.org/10.1017/ice.2020.1309,1/24/2021,3/2/2024,Verified
201130_Strasbourg_StrasbourgUniversityHospital_Abbott,"November 30, 2020",Local,France,FRA,Grand-Est ,Strasbourg,"May 7, 2020","June 26, 2020",Contacts of COVID patients,Adults (18-64 years),11,0.00%,,,Unclear,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Floriane Gallais,Strasbourg University Hospital,https://dx.doi.org/10.3201/eid2701.203611,1/24/2021,3/2/2024,Verified
201210_ Paris_UniversitéParis-Saclay,"December 10, 2020",Local,France,FRA,Île-de-France,Paris ,"April 29, 2020","June 26, 2020",Pregnant or parturient women,Adults (18-64 years),529,4.70%,3.00%,6.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.00%,High,Journal Article (Peer-Reviewed),Vassilis Tsatsarisa,Université Paris-Saclay,https://dx.doi.org/10.1016/j.jogoh.2020.102041,1/24/2021,3/2/2024,Verified
210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj,"February 8, 2021",National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Students and Daycares,Children and Youth (0-17 years),327,3.70%,1.30%,6.80%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,2/20/2021,8/15/2023,Verified
210118_France_SorbonneUniversité_primary,"January 18, 2021",National,France,FRA,Île-de-France and Grand Est ,,"May 15, 2020","June 15, 2020",Household and community samples,Multiple groups,9782,3.46%,,,Simplified probability,"EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Nathanael Lapidus,Sorbonne Université,https://dx.doi.org/10.1016/j.idnow.2020.12.007,2/26/2021,3/2/2024,Verified
201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children,"November 19, 2020",Local,France,FRA,Île-de-France,Paris,"April 14, 2020","May 12, 2020",Residual sera,Children and Youth (0-17 years),605,10.70%,8.40%,13.50%,Sequential,Biosynex,LFIA,"IgG,IgM",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Robert Cohen,Centre Hospitalier Intercommunal de Créteil,http://dx.doi.org/10.1136/bmjpo-2020-000887,3/1/2021,3/2/2024,Verified
201223_Paris_InstitutCurie_overall,"December 23, 2020",Local,France,FRA, Île-de-France,Paris,"April 28, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,1847,11.60%,10.20%,13.20%,Convenience,NA,Multiple Types,"IgG,Total Antibody,Neutralizing ",,99.00%,Moderate,Journal Article (Peer-Reviewed),Francois Anna, Institut Curie,https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058,3/20/2021,7/17/2022,Verified
210127_Nice_UniversitéCôted'Azur,"January 27, 2021",Local,France,FRA,Provence-Alpes-Côte d'Azur,Nice,"April 15, 2020","May 26, 2020",Health care workers and caregivers,Adults (18-64 years),196,15.00%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",100.00%,,High,Journal Article (Peer-Reviewed),Marion Cremoni,Université Côte d'Azur,https://dx.doi.org/10.3389/fmed.2020.608804,3/28/2021,3/2/2024,Verified
210312_Strasbourg_UniversityHospitalStrasbourg_overall,"March 12, 2021",Local,France,FRA,,Strasbourg,"February 18, 2021","February 25, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,241,10.80%,,,Unclear,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Ilies Benotmane,"University Hospital, Strasbourg",https://www.medrxiv.org/content/10.1101/2021.03.08.21252741v1.full-text,4/1/2021,3/2/2024,Verified
210312_Paris_SorbonneUniversite_M3,"March 12, 2021",Local,France,FRA,,Paris,"June 16, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),938,13.00%,11.10%,15.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Preprint,Pierre Hausfater,Sorbonne Universite ,10.1101/2021.03.09.21253200,4/2/2021,3/2/2024,Verified
210223_France_MontpellierUniversity_NursingHomeResidents,"February 23, 2021",Regional,France,FRA,Occitanie,,"April 21, 2020","July 29, 2020",Assisted living and long-term care facilities,Seniors (65+ years),456,30.70%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Hubert Blain, Montpellier University,https://dx.doi.org/10.1093/ageing/afab050,4/10/2021,7/17/2022,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Staff_Overall,"February 27, 2021",Local,France,FRA,,Dijon,"May 11, 2020","May 25, 2020",Health care workers and caregivers,Adults (18-64 years),663,1.80%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/19/2021,3/2/2024,Verified
210227_GeorgesFrancoisLeclercCancerCentre_CentreGeorgesFrancoisLeclerc_Patients_Overall,"February 27, 2021",Local,France,FRA,,Dijon,"May 25, 2020","June 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1011,1.70%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Francois Leclerc,https://dx.doi.org/10.1016/j.ejca.2021.02.027,4/19/2021,3/2/2024,Verified
210322_GrandEst_StrasbourgUniversityHospital_KidneyTransplantPatients,"March 22, 2021",Local,France,FRA,Grand Est,,,"September 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,780,6.20%,,,Convenience,"NA,Abbott Laboratories,EUROIMMUN,Biosynex,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd)",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Sophie Caillard,Strasbourg University Hospital,https://dx.doi.org/10.1097/TP.0000000000003766,4/19/2021,3/2/2024,Verified
210415_France_InstitutPasteur_HighSchool1_overall,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"March 30, 2020","April 4, 2020",Students and Daycares,Multiple groups,664,25.10%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,5/6/2021,7/17/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_overall,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"April 28, 2020","April 30, 2020",Students and Daycares,Multiple groups,1340,10.40%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,5/6/2021,7/17/2022,Unverified
210208_Paris_JeanVerdierHospital_DaycareStaff2_Overall_TestAdj,"February 8, 2021",National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Essential non-healthcare workers,Adults (18-64 years),197,6.80%,3.20%,11.50%,Convenience,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,5/10/2021,8/15/2023,Verified
210208_Paris_JeanVerdierHospital_HCW3_Overall_TestAdj,"February 8, 2021",National,France,FRA,"Île-de-France, Auvergne-Rhône-Alpes, Normandy","Paris, Annecy, Rouen","June 4, 2020","July 3, 2020",Health care workers and caregivers,Adults (18-64 years),164,5.00%,1.60%,9.80%,Unclear,Biosynex,LFIA,"IgM,IgG",91.80%,99.20%,High,Journal Article (Peer-Reviewed),Eric Lachassinne,Jean Verdier Hospital,https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,5/10/2021,8/15/2023,Verified
210101_Montpellier_UniversityHospitalMontpellier_HCW,"October 30, 2020",Local,France,FRA,,Montpellier,"April 21, 2020","June 3, 2020",Health care workers and caregivers,Adults (18-64 years),647,2.01%,0.93%,3.09%,Unclear,NA,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Marie Bistoquet,University Hospital Montpellier,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30505-3/fulltext,5/20/2021,7/17/2022,Verified
210428_Europe_SorbonneUniversité_2Île-de-France,"April 28, 2021",Regional,France,FRA,Île-de-France,,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,593,7.10%,,,Convenience,"Abbott Laboratories,Siemens,DiaSorin,Beckman Coulter,Roche Diagnostics",Not reported,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),David Saadoun,Sorbonne Université,https://dx.doi.org/10.1016/S2665-9913(21)00112-0,5/29/2021,3/2/2024,Verified
210513_Lyon_CentreHospitalierSaintJosephSaintLuc,"May 13, 2021",Local,France,FRA,Auvergne-Rhône-Alpes,Lyon,"June 8, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),971,9.00%,8.80%,9.20%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",99.00%,99.00%,High,Journal Article (Peer-Reviewed),Emmanuel Vivier,Centre Hospitalier Saint Joseph Saint Luc,https://dx.doi.org/10.1186/s13613-021-00868-8,5/29/2021,3/2/2024,Verified
210510_Paris_GroupeHospitalierNordEssonneLongjumeau,"May 10, 2021",Local,France,FRA,Île-de-France,Paris,"May 8, 2020","July 27, 2020",Contacts of COVID patients,Multiple groups,120,39.00%,,,Convenience,NA,LFIA,"IgG,IgM",100.00%,100.00%,High,Journal Article (Peer-Reviewed),Lorelei Charbonnier,Groupe Hospitalier Nord Essonne Longjumeau,https://dx.doi.org/10.3389/fped.2021.638502,6/6/2021,7/17/2022,Unverified
210531_Marseille_HôpitauxdeMarseille,"May 31, 2021",Local,France,FRA,Provence-Alpes-Côte d'Azur,Marseille,"June 1, 2020","August 5, 2020",Persons experiencing homelessness,Adults (18-64 years),1156,5.62%,2.90%,7.21%,Convenience,Biosynex,Not reported,"IgG,IgM",100.00%,99.50%,Moderate,Preprint,Sandrine Loubiere,Hôpitaux de Marseille,https://europepmc.org/article/PPR/PPR350578,6/7/2021,3/2/2024,Unverified
210521_France_SantePubliqueFrance_March1_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,"March 9, 2020","March 15, 2020",Residual sera,Multiple groups,3834,0.41%,0.05%,0.88%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/8/2021,7/17/2022,Verified
210521_France_SantePubliqueFrance_April2_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,"April 6, 2020","April 12, 2020",Residual sera,Multiple groups,3595,4.14%,3.31%,4.99%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/8/2021,7/17/2022,Verified
210521_France_SantePubliqueFrance_May3_Overall_PopAdj_TestAdj,"May 21, 2021",National,France,FRA,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-France, Centre-Val-de-Loire,  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur",,"May 11, 2020","May 17, 2020",Residual sera,Multiple groups,3592,4.93%,4.02%,5.89%,Stratified probability,NA,Multiple Types,"IgG,Neutralizing ",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Stephane Le Vu,Santé publique France,https://dx.doi.org/10.1038/s41467-021-23233-6,6/8/2021,7/17/2022,Verified
210525_Paris_SamusocialDeParis_Residents_Overall,"May 25, 2021",Local,France,FRA,Ile de France,Paris,"March 1, 2020","May 31, 2020",Persons experiencing homelessness,Multiple groups,96,69.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,6/30/2021,3/2/2024,Unverified
210525_Paris_SamusocialDeParis_Staff_Overall,"May 25, 2021",Local,France,FRA,Ile de France,Paris,"March 1, 2020","May 31, 2020",Essential non-healthcare workers,Multiple groups,81,18.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,96.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Maya Husain,Samusocial de Paris,http://dx.doi.org/10.1016/j.cmi.2021.05.039,6/30/2021,3/2/2024,Unverified
210604_Nancy_UniversiteDeLorraine_Overall_PopAdj,"June 4, 2021",Local,France,FRA,Grand Est,Nancy,"June 26, 2020","July 24, 2020",Household and community samples,Multiple groups,2006,2.50%,1.80%,3.30%,Convenience,"Bio-rad,Biosynex,EUROIMMUN",ELISA,"IgG,IgM,IgA,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Anne Petit,Université de Lorraine,http://dx.doi.org/10.3390/v13061076,7/1/2021,3/2/2024,Verified
210623_Marseille_Aix-MarseilleUniversity,"June 23, 2021",Local,France,FRA,Provence,Marseille,"June 1, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,99,6.10%,,,Convenience,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Emilie Mosnier,Aix-Marseille University,https://dx.doi.org/10.1016/j.puhip.2021.100154,7/7/2021,3/2/2024,Verified
210706_France_InstitutdeCancérologiedel’Ouest_patients_primary,"July 6, 2021",Regional,France,FRA,"Western France, Eastern France, Central France",,"July 17, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,878,6.70%,,,Convenience,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,7/14/2021,3/2/2024,Unverified
210706_France_InstitutdeCancérologiedel’Ouest_HCW_primary,"July 6, 2021",Regional,France,FRA,"Western France, Eastern France, Central France",,"July 17, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),940,7.80%,,,Self-referral,NG Biotech Laboratoires,LFIA,"IgG,IgM",100.00%,95.30%,High,Journal Article (Peer-Reviewed),Ke Zhou ,Institut de Cancérologie de l’Ouest,http://dx.doi.org/10.3390/cancers13143389,7/14/2021,3/2/2024,Unverified
210518_Paris_HopitalBichat-ClaudeBernard,"May 18, 2021",Local,France,FRA,,Paris,"May 12, 2020","June 2, 2020",Health care workers and caregivers,Adults (18-64 years),72,15.30%,6.90%,23.70%,Convenience,"AAZ LMB,NG Biotech Laboratoires,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Charlotte Charpentier,Hopital Bichat-Claude Bernard,https://dx.doi.org/10.1016/j.diagmicrobio.2021.115430,7/14/2021,3/2/2024,Unverified
210713_Strasbourg_HôpitauxUniversitairesdeStrasbourg_primary,"July 13, 2021",Local,France,FRA,,Strasbourg,"May 18, 2020","July 2, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,469,6.60%,,,Convenience,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Renaud Felten,Hôpitaux Universitaires de Strasbourg studied patienst with rare autoimmune diseases (n=469) and found a seroprevalence of 6.6%,https://dx.doi.org/10.1186/s13075-021-02565-0,7/20/2021,7/17/2022,Unverified
210721_Nancy_CHRUNancy_Primary,"July 21, 2021",Local,France,FRA,,Nancy,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Multiple groups,396,2.30%,,,Entire sample,Biosynex,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),C Hartard,Nancy University Hospital,https://dx.doi.org/10.1017/ice.2021.334,7/28/2021,3/2/2024,Unverified
210723_France_InstitutPasteur_overall_Luminex+Neut,"July 23, 2021",National,France,FRA,,,"February 15, 2020","August 15, 2020",Residual sera,Multiple groups,2399,5.29%,,,Convenience,NA,Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tom Woudenberg,Institut Pasteur,https://dx.doi.org/10.1016/j.ebiom.2021.103495,8/2/2021,7/17/2022,Verified
210722_Lyon_UniversitéClaudeBernardLyon1_overall,"July 22, 2021",Local,France,FRA,,Lyon,"May 10, 2020","June 28, 2020",Health care workers and caregivers,Adults (18-64 years),190,3.68%,,,Convenience,"Beijing Wantai Biological,BioMérieux",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Antonin Bal,Université Claude Bernard Lyon 1,https://dx.doi.org/10.1038/s41598-021-93828-y,8/3/2021,3/2/2024,Verified
210726_Corsica_UniversitédeCorse_Overall_PopTestAdj,"July 26, 2021",Regional,France,FRA,Corsica,,"November 6, 2020","February 12, 2021",Residual sera,Multiple groups,4505,8.70%,,,Convenience,EUROIMMUN,ELISA,IgG,90.30%,99.80%,Moderate,Journal Article (Peer-Reviewed),Lisandru Capai,Université de Corse,https://dx.doi.org/10.3389/fpubh.2021.715192,8/17/2021,8/15/2023,Verified
210727_FrenchAlps_AnnecyGenevoisHospital,"July 27, 2021",Regional,France,FRA,French Alps Region,,"June 27, 2020","September 30, 2020",Health care workers and caregivers,Adults (18-64 years),3454,5.00%,4.30%,5.80%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Virginie Vitrat,Annecy Genevois Hospital,http://dx.doi.org/10.3390/vaccines9080824,8/18/2021,3/2/2024,Verified
210801_Europe_UniversityHospitalsPitiéSalpêtrière_Primary,"August 1, 2021",National,France,FRA,,,"June 7, 2020","December 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,3028,5.50%,,,Unclear,NA,Not reported,Not reported,,,High,Presentation or Conference,D Saadoun,University Hospitals Pitié Salpêtrière,http://dx.doi.org/10.1136/annrheumdis-2021-eular.3368,8/25/2021,7/17/2022,Unverified
210812_Amiens_UniversitéPicardieJules-Verne_NH,"August 12, 2021",Local,France,FRA,Hauts-de-France  ,Amiens,"June 15, 2020","June 16, 2020",Assisted living and long-term care facilities,Seniors (65+ years),107,88.70%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Julien Moyet,Université Picardie Jules-Verne,https://www.jle.com/10.1684/pnv.2021.0952,8/31/2021,3/2/2024,Unverified
210812_Amiens_UniversitéPicardieJules-Verne_LTC,"August 12, 2021",Local,France,FRA,Hauts-de-France  ,Amiens,"June 15, 2020","June 16, 2020",Assisted living and long-term care facilities,Seniors (65+ years),114,45.60%,,,Convenience,Abbott Laboratories,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Julien Moyet,Université Picardie Jules-Verne,https://www.jle.com/10.1684/pnv.2021.0952,8/31/2021,3/2/2024,Unverified
210906_Strasbourg_CHUdeStrasbourg_Overall,"September 6, 2021",Local,France,FRA,Grand Est,Strasbourg,"June 22, 2020","November 1, 2020",Health care workers and caregivers,Adults (18-64 years),5694,8.47%,,,Convenience,Biosynex,LFIA,"IgG,IgM",93.00%,99.00%,High,Journal Article (Peer-Reviewed),Baptiste Panaget,Centres Hospitaliers et Universitaires de Strasbourg ,https://dx.doi.org/10.1017/ice.2021.402,9/15/2021,3/2/2024,Unverified
210920_France_ToulouseUniversityHospital,"September 21, 2021",National,France,FRA,,,"June 10, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),8758,3.20%,,,Unclear,Beijing Wantai Biological,ELISA,Total Antibody,,,Unclear,Journal Article (Peer-Reviewed),Chloe Dimeglio,Tolouse University Hospital,https://dx.doi.org/10.1016/j.jinf.2021.09.013,10/6/2021,3/2/2024,Verified
211014_Marseille_AixMarseilleUniversity,"October 14, 2021",Local,France,FRA,,Marseille,"April 2, 2020","April 6, 2020",Essential non-healthcare workers,Adults (18-64 years),85,25.88%,,,Entire sample,NA,Not reported,Neutralizing ,,,High,Journal Article (Peer-Reviewed),Guillaume Durand,Aix Marseille University,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.41.2001676,10/24/2021,7/17/2022,Unverified
211019_Paris_HopitalEuropeenGeorgesPompidou_Primary,"October 19, 2021",Local,France,FRA,,Paris,"March 5, 2020","December 4, 2020",Health care workers and caregivers,Adults (18-64 years),3186,12.10%,11.00%,13.30%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maxime Wack,Hopital Europeen Georges Pompidou,https://dx.doi.org/10.1016/j.jcv.2021.104999,11/3/2021,3/2/2024,Unverified
211026_France_UniversitéParisSaclay_November(Round2)_Primary,"October 26, 2021",National,France,FRA,,,"November 1, 2020","November 30, 2020",Household and community samples,Multiple groups,63524,6.20%,5.90%,6.60%,Simplified probability,EUROIMMUN,ELISA,IgG,94.40%,,Low,Preprint,Josiane Warszawski,Université Paris-Saclay,https://www.medrxiv.org/content/10.1101/2021.10.25.21265456v1.full-text,11/4/2021,3/2/2024,Verified
211021_France_UNIVIsanté,"October 21, 2021",National,France,FRA,,,"August 31, 2020","October 16, 2020",Assisted living and long-term care facilities,Seniors (65+ years),1141,14.40%,12.40%,16.40%,Unclear,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Marc Harboun,UNIVI santé,https://dx.doi.org/10.1016/j.revmed.2021.10.330,11/11/2021,7/17/2022,Unverified
211108_France_UniversitedeParis_Overall,"November 8, 2021, November 8, 2021",National,France,FRA,,,"May 15, 2020","November 15, 2020",Household and community samples,Adults (18-64 years),26823,4.07%,,,Convenience,EUROIMMUN,ELISA,IgG,87.00%,97.50%,Moderate,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","Joane Matta, Joane Matta",Universite de Paris,"https://dx.doi.org/10.1001/jamainternmed.2021.6454, https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2785832",11/18/2021,7/17/2022,Verified
211109_Strasbourg_StrasbourgUniversityHospitals_V0,"November 9, 2021",Local,France,FRA,,Strasbourg,"April 6, 2020","May 7, 2020",Health care workers and caregivers,Multiple groups,1497,34.40%,,,Stratified probability,"Biosynex,Epitope Diagnostics, Inc.",Multiple Types,"IgG,IgM",,,High,Preprint,A Velay,Strasbourg University Hospitals,https://dx.doi.org/10.1016/j.idnow.2021.11.002,11/23/2021,3/2/2024,Unverified
211111_Rennes_RennesUniversityHospital_Primary,"November 11, 2021",Local,France,FRA,,Rennes,"May 29, 2020","July 10, 2020",Health care workers and caregivers,Adults (18-64 years),3234,3.80%,,,Convenience,"NG Biotech Laboratoires,Beijing Wantai Biological",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Christophe Paris,Rennes University Hospital,https://dx.doi.org/10.1016/j.ajic.2021.11.001,11/25/2021,3/2/2024,Unverified
210528_Lille_OscarLambretComprehensiveCancerCenter,"May 28, 2021",Local,France,FRA,Hauts-de-France,Lille,"May 4, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),392,1.80%,0.70%,3.60%,Convenience,NA,LFIA,Not reported,,,High,Presentation or Conference,Philippe Doutrelant,Oscar Lambret Comprehensive Cancer Center,https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e13604,12/1/2021,1/3/2023,Unverified
211123_Perpignan_PerpignanHospitalCenter_Overall,"November 23, 2021",Local,France,FRA,Occitanie,Perpignan,"June 29, 2020","July 17, 2020",Household and community samples,Multiple groups,700,35.40%,30.20%,41.00%,Stratified probability,Roche Diagnostics,CLIA,"IgM,IgG",99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Adeline Beaumont,Perpignan Hospital Center,https://dx.doi.org/10.1136/bmjopen-2021-053201,12/2/2021,3/2/2024,Unverified
211125_France_UnitédesVirusÉmergents_Overall_PopAdjusted,"November 25, 2021",National,France,FRA,"Haut de France, Normandi, Ile de France, Bretagne, Grand Est, Bourgogne France Comte, Centre val de Loire, Auvergne Rhome Alpes, Pays de Loire, Occitanie, Nouvelle Aquitaine, Provence-Alpes-Côte d'Azur",,"May 4, 2020","September 30, 2020",Household and community samples,Multiple groups,82126,5.10%,4.90%,5.40%,Convenience,EUROIMMUN,ELISA,IgG,87.00%,97.50%,Moderate,Journal Article (Peer-Reviewed),Fabrice Carrat,Unité des Virus Émergents,https://dx.doi.org/10.1007/s15010-021-01731-5,12/3/2021,3/2/2024,Verified
211130_France_SorbonneParisNordUniversity_Primary,"November 30, 2021",National,France,FRA,,,"May 15, 2020","October 15, 2020",Blood donors,Multiple groups,7766,4.00%,,,Self-referral,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Melanie Deschasaux-Tanguy,Sorbonne Paris Nord University,https://dx.doi.org/10.1186/s12916-021-02168-1,12/7/2021,3/2/2024,Unverified
211201_Ermont_CliniqueClaudeBernard_Overall,"December 1, 2021",Local,France,FRA,Île-de-France,Ermont,"September 15, 2020","October 15, 2020",Residual sera,Multiple groups,299,19.70%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Henri Boulanger,Clinique Claude Bernard,https://dx.doi.org/10.1155/2021/4747221,12/17/2021,3/2/2024,Unverified
211201_NorthernFrance_CentreHospitalierdeTourcoing,"December 1, 2021",Local,France,FRA,Northern France,Tourcoing,"April 1, 2020","August 1, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,600,2.70%,,,Convenience,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Agnes Meybeck,Centre Hospitalier de Tourcoing,https://dx.doi.org/10.3390/microorganisms9122491,1/11/2022,7/17/2022,Unverified
211206_CochinHospital_ParisDescartesUniversity_Overall_Nonly,"December 6, 2021",Local,France,FRA,Île-de-France,Paris,"June 1, 2020","August 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,283,2.83%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Clothilde Gros,Paris Descartes Université,https://dx.doi.org/10.1016/j.jbspin.2021.105312,1/12/2022,3/2/2024,Unverified
220109_France_UniversityofParisSaclay_Overall_PopAdj,"January 9, 2022",National,France,FRA,,,"May 2, 2020","June 2, 2020",Household and community samples,Multiple groups,12114,4.50%,3.90%,5.00%,Stratified non-probability,EUROIMMUN,ELISA,IgG,94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Josiane Warszawski,University of Paris-Saclay,https://dx.doi.org/10.1186/s12879-021-06973-0,1/18/2022,3/2/2024,Verified
210415_France_InstitutPasteur_HighSchool1_Under12,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"March 30, 2020","April 4, 2020",Students and Daycares,Children and Youth (0-17 years),8,0.00%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,2/8/2022,7/17/2022,Unverified
210415_France_InstitutPasteur_HighSchool1_12-17,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"March 30, 2020","April 4, 2020",Students and Daycares,Children and Youth (0-17 years),235,34.90%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,2/8/2022,7/17/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_Under12,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"April 28, 2020","April 30, 2020",Students and Daycares,Children and Youth (0-17 years),538,8.60%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,2/8/2022,7/17/2022,Unverified
210415_France_InstitutPasteur_PrimarySchool2_12-17,"April 15, 2021",Local,France,FRA,Hauts-de-France,,"April 28, 2020","April 30, 2020",Students and Daycares,Children and Youth (0-17 years),78,15.40%,,,Convenience,NA,ELISA,IgG,99.40%,99.00%,High,Journal Article (Peer-Reviewed),Arnaud Fontanet,Institut Pasteur,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.15.2001695,2/8/2022,7/17/2022,Unverified
220210_Corte_UniversitéDeCorsePascalPaoli_TestAdjusted,"February 10, 2022",Local,France,FRA,Corsica,Corte,"November 23, 2020","January 31, 2021",Students and Daycares,Adults (18-64 years),418,12.80%,9.80%,16.60%,Convenience,EUROIMMUN,ELISA,IgG,99.80%,90.30%,High,Journal Article (Peer-Reviewed),Dorine Decarreaux,Université De Corse Pascal Paoli,https://dx.doi.org/10.3390/ijerph19041953,2/25/2022,8/15/2023,Unverified
220131_Dijon_CentreGeorgesFrancoisLeclerc_HCWs_Primary,"January 31, 2022",Local,France,FRA,,,"January 12, 2021","January 22, 2021",Health care workers and caregivers,Multiple groups,502,15.10%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Franc ois Leclerc,https://dx.doi.org/10.1016/j.ejca.2022.01.005,3/9/2022,3/2/2024,Unverified
220131_Dijon_CentreGeorgesFrancoisLeclerc_Patients_Primary,"January 31, 2022",Local,France,FRA,,,"January 25, 2021","February 26, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,507,4.10%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Sylvain Ladoire,Centre Georges Franc ois Leclerc,https://dx.doi.org/10.1016/j.ejca.2022.01.005,3/9/2022,3/2/2024,Unverified
220219_Italy_UniversityofVerona_Primary,"February 19, 2022",Local,France,FRA,,,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),1957,19.10%,,,Unclear,Abbott Laboratories,CLIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Alessandra Ruggiero,University of Verona,https://dx.doi.org/10.1016/j.ebiom.2022.103888,3/9/2022,3/2/2024,Unverified
220308_RobertDebréHospital_ParisUniversity_Psychiatric,"March 8, 2022",Local,France,FRA,Île-de-France,Paris,"December 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),52,9.61%,3.59%,21.80%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anael Ayrolles,Paris University,https://dx.doi.org/10.1002/npr2.12236,3/15/2022,3/2/2024,Verified
220308_RobertDebréHospital_ParisUniversity_Emergency,"March 8, 2022",Local,France,FRA,Île-de-France,Paris,"December 15, 2020","April 15, 2021",Residual sera,Children and Youth (0-17 years),52,34.61%,22.33%,49.16%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Anael Ayrolles,Paris University,https://dx.doi.org/10.1002/npr2.12236,3/15/2022,3/2/2024,Verified
220307_Marseille_HopitauxdeMarseille_Campaign2,"March 7, 2022",Local,France,FRA,Provence-Alpes-Côte d'Azur,Marseille,"September 11, 2020","December 18, 2020",Persons experiencing homelessness,Multiple groups,721,18.86%,,,Convenience,Biosynex,Not reported,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Agathe Allibert,Hôpitaux de Marseille,https://dx.doi.org/10.3390/ijerph19053129,3/22/2022,3/2/2024,Unverified
220420_France_HopitalLaPorteVerte_HCWs_Primary,"April 20, 2022",National,France,FRA,,,"July 24, 2020","October 16, 2020",Health care workers and caregivers,Adults (18-64 years),1334,12.80%,11.00%,14.70%,Unclear,NA,ELISA,Not reported,,,High,Journal Article (Peer-Reviewed),A. de Malherbe,UNIVI Group,https://dx.doi.org/10.1007/s12603-022-1780-1,5/4/2022,7/17/2022,Unverified
220420_France_HopitalLaPorteVerte_Residents_Primary,"April 20, 2022",National,France,FRA,,,"July 24, 2020","October 16, 2020",Assisted living and long-term care facilities,Seniors (65+ years),1145,14.40%,12.40%,16.60%,Unclear,NA,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),A. de Malherbe,UNIVI Group,https://dx.doi.org/10.1007/s12603-022-1780-1,5/4/2022,7/17/2022,Unverified
220504_Paris_SorbonneUniversité,"May 4, 2022",Local,France,FRA,Île-de-France,Paris,"March 16, 2020","April 24, 2020",Health care workers and caregivers,Adults (18-64 years),1060,5.90%,4.70%,7.50%,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pierre Hausfater,Sorbonne Université,https://dx.doi.org/10.1038/s41598-022-10945-y,5/11/2022,3/2/2024,Unverified
220511_Amiens_CHUAmiensPicardie_Overall,"May 11, 2022",Local,France,FRA,,Amiens,"May 18, 2020","July 26, 2020",Health care workers and caregivers,Adults (18-64 years),4840,9.70%,7.00%,12.40%,Convenience,Beijing Wantai Biological,ELISA,"Total Antibody,IgG",94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marion Pierson-Marchandise,CHU Amiens-Picardie,https://dx.doi.org/10.1136/bmjopen-2020-047010,5/25/2022,3/2/2024,Unverified
220503_France_UniversitédeCorsePascalPaoli_Neutralizing_Overall,"May 3, 2022",National,France,FRA,,,"May 10, 2021","August 31, 2021",Health care workers and caregivers,Multiple groups,1612,81.30%,79.40%,83.20%,Convenience,NA,Neutralization,Neutralizing ,,100.00%,Moderate,Journal Article (Peer-Reviewed),Dorine Decarreaux,Université de Corse Pascal Paoli,https://dx.doi.org/10.3390/v14050957,6/5/2022,7/17/2022,Unverified
220516_Nancy_CHRU-Nancy_Overall,"May 16, 2022",Local,France,FRA,,Nancy,"May 25, 2020","June 29, 2020",Health care workers and caregivers,Multiple groups,4696,5.10%,,,Convenience,"NA,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),EUROIMMUN",Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Stephanie Weber ,CHRU-Nancy,https://dx.doi.org/10.1016/j.idh.2022.05.002,6/10/2022,3/2/2024,Unverified
220601_Ile-de-France_HopitalPitie-Salpetriere_Overall,"June 1, 2022",Regional,France,FRA,Ile-de-France,,"April 15, 2020","September 15, 2021",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1901,13.40%,11.90%,15.00%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Basma Abdi,Hopital Pitie Salpetriere,https://dx.doi.org/10.1016/j.jinf.2022.05.036,6/15/2022,3/2/2024,Unverified
220601_Paris_HopitaldeFresnes,"June 1, 2022",Local,France,FRA,,Paris,"January 14, 2021","July 8, 2021",Persons who are incarcerated,Multiple groups,1014,18.20%,16.90%,19.40%,Unclear,Roche Diagnostics,CLIA,Not reported,,,High,Journal Article (Peer-Reviewed),Guillaume Mellon,Hopital Paul Brousse,https://dx.doi.org/10.1016/j.jinf.2022.05.032,6/24/2022,3/2/2024,Unverified
220412_Paris_AssistancePublique–HopitauxdeParis_SAPRIS-Sero_Overall,"April 12, 2022",Local,France,FRA,,Paris,"May 1, 2020","October 31, 2020",Household and community samples,Adults (18-64 years),844,9.20%,,,Convenience,EUROIMMUN,ELISA,IgG,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Constance Delaugerre,Universit de Paris,https://dx.doi.org/10.1093/ofid/ofac188,7/13/2022,3/2/2024,Unverified
220412_Paris_AssistancePublique–HopitauxdeParis_PREVENIR_Overall,"April 12, 2022",Local,France,FRA,,Paris,"May 1, 2020","October 31, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),844,10.80%,,,Convenience,Abbott Laboratories,CLIA,IgG,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Constance Delaugerre,Universit de Paris,https://dx.doi.org/10.1093/ofid/ofac188,7/13/2022,3/2/2024,Unverified
220713_AixMarseilleProvence_CentredeNéphrologieetTransplantationRénale_Caregiver_FU2,"July 13, 2022",Local,France,FRA,,Aix-en-Provence,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),191,12.60%,8.20%,18.10%,Convenience,Biosynex,LFIA,"IgG,IgM",82.90%,97.70%,High,Journal Article (Peer-Reviewed),Thomas Robert,Centre de Néphrologie et Transplantation Rénale,https://dx.doi.org/10.1038/s41598-022-15913-0,7/21/2022,3/2/2024,Unverified
220713_AixMarseilleProvence_CentredeNéphrologieetTransplantationRénale_Patients_FU2,"July 13, 2022",Local,France,FRA,,Aix-en-Provence,"December 1, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),382,13.80%,10.50%,17.70%,Convenience,Biosynex,LFIA,"IgG,IgM",82.90%,97.70%,High,Journal Article (Peer-Reviewed),Thomas Robert,Centre de Néphrologie et Transplantation Rénale,https://dx.doi.org/10.1038/s41598-022-15913-0,7/21/2022,3/2/2024,Unverified
220805_Ile-de-France_EtablissementFrancaisduSang_July2021_Euroimmun,"August 5, 2022",Regional,France,FRA,Ile-de-France ,,"July 1, 2021","July 17, 2021",Blood donors,Multiple groups,1001,83.00%,,,Sequential,EUROIMMUN,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unité des Virus Émergents,https://dx.doi.org/10.1016/j.tracli.2022.08.002,8/20/2022,4/3/2024,Verified
220805_Ile-de-France_EtablissementFrancaisduSang_Jan2021_Euroimmun,"August 5, 2022",Regional,France,FRA,Ile-de-France ,,"January 1, 2021","January 31, 2021",Blood donors,Multiple groups,875,8.57%,,,Sequential,EUROIMMUN,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Pierre Gallian,Unité des Virus Émergents,https://dx.doi.org/10.1016/j.tracli.2022.08.002,8/20/2022,4/3/2024,Verified
220913_HauteBretagne_CHUdeRennes,"September 13, 2022",Regional,France,FRA,Brittany,,"May 29, 2020","July 10, 2020",Health care workers and caregivers,Multiple groups,9453,1.06%,0.86%,1.27%,Unclear,NG Biotech Laboratoires,LFIA,IgG,,,Moderate,Preprint,Ronan Garlantezec,CHU de Rennes,https://dx.doi.org/10.1016/j.idnow.2022.09.004,10/3/2022,3/2/2024,Unverified
221109_France_SorbonneUniversity,"November 9, 2022",National,France,FRA,,,"May 1, 2020","November 30, 2020",Household and community samples,Multiple groups,53047,1.68%,,,Unclear,"EUROIMMUN,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Olivier Robineau,Sorbonne University,https://dx.doi.org/10.1001/jamanetworkopen.2022.40985,11/17/2022,3/2/2024,Unverified
221118_France_UniversitedeCorsePascalPaoli_Phase1_AntiS,"November 18, 2022",Local,France,FRA,,Corte,"November 23, 2020","January 31, 2021",Multiple populations,Adults (18-64 years),295,11.50%,8.20%,15.90%,Convenience,EUROIMMUN,ELISA,IgG,90.30%,99.80%,Moderate,Journal Article (Peer-Reviewed),Dorine Decarreaux,Universite de Corse Pascal Paoli,https://dx.doi.org/10.3390/ijerph192215257,12/6/2022,3/2/2024,Unverified
221118_France_UniversitedeCorsePascalPaoli_Phase2_AntiS,"November 18, 2022",Local,France,FRA,,Corte,"March 1, 2021","May 9, 2021",Multiple populations,Adults (18-64 years),295,10.50%,7.40%,14.70%,Convenience,EUROIMMUN,ELISA,IgG,90.30%,99.80%,Moderate,Journal Article (Peer-Reviewed),Dorine Decarreaux,Universite de Corse Pascal Paoli,https://dx.doi.org/10.3390/ijerph192215257,12/6/2022,3/2/2024,Unverified
221118_France_UniversitedeCorsePascalPaoli_Phase3_AntiS,"November 18, 2022",Local,France,FRA,,Corte,"June 14, 2021","July 31, 2021",Multiple populations,Adults (18-64 years),295,68.50%,62.80%,73.70%,Convenience,EUROIMMUN,ELISA,IgG,90.30%,99.80%,Moderate,Journal Article (Peer-Reviewed),Dorine Decarreaux,Universite de Corse Pascal Paoli,https://dx.doi.org/10.3390/ijerph192215257,12/6/2022,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Multiple groups,2232,7.53%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Multiple groups,3241,7.22%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Multiple groups,2951,6.13%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Multiple groups,6009,5.34%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Multiple groups,6156,7.81%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_Overall,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Multiple groups,12016,8.21%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,3/8/2023,3/2/2024,Unverified
230223_Marseille_HopitauxdeMarseille_FirstCampaign,"February 23, 2023",Local,France,FRA,,Marseille,"June 5, 2020","August 5, 2020",Persons experiencing homelessness,Adults (18-64 years),1241,6.00%,,,Convenience,Biosynex,,,,,,Journal Article (Peer-Reviewed),Emilie Mosnier,Hopitaux de Marseille,https://dx.doi.org/10.1136/bmjopen-2022-065734,4/4/2023,3/2/2024,Unverified
230223_Marseille_HopitauxdeMarseille_SecondCampaign,"February 23, 2023",Local,France,FRA,,Marseille,"September 11, 2020","December 18, 2020",Persons experiencing homelessness,Adults (18-64 years),721,18.90%,,,Convenience,Biosynex,,,,,,Journal Article (Peer-Reviewed),Emilie Mosnier,Hopitaux de Marseille,https://dx.doi.org/10.1136/bmjopen-2022-065734,4/4/2023,3/2/2024,Unverified
230323_France_SorbonneParisNordUniversity_Primary_AntiS-AntiN-nAb,"March 23, 2023",National,France,FRA,,,"May 15, 2020","November 15, 2020",Household and community samples,Multiple groups,67340,1.01%,,,Convenience,"EUROIMMUN,NA",,"IgG,Neutralizing ",,,,Journal Article (Peer-Reviewed),Melanie Deschasaux-Tanguy,Sorbonne Paris Nord University,https://dx.doi.org/10.1038/s41598-023-30714-9,4/26/2023,3/2/2024,Unverified
220502_Bordeaux_UnitéDeRechercheEtD’épidémiologieCliniques_Overall,"May 2, 2022",Local,France,FRA,,Bordeaux,"June 15, 2020","September 15, 2021",Health care workers and caregivers,Multiple groups,517,10.64%,,,Convenience,NA,,IgG,,,,Presentation or Conference,C. Cantarel,Unité de recherche et d’épidémiologie cliniques,https://dx.doi.org/10.1016/j.respe.2022.03.083,5/6/2023,5/6/2023,Unverified
230405_France_HopitalHotelDieu,"April 5, 2023",National,France,FRA,,,"May 15, 2020","November 15, 2020",Household and community samples,Multiple groups,20985,4.19%,,,Stratified probability,EUROIMMUN,ELISA,IgG,87.00%,97.50%,Moderate,Journal Article (Peer-Reviewed),Joane Matta,Hôtel Dieu Hospital,https://dx.doi.org/10.1016/j.jpsychores.2023.111326,5/9/2023,4/23/2024,Verified
230511_France_SorbonneUniversiteprim,"May 11, 2023",National,France,FRA,,,"October 26, 2020","December 14, 2020",Household and community samples,Multiple groups,45260,9.40%,9.10%,9.80%,Stratified probability,EUROIMMUN,ELISA,,86.40%,96.20%,,Journal Article (Peer-Reviewed),Alexandra Rouquette,Sorbonne University,https://dx.doi.org/10.1001/jamanetworkopen.2023.12892,6/1/2023,3/2/2024,Unverified
230525_Bordeaux_ComprehensiveCancerCenter_12m_Overall,"May 25, 2023",Local,France,FRA,Nouvelle-Aquitaine,Bordeaux,"June 10, 2021","October 4, 2021",Health care workers and caregivers,Adults (18-64 years),462,93.29%,,,Convenience,"Roche Diagnostics,EUROIMMUN",,"Total Antibody,IgG",,,,Journal Article (Peer-Reviewed),Brice Richez,Comprehensive Cancer Center,https://dx.doi.org/10.3390/ijerph20115949,6/28/2023,3/2/2024,Unverified
230501_Orleans_UnitederecherchecliniquePARADICT-O,"May 1, 2023",Regional,France,FRA,Centre Val de Loire,,"August 15, 2020","December 15, 2020",Household and community samples,Adults (18-64 years),3328,3.03%,,,Convenience,AAZ LMB,LFIA,"IgG,IgM",,100.00%,,Journal Article (Peer-Reviewed),Guerrout Hanane,Unite de recherche clinique PARADICT-O,https://dx.doi.org/10.1136/bmjopen-2022-066504,6/29/2023,3/2/2024,Unverified
230828_France_NantesUniversite,"August 28, 2023",National,France,FRA,,,"March 15, 2020","June 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1026,3.70%,,,Convenience,Roche Diagnostics,,,,,,Journal Article (Peer-Reviewed),Margaux Lelong,Nantes Universite,https://dx.doi.org/10.3389/fimmu.2023.1243898,10/6/2023,3/2/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Adults (18-64 years),663,4.98%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_31to40,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Adults (18-64 years),436,13.99%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_41to50,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Adults (18-64 years),527,7.40%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_51to60,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Adults (18-64 years),408,4.90%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T1_61to70,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"March 27, 2020","April 4, 2020",Blood donors,Multiple groups,198,7.58%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Adults (18-64 years),949,5.80%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_31to40,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Adults (18-64 years),581,10.67%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_41to50,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Adults (18-64 years),692,8.67%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_51to60,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Adults (18-64 years),618,6.15%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T2_61to70,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"May 11, 2020","May 29, 2020",Blood donors,Multiple groups,401,4.74%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,4/30/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Adults (18-64 years),827,4.96%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_31to40,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Adults (18-64 years),535,10.47%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_41to50,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Adults (18-64 years),610,5.57%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_51to60,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Adults (18-64 years),593,5.56%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T3_61to70,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"July 1, 2020","July 23, 2020",Blood donors,Multiple groups,386,4.40%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Adults (18-64 years),2049,4.83%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_31to40,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Adults (18-64 years),1045,8.13%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_41to50,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Adults (18-64 years),1178,6.54%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_51to60,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Adults (18-64 years),1097,3.92%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T4_61to70,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"September 28, 2020","October 29, 2020",Blood donors,Multiple groups,640,2.66%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Adults (18-64 years),1821,10.82%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_31to40,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Adults (18-64 years),1308,8.33%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_41to50,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Adults (18-64 years),1305,7.36%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_51to60,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Adults (18-64 years),1095,5.57%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T5_61to70,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"November 3, 2020","November 18, 2020",Blood donors,Multiple groups,627,2.87%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_18to30,"February 15, 2023",National,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Adults (18-64 years),3762,10.90%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_31to40,"February 15, 2023",,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Adults (18-64 years),2191,6.66%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_41to50,"February 15, 2023",,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Adults (18-64 years),2475,7.31%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_51to60,"February 15, 2023",,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Adults (18-64 years),2177,7.90%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
230215_France_EtablissementFrancaisduSang_T6_61to70,"February 15, 2023",,France,FRA,"mainland France, Guadeloupe, Martinique, La Réunion",,"January 14, 2021","February 9, 2021",Blood donors,Multiple groups,1411,5.46%,,,Convenience,EUROIMMUN,,,,,,Journal Article (Peer-Reviewed),Pierre Gallian,Établissement Français du Sang,https://dx.doi.org/10.1016/j.isci.2023.106222,4/30/2024,5/1/2024,Unverified
201213_Helsinki_UniversityofHelsinki_HCW_unadj,"December 13, 2020",Local,Finland,FIN,Uusimaa,Helsinki,"April 22, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),1095,3.00%,,,Convenience,"EUROIMMUN,Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Anu Kantele,University of Helsinki,https://dx.doi.org/10.1016/j.tmaid.2020.101949,2/2/2021,3/2/2024,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W42,"October 7, 2021",National,Finland,FIN,,,"October 11, 2020","October 17, 2020",Household and community samples,Adults (18-64 years),59,1.69%,0.30%,9.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W36,"October 7, 2021",National,Finland,FIN,,,"August 30, 2020","September 5, 2020",Household and community samples,Adults (18-64 years),63,0.00%,0.00%,5.75%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W06,"October 7, 2021",National,Finland,FIN,,,"February 7, 2021","February 13, 2021",Household and community samples,Adults (18-64 years),111,5.41%,2.50%,11.29%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W53,"October 7, 2021",National,Finland,FIN,,,"December 27, 2020","January 2, 2021",Household and community samples,Adults (18-64 years),26,0.00%,0.00%,12.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W11,"October 7, 2021",National,Finland,FIN,,,"March 14, 2021","March 20, 2021",Household and community samples,Adults (18-64 years),104,6.73%,3.30%,13.25%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W23,"October 7, 2021",National,Finland,FIN,,,"June 6, 2021","June 12, 2021",Household and community samples,Adults (18-64 years),68,60.29%,48.42%,71.07%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W21,"October 7, 2021",National,Finland,FIN,,,"May 23, 2021","May 29, 2021",Household and community samples,Adults (18-64 years),93,49.46%,39.53%,59.44%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W27,"October 7, 2021",National,Finland,FIN,,,"July 4, 2021","July 10, 2021",Household and community samples,Adults (18-64 years),12,58.33%,31.95%,80.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W28,"October 7, 2021",National,Finland,FIN,,,"July 11, 2021","July 17, 2021",Household and community samples,Adults (18-64 years),2,100.00%,34.24%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W18,"October 7, 2021",National,Finland,FIN,,,"April 26, 2020","May 2, 2020",Household and community samples,Adults (18-64 years),426,0.47%,0.13%,1.70%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W21,"October 7, 2021",National,Finland,FIN,,,"May 17, 2020","May 23, 2020",Household and community samples,Adults (18-64 years),210,0.48%,0.08%,2.65%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W26,"October 7, 2021",National,Finland,FIN,,,"June 27, 2021","July 3, 2021",Household and community samples,Adults (18-64 years),48,68.75%,54.67%,80.05%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W23,"October 7, 2021",National,Finland,FIN,,,"May 31, 2020","June 6, 2020",Household and community samples,Adults (18-64 years),214,0.47%,0.08%,2.60%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W32,"October 7, 2021",National,Finland,FIN,,,"August 2, 2020","August 8, 2020",Household and community samples,Adults (18-64 years),49,2.04%,0.36%,10.69%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W05,"October 7, 2021",National,Finland,FIN,,,"January 31, 2021","February 6, 2021",Household and community samples,Adults (18-64 years),110,2.73%,0.93%,7.71%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W34,"October 7, 2021",National,Finland,FIN,,,"August 16, 2020","August 22, 2020",Household and community samples,Adults (18-64 years),63,0.00%,0.00%,5.75%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W16,"October 7, 2021",National,Finland,FIN,,,"April 18, 2021","April 24, 2021",Household and community samples,Adults (18-64 years),102,18.63%,12.26%,27.27%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W33,"October 7, 2021",National,Finland,FIN,,,"August 9, 2020","August 15, 2020",Household and community samples,Adults (18-64 years),64,0.00%,0.00%,5.66%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W02,"October 7, 2021",National,Finland,FIN,,,"January 10, 2021","January 16, 2021",Household and community samples,Adults (18-64 years),6,0.00%,0.00%,39.03%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W25,"October 7, 2021",National,Finland,FIN,,,"June 14, 2020","June 20, 2020",Household and community samples,Adults (18-64 years),78,0.00%,0.00%,4.69%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W51,"October 7, 2021",National,Finland,FIN,,,"December 13, 2020","December 19, 2020",Household and community samples,Adults (18-64 years),115,0.87%,0.15%,4.76%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W24,"October 7, 2021",National,Finland,FIN,,,"June 7, 2020","June 13, 2020",Household and community samples,Adults (18-64 years),174,0.00%,0.00%,2.16%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W49,"October 7, 2021",National,Finland,FIN,,,"November 29, 2020","December 5, 2020",Household and community samples,Adults (18-64 years),80,2.50%,0.69%,8.66%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W52,"October 7, 2021",National,Finland,FIN,,,"December 20, 2020","December 26, 2020",Household and community samples,Adults (18-64 years),65,0.00%,0.00%,5.58%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W47,"October 7, 2021",National,Finland,FIN,,,"November 15, 2020","November 21, 2020",Household and community samples,Adults (18-64 years),64,3.12%,0.86%,10.70%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W04,"October 7, 2021",National,Finland,FIN,,,"January 24, 2021","January 30, 2021",Household and community samples,Adults (18-64 years),30,0.00%,0.00%,11.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W10,"October 7, 2021",National,Finland,FIN,,,"March 7, 2021","March 13, 2021",Household and community samples,Adults (18-64 years),64,3.12%,0.86%,10.70%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W28,"October 7, 2021",National,Finland,FIN,,,"July 5, 2020","July 11, 2020",Household and community samples,Adults (18-64 years),51,0.00%,0.00%,7.00%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W48,"October 7, 2021",National,Finland,FIN,,,"November 22, 2020","November 28, 2020",Household and community samples,Adults (18-64 years),85,3.53%,1.21%,9.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W01,"October 7, 2021",National,Finland,FIN,,,"January 3, 2021","January 9, 2021",Household and community samples,Adults (18-64 years),12,0.00%,0.00%,24.25%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W19,"October 7, 2021",National,Finland,FIN,,,"May 3, 2020","May 9, 2020",Household and community samples,Adults (18-64 years),514,0.00%,0.00%,0.74%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W50,"October 7, 2021",National,Finland,FIN,,,"December 6, 2020","December 12, 2020",Household and community samples,Adults (18-64 years),106,0.94%,0.17%,5.15%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W20,"October 7, 2021",National,Finland,FIN,,,"May 10, 2020","May 16, 2020",Household and community samples,Adults (18-64 years),401,0.25%,0.04%,1.40%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W31,"October 7, 2021",National,Finland,FIN,,,"July 26, 2020","August 1, 2020",Household and community samples,Adults (18-64 years),75,1.33%,0.24%,7.17%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W38,"October 7, 2021",National,Finland,FIN,,,"September 13, 2020","September 19, 2020",Household and community samples,Adults (18-64 years),48,2.08%,0.37%,10.90%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W09,"October 7, 2021",National,Finland,FIN,,,"February 28, 2021","March 6, 2021",Household and community samples,Adults (18-64 years),132,2.27%,0.78%,6.47%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W45,"October 7, 2021",National,Finland,FIN,,,"November 1, 2020","November 7, 2020",Household and community samples,Adults (18-64 years),55,5.45%,1.87%,14.85%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W26,"October 7, 2021",National,Finland,FIN,,,"June 21, 2020","June 27, 2020",Household and community samples,Adults (18-64 years),32,0.00%,0.00%,10.72%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W08,"October 7, 2021",National,Finland,FIN,,,"February 21, 2021","February 27, 2021",Household and community samples,Adults (18-64 years),123,6.50%,3.33%,12.31%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W17,"October 7, 2021",National,Finland,FIN,,,"April 19, 2020","April 25, 2020",Household and community samples,Adults (18-64 years),674,0.30%,0.08%,1.08%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,Moderate,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W17,"October 7, 2021",National,Finland,FIN,,,"April 25, 2021","May 1, 2021",Household and community samples,Adults (18-64 years),109,22.94%,16.05%,31.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W44,"October 7, 2021",National,Finland,FIN,,,"October 25, 2020","October 31, 2020",Household and community samples,Adults (18-64 years),56,1.79%,0.32%,9.45%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W12,"October 7, 2021",National,Finland,FIN,,,"March 21, 2021","March 27, 2021",Household and community samples,Adults (18-64 years),73,10.56%,6.66%,20.16%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W03,"October 7, 2021",National,Finland,FIN,,,"January 17, 2021","January 23, 2021",Household and community samples,Adults (18-64 years),5,0.00%,0.00%,43.45%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W19,"October 7, 2021",National,Finland,FIN,,,"May 9, 2021","May 15, 2021",Household and community samples,Adults (18-64 years),52,26.92%,16.77%,40.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W13,"October 7, 2021",National,Finland,FIN,,,"March 28, 2021","April 3, 2021",Household and community samples,Adults (18-64 years),60,8.33%,3.61%,18.07%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W30,"October 7, 2021",National,Finland,FIN,,,"July 19, 2020","July 25, 2020",Household and community samples,Adults (18-64 years),9,11.11%,1.99%,43.50%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W27,"October 7, 2021",National,Finland,FIN,,,"June 28, 2020","July 4, 2020",Household and community samples,Adults (18-64 years),85,0.00%,0.00%,4.32%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W37,"October 7, 2021",National,Finland,FIN,,,"September 6, 2020","September 12, 2020",Household and community samples,Adults (18-64 years),54,0.00%,0.00%,6.64%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W24,"October 7, 2021",National,Finland,FIN,,,"June 13, 2021","June 19, 2021",Household and community samples,Adults (18-64 years),47,57.45%,43.28%,70.49%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W25,"October 7, 2021",National,Finland,FIN,,,"June 20, 2021","June 26, 2021",Household and community samples,Adults (18-64 years),44,72.73%,58.15%,80.67%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W35,"October 7, 2021",National,Finland,FIN,,,"August 23, 2020","August 29, 2020",Household and community samples,Adults (18-64 years),48,2.08%,0.37%,10.90%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W22,"October 7, 2021",National,Finland,FIN,,,"May 30, 2021","June 5, 2021",Household and community samples,Adults (18-64 years),39,48.72%,33.87%,63.80%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W39,"October 7, 2021",National,Finland,FIN,,,"September 20, 2020","September 26, 2020",Household and community samples,Adults (18-64 years),56,1.79%,0.32%,9.45%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W18,"October 7, 2021",National,Finland,FIN,,,"May 2, 2021","May 8, 2021",Household and community samples,Adults (18-64 years),74,28.38%,19.37%,39.52%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W14,"October 7, 2021",National,Finland,FIN,,,"April 4, 2021","April 10, 2021",Household and community samples,Adults (18-64 years),59,6.78%,2.67%,16.18%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W22,"October 7, 2021",National,Finland,FIN,,,"May 24, 2020","May 30, 2020",Household and community samples,Adults (18-64 years),178,0.00%,0.00%,2.11%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W46,"October 7, 2021",National,Finland,FIN,,,"November 8, 2020","November 14, 2020",Household and community samples,Adults (18-64 years),52,1.92%,0.34%,10.12%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W20,"October 7, 2021",National,Finland,FIN,,,"May 16, 2021","May 22, 2021",Household and community samples,Adults (18-64 years),86,44.19%,34.16%,54.71%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W40,"October 7, 2021",National,Finland,FIN,,,"September 27, 2020","October 3, 2020",Household and community samples,Adults (18-64 years),60,1.67%,0.29%,8.86%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W07,"October 7, 2021",National,Finland,FIN,,,"February 14, 2021","February 20, 2021",Household and community samples,Adults (18-64 years),69,7.25%,3.13%,15.87%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W16,"October 7, 2021",National,Finland,FIN,,,"April 12, 2020","April 18, 2020",Household and community samples,Adults (18-64 years),362,0.28%,0.05%,1.55%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W41,"October 7, 2021",National,Finland,FIN,,,"October 4, 2020","October 10, 2020",Household and community samples,Adults (18-64 years),51,0.00%,0.00%,7.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W15,"October 7, 2021",National,Finland,FIN,,,"April 11, 2021","April 17, 2021",Household and community samples,Adults (18-64 years),29,13.79%,5.50%,30.56%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W43,"October 7, 2021",National,Finland,FIN,,,"October 18, 2020","October 24, 2020",Household and community samples,Adults (18-64 years),55,0.00%,0.00%,6.53%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2020-W29,"October 7, 2021",National,Finland,FIN,,,"July 12, 2020","July 18, 2020",Household and community samples,Adults (18-64 years),7,0.00%,0.00%,35.43%,Simplified probability,NA,Multiple Types,"IgG,Neutralizing ",,,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,9/21/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W31,"October 7, 2021",National,Finland,FIN,,,"August 1, 2021","August 7, 2021",Household and community samples,Adults (18-64 years),42,92.86%,80.99%,97.54%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W30,"October 7, 2021",National,Finland,FIN,,,"July 25, 2021","July 31, 2021",Household and community samples,Adults (18-64 years),11,81.82%,52.30%,94.86%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W33,"October 7, 2021",National,Finland,FIN,,,"August 15, 2021","August 21, 2021",Household and community samples,Adults (18-64 years),7,85.71%,48.69%,97.43%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W34,"October 7, 2021",National,Finland,FIN,,,"August 22, 2021","August 28, 2021",Household and community samples,Adults (18-64 years),8,75.00%,40.93%,92.85%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W29,"October 7, 2021",National,Finland,FIN,,,"July 18, 2021","July 24, 2021",Household and community samples,Adults (18-64 years),2,100.00%,34.24%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W32,"October 7, 2021",National,Finland,FIN,,,"August 8, 2021","August 14, 2021",Household and community samples,Adults (18-64 years),25,84.00%,65.35%,93.60%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W35,"October 7, 2021",National,Finland,FIN,,,"August 29, 2021","September 4, 2021",Household and community samples,Adults (18-64 years),1,0.00%,0.00%,79.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,10/15/2021,7/17/2022,Verified
210912_Turku_UniversityofTurku_Overall,"January 19, 2022",Local,Finland,FIN,Southwest Finland,Turku,"May 13, 2020","December 17, 2020",Health care workers and caregivers,Multiple groups,222,8.11%,,,Convenience,NA,ELISA,IgG,96.30%,99.00%,High,Journal Article (Peer-Reviewed),Paula Tahtinen,University of Turku,https://dx.doi.org/10.1080/23744235.2022.2027008,1/27/2022,7/17/2022,Unverified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W44,"October 7, 2021",National,Finland,FIN,,,"October 31, 2021","November 6, 2021",Household and community samples,Adults (18-64 years),79,91.14%,82.82%,95.64%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W42,"October 7, 2021",National,Finland,FIN,,,"October 17, 2021","October 23, 2021",Household and community samples,Adults (18-64 years),1,0.00%,0.00%,79.35%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W50,"October 7, 2021",National,Finland,FIN,,,"December 12, 2021","December 18, 2021",Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W39,"October 7, 2021",National,Finland,FIN,,,"September 26, 2021","October 2, 2021",Household and community samples,Adults (18-64 years),2,50.00%,9.45%,90.55%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W37,"October 7, 2021",National,Finland,FIN,,,"September 12, 2021","September 18, 2021",Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W46,"October 7, 2021",National,Finland,FIN,,,"November 14, 2021","November 20, 2021",Household and community samples,Adults (18-64 years),13,92.31%,66.69%,98.63%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W45,"October 7, 2021",National,Finland,FIN,,,"November 7, 2021","November 13, 2021",Household and community samples,Adults (18-64 years),30,93.33%,78.68%,98.15%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W47,"October 7, 2021",National,Finland,FIN,,,"November 21, 2021","November 27, 2021",Household and community samples,Adults (18-64 years),8,87.50%,52.91%,97.76%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W48,"October 7, 2021",National,Finland,FIN,,,"November 28, 2021","December 4, 2021",Household and community samples,Adults (18-64 years),4,75.00%,30.06%,95.44%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W49,"October 7, 2021",National,Finland,FIN,,,"December 5, 2021","December 11, 2021",Household and community samples,Adults (18-64 years),4,100.00%,51.01%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W36,"October 7, 2021",National,Finland,FIN,,,"September 5, 2021","September 11, 2021",Household and community samples,Adults (18-64 years),1,100.00%,20.65%,100.00%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W51,"October 7, 2021",National,Finland,FIN,,,"December 19, 2021","December 25, 2021",Household and community samples,Adults (18-64 years),2,50.00%,9.45%,90.55%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
211007_Finland_FinnishInstituteforHealthandWelfare_2021-W43,"October 7, 2021",National,Finland,FIN,,,"October 24, 2021","October 30, 2021",Household and community samples,Adults (18-64 years),11,90.91%,62.26%,98.38%,Simplified probability,NA,IFA,IgG,100.00%,100.00%,High,Institutional Report,Finnish institute for health and welfare,Finnish Institute for Health and Welfare,https://www.thl.fi/roko/cov-vaestoserologia/sero_report_weekly_en.html,3/2/2022,7/17/2022,Verified
220428_Finland_UniversityofHelsinkiTime2,"April 28, 2022",Local,Finland,FIN,,Helsinki,"January 31, 2021","March 6, 2021",Residual sera,Multiple groups,500,28.20%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maarit Ahava,University of Helsinki,https://link.springer.com/article/10.1007/s10096-022-04448-x,6/2/2022,3/2/2024,Unverified
220428_Finland_UniversityofHelsinkiTime1,"April 28, 2022",Local,Finland,FIN,,Helsinki,"November 15, 2021","December 19, 2021",Residual sera,Multiple groups,500,5.20%,,,Simplified probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Maarit Ahava,University of Helsinki,https://link.springer.com/article/10.1007/s10096-022-04448-x,6/2/2022,3/2/2024,Unverified
230612_Finland_UniversityOfHelsinki_AntiS_Primary,"June 12, 2023",Regional,Finland,FIN,Southern Finland,,"January 15, 2020","December 15, 2020",Pregnant or parturient women,Adults (18-64 years),12000,3.62%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Preprint,J Virtanen,University of Helsinki,https://www.medrxiv.org/content/10.1101/2023.06.07.23290927v1,6/29/2023,4/24/2024,Verified
230404_Finland_FinnishInstituteforHealthandWelfare_antiN_2020Q2,"April 4, 2023",National,Finland,FIN,"Helsinki and Uusimaa, Pirkanmaa, Northern Ostrobothnia, Northern Savonia , Southwest, Finland ",,"April 1, 2020","June 30, 2020",Household and community samples,Multiple groups,3450,2.00%,1.00%,4.00%,Simplified probability,NA,Not reported,IgG,92.80%,100.00%,,Journal Article (Peer-Reviewed),Anna Solastie,Finnish Institute for Health and Welfare,https://dx.doi.org/10.1080/22221751.2023.2222849,6/30/2023,7/4/2023,Unverified
221219_Fiji_NationalCriticalCareAndTraumaResponseCentre,"December 19, 2022",National,Fiji,FJI,Central and Western Divisions,,"November 24, 2021","December 1, 2021",Multiple populations,Multiple groups,539,95.50%,93.40%,97.10%,Stratified non-probability,Beijing Wantai Biological,,,96.70%,97.50%,,Journal Article (Peer-Reviewed),Stephanie Curtis,National Critical Care and Trauma Response Centre,https://dx.doi.org/10.3201/eid2901.221514,1/13/2023,3/2/2024,Unverified
200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj,"July 27, 2020",Regional,Faroe Islands,FRO,Faroe Islands,,"April 27, 2020","May 1, 2020",Household and community samples,Adults (18-64 years),1075,0.70%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgG,IgM",94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,University of the Faroe Islands,http://dx.doi.org/10.3201/eid2611.202736,9/27/2020,7/5/2023,Verified
210826_FaroeIslands_UniversityoftheFaroeIslands_TestAdjusted,"August 26, 2021",National,Faroe Islands,FRO,,,"May 1, 2020","September 15, 2020",Contacts of COVID patients,Multiple groups,584,5.30%,3.50%,7.50%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Maria Petersen,University of the Faroe Islands,https://wwwnc.cdc.gov/eid/article/27/11/20-4948_article,9/29/2021,8/15/2023,Unverified
211110_FaroeIslands_TheFaroeseHospitalSystem_TestAdj,"November 10, 2021",National,Faroe Islands,FRO,,,"November 21, 2020","November 30, 2020",Household and community samples,Multiple groups,960,0.40%,0.10%,1.00%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Maria Skaalum Petersen,The Faroese Hospital System,https://dx.doi.org/10.3201/eid2801.210917,11/18/2021,8/15/2023,Verified
200922_AddisAbaba_KuwaitUniversity_GenPop,"September 22, 2020",Local,Ethiopia,ETH,Oromia,Addis Ababa,"May 18, 2020","May 21, 2020",Residual sera,Multiple groups,99,3.00%,0.60%,8.60%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.90%,High,Journal Article (Peer-Reviewed),John Kempen,Kuwait University,https://dx.doi.org/10.4269/ajtmh.20-0816,12/7/2020,3/2/2024,Verified
201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj,"October 13, 2020",Local,Ethiopia,ETH,,Addis Ababa,"April 23, 2020","April 28, 2020",Household and community samples,Adults (18-64 years),301,8.80%,5.50%,11.60%,Simplified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",87.90%,100.00%,Moderate,Preprint,Berhanu Alemu,"Ministry of Health, Ethiopia",https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1,12/11/2020,7/5/2023,Verified
210507_Ethiopia_EthiopianPublicHealthInstitute_AddisAbaba,"May 7, 2021",Local,Ethiopia,ETH,Oromia Region,Addis Ababa,"July 22, 2020","September 2, 2020",Household and community samples,Multiple groups,956,3.50%,1.70%,5.40%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",69.00%,97.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,5/29/2021,8/15/2023,Verified
210507_Ethiopia_EthiopianPublicHealthInstitute_JimmaRegion,"May 7, 2021",Local,Ethiopia,ETH,Oromia Region,Jimma,"July 22, 2020","September 2, 2020",Household and community samples,Multiple groups,900,0.60%,0.10%,1.80%,Stratified probability,Core Technology Co. Ltd,LFIA,"IgG,IgM",69.00%,97.00%,Moderate,Journal Article (Peer-Reviewed),Saro Abdella,Ethiopian Public Health Institute,http://dx.doi.org/10.1016/j.eclinm.2021.100880,5/29/2021,8/15/2023,Verified
210710_EthiopiaDireDawa_JimmaUniversityInstituteofHealth_Primary,"July 10, 2021",Local,Ethiopia,ETH,,Dire Dawa city,"June 15, 2020","July 30, 2020",Household and community samples,Multiple groups,684,3.20%,2.00%,4.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Low,Journal Article (Peer-Reviewed),Tamrat Shaweno,Jimma University Institute of Health,https://dx.doi.org/10.1186/s41182-021-00347-7,7/20/2021,3/2/2024,Verified
210815_Ethiopia_FederalMinistryofHealth_Overall_Adjusted,"August 15, 2021",National,Ethiopia,ETH,,,"June 24, 2020","July 8, 2020",Household and community samples,Multiple groups,16932,3.50%,3.20%,3.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,54.50%,100.00%,Low,Journal Article (Peer-Reviewed),Enyew Birru Tadesse,Federal Ministry of Health,http://dx.doi.org/10.1016/j.ijid.2021.08.028,9/21/2021,8/15/2023,Verified
211101_Ethiopia_UniversityofMunich_JimmaUrban_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Jimma,"February 2, 2021","March 15, 2021",Household and community samples,Multiple groups,166,45.20%,37.70%,52.70%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211101_Ethiopia_UniversityofMunich_AddisAbaba_AddisKetema_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Addis Ababa,"April 8, 2021","April 10, 2021",Household and community samples,Multiple groups,176,72.70%,65.90%,79.10%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211101_Ethiopia_UniversityofMunich_HCW_Jimma_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Jimma,"January 5, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),372,56.10%,51.10%,61.10%,Unclear,Roche Diagnostics,Not reported,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211101_Ethiopia_UniversityofMunich_JimmaRural_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Jimma,"February 4, 2021","March 16, 2021",Household and community samples,Multiple groups,100,31.00%,22.30%,40.30%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211101_Ethiopia_UniversityofMunich_HCW_AddisAbaba_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Addis Ababa,"January 19, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),121,53.70%,44.80%,62.50%,Unclear,Roche Diagnostics,Not reported,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211101_Ethiopia_UniversityofMunich_AddisAbaba_Yeka_Round3,"November 1, 2021",Local,Ethiopia,ETH,,Addis Ababa,"April 1, 2021","April 3, 2021",Household and community samples,Multiple groups,188,54.80%,47.70%,61.90%,Convenience,Roche Diagnostics,CLIA,Not reported,100.00%,99.80%,Moderate,Journal Article (Peer-Reviewed),Esayas Gudina,University of Munich,https://dx.doi.org/10.1016/S2214-109X(21)00386-7,11/4/2021,3/2/2024,Verified
211124_EastHararghe_UniversityofLondon_Overall,"November 24, 2021",Regional,Ethiopia,ETH,"Oromia, Harari","Haramaya, Harar","April 1, 2020","March 31, 2021",Pregnant or parturient women,Adults (18-64 years),1447,5.70%,4.60%,7.00%,Simplified probability,Beijing Wantai Biological,LFIA,Total Antibody,100.00%,98.80%,Moderate,Journal Article (Peer-Reviewed),Nega Assefa,The London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.1136/bmjopen-2021-055834,12/3/2021,3/2/2024,Verified
20220207_Ethiopia_WoldiaUniversity,"February 7, 2022",Regional,Ethiopia,ETH,North West Ethiopia,Asosa and Pawe COVID-19 treatment centres. ,"April 30, 2020","May 30, 2020",Multiple populations,Multiple groups,446,4.69%,3.10%,7.20%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Fassikaw Kebede,Woldia University,https://dx.doi.org/10.1177/20503121221076931,2/25/2022,3/2/2024,Unverified
220316_Ethiopia_ArmauerHansenResearchInstitute,"March 16, 2022",National,Ethiopia,ETH,,,"December 15, 2020","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),1997,39.80%,37.40%,41.70%,Entire sample,NA,ELISA,IgG,67.30%,97.70%,Moderate,Journal Article (Peer-Reviewed),Tesfaye Gelanew,Armauer Hansen Research Institute,https://doi.org/10.1186/s12879-022-07247-z,3/24/2022,7/17/2022,Unverified
230203_Oromia_JimmaUniversity,"February 3, 2023",Regional,Ethiopia,ETH,Oromia,,"December 1, 2020","December 31, 2020",Students and Daycares,Multiple groups,1884,25.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,100.00%,99.81%,,Journal Article (Peer-Reviewed),Dabesa Gobena,Jimma University,https://dx.doi.org/10.1371/journal.pone.0280801,3/10/2023,3/2/2024,Unverified
230615_Hawassa_HawassaUniversity_Baseline,"June 15, 2023",Local,Ethiopia,ETH,,Hawassa,"December 1, 2021","December 8, 2021",Students and Daycares,Children and Youth (0-17 years),419,51.80%,47.00%,56.50%,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Yared Merid,Hawassa University,https://dx.doi.org/10.3389/fimmu.2023.1163688,7/30/2023,8/15/2023,Unverified
230615_Hawassa_HawassaUniversity_FollowUp,"June 15, 2023",Local,Ethiopia,ETH,,Hawassa,"May 9, 2022","May 18, 2022",Students and Daycares,Children and Youth (0-17 years),300,82.30%,,,Convenience,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Yared Merid,Hawassa University,https://dx.doi.org/10.3389/fimmu.2023.1163688,7/30/2023,8/15/2023,Unverified
210226_Estonia_UniversityOfTartu_Stage14_Overall,"January 30, 2023",National,Estonia,EST,,,"February 11, 2021","February 22, 2021",Household and community samples,Multiple groups,2626,11.49%,10.29%,12.77%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,2/27/2021,9/23/2022,Verified
210107_Estonia_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Estonia,EST,NR,,"June 10, 2020","June 12, 2020",Health care workers and caregivers,Adults (18-64 years),130,0.00%,0.00%,2.87%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Verified
200924_Estonia_UniversityofTartu_overall,"September 24, 2020",National,Estonia,EST,,,"May 4, 2020","June 10, 2020",Pregnant or parturient women,Adults (18-64 years),433,0.46%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Piret Veerus,University of Tartu,https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995,3/20/2021,3/2/2024,Verified
210323_Estonia_UniversityOfTartu_Stage15_Overall,"January 30, 2023",National,Estonia,EST,,,"March 11, 2021","March 22, 2021",Household and community samples,Multiple groups,2382,21.41%,19.78%,23.11%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,3/26/2021,9/23/2022,Verified
210420_Estonia_UniversityOfTartu_Stage16_Overall,"January 30, 2023",National,Estonia,EST,,,"April 8, 2021","April 19, 2021",Household and community samples,Multiple groups,2491,35.87%,33.97%,37.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,4/21/2021,9/23/2022,Verified
210527_Estonia_UniversityOfTartu_Stage17_Overall,"January 30, 2023",National,Estonia,EST,,,"May 13, 2021","May 24, 2021",Household and community samples,Multiple groups,2290,49.52%,47.45%,51.59%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,5/30/2021,10/21/2022,Verified
210622_Estonia_UniversityOfTartu_Stage18_Overall,"January 30, 2023",National,Estonia,EST,,,"June 10, 2021","June 21, 2021",Household and community samples,Multiple groups,2330,67.90%,65.96%,69.79%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,6/29/2021,11/18/2022,Verified
210805_Estonia_TartuUniversityHospital_Tallinn_overall_testadj,"September 7, 2021",Local,Estonia,EST,,Tallinn,"May 8, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1006,1.50%,0.60%,2.40%,Stratified probability,"Abbott Laboratories,DiaSorin,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Piia Jogi,University of Tartu,https://dx.doi.org/10.1016/j.vaccine.2021.07.093,8/25/2021,8/15/2023,Verified
210805_Estonia_TartuUniversityHospital_Saaremaa_overall_testadj,"September 7, 2021",Local,Estonia,EST,,Saaremaa,"May 8, 2020","July 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,954,6.70%,5.00%,8.40%,Stratified probability,"Abbott Laboratories,DiaSorin,SD Biosensor,NA",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Piia Jogi,University of Tartu,https://dx.doi.org/10.1016/j.vaccine.2021.07.093,8/25/2021,8/15/2023,Verified
210914_Estonia_UniversityofTartu_overall,"September 14, 2021",National,Estonia,EST,,,"February 8, 2021","March 25, 2021",Residual sera,Multiple groups,2517,20.10%,18.50%,21.70%,Stratified non-probability,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Hiie Soeorg,University of Tartu,https://dx.doi.org/10.1080/23744235.2021.1974540,9/21/2021,3/2/2024,Verified
211001_Estonia_UniversityOfTartu_Stage20_Overall,"January 30, 2023",National,Estonia,EST,,,"September 15, 2021","September 27, 2021",Household and community samples,Multiple groups,2302,76.70%,74.91%,78.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,10/14/2021,9/9/2022,Verified
211025_Estonia_UniversityOfTartu_Stage21_Overall,"January 30, 2023",National,Estonia,EST,,,"October 13, 2021","October 25, 2021",Household and community samples,Multiple groups,2312,76.40%,74.30%,78.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,11/3/2021,9/9/2022,Verified
211213_Estonia_UniversityOfTartu_Stage22_Overall,"January 30, 2023",National,Estonia,EST,,,"December 1, 2021","December 13, 2021",Household and community samples,Multiple groups,2290,81.50%,78.10%,84.80%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,1/10/2022,9/9/2022,Verified
220124_Estonia_UniversityOfTartu_Stage23_Overall,"January 30, 2023",National,Estonia,EST,,,"January 11, 2022","January 24, 2022",Household and community samples,Multiple groups,2301,82.80%,80.00%,85.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,2/4/2022,9/9/2022,Verified
220321_Estonia_UniversityOfTartu_Stage24_Overall,"January 30, 2023",National,Estonia,EST,,,"March 9, 2022","March 21, 2022",Household and community samples,Multiple groups,2308,89.10%,87.40%,90.80%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,4/1/2022,9/9/2022,Unverified
220411_Estonia_UniversityOfTartu_Stage25,"January 30, 2023",National,Estonia,EST,,,"March 30, 2022","April 11, 2022",Household and community samples,Multiple groups,2304,87.10%,84.70%,89.40%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,4/25/2022,9/9/2022,Unverified
220509_Estonia_UniversityOfTartu_Stage26,"January 30, 2023",National,Estonia,EST,,,"April 27, 2022","May 9, 2022",Household and community samples,Multiple groups,2228,86.50%,83.20%,89.60%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,Univeristy of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,5/18/2022,9/9/2022,Unverified
220613_Estonia_UniversityOfTartu_Stage27,"January 30, 2023",National,Estonia,EST,,,"June 1, 2022","June 13, 2022",Household and community samples,Multiple groups,2439,87.50%,84.90%,89.90%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,6/29/2022,9/9/2022,Unverified
220829_Estonia_UniversityOfTartu_Stage28_PopAdj,"January 30, 2023",National,Estonia,EST,,,"August 17, 2022","August 29, 2022",Household and community samples,Multiple groups,2431,88.40%,85.40%,91.30%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,9/9/2022,9/9/2022,Unverified
220926_Estonia_UniversityOfTartu_Stage29_PopAdj,"January 30, 2023",National,Estonia,EST,,,"September 15, 2022","September 26, 2022",Household and community samples,Multiple groups,2184,91.60%,90.40%,92.80%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,10/5/2022,10/5/2022,Unverified
221024_Estonia_UniversityOfTartu_Stage30_PopAdj,"January 30, 2023",National,Estonia,EST,,,"October 12, 2022","October 24, 2022",Household and community samples,Multiple groups,2056,91.40%,90.10%,92.60%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,11/1/2022,11/1/2022,Unverified
221121_Estonia_UniversityOfTartu_Stage31_PopAdj,"January 30, 2023",National,Estonia,EST,,,"November 9, 2022","November 21, 2022",Household and community samples,Multiple groups,1995,89.90%,88.50%,91.20%,Stratified probability,Synlab,CLIA,IgG,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,11/30/2022,3/20/2023,Unverified
221219_Estonia_UniversityOfTartu_Stage32_PopAdj,"January 30, 2023",National,Estonia,EST,,,"December 7, 2022","December 19, 2022",Household and community samples,Multiple groups,1876,90.60%,89.20%,91.90%,Stratified probability,Synlab,,,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,1/11/2023,3/20/2023,Unverified
230130_Estonia_UniversityOfTartu_Stage33_PopAdj,"January 30, 2023",National,Estonia,EST,,,"January 18, 2023","January 30, 2023",Household and community samples,Multiple groups,2152,93.20%,92.10%,94.30%,Stratified probability,Synlab,,,,,Moderate,Institutional Report,University of Tartu,University of Tartu,https://ut.ee/et/sisu/koroonaviiruse-levimuse-seireuuringu-antikehade-analuusi-tulemused,2/17/2023,3/10/2024,Unverified
220207_SanSalvador_OsakaCityUniversity_HCW_Overall,"February 7, 2022",Local,El Salvador,SLV,,San Salvador,"January 18, 2021","February 14, 2021",Health care workers and caregivers,Adults (18-64 years),973,52.60%,,,Convenience,"Roche Diagnostics,Abbott Laboratories",CLIA,"Total Antibody,IgG",,,Moderate,Preprint,Yu Nakagama,Osaka City University,10.1101/2022.02.06.22270565,2/18/2022,3/2/2024,Unverified
200721_Egypt_CairoUniversity_TotalHCW_Overall,"July 21, 2020",Local,Egypt,EGY,,Cairo,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),74,12.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Abdel Meguid Kassem,Cairo University,https://dx.doi.org/10.1016/j.ajg.2020.07.005,9/30/2020,3/2/2024,Verified
210115_Cairo_CairoUniversity,"January 15, 2021",Local,Egypt,EGY,,Cairo,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),203,18.20%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",93.40%,97.70%,High,Journal Article (Peer-Reviewed),Reham Abdelmoniem,Cairo University ,https://dx.doi.org/10.1016/j.jcv.2020.104710,1/24/2021,3/2/2024,Verified
201023_Egypt_AinShamsUniversity_Overall,"October 23, 2020",Local,Egypt,EGY,Cairo Governorate,Cairo,"April 22, 2020","May 14, 2020",Health care workers and caregivers,Multiple groups,4040,1.31%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",83.30%,100.00%,High,Journal Article (Peer-Reviewed),Aya Mostafa,Ain Shams University,https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053,1/24/2021,3/2/2024,Verified
210402_Cairo_CairoUniversity_HCW,"April 2, 2021",Local,Egypt,EGY,,,"May 5, 2020","June 11, 2020",Health care workers and caregivers,Adults (18-64 years),455,7.90%,5.80%,10.80%,Convenience,"SD Biosensor,Shenzhen Yhlo Biotech Co. Ltd",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Ahmed Mukhtar,Cairo University,https://dx.doi.org/10.4081/jphr.2021.2102,4/19/2021,3/2/2024,Verified
210311_Egypt_CenterofScientificExcellenceforInfluenzaViruses_October3,"March 11, 2021",National,Egypt,EGY,"Sharkiyah Governorate, Gharbiyah Governorate, Kafr El Sheikh Governorate, Qalyubiyah Governorate, Fayyoum Governorate",,"October 1, 2020","October 31, 2020",Household and community samples,Multiple groups,1260,34.80%,,,Simplified probability,NA,Neutralization,Neutralizing ,,,Unclear,Journal Article (Peer-Reviewed),Mokhtar R Gomaa,Center of Scientific Excellence for Influenza Viruses ,https://dx.doi.org/10.1371/journal.ppat.1009413,5/11/2021,7/17/2022,Verified
210610_Cairo_CairoUniversity_HCW1_overall,"June 10, 2021",Local,Egypt,EGY,,Cairo,"June 1, 2020","June 14, 2020",Health care workers and caregivers,Adults (18-64 years),386,15.80%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,7/6/2021,3/2/2024,Verified
210610_Cairo_CairoUniversity_GenPop2_overall_TotalAbCLIA,"June 10, 2021",Local,Egypt,EGY,,Cairo,"June 1, 2020","June 14, 2020",Household and community samples,Adults (18-64 years),725,29.40%,,,Simplified probability,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Sherief Musa,Cairo University,https://dx.doi.org/10.1016/j.jiph.2021.06.001,7/6/2021,3/2/2024,Verified
210715_Egypt_NationalResearchCentre_Primary,"July 15, 2021",Local,Egypt,EGY,,Cairo,"August 15, 2020","October 15, 2020",Multiple general populations,Multiple groups,888,30.00%,,,Convenience,NA,Neutralization,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Amira S. El Rifay,National Research Centre,https://dx.doi.org/10.1111/irv.12889,7/19/2021,7/17/2022,Unverified
210715_Cairo_Ain-ShamsUniversity_TestAdj,"July 15, 2021",Local,Egypt,EGY,Cairo Governate,Cairo,"May 5, 2020","October 31, 2020",Residual sera,Multiple groups,2927,29.82%,28.16%,31.51%,Sequential,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Moderate,Journal Article (Peer-Reviewed),Samia Girgis,Ain-Shams University,http://dx.doi.org/10.1371/journal.pone.0254581,8/4/2021,8/15/2023,Unverified
210920_Egypt_AssiutUniversity_Overall,"September 20, 2021",National,Egypt,EGY,"Ash Sharqiyah, Asyut","Zagazig, Assiut","October 15, 2020","December 15, 2020",Health care workers and caregivers,Adults (18-64 years),82,46.30%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Rehab El-Sokkary,Assiut University,https://dx.doi.org/10.1016/j.jiph.2021.09.011,10/5/2021,7/17/2022,Unverified
211029_Cairo_AinShamsUniversity,"October 29, 2021",Local,Egypt,EGY,,Cairo,"September 6, 2020","October 31, 2020",Blood donors,Adults (18-64 years),100,38.00%,,,Simplified probability,AMEDA Labordiagnostik GmbH,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Sahar Abdelmaksoud,Ain-Shams University,https://www.ehj.eg.net/article.asp?issn=1110-1067;year=2021;volume=46;issue=2;spage=65;epage=69;aulast=Abdelmaksoud,12/14/2021,3/2/2024,Verified
220429_Egypt_AssiutUniversity_Mother_TotalAb,"April 29, 2022",Local,Egypt,EGY,,Assiut,"July 1, 2020","September 30, 2020",Pregnant or parturient women,Adults (18-64 years),171,32.20%,,,Sequential,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Tarek Al-Hussaini,Assiut University,https://dx.doi.org/10.1080/01443615.2022.2049720,5/11/2022,3/2/2024,Unverified
220429_Egypt_AssiutUniversity_Baby_TotalAb,"April 29, 2022",Local,Egypt,EGY,,Assiut,"July 1, 2020","September 30, 2020",Perinatal,Children and Youth (0-17 years),171,28.10%,,,Sequential,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Tarek Al-Hussaini,Assiut University,https://dx.doi.org/10.1080/01443615.2022.2049720,5/11/2022,3/2/2024,Unverified
220512_Egypt_CairoUniversity_Group2,"May 12, 2022",Local,Egypt,EGY,,Cairo,"June 3, 2021","June 10, 2021",Blood donors,Adults (18-64 years),990,19.19%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,6/4/2022,3/2/2024,Unverified
220512_Egypt_CairoUniversity_Group3,"May 12, 2022",Local,Egypt,EGY,,Cairo,"July 20, 2021","July 30, 2021",Blood donors,Adults (18-64 years),1114,66.16%,,,Convenience,Abbott Laboratories,Not reported,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,6/4/2022,3/2/2024,Unverified
220512_Egypt_CairoUniversity_Group1,"May 12, 2022",Local,Egypt,EGY,,Cairo,"March 20, 2021","March 30, 2021",Blood donors,Adults (18-64 years),954,13.21%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Nermeen Eldesoukey,Cairo University,https://dx.doi.org/10.1002/hsr2.634,6/4/2022,3/2/2024,Unverified
220506_Asyut_AssiutUniversityHospitals,"May 6, 2022",Local,Egypt,EGY,,Asyut,"April 15, 2020","June 15, 2020",Health care workers and caregivers,Adults (18-64 years),199,24.60%,,,Convenience,"Artron Laboratories Inc.,Roche Diagnostics,Abbott Laboratories",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Azza Eldin,Assiut University Hospitals,https://dx.doi.org/10.1155/2022/7833623,6/5/2022,3/2/2024,Unverified
220604_Egypt_AlexandriaUniversity_Primary,"June 4, 2022",National,Egypt,EGY,"Giza, Alexandria, Menoufeya, Cairo, Kafr El-Sheikh",,"January 15, 2021","June 15, 2021",Health care workers and caregivers,Multiple groups,559,59.00%,,,Stratified non-probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Engy Mohamed El-Ghitany,Alexandria University,https://dx.doi.org/10.1186/s42506-022-00106-4,6/16/2022,8/15/2023,Unverified
220810_Egypt_AlexandriaUniversity_TestAdjusted,"August 10, 2022",National,Egypt,EGY,,,"January 15, 2021","June 15, 2021",Household and community samples,Multiple groups,2360,46.30%,44.20%,48.30%,Convenience,EUROIMMUN,ELISA,IgG,93.20%,99.80%,Moderate,Journal Article (Peer-Reviewed),Engy Mohamed El‑Ghitany,Alexandria University,https://dx.doi.org/10.1186/s41182-022-00448-x,8/25/2022,3/13/2024,Verified
230115_Egypt_SohagUniversity_Overall,"January 15, 2023",National,Egypt,EGY,,,"August 1, 2021","August 31, 2021",Blood donors,Multiple groups,287,50.00%,,,Unclear,NA,Not reported,IgG,,,,Presentation or Conference,Mona M Abdelrahmans,Sohag University,https://doi.org/10.55133/eji.300104,2/11/2023,3/22/2023,Unverified
230505_Fayoum_FayoumUniversity_Overall,"May 5, 2023",Local,Egypt,EGY,Fayoum Governorate,Fayoum,"February 15, 2021","July 15, 2021",Household and community samples,Multiple groups,155,60.60%,,,Simplified probability,DIALAB,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Salwa Bakr,Fayoum University,https://dx.doi.org/10.11604/pamj.2023.45.22.36513,8/3/2023,4/23/2024,Verified
200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall,"July 27, 2020",Local,Ecuador,ECU,El Oro,,"May 1, 2020","May 25, 2020",Household and community samples,Multiple groups,673,45.00%,,,Convenience,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Peruana Cayetano Heredia,http://dx.doi.org/10.1093/cid/ciaa1055,10/3/2020,3/2/2024,Verified
200929_Atahualpa_UniversidadPeruanaCayetanoHeredia_overall,"September 29, 2020",Local,Ecuador,ECU,,Atahualpa,"June 25, 2020","June 30, 2020",Household and community samples,Adults (18-64 years),362,7.70%,,,Simplified probability,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar H Del Brutto,Universidad Peruana Cayetano Heredia,https://www.tandfonline.com/doi/full/10.1080/20477724.2020.1826152,4/27/2021,3/2/2024,Verified
200923_Ecuador_UniversidadCatólicaDelEcuador_Patients,"September 23, 2020",National,Ecuador,ECU,,Quito,"May 12, 2020","July 20, 2020",Household and community samples,Multiple groups,11540,19.00%,,,Self-referral,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Camilo Zurita Salinas,Universidad Católica Del Ecuador,https://www.researchgate.net/publication/344477310_SEROPREVALENCE_OF_ANTI-SARS-COV-2_IGG_ANTIBODIES_IN_ECUADORIAN_POPULATION,5/3/2021,3/2/2024,Verified
210427_Cuenca_UniversityOfAntwerp_overall_UnAdj,"April 27, 2021",Local,Ecuador,ECU,Azuay,,"August 11, 2020","November 1, 2020",Household and community samples,Multiple groups,2457,13.20%,,,Stratified probability,SD Biosensor,LFIA,"IgG,IgM",87.90%,94.30%,Moderate,Journal Article (Peer-Reviewed),David Acurio Paez,University of Antwerp,https://www.mdpi.com/1660-4601/18/9/4657,5/22/2021,3/2/2024,Verified
210319_Ecuador_ InstitutoEcuatorianodeEnfermedadesDigestivas,"March 19, 2021",Local,Ecuador,ECU,Guayas,Guayaquil,"April 15, 2020","May 22, 2020",Residual sera,Adults (18-64 years),127,7.09%,,,Convenience,NA,Not reported,IgM,,,High,Journal Article (Peer-Reviewed),C Robles Medranda,Instituto Ecuatoriano de Enfermedades Digestivas,http://dx.doi.org/10.1055/s-0041-1724977,6/7/2021,7/17/2022,Verified
210929_Atahualpa_StonyBrookUniversity_April2021_primary,"September 29, 2021",Local,Ecuador,ECU,,Atahualpa,"April 1, 2021","April 30, 2021",Household and community samples,Multiple groups,277,63.20%,,,Unclear,Biohit Health Care Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Stony Brook University,https://dx.doi.org/10.1177/21501327211047781,10/7/2021,3/2/2024,Verified
211006_Babahoyo_WayneStateUniversity,"October 6, 2021",Local,Ecuador,ECU,Los Ríos,Babahoyo,"September 3, 2020","January 31, 2021",Pregnant or parturient women,Multiple groups,100,32.00%,,,Unclear,NA,ELISA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Hector Zambrano,Wayne State University,https://dx.doi.org/10.1016/j.placenta.2021.10.001,10/20/2021,7/17/2022,Unverified
211029_Ecuador_UniversidadEspirituSanto,"October 29, 2021",Local,Ecuador,ECU,Santa Elena Province,Atahualpa,"May 1, 2020","April 30, 2021",Household and community samples,Adults (18-64 years),673,63.70%,,,Convenience,Biohit Health Care Ltd,LFIA,"IgG,IgM",97.50%,100.00%,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Universidad Espíritu Santo,https://dx.doi.org/10.1177/21501327211054989,11/11/2021,3/2/2024,Verified
220122_Atahualpa_UniversidadEspirituSanto_Overall,"January 22, 2022",Local,Ecuador,ECU,,,"May 15, 2020","April 15, 2021",Household and community samples,Adults (18-64 years),519,63.00%,,,Convenience,Biohit Health Care Ltd,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Oscar Del Brutto,Stony Brook University,https://dx.doi.org/10.1177/21501319211070685,2/1/2022,3/2/2024,Unverified
220818_Ecuador_UniversidadDeLasAmericas_Overall,"August 18, 2022",National,Ecuador,ECU,"Atacames, Quininde, Esmeraldas, Muisne, Río Verde",,"October 12, 2020","October 19, 2020",Blood donors,Multiple groups,1259,11.68%,9.98%,13.62%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,IgG,79.50%,100.00%,High,Journal Article (Peer-Reviewed),Alexander Paolo Vallejo-Janeta,Universidad de Las Americas,https://dx.doi.org/10.3389/fmed.2022.933260,9/13/2022,4/22/2024,Unverified
201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG,"December 2, 2020",National,Dominican Republic,DOM,,,"April 15, 2020","June 15, 2020",Household and community samples,Multiple groups,12897,5.50%,,,Simplified probability,GenBody Inc.,LFIA,IgG,56.70%,100.00%,High,Journal Article (Peer-Reviewed),Robert Paulino Ramirez,Universidad Iberoamericana,https://dx.doi.org/10.4269/ajtmh.20-0907,1/13/2021,3/2/2024,Verified
221108_DominicanRepublic_UniversityofQueensland_Overall_PopAdj,"November 8, 2022",National,Dominican Republic,DOM,,,"June 30, 2021","October 12, 2021",Household and community samples,Multiple groups,6683,85.00%,82.10%,88.00%,Stratified probability,Roche Diagnostics,,,98.20%,99.80%,Low,Journal Article (Peer-Reviewed),Eric Nilles,University of Queensland,https://dx.doi.org/10.1016/j.lana.2022.100390,12/16/2022,3/2/2024,Unverified
200625_Denmark_GeneralPopTestAdj,"June 25, 2020",National,Denmark,DNK,,,"April 6, 2020","May 3, 2020",Blood donors,Adults (18-64 years),20640,1.90%,0.80%,2.30%,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",82.58%,99.54%,Moderate,Journal Article (Peer-Reviewed),Christian Erikstrup,Copenhagen University Hospital,https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661,6/27/2020,7/5/2023,Verified
200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,"August 3, 2020",Regional,Denmark,DNK,Capital Region of Denmark,,"April 15, 2020","April 22, 2020",Blood donors,Adults (18-64 years),4672,3.04%,2.58%,3.57%,Sequential,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",73.40%,99.90%,High,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,https://dx.doi.org/10.1016/S1473-3099(20)30589-2,10/2/2020,7/5/2023,Verified
201003_Denmark_AarhusUniversity_HCW_testadj,"October 3, 2020",Regional,Denmark,DNK,Central Denmark Region,,"May 18, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),17948,3.36%,2.38%,3.82%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Senne Jespersen,Aarhus University Hospital,https://dx.doi.org/10.1093/cid/ciaa1471,12/20/2020,7/5/2023,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj,"October 27, 2020",Local,Denmark,DNK,Capital Region of Denmark,Copenhagen,"April 4, 2020","July 3, 2020",Pregnant or parturient women,Adults (18-64 years),1313,2.60%,1.70%,4.00%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,7/17/2022,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj,"October 27, 2020",Local,Denmark,DNK,Capital Region of Denmark,Copenhagen ,"April 4, 2020","July 3, 2020",Hospital visitors,Adults (18-64 years),1188,3.50%,2.30%,5.10%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,Moderate,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/10/2021,7/17/2022,Verified
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns,"October 27, 2020",Local,Denmark,DNK,Capital Region of Denmark,Copenhagen ,"April 4, 2020","July 3, 2020",Perinatal,Children and Youth (0-17 years),1206,1.40%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",94.00%,99.30%,High,Journal Article (Peer-Reviewed),Pia Egerup,Copenhagen University Hospital Hvidovre,https://dx.doi.org/10.1097/AOG.0000000000004199,1/10/2021,7/17/2022,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj,"October 26, 2020",National,Denmark,DNK,,,"June 2, 2020","June 19, 2020",Blood donors,Seniors (65+ years),1200,1.40%,0.30%,2.50%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/11/2021,7/5/2023,Verified
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj,"October 26, 2020",National,Denmark,DNK,,,"June 1, 2020","June 26, 2020",Blood donors,Adults (18-64 years),1110,2.50%,1.30%,3.80%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Ole Birger Pedersen,Copenhagen University Hospital Rigshospitalet,https://dx.doi.org/10.1093/cid/ciaa1627,1/12/2021,7/5/2023,Verified
201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall,"December 27, 2020",Local,Denmark,DNK,Copenhagen,Copenhagen,"April 14, 2020","May 21, 2020",Pregnant or parturient women,Adults (18-64 years),36,0.00%,,,Self-referral,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,1/16/2021,7/17/2022,Verified
201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM,"November 20, 2020",Local,Denmark,DNK,Central Denmark Region,Aarhus,"June 1, 2020","June 4, 2020",Persons experiencing homelessness,Adults (18-64 years),129,4.70%,2.10%,9.80%,Convenience,NA,LFIA,"IgG,IgM",98.90%,97.60%,High,Journal Article (Peer-Reviewed),Signe Storgaard,Aarhus Department of Public Health ,"https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.",1/24/2021,7/17/2022,Verified
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall,"December 27, 2020",Local,Denmark,DNK,Copenhagen,Copenhagen,"February 17, 2020","April 17, 2020",Pregnant or parturient women,Adults (18-64 years),1019,1.80%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), ‪Nina Freiesleben,Copenhagen University Hospital,https://dx.doi.org/10.1093/humrep/deaa311,2/14/2021,7/17/2022,Verified
210121_Denmark_CopenhagenUniversityHospital_Denmark,"January 21, 2021",National,Denmark,DNK,,,"June 22, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),2024,2.80%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Guangzhou Wondfo Biotech Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jannie Laursen,Copenhagen University Hospital,https://dx.doi.org/10.3390/ijerph18030923,2/26/2021,3/2/2024,Verified
210212_Copenhagen_Herlev-GentofteHospital_Overall,"February 12, 2021",Local,Denmark,DNK,Capital Region,Copenhagen,"October 19, 2020","October 26, 2020",Health care workers and caregivers,Adults (18-64 years),1096,34.58%,31.82%,37.45%,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",97.00%,99.50%,Moderate,Preprint,Johannes R Madsen,Herlev-Gentofte Hospital,https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1,3/19/2021,3/2/2024,Verified
210401_Denmark_SlagelseSygehus_blooddonors_primary,"April 1, 2021",Regional,Denmark,DNK,Capital Region and Region Zealand,,"June 22, 2020","July 3, 2020",Blood donors,Adults (18-64 years),750,2.00%,1.10%,3.30%,Simplified probability,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,5/19/2021,3/2/2024,Verified
210401_Denmark_SlagelseSygehus_children_primary,"April 1, 2021",Regional,Denmark,DNK,Capital Region and Region Zealand,,"June 22, 2020","July 3, 2020",Residual sera,Children and Youth (0-17 years),1033,1.60%,1.00%,2.60%,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Maren J H Rytter,Slagelse Sygehus,http://dx.doi.org/10.1097/INF.0000000000003048,5/19/2021,3/2/2024,Verified
210512_Denmark_CopenhagenUniversityHospital_ShelterWorkers2_Overall,"May 12, 2021",National,Denmark,DNK,"Central, North, Capital, South"," Copenhagen, Aarhus, Aalborg and Odense","November 2, 2020","November 20, 2020",Essential non-healthcare workers,Adults (18-64 years),191,6.30%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,High,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,5/26/2021,3/2/2024,Verified
210512_Denmark_CopenhagenUniversityHospital_PEH1_Overall,"May 12, 2021",National,Denmark,DNK,"Central, North, Capital, South"," Copenhagen, Aarhus, Aalborg and Odense","November 2, 2020","November 20, 2020",Persons experiencing homelessness,Adults (18-64 years),628,6.80%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,Moderate,Preprint,Alexandra R Rothlin Eriksen,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.05.07.21256388v2,5/26/2021,3/2/2024,Verified
210510_Denmark_CopenhagenUniversityHospital_SHOverall,"May 10, 2021",National,Denmark,DNK,,"Copenhagen, Aarhus, Odense, Hoeje Taastrup, Helsingoer and Slagelse ","January 8, 2021","January 31, 2021",Household and community samples,Multiple groups,13279,17.30%,,,Stratified non-probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,100.00%,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,5/31/2021,3/2/2024,Verified
210510_Denmark_CopenhagenUniversityHospital_BloodDonorsOverall,"May 10, 2021",National,Denmark,DNK,,,"January 8, 2021","January 31, 2021",Blood donors,Multiple groups,22677,5.80%,,,Entire sample,Beijing Wantai Biological,ELISA,Not reported,,,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://doi.org/10.1101/2021.05.07.21256725,5/31/2021,3/2/2024,Verified
201212_Europe_UniversityOfGlasgow_Denmark4,"December 12, 2020",National,Denmark,DNK,,Aarhus and Copenhagen,"April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),34,2.94%,0.52%,14.91%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,3/2/2024,Verified
210531_Denmark_AarhusUniversity_CRDPatients1,"May 31, 2021",National,Denmark,DNK,,,"June 8, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,365,0.30%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,High,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,6/8/2021,3/2/2024,Unverified
210531_Denmark_AarhusUniversity_BloodDonors2,"May 31, 2021",National,Denmark,DNK,,,"June 8, 2020","June 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,513,1.90%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Christian Ammitzboll,Aarhus University,https://dx.doi.org/10.1002/acr.24716,6/8/2021,3/2/2024,Unverified
210609_CentralDenmarkRegion_AarhusUniversity,"June 9, 2021",Regional,Denmark,DNK,Central Denmark Region,,"May 18, 2020","June 19, 2020",Health care workers and caregivers,Adults (18-64 years),11138,4.00%,,,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Agergard Kaspersen,Aarhus University,https://dx.doi.org/10.1016/j.ijid.2021.06.017,6/21/2021,3/2/2024,Unverified
210813_Denmark_CopenhagenUniversityHospital_Primary,"August 13, 2021",National,Denmark,DNK,,,"October 2, 2020","October 11, 2020",Household and community samples,Multiple groups,318552,0.79%,,,Simplified probability,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",93.30%,98.20%,Moderate,Preprint,Kamille Fogh,Copenhagen University Hospital,https://www.medrxiv.org/content/10.1101/2021.08.10.21261777v1,8/24/2021,3/2/2024,Verified
210822_Denmark_StatensSerumInstitut_May_testadj,"August 22, 2021",National,Denmark,DNK,,,"May 5, 2020","May 15, 2020",Household and community samples,Multiple groups,2512,1.50%,0.90%,2.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Low,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,9/1/2021,8/15/2023,Verified
210822_Denmark_StatensSerumInstitut_August_testadj,"August 22, 2021",National,Denmark,DNK,,,"August 15, 2020","September 30, 2020",Household and community samples,Multiple groups,11478,2.00%,1.70%,2.40%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,9/1/2021,8/15/2023,Verified
210822_Denmark_StatensSerumInstitut_October_testadj,"August 22, 2021",National,Denmark,DNK,,,"October 1, 2020","November 30, 2020",Household and community samples,Multiple groups,9654,2.40%,1.90%,2.80%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,9/1/2021,8/15/2023,Verified
210822_Denmark_StatensSerumInstitut_December_testadj,"August 22, 2021",National,Denmark,DNK,,,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,4044,4.30%,3.40%,5.10%,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Laura Espenhain,Statens Serum Institut,https://dx.doi.org/10.1007/s10654-021-00796-8,9/1/2021,8/15/2023,Verified
210914_Denmark_OdenseUniversityTestAdj,"September 14, 2021",Regional,Denmark,DNK,Region of Southern Denmark,,"May 1, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),7950,1.40%,1.00%,1.80%,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",78.00%,99.30%,High,Journal Article (Peer-Reviewed),Sebastian von Huth,Odense University,https://dx.doi.org/10.1016/j.ijid.2021.09.023,9/28/2021,8/15/2023,Unverified
210917_DenmarkCapitalRegion_UniversityofCopenhagen_Round3_Overall,"September 17, 2021",Regional,Denmark,DNK,Capital Region of Denmark,,"September 30, 2020","October 7, 2020",Health care workers and caregivers,Adults (18-64 years),27457,7.36%,,,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kasper Iversen,University of Copenhagen,http://dx.doi.org/10.1016/j.cmi.2021.09.005,10/20/2021,3/2/2024,Unverified
211112_Denmark_AarhusUniversity_2020Weeks41to44_TestAdjusted,"November 12, 2021",National,Denmark,DNK,,,"October 5, 2020","November 1, 2020",Blood donors,Adults (18-64 years),22690,2.08%,1.17%,2.47%,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Kaspersen,Aarhus University,https://dx.doi.org/10.1093/infdis/jiab566,11/22/2021,8/15/2023,Verified
211112_Denmark_AarhusUniversity_2021Weeks5to8_Unadjusted,"November 12, 2021",National,Denmark,DNK,,,"February 1, 2021","February 28, 2021",Blood donors,Adults (18-64 years),20398,7.40%,,,Entire sample,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,99.50%,Moderate,Journal Article (Peer-Reviewed),Kathrine Kaspersen,Aarhus University,https://dx.doi.org/10.1093/infdis/jiab566,11/22/2021,3/2/2024,Verified
220301_CapitalRegionofDenmark_UniversityofCopenhagen_SMIPatients_Overall_TestAdj,"March 1, 2022",Regional,Denmark,DNK,Capital Region of Denmark,,"January 18, 2021","February 19, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,1258,4.96%,3.87%,,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marie Reeberg Sass,University of Copenhagen,https://dx.doi.org/10.1371/journal.pone.0264325,3/8/2022,8/15/2023,Unverified
220301_CapitalRegionofDenmark_UniversityofCopenhagen_BloodDonors_Overall_TestAdj,"March 1, 2022",Regional,Denmark,DNK,Capital Region of Denmark,,"January 18, 2021","February 19, 2021",Blood donors,Adults (18-64 years),6088,12.24%,11.41%,13.11%,Sequential,Beijing Wantai Biological,ELISA,Total Antibody,94.50%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marie Reeberg Sass,University of Copenhagen,https://dx.doi.org/10.1371/journal.pone.0264325,3/8/2022,8/15/2023,Unverified
220407_Denmark_UniversityOfCopenhagen,"April 7, 2022",National,Denmark,DNK,,,"March 30, 2020","June 29, 2020",Health care workers and caregivers,Adults (18-64 years),379,5.30%,,,Sequential,NA,Multiple Types,"IgG,IgM,IgA",,,High,Journal Article (Peer-Reviewed),Caroline Klint Johannesen,University of Copenhagen,https://pubmed.ncbi.nlm.nih.gov/35485785/,5/11/2022,7/17/2022,Unverified
220627_Denmark_CopenhagenUniversityHospital_BloodDonors_Adj,"June 27, 2022",National,Denmark,DNK,,,"November 1, 2020","November 22, 2020",Blood donors,Multiple groups,18505,2.50%,2.26%,2.76%,Entire sample,Beijing Wantai Biological,ELISA,"IgG,IgM",96.70%,99.50%,Low,Journal Article (Peer-Reviewed),Alexandra Eriksen,Copenhagen University Hospital,https://dx.doi.org/10.1186/s12889-022-13642-7,7/12/2022,8/15/2023,Unverified
220627_Denmark_CopenhagenUniversityHospital_Overall,"June 27, 2022",National,Denmark,DNK,,,"November 2, 2020","November 20, 2020",Multiple populations,Multiple groups,819,6.70%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",96.86%,99.39%,Moderate,Journal Article (Peer-Reviewed),Alexandra Eriksen,Copenhagen University Hospital,https://dx.doi.org/10.1186/s12889-022-13642-7,7/12/2022,3/2/2024,Unverified
220805_Denmark_AarhusUniversityHospital_NovemberBaseline_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"October 26, 2021","November 30, 2021",Blood donors,Multiple groups,8701,1.20%,1.00%,1.50%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week7_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"February 15, 2022","February 21, 2022",Blood donors,Multiple groups,5310,31.00%,29.00%,32.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week9_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"March 1, 2022","March 7, 2022",Blood donors,Multiple groups,5771,46.00%,44.00%,48.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week11_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"March 15, 2022","March 21, 2022",Blood donors,Multiple groups,6132,50.00%,49.00%,52.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week13_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"March 29, 2022","April 3, 2022",Blood donors,Multiple groups,6604,51.00%,49.00%,53.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week5_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"February 1, 2022","February 7, 2022",Blood donors,Multiple groups,5847,18.00%,17.00%,19.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
220805_Denmark_AarhusUniversityHospital_Week3_Primary,"August 5, 2022",National,Denmark,DNK,"Capital Region of Denmark, Region Zealand, Region of Southern Denmark, Central Denmark Region, North Denmark Region",,"January 18, 2022","January 24, 2022",Blood donors,Multiple groups,4722,12.00%,11.00%,13.00%,Sequential,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Christian Erikstrup,University of Copenhagen,10.1016/j.lanepe.2022.100479,10/16/2022,4/17/2024,Verified
221109_Denmark_CopenhagenUniversityHospital_Overall,"November 9, 2022",National,Denmark,DNK,,,"February 10, 2020","March 11, 2021",Blood donors,Multiple groups,341,68.04%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Journal Article (Peer-Reviewed),Kamille Fogh,Copenhagen University Hospital,https://dx.doi.org/10.1128/spectrum.02537-22,11/18/2022,3/2/2024,Unverified
221222_Denmark_CopenhagenUniversityHospital_Overall,"December 22, 2022",National,Denmark,DNK,,,"February 15, 2021","March 15, 2021",Essential non-healthcare workers,Adults (18-64 years),20267,9.20%,,,Convenience,"CTK Biotech, Inc.",LFIA,"IgG,IgM",90.00%,100.00%,,Journal Article (Peer-Reviewed),Kamille Fogh,Copenhagen University Hospital,https://dx.doi.org/10.1128/spectrum.04174-22,1/12/2023,3/2/2024,Unverified
230115_Denmark_StatensSerumInstitut_Round4,"January 15, 2023",National,Denmark,DNK,,,"March 1, 2021","March 22, 2021",Household and community samples,Multiple groups,11275,7.20%,6.60%,7.60%,Convenience,Beijing Wantai Biological,ELISA,,,,,Journal Article (Peer-Reviewed),Lene Wulff Krogsgaard,Statens Serum Institut,https://dx.doi.org/10.2147/IDR.S383491,2/9/2023,3/20/2023,Unverified
230115_Denmark_StatensSerumInstitut_Round5,"January 15, 2023",National,Denmark,DNK,,,"May 10, 2021","May 31, 2021",Household and community samples,Multiple groups,5139,8.60%,7.60%,9.50%,Convenience,Beijing Wantai Biological,ELISA,,,,,Journal Article (Peer-Reviewed),Lene Wulff Krogsgaard,Statens Serum Institut,https://dx.doi.org/10.2147/IDR.S383491,2/9/2023,3/20/2023,Unverified
230406_Denmark_CopenhagenUniversityHospital_baseline_overall,"April 6, 2023",National,Denmark,DNK,,,"June 1, 2020","August 31, 2020",Residual sera,Adults (18-64 years),14895,3.90%,,,Convenience,NA,ELISA,Total Antibody,97.00%,98.00%,High,Journal Article (Peer-Reviewed),Cecilie Bo Hansen,Copenhagen University,https://dx.doi.org/10.1111/joim.13637,5/8/2023,4/23/2024,Verified
230705_Denmark_UniversityHospitalofSouthernDenmark,"July 5, 2023",Local,Denmark,DNK,,,"April 23, 2020","November 15, 2020",Pregnant or parturient women,Adults (18-64 years),1042,1.60%,,,Convenience,Beijing Wantai Biological,ELISA,"IgG,IgM,IgA",96.70%,99.50%,,Journal Article (Peer-Reviewed),Stine Yde Nielsen,University Hospital of Southern Denmark,https://dx.doi.org/10.1080/14767058.2023.2229933,8/1/2023,5/1/2024,Verified
210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA,"February 16, 2021",Local,Democratic Republic of the Congo,COD,South-Kivu,Bukavu,"July 2, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),359,41.20%,,,Convenience,EUROIMMUN,ELISA,IgG,61.70%,98.60%,High,Journal Article (Peer-Reviewed),Denis Mukwege ,Université Libre de Bruxelles (ULB),https://dx.doi.org/10.4269/ajtmh.20-1526,3/14/2021,3/2/2024,Verified
210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN,"February 17, 2021",Local,Democratic Republic of the Congo,COD,Kinhasa,Kinhasa,"July 17, 2020","August 13, 2020",Health care workers and caregivers,Adults (18-64 years),562,36.00%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.60%,99.80%,Moderate,Journal Article (Peer-Reviewed),Antoine Nkuba Ndaye,Institut National de Recherche Biomedicale,https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext,3/21/2021,3/2/2024,Verified
210127_Bukavu_CliniqueSaint-LucDeBukavu_Overall,"January 27, 2021",Local,Democratic Republic of the Congo,COD,,Bukavu,"May 15, 2020","August 30, 2020",Multiple populations,Multiple groups,684,40.79%,,,Self-referral,Cellex Inc.,LFIA,"IgG,IgM",93.80%,96.00%,High,Journal Article (Peer-Reviewed),Philippe Bianga Katchunga,Clinique Saint-Luc de Bukavu,https://www.panafrican-med-journal.com/content/article/38/93/full/,4/16/2021,3/2/2024,Verified
210605_Kinshasa_InstitutNationaldeRechercheBiomédicale_primary,"June 5, 2021",Local,Democratic Republic of the Congo,COD,,Kinshasa,"October 22, 2020","November 8, 2020",Household and community samples,Multiple groups,1080,16.60%,14.00%,19.50%,Stratified probability,NA,CLIA,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Antoine Nkuba,Institut National de Recherche Biomédicale,https://dx.doi.org/10.1093/cid/ciab515,6/17/2021,7/17/2022,Verified
221212_USA_RTIInternational_DRC,"December 12, 2022",National,Democratic Republic of the Congo,COD,,,"November 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),1816,29.10%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221218_Kinshasa_HokkaidoUniversity,"December 18, 2022",Local,Democratic Republic of the Congo,COD,,Kinshasa,"March 6, 2021","March 14, 2021",Household and community samples,Multiple groups,2476,72.20%,69.80%,74.40%,Stratified probability,Beijing Wantai Biological,ELISA,,,,Low,Journal Article (Peer-Reviewed),Yannick Munyeku-Bazitama,Hokkaido University,https://dx.doi.org/10.3201/eid2901.221009,1/12/2023,4/12/2024,Verified
230919_DRC_UCLouvain_Customers_nonAdj,"September 19, 2023",Local,Democratic Republic of the Congo,COD,,Goma,"September 1, 2021","November 8, 2021",Household and community samples,Multiple groups,342,70.20%,,,Convenience,"ZenTech, Angleur, Belgium",LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Prudence Ndeba Mitangala,Université catholique de Louvain,https://dx.doi.org/10.1017/S0950268823001498,3/7/2023,3/2/2024,Unverified
230919_DRC_UCLouvain_Vendors_nonAdj,"September 19, 2023",Local,Democratic Republic of the Congo,COD,,Goma,"September 1, 2021","November 8, 2021",Non-essential workers and unemployed persons,Multiple groups,454,70.30%,,,Convenience,"ZenTech, Angleur, Belgium",LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Prudence Ndeba Mitangala,Université catholique de Louvain,https://dx.doi.org/10.1017/S0950268823001498,3/7/2023,3/2/2024,Unverified
230118_Matadi_InstitutNationalDeRechercheBiomedicale_Overall_TestAdj,"January 18, 2023",Local,Democratic Republic of the Congo,COD,Kongo Central,Matadi,"October 16, 2021","October 24, 2021",Household and community samples,Multiple groups,2197,88.10%,86.20%,90.10%,Stratified probability,Beijing Wantai Biological,,,94.40%,100.00%,Low,Journal Article (Peer-Reviewed),Yannick Munyeku-Bazitama,Institut National de Recherche Biomédicale,https://doi.org/10.1093/ofid/ofad023,3/10/2023,3/27/2024,Verified
230201_Bukavu_UniversiteCatholiqueDeLouvain_Overall_TestAdj,"February 1, 2023",Local,Democratic Republic of the Congo,COD,South Kivu,Bukavu,"June 24, 2021","September 15, 2021",Household and community samples,Multiple groups,507,84.00%,76.20%,92.40%,Stratified probability,"ZenTech, Angleur, Belgium",,,71.10%,100.00%,,Journal Article (Peer-Reviewed),Leonid Irenge,Université catholique de Louvain,https://dx.doi.org/10.1017/S0950268823000158,3/10/2023,3/20/2023,Unverified
230329_Goma_InstituteNationalResearchBiomedical_M4_Overall,"March 29, 2023",Local,Democratic Republic of the Congo,COD,,Goma,"June 1, 2021","June 30, 2021",Health care workers and caregivers,Multiple groups,189,83.10%,,,Convenience,Luminex Corporation,Luminex,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Bolarinde Lawal,Institute National Research biomedical,https://dx.doi.org/10.1016/j.ijid.2023.03.049,4/1/2023,3/2/2024,Unverified
230608_Lumbashi_Epicentre,"June 8, 2023",Local,Democratic Republic of the Congo,COD,,Lumbashi,"April 15, 2021","May 15, 2021",Household and community samples,Multiple groups,1897,43.20%,40.00%,46.40%,Convenience,EUROIMMUN,ELISA,,90.00%,100.00%,High,Journal Article (Peer-Reviewed),Erica Simons,Epicentre,https://dx.doi.org/10.1371/journal.pgph.0001457,6/30/2023,3/2/2024,Unverified
230720_Congo_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Democratic Republic of the Congo,COD,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2898,37.60%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
200714_CzechRepublic_ResearchCenterIBD_HCW,"July 14, 2020",Local,Czechia,CZE,Central Bohemian,Prague,,"April 15, 2020",Health care workers and caregivers,Adults (18-64 years),92,2.17%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed), Karin Malickova,Clinical and Research Center for Inflammatory Bowel Disease,https://dx.doi.org/10.1080/00365521.2020.1791244,8/3/2020,3/2/2024,Verified
201112_Prague_CharlesUniversityandThomayer'sHospital_Roche,"November 12, 2020",Local,Czechia,CZE,Prague,Prague,"July 3, 2020","August 19, 2020",Residual sera,Children and Youth (0-17 years),200,0.00%,0.00%,0.50%,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Marketa Bloomfield,Charles University and Thomayer’s Hospital,http://dx.doi.org/10.3389/fped.2020.597736,1/24/2021,7/5/2023,Verified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Brno/South Moravian Region,"May 6, 2020",Regional,Czechia,CZE,Brno / South Moravian,,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,5049,0.08%,0.01%,0.15%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/17/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Prague,"May 6, 2020",Local,Czechia,CZE,,Prague,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,5021,0.17%,0.05%,0.28%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/17/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litomerice,"May 6, 2020",Local,Czechia,CZE,,Litomerice,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,3106,0.24%,0.07%,0.42%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/17/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Litovel_Unicov,"May 6, 2020",Local,Czechia,CZE,,"Litovel, Unicov","April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,2409,1.79%,1.24%,2.34%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/17/2022,Unverified
200506_CzechRepublic_MinistryofHealthoftheCzechRepublic_Olomouc/Olomouckykraj,"May 6, 2020",Regional,Czechia,CZE,Olomouc / Olomouc ,,"April 23, 2020","May 1, 2020",Household and community samples,Multiple groups,6686,0.69%,0.48%,0.91%,Stratified non-probability,Fortress Diagnostics,LFIA,Not reported,95.00%,100.00%,Moderate,Presentation or Conference,Ladislav Dušek,Ministry o fHealth of the Czech Republic,https://covid-imunita.uzis.cz/res/file/prezentace/20200506-dusek.pdf,6/8/2021,7/17/2022,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_Patients,"July 1, 2021",Local,Czechia,CZE,,Prague,"October 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1002,6.80%,,,Convenience,DiaSorin,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,7/13/2021,3/2/2024,Unverified
210701_Prague_InstituteForClinicalAndExperimentalMedicine_HCWs,"July 1, 2021",Local,Czechia,CZE,,Prague,"October 1, 2020","November 30, 2020",Health care workers and caregivers,Adults (18-64 years),512,11.90%,,,Convenience,DiaSorin,CLIA,IgG,91.20%,90.20%,High,Journal Article (Peer-Reviewed),Maria Magicova,Institute for Clinical and Experimental Medicine,https://dx.doi.org/10.1111/ajt.16746,7/13/2021,3/2/2024,Unverified
210815_ Czechia_GENNETImmunologyLaboratory_Primary,"August 15, 2021",Local,Czechia,CZE,,Prague,"March 28, 2020","March 28, 2021",Health care workers and caregivers,Adults (18-64 years),182,35.70%,,,Convenience,"EUROIMMUN,Abbott Laboratories",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Zuzana Kratka,GENNET Immunology Laboratory,https://www.prolekare.cz/casopisy/casopis-lekaru-ceskych/2021-4-5/download?hl=cs,8/31/2021,3/2/2024,Unverified
210728_HavlickuvBrod_CharlesUniversity_Overall,"July 28, 2021",Local,Czechia,CZE,Vysočina,Havlíčkův Brod,"June 8, 2021","June 21, 2021",Students and Daycares,Children and Youth (0-17 years),196,45.90%,38.80%,53.20%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,High,Journal Article (Peer-Reviewed),Vaclav Fejt,Charles University (Univerzity Karlovy),https://www.prolekare.cz/en/journals/journal-of-czech-physicians/2021-4-5/what-is-the-immunity-of-high-school-students-to-coronavirus-127893,8/31/2021,3/2/2024,Unverified
220301_CzechRepublic_MasarykUniversity_1Oct2020Nov2020_OverallAdjusted,"March 1, 2022",National,Czechia,CZE,,,"October 1, 2020","November 30, 2020",Household and community samples,Multiple groups,3626,27.90%,26.10%,29.70%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Pavel Piler,Masaryk University,https://doi.org/10.1038/s43856-022-00080-0,3/17/2022,3/2/2024,Verified
220301_CzechRepublic_MasarykUniversity_2Dec2020Jan2021_OverallAdjusted,"March 1, 2022",National,Czechia,CZE,,,"December 1, 2020","January 31, 2021",Household and community samples,Multiple groups,6880,42.20%,40.80%,43.50%,Convenience,"DiaSorin,Abbott Laboratories",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Pavel Piler,Masaryk University,https://doi.org/10.1038/s43856-022-00080-0,3/17/2022,3/2/2024,Verified
220105_Prague_ThomayerUniversityHospital_IgG,"January 5, 2022",Local,Czechia,CZE,,Prague,"June 30, 2020","September 7, 2020",Health care workers and caregivers,Multiple groups,808,1.86%,,,Convenience,"Roche Diagnostics,EUROIMMUN",Multiple Types,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Marketa Ibrahimova,Thomayer University Hospital,https://www.prolekare.cz/en/journals/epidemiology-microbiology-immunology/2022-1-21/prevalence-of-sars-cov-2-antibodies-in-the-thomayer-university-hospital-staff-after-the-first-wave-of-covid-19-130625,5/5/2022,3/2/2024,Unverified
211231_Cyprus_CyprusSchoolofMolecularMedicine_AntiS1RBD_TestAdjusted,"December 31, 2021",National,Cyprus,CYP,,,"October 15, 2020","May 15, 2021",Household and community samples,Multiple groups,194,6.61%,,,Convenience,ImmunoDiagnostics,ELISA,IgG,92.50%,93.30%,High,Journal Article (Peer-Reviewed),George Krashias,Cyprus School of Molecular Medicine,https://www.mdpi.com/2076-2607/10/1/85,2/8/2022,3/2/2024,Unverified
220101_NorthernCyprus_NearEastUniversity,"January 1, 2022",Local,Cyprus,CYP,Northern Cyprus,North Nicosia,"September 15, 2020","January 15, 2021",Residual sera,Children and Youth (0-17 years),80,1.25%,,,Convenience,Diagnostic Bioprobes,ELISA,IgG,92.20%,84.00%,High,Journal Article (Peer-Reviewed),Umut Gazi,Near East University,https://dx.doi.org/10.24953/turkjped.2021.1330,3/25/2022,7/17/2022,Unverified
200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos,"August 23, 2020",Local,Cuba,CUB,Cienfuegos,Aguada de Pasajeros,"March 23, 2020","April 6, 2020",Contacts of COVID patients,Multiple groups,200,0.00%,,,Convenience,NA,Not reported,"IgM,IgG",,,Unclear,Journal Article (Peer-Reviewed),Alain Morejon Giraldoni,University of Medical Sciences of Cienfuegos,http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721,1/8/2021,7/17/2022,Verified
200515_Croatia_UniversityofSplit_IndustryWorkers_Overall,"May 15, 2020",Local,Croatia,HRV,,,"April 23, 2020","April 28, 2020",Essential non-healthcare workers,Multiple groups,1494,1.27%,0.77%,1.98%,Convenience,AMEDA Labordiagnostik GmbH,LFIA,"IgM,IgG",91.80%,96.40%,High,Journal Article (Peer-Reviewed),Ivan Jerkovic,University of Split,https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx,7/17/2020,3/2/2024,Verified
200826_Croatia_UniversityofZagreb_HCWsIgG,"August 26, 2020",National,Croatia,HRV,,,"April 25, 2020","May 24, 2020",Health care workers and caregivers,Adults (18-64 years),592,2.70%,,,Convenience,Vircell S.L.,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic Cavlek,University of Zagreb,https://dx.doi.org/10.1590/0037-8682-0458-2020,10/18/2020,3/2/2024,Verified
201231_Zagreb_ZagrebUniversity_overall,"December 31, 2020",Local,Croatia,HRV,,Zagreb,"May 1, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),1678,0.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,Moderate,Journal Article (Peer-Reviewed),Ivana Lapic,Zagreb University,https://pubmed.ncbi.nlm.nih.gov/33410294/,2/2/2021,3/2/2024,Verified
201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff,"November 4, 2020",Local,Croatia,HRV,,,"May 29, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),305,20.00%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,Moderate,Preprint,Adriana Vince,Croatian Football Federation,https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1,2/7/2021,3/2/2024,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint1_primary,"April 15, 2021",Local,Croatia,HRV,,Zagreb,"May 13, 2020","May 29, 2020",Residual sera,Children and Youth (0-17 years),240,2.90%,,,Convenience,"Vircell S.L.,NA",Multiple Types,"IgA,IgM,IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,5/20/2021,3/2/2024,Verified
210415_Croatia_ChildrensHospitalZagreb_timepoint2_primary,"April 15, 2021",Local,Croatia,HRV,,Zagreb,"October 24, 2020","November 23, 2020",Residual sera,Children and Youth (0-17 years),308,8.40%,,,Convenience,"NA,Roche Diagnostics",Multiple Types,"IgG,IgM,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Jasna Lenicek Krleza,Children's Hospital Zagreb,https://dx.doi.org/10.11613/BM.2021.020706,5/20/2021,3/2/2024,Verified
210620_Croatia_CroatianInstituteOfPublicHealth_FirstWave_Overall,"June 20, 2021",National,Croatia,HRV,,,"May 15, 2020","July 15, 2020",Multiple general populations,Multiple groups,1088,2.20%,1.40%,3.30%,Convenience,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,7/14/2021,3/2/2024,Verified
210620_Croatia_CroatianInstituteOfPublicHealth_SecondWave_Overall,"June 20, 2021",National,Croatia,HRV,,,"December 15, 2020","February 15, 2021",Multiple general populations,Multiple groups,1436,25.10%,22.80%,27.40%,Convenience,"Vircell S.L.,NA",Multiple Types,"IgG,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Tatjana Vilibic-Cavlek,Croatian Institute of Public Health,https://dx.doi.org/10.3390/pathogens10060774,7/14/2021,3/2/2024,Verified
210602_Croatia_UniversityofZagreb,"June 2, 2021",Local,Croatia,HRV,,,"September 7, 2020","November 27, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,512,20.10%,16.40%,26.30%,Entire sample,Vircell S.L.,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Mrzljak,University of Zagreb,https://dx.doi.org/10.11613/BM.2021.030901,10/24/2021,3/2/2024,Unverified
210318_IvoryCoast_CentreHospitalierRegionald’Orleans_Overall,"March 18, 2021",National,Côte d'Ivoire,CIV,,,"July 15, 2020","October 13, 2020",Essential non-healthcare workers,Adults (18-64 years),1687,25.10%,,,Convenience,AAZ LMB,LFIA,"IgG,IgM",100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Jean Milleliri,Centre Hospitalier Regional d’Orleans,https://dx.doi.org/10.4269/ajtmh.21-0081,4/16/2021,3/2/2024,Unverified
220924_CoteDIvoire_RobertKochInstitut_Overall,"September 24, 2022",Local,Côte d'Ivoire,CIV,,Bouaké,"February 9, 2021","February 19, 2021",Health care workers and caregivers,Adults (18-64 years),286,13.70%,10.00%,18.40%,Self-referral,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sarah Kribi,Robert Koch Institut,https://dx.doi.org/10.1093/trstmh/trac089,10/5/2022,8/15/2023,Unverified
230608_Abidjan_Epicentre,"June 8, 2023",National,Côte d'Ivoire,CIV,,,"July 15, 2021","November 10, 2021",Household and community samples,Multiple groups,1471,38.80%,,,Convenience,Roche Diagnostics,CLIA,"IgM,IgG",98.80%,100.00%,High,Journal Article (Peer-Reviewed),Erica Simons,Epicentre,https://dx.doi.org/10.1371/journal.pgph.0001457,6/30/2023,7/4/2023,Unverified
201222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall,"December 22, 2020",Local,Congo,COG,,Brazzaville,"April 1, 2020","July 31, 2020",Household and community samples,Adults (18-64 years),754,19.70%,,,Self-referral,"Wuhan UNscience Biotechnology Co. Ltd,Salofa Oy",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed), Armel Batchi Bouyou,Fondation Congolaise pour la Recherche Médicale,https://dx.doi.org/10.1016/j.ijid.2020.12.065,1/31/2021,3/2/2024,Verified
220315_Bomassa_FCRM_IgGIgM,"March 15, 2022",Local,Congo,COG,,"Bomassa
","May 20, 2021","June 2, 2021",Household and community samples,Adults (18-64 years),304,36.00%,,,Simplified probability,VIROTECH,ELISA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),LineLobaloba Ingoba,Fondation Congolaise pour la Recherche Médicale,https://www.sciencedirect.com/science/article/pii/S2772707622000066?via%3Dihub,4/27/2022,3/2/2024,Unverified
221006_RepublicOfCongo_NationalLaboratoryOfPublicHealth_Overall,"October 6, 2022",National,Congo,COG,,"Brazzaville, Pointe-Noire, a rural site in Ouesso.","June 15, 2021","July 15, 2021",Household and community samples,Multiple groups,1669,31.80%,29.50%,34.00%,Convenience,Biosynex,LFIA,"IgG,IgM",95.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Fabien Niama,National Laboratory of Public Health,https://dx.doi.org/10.1016/j.ijregi.2022.09.012,10/20/2022,3/2/2024,Unverified
200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj,"January 3, 2021",Local,Colombia,COL,Capital District Cundinamarca,Bogotá,"June 25, 2020","August 10, 2020",Health care workers and caregivers,Adults (18-64 years),351,8.26%,5.81%,11.61%,Self-referral,Abbott Laboratories,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Beatriz Ariza,Pontificia Universidad Javeriana,http://www.revistainfectio.org/index.php/infectio/article/view/938,10/6/2020,3/2/2024,Verified
201030_Colombia_UniversidadIndustrialdeSantander_primary,"October 30, 2020",National,Colombia,COL,,,"April 17, 2020","July 14, 2020",Essential non-healthcare workers,Multiple groups,4234,4.00%,,,Unclear,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Alvaro J Idrovo,Universidad Industrial de Santander,https://dx.doi.org/10.7705/biomedica.5829,1/24/2021,7/17/2022,Verified
201112_Monteria_UniversidaddeCórdoba_GenPopAdj,"November 12, 2020",Local,Colombia,COL,Caribbean Region,Monteria,"August 4, 2020","September 1, 2020",Household and community samples,Multiple groups,1368,55.30%,52.50%,57.80%,Stratified probability,Eurofins Ingenasa,ELISA,"IgG,IgM,IgA",92.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Salim Mattar,Universidad de Córdoba,https://dx.doi.org/10.1093/ofid/ofaa550,2/5/2021,3/2/2024,Verified
210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj,"January 22, 2021",Local,Colombia,COL,Capital District Cundinamarca,Bogota,"June 1, 2020","September 30, 2020",Essential non-healthcare workers,Adults (18-64 years),212,16.03%,10.43%,21.62%,Convenience,Abbott Laboratories,CLIA,Total Antibody,85.50%,97.30%,High,Journal Article (Peer-Reviewed),Jeadran Malagon Rojas,Instituto Nacional de Salud,https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1,3/13/2021,8/15/2023,Verified
210317_UniversidadDeLosAndes_UniversidadDeLosAndes_overall,"March 17, 2021",Local,Colombia,COL,Capital District Cundinamarca,Bogotá,"November 23, 2020","December 6, 2020",Essential non-healthcare workers,Adults (18-64 years),237,13.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,John M Gonzalez,Universidad de Los Andes,https://www.medrxiv.org/content/10.1101/2021.03.15.21253609v1,3/30/2021,3/2/2024,Verified
210425_Bucaramanga_FundaciónCardiovascularDeColombia_overall_popadj_testadj,"April 15, 2021",Local,Colombia,COL,,Bucaramanga,"September 28, 2020","December 24, 2020",Essential non-healthcare workers,Adults (18-64 years),7045,19.50%,18.60%,20.40%,Stratified probability,Abbott Laboratories,Multiple Types,"IgG,IgM",85.20%,97.30%,Moderate,Journal Article (Peer-Reviewed),Claudia Colmenares-Mejia ,Fundación Cardiovascular de Colombia,http://dx.doi.org/10.3390/ijerph18084172,5/23/2021,8/15/2023,Verified
210611_Cordoba_UniversidadNacionaldeColombia_Primary,"June 11, 2021",Regional,Colombia,COL,Cordoba,,"March 15, 2020","October 2, 2020",Household and community samples,Multiple groups,2447,40.80%,,,Stratified probability,Eurofins Ingenasa,ELISA,"IgG,IgM,IgA",93.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Nelson Alvis Guzma,Universidad de Cordoba,https://dx.doi.org/10.1016/j.ijid.2021.06.018,6/21/2021,3/2/2024,Verified
210629_Cordoba_ColombiaUniversidadDeCordoba_Overall,"June 29, 2021",Regional,Colombia,COL,Cordoba Department,,"July 15, 2020","November 15, 2020",Household and community samples,Multiple groups,2564,40.80%,,,Stratified non-probability,Eurofins Ingenasa,ELISA,"IgA,IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Evelin Garay,Colombia-Universidad de Cordoba,https://dx.doi.org/10.1093/trstmh/trab094,7/7/2021,3/2/2024,Verified
211001_Colombia_MedicalMissionInstitute_Overall,"October 1, 2021",Regional,Colombia,COL,"Department of Cesar, Department of La Guajira","San Juan, Sabana de Higuieron, Piñoncito, Ahuyamal, Surimena, Tezhumake, Valledupar, La Junta, Atanquez, Los Corazones, Patillal, Siminke and Vereda Platanal.","March 28, 2021","April 26, 2021",Household and community samples,Multiple groups,452,27.70%,,,Convenience,PharmACT,LFIA,IgG,,100.00%,High,Journal Article (Peer-Reviewed),Gustavo Concha,Medical Mission Institute,http://dx.doi.org/10.3390/vaccines9101120,10/14/2021,3/2/2024,Verified
211027_Amazon_UniversidaddeCórdoba_Primary,"October 27, 2021",Local,Colombia,COL,Columbian Amazon,Mitú,"December 1, 2020","December 31, 2020",Household and community samples,Multiple groups,589,57.60%,,,Convenience,Eurofins Ingenasa,ELISA,Total Antibody,90.10%,99.20%,Moderate,Journal Article (Peer-Reviewed),Hector Serrano-Coll,Universidad de Córdoba,http://dx.doi.org/10.3390/tropicalmed6040191,11/9/2021,3/2/2024,Verified
211105_Colombia_InstitutoNacionaldeSalud_TestAdj,"November 5, 2021",National,Colombia,COL,,"Bogotá, Barranquilla, Bucaramanga, Cali, Cúcuta, Medellín, Villavicencio, Leticia, Ipiales, Guapi","September 15, 2020","November 15, 2020",Health care workers and caregivers,Adults (18-64 years),3296,35.00%,33.00%,37.00%,Convenience,Siemens,CLIA,Total Antibody,86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Jeadran Nevardo Malagon-Rojas,Instituto Nacional de Salud,https://dx.doi.org/10.1136/oemed-2021-107487,11/18/2021,8/15/2023,Unverified
20220223_Colombia_InstitutoNacionaldeSalud_Analysis,"February 22, 2022",National,Colombia,COL,,"Bogota, Medellin, Cali, Barranquilla, Cucuta,
Bucaramanga and Villavicencio Leticia, Ipiales and Guapi","September 21, 2020","December 11, 2020",Household and community samples,Multiple groups,17863,32.53%,32.00%,33.00%,Stratified probability,Siemens,CLIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcela Mercado-Reye,Instituto Nacional de Salud,https://dx.doi.org/10.1016/j.lana.2022.100195,2/23/2022,3/2/2024,Verified
220323_Colombia_FundacionSantaFedeBogota_Overall,"March 23, 2022",Local,Colombia,COL,Bogotá,Bogotá,"June 25, 2020","October 30, 2020",Health care workers and caregivers,Adults (18-64 years),420,23.10%,,,Convenience,"Qingdao Hightop Biotech Co. Ltd ,Dynamiker Biotechnology (Tianjin) Co. Ltd",Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nohemí Caballero,Fundación Santa Fe de Bogotá,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942465/,6/30/2022,3/2/2024,Unverified
220905_Colombia_UniversidadDeLaSalle_Overall_TestAdj,"September 5, 2022",National,Colombia,COL,,,"March 15, 2021","June 15, 2021",Multiple populations,Multiple groups,1225,39.20%,,,Convenience,Siemens,Not reported,"IgG,IgM",100.00%,99.80%,High,Journal Article (Peer-Reviewed),Martha Rodríguez,Universidad de La Salle,https://dx.doi.org/10.1016/j.nmni.2022.101026,9/20/2022,8/15/2023,Unverified
220919_Bogota_PontificiaUniversidadJaveriana_Overall,"September 19, 2022",Local,Colombia,COL,,Bogota,"November 17, 2020","February 12, 2021",Health care workers and caregivers,Adults (18-64 years),2597,21.50%,,,Self-referral,"NA,Abbott Laboratories,BioMérieux",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Sandra Liliana Valderrama-Beltran,Pontificia Universidad Javeriana,https://dx.doi.org/10.1371/journal.pone.0274484,9/27/2022,3/2/2024,Unverified
220901_Colombia_IPSSanPabloApóstol_overall,"September 1, 2022",Local,Colombia,COL,,,"March 15, 2021","June 15, 2021",Perinatal,Adults (18-64 years),360,29.40%,,,Convenience,Eurofins Ingenasa,ELISA,"IgG,IgM,IgA",92.50%,99.20%,High,Journal Article (Peer-Reviewed),Jose Berrocal,IPS San Pablo Apóstol,https://dx.doi.org/10.1016/j.jiph.2022.08.017,9/28/2022,3/2/2024,Unverified
221215_Medellin_InstituciónUniversitariaColegioMayordeAntioquia,"December 15, 2022",Local,Colombia,COL,,Medellin,"November 15, 2020","January 15, 2021",Household and community samples,Multiple groups,260,11.20%,,,Convenience,Guangzhou Wondfo Biotech Co. Ltd,,,,,,Journal Article (Peer-Reviewed),Miguel Octavio Perez Navarro,Institución Universitaria Colegio Mayor de Antioquia,https://dx.doi.org/10.1016/j.puhip.2022.100347,1/13/2023,3/2/2024,Unverified
230131_Bogota_FundaciónCardioinfantil-InstitutodeCardiología,"January 31, 2023",Local,Colombia,COL,,Bogota,"April 19, 2021","May 13, 2021",Health care workers and caregivers,Adults (18-64 years),1021,34.48%,,,Convenience,Abbott Laboratories,LFIA,IgG,97.80%,92.80%,,Journal Article (Peer-Reviewed),Karen Moreno-Medina,Fundación Cardioinfantil-Instituto de Cardiología,https://dx.doi.org/10.1093/occmed/kqad003,3/6/2023,3/2/2024,Unverified
230215_Colombia_GlobalInstituteOfClinicalExcellence_IgG,"February 15, 2023",Local,Colombia,COL,,Bogota,"March 1, 2020","January 28, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,162,25.00%,,,Convenience,NA,Not reported,IgG,,,,Journal Article (Peer-Reviewed),Camilo Alberto González González,Global Institute of Clinical Excellence,https://dx.doi.org/10.4067/S0034-98872023000100072,10/3/2023,10/4/2023,Unverified
200605_China_NationalClinicalResearchCentre_CommunitySetting,"June 5, 2020",National,China,CHN,"Hubei, Sichuan, Guangdong","Wuhan, Guangzhou, Chengdu","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),10449,0.80%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,6/7/2020,7/17/2022,Verified
200602_Wuhan_SunYat-senUniversity_HCW_IgG,"June 10, 2020",Local,China,CHN,Hubei,Wuhan,"February 7, 2020","April 21, 2020",Health care workers and caregivers,Adults (18-64 years),420,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,High,Journal Article (Peer-Reviewed),Min Liu,Sun Yat-sen University,https://www.bmj.com/content/369/bmj.m2195,6/13/2020,7/5/2023,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,"November 2, 2020",Local,China,CHN,Hubei,Wuhan,"February 29, 2020","April 29, 2020",Health care workers and caregivers,Multiple groups,3832,4.00%,3.40%,4.70%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,7/5/2023,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,"November 2, 2020",Local,China,CHN,Hubei,Wuhan,"February 29, 2020","April 29, 2020",Household and community samples,Multiple groups,19555,4.60%,4.30%,4.90%,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,7/5/2023,Verified
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,"November 2, 2020",Local,China,CHN,Hubei,Wuhan,"February 29, 2020","April 29, 2020",Residual sera,Multiple groups,1616,1.00%,0.50%,1.50%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,97.80%,97.90%,Moderate,Preprint,Tao Liu,Zhongnan Hospital of Wuhan University,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,7/5/2023,Verified
200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients,"April 20, 2020",Local,China,CHN,Hubei,Wuhan,"April 3, 2020","April 15, 2020",Residual sera,Multiple groups,381,10.49%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/20/2020,3/2/2024,Verified
200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork,"April 20, 2020",Local,China,CHN,Hubei,Wuhan,"April 3, 2020","April 15, 2020",Essential non-healthcare workers,Adults (18-64 years),1021,9.60%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Xiaodong Wu,Wuhan University,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/20/2020,3/2/2024,Verified
200605_China_NationalClinicalResearchCentre_HospitalSetting,"June 5, 2020",National,China,CHN,"Hubei, Sichuan, Guangdong","Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan","March 9, 2020","April 10, 2020",Multiple populations,Adults (18-64 years),6919,2.46%,,,Self-referral,Bioscience Diagnostics,CLIA,"IgG,IgM",,99.30%,High,Journal Article (Peer-Reviewed),Xin Xu,National Clinical Research Centre for Kidney Disease,https://www.nature.com/articles/s41591-020-0949-6,7/25/2020,7/17/2022,Verified
200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM,"July 20, 2020",Local,China,CHN,Guangdong,Guangzhou,"January 20, 2020","April 30, 2020",Multiple populations,Multiple groups,8782,0.59%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgG,IgM",,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,7/17/2022,Verified
200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,"July 20, 2020",Local,China,CHN,Hubei,Wuhan,"January 19, 2020","April 30, 2020",Multiple populations,Multiple groups,8272,2.14%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",87.30%,100.00%,High,Journal Article (Peer-Reviewed),Wenhua Liang,The First Affiliated Hospital of Guangzhou Medical University,https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,3/2/2024,Verified
200829_Hubei_HuazhongUniversity_HospitalizedChildren,"August 29, 2020",Local,China,CHN,Hubei,"Wuhan, Xiangyang","January 23, 2020","April 24, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),299,0.00%,,,Unclear,NA,CLIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Song mi Want,Huazhong University of Science and Technology,https://link.springer.com/article/10.1007/s11596-020-2228-7,10/4/2020,7/17/2022,Verified
200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG,"August 11, 2020",Local,China,CHN,Hubei,Wuhan,"January 23, 2020","March 27, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),44,0.00%,,,Sequential,NA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ai Zhang,Huazhong University of Science and Technology,https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424,10/10/2020,7/17/2022,Verified
200820_Hubei_NanjingUniversity_hcw_IgG,"August 20, 2020",Local,China,CHN,Hubei,Wuhan,"May 12, 2020","May 15, 2020",Health care workers and caregivers,Adults (18-64 years),191,0.00%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Xin Tong,Nanjing University Medical School,https://dx.doi.org/10.1002/iid3.340,10/13/2020,7/5/2023,Verified
200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti,"August 19, 2020",Local,China,CHN,Guangdong,Guangzhou,"March 23, 2020","April 2, 2020",Blood donors,Adults (18-64 years),2199,0.32%,,,Simplified probability,Beijing Wantai Biological,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Ru Xu,Institute of Blood Transfusion,http://dx.doi.org/10.1002/jmv.26445,10/18/2020,3/2/2024,Verified
200824_Wuhan_WuhanUniversity_IgG_T2,"August 24, 2020",Local,China,CHN,Hubei,Wuhan,"May 13, 2020","June 10, 2020",Health care workers and caregivers,Adults (18-64 years),1059,9.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lu He,Wuhan University,http://dx.doi.org/10.1016/j.jinf.2020.08.027,10/19/2020,3/2/2024,Verified
200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal,"September 14, 2020",Local,China,CHN,Hubei,Wuhan,"March 16, 2020","March 25, 2020",Health care workers and caregivers,Adults (18-64 years),3674,1.70%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fuling Zhou,Zhongnan Hospital of Wuhan University,http://dx.doi.org/10.1016/j.eclinm.2020.100510,10/30/2020,7/5/2023,Verified
200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall,"September 23, 2020",Local,China,CHN,Hubei,Wuhan,"February 10, 2020","March 22, 2020",Contacts of COVID patients,Multiple groups,300,47.67%,,,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",97.10%,95.30%,High,Journal Article (Peer-Reviewed),Yaqing Li,National Center for Medical Service Administration,https://dx.doi.org/10.5858/arpa.2020-0310-SA,11/20/2020,3/2/2024,Verified
200923_Beijing_PekingUniversity_Overall,"September 23, 2020",Local,China,CHN,Hebei,Beijing,"April 15, 2020","April 18, 2020",Household and community samples,Multiple groups,2184,0.17%,,,Stratified probability,"Innovita Biological Technology Co. Ltd,Guangzhou Wondfo Biotech Co. Ltd",Multiple Types,"IgG,IgM",,,Moderate,Preprint,Xiaoli Wang,Peking University,https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1,11/23/2020,3/2/2024,Verified
200921_Wuhan_TongjiMedicalCollege_Overall,"September 21, 2020",Local,China,CHN,Hubei,Wuhan,"February 17, 2020","April 28, 2020",Multiple populations,Multiple groups,11766,0.50%,,,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,"IgM,IgG",66.70%,99.50%,High,Journal Article (Peer-Reviewed),Qing Lei, Tongji Medical College,https://dx.doi.org/10.1111/all.14622,11/26/2020,7/17/2022,Verified
201119_Shanghai_FudanUniversity_Overall,"November 19, 2020",Local,China,CHN,Shanghai Municipality,Shanghai,"May 15, 2020","October 15, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,6414,0.31%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Preprint,Shengjie Li,Fudan University,https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v2,12/1/2020,7/5/2023,Verified
200922_Wuhan_WuhanUniversity_IgM/IgG,"October 6, 2020",Local,China,CHN,Hubei,Wuhan,"May 15, 2020","May 26, 2020",Household and community samples,Multiple groups,61437,2.39%,2.27%,2.52%,Stratified probability,Nanjing Vazyme Medical Technology Co. Ltd,LFIA,"IgG,IgM",91.54%,97.02%,Moderate,Journal Article (Peer-Reviewed),Yunbao Pan,Wuhan University,https://dx.doi.org/10.1016/j.cmi.2020.09.044,12/9/2020,2/21/2024,Verified
201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj,"October 23, 2020",Local,China,CHN,Hubei,Wuhan,"March 27, 2020","May 26, 2020",Household and community samples,Multiple groups,35040,3.90%,3.70%,4.10%,Unclear,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anding Liu,Huazhong University of Science and Technology,https://dx.doi.org/10.1001/jamanetworkopen.2020.25717,1/23/2021,7/5/2023,Verified
201225_Wuhan_RenminHospitalofWuhanUniversity_Community,"December 25, 2020",Local,China,CHN,Hubei,Wuhan,"May 15, 2020","May 29, 2020",Household and community samples,Multiple groups,4454,2.90%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/29/2021,3/2/2024,Verified
201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW,"December 25, 2020",Local,China,CHN,Hubei,Wuhan,"May 15, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),4614,3.30%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lu He,Renmin Hospital of Wuhan University,https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/29/2021,3/2/2024,Verified
201228_Beijing_CapitalMedicalUniversity_IgG,"December 28, 2020",Local,China,CHN,,Beijing,"January 1, 2020","August 31, 2020",Residual sera,Children and Youth (0-17 years),19797,0.06%,,,Sequential,Innovita Biological Technology Co. Ltd,LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Ran Wang,Capital Medical University ,https://dx.doi.org/10.1002/ped4.12231,2/1/2021,3/2/2024,Verified
210107_China_WuhanUniversity,"January 7, 2021",Regional,China,CHN,Hubei,,"March 6, 2020","May 3, 2020",Essential non-healthcare workers,Multiple groups,63107,0.74%,,,Unclear,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shuhui Duan,Wuhan University,https://dx.doi.org/10.1371/journal.pntd.0008975,2/7/2021,3/2/2024,Unverified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj,"January 19, 2021",Local,China,CHN,,Shenzen,"April 12, 2020","May 4, 2020",Contacts of COVID patients,Multiple groups,880,4.10%,2.90%,5.70%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/25/2021,7/5/2023,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj,"January 19, 2021",Local,China,CHN,,Shenzen,"April 17, 2020","April 23, 2020",Household and community samples,Multiple groups,350,0.00%,0.00%,1.10%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/25/2021,7/5/2023,Verified
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj,"January 19, 2021",Local,China,CHN,,Shenzen,"April 17, 2020","April 23, 2020",Household and community samples,Multiple groups,50,0.00%,0.00%,6.80%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,98.00%,99.00%,High,Journal Article (Peer-Reviewed),Zhen Zhang,Shenzhen Center for Disease Control and Prevention,https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/25/2021,7/5/2023,Verified
210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall,"January 9, 2021",Local,China,CHN,Taiwan,Taipei,"July 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),194,0.00%,,,Convenience,"Abbott Laboratories,Mikrogen GmbH,Roche Diagnostics",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Sung Ching Pan,National Taiwan University Hospital,https://dx.doi.org/10.1016/j.jfma.2021.01.002,3/15/2021,3/2/2024,Unverified
210206_China_ChineseCenterforDiseaseControlandPrevention_Overall,"February 6, 2021",National,China,CHN,,,"April 10, 2020","April 18, 2020",Household and community samples,Multiple groups,34857,1.23%,,,Stratified probability,"Guangzhou Wondfo Biotech Co. Ltd,Innovita Biological Technology Co. Ltd,Bioscience Diagnostics,NA",Multiple Types,"IgM,IgG,Neutralizing ,Total Antibody",,,Low,Journal Article (Peer-Reviewed),Zhongjie Li ,Chinese Center for Disease Control and Prevention,https://dx.doi.org/10.1016/j.lanwpc.2021.100094,3/24/2021,3/2/2024,Verified
210320_Wuhan_ChineseAcademyOfMedicalSciences_overall_Roche,"March 20, 2021",Regional,China,CHN,Wuhan,,"April 14, 2020","April 15, 2020",Household and community samples,Multiple groups,9542,6.92%,6.41%,7.43%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,100.00%,100.00%,Low,Journal Article (Peer-Reviewed),Zhenyu He,Chinese Academy of Medical Sciences & Peking Union Medical College,https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00238-5/fulltext?dgcid=raven_jbs_etoc_email,3/25/2021,3/2/2024,Verified
200825_Wuhan_ChineseCenterforDiseaseControlandPrevention_primary,"August 25, 2020",Local,China,CHN,Hubei,Wuhan,"March 25, 2020","April 28, 2020",Household and community samples,Multiple groups,18712,3.27%,3.02%,3.52%,Self-referral,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",89.50%,99.00%,Moderate,Preprint,Ruijie Ling,Chinese Center for Disease Control and Prevention,https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v3,4/9/2021,3/2/2024,Verified
210302_Wuhan_ChineseAcademyofMedicalSciences1_overall_adj,"March 2, 2021",Local,China,CHN,Hubei Province,Wuhan,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),17794,2.66%,2.24%,3.07%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,7/17/2022,Verified
210302_Shenzhen_ChineseAcademyofMedicalSciences2_overall_adj,"March 2, 2021",Local,China,CHN,,Shenzhen,"January 15, 2020","April 15, 2020",Blood donors,Multiple groups,6810,0.03%,0.00%,0.27%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,7/17/2022,Unverified
210302_Shijiazhuang_ChineseAcademyofMedicalSciences3_overall_adj,"March 2, 2021",Local,China,CHN,Hebei Province,Shijiazhuang,"January 15, 2020","April 15, 2020",Blood donors,Adults (18-64 years),13540,0.00%,0.00%,0.16%,Convenience,NA,Neutralization,"IgG,Total Antibody,IgM",,,Moderate,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1038/s41467-021-21503-x,4/12/2021,7/17/2022,Verified
210308_ZhongnanHospital_Wuhan,"March 8, 2021",Local,China,CHN,Hubei,Wuhan,"January 1, 2020","April 8, 2020",Health care workers and caregivers,Adults (18-64 years),112,0.00%,,,Entire sample,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yin-xian Wen,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1111/os.12898,4/19/2021,7/17/2022,Verified
210408_Taiwan_NationalChengKungUniversityHospital_overall,"April 8, 2021",National,China,CHN,Taiwan,,"August 15, 2020","September 13, 2020",Residual sera,Adults (18-64 years),969,0.00%,,,Convenience,"TONYAR Biotech Inc., Taiwan,Guangzhou Wondfo Biotech Co. Ltd,Roche Diagnostics",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Ming Chi Li,National Cheng Kung University Hospital,https://dx.doi.org/10.1016/j.jmii.2021.03.018,5/19/2021,3/2/2024,Unverified
210419_Wuhan_ChineseAcademyofSciences,"April 19, 2021",Local,China,CHN,Hubei,Wuhan,"May 30, 2020","June 12, 2020",Essential non-healthcare workers,Adults (18-64 years),508,5.91%,,,Unclear,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Yong Yang,Chinese Academy of Sciences,https://dx.doi.org/10.1080/22221751.2021.1919032,5/20/2021,7/17/2022,Verified
210421_Wuhan_WuhanUniversity_overall,"April 21, 2021",Local,China,CHN,Hubei,"Wuhan
","April 23, 2020","May 24, 2020",Household and community samples,Multiple groups,35326,3.77%,3.58%,3.97%,Convenience,"Nanjing Vazyme Medical Technology Co. Ltd,Shenzhen Yhlo Biotech Co. Ltd",CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Huan Han,Wuhan University,https://pubmed.ncbi.nlm.nih.gov/33883260/,5/23/2021,2/28/2024,Verified
210118_Hangzhou_ZhejiangUniversitySchoolofMedicine_Overall,"January 18, 2021",Local,China,CHN,Zhejiang,Hangzhou,"April 24, 2020","May 8, 2020",Multiple populations,Multiple groups,16043,0.46%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Nanjing Vazyme Medical Technology Co. Ltd",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jun Huang,Zhejiang University School of Medicine,https://dx.doi.org/10.21037/atm-20-7163,5/28/2021,3/2/2024,Verified
210518_Taiwan_NationalTaiwanUniversity_GroupH1,"May 18, 2021",National,China,CHN,Taiwan,"Taipei, Zhubei","June 25, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),464,0.00%,0.00%,0.79%,Convenience,"Abbott Laboratories,Roche Diagnostics,Mikrogen GmbH",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,National Taiwan University,https://dx.doi.org/10.3389/fimmu.2021.626609,6/16/2021,3/2/2024,Unverified
210518_Taiwan_NationalTaiwanUniversity_GroupC2,"May 18, 2021",National,China,CHN,Taiwan,"Taipei, Zhubei","June 25, 2020","July 29, 2020",Health care workers and caregivers,Adults (18-64 years),1142,0.09%,0.00%,0.49%,Convenience,NA,Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Wen Pin Tseng,Researchers at the National Taiwan University studied symptomatic patients with frontline healthcare workers (n=464) and found a stringently judged seroprevalence of 0%.,https://dx.doi.org/10.3389/fimmu.2021.626609,6/17/2021,8/15/2023,Unverified
201010_Taipei_TaipeiVeteransGeneralHospital_popadj,"October 10, 2020",Local,China,CHN,,Taipei,"May 25, 2020","July 8, 2020",Residual sera,Multiple groups,14765,0.05%,0.02%,0.10%,Sequential,"Academia Sinica,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Hsiang-Ling Ho,Taipei Veterans General Hospital,https://dx.doi.org/10.1016/j.lanwpc.2020.100041,7/7/2021,3/2/2024,Verified
210722_Wuhan_HospitalofHubeiProvince_pregnant_primary,"July 22, 2021",Local,China,CHN,Hubei,Wuhan,"April 1, 2020","December 30, 2020",Pregnant or parturient women,Adults (18-64 years),15953,0.66%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/28/2021,7/17/2022,Verified
210722_Wuhan_HospitalofHubeiProvince_partners_primary,"July 22, 2021",Local,China,CHN,Hubei,Wuhan,"April 1, 2020","December 30, 2020",Multiple general populations,Adults (18-64 years),15671,0.73%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/28/2021,7/17/2022,Verified
210722_Wuhan_HospitalofHubeiProvince_HCW_primary,"July 22, 2021",Local,China,CHN,Hubei,Wuhan,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),385,1.80%,,,Entire sample,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Hongwen Ma,Hospital of Hubei Province,https://dx.doi.org/10.1007/s12026-021-09213-4,7/28/2021,7/17/2022,Verified
210806_China_FudanUniversity_OcularSurfaceDisease_Overall,"August 6, 2021",National,China,CHN,,,"May 15, 2020","March 15, 2021",Representative patient population,Multiple groups,1755,2.28%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,8/31/2021,7/17/2022,Unverified
210806_China_FudanUniversity_NoOcularSurfaceDisease_Overall,"August 6, 2021",National,China,CHN,,,"May 15, 2020","March 15, 2021",Representative patient population,Multiple groups,12550,0.70%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,9/1/2021,7/17/2022,Unverified
210806_China_FudanUniversity_NoOcularDisease_Overall,"August 6, 2021",National,China,CHN,,,"May 15, 2020","March 15, 2021",Residual sera,Multiple groups,5852,0.92%,,,Convenience,Bioscience Diagnostics,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Shengjie Li,Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care,https://dx.doi.org/10.3389/fimmu.2021.695428,9/1/2021,7/17/2022,Unverified
210915_Wuhan_HubeiProvincialHospital_AgeSexAdj,"September 15, 2021",Local,China,CHN,Hubei,Wuhan,"March 25, 2020","April 28, 2020",Multiple populations,Multiple groups,18712,3.15%,2.90%,3.40%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),LING Rui Jie,Hubei Provincial Hospital,https://dx.doi.org/10.3967/bes2021.103,9/29/2021,3/2/2024,Verified
211115_HongKong_TheChineseUniversityofHongKong_Overall_PopAdjusted,"November 15, 2021",National,China,CHN,NR,,"April 21, 2020","April 18, 2021",Household and community samples,Multiple groups,4198,0.15%,0.06%,0.32%,Convenience,"Roche Diagnostics,NA",Multiple Types,"IgG,Not reported",,,Moderate,Journal Article (Peer-Reviewed),Siaw Boon,The Chinese University of Hong Kong,https://dx.doi.org/10.1001/jamanetworkopen.2021.32923,11/22/2021,3/2/2024,Unverified
211118_Guangdong_GuangzhouMedicalUniversity_OverallPopAdjust,"November 18, 2021",Regional,China,CHN,Guangdong,"Chaozhou,Heyuan,Jiangmen,Jieyang,Maoming,Meizhou,Qingyuan,Shantou,Shanwei,Shaoguan,Yangjiang,Yunfu,Zhanjiang,Zhaoqing,Dongguan,Foshan,Guangzhou,Huizhou,Shenzhen,Zhongshan,Zhuhai","March 11, 2020","June 24, 2020",Residual sera,Multiple groups,14629,0.15%,0.06%,0.24%,Convenience,Bioscience Diagnostics,CLIA,IgG,89.60%,99.20%,Moderate,Journal Article (Peer-Reviewed),Cheng Xiao,Guangzhou Medical University,https://www.mdpi.com/2076-0817/10/11/1505/htm,12/8/2021,7/17/2022,Unverified
211201_Wuhan_ZhongnanHospitalUniversityOfWuhan_IgG,"December 1, 2021",Local,China,CHN,Hubei,Wuhan,"March 1, 2020","June 30, 2020",Multiple populations,Multiple groups,21398,4.57%,4.30%,4.86%,Convenience,"Shenzhen Yhlo Biotech Co. Ltd,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Yufeng Shang,University of Wuhan Zhongnan Hospital,https://dx.doi.org/10.1002/jmv.27483,12/10/2021,7/17/2022,Unverified
200720_Guangzhou_NanfangHospital_Primary,"July 20, 2020",Local,China,CHN,Hubei,Wuhan,"March 20, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),943,0.00%,,,Entire sample,NA,Not reported,"IgG,IgM",87.30%,99.50%,High,Journal Article (Peer-Reviewed),Fan Fan Hou,Nanfang Hospital,https://dx.doi.org/10.1093/PCMEDI/PBAA024,1/8/2022,7/17/2022,Unverified
200720_Wuhan_NanfangHospital_Primary,"July 20, 2020",Local,China,CHN,Hubei,Wuhan,"March 20, 2020","April 15, 2020",Health care workers and caregivers,Adults (18-64 years),7586,3.20%,,,Entire sample,NA,Not reported,"IgG,IgM",87.30%,99.50%,,Journal Article (Peer-Reviewed),Fan Fan Hou,Nanfang Hospital,https://dx.doi.org/10.1093/PCMEDI/PBAA024,1/8/2022,7/17/2022,Unverified
220104_Wuhan_ZhongnanHospitalOfWuhanUniversity_IgG,"January 4, 2022",Local,China,CHN,Hubei,Wuhan,"March 21, 2020","May 21, 2020",Residual sera,Multiple groups,3062,7.51%,,,Convenience,Innovita Biological Technology Co. Ltd,Other,IgG,89.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Yueting Tang,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.1186/s12879-021-07010-w,1/9/2022,3/2/2024,Unverified
220110_Chongqing_ArmyMedicalUniversity_GenPop,"January 10, 2022",Local,China,CHN,,Chongqing,"January 1, 2020","March 31, 2020",Blood donors,Adults (18-64 years),250,0.00%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shichun Wang,Army Medical University,https://dx.doi.org/10.1016/j.jfma.2022.01.004,1/26/2022,7/17/2022,Unverified
220110_Chongqing_ArmyMedicalUniversity_HCW,"January 10, 2022",Local,China,CHN,,Chongqing,"January 1, 2020","March 31, 2020",Household and community samples,Adults (18-64 years),248,0.00%,,,Unclear,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Shichun Wang,Army Medical University,https://dx.doi.org/10.1016/j.jfma.2022.01.004,1/26/2022,7/17/2022,Unverified
220128_HongKong_TheChineseUniversityofHongKong,"January 28, 2022",Local,China,CHN,Hong Kong,Hong Kong,"November 15, 2019","October 15, 2020",Pregnant or parturient women,Adults (18-64 years),1830,0.34%,,,Convenience,"Roche Diagnostics,ImmunoDiagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Hillary Leung,The Chinese University of Hong Kong,https://dx.doi.org/10.12809/hkmj219653,2/9/2022,3/2/2024,Unverified
220128_HongKong_TheChineseUniversityofHongKong_AND,"January 28, 2022",Local,China,CHN,Hong Kong,Hong Kong,"November 15, 2019","October 15, 2020",Pregnant or parturient women,Adults (18-64 years),1830,0.05%,,,Convenience,"Roche Diagnostics,ImmunoDiagnostics",Multiple Types,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Hillary Leung,The Chinese University of Hong Kong,https://dx.doi.org/10.12809/hkmj219653,2/9/2022,3/2/2024,Unverified
220121_HongKong_UniversityOfOxford,"January 21, 2022",Local,China,CHN,,Hong Kong,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,72,0.00%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
220407_HongKong_UniversityofHongKong_Overall,"April 7, 2022",Regional,China,CHN,Hong Kong,,"January 15, 2021","December 15, 2021",Residual sera,Multiple groups,1800,14.70%,,,Convenience,Shenzhen Yhlo Biotech Co. Ltd,CLIA,Neutralizing ,,,Moderate,Preprint,Lin-Lei Chen,The University of Hong Kong,https://www.researchsquare.com/article/rs-1512533/v1,4/15/2022,3/2/2024,Verified
220429_Wuhan_ZhongnanHospitalofWuhanUniversity_HIVpositive_Overall,"April 29, 2022",Local,China,CHN,Hubei,Wuhan,"May 1, 2020","May 30, 2020",Household and community samples,Multiple groups,857,0.47%,,,Simplified probability,NA,LFIA,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Mengmeng Wu,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.3389/fpubh.2022.833783,5/25/2022,7/17/2022,Unverified
220429_Wuhan_ZhongnanHospitalofWuhanUniversity_HIVnegative_Overall,"April 29, 2022",Local,China,CHN,Hubei,Wuhan,"May 1, 2020","May 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,1048,6.01%,,,Simplified probability,NA,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Mengmeng Wu,Zhongnan Hospital of Wuhan University,https://dx.doi.org/10.3389/fpubh.2022.833783,5/25/2022,7/17/2022,Unverified
220715_Wuhan_UnionMedicalCollege_overall,"July 15, 2022",Local,China,CHN,,Wuhan,"April 9, 2020","April 13, 2020",Household and community samples,Multiple groups,5067,6.18%,,,Stratified probability,Roche Diagnostics,CLIA,"IgG,IgM,IgA",100.00%,99.50%,Moderate,Journal Article (Peer-Reviewed),Jin Yang,Union Medical College,https://dx.doi.org/10.1186/s12931-022-02096-5,7/27/2022,4/1/2024,Verified
20220726_HongKong_QueenMaryHospital_Dec2021_RBD,"July 26, 2022",Regional,China,CHN,Hong Kong,Hong Kong,"December 1, 2021","December 31, 2021",Residual sera,Multiple groups,423,52.20%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,,Journal Article (Peer-Reviewed),Rosana Wing-Shan Poon,Queen Mary Hospital,https://dx.doi.org/10.1080/22221751.2022.2106899,8/4/2022,3/2/2024,Verified
20220726_HongKong_QueenMaryHospital_May2022_RBD,"July 26, 2022",Regional,China,CHN,Hong Kong,Hong Kong,"May 1, 2022","May 31, 2022",Residual sera,Multiple groups,450,89.30%,,,Convenience,Abbott Laboratories,Not reported,IgG,,,,Journal Article (Peer-Reviewed),Rosana Wing-Shan Poon,Queen Mary Hospital,https://dx.doi.org/10.1080/22221751.2022.2106899,8/4/2022,3/2/2024,Verified
220916_Taiwan_TaiwanBloodServicesFoundation,"September 16, 2022",Regional,China,CHN,Taiwan,,"January 1, 2021","February 28, 2021",Blood donors,Multiple groups,10000,0.02%,,,Convenience,Roche Diagnostics,CLIA,Not reported,,,High,Presentation or Conference,Min-Hui Yang,Taiwan Blood Services Foundation,https://dx.doi.org/10.1111/trf.17058,11/10/2022,3/2/2024,Unverified
220524_Wuhan_ChineseAcademyOfMedicalSciences_Overall_Total-Ig-nAb,"May 24, 2022",Local,China,CHN,Hubei,Wuhan,"September 1, 2019","December 31, 2019",Blood donors,Multiple groups,43850,0.00%,,,Sequential,"Beijing Wantai Biological,NA",,,,,,Journal Article (Peer-Reviewed),Le Chang,Chinese Academy of Medical Sciences,https://dx.doi.org/10.1093/procel/pwac013,3/10/2023,3/2/2024,Unverified
221107_Beijing_CapitalInstituteofPediatrics,"November 7, 2022",Local,China,CHN,,Beijing,"January 15, 2022","July 15, 2022",Residual sera,Children and Youth (0-17 years),5309,2.00%,,,Sequential,Maccura Biotechnology Ltd,,,,,,Journal Article (Peer-Reviewed),Jing Li,Capital Institute of Pediatrics,https://dx.doi.org/10.3389/fimmu.2022.1030238,4/4/2023,4/12/2023,Unverified
230624_HongKong_MountSinai,"June 24, 2023",National,China,CHN,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,72,0.00%,,,Convenience,Roche Diagnostics,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
231108_Jiangsu_YixingSecondPeoplesHospital_Overall,"November 8, 2023",Regional,China,CHN,Jiangsu,,"February 10, 2023","March 10, 2023",Residual sera,Children and Youth (0-17 years),1065,92.80%,91.20%,94.30%,Sequential,Shenzhen Yhlo Biotech Co. Ltd,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Yi-Hua Zhou,Yixing Second People's Hospital,https://dx.doi.org/10.3389/fpubh.2023.1283158,3/9/2024,3/9/2024,Unverified
200710_Santiago_UniversidadDeChile_AllStudents,"July 10, 2020",Local,Chile,CHL,Santiago,Vitacura,"May 4, 2020","May 19, 2020",Students and Daycares,Children and Youth (0-17 years),1009,9.90%,8.60%,11.50%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,3/2/2024,Verified
200710_Santiago_UniversidadDeChile_AllStaff,"July 10, 2020",Local,Chile,CHL,Santiago,Vitacura,"May 4, 2020","May 19, 2020",Essential non-healthcare workers,Adults (18-64 years),235,16.60%,12.10%,21.90%,Stratified probability,Genrui Biotech,LFIA,"IgG,IgM",91.01%,95.37%,High,Journal Article (Peer-Reviewed),Juan Pablo Torres,Universidade de Chile,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,3/2/2024,Verified
210215_Chile_UniversityOfChile_HCW,"February 15, 2021",National,Chile,CHL,,,"September 11, 2020","October 24, 2020",Health care workers and caregivers,Multiple groups,85528,7.20%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",95.80%,100.00%,Low,Preprint,Marcela Zuniga,Universidad de Chile,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3785998,5/22/2021,3/2/2024,Verified
210526_Chile_UniversidadDelDesarrollo_Overall2_Overall,"May 26, 2021",Local,Chile,CHL,Santiago,Santiago,"April 27, 2020","July 31, 2020",Health care workers and caregivers,Multiple groups,446,24.00%,20.20%,28.30%,Convenience,"Vircell S.L.,EUROIMMUN",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Mirentxu Iruretagoyena,Universidad del Desarrollo,https://dx.doi.org/10.1186/s12879-021-06208-2,6/6/2021,3/2/2024,Verified
210909_Chile_UniversidaddeChile,"September 9, 2021",National,Chile,CHL,,,"March 12, 2021","July 2, 2021",Household and community samples,Multiple groups,54261,52.84%,,,Convenience,"CTK Biotech, Inc.",LFIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Denis Saure,Universidad de Chile,https://dx.doi.org/10.1016/S1473-3099(21)00479-5,9/23/2021,3/2/2024,Unverified
211226_Chile_UniversidaddeChile_Overall,"December 26, 2021",National,Chile,CHL,,,"September 11, 2020","October 24, 2020",Health care workers and caregivers,Multiple groups,85529,7.18%,,,Convenience,Zhuhai Livzon Diagnostics Inc,LFIA,"IgG,IgM",95.80%,100.00%,Moderate,Journal Article (Peer-Reviewed),Marcela Zuniga,Universidad de Chile,https://dx.doi.org/10.1016/j.jclinepi.2021.12.026,1/12/2022,3/2/2024,Unverified
220128_Chile_UniversidaddelDesarrollo_Overall_PopAdj,"January 28, 2022",National,Chile,CHL,"Coquimbo, Talca, Santiago",,"September 25, 2020","November 25, 2020",Household and community samples,Multiple groups,2493,10.40%,7.80%,13.70%,Stratified probability,"Roche Diagnostics,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,Low,Journal Article (Peer-Reviewed),Pablo Vial,Universidad del Desarrollo,https://dx.doi.org/10.1186/s12879-022-07045-7,2/9/2022,3/2/2024,Verified
220413_Chile_UniversidadDelDesarrollo_Overall,"April 13, 2022",Regional,Chile,CHL,Center zone,Santiago; Coquimbo/La Serena; Talca.,"October 5, 2021","November 25, 2021",Household and community samples,Multiple groups,2198,97.32%,,,Stratified probability,"Beijing Wantai Biological,Cellex Inc.",Multiple Types,"Total Antibody,IgG,IgM",,,High,Preprint,Ximena Aguilera,Universidad del Desarrollo,https://doi.org/10.21203/rs.3.rs-1548211/v1,4/23/2022,3/2/2024,Unverified
220407_Chile_ClinicaAlemanaUniversidaddelDesarrollo_TestAdj,"April 7, 2022",National,Chile,CHL,Valparaiso; Metropolitan; O'Higgins,,"September 15, 2020","November 15, 2020",Assisted living and long-term care facilities,Seniors (65+ years),2088,16.20%,14.60%,17.90%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgG,IgM",90.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Paola Rubilar,Fundacion Chile,https://dx.doi.org/10.5867/medwave.2022.03.002553,4/29/2022,8/15/2023,Unverified
220423_Chile_UniversidadDeChile_Primary,"April 23, 2022",National,Chile,CHL,,,,"December 24, 2021",Students and Daycares,Children and Youth (0-17 years),2302,85.70%,84.30%,87.10%,Convenience,"CTK Biotech, Inc.",LFIA,IgG,96.70%,98.10%,High,Journal Article (Peer-Reviewed),Juan Torres,Universidad de Chile,https://dx.doi.org/10.1016/j.ijid.2022.04.039,5/5/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Overall,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Multiple groups,1368,6.79%,5.58%,8.26%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/11/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Sex_Male,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Multiple groups,590,7.30%,5.40%,9.70%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Sex_Female,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Multiple groups,778,6.40%,4.90%,8.40%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_7-14,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Children and Youth (0-17 years),67,10.40%,5.10%,20.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_15-24,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Multiple groups,167,4.80%,2.40%,9.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_25-39,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Adults (18-64 years),455,5.70%,3.90%,8.30%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_40-59,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Adults (18-64 years),470,7.40%,5.40%,10.20%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220713_Santiago_ UniversidadDelDesarrollo_Age_60+,"July 13, 2022",Local,Chile,CHL,Santiago Province,Santiago,"April 24, 2020","June 21, 2020",Household and community samples,Seniors (65+ years),209,8.10%,5.10%,12.70%,Simplified probability,"ACRO Biotech Inc,Cellex Inc.,Dynamiker Biotechnology (Tianjin) Co. Ltd,Zhuhai Livzon Diagnostics Inc",Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Pablo A. Vial,Universidad del Desarrollo,https://dx.doi.org/10.1016/j.epidem.2022.100606,8/12/2022,3/2/2024,Unverified
220803_Santiago_UniversidadDelDesarrollo_Overall,"August 3, 2022",Local,Chile,CHL,,Santiago,"November 1, 2020","November 30, 2020",Health care workers and caregivers,Multiple groups,463,22.25%,,,Convenience,Vircell S.L.,ELISA,IgG,85.70%,98.50%,High,Preprint,Andrea Olea,Universidad del Desarrollo,http://doi.org/10.1101/2022.08.03.22278369,8/18/2022,3/2/2024,Unverified
221124_Santiago_UniversidadDelDesarrollo_Overall,"November 24, 2022",Local,Chile,CHL,,Santiago,"November 1, 2020","November 30, 2020",Health care workers and caregivers,Multiple groups,463,22.20%,,,Convenience,Vircell S.L.,ELISA,IgG,85.70%,98.50%,High,Journal Article (Peer-Reviewed),Andrea Olea,Universidad del Desarrollo,https://dx.doi.org/10.4067/s0716-10182022000400382,12/9/2022,3/2/2024,Unverified
230110_Chile_UniversidadDelDesarrollo_Round1,"January 10, 2023",Local,Chile,CHL,,"La Serena-Coquimbo, Talca","September 15, 2020","November 15, 2020",Household and community samples,Multiple groups,14,3.60%,,,Stratified probability,Roche Diagnostics,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Loreto Nunez Franz,Universidad del Desarrollo,https://dx.doi.org/10.3390/v15010201,2/10/2023,3/20/2023,Unverified
230110_Chile_UniversidadDelDesarrollo_Round2,"January 10, 2023",Local,Chile,CHL,,"La Serena-Coquimbo, Talca","October 15, 2021","November 15, 2021",Household and community samples,Multiple groups,374,96.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Loreto Nunez Franz,Universidad del Desarrollo,https://dx.doi.org/10.3390/v15010201,2/10/2023,3/2/2024,Unverified
230110_Chile_UniversidadDelDesarrollo_Round3,"January 10, 2023",Local,Chile,CHL,,"La Serena-Coquimbo, Talca","April 15, 2022","September 15, 2022",Household and community samples,Multiple groups,381,98.70%,,,Stratified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Loreto Nunez Franz,Universidad del Desarrollo,https://dx.doi.org/10.3390/v15010201,2/10/2023,3/20/2023,Unverified
230215_Valdivia_HospitalBaseDeValdivia_3tests,"February 15, 2023",Local,Chile,CHL,Los Ríos,Valdivia,"April 12, 2020","July 25, 2020",Health care workers and caregivers,Adults (18-64 years),179,0.56%,,,Convenience,"Vircell S.L.,Institut Virion/Serion,AdipoGen LifeSciences",ELISA,"IgG,Neutralizing ",,,,Journal Article (Peer-Reviewed),Alberto Fica,Hospital Base de Valdivia,https://dx.doi.org/10.4067/S0034-98872023000100023,10/11/2023,3/2/2024,Unverified
230111_Chad_GoodSamaritanUniversityHospitalCentre_AntiN,"January 11, 2023",Local,Chad,TCD,Ndjamena,Ndjamena,"August 12, 2021","October 26, 2021",Blood donors,Multiple groups,2700,69.50%,67.70%,71.30%,Self-referral,"Diatheva SRL, Cartaceto, Italy",ELISA,IgG,99.50%,99.80%,,Journal Article (Peer-Reviewed),Andrillene Laure Deutou Wondeu,Good Samaritan University Hospital Centre,https://dx.doi.org/10.4081/jphia.2022.2255,2/7/2023,3/2/2024,Unverified
211121_Bengui_UniversityofBangui,"November 21, 2021",Local,Central African Republic,CAF,,Bangui,"July 12, 2021","August 20, 2021",Household and community samples,Multiple groups,799,74.10%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,,99.40%,Moderate,Preprint,Alexandre Manirakiza,University of Bangui,https://www.medrxiv.org/content/10.1101/2021.11.18.21266496v1.full-text,11/30/2021,3/2/2024,Unverified
221226_Bangui_InstitutPasteurofBangui_survey1_overall,"December 26, 2022",Regional,Central African Republic,CAF,"Bangui
",,"April 1, 2021","April 30, 2021",Health care workers and caregivers,Adults (18-64 years),179,36.31%,,,Convenience,NA,ELISA,"IgG,IgM",,,,Preprint,Alexandre Manirakiza,Institut Pasteur of Bangui,10.1101/2022.12.22.22283871,1/10/2023,3/20/2023,Unverified
221226_Bangui_InstitutPasteurofBangui_survey2_overall,"December 26, 2022",Regional,Central African Republic,CAF,"Bangui
",,"May 1, 2022","May 31, 2022",Health care workers and caregivers,Adults (18-64 years),141,95.74%,,,Convenience,NA,ELISA,"IgG,IgM",,,,Preprint,Alexandre Manirakiza,Institut Pasteur of Bangui,10.1101/2022.12.22.22283871,1/11/2023,3/20/2023,Unverified
200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj,"July 15, 2020",Regional,Canada,CAN,British Columbia,,"March 5, 2020","March 13, 2020",Residual sera,Multiple groups,869,0.28%,0.03%,0.95%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.,NA,Siemens",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/17/2020,3/2/2024,Verified
200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj,"July 15, 2020",Regional,Canada,CAN,British Columbia,,"May 15, 2020","May 27, 2020",Residual sera,Multiple groups,885,0.55%,0.15%,1.37%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,"IgA,IgM,IgG",,,Moderate,Preprint,Danuta Skowronski,British Columbia Centre for Disease Control,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/17/2020,3/2/2024,Verified
210205_Ontario_PublicHealthOntario_July_Abbott,"February 2, 2021",Regional,Canada,CAN,Ontario,,"July 4, 2020","July 31, 2020",Residual sera,Multiple groups,7001,1.39%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/8/2020,3/2/2024,Verified
210205_Ontario_PublicHealthOntario_August_Abbott,"February 2, 2021",Regional,Canada,CAN,Ontario,,"August 1, 2020","August 21, 2020",Residual sera,Multiple groups,5764,1.56%,,,Stratified non-probability,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.1093/infdis/jiaa796,12/8/2020,3/2/2024,Verified
201017_Vancouver_UniversityofBritishColumbia_LTCF_overall,"October 17, 2020",Local,Canada,CAN,British Columbia,Vancouver,"May 4, 2020","May 14, 2020",Assisted living and long-term care facilities,Multiple groups,291,39.00%,,,Convenience,"DiaSorin,Abbott Laboratories,Ortho Clinical Diagnostics Inc.,Siemens",Not reported,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Rohit Vijh,University of British Columbia,https://dx.doi.org/10.1016/j.ajic.2020.10.009,12/18/2020,3/2/2024,Verified
201027_Montreal_ShrinersHospital_children_unadj,"October 27, 2020",Local,Canada,CAN,Québec,Montreal,"June 10, 2020","July 27, 2020",Residual sera,Children and Youth (0-17 years),39,8.00%,,,Convenience,Generic Diagnostics Ltd,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/19/2020,3/2/2024,Verified
201027_Montreal_ShrinersHospital_accompanying_unadj,"October 27, 2020",Local,Canada,CAN,Québec,Montreal,"June 10, 2020","July 27, 2020",Hospital visitors,Adults (18-64 years),61,11.48%,,,Convenience,Generic Diagnostics Ltd,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/19/2020,3/2/2024,Verified
201027_Montreal_ShrinersHospital_employees_unadj,"October 27, 2020",Local,Canada,CAN,Québec,Montreal,"June 10, 2020","July 27, 2020",Health care workers and caregivers,Adults (18-64 years),99,12.00%,,,Convenience,Generic Diagnostics Ltd,ELISA,IgG,,97.00%,High,Journal Article (Peer-Reviewed),Ghalib Bardai,Shriners Hospital for Children,https://doi.org/10.1111/pan.14047,12/19/2020,3/2/2024,Verified
210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj,"January 12, 2021",National,Canada,CAN,,,"November 7, 2020","November 25, 2020",Blood donors,Multiple groups,17049,1.51%,1.31%,1.71%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a,1/21/2021,7/5/2023,Verified
201218_Canada_CBS_BloodDonors_Overall_PopTestAdj,"December 18, 2020",National,Canada,CAN,,,"October 12, 2020","October 31, 2020",Blood donors,Multiple groups,16811,0.88%,0.73%,1.04%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,1/22/2021,7/5/2023,Verified
201203_Edmonton_UniversityofAlberta_Children,"December 3, 2020",Local,Canada,CAN,Alberta,Edmonton,"August 14, 2020","October 23, 2020",Household and community samples,Children and Youth (0-17 years),565,1.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,84.20%,100.00%,High,Preprint,Emilie Manny,University of Alberta,https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE,1/31/2021,3/2/2024,Verified
210208_Canada_CBS_BloodDonors_Overall_PopTestAdj,"February 8, 2021",National,Canada,CAN,,,"December 10, 2020","December 23, 2020",Blood donors,Multiple groups,16961,1.37%,1.18%,1.56%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,2/20/2021,7/5/2023,Verified
210201_Canada_CanadianBloodServices_Overall_adj,"February 1, 2021",National,Canada,CAN,"Yukon, Northwest Territories, Nunavut, British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nove Scotia, Prince Edward Island, Newfoundland and Labrador",,"May 9, 2020","July 21, 2020",Blood donors,Multiple groups,74642,0.70%,0.63%,0.76%,Sequential,Abbott Laboratories,CLIA,IgG,92.70%,99.90%,Moderate,Journal Article (Peer-Reviewed),Sahar Saeed,Canadian Blood Services,http://dx.doi.org/10.1111/trf.16296,3/22/2021,7/5/2023,Verified
210216_Toronto_UniversityHealthNetwork_Euroimmun+Microarray,"February 16, 2021",Local,Canada,CAN,Ontario,Toronto,"April 17, 2020","May 29, 2020",Health care workers and caregivers,Adults (18-64 years),996,0.50%,,,Convenience,"EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Victor Ferreira,University Health Network,https://dx.doi.org/10.1371/journal.pone.0247258,3/23/2021,3/2/2024,Verified
210315_Vancouver_BCChildren’sHospitalResearchInstitute_OverallPrimary,"March 15, 2021",Local,Canada,CAN,British Columbia,Vancouver,"May 17, 2020","June 19, 2020",Household and community samples,Adults (18-64 years),276,0.60%,0.00%,2.71%,Convenience,"Meso Scale Discovery,Ortho Clinical Diagnostics Inc.",Multiple Types,Total Antibody,,,High,Journal Article (Peer-Reviewed),Abdelilah Majdoubi,BC Children’s Hospital Research Institute,https://dx.doi.org/10.1172/jci.insight.146316,4/11/2021,8/15/2023,Verified
210517_Quebec_Héma-Québec_PopAdj,"May 17, 2021",Regional,Canada,CAN,Québec,,"May 25, 2020","July 9, 2020",Blood donors,Adults (18-64 years),7691,2.23%,1.90%,2.56%,Convenience,NA,ELISA,"IgA,IgM,IgG",98.90%,98.50%,Moderate,Journal Article (Peer-Reviewed),Hema-Quebec,Héma-Québec,https://dx.doi.org/10.17269/s41997-021-00531-6,6/4/2021,7/17/2022,Verified
210512_Canada_UniversityofAlberta_April1,"May 12, 2021",National,Canada,CAN,,,"April 1, 2020","April 30, 2020",Blood donors,Adults (18-64 years),8999,3.07%,,,Convenience,NA,ELISA,IgG,89.10%,,High,Preprint,Sahar Saeed,University of Alberta,https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1,6/5/2021,7/17/2022,Unverified
210512_Canada_UniversityofAlberta_September2,"May 12, 2021",National,Canada,CAN,,,"September 1, 2020","September 30, 2020",Blood donors,Adults (18-64 years),8999,2.67%,,,Simplified probability,NA,ELISA,IgG,89.10%,98.20%,Moderate,Preprint,Sahar Saeed,University of Alberta,https://www.medrxiv.org/content/10.1101/2021.05.11.21256992v1.full-text#T1,6/5/2021,7/17/2022,Unverified
210510_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"May 10, 2021",National,Canada,CAN,,,"January 1, 2021","January 27, 2021",Blood donors,Multiple groups,33400,2.78%,2.58%,2.97%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,6/8/2021,8/15/2023,Verified
210618_Vancouver_UniversityOfBritishColumbia_TestAdj,"June 18, 2021",Local,Canada,CAN,British Columbia,Vancouver,"February 10, 2021","May 15, 2021",Essential non-healthcare workers,Adults (18-64 years),1556,2.30%,1.60%,3.20%,Self-referral,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,Moderate,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,7/1/2021,8/15/2023,Unverified
210618_Vancouver_UniversityOfBritishColumbia_BloodDonors_TestAdj,"June 18, 2021",Local,Canada,CAN,British Columbia,Vancouver,"January 1, 2021","January 31, 2021",Blood donors,Adults (18-64 years),2502,2.30%,1.70%,3.00%,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,High,Preprint,David Goldfarb,University of British Columbia,10.1101/2021.06.16.21258861,7/1/2021,8/15/2023,Unverified
210706_Canada_StatisticsCanada_Overall,"July 6, 2021",National,Canada,CAN,,,"November 15, 2020","April 15, 2021",Household and community samples,Multiple groups,11124,3.60%,2.60%,4.20%,Stratified probability,NA,Not reported,Not reported,,,Moderate,News and Media,Statistics Canada,Statistics Canada,https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310081801,7/31/2021,7/17/2022,Verified
210802_Calgary_UniversityofCalgary,"August 2, 2021",Local,Canada,CAN,Alberta,Calgary,"October 15, 2020","April 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,279,1.08%,0.22%,3.11%,Sequential,Abbott Laboratories,CLIA,IgG,95.00%,99.00%,High,Journal Article (Peer-Reviewed),Gilaad Kaplan,University of Calgary,https://dx.doi.org/10.1136/gutjnl-2021-325238,8/12/2021,3/2/2024,Verified
210630_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 30, 2021",National,Canada,CAN,,,"April 13, 2021","April 30, 2021",Blood donors,Multiple groups,16931,26.92%,26.24%,27.60%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,8/19/2021,8/15/2023,Verified
210609_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 9, 2021",National,Canada,CAN,,,"February 27, 2021","March 13, 2021",Blood donors,Multiple groups,16873,9.85%,9.39%,10.31%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,8/19/2021,8/15/2023,Verified
210727_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"July 27, 2021",National,Canada,CAN,,,"May 8, 2021","June 4, 2021",Blood donors,Multiple groups,17001,63.90%,63.17%,64.64%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,8/19/2021,8/15/2023,Verified
210818_Alberta_AlbertaPrecisionLaboratories_1_June_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"June 1, 2020","June 5, 2020",Residual sera,Multiple groups,8442,0.92%,0.91%,0.93%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_2_July_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"July 6, 2020","July 10, 2020",Residual sera,Multiple groups,13175,0.86%,0.85%,0.87%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_3_August_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"August 4, 2020","August 11, 2020",Residual sera,Multiple groups,12284,1.24%,1.23%,1.25%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_4_September_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"September 7, 2020","September 11, 2020",Residual sera,Multiple groups,12006,1.02%,1.00%,1.02%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_5_October_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"October 5, 2020","October 9, 2020",Residual sera,Multiple groups,13490,1.16%,1.15%,1.17%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_6_November_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"November 9, 2020","November 13, 2020",Residual sera,Multiple groups,11471,1.61%,1.60%,1.62%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_7_December_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"December 7, 2020","December 10, 2020",Residual sera,Multiple groups,12076,2.47%,2.46%,2.49%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210818_Alberta_AlbertaPrecisionLaboratories_8_January_Overall_PopAdj,"August 18, 2021",Regional,Canada,CAN,Alberta,,"January 11, 2021","January 14, 2021",Residual sera,Multiple groups,11094,4.62%,4.60%,4.64%,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Carmen Charlton,Alberta Precision Laboratories,https://dx.doi.org/10.1128/Spectrum.00291-21,9/3/2021,3/2/2024,Verified
210830_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"August 30, 2021",National,Canada,CAN,,,"June 14, 2021","June 29, 2021",Blood donors,Multiple groups,16884,90.78%,90.32%,91.25%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services,N/A,9/16/2021,8/15/2023,Verified
211012_Ontario_TheHospitalforSickChildren_Primary,"October 12, 2021",Regional,Canada,CAN,Ontario,,"April 1, 2020","November 13, 2020",Health care workers and caregivers,Adults (18-64 years),1062,5.37%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,98.00%,Moderate,Journal Article (Peer-Reviewed),Michelle Science,The Hospital for Sick Children ,https://dx.doi.org/10.9778/cmajo.20210044,10/20/2021,3/2/2024,Unverified
211013_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"October 13, 2021",National,Canada,CAN,,,"July 14, 2021","July 23, 2021",Blood donors,Multiple groups,8457,94.69%,94.16%,95.22%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,10/20/2021,8/15/2023,Verified
211122_Montreal_UniversityOfMontreal,"November 23, 2021",Local,Canada,CAN,Québec,Montreal,"October 22, 2020","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),1632,5.80%,4.90%,7.00%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,12/2/2021,7/17/2022,Unverified
211207_Calgary_CummingSchoolofMedicine,"December 7, 2021",Local,Canada,CAN,Alberta,Calgary,"January 1, 2020","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,173,3.50%,,,Convenience,"EUROIMMUN,Luminex Corporation",Multiple Types,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Hanna Mathew,"Cumming School of Medicine, University of Calgary",https://dx.doi.org/10.1177/09612033211063793,12/14/2021,3/2/2024,Unverified
211022_Canada_UniversityofAlberta,"October 22, 2021",National,Canada,CAN,"British Columbia, Alberta, Ontario, Québec",,"March 19, 2020","September 22, 2020",Health care workers and caregivers,Adults (18-64 years),5135,0.19%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Presentation or Conference,Nicola Cherry,University of Alberta,http://dx.doi.org/10.1136/OEM-2021-EPI.34,12/15/2021,7/17/2022,Unverified
211130_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"November 30, 2021",National,Canada,CAN,,,"September 14, 2021","September 24, 2021",Blood donors,Multiple groups,9363,97.03%,96.62%,97.44%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/antibody-wane-being-observed-yet-breakthrough-infections-rare-latest-canadian-blood-services-report/,12/23/2021,8/15/2023,Verified
211027_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"October 27, 2021",National,Canada,CAN,,,"August 15, 2021","August 26, 2021",Blood donors,Multiple groups,9109,96.09%,95.63%,96.54%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,12/23/2021,8/15/2023,Verified
220103_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"January 3, 2022",National,Canada,CAN,,,"October 14, 2021","October 23, 2021",Blood donors,Multiple groups,9627,98.01%,97.65%,98.36%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Low,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/canadian-blood-services-data-reveal-evidence-of-antibody-wane-among-adult-population/,1/14/2022,8/15/2023,Verified
220117_Quebec_McGillUniversity_EDM,"January 17, 2022",Local,Canada,CAN,Québec,Montreal,"January 19, 2021","July 20, 2021",Persons who are incarcerated,Adults (18-64 years),600,27.33%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,Moderate,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,1/26/2022,3/2/2024,Verified
220117_Quebec_McGillUniversity_EDRDP,"January 17, 2022",Local,Canada,CAN,Québec,Montreal,"February 3, 2021","March 24, 2021",Persons who are incarcerated,Adults (18-64 years),300,14.67%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,1/26/2022,3/2/2024,Verified
220117_Quebec_McGillUniversity_EDSJ,"January 17, 2022",Local,Canada,CAN,Québec,Saint-Jérôme,"March 30, 2021","September 15, 2021",Persons who are incarcerated,Adults (18-64 years),200,19.00%,,,Convenience,Roche Diagnostics,Not reported,IgG,99.50%,99.80%,High,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://dx.doi.org/10.1093/cid/ciac031,1/26/2022,3/2/2024,Verified
220103_BritishColumbia_UniversityofBritishColumbia_May2020_Overall,"January 3, 2022",Local,Canada,CAN,British Columbia,,"May 4, 2020","May 14, 2020",Assisted living and long-term care facilities,Seniors (65+ years),87,40.20%,,,Convenience,"DiaSorin,Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2021.775420,1/28/2022,3/2/2024,Unverified
220103_BritishColumbia_UniversityofBritishColumbia_Dec2020_Overall,"January 3, 2022",Local,Canada,CAN,British Columbia,,,"December 22, 2020",Assisted living and long-term care facilities,Seniors (65+ years),45,44.40%,,,Convenience,"Siemens,Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2021.775420,1/28/2022,3/2/2024,Unverified
211122_Montreal_UniversityOfMontreal_2-4,"November 23, 2021",Local,Canada,CAN,Québec,Montreal,"October 22, 2020","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),332,4.80%,2.90%,6.70%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,2/7/2022,7/17/2022,Unverified
211122_Montreal_UniversityOfMontreal_5-9,"November 23, 2021",Local,Canada,CAN,Québec,Montreal,"October 22, 2020","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),542,5.00%,3.40%,6.60%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,2/7/2022,7/17/2022,Unverified
211122_Montreal_UniversityOfMontreal_10-14,"November 23, 2021",Local,Canada,CAN,Québec,Montreal,"October 22, 2020","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),529,6.80%,4.20%,9.40%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,2/7/2022,7/17/2022,Unverified
211122_Montreal_UniversityOfMontreal_15-17,"November 23, 2021",Local,Canada,CAN,Québec,Montreal,"October 22, 2020","March 22, 2021",Students and Daycares,Children and Youth (0-17 years),221,7.20%,3.40%,11.00%,Convenience,NA,ELISA,IgG,95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1001/jamanetworkopen.2021.35975,2/7/2022,7/17/2022,Unverified
211130_Calgary_UniversityofCalgary_Visit3_Spike,"November 30, 2021",Local,Canada,CAN,Alberta,Calgary,"August 11, 2021","October 22, 2021",Household and community samples,Children and Youth (0-17 years),783,48.28%,,,Self-referral,NA,Not reported,Not reported,,,High,Institutional Report,James Kellner,University of Calgary,,2/17/2022,1/4/2023,Unverified
220217_Ontario_SinaiHealthSystem_Overall,"February 17, 2022",Regional,Canada,CAN,Ontario,,"February 18, 2021","July 17, 2021",Essential non-healthcare workers,Multiple groups,1252,1.84%,,,Convenience,Bio-rad,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Brenda Coleman,Sinai Health System,https://dx.doi.org/10.17269/s41997-022-00613-z,2/24/2022,3/2/2024,Unverified
220125_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"January 25, 2022",National,Canada,CAN,,,"November 13, 2021","November 24, 2021",Blood donors,Multiple groups,9018,98.52%,98.18%,98.86%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/latest-canadian-blood-services-data-reflect-uptick-in-infections-prior-to-omicron-surge/,3/8/2022,8/15/2023,Verified
220209_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"February 9, 2022",National,Canada,CAN,,,"December 14, 2021","December 30, 2021",Blood donors,Multiple groups,16816,98.58%,98.34%,98.82%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Low,Institutional Report,Canadian Blood Services,Canadian Blood Services ,https://www.covid19immunitytaskforce.ca/canadian-blood-services-december-report-the-advance-of-omicron/,3/8/2022,8/15/2023,Verified
220121_Toronto_UniversityOfOxford,"January 21, 2022",Local,Canada,CAN,,Toronto,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,28,3.57%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
220223_Canada_CanadianBloodServices_OverallAND,"February 23, 2022",National,Canada,CAN,,,"April 15, 2020","March 15, 2021",Blood donors,Multiple groups,17999,2.10%,1.90%,2.30%,Convenience,"Abbott Laboratories,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Ashleigh Tuite,Canadian Blood Services,https://dx.doi.org/10.1128/spectrum.02563-21,3/10/2022,8/15/2023,Verified
211106_Calgary_UniversityofCalgary_Ambulatory_Overall,"November 6, 2021",Local,Canada,CAN,Alberta,,"March 15, 2020","January 31, 2021",Residual sera,Multiple groups,148,3.38%,,,Sequential,"EUROIMMUN,Luminex Corporation",ELISA,"IgG,IgA",,,High,Presentation or Conference,Hannah Mathew,University of Calgary,https://acrabstracts.org/abstract/sars-cov-2-seroprevalence-and-seroconversion-in-a-systemic-lupus-erythematosus-cohort-and-comparison-to-general-population-controls/,3/10/2022,3/2/2024,Unverified
211106_Calgary_UniversityofCalgary_SLE_Overall,"November 6, 2021",Local,Canada,CAN,Alberta,,"March 15, 2020","January 31, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,173,3.47%,,,Sequential,"EUROIMMUN,Luminex Corporation",ELISA,"IgG,IgA",,,High,Presentation or Conference,Hannah Mathew,University of Calgary,https://acrabstracts.org/abstract/sars-cov-2-seroprevalence-and-seroconversion-in-a-systemic-lupus-erythematosus-cohort-and-comparison-to-general-population-controls/,3/10/2022,3/2/2024,Unverified
220311_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"March 11, 2022",National,Canada,CAN,,,"January 1, 2022","January 31, 2022",Blood donors,Multiple groups,32505,98.89%,98.73%,99.06%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,3/22/2022,8/15/2023,Verified
220307_Quebec_InstitutnationaldesantépubliqueduQuébec_Overall,"March 7, 2022",Regional,Canada,CAN,Quebec,,"July 6, 2020","September 24, 2020",Health care workers and caregivers,Adults (18-64 years),2056,11.72%,,,Convenience,DiaSorin,CLIA,IgG,82.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nicholas Brousseau,Institut national de santé publique du Québec,https://dx.doi.org/10.1503/cmaj.202783-f,4/13/2022,3/2/2024,Unverified
220323_BC_UniversityOfBritishColumbia_Spike,"March 23, 2022",Regional,Canada,CAN,British Columbia,,"March 15, 2020","May 31, 2020",Residual sera,Multiple groups,488,1.84%,,,Stratified probability,Meso Scale Discovery,CLIA,IgG,100.00%,100.00%,High,Journal Article (Peer-Reviewed),Guadalein Tanunliong,University of British Columbia,https://dx.doi.org/10.3389/fimmu.2022.836449,4/22/2022,6/23/2023,Verified
220401_Ontario_McMasterUniversity_Overall_Pop_Adj,"April 1, 2022",Regional,Canada,CAN,Ontario,,"April 14, 2021","July 28, 2021",Household and community samples,Multiple groups,916,23.10%,22.90%,23.40%,Convenience,NA,ELISA,IgG,,,High,Preprint,Sonia Anand,McMaster University,https://www.medrxiv.org/content/10.1101/2022.04.01.22273252v1.full-text,4/25/2022,7/17/2022,Unverified
20220420_Canada_StatisticsCanada_OverallUnadj,"April 20, 2022",National,Canada,CAN,10 provinces and 3 territories,,"November 15, 2020","April 15, 2021",Household and community samples,Multiple groups,10820,1.90%,,,Stratified probability,NA,ELISA,IgG,,,Low,Institutional Report,Tracey Bushnik,Statistics Canada,https://dx.doi.org/10.25318/82-003-x202200400003-eng,4/27/2022,7/17/2022,Unverified
220504_Vancouver_UniversityOfBritishColumbia_SchoolStaff1_PopAdj,"April 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"February 10, 2021","May 15, 2021",Essential non-healthcare workers,Adults (18-64 years),1556,2.60%,1.90%,3.60%,Convenience,"Ortho Clinical Diagnostics Inc.,Roche Diagnostics",CLIA,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),David Goldfarb,University of British Colombia,https://dx.doi.org/10.1136/bmjopen-2021-057846,5/2/2022,3/2/2024,Verified
220504_Vancouver_UniversityOfBritishColumbia_BloodDonors2,"April 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"January 1, 2021","May 31, 2021",Blood donors,Adults (18-64 years),5417,2.60%,2.20%,3.10%,Convenience,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Journal Article (Peer-Reviewed),David Goldfarb,University of British Colombia,https://dx.doi.org/10.1136/bmjopen-2021-057846,5/2/2022,8/15/2023,Verified
211216_Ontario_PublicHealthOntario_March_Overall_PopTestAdj,"December 16, 2021",Regional,Canada,CAN,Ontario,,"March 27, 2020","April 30, 2020",Residual sera,Multiple groups,827,0.50%,0.10%,1.50%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,5/6/2022,8/15/2023,Verified
211216_Ontario_PublicHealthOntario_May_Overall_PopTestAdj,"December 16, 2021",Regional,Canada,CAN,Ontario,,"May 26, 2020","May 31, 2020",Residual sera,Multiple groups,1061,1.50%,0.70%,2.20%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,5/6/2022,8/15/2023,Verified
211216_Ontario_PublicHealthOntario_June_Overall_PopTestAdj,"December 16, 2021",Regional,Canada,CAN,Ontario,,"June 5, 2020","June 30, 2020",Residual sera,Multiple groups,7014,1.10%,0.80%,1.30%,Stratified probability,"Abbott Laboratories,Ortho Clinical Diagnostics Inc.",CLIA,IgG,92.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Shelly Bolotin,Public Health Ontario,https://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001559,5/6/2022,8/15/2023,Verified
220410_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"April 10, 2022",National,Canada,CAN,,,"February 1, 2022","February 28, 2022",Blood donors,Multiple groups,28616,99.60%,99.45%,99.75%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,5/24/2022,8/15/2023,Verified
220506_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"May 6, 2022",National,Canada,CAN,,,"March 1, 2022","March 31, 2022",Blood donors,Multiple groups,26026,99.57%,99.42%,99.73%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,5/24/2022,8/15/2023,Verified
220517_Canada_CBS_BloodDonors_RocheS_Overall_Unadj,"May 17, 2022",National,Canada,CAN,,,"April 1, 2022","April 15, 2022",Blood donors,Multiple groups,14341,99.80%,99.60%,99.99%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Service,Canadian Blood Services ,N/A,5/24/2022,3/2/2024,Verified
220518_Canada_UnityHealthToronto_Phase4_Overall_UnAdj,"May 18, 2022",National,Canada,CAN,,,"January 24, 2022","March 15, 2022",Household and community samples,Multiple groups,5031,37.15%,,,Convenience,NA,ELISA,IgG,90.00%,90.00%,High,Journal Article (Peer-Reviewed),Patrick Brown,Unity Health Toronto,https://doi.org/10.1056/NEJMc2202879,6/7/2022,7/17/2022,Unverified
220531_Alberta_AlbertaPrecisionLaboratories_March_OverallAdj,"May 31, 2022",Regional,Canada,CAN,Alberta,,"February 26, 2021","March 4, 2021",Residual sera,Multiple groups,12490,11.90%,11.90%,12.00%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,6/8/2022,5/1/2024,Verified
220531_Alberta_AlbertaPrecisionLaboratories_April_Overall_Adj,"May 31, 2022",Regional,Canada,CAN,Alberta,,"April 9, 2021","April 16, 2021",Residual sera,Multiple groups,12123,11.90%,11.90%,12.00%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,6/8/2022,5/1/2024,Verified
220531_Alberta_AlbertaPrecisionLaboratories_May_OverallAdj,"May 31, 2022",Regional,Canada,CAN,Alberta,,"April 30, 2021","May 7, 2021",Residual sera,Multiple groups,11586,34.60%,34.50%,34.60%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,6/8/2022,5/1/2024,Verified
220531_Alberta_AlbertaPrecisionLaboratories_June_OverallAdj,"May 31, 2022",Regional,Canada,CAN,Alberta,,"June 3, 2021","June 11, 2021",Residual sera,Multiple groups,11894,62.40%,62.40%,62.50%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,6/8/2022,5/1/2024,Verified
220531_Alberta_AlbertaPrecisionLaboratories_July_OverallAdj,"May 31, 2022",Regional,Canada,CAN,Alberta,,"July 2, 2021","July 9, 2021",Residual sera,Multiple groups,12539,70.20%,70.20%,70.30%,Convenience,Abbott Laboratories,CLIA,IgG,98.10%,99.60%,Low,Journal Article (Peer-Reviewed),Jamil N. Kanji,Alberta Precision Laboratories,https://dx.doi.org/10.1080/23744235.2022.2080250,6/8/2022,5/1/2024,Verified
220301_Quebec_McGillUniversity,"March 1, 2022",Regional,Canada,CAN,Quebec,,"January 19, 2021","September 15, 2021",Persons who are incarcerated,Adults (18-64 years),1100,22.36%,,,Unclear,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University,https://www.iasusa.org/tam/march-2022/,6/18/2022,7/17/2022,Unverified
220705_Ontario_McMasterUniversity_Overall_Pop_Adj,"July 5, 2022",Regional,Canada,CAN,Ontario,,"April 14, 2021","July 28, 2021",Household and community samples,Multiple groups,916,22.90%,20.10%,26.10%,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Sonia Anand,McMaster University,https://doi.org/10.9778/cmajo.20220031,7/15/2022,7/17/2022,Unverified
220712_Ottawa_OMNIResearchGroup_Primary,"July 12, 2022",Local,Canada,CAN,Ontario,"Ottawa
","October 19, 2020","November 27, 2020",Pregnant or parturient women,Adults (18-64 years),352,18.50%,,,Convenience,NA,ELISA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Romina Fakhraei,OMNI Research Group,https://dx.doi.org/10.9778/cmajo.20210228,7/19/2022,7/19/2022,Unverified
220623_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 23, 2022",National,Canada,CAN,,,"May 1, 2022","May 31, 2022",Blood donors,Multiple groups,31764,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/26/2022,4/24/2024,Verified
220803_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"August 3, 2022",National,Canada,CAN,,,"June 1, 2022","June 30, 2022",Blood donors,Multiple groups,32121,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/26/2022,2/22/2024,Verified
220803_Canada_CBS_BloodDonors_RocheN_Overall_PopTestAdj,"August 3, 2022",National,Canada,CAN,,,"June 1, 2022","June 30, 2022",Blood donors,Multiple groups,32121,50.70%,50.15%,51.26%,Sequential,Roche Diagnostics,CLIA,Total Antibody,99.50%,99.80%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/26/2022,3/30/2024,Verified
220603_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 3, 2022",National,Canada,CAN,,,"April 1, 2022","April 30, 2022",Blood donors,Multiple groups,29786,99.74%,99.60%,99.88%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/31/2022,5/6/2024,Verified
220825_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"August 25, 2022",National,Canada,CAN,,,"July 1, 2022","July 31, 2022",Blood donors,Multiple groups,31275,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/31/2022,8/15/2023,Unverified
220501_Ottawa_OttawaHospitalResearchInstitute,"May 1, 2022",Local,Canada,CAN,Ontario,Ottawa,"October 19, 2020","November 27, 2020",Pregnant or parturient women,Adults (18-64 years),353,4.50%,,,Sequential,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Kameela Alibhai,Ottawa Hospital Research Institute,https://dx.doi.org/10.1016/j.jogc.2022.02.017,9/8/2022,9/23/2022,Unverified
220829_BritishColumbia_UniversityofBritishColumbia,"August 29, 2022",Regional,Canada,CAN,British Columbia,,"November 15, 2020","June 15, 2021",Household and community samples,Multiple groups,4048,2.90%,,,Convenience,Meso Scale Discovery,CLIA,IgG,79.00%,97.00%,High,Journal Article (Peer-Reviewed),C Sarai Racey,The University of British Columbia,https://dx.doi.org/10.1136/bmjopen-2022-062567,9/10/2022,6/23/2023,Unverified
230601_Vancouver_UBC_Ad,"June 1, 2023",Local,Canada,CAN,British Columbia,Vancouver,"January 26, 2022","April 8, 2022",Essential non-healthcare workers,Adults (18-64 years),1620,26.50%,23.90%,29.30%,Stratified non-probability,Roche Diagnostics,Not reported,Not reported,,,Low,Journal Article (Peer-Reviewed),Allison W Watts,University of British Columbia,https://dx.doi.org/10.1136/bmjopen-2022-071228,9/14/2022,8/15/2023,Unverified
221205_Vancouver_BCCentreforDiseaseControl_Round1_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"March 5, 2020","March 13, 2020",Residual sera,Multiple groups,895,0.30%,0.07%,0.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens",Multiple Types,Total Antibody,100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round2_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"May 8, 2020","May 27, 2020",Residual sera,Multiple groups,890,0.60%,0.20%,1.10%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens",Multiple Types,Total Antibody,100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round3_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"September 17, 2020","September 29, 2020",Residual sera,Multiple groups,2000,1.00%,0.60%,1.52%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens",Multiple Types,Total Antibody,100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round4_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"January 16, 2021","January 27, 2021",Residual sera,Multiple groups,1999,3.48%,2.70%,4.40%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens,Roche Diagnostics",Multiple Types,Total Antibody,100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round5_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"May 30, 2021","June 11, 2021",Residual sera,Multiple groups,1991,10.10%,8.80%,11.60%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Abbott Laboratories,Siemens,Roche Diagnostics",Multiple Types,Total Antibody,100.00%,99.50%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round6_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"September 26, 2021","October 8, 2021",Residual sera,Multiple groups,1990,9.40%,8.10%,10.80%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Siemens,Roche Diagnostics",Multiple Types,Total Antibody,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round7_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"March 13, 2022","March 24, 2022",Residual sera,Multiple groups,2000,42.48%,40.20%,44.90%,Stratified non-probability,"Ortho Clinical Diagnostics Inc.,Siemens,Roche Diagnostics",Multiple Types,Total Antibody,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
221205_Vancouver_BCCentreforDiseaseControl_Round8_Adj,"December 5, 2022",Local,Canada,CAN,British Columbia,Vancouver,"July 31, 2022","August 11, 2022",Residual sera,Multiple groups,2000,61.10%,58.80%,63.40%,Stratified non-probability,"Siemens,Roche Diagnostics,Abbott Laboratories",Multiple Types,Total Antibody,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Danuta Skowronski,BC Centre for Disease Control,https://doi.org/10.1503/cmaj.221335,9/20/2022,5/1/2024,Verified
220929_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"September 29, 2022",National,Canada,CAN,,,"August 1, 2022","August 31, 2022",Blood donors,Multiple groups,35118,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,10/21/2022,4/24/2024,Verified
221030_Montreal_UniversityofMontreal_Round1_Primary,"October 30, 2022",Regional,Canada,CAN,Québec,Québec,"October 20, 2020","March 15, 2021",Students and Daycares,Children and Youth (0-17 years),1632,5.80%,4.80%,7.10%,Convenience,NA,ELISA,IgG,,,,Preprint,Kate Zinszer,University of Montreal,10.1101/2022.10.28.22281660,11/10/2022,3/20/2023,Unverified
221105_Calgary_UniversityofCalgary_visit1,"November 5, 2022",Local,Canada,CAN,Alberta,Calgary,"July 15, 2020","November 15, 2020",Household and community samples,Children and Youth (0-17 years),1012,9.50%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Preprint,Emily J Doucette,University of Calgary,https://doi.org/10.1101/2022.11.02.22281665,11/11/2022,3/2/2024,Unverified
221105_Calgary_UniversityofCalgary_visit2,"November 5, 2022",Local,Canada,CAN,Alberta,Calgary,"February 15, 2021","April 15, 2021",Household and community samples,Children and Youth (0-17 years),950,12.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Preprint,Emily J Doucette,University of Calgary,https://doi.org/10.1101/2022.11.02.22281665,11/11/2022,3/2/2024,Unverified
221105_Calgary_UniversityofCalgary_visit3,"November 5, 2022",Local,Canada,CAN,Alberta,Calgary,"August 15, 2021","October 15, 2021",Household and community samples,Children and Youth (0-17 years),923,51.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Preprint,Emily J Doucette,University of Calgary,https://doi.org/10.1101/2022.11.02.22281665,11/11/2022,3/2/2024,Unverified
221105_Calgary_UniversityofCalgary_visit4,"November 5, 2022",Local,Canada,CAN,Alberta,Calgary,"February 15, 2022","April 15, 2022",Household and community samples,Children and Youth (0-17 years),865,90.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.00%,100.00%,High,Preprint,Emily J Doucette,University of Calgary,https://doi.org/10.1101/2022.11.02.22281665,11/11/2022,3/2/2024,Unverified
221107_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"November 7, 2022",National,Canada,CAN,,,"September 1, 2022","September 30, 2022",Blood donors,Multiple groups,31606,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,11/14/2022,4/18/2024,Verified
221109_Quebec_McGillUniversityHealthCentre_Overall,"November 9, 2022",Regional,Canada,CAN,Quebec,,"July 14, 2021","November 15, 2021",Essential non-healthcare workers,Adults (18-64 years),600,18.00%,,,Stratified non-probability,Roche Diagnostics,,,99.50%,99.80%,,Journal Article (Peer-Reviewed),Nadine Kronfli,McGill University Health Centre,https://dx.doi.org/10.3389/fpubh.2022.1021871,12/14/2022,3/2/2024,Unverified
221202_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"December 2, 2022",National,Canada,CAN,,,"October 1, 2022","October 31, 2022",Blood donors,Multiple groups,31451,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,12/17/2022,4/19/2024,Verified
221030_Montreal_UniversityofMontreal_Round2_Primary,"October 30, 2022",Regional,Canada,CAN,Québec,Montreal,"May 18, 2021","July 21, 2021",Students and Daycares,Children and Youth (0-17 years),936,10.50%,8.60%,12.70%,Convenience,NA,ELISA,IgG,,,,Preprint,Kate Zinszer,University of Montreal,10.1101/2022.10.28.22281660,1/5/2023,3/20/2023,Unverified
221030_Montreal_UniversityofMontreal_Round3_Primary,"October 30, 2022",Regional,Canada,CAN,Québec,Montreal,"November 18, 2021","January 20, 2022",Students and Daycares,Children and Youth (0-17 years),723,10.90%,8.80%,13.50%,Convenience,NA,ELISA,IgG,,,,Preprint,Kate Zinszer,University of Montreal,10.1101/2022.10.28.22281660,1/5/2023,3/20/2023,Unverified
230106_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"January 6, 2023",National,Canada,CAN,,,"November 1, 2022","November 30, 2022",Blood donors,Multiple groups,31080,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,1/12/2023,4/21/2024,Verified
220117_Quebec_ McGillUniversityHealthCentre,"January 17, 2022",Regional,Canada,CAN,Quebec,,"January 20, 2021","September 20, 2021",Persons who are incarcerated,Multiple groups,1100,22.00%,,,Convenience,Roche Diagnostics,CLIA,IgG,99.50%,99.80%,,Journal Article (Peer-Reviewed),Nadine Kronfli, McGill University Health Centre,https://dx.doi.org/10.1093/cid/ciac031,1/23/2023,3/2/2024,Unverified
230112_BritishColumbia_UniversityOfBritishColumbia_Phase2_antiS,"January 12, 2023",Regional,Canada,CAN,British Columbia,,"November 15, 2021","December 3, 2021",Pregnant or parturient women,Adults (18-64 years),3369,88.10%,,,Sequential,NA,Not reported,Not reported,,,,Presentation or Conference,A Atkinson,University of British Columbia,https://dx.doi.org/10.1016/j.ajog.2022.11.132,2/8/2023,3/20/2023,Unverified
230117_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"January 17, 2023",National,Canada,CAN,,,"December 1, 2022","December 15, 2022",Blood donors,Multiple groups,17053,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,2/9/2023,3/30/2024,Verified
230202_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"February 2, 2023",National,Canada,CAN,,,"December 1, 2022","December 31, 2022",Blood donors,Multiple groups,32720,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,2/9/2023,4/22/2024,Verified
230302_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"March 2, 2023",National,Canada,CAN,,,"January 1, 2023","January 31, 2023",Blood donors,Multiple groups,32062,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,3/10/2023,4/22/2024,Verified
230215_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"February 15, 2023",National,Canada,CAN,,,"January 1, 2023","January 15, 2023",Blood donors,Multiple groups,16293,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,3/10/2023,4/7/2024,Verified
230405_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"April 5, 2023",National,Canada,CAN,,,"February 1, 2023","February 28, 2023",Blood donors,Multiple groups,31755,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,4/12/2023,4/22/2024,Verified
230406_Calgary_UniversityofCalgary_Visit4_Anti-S,"April 6, 2023",Local,Canada,CAN,Alberta,Calgary,"February 15, 2022","April 15, 2022",Household and community samples,Children and Youth (0-17 years),770,89.40%,86.90%,91.40%,Convenience,Abbott Laboratories,Not reported,IgG,,,,Journal Article (Peer-Reviewed),Emily Doucette,University of Calgary,https://dx.doi.org/10.1371/journal.pone.0284046,5/9/2023,3/2/2024,Unverified
230322_Montreal_UniversityofMontreal_Round3,"March 22, 2023",Local,Canada,CAN,Quebec,Montreal,"November 15, 2021","March 15, 2022",Students and Daycares,Children and Youth (0-17 years),723,11.00%,8.80%,13.50%,Convenience,NA,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),Kate Zinszer,University of Montreal,https://dx.doi.org/10.1016/j.ijid.2023.03.036,5/9/2023,5/9/2023,Unverified
230404_Canada_UniversityofBritishColumbia_PeriodB_NL,"April 4, 2023",Regional,Canada,CAN,Newfoundland and Labrador,,"August 24, 2020","September 11, 2020",Pregnant or parturient women,Adults (18-64 years),33,0.00%,,,Sequential,EUROIMMUN,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Andrea Atkinson,University of British Columbia,https://dx.doi.org/10.9778/cmajo.20220045,5/9/2023,3/2/2024,Unverified
230404_Canada_UniversityofBritishColumbia_PeriodB_NS,"April 4, 2023",Regional,Canada,CAN,Nova Scotia,,"August 24, 2020","September 11, 2020",Pregnant or parturient women,Adults (18-64 years),489,0.41%,0.05%,1.47%,Sequential,Ortho Clinical Diagnostics Inc.,,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Andrea Atkinson,University of British Columbia,https://dx.doi.org/10.9778/cmajo.20220045,5/9/2023,3/2/2024,Unverified
230404_Canada_UniversityofBritishColumbia_PeriodB_AB,"April 4, 2023",Regional,Canada,CAN,Alberta,,"August 24, 2020","September 11, 2020",Pregnant or parturient women,Adults (18-64 years),3497,1.57%,1.16%,2.08%,Sequential,Abbott Laboratories,,IgG,,,Moderate,Journal Article (Peer-Reviewed),Andrea Atkinson,University of British Columbia,https://dx.doi.org/10.9778/cmajo.20220045,5/9/2023,3/2/2024,Unverified
230404_Canada_UniversityofBritishColumbia_PeriodB_BC,"April 4, 2023",Regional,Canada,CAN,British Columbia,,"August 24, 2020","September 11, 2020",Pregnant or parturient women,Adults (18-64 years),2427,0.34%,0.12%,0.73%,Sequential,Ortho Clinical Diagnostics Inc.,,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Andrea Atkinson,University of British Columbia,https://dx.doi.org/10.9778/cmajo.20220045,5/9/2023,3/2/2024,Unverified
230404_Canada_UniversityofBritishColumbia_PeriodB_SK,"April 4, 2023",Regional,Canada,CAN,Saskatchewan,,"August 24, 2020","September 11, 2020",Pregnant or parturient women,Adults (18-64 years),2427,0.66%,0.18%,1.68%,Sequential,Ortho Clinical Diagnostics Inc.,,Total Antibody,,,Moderate,Journal Article (Peer-Reviewed),Andrea Atkinson,University of British Columbia,https://dx.doi.org/10.9778/cmajo.20220045,5/9/2023,3/2/2024,Unverified
230602_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 2, 2023",National,Canada,CAN,,,"March 1, 2023","March 31, 2023",Blood donors,Multiple groups,30792,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,6/30/2023,4/26/2024,Verified
230628_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 28, 2023",National,Canada,CAN,,,"May 1, 2023","May 31, 2023",Blood donors,Multiple groups,31708,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,6/30/2023,4/26/2024,Verified
230608_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"June 8, 2023",National,Canada,CAN,,,"April 1, 2023","April 30, 2023",Blood donors,Multiple groups,31978,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,6/30/2023,4/26/2024,Verified
230624_Canada_MountSinai,"June 24, 2023",National,Canada,CAN,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,13,0.00%,,,Convenience,Siemens,CLIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230728_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"July 28, 2023",National,Canada,CAN,,,"June 1, 2023","June 30, 2023",Blood donors,Multiple groups,31790,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,8/3/2023,4/26/2024,Verified
230720_Canada_UniversityofOttawa,"July 20, 2023",National,Canada,CAN,,,"April 28, 2020","September 20, 2020",Residual sera,Multiple groups,739,63.10%,,,Sequential,NA,ELISA,"IgA,IgG,IgM",,,,Journal Article (Peer-Reviewed),Marilyn Whelan,University of Ottawa,https://dx.doi.org/10.1093/ofid/ofad384,8/24/2023,8/26/2023,Unverified
230806_Toronto_TheHospitalForSickChildren,"August 6, 2023",Local,Canada,CAN,Ontario,Toronto,"July 15, 2022","September 15, 2022",Residual sera,Children and Youth (0-17 years),2662,73.00%,,,Sequential,"Abbott Laboratories,DiaSorin",CLIA,IgG,,,,Journal Article (Peer-Reviewed),Mary Kathryn Bohn,The Hospital for Sick Children,https://dx.doi.org/10.1016/j.clinbiochem.2023.110630,8/25/2023,3/2/2024,Unverified
230828_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"August 28, 2023",National,Canada,CAN,,,"July 1, 2023","July 31, 2023",Blood donors,Multiple groups,31977,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,9/26/2023,4/26/2024,Verified
240923_Canada_CBS_BloodDonors_RocheS_Overall_PopTestAdj,"September 29, 2023",National,Canada,CAN,,,"August 1, 2023","August 31, 2023",Blood donors,Multiple groups,31651,100.00%,100.00%,100.00%,Sequential,Roche Diagnostics,CLIA,Total Antibody,98.80%,99.60%,Moderate,Institutional Report,Canadian Blood Services,Canadian Blood Services ,N/A,3/9/2024,4/27/2024,Verified
231020_LowerMainland_BritishColumbiaCovid19Cohort_AntiN,"October 20, 2023",Regional,Canada,CAN,British Columbia,,"July 16, 2022","July 25, 2022",Household and community samples,Multiple groups,2000,79.00%,77.10%,80.80%,Unclear,"Abbott Laboratories,Roche Diagnostics",CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Danuta M. Skowronski,British Columbia Centre for Disease Control (BCCDC),https://dx.doi.org/10.1503/cmaj.230721,3/9/2024,3/9/2024,Unverified
210530_Cameroon_UniversityofYaoundé_primary,"May 30, 2021",Regional,Cameroon,CMR,,,"June 15, 2020","August 15, 2020",Multiple populations,Multiple groups,999,32.00%,27.00%,35.00%,Convenience,Innovita Biological Technology Co. Ltd,LFIA,"IgM,IgG",,,High,Journal Article (Peer-Reviewed),Karl Njuwa Fai,University of Yaoundé,https://dx.doi.org/10.1016/j.sciaf.2021.e00802,6/17/2021,3/2/2024,Unverified
211006_Yaoundé_HopitalCentraldeYaounde_PopTestAdj_Overall,"October 6, 2021",Local,Cameroon,CMR,Centre,Yaoundé,"October 14, 2020","November 26, 2020",Household and community samples,Multiple groups,971,29.20%,23.80%,34.90%,Simplified probability,Abbott Laboratories,LFIA,IgG,91.50%,93.50%,Low,Journal Article (Peer-Reviewed),Kene Nwosu,Hopital Central de Yaounde,https://dx.doi.org/10.1038/s41467-021-25946-0,10/14/2021,8/15/2023,Verified
230127_Cameroon_UniversityofRomeTorVergata,"January 27, 2023",Local,Cameroon,CMR,Bandjoun,,"December 15, 2020","December 15, 2021",Multiple populations,Adults (18-64 years),106,91.90%,84.70%,96.40%,Convenience,Phamatech,LFIA,"IgG,IgM",98.20%,99.70%,,Journal Article (Peer-Reviewed),Andrillene Laure Deutou Wondeu,University of Rome Tor Vergata,https://dx.doi.org/10.4081/jphia.2023.2242,3/7/2023,3/2/2024,Unverified
230502_Cameroon_ CentrePasteurduCameroun_round3_poptestadj,"May 2, 2023",Local,Cameroon,CMR,,Yaoundé and Douala,"November 29, 2021","December 31, 2021",Blood donors,Adults (18-64 years),1500,98.40%,96.80%,99.70%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,96.70%,97.50%,Moderate,Journal Article (Peer-Reviewed),Arsene Brunelle Sandie, Centre Pasteur du Cameroun,https://dx.doi.org/10.1007/s44197-023-00102-7,6/1/2023,5/1/2024,Verified
230504_Cameroon_ColumbiaUniversity,"May 4, 2023",National,Cameroon,CMR,,,"October 16, 2020","December 15, 2020",Household and community samples,Multiple groups,9332,10.50%,9.10%,12.00%,Convenience,"Abbott Laboratories,Beijing Wantai Biological",Multiple Types,,,,,Preprint,Karampreet Sachathep,Columbia University,10.22541/au.168319263.36814253/v1,6/1/2023,3/2/2024,Unverified
230420_Yaounde_CentralHospitalofYaounde_PopAdj,"April 20, 2023",Local,Cameroon,CMR,,Yaounde,"May 1, 2022","May 31, 2022",Household and community samples,Multiple groups,1425,74.71%,71.99%,77.25%,Simplified probability,Luminex Corporation,Luminex,IgG,,,Moderate,Journal Article (Peer-Reviewed),Mamadou Diallo,Central Hospital of Yaounde,https://dx.doi.org/10.1093/ofid/ofad216,6/3/2023,4/28/2024,Verified
220426_Yaoundé_MinistryOfPublicHealthOfCameroon_1_Overall,"April 26, 2022",Local,Cameroon,CMR,,Yaoundé,"January 27, 2021","February 6, 2021",Household and community samples,Multiple groups,722,18.60%,15.70%,21.70%,Stratified probability,Luminex Corporation,Not reported,Not reported,,99.70%,,Journal Article (Peer-Reviewed),Francis Ndongo,Ministry of Public Health of Cameroon,https://pubmed.ncbi.nlm.nih.gov/35470795/,6/30/2023,3/22/2024,Verified
220426_Yaoundé_MinistryOfPublicHealthOfCameroon_2_Overall,"April 26, 2022",Local,Cameroon,CMR,,Yaoundé,"April 24, 2021","May 19, 2021",Household and community samples,Multiple groups,1228,51.30%,48.30%,54.20%,Stratified probability,Luminex Corporation,Not reported,Not reported,,99.70%,,Journal Article (Peer-Reviewed),Francis Ndongo,Ministry of Public Health of Cameroon,https://pubmed.ncbi.nlm.nih.gov/35470795/,6/30/2023,3/22/2024,Verified
230825_Cameroon_TheUniversityofDouala_IgG,"August 25, 2023",Local,Cameroon,CMR,,,"January 1, 2022","September 30, 2022",Patients seeking care for non-COVID-19 reasons,Multiple groups,342,88.90%,,,Convenience,BioMérieux,Not reported,IgG,,,,Journal Article (Peer-Reviewed),Arlette Flore Moguem Soubgui,The University of Douala,10.1101/2023.08.24.23294559,9/21/2023,3/2/2024,Unverified
210108_CapeVerde_MestreEmSaúdeEDesenvolvimento_overall,"January 8, 2021",National,Cabo Verde,CPV,,,"June 26, 2020","July 4, 2020",Household and community samples,Multiple groups,5348,0.40%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Lara Ferrero Gomez,Mestre em Saúde e Desenvolvimento,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3762489,4/30/2021,3/2/2024,Verified
220525_BurkinaFaso_CentredeRechercheBiomoleculairePietroAnnigoni_Overall_TestAdj,"May 25, 2022",Local,Burkina Faso,BFA,,,"November 2, 2020","November 30, 2020",Representative patient population,Multiple groups,200,18.72%,,,Convenience,SD Biosensor,LFIA,"IgG,IgM",81.80%,96.70%,High,Journal Article (Peer-Reviewed),Tani Sagna,Centre de Recherche Biomoléculaire Pietro Annigoni,https://dx.doi.org/10.4081/jphia.2022.1778,6/30/2022,2/20/2024,Unverified
220905_Germany_BernhardNochtInsituteForTropicalMedicine_Bobo‐Dioulasso_Adj,"September 5, 2022",Local,Burkina Faso,BFA,Houet Province,Bobo‐Dioulasso,"February 3, 2021","March 11, 2021",Household and community samples,Multiple groups,627,55.70%,49.00%,68.20%,Stratified probability,NA,ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Nicole S. Struck,Bernhard Nocht Insitute for Tropical Medicine,https://dx.doi.org/10.1186/s12889-022-13918-y,9/13/2022,9/23/2022,Unverified
220905_Germany_BernhardNochtInsituteForTropicalMedicine_Ouagadougou_Adj,"September 5, 2022",Local,Burkina Faso,BFA,Kadiogo Province,Ouagadougou,"February 2, 2021","March 13, 2021",Household and community samples,Multiple groups,522,37.40%,31.30%,43.50%,Stratified probability,NA,ELISA,IgG,,,Low,Journal Article (Peer-Reviewed),Nicole S. Struck,Bernhard Nocht Insitute for Tropical Medicine,https://dx.doi.org/10.1186/s12889-022-13918-y,9/13/2022,9/13/2022,Unverified
220924_BurkinaFaso_RobertKochInstitut_Overall,"September 24, 2022",Local,Burkina Faso,BFA,,Bobo Dioulasso,"February 25, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),221,47.20%,40.40%,54.20%,Self-referral,"EUROIMMUN,Beijing Wantai Biological,NA",Multiple Types,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Sarah Kribi,Robert Koch Institut,https://dx.doi.org/10.1093/trstmh/trac089,10/5/2022,8/15/2023,Unverified
221211_BurkinaFaso_IPBLN-CSIC_Overall,"December 11, 2022",National,Burkina Faso,BFA,,,"August 22, 2020","November 19, 2020",Household and community samples,Multiple groups,998,3.20%,2.10%,4.30%,Unclear,Eurofins Ingenasa,LFIA,Total Antibody,94.50%,99.30%,Moderate,Journal Article (Peer-Reviewed),Diana Lopez-Farfan,Consejo Superior de Investigaciones Cientíﬁcas,https://dx.doi.org/10.3389/fpubh.2022.1048404,1/14/2023,4/20/2024,Verified
230614_BurkinaFaso_SouroSanouUniversityHospital,"June 14, 2023",National,Burkina Faso,BFA,,,"March 9, 2020","March 8, 2021",Residual sera,Multiple groups,419,31.00%,26.20%,35.70%,Sequential,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Odilon Kabore,Souro Sanou University Hospital,https://dx.doi.org/10.1371/journal.pone.0286665,6/30/2023,7/4/2023,Unverified
200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,"May 27, 2020",Local,Bulgaria,BGR,Varna, Varna,"March 26, 2020","April 20, 2020",Residual sera,Multiple groups,586,4.80%,3.20%,6.80%,Convenience,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Denitsa Tsaneva-Damyanova,"Medical Diagnostic Laboratory ""STATUS"" ",https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true,7/21/2020,3/2/2024,Verified
230914_Sofia_NationalCenterofInfectiousandParasiticDiseases_HCW,"September 14, 2023",Local,Bulgaria,BGR,,Sofia,"February 1, 2023","March 1, 2023",Health care workers and caregivers,Adults (18-64 years),104,99.00%,97.00%,100.00%,Convenience,"EUROIMMUN,GenScript",Multiple Types,"IgG,IgA,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Iva Trifonova,National Center of Infectious and Parasitic Diseases,10.1080/13102818.2023.2256417,3/9/2024,3/9/2024,Unverified
230914_Sofia_NationalCenterofInfectiousandParasiticDiseases_GenPop2021,"September 14, 2023",Local,Bulgaria,BGR,,Sofia,"December 1, 2021","January 1, 2022",Household and community samples,Multiple groups,124,70.00%,62.00%,78.00%,Convenience,"EUROIMMUN,GenScript",Multiple Types,"IgG,IgA,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Iva Trifonova,National Center of Infectious and Parasitic Diseases,10.1080/13102818.2023.2256417,3/9/2024,3/9/2024,Unverified
230914_Sofia_NationalCenterofInfectiousandParasiticDiseases_GenPop2023,"September 14, 2023",Local,Bulgaria,BGR,,Sofia,"February 1, 2023","March 1, 2023",Household and community samples,Multiple groups,113,78.00%,70.00%,85.00%,Convenience,"EUROIMMUN,GenScript",Multiple Types,"IgG,IgA,Neutralizing ",,,High,Journal Article (Peer-Reviewed),Iva Trifonova,National Center of Infectious and Parasitic Diseases,10.1080/13102818.2023.2256417,3/9/2024,3/9/2024,Unverified
200517_SaoPaolo_GrupoFleury_GenPop,"May 17, 2020",Local,Brazil,BRA,São Paulo,São Paulo,"May 4, 2020","May 12, 2020",Household and community samples,Multiple groups,520,5.19%,,,Stratified probability,NA,Not reported,Not reported,90.00%,,Unclear,News and Media,Phillippe Watanabe,Grupo Fleury,https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml,6/2/2020,7/17/2022,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban,"June 16, 2020",Regional,Brazil,BRA,Espírito Santo,,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,4612,2.10%,1.67%,2.52%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,3/2/2024,Verified
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban,"June 16, 2020",Regional,Brazil,BRA,Espírito Santo,,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,1163,0.26%,0.05%,0.75%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Preprint,Cristiana Gomes,Secretaria de Estado da Saúde do Espírito Santo,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,3/2/2024,Verified
200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj,"July 6, 2020",Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,"April 14, 2020","April 27, 2020",Blood donors,Adults (18-64 years),2857,3.30%,2.60%,4.10%,Sequential,MedLevensohn,LFIA,"IgG,IgM",85.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Amorim Filho,Universidade do Estado do Rio de Janeiro,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/,7/10/2020,7/17/2022,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"April 19, 2020","April 19, 2020",Household and community samples,Multiple groups,900,0.56%,0.18%,1.30%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"April 26, 2020","April 26, 2020",Household and community samples,Multiple groups,900,0.89%,0.39%,1.75%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"May 3, 2020","May 3, 2020",Household and community samples,Multiple groups,900,1.44%,0.77%,2.45%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"May 10, 2020","May 10, 2020",Household and community samples,Multiple groups,900,2.00%,1.19%,3.14%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"May 17, 2020","May 17, 2020",Household and community samples,Multiple groups,900,3.78%,2.63%,5.24%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"May 24, 2020","May 24, 2020",Household and community samples,Multiple groups,900,5.78%,4.30%,7.30%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31,"July 3, 2020",Local,Brazil,BRA,Piaui,Teresina,"May 31, 2020","May 31, 2020",Household and community samples,Multiple groups,900,8.33%,6.61%,10.33%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Marcelo Vieira, Centro de Operações de Emergências em Saúde Pública,https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/2/2024,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey1,"September 16, 2020",Local,Brazil,BRA,Rio Grande do Sul,Lajeado,"May 30, 2020","June 4, 2020",Household and community samples,Multiple groups,1450,4.03%,3.08%,5.18%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/13/2020,7/5/2023,Verified
200916_Lajeado_UniversidadedoValedodoTaquari_Survey2,"September 16, 2020",Local,Brazil,BRA,Rio Grande do Sul,Lajeado,"June 13, 2020","June 17, 2020",Household and community samples,Multiple groups,1127,2.59%,1.75%,3.70%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgM,IgG",76.24%,99.57%,Moderate,Journal Article (Peer-Reviewed),Rafael Picon,Universidade do Vale do Taquari,http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/13/2020,7/5/2023,Verified
200930_Sergipe_FederalUniversityofSergipe_OverallIgG,"September 30, 2020",Regional,Brazil,BRA,Sergipe,,"June 1, 2020","June 30, 2020",Health care workers and caregivers,Multiple groups,471,13.59%,,,Convenience,Boditech Med Inc.,Other,IgG,95.80%,97.00%,High,Preprint,Monica de Melo,Federal University of Sergipe,https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf,11/24/2020,3/2/2024,Verified
201006_Brazil_FederalUniversityofSergipe_genpop_IgG,"October 6, 2020",Regional,Brazil,BRA,Sergipe,"Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória","May 2, 2020","May 9, 2020",Household and community samples,Multiple groups,2635,8.30%,7.20%,9.40%,Convenience,Boditech Med Inc.,LFIA,IgG,,,High,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/,12/20/2020,3/2/2024,Verified
200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM,"September 1, 2020",Local,Brazil,BRA,Rio de Janeiro,Petrópolis,"April 9, 2020","April 29, 2020",Health care workers and caregivers,Adults (18-64 years),61,4.91%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),P Ismael Amaral Silva,Centro de Terapia Oncológica,http://dx.doi.org/10.1016/j.annonc.2020.08.1825,1/5/2021,7/17/2022,Verified
201021_SaoPaulo_AdolfoLutzCentralInstitute,"October 21, 2020",Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,"June 5, 2020","July 31, 2020",Multiple populations,Multiple groups,406,8.60%,,,Convenience,"Guangzhou Wondfo Biotech Co. Ltd,Roche Diagnostics",Multiple Types,"IgG,IgM",,,High,Preprint,Valeria Oliveira Silva,Adolfo Lutz Central Institute,https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1,1/17/2021,3/2/2024,Verified
201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall,"December 13, 2020",Local,Brazil,BRA,São Paulo State,São Paulo ,"May 14, 2020","May 28, 2020",Health care workers and caregivers,Adults (18-64 years),4987,14.10%,13.10%,15.00%,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Silvia Costa,Faculdade De Medicina da Universidade,https://dx.doi.org/10.1093/cid/ciaa1845,1/24/2021,3/2/2024,Verified
201119_SaoPaulo_ClinicaDeReumatologia_RheumaticPatients,"November 19, 2020",Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,"March 15, 2020","August 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),100,21.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",,,High,Preprint,Felipe Santana,Clínica de Reumatologia,https://www.researchsquare.com/article/rs-97191/v1,1/24/2021,3/2/2024,Verified
201113_SaoPaulo_UniversidadeSaoPaulo_primary,"November 13, 2020",Local,Brazil,BRA,State of Sao Paulo,Sao Paulo,"June 30, 2020","August 4, 2020",Residual sera,Multiple groups,439,13.90%,,,Convenience,"DiaSorin,Roche Diagnostics",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Luanda Mara da Silva Oliveira,Universidade de São Paulo,https://dx.doi.org/10.1590/S1678-9946202062091,1/24/2021,3/2/2024,Verified
201130_Sergipe_FederalUniversityofSergipe_residualsera_primary,"November 30, 2020",Local,Brazil,BRA,Sergipe,Aracaju,"January 15, 2020","April 15, 2020",Residual sera,Multiple groups,987,1.60%,,,Sequential,"NA,Boditech Med Inc.",LFIA,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Ricardo Queiroz Gurgel,Federal University of Sergipe,http://dx.doi.org/10.1016/j.jinf.2020.11.037,1/30/2021,3/2/2024,Verified
210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary,"January 6, 2021",Regional,Brazil,BRA,Espírito Santo,,"December 1, 2019","June 30, 2020",Representative patient population,Multiple groups,7370,2.85%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Lorenzzo Lyrio Stringari,Secretaria de Estado da Saúde do Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0244937,1/31/2021,3/2/2024,Verified
210128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall,"January 28, 2021",Local,Brazil,BRA,Pará,Xikrin of Bacaja Villages,"September 1, 2020","September 30, 2020",Household and community samples,Multiple groups,100,73.00%,,,Unclear,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Eliene Putira Sacuema Rodrigues,Instituto de Ciências Biológicas da Universidade Federal do Pará,https://dx.doi.org/10.1186/s12939-021-01392-8,3/10/2021,3/2/2024,Verified
210129_Botuacato_InstitutoButantan_Primary,"January 29, 2021",Local,Brazil,BRA,Sao Paolo,Botucato,"June 22, 2020","July 8, 2020",Assisted living and long-term care facilities,Multiple groups,209,11.50%,7.10%,16.60%,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Eliana Nogueira Castro de Barros,Instituto Butantan,https://dx.doi.org/10.1590/S1678-9946202163010,3/19/2021,3/2/2024,Verified
210116_SaoPaulo_UniversityOfSãoPaulo_overall_IgG,"January 16, 2021",Local,Brazil,BRA,Sao Paulo,Sao Paulo,"May 20, 2020","May 22, 2020",Multiple populations,Multiple groups,938,5.80%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Bruno Caramelli,University of São Paulo,https://dx.doi.org/10.7189/jogh.11.05001,3/27/2021,3/2/2024,Verified
210209_Sergipe_FederalUniversityofSergipe,"February 9, 2021",Regional,Brazil,BRA,Sergipe,"Aracaji, Itabaiana, Lagarto, Larangeiras, Nossa Senhora da Gloria, Sao Cristovao","September 15, 2020","October 6, 2020",Students and Daycares,Adults (18-64 years),276,22.50%,17.90%,27.70%,Convenience,"Boditech Med Inc.,Kovalent",LFIA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-3459,3/28/2021,3/2/2024,Verified
210115_Manaus_UniversidadedeSãoPaulo_Feb_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"February 7, 2020","February 13, 2020",Blood donors,Multiple groups,821,0.40%,0.00%,3.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Feb_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"February 8, 2020","February 29, 2020",Blood donors,Multiple groups,799,1.00%,0.00%,2.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Mar_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"March 6, 2020","March 12, 2020",Blood donors,Multiple groups,832,0.00%,0.00%,0.80%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Mar_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"March 9, 2020","March 21, 2020",Blood donors,Multiple groups,2454,2.80%,1.80%,3.90%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Apr_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"April 6, 2020","April 17, 2020",Blood donors,Multiple groups,829,5.00%,2.90%,7.40%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Apr_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"April 8, 2020","April 30, 2020",Blood donors,Multiple groups,900,4.00%,1.80%,6.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_May_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"May 5, 2020","May 14, 2020",Blood donors,Multiple groups,901,43.40%,38.40%,48.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_May_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"May 8, 2020","May 21, 2020",Blood donors,Multiple groups,826,4.70%,2.60%,7.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jun_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"June 5, 2020","June 15, 2020",Blood donors,Multiple groups,911,55.40%,50.70%,60.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jun_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"June 8, 2020","June 20, 2020",Blood donors,Multiple groups,880,13.10%,10.30%,16.30%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Jul_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"July 6, 2020","July 15, 2020",Blood donors,Multiple groups,1147,49.00%,44.20%,53.60%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Jul_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"July 13, 2020","July 25, 2020",Blood donors,Multiple groups,879,10.60%,8.10%,13.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_DonorsTestOverall,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"July 1, 2020","July 31, 2020",Blood donors,Multiple groups,1000,13.30%,,,Unclear,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,3/2/2024,Verified
210115_Manaus_UniversidadedeSãoPaulo_Aug_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"August 8, 2020","August 19, 2020",Blood donors,Multiple groups,881,45.60%,41.10%,50.10%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Aug_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"August 10, 2020","August 29, 2020",Blood donors,Multiple groups,906,15.50%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Sept_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"September 5, 2020","September 14, 2020",Blood donors,Multiple groups,868,47.30%,42.10%,52.50%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Sept_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"September 7, 2020","September 29, 2020",Blood donors,Multiple groups,933,15.10%,12.30%,18.20%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_Manaus_UniversidadedeSãoPaulo_Oct_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Amazonas,Manaus,"October 10, 2020","October 17, 2020",Blood donors,Multiple groups,882,44.60%,39.30%,50.00%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210115_SaoPaulo_UniversidadedeSãoPaulo_Oct_PopTestAdj,"January 16, 2021",Local,Brazil,BRA,Sao Paulo State,Sao Paulo,"October 12, 2020","October 24, 2020",Blood donors,Multiple groups,877,18.20%,15.00%,21.70%,Sequential,Abbott Laboratories,CLIA,IgG,92.20%,96.10%,Moderate,Journal Article (Peer-Reviewed),Lewis Buss,Universidade de Sao Paulo,https://science.sciencemag.org/content/371/6526/288,4/7/2021,7/5/2023,Verified
210324_SaoPaulo_UniversityofSaoPaulo_overall,"March 24, 2021",Local,Brazil,BRA,Sao Paulo,Sao Paulo,"June 17, 2020","July 8, 2020",Health care workers and caregivers,Adults (18-64 years),1996,5.51%,,,Convenience,NA,ELISA,IgG,95.00%,100.00%,High,Journal Article (Peer-Reviewed),Maura Salaroli de Oliveira,University of São Paulo,https://dx.doi.org/10.1016/j.ajic.2021.03.010,4/19/2021,7/17/2022,Verified
210326_RiodeJaneiro_InstitutoD’OrdePesquisaeEnsino,"March 26, 2021",Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,"June 30, 2020","August 28, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),114,30.70%,,,Sequential,Beijing Lepu Medical Technology,Other,"IgG,IgM",66.00%,97.00%,High,Journal Article (Peer-Reviewed),Thais Cleto Yamane,Instituto D’Or de Pesquisa e Ensino,https://dx.doi.org/10.1007/s00431-021-04044-9,4/23/2021,3/2/2024,Unverified
200602_Biguacu_SecretariaMunicipaldeSaude_primary,"June 2, 2020",Local,Brazil,BRA,,Biguacu,"May 30, 2020","May 30, 2020",Household and community samples,Multiple groups,217,0.40%,,,Stratified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Ozias Alves Jr,Secretaria Municipal de Saude,http://jbfoco.com.br/2020/06/confira-um-estudo-sobre-a-pandemia-de-covid-19-em-biguacu-em-graficos/,4/23/2021,7/17/2022,Verified
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 1,"September 28, 2020",Local,Brazil,BRA,São Paulo state,Baixada Santista,"April 29, 2020","May 1, 2020",Household and community samples,Multiple groups,2314,1.40%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,4/27/2021,3/2/2024,Verified
201027_FernandoNoronha_UniversidadeFederaldoCeará,"October 27, 2020",Local,Brazil,BRA,State of Pernambuco,Fernando de Noronha,"May 22, 2020","May 31, 2020",Household and community samples,Multiple groups,904,4.30%,3.20%,5.90%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,Not reported,"IgG,IgM",,,Moderate,Preprint,Mozart Julio Tabosa Sales,Universidade Federal do Ceará,https://www.medrxiv.org/content/10.1101/2020.10.22.20216010v1.full-text,4/27/2021,3/2/2024,Verified
200928_BaixadaSantistaMetropolitanRegion_UniversidadeSantaCecília_overall_Phase 2,"September 28, 2020",Local,Brazil,BRA,São Paulo state,Baixada Santista,"May 13, 2020","May 15, 2020",Household and community samples,Multiple groups,2415,2.20%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Total Antibody,,,High,Preprint,Arthur Chioro,Baixada Santista Metropolitan Region ,https://preprints.scielo.org/index.php/scielo/preprint/view/1270,4/28/2021,3/2/2024,Verified
200604_Goiania_CityOfGoiania_overall,"June 4, 2020",Local,Brazil,BRA,Goiás,Goiania,"May 30, 2020","May 30, 2020",Household and community samples,Multiple groups,2400,0.75%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,Mauro Junio,City of Goiania,https://www.goiania.go.gov.br/inquerito-aponta-que-1-das-pessoas-ja-tiveram-covid-19-em-goiania/,4/30/2021,7/17/2022,Verified
200527_RioGrandeDoSul_FederalUniversityOfPelotas_overall,"May 27, 2020",Regional,Brazil,BRA,Rio Grande do Sul,,"May 23, 2020","May 25, 2020",Household and community samples,Multiple groups,4500,0.18%,0.08%,0.35%,Unclear,NA,LFIA,Not reported,,,Unclear,News and Media,Governo do Estato do Rio Grande do Sul,Governo do Estato do Rio Grande do Sul,https://estado.rs.gov.br/quarta-etapa-de-pesquisa-aponta-estabilidade-no-total-de-infectados-por-coronavirus-no-rs,5/4/2021,7/17/2022,Verified
200629_Goiania_CityOfGoiania_overall,"June 29, 2020",Local,Brazil,BRA,Goiás,Goiania,"June 10, 2020","June 10, 2020",Household and community samples,Multiple groups,2628,2.10%,,,Simplified probability,NA,Not reported,Not reported,,,Unclear,News and Media,City of Goiania,Municipal Health Department of the City of Goiania,https://www.goiania.go.gov.br/pesquisa-aponta-que-31-838-mil-pessoas-ja-foram-infectadas-por-covid-19-em-goiania/,5/4/2021,7/17/2022,Verified
200626_BomJesus_InstitutoPiaunienseDeOpiniaoPubilca_overall,"June 26, 2020",Local,Brazil,BRA,Piauí,Bom Jesus,"June 24, 2020","June 26, 2020",Household and community samples,Multiple groups,200,8.00%,,,Simplified probability,NA,Not reported,"IgG,IgM",,,High,Institutional Report,Instituto Piauniense de Opiniao Publica,Instituto Piauniense de Opinião Pública,https://portalpontox.com/wp-content/uploads/2020/06/PESQUISA-BOM-JESUS-COVID-24a26-06.2020.pdf,5/6/2021,7/17/2022,Verified
200812_Cajamar_MunicipalSecretariatOfCajamar_overall,"August 12, 2020",Local,Brazil,BRA,São Paulo,Municipality of Cajamar,"July 21, 2020","July 27, 2020",Household and community samples,Multiple groups,1015,4.00%,,,Convenience,NA,LFIA,Not reported,,,High,News and Media,Municipal Secretariat of Cajamar,Municipal Secretariat of Cajamar,https://cajamar.sp.gov.br/noticias/2020/08/12/secretaria-de-saude-divulga-balanco-da-pesquisa-de-busca-ativa-de-anticorpos-para-sars-cov-2/,5/6/2021,7/17/2022,Verified
200831_Limeira_LimeriaCityHall_overall,"August 31, 2020",Local,Brazil,BRA,São Paulo,Limeira,"August 24, 2020","August 29, 2020",Household and community samples,Multiple groups,1291,14.60%,11.90%,17.30%,Simplified probability,NA,Not reported,"IgG,IgM",,,High,News and Media,Redacao Educadora,Limeira City Hall,https://elimeira.com.br/noticias/limeira/estudo-sugere-que-quase-36-mil-moradores-de-limeira-tiveram-covid-19/,5/11/2021,7/17/2022,Verified
211006_Goiânia_MunicipalityofGoiâniaHealthDepartment,"October 6, 2020",Local,Brazil,BRA,Goiás,,"September 19, 2020","September 19, 2020",Household and community samples,Multiple groups,2436,13.96%,,,Unclear,NA,CLIA,IgG,,,High,News and Media,Prefeitura De Goiania,Health Department of the Municipality of Goiânia ,https://www.goiania.go.gov.br/inquerito-populacional-ajuda-identificar-areas-de-maior-concentracao-da-covid-19/,5/14/2021,7/17/2022,Verified
210210_Joinville_CityHallofJoinville_PopAdj,"February 10, 2021",Local,Brazil,BRA,Santa Catarina,Joinville,"June 15, 2020","August 7, 2020",Household and community samples,Multiple groups,4403,4.84%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Preprint,Henrique Diegoli,City Hall of Joinville,https://www.medrxiv.org/content/10.1101/2021.02.08.21251009v1.full,5/14/2021,3/2/2024,Verified
201210_MatoGrosso_StateUniversityOfMatoGrosso,"December 20, 2020",Regional,Brazil,BRA,Mato Grosso,"Água Boa, Alta Floresta, Barra do Garças, Cáceres, Cuiabá, Juína, Rondonópolis, Sinop, Tangará da Serra and Várzea Grande","September 16, 2020","October 15, 2020",Household and community samples,Multiple groups,4206,12.50%,,,Simplified probability,NA,CLIA,IgG,,,High,News and Media,Lygia Lima,State University of Mato Gross,http://www.mt.gov.br/-/16042707-unemat-coordena-estudo-sobre-condicoes-de-saude-da-populacao-de-mt-durante-pandemia,5/17/2021,7/17/2022,Unverified
210422_RioGrandeDoSul_SantaCasaDeMisericordiaDePortoAlegre_police,"April 22, 2021",Regional,Brazil,BRA,Rio Grande do Sul State,"Porto Alegre, Caxias do Sul, Canoas, Pelotas, Santa Maria, Passo Fundo, Uruguaiana, Santa Cruz do Sul, Ijui, and Lajeado ","July 23, 2020","July 25, 2020",Essential non-healthcare workers,Adults (18-64 years),1592,3.30%,,,Stratified probability,EUROIMMUN,ELISA,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Alessandro Pasqualotto,Molecular Biology Laboratory at Santa Casa de Misericordia de Porto Alegre,https://dx.doi.org/10.1371/journal.pone.0249672,5/17/2021,3/2/2024,Verified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage3_overall_unadj copy,"April 19, 2021",Regional,Brazil,BRA,Sergipe,,"February 18, 2021","March 30, 2021",Household and community samples,Multiple groups,5527,15.40%,14.50%,16.40%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,5/20/2021,3/2/2024,Unverified
210419_Sergipe_UniversidadeFederalDeSergipe_Stage2_overall_unadj copy,"April 19, 2021",Regional,Brazil,BRA,Sergipe,,"August 11, 2020","November 17, 2020",Household and community samples,Multiple groups,5405,7.90%,6.80%,9.10%,Stratified probability,"Kovalent,Boditech Med Inc.",Multiple Types,"IgG,IgM",,,Moderate,Institutional Report,Adriano Araujo,The Federal Univeristy of Sergipe,https://www.researchgate.net/publication/350976274_Evolucao_da_Prevalencia_de_Infeccao_por_SARS-CoV-2_em_Sergipe_Resultados_da_Terceira_Fase_18_de_fevereiro_a_30_de_marco_de_2021,5/20/2021,3/2/2024,Unverified
201110_Maranhao_UniversidadeFederaldoMaranhao_Phase2_OverallPopAdj,"November 10, 2020",Regional,Brazil,BRA,Maranhão,,"October 19, 2020","October 30, 2020",Household and community samples,Multiple groups,4563,38.10%,34.80%,41.40%,Stratified probability,Roche Diagnostics,CLIA,Total Antibody,,,Moderate,Institutional Report,Antonio da Silva,Universidade Federal do Maranhao,https://www.saude.ma.gov.br/wp-content/uploads/2020/11/Inquerito-Sorologico-Maranhao-Fase-2.pdf,5/21/2021,3/2/2024,Verified
200821_Campinas_CampinasMunicipalHealthDepartment,"August 21, 2020",Local,Brazil,BRA,Sao Paulo,Campinas,"August 3, 2020","August 15, 2020",Household and community samples,Multiple groups,1876,3.68%,,,Simplified probability,NA,Not reported,Not reported,,,High,News and Media,Campinas City Hall,Campinas Municipal Health Department,https://covid-19.campinas.sp.gov.br/prefeitura-de-campinas-apresenta-segundo-inqu-rito-sorol-gico-da-covid-19,5/21/2021,7/17/2022,Verified
210113_SaoPaulo_CidadeDeSaoPaolo_2021_Phase1_overall,"January 13, 2021",Local,Brazil,BRA,Sao Paulo,Sao Paulo,"January 5, 2021","January 7, 2021",Household and community samples,Multiple groups,1960,14.10%,11.70%,16.80%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",97.87%,,Moderate,Institutional Report,City of Sao Paulo,Cidade de São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/coletiva_saude_14-01.pdf,5/21/2021,3/2/2024,Verified
210204_SaoPaulo_CityOfSaoPaulo_2021_Phase2,"February 4, 2021",Local,Brazil,BRA,Sao Paulo,Sao Paulo,"January 7, 2021","January 21, 2021",Household and community samples,Multiple groups,1841,13.90%,11.70%,16.40%,Simplified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",97.87%,,High,Institutional Report,City of Sao Paulo,City of Sao Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-02_2021.pdf/view,5/21/2021,3/2/2024,Verified
210501_SãoPaulo_Ipec_overall_Unadj,"May 1, 2021",Local,Brazil,BRA,São Paulo,São Paulo,"April 22, 2021","May 1, 2021",Household and community samples,Multiple groups,1187,41.60%,,,Stratified probability,"Abbott Laboratories,Roche Diagnostics",CLIA,"IgG,IgM",,,Moderate,Institutional Report,Beatriz Tess,Inteligência em Pesquisa e Consultoria,https://www.monitoramentocovid19.org/resultados,5/22/2021,3/2/2024,Verified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_firstfase_primary,"December 11, 2020",Local,Brazil,BRA,,Pitangueiras,"August 24, 2020","August 29, 2020",Household and community samples,Multiple groups,150,1.72%,0.51%,2.93%,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,5/22/2021,7/17/2022,Unverified
201211_Pitangueiras_PrefeituraMunicipaldePitangueiras_secondfase_primary,"December 11, 2020",Local,Brazil,BRA,,Pitangueiras,"September 24, 2020","September 29, 2020",Household and community samples,Multiple groups,125,8.00%,,,Stratified probability,NA,Not reported,"IgG,IgM",,,Moderate,Institutional Report,Ana Celeste Crotti Peixoto,Prefeitura Municipal de Pitangueiras  ,https://pitangueiras.sp.gov.br/wp-content/uploads/2020/12/Relatorio-Inquerito-COVID-19-Final.pdf,5/22/2021,7/17/2022,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_IGHDCohort1,"April 16, 2021",Local,Brazil,BRA,Sergipe,Itabaianinha,"October 1, 2020","October 3, 2020",Household and community samples,Multiple groups,27,22.20%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,5/23/2021,3/2/2024,Unverified
210416_Itabaianinha_FederalUniversityofSergipe_ControlCohort2,"April 16, 2021",Local,Brazil,BRA,Sergipe,Itabaianinha,"October 1, 2020","October 3, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,27,18.50%,,,Convenience,Boditech Med Inc.,ELISA,"IgG,IgM",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Manuela A Melo,"Federal University of Sergipe, Aracaju",https://dx.doi.org/10.1007/s12020-021-02728-8,5/23/2021,3/2/2024,Verified
210429_Fortaleza_StateUniversityofCearáCampusdoItaperi_Overall,"May 1, 2021",Local,Brazil,BRA,Ceará,Fortaleza,"November 9, 2020","December 9, 2020",Multiple populations,Multiple groups,1559,26.70%,,,Simplified probability,Beijing Lepu Medical Technology,Other,"IgG,IgM",98.90%,97.60%,Moderate,Journal Article (Peer-Reviewed),Valdester Cavalcante Pinto Junior,"State University of Ceará, Campus do Itaperi",https://dx.doi.org/10.1016/j.ijid.2021.04.086,5/28/2021,3/2/2024,Verified
210518_Sergipe_FederalUniversityofSergipe_overall,"May 18, 2021",Regional,Brazil,BRA,Sergipe,,"July 1, 2020","July 31, 2020",Household and community samples,Multiple groups,5615,9.26%,8.50%,10.10%,Stratified probability,"Guangzhou Wondfo Biotech Co. Ltd,Boditech Med Inc.",Multiple Types,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araújo,Federal University of Sergipe,https://dx.doi.org/10.1017/S0950268821001163,5/31/2021,3/2/2024,Verified
210609_SouthBrazil_UniversidadeFederaldoParaná,"June 9, 2021",Regional,Brazil,BRA,Mato Grosso do Sul,Curitiba,"September 15, 2020","October 15, 2020",Pregnant or parturient women,Adults (18-64 years),195,8.70%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Preprint,Jullie Anne Chiste,Complexo Hospital de Clínicas da Universidade Federal do Paraná ,https://dx.doi.org/10.1515/jpm-2021-0173,6/18/2021,7/17/2022,Unverified
210624_Brazil_UniversidadeFederalDePelotas_overall,"June 24, 2021",National,Brazil,BRA,,,"June 21, 2020","June 24, 2020",Household and community samples,Multiple groups,31869,2.70%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",84.80%,99.95%,Moderate,Journal Article (Peer-Reviewed),Ana M. B. Menezes,Universidade Federal de Pelotas,https://dx.doi.org/10.1038/s41598-021-92775-y,7/6/2021,3/2/2024,Verified
210630_RioDeJaneiro_HospitalFederaldosServidoresdoEstado,"June 30, 2021",Local,Brazil,BRA,,Rio de Janeiro,"April 13, 2020","June 17, 2020",Pregnant or parturient women,Adults (18-64 years),115,23.50%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Maria de Lourdes Benamor Teixeira,Hospital Federaldo dos Servidores do Estado,https://dx.doi.org/10.3390/v13071277,7/13/2021,7/17/2022,Verified
210701_RioDeJaneiro_OswaldoCruzFoundation_Primarysam,"July 1, 2021",Local,Brazil,BRA,Rio de Janeiro,"Rio de Janeiro
","May 18, 2020","September 24, 2020",Multiple general populations,Multiple groups,515,29.30%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Pamella Lugon,Oswaldo Cruz Foundation,https://europepmc.org/article/MED/33863845,7/14/2021,3/2/2024,Verified
210702_RibeiraoPreto_UniversidadedeSãoPaulo_Followup,"July 2, 2021",Local,Brazil,BRA,São Paulo,Ribeirão Preto (RP),"June 11, 2020","June 14, 2020",Household and community samples,Multiple groups,646,2.79%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,86.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Edson Zangiacomi Martinez,Universidade de São Paulo,https://dx.doi.org/10.1590/0037-8682-0210-2021,7/14/2021,3/2/2024,Verified
210312_SaoPaulo_CityOfSaoPaulo_2021_Phase4_overall,"March 12, 2021",Local,Brazil,BRA,São Paulo,São Paulo,"February 16, 2021","February 18, 2021",Household and community samples,Multiple groups,1793,25.00%,21.70%,28.70%,Simplified probability,"Guangzhou Wondfo Biotech Co. Ltd,EUROIMMUN",Multiple Types,"IgG,IgM",,,High,Institutional Report,City of Sao Paulo,City of São Paulo,http://www.capital.sp.gov.br/arquivos/pdf/2021/inquerito_fase-04_2021.pdf/,7/20/2021,3/2/2024,Verified
210618_Brazil_UniversidadeFederaldePelotas_primary,"June 18, 2021",National,Brazil,BRA,,,"May 14, 2020","June 23, 2020",Household and community samples,Multiple groups,89362,2.30%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),Fernando C Barros,Universidade Federal de Pelotas,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225319/,7/22/2021,3/2/2024,Verified
210629_SaoPaulo_UniversidadeFederaldeSãoPaulo_Overall,"July 29, 2021",Local,Brazil,BRA,,Sao Paulo,"September 1, 2020","September 25, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,416,8.20%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Preprint,Marina P Cristelli,Universidade Federal de São Paulo,https://dx.doi.org/10.1111/tid.13706,8/2/2021,3/2/2024,Unverified
210726_Chapecó_CommunityUniversityOfChapecóRegion_Primary,"July 26, 2021",Local,Brazil,BRA,Santa Catarina,Chapecó,"June 15, 2020","August 15, 2020",Household and community samples,Multiple groups,2179,0.64%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Maria Silva,Community University of Chapecó Region,https://rsdjournal.org/index.php/rsd/article/view/17996/16175,8/4/2021,3/2/2024,Verified
210729_Mariana+OuroPreto_FederalUniversityOfOuro,"July 29, 2021",Local,Brazil,BRA,Minas Gerais,"Mariana, OuroPreto","October 15, 2020","December 15, 2020",Household and community samples,Multiple groups,1762,5.50%,,,Convenience,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,High,Preprint,Adriana Lucia Meireles,Federal University of Ouro,https://preprints.scielo.org/index.php/scielo/preprint/view/2720,8/11/2021,3/2/2024,Unverified
210801_Aracuja_FederalUniversityofSergipe_Overall_IgG,"August 1, 2021",Local,Brazil,BRA,Sergipe,Aracuja,"January 1, 2021","January 31, 2021",Essential non-healthcare workers,Adults (18-64 years),123,26.00%,,,Convenience,Boditech Med Inc.,LFIA,IgG,95.80%,97.00%,High,Journal Article (Peer-Reviewed),Lysandro Borges,"Federal University of Sergipe
",http://dx.doi.org/10.3390/ijerph18158148,8/14/2021,3/2/2024,Verified
210729_SãoPaulo_HospitalIsraelitaAlbertEinstein_Adj,"July 29, 2021",Local,Brazil,BRA,"São Paulo State
",São Paulo,"September 15, 2020","December 15, 2020",Household and community samples,Multiple groups,272,45.20%,39.40%,51.00%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,Moderate,Journal Article (Peer-Reviewed),Joao Luiz Miraglia ,Hospital Israelita Albert Einstein,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255412,8/18/2021,3/2/2024,Verified
210813_Brazil_FederalUniversityofOuroPreto_Town1,"August 13, 2021",Local,Brazil,BRA,Minas Gerais,Nepomuceno,"May 30, 2020","May 31, 2020",Household and community samples,Multiple groups,400,0.50%,0.13%,1.80%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Breno Bernardes-Souza,Federal University of Ouro Preto,https://dx.doi.org/10.2196/30406,8/25/2021,3/2/2024,Verified
210813_Brazil_FederalUniversityofOuroPreto_Town2,"August 13, 2021",Local,Brazil,BRA,Minas Gerais,Carmópolis,"June 27, 2020","June 28, 2020",Household and community samples,Multiple groups,400,1.75%,0.85%,3.57%,Stratified probability,Qingdao Hightop Biotech Co. Ltd ,LFIA,"IgG,IgM",95.00%,100.00%,Low,Journal Article (Peer-Reviewed),Breno Bernardes-Souza,Federal University of Ouro Preto,https://dx.doi.org/10.2196/30406,8/25/2021,3/2/2024,Verified
210810_SaoPaulo_UniversidadedeSaoPaulo_Primary,"August 10, 2021",Regional,Brazil,BRA,,Sao Paulo,"May 4, 2020","May 12, 2020",Multiple general populations,Multiple groups,463,6.00%,3.90%,8.30%,Stratified non-probability,"Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),Roche Diagnostics",Multiple Types,"IgG,IgM,Total Antibody",,,Moderate,Journal Article (Peer-Reviewed),Beatriz Tess,Universidade de Sao Paulo,https://dx.doi.org/10.1016/j.bjid.2021.101604,8/30/2021,3/2/2024,Verified
210617_Campinas_UniversityOfCampinas,"June 17, 2021",Regional,Brazil,BRA,Sao Paulo,Campinas,"August 15, 2020","January 15, 2021",Representative patient population,Multiple groups,135,11.00%,,,Convenience,Abbott Laboratories,CLIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Luiza Francisco Trafane,University of Campinas,https://onlinelibrary.wiley.com/doi/10.1002/jha2.254,9/8/2021,3/2/2024,Verified
210629_RioGrandedoSul_UniversidadeFederaldePelotas_Primary,"June 29, 2021",Regional,Brazil,BRA,Rio Grande do Sul,,"April 11, 2020","September 6, 2020",Household and community samples,Multiple groups,35611,0.58%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,Not reported,84.80%,99.95%,Moderate,Journal Article (Peer-Reviewed),Pedro C. Hallal ,Universidade Federal de Pelotas ,https://dx.doi.org/10.2105/AJPH.2021.306351,9/9/2021,3/2/2024,Verified
210902_Manaus_InstitutoNacionaldePesquisasdaAmazônia_overall,"September 2, 2021",Local,Brazil,BRA,Amazonas,Manaus,"October 10, 2020","November 14, 2020",Household and community samples,Multiple groups,280,64.64%,59.01%,70.28%,Sequential,EUROIMMUN,ELISA,"IgA,IgG",,,Moderate,Journal Article (Peer-Reviewed),Gemilson Soares Pontes,Instituto Nacional de Pesquisas da Amazônia,https://www.nature.com/articles/s41598-021-96843-1,9/15/2021,3/2/2024,Verified
210913_Belém_UniversidadeFederaldoPará,"September 13, 2021",Local,Brazil,BRA,Pará State,Belém,"September 15, 2020","January 15, 2021",Household and community samples,Multiple groups,101,83.20%,,,Entire sample,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Hilton Pereira da Silva,Universidade Federal do Pará,https://dx.doi.org/10.1186/s12889-021-11696-7,9/22/2021,3/2/2024,Unverified
210901_Petropolis_SociedadeFrancoBrasileiradeOncologia_followup,"September 1, 2021",Local,Brazil,BRA,,Petropolis,"November 5, 2020","December 28, 2020",Health care workers and caregivers,Adults (18-64 years),60,10.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Presentation or Conference,Carla Ismael,Sociedade Franco Brasileira de Oncologia (SFBO),http://dx.doi.org/10.1016/j.annonc.2021.08.1596,9/28/2021,3/2/2024,Unverified
210926_RiodeJaneiro_OswaldoCruzFoundation_Primary,"September 26, 2021",Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,"January 7, 2020","January 11, 2021",Pregnant or parturient women,Adults (18-64 years),31,19.35%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Alanna Calheiros Santos,Oswaldo Cruz Foundation,http://dx.doi.org/10.1016/j.aohep.2021.100450,10/5/2021,3/2/2024,Verified
210922_EspiritoSanto_LaboratoriodeEpidemiologia_Overall,"September 22, 2021",Regional,Brazil,BRA,Espirito Santo,"Colatina, Linhares, São Mateus, Afonso Cláudio, Nova Venécia, Cachoeiro de Itapemirim, Alegre, Vila Velha, Cariacica, Serra, Vitória","May 10, 2020","June 21, 2020",Household and community samples,Children and Youth (0-17 years),1693,6.10%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",86.40%,99.60%,High,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Laboratorio de Epidemiologia,https://dx.doi.org/10.1590/S1679-49742021000400001,10/6/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase9,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"January 19, 2021","January 21, 2021",Household and community samples,Multiple groups,1795,13.90%,11.70%,16.40%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase2,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"July 13, 2020","July 16, 2020",Household and community samples,Multiple groups,2323,11.10%,9.60%,12.90%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase5,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"August 25, 2020","August 27, 2020",Household and community samples,Multiple groups,2225,13.90%,11.80%,16.20%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase8,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"January 5, 2021","January 7, 2021",Household and community samples,Multiple groups,1908,14.10%,11.70%,16.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase10,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"February 2, 2021","February 4, 2021",Household and community samples,Multiple groups,1742,16.00%,13.10%,19.30%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase4,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"August 11, 2020","August 13, 2020",Household and community samples,Multiple groups,2447,11.00%,9.00%,13.30%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase11,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"February 16, 2021","February 18, 2021",Household and community samples,Multiple groups,1780,25.00%,21.70%,28.70%,Stratified probability,"Celer Technologies Inc.,EUROIMMUN",Multiple Types,"IgM,IgG",,,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase6,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"September 8, 2020","September 10, 2020",Household and community samples,Multiple groups,2125,11.90%,10.00%,14.10%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase3,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"July 28, 2020","July 30, 2020",Household and community samples,Multiple groups,2529,10.90%,9.20%,12.90%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase1,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"June 29, 2020","July 2, 2020",Household and community samples,Multiple groups,2481,9.70%,7.90%,11.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Phase7,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"September 22, 2020","September 24, 2020",Household and community samples,Multiple groups,2012,13.60%,11.60%,15.80%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211022_SaoPaulo_SecretariaMunicipalDeSaudeDeSaoPaulo_Pilot,"October 22, 2021",Regional,Brazil,BRA,Greater São Paulo,,"June 10, 2020","June 17, 2020",Household and community samples,Multiple groups,2645,9.50%,7.90%,11.40%,Stratified probability,Celer Technologies Inc.,LFIA,"IgM,IgG",84.80%,99.00%,Moderate,Journal Article (Peer-Reviewed),José Olimpio Moura de Albuquerque,Secretaria Municipal de Saude de Sao Paulo,https://dx.doi.org/10.11606/s1518-8787.2021055003970,11/4/2021,3/2/2024,Verified
211101_Manaus_UniversidadeFederaldoAmazona_Primary,"November 1, 2021",Local,Brazil,BRA,Amazonas,Manaus,"August 20, 2020","November 20, 2020",Household and community samples,Multiple groups,1631,13.06%,11.52%,14.79%,Convenience,NA,ELISA,IgG,94.28%,97.03%,Moderate,Journal Article (Peer-Reviewed),Pritesh Lalwani,Universidade Federal do Amazonas,https://dx.doi.org/10.1016/S2214-109X(21)00355-7,11/6/2021,7/17/2022,Verified
211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGSN,"October 29, 2021",Regional,Brazil,BRA,Espírito Santo,Vitória,"June 22, 2020","June 26, 2020",Household and community samples,Multiple groups,714,12.05%,9.59%,14.50%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210048,11/11/2021,3/2/2024,Unverified
211029_Vitória_UniversidadeFederalDoEspíritoSanto_AGNSN,"October 29, 2021",Regional,Brazil,BRA,Espírito Santo,Vitória,"June 22, 2020","June 26, 2020",Persons living in slums,Multiple groups,733,10.23%,7.97%,12.50%,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.63%,High,Journal Article (Peer-Reviewed),Ethel Leonor Noia Maciel,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210048,11/11/2021,3/2/2024,Unverified
211019_SãoPaulo_FederalUniversityofParaná_homeless_overall,"October 19, 2021",Local,Brazil,BRA,São Paulo State,São Paulo,"August 25, 2020","August 27, 2020",Persons experiencing homelessness,Multiple groups,203,54.70%,47.80%,61.50%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anahi Chechia do Couto,Federal University of Paraná,https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754,11/17/2021,7/17/2022,Unverified
211019_SãoPaulo_FederalUniversityofParaná_workers_overall,"October 19, 2021",Local,Brazil,BRA,São Paulo State,São Paulo,"August 25, 2020","August 27, 2020",Essential non-healthcare workers,Multiple groups,87,49.43%,,,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Anahi Chechia do Couto,Federal University of Paraná,https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009754,11/17/2021,7/17/2022,Unverified
211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_July_Overall,"November 16, 2021",Regional,Brazil,BRA,Rio Grande do Sul,,"July 1, 2020","July 31, 2020",Essential non-healthcare workers,Multiple groups,48,6.10%,1.90%,17.70%,Stratified non-probability,ACRO Biotech Inc,LFIA,Not reported,,,High,Preprint,Sergio Renato da Rosa Decker,Universidade Federal do Rio Grande do Sul,https://dx.doi.org/10.1080/23744235.2021.1995039,11/23/2021,3/2/2024,Unverified
211116_RioGrandedoSul_UniversidadeFederaldoRioGrandedoSul_August_Overall,"November 16, 2021",Regional,Brazil,BRA,Rio Grande do Sul,,"August 1, 2020","August 31, 2020",Essential non-healthcare workers,Multiple groups,46,2.30%,0.30%,14.70%,Stratified non-probability,ACRO Biotech Inc,LFIA,Not reported,,,High,Preprint,Sergio Renato da Rosa Decker,Universidade Federal do Rio Grande do Sul,https://dx.doi.org/10.1080/23744235.2021.1995039,11/23/2021,3/2/2024,Unverified
211119_RiodeJaneiro_FundaçãoOswaldoCruz_Primary,"November 19, 2021",Local,Brazil,BRA,,Rio de Janeiro,"September 1, 2020","February 28, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,83,26.50%,17.00%,36.00%,Convenience,NA,LFIA,"IgG,IgM",,,High,Preprint,Karen Gomes,Fundação Oswaldo Cruz,10.1101/2021.11.17.21266274,12/1/2021,7/17/2022,Unverified
211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round9_Overall,"November 22, 2021",Regional,Brazil,BRA,Rio Grande do Sul,,"February 5, 2021","February 7, 2021",Household and community samples,Multiple groups,4501,9.97%,9.06%,10.95%,Stratified probability,NA,ELISA,IgG,95.00%,98.60%,Low,Journal Article (Peer-Reviewed),Aluisio Barros,Universidade Federal de Pelotas,https://www.scielosp.org/article/rsp/2021.v55/78/,12/2/2021,7/17/2022,Verified
211122_RioGrandedoSul_UniversidadeFederaldePelotas_Round10_Overall,"November 22, 2021",Regional,Brazil,BRA,Rio Grande do Sul,,"April 9, 2021","April 11, 2021",Household and community samples,Multiple groups,4499,18.16%,16.90%,19.49%,Stratified probability,NA,ELISA,IgG,95.00%,98.60%,Low,Journal Article (Peer-Reviewed),Aluisio Barros,Universidade Federal de Pelotas,https://www.scielosp.org/article/rsp/2021.v55/78/,12/2/2021,7/17/2022,Verified
211111_Brazil_UniversidadedeSantaCruzdoSul_Primary,"November 11, 2021",Regional,Brazil,BRA,Vale do Rio Pardo,,"August 1, 2020","October 17, 2020",Household and community samples,Multiple groups,4252,2.90%,,,Stratified probability,Beijing Lepu Medical Technology,LFIA,"IgG,IgM",96.80%,97.60%,Low,Journal Article (Peer-Reviewed),Ana Schneider,Universidade de Santa Cruz do Sul,https://dx.doi.org/10.26633/RPSP.2021.145,12/9/2021,3/2/2024,Verified
211105_Sergipe_FederalUniversityofSergipe_Phase1_Overall,"November 5, 2021",Regional,Brazil,BRA,Sergipe,,"August 31, 2020","September 9, 2020",Persons who are incarcerated,Multiple groups,778,32.00%,,,Simplified probability,Nantong Egens Biotechnology,LFIA,"IgG,IgM",97.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe,https://dx.doi.org/10.3390/life11111184,12/9/2021,7/17/2022,Unverified
211105_Sergipe_FederalUniversityofSergipe_Phase2,"November 5, 2021",Regional,Brazil,BRA,Sergipe,,"October 5, 2020","October 9, 2020",Persons who are incarcerated,Multiple groups,453,19.60%,,,Simplified probability,Nantong Egens Biotechnology,LFIA,"IgG,IgM",97.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Lysandro Pinto Borges,Federal University of Sergipe,https://dx.doi.org/10.3390/life11111184,12/9/2021,7/17/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_HCW_Primary,"December 10, 2021",Regional,Brazil,BRA,Espírito Santo,,"August 31, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),311,11.89%,8.14%,15.66%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,12/16/2021,7/17/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PrisonOfficer_Primary,"December 10, 2021",Regional,Brazil,BRA,Espírito Santo,,"August 31, 2020","September 4, 2020",Essential non-healthcare workers,Adults (18-64 years),675,22.07%,18.87%,25.28%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,12/16/2021,7/17/2022,Unverified
211210_EspíritoSanto_UniversidadeFederaldoEspíritoSanto_PDL_Primary,"December 10, 2021",Regional,Brazil,BRA,Espírito Santo,,"August 31, 2020","September 4, 2020",Persons who are incarcerated,Adults (18-64 years),884,31.64%,28.44%,34.83%,Stratified probability,MedLevensohn,LFIA,"IgG,IgM",97.40%,99.30%,Moderate,Journal Article (Peer-Reviewed),Adriana Ilha da Silva,Universidade Federal do Espírito Santo,https://dx.doi.org/10.1590/1980-549720210053,12/16/2021,7/17/2022,Unverified
211228_MâncioLima_UniversityofSãoPaulo_OcttoNov2020,"December 28, 2021",Regional,Brazil,BRA,Acre,Mâncio Lima,"October 15, 2020","November 15, 2020",Household and community samples,Multiple groups,1215,33.50%,33.20%,44.80%,Unclear,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vanessa Nicolete,University of São Paulo,https://dx.doi.org/10.3201/eid2803.211993,1/8/2022,8/15/2023,Unverified
211228_MâncioLima_UniversityofSãoPaulo_AprtoMay2021,"December 28, 2021",Regional,Brazil,BRA,Acre,Mâncio Lima,"April 15, 2021","May 15, 2021",Household and community samples,Multiple groups,1215,54.20%,51.30%,57.10%,Unclear,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Vanessa Nicolete,University of São Paulo,https://dx.doi.org/10.3201/eid2803.211993,1/8/2022,8/15/2023,Unverified
211231_RiodeJaneiro_NationalInstituteofHealthforWomenChildrenandAdolescentsFernandesFigueira,"December 31, 2021",Local,Brazil,BRA,,Rio de Janeiro,"June 1, 2020","July 31, 2020",Health care workers and caregivers,Adults (18-64 years),1141,30.00%,,,Convenience,EUROIMMUN,ELISA,IgG,99.40%,99.60%,High,Journal Article (Peer-Reviewed),Roberta Correia,"National Institute of Health for Women, Children and Adolescents Fernandes Figueira",https://dx.doi.org/10.1016/j.lana.2021.100170,1/19/2022,3/2/2024,Unverified
220210_Cameta_UniversidadeFederaldoPara_Overall,"February 10, 2022",Local,Brazil,BRA,Para,,"April 1, 2021","April 30, 2021",Household and community samples,Multiple groups,140,52.10%,,,Convenience,EUROIMMUN,ELISA,IgG,,,Unclear,Journal Article (Peer-Reviewed),Keise Pereira,Universidade Federal do Para,https://dx.doi.org/10.1016/j.bjid.2021.102060,2/22/2022,3/2/2024,Verified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave1,"January 1, 2022",Local,Brazil,BRA,Minas Gerais,"Divinopolis
","November 15, 2020","December 15, 2020",Multiple general populations,Multiple groups,616,6.50%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,2/22/2022,7/17/2022,Unverified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave2,"January 1, 2022",Local,Brazil,BRA,Minas Gerais,"Divinopolis
","January 15, 2021","February 15, 2021",Multiple general populations,Multiple groups,671,7.20%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,2/22/2022,7/17/2022,Unverified
220101_DivonopolisUniversidade FederaldeSaoJoaoDelRei_Wave3,"January 1, 2022",Local,Brazil,BRA,Minas Gerais,"Divinopolis
","May 15, 2021","July 15, 2021",Multiple general populations,Multiple groups,619,13.30%,,,Unclear,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Gustavo Rocha,Universidade Federal de Sao Joao Del-Rei,https://dx.doi.org/10.1016/j.bjid.2021.102059,2/22/2022,7/17/2022,Unverified
220101_Maracana_UniversidadeFederaldoPará,"January 1, 2022",Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,"May 1, 2021","May 31, 2021",Household and community samples,Multiple groups,117,42.30%,,,Unclear,NA,ELISA,IgG,,,High,Presentation or Conference,Aline Lima,Universidade Federal do Pará,https://dx.doi.org/10.1016/j.bjid.2021.102011,2/25/2022,7/17/2022,Unverified
220218_MinasGerais_FundacaoHemominas_Overall_TestAdj,"February 18, 2022",Regional,Brazil,BRA,Minas Gerais,"Belo Horizonte, Governador Valadares, Juiz de Fora, Montes Claros, Pouso Alegre, Uberaba, and Uberlândia","March 1, 2020","December 31, 2020",Blood donors,Multiple groups,7837,5.20%,4.70%,5.80%,Simplified probability,Abbott Laboratories,CLIA,IgG,90.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Daniel Chaves,Fundacao Hemominas,https://dx.doi.org/10.3201/eid2804.211961,3/1/2022,8/15/2023,Verified
220112_Sergipe_FederalUniversityofSergipe_Overall,"January 12, 2022",Regional,Brazil,BRA,Sergipe,,"December 1, 2020","December 20, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),113,24.80%,17.70%,33.50%,Convenience,Boditech Med Inc.,IFA,"IgM,IgG",95.80%,97.00%,High,Journal Article (Peer-Reviewed),Paulo Ricardo Martins-Filho,Federal University of Sergipe,https://dx.doi.org/10.17179/excli2021-4545,3/8/2022,3/2/2024,Unverified
220207_Betim_UniversidadeFederaldeMinasGerais,"February 7, 2022",Local,Brazil,BRA,Minas Gerais,Betim,"June 3, 2020","July 15, 2020",Household and community samples,Multiple groups,3239,1.20%,,,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Journal Article (Peer-Reviewed),Ana Silva,Universidade Federal de Minas Gerais,https://dx.doi.org/10.3389/fmicb.2022.799713,3/8/2022,3/2/2024,Verified
220222_Brasilia_MinisteriodaSaudeBrazil_Overall,"February 22, 2022",Local,Brazil,BRA,Federal District,Brasilia,"June 17, 2020","July 22, 2020",Persons who are incarcerated,Adults (18-64 years),455,81.10%,74.40%,87.80%,Stratified probability,Abbott Laboratories,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Fernando Gouvea-Reis,Universidade de Brasilia,10.1108/IJPH-08-2021-0083,3/15/2022,3/2/2024,Unverified
220228_EspíritoSanto_DiretoriaDeSaúdeDoSistemaPenal_HealthcareProfessional,"February 28, 2022",Regional,Brazil,BRA,Espírito Santo,,"August 31, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),311,11.90%,8.10%,15.70%,Simplified probability,MedLevensohn,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Camila Leal Cravo Duque,Diretoria de Saúde do Sistema Penal,https://dx.doi.org/10.1590/S1679-49742022000100008,3/18/2022,7/17/2022,Unverified
220228_EspíritoSanto_DiretoriaDeSaúdeDoSistemaPenal_PrisonOfficers,"February 28, 2022",Regional,Brazil,BRA,Espírito Santo,,"August 31, 2020","September 4, 2020",Health care workers and caregivers,Adults (18-64 years),675,22.10%,18.80%,25.30%,Simplified probability,MedLevensohn,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Camila Leal Cravo Duque,Diretoria de Saúde do Sistema Penal,https://dx.doi.org/10.1590/S1679-49742022000100008,3/18/2022,7/17/2022,Unverified
211122_Ipojuca_UniversidadedePernambuco,"November 22, 2021",Local,Brazil,BRA,Pernambuco,,"March 15, 2020","July 15, 2020",Residual sera,Children and Youth (0-17 years),54,16.70%,,,Convenience,NA,Not reported,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thaysa Santos,Universidade de Pernambuco,https://dx.doi.org/10.1590/1807-3107bor-2022.vol36.0029,3/18/2022,7/17/2022,Unverified
210118_SaoPaulo_ProvinciaFranciscanadaImaculadaConceicaodoBrasil_Overall,"January 18, 2021",Local,Brazil,BRA,,Sao Paulo,"May 20, 2020","June 2, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),173,26.60%,,,Convenience,NA,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Nidia Horie,Província Franciscana da Imaculada Conceição do Brasil,https://dx.doi.org/10.31744/einstein_journal/2022AO6237,3/22/2022,7/17/2022,Unverified
220312_Brazil_FederalUniversityofParaná,"March 12, 2022",Regional,Brazil,BRA,Paraná,Matinhos ,"January 15, 2021","December 15, 2021",Household and community samples,Multiple groups,1384,11.10%,9.60%,12.60%,Self-referral,NA,IFA,IgG,95.00%,99.50%,High,Preprint,Luciano Huergo,Federal University of Paraná,https://www.medrxiv.org/content/10.1101/2022.03.10.22271805v1.full-text,3/22/2022,7/17/2022,Unverified
220311_Vitoria_FederalUniversityofEspiritoSanto,"March 11, 2022",Local,Brazil,BRA,Espírito Santo,Victória,"July 15, 2020","October 15, 2020",Pregnant or parturient women,Adults (18-64 years),261,27.20%,,,Sequential,ECO Diagnostica LTDA,CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Carolina Ferrugini,Federal University of Espírito Santo,https://dx.doi.org/10.1371/journal.pone.0264901,3/24/2022,3/2/2024,Verified
220314_FederalDistrict_UniversidadedeBrasilia,"March 14, 2022",Regional,Brazil,BRA,Federal District,,"October 15, 2020","November 15, 2020",Health care workers and caregivers,Multiple groups,324,19.10%,,,Stratified non-probability,"CTK Biotech, Inc.",LFIA,"IgG,IgM",97.10%,97.80%,High,Journal Article (Peer-Reviewed),Jaiane Ribeiro,Universidade de Brasília,https://dx.doi.org/10.1590/1807-3107bor-2022.vol36.0035,3/24/2022,3/2/2024,Unverified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2021February_Overall,"February 18, 2022",Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,"February 1, 2021","February 28, 2021",Blood donors,Adults (18-64 years),940,30.90%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,3/30/2022,3/2/2024,Verified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2020October_Overall,"February 18, 2022",Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,"October 1, 2020","October 31, 2020",Blood donors,Adults (18-64 years),940,22.00%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,3/30/2022,3/2/2024,Verified
220218_SaoPaulo_UniversidadeFederaldeSaoPaulo_2020June_Overall,"February 18, 2022",Regional,Brazil,BRA,São Paulo,Sao Paulo city (Campo Limpo in the south and Tatuape in the east regions of the city); Sao Bernardo do Campo; Sorocaba.,"June 1, 2020","June 30, 2020",Blood donors,Adults (18-64 years),926,11.40%,,,Simplified probability,Roche Diagnostics,CLIA,"IgG,IgM",95.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Nayara Vale,Universidade Federal de São Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100016,3/30/2022,3/2/2024,Verified
220414_DantePazzaneseInstituteofCardiology_DantePazzaneseInstituteofCardiology_Coronavac,"April 14, 2022",Local,Brazil,BRA,,São Paulo,"January 15, 2021","February 15, 2021",Health care workers and caregivers,Adults (18-64 years),750,33.47%,,,Unclear,NA,ELISA,IgG,94.00%,,High,Journal Article (Peer-Reviewed),Hui Lin-Wang,Dante Pazzanese Institute of Cardiology,https://dx.doi.org/10.1002/jmv.27782,4/22/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-04_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"April 1, 2020","April 30, 2020",Residual sera,Multiple groups,202,5.94%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-05_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"May 1, 2020","May 31, 2020",Residual sera,Multiple groups,496,4.84%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-06_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"June 1, 2020","June 30, 2020",Residual sera,Multiple groups,1446,14.87%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-07_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"July 1, 2020","July 31, 2020",Residual sera,Multiple groups,4221,27.03%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-08_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"August 1, 2020","August 31, 2020",Residual sera,Multiple groups,1224,31.05%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-09_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"September 1, 2020","September 30, 2020",Residual sera,Multiple groups,402,21.64%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-10_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"October 1, 2020","October 31, 2020",Residual sera,Multiple groups,330,15.76%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-11_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"November 1, 2020","November 30, 2020",Residual sera,Multiple groups,184,13.59%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220415_Cuiaba_UniversidadeFederaldeMatoGrosso_2020-12_Overall,"April 15, 2022",Local,Brazil,BRA,Mato Grosso,Cuiabá,"December 1, 2020","December 31, 2020",Residual sera,Multiple groups,379,15.04%,,,Convenience,NA,Not reported,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Cristiane Paula,Universidade Federal de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20210769,4/27/2022,7/17/2022,Unverified
220429_Brazil_UniversidadeFederaldoCeará_Overall,"April 29, 2022",Local,Brazil,BRA,Ceará,Fortaleza,"October 15, 2020","November 15, 2020",Essential non-healthcare workers,Multiple groups,1901,8.00%,,,Convenience,Abbott Laboratories,Not reported,IgG,94.40%,100.00%,Moderate,Journal Article (Peer-Reviewed),Pamela Franca,Universidade Federal do Ceará,https://dx.doi.org/10.1590/0037-8682-0606-2021,5/17/2022,3/2/2024,Unverified
220520_Belem_FederalUniversityofPara_Overall,"May 20, 2022",Local,Brazil,BRA,"Para
",Belem,"October 15, 2020","February 15, 2021",Household and community samples,Multiple groups,704,39.10%,,,Unclear,EUROIMMUN,ELISA,IgG,,99.60%,High,Journal Article (Peer-Reviewed),Maria Torres,Federal University of Pará ,https://dx.doi.org/10.1038/s41598-022-12629-z,6/3/2022,3/2/2024,Unverified
211022_MinasGerais_FundacaoHemominas_Overall,"October 22, 2021",Regional,Brazil,BRA,Minas Gerais,,"March 15, 2020","December 15, 2020",Blood donors,Multiple groups,7837,5.60%,,,Convenience,NA,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),IR Oliveira,Fundacao Hemominas,https://dx.doi.org/10.1016/j.htct.2021.10.912,6/3/2022,7/17/2022,Unverified
220510_BeloHorizonte_UniversidadeFederalDeMinasGerais,"May 10, 2022",Local,Brazil,BRA,Minas Gerais,Belo Horizonte,"January 11, 2021","March 12, 2021",Health care workers and caregivers,Adults (18-64 years),99,16.20%,,,Convenience,NA,Multiple Types,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Lucyene Miguita,Universidade Federal de Minas Gerais,https://dx.doi.org/10.3389/froh.2022.871107,6/8/2022,7/17/2022,Unverified
220526_RioDeJaneiro_OswaldoCruzFoundation,"May 26, 2022",Local,Brazil,BRA,Rio de Janeiro,Rio de Janeiro,"May 15, 2020","November 14, 2021",Household and community samples,Multiple groups,2501,59.13%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Marilia Sa Carvalho,Oswaldo Cruz Foundation,https://dx.doi.org/10.1016/j.lana.2022.100283,6/17/2022,3/24/2024,Verified
220606_Brazil_FederalUniversityOfParana_HCWs_Primary,"June 6, 2022",Local,Brazil,BRA,Parana,Curitiba,"June 15, 2020","October 15, 2020",Health care workers and caregivers,Adults (18-64 years),50,8.00%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Mobile,Federal University of Parana,https://dx.doi.org/10.1590/S1678-9946202264039,6/21/2022,7/17/2022,Unverified
220606_Brazil_FederalUniversityOfParana_Patients_Primary,"June 6, 2022",Local,Brazil,BRA,Parana,Curitiba,"June 15, 2020","December 15, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),29,6.90%,,,Convenience,NA,Other,IgG,,,High,Journal Article (Peer-Reviewed),Rafael Mobile,Federal University of Parana,https://dx.doi.org/10.1590/S1678-9946202264039,6/21/2022,7/17/2022,Unverified
220608_MatoGrosso_FederalUniversityOfMatoGrosso_Overall,"June 8, 2022",Regional,Brazil,BRA,Mato Grosso,,"September 16, 2020","October 15, 2020",Household and community samples,Adults (18-64 years),4306,12.50%,10.50%,14.70%,Stratified probability,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Elaine Oliveira,Federal University of Mato Grosso,https://dx.doi.org/10.1590/0102-311XPT093021,6/27/2022,3/25/2024,Verified
220602_SaoPaulo_UniversityOfSaoPaulo,"June 2, 2022",Local,Brazil,BRA,Sao Paulo,Sao Paulo,"March 15, 2020","July 15, 2020",Multiple populations,Multiple groups,1119,11.53%,,,Unclear,Roche Diagnostics,CLIA,Not reported,96.92%,98.78%,High,Journal Article (Peer-Reviewed),Robert Andreata-Santos,University of São Paulo,https://dx.doi.org/10.3389/fcimb.2022.787411,6/29/2022,3/2/2024,Unverified
220706_ SaoPaulo_UniversityofSaoPaulo,"July 6, 2022",Local,Brazil,BRA,,Sao Paulo,"May 26, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),233,11.20%,,,Convenience,Siemens,CLIA,Total Antibody,99.80%,100.00%,High,Journal Article (Peer-Reviewed),Sandro da Costa Ferreira,University of Sao Paulo,https://dx.doi.org/10.1590/S0004-2803.202202000-32,7/22/2022,3/2/2024,Unverified
220718_CruzeirodoSul_UniversityofSaoPaulo_Overall,"July 18, 2022",Local,Brazil,BRA,Acre State,Cruzeiro do Sul,"January 15, 2021","July 4, 2021",Perinatal,Children and Youth (0-17 years),660,45.00%,41.20%,48.90%,Convenience,Roche Diagnostics,CLIA,Total Antibody,97.20%,99.80%,High,Journal Article (Peer-Reviewed),Marcelo Ferreira,University of Sao Paulo,https://dx.doi.org/10.1371/journal.pntd.0010580,7/26/2022,3/2/2024,Unverified
220722_MatoGrosso_UniversidadedeSaoPaulo_Overall,"July 22, 2022",Regional,Brazil,BRA,Mato Grosso,"Cuiabá, Várzea
Grande, Cáceres, Rondonópolis, Barra do Garças,
Tangará da Serra, Alta Floresta, Água Boa, Juína and Sinop","September 15, 2020","October 15, 2020",Household and community samples,Multiple groups,4203,13.80%,,,Stratified probability,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ana Trettel,Universidade de Sao Paulo,https://dx.doi.org/10.1590/1413-81232022278.04972022,8/4/2022,4/1/2024,Verified
220721_Salvador_UniversidadeFederaldaBahia_Overall,"July 21, 2022",Local,Brazil,BRA,,Salvador,"May 15, 2020","September 15, 2020",Health care workers and caregivers,Adults (18-64 years),2083,13.00%,,,Convenience,"ECO Diagnostica LTDA,NA",Multiple Types,IgG,,,High,Journal Article (Peer-Reviewed),Iris Montano-Castellon,Universidade Federal da Bahia,https://dx.doi.org/10.1016/j.bjid.2022.102387,8/9/2022,3/2/2024,Unverified
220729_RiodeJaneiro_FIOCRUZ_AntiS,"July 29, 2022",Local,Brazil,BRA,,Rio de Janeiro,"September 15, 2020","February 10, 2021",Household and community samples,Multiple groups,4033,48.97%,46.80%,51.20%,Stratified probability,Abbott Laboratories,CLIA,IgG,99.37%,99.55%,Low,Journal Article (Peer-Reviewed),Lara E. Coelho,FIOCRUZ,https://doi.org/10.1016/j.lana.2022.100338,8/10/2022,4/19/2024,Verified
220805_RibeiraoPreto_FundacaoOswaldoCruz_Phase2,"August 5, 2022",Local,Brazil,BRA,Sao Paulo,Ribeirao Preto,"October 2, 2020","November 3, 2020",Health care workers and caregivers,Adults (18-64 years),2129,12.10%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Patricia Evora,Fundacao Oswaldo Cruz,https://dx.doi.org/10.1590/0037-8682-0088-2022,8/18/2022,3/2/2024,Unverified
220805_RibeiraoPreto_FundacaoOswaldoCruz_Phase1,"August 5, 2022",Local,Brazil,BRA,Sao Paulo,Ribeirao Preto,"June 29, 2020","August 26, 2020",Health care workers and caregivers,Adults (18-64 years),10172,12.70%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Patricia Evora,Fundacao Oswaldo Cruz,https://dx.doi.org/10.1590/0037-8682-0088-2022,8/18/2022,3/2/2024,Unverified
220808_MatoGrosso_UniversidadedoEstadodeMatoGrosso,"August 8, 2022",Regional,Brazil,BRA,Mato Grosso,,"September 16, 2020","October 15, 2020",Household and community samples,Multiple groups,4206,12.50%,10.50%,14.70%,Stratified probability,DiaSorin,CLIA,IgG,97.40%,98.50%,Moderate,Journal Article (Peer-Reviewed),Ana Cláudia Pereira Tercas-Trettel,Universidade do Estado de Mato Grosso,https://dx.doi.org/10.1590/1806-9282.20220078,8/23/2022,3/13/2024,Verified
220812_Brazil_HospitalSirioLibanes,"August 12, 2022",Local,Brazil,BRA,,Sao Paulo,"May 28, 2020","June 26, 2020",Health care workers and caregivers,Adults (18-64 years),164,26.80%,,,Convenience,NA,ELISA,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Ricardo Madureira,Sirio-Libanes Hospital ,https://dx.doi.org/10.1089/hs.2022.0045,8/24/2022,8/26/2022,Unverified
220829_EspiritoSanto_SubsecretariadeEstadodeVigilânciaemSaúde_Overall,"August 29, 2022",Regional,Brazil,BRA,"Espírito Santo, Greater Vitória, and interior region of the state",,"May 10, 2020","June 27, 2020",Household and community samples,Multiple groups,18786,6.10%,,,Stratified probability,Celer Technologies Inc.,LFIA,"IgG,IgM",86.40%,97.60%,Moderate,Journal Article (Peer-Reviewed),Orlei Amaral Cardoso,Subsecretaria de Estado de Vigilância em Saúde,https://doi.org/10.1590/S1679-49742022000200023,9/8/2022,4/10/2024,Verified
220908_Salvador_YaleSchoolofPublicHealth_TestPopAdjusted_Overall,"September 8, 2022",Local,Brazil,BRA,Bahia,Salvador,"November 18, 2020","February 26, 2021",Persons living in slums,Multiple groups,2041,47.93%,44.22%,52.10%,Entire sample,EUROIMMUN,ELISA,IgG,91.10%,100.00%,Moderate,Journal Article (Peer-Reviewed),Mariam Fofana,Yale School of Public Health,https://dx.doi.org/10.1371/journal.pmed.1004093,9/14/2022,4/15/2024,Verified
220912_Brazil_FederalUniversityofSergipe_Phase1_overall,"September 12, 2022",Regional,Brazil,BRA,"Sergipe
",,"July 1, 2020","July 30, 2020",Household and community samples,Multiple groups,5619,9.30%,,,Simplified probability,"BioSys Laboratories,Kovalent,Boditech Med Inc.,Guangzhou Wondfo Biotech Co. Ltd,ECO Diagnostica LTDA",Multiple Types,"IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.1080/20477724.2022.2121366,9/19/2022,3/2/2024,Unverified
220912_Brazil_FederalUniversityofSergipe_Phase2_overall,"September 12, 2022",Regional,Brazil,BRA,"Sergipe
",,"August 11, 2020","November 17, 2020",Household and community samples,Multiple groups,5400,12.00%,,,Simplified probability,"BioSys Laboratories,Kovalent,Boditech Med Inc.,Guangzhou Wondfo Biotech Co. Ltd,ECO Diagnostica LTDA",Multiple Types,"IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.1080/20477724.2022.2121366,9/19/2022,3/2/2024,Unverified
220912_Brazil_FederalUniversityofSergipe_Phase3_overall,"September 12, 2022",Regional,Brazil,BRA,"Sergipe
",,"February 18, 2021","March 30, 2021",Household and community samples,Multiple groups,5525,15.40%,,,Simplified probability,"BioSys Laboratories,Kovalent,Boditech Med Inc.,Guangzhou Wondfo Biotech Co. Ltd,ECO Diagnostica LTDA",Multiple Types,"IgA,IgM",,,Moderate,Journal Article (Peer-Reviewed),Adriano Antunes de Souza Araujo,Federal University of Sergipe,https://dx.doi.org/10.1080/20477724.2022.2121366,9/19/2022,3/2/2024,Unverified
220801_Brazil_UniversidadeFederaldeUberlândia_Mothers,"August 1, 2022",Regional,Brazil,BRA,Minas Gerais,,"April 15, 2021","August 15, 2021",Perinatal,Adults (18-64 years),1609,13.10%,,,Convenience,MBiolog Diagnosticos,ELISA,IgG,80.00%,97.00%,High,Journal Article (Peer-Reviewed),Gabriela Soutto Mayor Assumpcao Pinheiro,Universidade Federal de Uberlândia,https://dx.doi.org/10.1590/0102-311XEN021022,9/21/2022,2/18/2024,Unverified
220801_Brazil_UniversidadeFederaldeUberlândia_Neonates,"August 1, 2022",Regional,Brazil,BRA,Minas Gerais,,"April 15, 2021","August 15, 2021",Perinatal,Children and Youth (0-17 years),1901,14.70%,,,Convenience,MBiolog Diagnosticos,ELISA,IgG,80.00%,97.00%,High,Journal Article (Peer-Reviewed),Gabriela Soutto Mayor Assumpcao Pinheiro,Universidade Federal de Uberlândia,https://dx.doi.org/10.1590/0102-311XEN021022,9/21/2022,1/12/2024,Unverified
220909_Brazil_UniversidadedeSãoPaulo_overall,"September 9, 2022",National,Brazil,BRA,,,"April 15, 2020","January 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,442,16.70%,,,Unclear,NA,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Lucas Chaves Netto,Universidade de São Paulo,https://dx.doi.org/10.1016/j.bjid.2022.102496,9/28/2022,10/21/2022,Unverified
220916_Belem_Federal UniversityofPara_overall,"September 16, 2022",Local,Brazil,BRA,State of Para,Belem,"October 15, 2020","December 15, 2021",Household and community samples,Multiple groups,1262,44.30%,,,Convenience,EUROIMMUN,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Maria Karoliny da Silva Torres,Federal University of Para,https://dx.doi.org/10.3389/fcimb.2022.932563,10/13/2022,3/2/2024,Unverified
220912_Brazil_UniversidadedeSaoPaulo_overall,"September 12, 2022",Local,Brazil,BRA,São Paulo estado ,Sao Paulo,"March 1, 2021","March 31, 2021",Residual sera,Children and Youth (0-17 years),122,19.70%,,,Sequential,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.43%,99.57%,Moderate,Journal Article (Peer-Reviewed),Juliana Simon,Universidade de Sao Paulo,https://dx.doi.org/10.1016/j.clinsp.2022.100110,10/15/2022,3/2/2024,Unverified
220922_Brazil_UniversityofSãoPaulo_overall,"September 22, 2022",National,Brazil,BRA,,"Belo Horizonte, Curitiba, Fortaleza, Manaus, Recife, Rio de Janeiro, Salvador, and São Paulo","March 15, 2020","March 15, 2021",Blood donors,Adults (18-64 years),98640,20.22%,,,Sequential,Abbott Laboratories,CLIA,IgG,90.60%,97.50%,High,Journal Article (Peer-Reviewed),Carlos Prete Jr,University of São Paulo,https://doi.org/10.7554/eLife.78233,10/21/2022,4/15/2024,Verified
221104_Sergipe_UniversityofSaoPaulo_Students_Overall,"November 4, 2022",Regional,Brazil,BRA,Sergipe,,"November 17, 2020","January 21, 2021",Students and Daycares,Children and Youth (0-17 years),1139,16.42%,,,Unclear,Nantong Egens Biotechnology,LFIA,"IgG,IgM",96.80%,96.52%,High,Journal Article (Peer-Reviewed),Lysandro Borges,University of Sao Paulo,https://dx.doi.org/10.1016/j.heliyon.2022.e11368,11/17/2022,11/17/2022,Unverified
221104_Sergipe_UniversityofSaoPaulo_SchoolWorkers_Overall,"November 4, 2022",Regional,Brazil,BRA,Sergipe,,"November 17, 2020","January 21, 2021",Essential non-healthcare workers,Adults (18-64 years),1120,22.32%,,,Unclear,Nantong Egens Biotechnology,LFIA,"IgG,IgM",96.80%,96.52%,High,Journal Article (Peer-Reviewed),Lysandro Borges,University of Sao Paulo,https://dx.doi.org/10.1016/j.heliyon.2022.e11368,11/17/2022,11/17/2022,Unverified
221114_Brazil_RiodeJaneiroCityGovernment_Primary,"November 14, 2022",Local,Brazil,BRA,,Rio de Janeiro city,"June 16, 2021","June 19, 2021",Household and community samples,Multiple groups,3016,53.60%,51.00%,56.30%,Self-referral,"Abbott Laboratories,Azure Tech. Co., Ltd.—Hangzhou, Zhejiang, China",Multiple Types,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Jose Cerbino-Neto,Rio de Janeiro City Government,https://dx.doi.org/10.3389/fpubh.2022.1017337,12/25/2022,3/2/2024,Unverified
221015_RibeiraoPreto_FundacaoHemocentroDeRibeiraoPreto,"October 15, 2022",Local,Brazil,BRA,,Ribeirao Preto,"January 15, 2020","December 15, 2020",Blood donors,Multiple groups,646,4.87%,,,Sequential,NA,Not reported,IgG,,,,Presentation or Conference,M Evaristo,Fundação Hemocentro de Ribeirão Preto,https://dx.doi.org/10.1016/j.htct.2022.09.1139,1/11/2023,3/20/2023,Unverified
221015_PortoAlegre_UniversidadeFederalDoRioGrandeDoSul,"October 15, 2022",Local,Brazil,BRA,Rio Grande do Sul,Porto Alegre,"January 15, 2021","March 15, 2021",Blood donors,Multiple groups,1837,13.30%,,,Sequential,Celer Technologies Inc.,,,,,,Presentation or Conference,MB Silva,Universidade Federal do Rio Grande do Sul ,https://dx.doi.org/10.1016/j.htct.2022.09.1146,1/12/2023,3/2/2024,Unverified
230105_SaoPaulo_LondonSchoolofHygieneTropicalMedicine_Overall,"January 5, 2023",Local,Brazil,BRA,,Sao Paulo,"July 20, 2020","February 21, 2021",Pregnant or parturient women,Adults (18-64 years),763,29.00%,,,Sequential,Roche Diagnostics,CLIA,"IgG,IgM,IgA",,,Moderate,Journal Article (Peer-Reviewed),Mariana Yumi Miyadahira,London School of Hygiene & Tropical Medicine,https://dx.doi.org/10.1371/journal.pone.0280109,2/10/2023,3/27/2024,Verified
220909_Jundiai_JundiaiMedicalSchool,"September 9, 2022",Local,Brazil,BRA,Sao Paolo,Jundiai,"June 1, 2020","June 19, 2020",Multiple populations,Multiple groups,2431,17.40%,,,Convenience,Vyttra Diagnosticos,Other,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Marília Jesus Batista,Jundiai Medical School,https://dx.doi.org/10.1371/journal.pgph.0000460,5/4/2023,5/9/2023,Unverified
230403_Brazil_UniversityofSão Paulo,"April 3, 2023",Local,Brazil,BRA,,,"January 15, 2022","August 15, 2022",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),144,47.22%,,,Convenience,NA,Not reported,"IgG,IgM",,,,Journal Article (Peer-Reviewed),C.A. Villari,University of São Paulo,https://dx.doi.org/10.1016/j.healun.2023.02.434,5/5/2023,5/9/2023,Unverified
230413_MinasGerais_UniversidadeFederalDeAlfenas_Overall,"April 13, 2023",Regional,Brazil,BRA,Minas Gerais state,,"August 15, 2020","December 15, 2020",Health care workers and caregivers,Multiple groups,859,21.60%,,,Simplified probability,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Duillio Alves Caixeta,Universidade Federal de Alfenas,https://dx.doi.org/10.1007/s42770-023-00966-8,5/9/2023,5/9/2023,Unverified
230508_Mato Grosso_UniversidadeFederalDoMatoGrosso,"May 8, 2023",Regional,Brazil,BRA,Mato Grosso,,"September 15, 2020","October 15, 2020",Household and community samples,Adults (18-64 years),4206,12.50%,,,Stratified probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Nathalia Beatriz Lobo da Silva,Universidade Federal do Mato Grosso,https://dx.doi.org/10.1590/1980-549720230026,6/2/2023,6/3/2023,Unverified
230606_SãoPaulo_UniversidadedeSãoPaulo_Inmate_Overall,"June 6, 2023",Local,Brazil,BRA,,São Paulo,"June 24, 2020","August 20, 2020",Persons who are incarcerated,Multiple groups,879,6.10%,4.70%,7.70%,Entire sample,NA,LFIA,"IgG,IgM",98.11%,99.72%,,Journal Article (Peer-Reviewed),Soraya Gomes de Amorim Andrade,Universidade de São Paulo,https://dx.doi.org/10.11606/s1518-8787.2023057004717,6/23/2023,7/4/2023,Unverified
230606_SãoPaulo_UniversidadedeSãoPaulo_Servant_Overall,"June 6, 2023",Local,Brazil,BRA,,São Paulo,"June 24, 2020","August 20, 2020",Essential non-healthcare workers,Multiple groups,159,7.50%,4.00%,12.80%,Entire sample,NA,LFIA,"IgG,IgM",98.11%,99.72%,,Journal Article (Peer-Reviewed),Soraya Gomes de Amorim Andrade,Universidade de São Paulo,https://dx.doi.org/10.11606/s1518-8787.2023057004717,6/23/2023,7/4/2023,Unverified
230428_SãoSebastião_HospitalUniversitáriodeBrasília_Overall,"April 28, 2023",Local,Brazil,BRA,Federal District,São Sebastião,"September 24, 2021","December 19, 2021",Household and community samples,Multiple groups,733,24.15%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Raissa Nogueira de Brito,Hospital Universitário de Brasília,https://dx.doi.org/10.3390/vaccines11050916,6/29/2023,4/26/2024,Verified
230511_SãoPaulo_ CoordenadoriadeVigilânciaemSaúde_overall,"May 11, 2023",Local,Brazil,BRA,,São Paulo,"September 1, 2020","September 16, 2020",Students and Daycares,Children and Youth (0-17 years),4198,16.60%,15.40%,17.80%,Stratified probability,Guangzhou Wondfo Biotech Co. Ltd,LFIA,"IgG,IgM",86.40%,99.60%,,Journal Article (Peer-Reviewed),Gabriela Akemi Kamioka, Coordenadoria de Vigilância em Saúde,https://dx.doi.org/10.11606/s1518-8787.2023057004782,6/30/2023,3/2/2024,Unverified
230918_Alvorada_UniversidadeFederalDoRioGrandeDoSul,"September 18, 2023",Local,Brazil,BRA,Rio Grande do Sul,Alvorada,"October 15, 2020","December 15, 2020",Residual sera,Multiple groups,52,30.77%,,,Convenience,Ortho Clinical Diagnostics Inc.,CLIA,Total Antibody,79.40%,99.10%,,Journal Article (Peer-Reviewed),Natan José Dutra Dias,Universidade Federal do Rio Grande do Sul,https://dx.doi.org/10.1590/1806-9282.20230661,10/11/2023,3/2/2024,Unverified
210318_Sarajevo_InternationalBurchUniversity_DrAbdulahNakasGeneralHospital1_overall,"March 18, 2021",Local,Bosnia and Herzegovina,BIH,,Sarajevo,"April 15, 2020","May 15, 2020",Residual sera,Multiple groups,1720,3.41%,,,Convenience,Artron Laboratories Inc.,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,5/30/2021,3/2/2024,Verified
210318_Sarajevo_InternationalBurchUniversity_EurofarmCentreLaboratory2_overall,"March 18, 2021",Local,Bosnia and Herzegovina,BIH,,Sarajevo,"April 21, 2020","July 17, 2020",Residual sera,Multiple groups,1121,4.28%,,,Convenience,Dynamiker Biotechnology (Tianjin) Co. Ltd,LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Adna Asic,International Burch University,https://dx.doi.org/10.5114/aoms/134143,5/30/2021,3/2/2024,Verified
210604_RepublicOfSrpska_InstituteforTransfusionMedicine_Primary,"June 4, 2021",National,Bosnia and Herzegovina,BIH,Republic of Srpska,,"June 17, 2020","July 16, 2020",Blood donors,Adults (18-64 years),807,2.70%,,,Unclear,Biomerieux,Other,IgG,,,Unclear,Journal Article (Peer-Reviewed),Gordana Guzijan,Institute for Transfusion Medicine of the Republic of Srpska,http://dx.doi.org/10.2298/VSP200122059G,7/19/2021,3/2/2024,Verified
211013_SarajevoCanton_PublicHealthInstitute_Overall,"October 13, 2021",Local,Bosnia and Herzegovina,BIH,,Sarajevo Canton,"January 5, 2021","March 20, 2021",Multiple populations,Multiple groups,3650,27.26%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,Moderate,Institutional Report,Anes Joguncic,Public Health Institute,,11/1/2021,3/2/2024,Unverified
220128_RepublicOfSrpska_UniversityOfBanjaLuka_Overall,"January 28, 2022",Regional,Bosnia and Herzegovina,BIH,Republic of Srpska,"""a total of 64 municipalities""","December 1, 2020","January 15, 2021",Household and community samples,Multiple groups,1855,40.27%,,,Simplified probability,Beijing Wantai Biological,ELISA,Total Antibody,94.36%,100.00%,Moderate,Journal Article (Peer-Reviewed),Biljana Mijovic,University of Banja Luka,https://dx.doi.org/10.1371/journal.pone.0262738,2/9/2022,3/2/2024,Verified
220214_RepublicofSrpska_UniversityofBanjaLuka_Overall,"February 14, 2022",Regional,Bosnia and Herzegovina,BIH,Republic of Srpska,,"March 19, 2021","April 30, 2021",Health care workers and caregivers,Adults (18-64 years),1023,69.50%,,,Convenience,NA,ELISA,Not reported,,,Unclear,Journal Article (Peer-Reviewed),Darija Knezevic,University of Banja Luka,https://akjournals.com/view/journals/030/aop/article-10.1556-030.2022.01706/article-10.1556-030.2022.01706.xml,3/10/2022,7/17/2022,Unverified
220331_CantonSarajevo_InternationalBurchUniversity_Overall,"March 31, 2022",Local,Bosnia and Herzegovina,BIH,,,"September 15, 2020","May 15, 2021",Household and community samples,Multiple groups,18066,29.92%,,,Self-referral,Roche Diagnostics,CLIA,Total Antibody,,99.80%,High,Journal Article (Peer-Reviewed),Jasminka Prguda-Mujic,International Burch University,https://dx.doi.org/10.1371/journal.pone.0265431,4/14/2022,3/2/2024,Unverified
20220915_BosniaandHerzegovina_InstituteforHealthandFoodSafety_Overall,"September 15, 2022",Local,Bosnia and Herzegovina,BIH,Zenica-Doboj Canton,Zavidovići municipality,"March 15, 2021","April 15, 2021",Residual sera,Multiple groups,256,40.63%,,,Sequential,"Tigsun, Beijing",LFIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Amir Ibrahimagic,Institute for Health and Food Safety,https://pubmed.ncbi.nlm.nih.gov/36101851/,9/22/2022,9/22/2022,Unverified
230611_Sarajevo_AcademyofSciencesandArtsofBosniaandHerzegovina_Overall,"June 11, 2023",Local,Bosnia and Herzegovina,BIH,,Sarajevo,"September 15, 2020","May 15, 2021",Residual sera,Children and Youth (0-17 years),762,24.50%,,,Convenience,Roche Diagnostics,CLIA,"IgG,IgM,IgA,Total Antibody",99.50%,99.80%,High,Journal Article (Peer-Reviewed),Senka Mesihovic-Dinarevic,Academy of Sciences and Arts of Bosnia and Herzegovina,https://dx.doi.org/10.5644/ama2006-124.403,8/1/2023,4/30/2024,Verified
230822_SarajevoCanton_WorldHealthOrganizationRegionalOfficeForEurope_NovDec2020,"August 22, 2023",Regional,Bosnia and Herzegovina,BIH,Sarajevo Canton,,"November 2, 2020","December 11, 2020",Blood donors,Adults (18-64 years),1015,17.70%,15.40%,20.20%,Sequential,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Sanjin Musa,World Health Organization Regional Office for Europe,https://dx.doi.org/10.1111/irv.13182,9/23/2023,3/2/2024,Unverified
230822_SarajevoCanton_WorldHealthOrganizationRegionalOfficeForEurope_NovDec2021,"August 22, 2023",Regional,Bosnia and Herzegovina,BIH,Sarajevo Canton,,"November 7, 2021","December 31, 2021",Blood donors,Adults (18-64 years),1152,91.60%,87.00%,96.50%,Sequential,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Sanjin Musa,World Health Organization Regional Office for Europe,https://dx.doi.org/10.1111/irv.13182,9/23/2023,3/2/2024,Unverified
220125_Cochabamba_Aix-MarseilleUniversity_Overall,"January 25, 2022",Local,Bolivia (Plurinational State of),BOL,,Cochabamba,"January 1, 2021","January 31, 2021",Health care workers and caregivers,Adults (18-64 years),783,43.40%,38.80%,48.00%,Convenience,"Beckman Coulter,EUROIMMUN,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Paola Villarroel,Aix-Marseille University,https://dx.doi.org/10.3390/v14020232,2/10/2022,3/2/2024,Unverified
230527_Cotonou_UniversiteDeParisCite_Survey1,"May 27, 2023",Local,Benin,BEN,,Cotonou,"March 3, 2021","March 15, 2021",Household and community samples,Multiple groups,1405,29.77%,23.12%,37.41%,Stratified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Parfait Houngbegnon,Université de Paris Cité,https://dx.doi.org/10.1111/tmi.13895,6/28/2023,5/1/2024,Verified
230527_Cotonou_UniversiteDeParisCite_Survey2,"May 27, 2023",Local,Benin,BEN,,Cotonou,"May 27, 2021","June 8, 2021",Household and community samples,Multiple groups,1460,34.86%,31.57%,38.30%,Stratified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Parfait Houngbegnon,Université de Paris Cité,https://dx.doi.org/10.1111/tmi.13895,6/28/2023,5/1/2024,Verified
230527_Natitingou_UniversiteDeParisCite,"May 27, 2023",Local,Benin,BEN,,Natitingou,"August 20, 2021","August 26, 2021",Household and community samples,Multiple groups,735,33.34%,27.75%,39.44%,Stratified probability,Luminex Corporation,Luminex,IgG,100.00%,99.70%,Low,Journal Article (Peer-Reviewed),Parfait Houngbegnon,Université de Paris Cité,https://dx.doi.org/10.1111/tmi.13895,6/28/2023,5/1/2024,Verified
200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,"June 15, 2020",Local,Belgium,BEL,Limburg,Genk,"April 22, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),3056,6.40%,5.50%,7.30%,Convenience,Multi-G B.V.,LFIA,IgG,92.20%,97.00%,High,Journal Article (Peer-Reviewed),Deborah Steensels,ZiekenhuisOost-Limburg,https://jamanetwork.com/journals/jama/fullarticle/2767382,6/18/2020,3/2/2024,Verified
200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,"June 25, 2020",Local,Belgium,BEL,Brussels,City of Brussels,"April 15, 2020","May 18, 2020",Health care workers and caregivers,Adults (18-64 years),326,11.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Charlotte Martin,Université Libre de Bruxelles,https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext,7/21/2020,3/2/2024,Verified
200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,"July 30, 2020",Local,Belgium,BEL,Brussels,City of Brussels,"May 25, 2020","June 19, 2020",Health care workers and caregivers,Multiple groups,1485,14.61%,,,Convenience,DiaSorin,CLIA,IgG,100.00%,,High,Journal Article (Peer-Reviewed),Laurent Blairon,Iris Hospitals South,https://dx.doi.org/10.1016/j.jinf.2020.07.033,10/5/2020,3/2/2024,Verified
200811_Belgium_universitairesSaint-Luc_Overall,"August 10, 2020",Local,Belgium,BEL,,City of Brussels,"April 16, 2020","May 19, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,149,2.70%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Silvia Berardis,Cliniques universitaires Saint-Luc,https://www.sciencedirect.com/science/article/pii/S1569199320308213,10/24/2020,3/2/2024,Verified
201018_Belgium_UniversityHospitalsLeuven_Overall_unadj,"October 18, 2020",Local,Belgium,BEL,Limburg,Lanaken,"April 14, 2020","April 16, 2020",Multiple populations,Multiple groups,188,18.60%,,,Convenience,SureScreen Diagnostics,LFIA,"IgG,IgM",74.70%,95.10%,High,Journal Article (Peer-Reviewed),Frank Buntinx,University of Leuven,http://dx.doi.org/10.1080/17843286.2020.1834285,1/16/2021,3/2/2024,Verified
210120_Antwerp_UniversityofAntwerp_primary,"January 20, 2021",Local,Belgium,BEL,,Antwerp,"June 3, 2020","June 17, 2020",Health care workers and caregivers,Adults (18-64 years),431,3.20%,1.90%,5.40%,Convenience,NA,ELISA,IgG,80.00%,98.50%,High,Journal Article (Peer-Reviewed),Kawtar El Abdellati,University of Antwerp,https://dx.doi.org/10.1192/bjo.2020.172,2/7/2021,7/5/2023,Verified
210227_Belgium_AntwerpUniversityHospital_PediatricCancer_DiaSorin,"February 27, 2021",Local,Belgium,BEL,,,"March 24, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),11,9.10%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,4/21/2021,3/2/2024,Verified
210227_Belgium_AntwerpUniversityHospital_HCW_DiaSorin,"February 27, 2021",Local,Belgium,BEL,,,"March 24, 2020","May 31, 2020",Health care workers and caregivers,Adults (18-64 years),92,12.00%,,,Convenience,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,4/21/2021,3/2/2024,Verified
210415_Belgium_UniversiteCatholiquedeLouvain_T4_overall,"April 15, 2021",Local,Belgium,BEL,Brussels,Brussels,"July 7, 2020","July 8, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,96,8.33%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Laura Labriola,University Catholique de Louvain,http://dx.doi.org/10.2215/CJN.12490720,5/18/2021,3/2/2024,Verified
210828_Belgium_KatholiekeUniversiteitLeuven_Overall,"August 28, 2021",Local,Belgium,BEL,Limburg Province,"Pelt Municipality, Alken Municipality","September 21, 2020","October 6, 2020",Students and Daycares,Children and Youth (0-17 years),362,9.40%,5.70%,13.10%,Stratified probability,Beijing Wantai Biological,ELISA,"IgG,IgA,IgM",100.00%,99.60%,High,Journal Article (Peer-Reviewed),Lisa Boey,Katholieke Universiteit Leuven,https://dx.doi.org/10.1007/s00431-021-04222-9,5/24/2021,3/2/2024,Verified
210227_Belgium_AntwerpUniversityHospital_Adult_nonCancer_DiaSorin,"February 27, 2021",Local,Belgium,BEL,,,"March 24, 2020","May 31, 2020",Residual sera,Multiple groups,90,5.60%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,5/24/2021,3/2/2024,Verified
210227_Belgium_AntwerpUniversityHospital_AdultCancer_DiaSorin,"February 27, 2021",Local,Belgium,BEL,,,"March 24, 2020","May 31, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,827,6.20%,,,Sequential,DiaSorin,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Peter van Dam,Antwerp University Hospital,https://dx.doi.org/10.1016/j.ejca.2021.02.024,5/24/2021,3/2/2024,Verified
210505_Brussels_CliniquesUniversitairesSaint-Luc,"May 5, 2021",Local,Belgium,BEL,Brussels-Capital,City of Brussels,"June 19, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),3255,7.80%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,95.00%,Moderate,Journal Article (Peer-Reviewed),Anais Scohy,Cliniques universitaires Saint-Luc,http://dx.doi.org/10.1016/j.diagmicrobio.2021.115414,6/17/2021,3/2/2024,Unverified
210719_Brussels_UniversitéLibredeBruxelles,"July 19, 2021",Local,Belgium,BEL,NR,Brussels,"March 15, 2020","February 15, 2021",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),75,20.00%,,,Sequential,NA,Not reported,Not reported,,,High,Journal Article (Peer-Reviewed),Anissa Messaaoui,Université Libre de Bruxelles,https://dx.doi.org/10.1515/jpem-2021-0289,7/30/2021,7/17/2022,Unverified
210722_Belgium_UniversityOfNamur_overall,"July 22, 2021",National,Belgium,BEL,,,"January 16, 2021","February 15, 2021",Health care workers and caregivers,Multiple groups,200,29.00%,,,Unclear,Roche Diagnostics,CLIA,Total Antibody,,,High,Journal Article (Peer-Reviewed),Julien Favresse,University of Namur,http://dx.doi.org/10.1080/22221751.2021.1953403,8/2/2021,3/2/2024,Verified
210810_Antwerp_UniversityOfAntwerp,"August 10, 2021",Local,Belgium,BEL,Antwerp Province,Antwerp,"June 9, 2020","June 29, 2020",Health care workers and caregivers,Multiple groups,5233,7.60%,6.90%,8.30%,Convenience,Roche Diagnostics,ELISA,"IgG,IgM",95.00%,99.00%,Moderate,Journal Article (Peer-Reviewed),Reinout Naesens,University Of Antwerp,https://dx.doi.org/10.1017/S0950268821001497,8/17/2021,3/2/2024,Unverified
200529_Belgium_BelgianInstituteofHealth_blooddonors_march_primary,"May 29, 2020",National,Belgium,BEL,,,"March 30, 2020","March 30, 2020",Blood donors,Multiple groups,584,1.30%,,,Convenience,NA,Not reported,Not reported,,,High,Institutional Report,Belgian Institute of Health,Belgian Institute of Health ,https://covid-19.sciensano.be/sites/default/files/Covid19/COVID-19_Weekly%20report_20200529%20-%20NL_0.pdf,9/15/2021,7/17/2022,Unverified
210827_Flanders_UniversityofAntwerp_December,"August 27, 2021",Regional,Belgium,BEL,Flanders,,"December 1, 2020","December 31, 2020",Health care workers and caregivers,Adults (18-64 years),698,13.40%,10.80%,16.40%,Convenience,NA,ELISA,IgG,,99.00%,High,Journal Article (Peer-Reviewed),Joachim Marien,University of Antwerp,https://dx.doi.org/10.1093/fampra/cmab094,9/15/2021,7/17/2022,Unverified
210827_Belgium_UniversityofLiegeHospital_Overall,"August 27, 2021",National,Belgium,BEL,,,"March 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,525,2.67%,,,Unclear,DiaSorin,CLIA,IgG,,,Unclear,Presentation or Conference,Louis Firket,University of Liege Hospital,http://dx.doi.org/10.1111/tri.13944,9/21/2021,3/2/2024,Unverified
210922_Flanders_GhentUniversity_residents,"September 22, 2021",Regional,Belgium,BEL,Flanders,"Wingene, Liedekerke, Assenede, Wetteren","August 1, 2020","August 31, 2020",Assisted living and long-term care facilities,Seniors (65+ years),199,30.15%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Eline Meyers,Ghent University,https://dx.doi.org/10.1128/Spectrum.00178-21,9/29/2021,3/2/2024,Unverified
210922_Flanders_GhentUniversity_staff,"September 22, 2021",Regional,Belgium,BEL,Flanders,"Wingene, Liedekerke, Assenede, Wetteren","August 1, 2020","August 31, 2020",Assisted living and long-term care facilities,Adults (18-64 years),241,28.63%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Eline Meyers,Ghent University,https://dx.doi.org/10.1128/Spectrum.00178-21,9/29/2021,3/2/2024,Unverified
211022_Belgium_UniversitéLibreDeBruxelles,"October 22, 2021",National,Belgium,BEL,,,"July 1, 2020","October 31, 2020",Students and Daycares,Children and Youth (0-17 years),112,12.50%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Lorraine Dethioux,Université Libre de Bruxelles,https://dx.doi.org/10.1007/s00431-021-04284-9,11/6/2021,3/2/2024,Unverified
211118_Belgium_CliniqueNotreDamedeGrace,"November 18, 2021",Local,Belgium,BEL,,Gosselies,"January 18, 2021","February 8, 2021",Health care workers and caregivers,Adults (18-64 years),189,41.80%,,,Convenience,"DiaSorin,EUROIMMUN,Siemens",CLIA,"IgG,Total Antibody",,,High,Journal Article (Peer-Reviewed),Loris Wauthier,Clinique Notre-Dame de Grâce,https://dx.doi.org/10.1080/17843286.2021.2004349,11/25/2021,3/2/2024,Unverified
211111_UZBrussel_UZBrussel_Phase2,"November 11, 2021",Local,Belgium,BEL,,Brussels,"October 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),2336,7.92%,,,Convenience,NA,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Marco Moretti,University Hospital Brussels,https://dx.doi.org/10.1016/j.ajic.2021.10.042,11/25/2021,7/17/2022,Unverified
211227_Ghent_GhentUniversityHospital_Overall,"December 27, 2021",Local,Belgium,BEL,East Flanders,Ghent,"January 15, 2020","November 15, 2020",Pregnant or parturient women,Adults (18-64 years),265,1.50%,,,Convenience,"EUROIMMUN,Epitope Diagnostics, Inc.",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Laura Heireman,Ghent University Hospital,https://dx.doi.org/10.1080/01443615.2021.1997960,1/14/2022,3/2/2024,Verified
220127_Flanders_Sciensano_30Mar2020,"January 27, 2022",Regional,Belgium,BEL,Flanders (Flemish region),,"March 30, 2020","March 30, 2020",Blood donors,Multiple groups,584,2.00%,0.60%,3.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_4-6Jan2021,"January 27, 2022",National,Belgium,BEL,,,"January 4, 2021","January 6, 2021",Blood donors,Multiple groups,1011,18.70%,15.60%,21.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_29-30Mar2021,"January 27, 2022",National,Belgium,BEL,,,"March 29, 2021","March 30, 2021",Blood donors,Multiple groups,1200,31.50%,27.30%,35.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_12-14Oct2020,"January 27, 2022",National,Belgium,BEL,,,"October 12, 2020","October 14, 2020",Blood donors,Multiple groups,900,5.70%,3.80%,7.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_21-22Jun2021,"January 27, 2022",National,Belgium,BEL,,,"June 21, 2021","June 22, 2021",Blood donors,Multiple groups,1199,78.70%,75.90%,81.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_1-2Mar2021,"January 27, 2022",National,Belgium,BEL,,,"March 1, 2021","March 2, 2021",Blood donors,Multiple groups,1175,25.60%,21.40%,29.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_19-20Jul2021,"January 27, 2022",National,Belgium,BEL,,,"July 19, 2021","July 20, 2021",Blood donors,Multiple groups,1185,98.00%,,,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_9-11Nov2020,"January 27, 2022",National,Belgium,BEL,,,"November 9, 2020","November 11, 2020",Blood donors,Multiple groups,900,13.60%,10.60%,16.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_20-23Jul2020,"January 27, 2022",National,Belgium,BEL,,,"July 20, 2020","July 23, 2020",Blood donors,Multiple groups,900,5.20%,3.50%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_8-10Jun2020,"January 27, 2022",National,Belgium,BEL,,,"June 8, 2020","June 10, 2020",Blood donors,Multiple groups,900,4.50%,3.00%,6.10%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_18-20Jan2021,"January 27, 2022",National,Belgium,BEL,,,"January 18, 2021","January 20, 2021",Blood donors,Multiple groups,900,19.40%,16.00%,22.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_6-7Jul2020,"January 27, 2022",National,Belgium,BEL,,,"July 6, 2020","July 7, 2020",Blood donors,Multiple groups,900,5.80%,4.00%,7.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_24-25May2021,"January 27, 2022",National,Belgium,BEL,,,"May 24, 2021","May 25, 2021",Blood donors,Multiple groups,1186,61.10%,57.50%,65.10%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_7-9Dec2020,"January 27, 2022",National,Belgium,BEL,,,"December 7, 2020","December 9, 2020",Blood donors,Multiple groups,900,18.70%,14.90%,22.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_31Aug-2Sep2020,"January 27, 2022",National,Belgium,BEL,,,"August 31, 2020","September 2, 2020",Blood donors,Multiple groups,900,4.90%,3.00%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_26-27Apr2021,"January 27, 2022",National,Belgium,BEL,,,"April 26, 2021","April 27, 2021",Blood donors,Multiple groups,1200,45.60%,41.20%,50.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_25-27May2020,"January 27, 2022",National,Belgium,BEL,,,"May 25, 2020","May 27, 2020",Blood donors,Multiple groups,900,5.50%,3.80%,7.40%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_1-2Feb2021,"January 27, 2022",National,Belgium,BEL,,,"February 1, 2021","February 2, 2021",Blood donors,Multiple groups,1135,20.30%,17.50%,23.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_11-13May2020,"January 27, 2022",National,Belgium,BEL,,,"May 11, 2020","May 13, 2020",Blood donors,Multiple groups,900,5.30%,3.60%,7.20%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_28-30Sep2020,"January 27, 2022",National,Belgium,BEL,,,"September 28, 2020","September 30, 2020",Blood donors,Multiple groups,900,4.80%,3.00%,6.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_22-24Jun2020,"January 27, 2022",National,Belgium,BEL,,,"June 22, 2020","June 24, 2020",Blood donors,Multiple groups,900,5.90%,4.30%,7.80%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_23-25Nov2020,"January 27, 2022",National,Belgium,BEL,,,"November 23, 2020","November 25, 2020",Blood donors,Multiple groups,900,16.40%,13.10%,20.30%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_27-29Apr2020,"January 27, 2022",National,Belgium,BEL,,,"April 27, 2020","April 29, 2020",Blood donors,Multiple groups,900,5.00%,3.40%,6.70%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_3-5Aug2020,"January 27, 2022",National,Belgium,BEL,,,"August 3, 2020","August 5, 2020",Blood donors,Multiple groups,869,4.80%,3.10%,6.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_17-19Aug2020,"January 27, 2022",National,Belgium,BEL,,,"August 17, 2020","August 19, 2020",Blood donors,Multiple groups,900,6.00%,4.20%,7.90%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_26-28Oct2020,"January 27, 2022",National,Belgium,BEL,,,"October 26, 2020","October 28, 2020",Blood donors,Multiple groups,900,9.20%,6.80%,12.00%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_21Dec2020,"January 27, 2022",National,Belgium,BEL,,,"December 21, 2020","December 21, 2020",Blood donors,Multiple groups,900,19.60%,15.50%,24.50%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_14-16Apr2020,"January 27, 2022",National,Belgium,BEL,,,"April 14, 2020","April 16, 2020",Blood donors,Multiple groups,900,5.30%,3.50%,6.60%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_14-16Sep2020,"January 27, 2022",National,Belgium,BEL,,,"September 14, 2020","September 16, 2020",Blood donors,Multiple groups,900,4.40%,2.80%,6.20%,Convenience,,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/16/2022,2/16/2022,Unverified
220127_Belgium_Sciensano_Primary_3Dec2020-28Jan2021_Overall,"January 27, 2022",National,Belgium,BEL,,,"December 3, 2020","January 28, 2021",Students and Daycares,Children and Youth (0-17 years),479,11.00%,7.60%,15.90%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Secondary_3Dec2020-28Jan2021,"January 27, 2022",National,Belgium,BEL,,,"December 3, 2020","January 28, 2021",Students and Daycares,Children and Youth (0-17 years),451,13.60%,9.90%,18.50%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Primary_20Sep-8Oct2021,"January 27, 2022",National,Belgium,BEL,,,"September 20, 2021","October 8, 2021",Students and Daycares,Children and Youth (0-17 years),478,26.60%,21.50%,32.80%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Primary_6-17Dec2021_Overall,"January 27, 2022",National,Belgium,BEL,,,"December 6, 2021","December 17, 2021",Students and Daycares,Children and Youth (0-17 years),432,50.90%,,,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Primary_1-26Mar2021_Overall,"January 27, 2022",National,Belgium,BEL,,,"March 1, 2021","March 26, 2021",Students and Daycares,Children and Youth (0-17 years),648,17.10%,13.30%,21.90%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Secondary_17May-11Jun2021,"January 27, 2022",National,Belgium,BEL,,,"May 17, 2021","June 11, 2021",Students and Daycares,Children and Youth (0-17 years),525,17.20%,13.10%,22.70%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_SchoolStaff_3Dec2020-28Jan2021,"January 27, 2022",National,Belgium,BEL,,,"December 3, 2020","January 28, 2021",Essential non-healthcare workers,Adults (18-64 years),629,14.80%,12.20%,18.00%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_SchoolStaff_17May-11Jun2021,"January 27, 2022",National,Belgium,BEL,,,"May 17, 2021","June 11, 2021",Essential non-healthcare workers,Adults (18-64 years),643,38.00%,33.40%,43.30%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_SchoolStaff_1-26Mar2021,"January 27, 2022",National,Belgium,BEL,,,"March 1, 2021","March 26, 2021",Essential non-healthcare workers,Adults (18-64 years),691,19.00%,16.10%,22.30%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Secondary_1-26Mar2021,"January 27, 2022",National,Belgium,BEL,,,"March 1, 2021","March 26, 2021",Students and Daycares,Children and Youth (0-17 years),515,18.00%,13.60%,23.80%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_Primary_17May-11Jun2021,"January 27, 2022",National,Belgium,BEL,,,"May 17, 2021","June 11, 2021",Students and Daycares,Children and Youth (0-17 years),664,15.40%,12.20%,19.60%,Stratified probability,EUROIMMUN,ELISA,IgG,95.90%,98.60%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_PHCPs_13-26Dec2021,"January 27, 2022",National,Belgium,BEL,,,"December 13, 2021","December 26, 2021",Health care workers and caregivers,Adults (18-64 years),2498,93.90%,,,Convenience,"Zhejiang Orient Gene Biotech,Roche Diagnostics,Siemens,DiaSorin",Multiple Types,"IgG,IgM,IgA",,,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_HCWs_21-25Apr2021,"January 27, 2022",National,Belgium,BEL,,,"April 21, 2021","April 25, 2021",Health care workers and caregivers,Adults (18-64 years),304,96.70%,93.40%,98.40%,Stratified probability,EUROIMMUN,ELISA,IgG,93.00%,99.00%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/17/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_29Jul-31Aug2021,"January 27, 2022",National,Belgium,BEL,,,"July 29, 2021","August 31, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1385,68.00%,64.00%,72.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_1Feb-24Mar2021,"January 27, 2022",National,Belgium,BEL,,,"February 1, 2021","March 24, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1624,69.00%,63.00%,74.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_31Mar-1May2021,"January 27, 2022",National,Belgium,BEL,,,"March 31, 2021","May 1, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1553,90.00%,87.00%,92.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_27Sep-28Oct2021,"January 27, 2022",National,Belgium,BEL,,,"September 27, 2021","October 28, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1347,69.00%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_1Feb-24Mar2021,"January 27, 2022",National,Belgium,BEL,,,"February 1, 2021","March 24, 2021",Assisted living and long-term care facilities,Adults (18-64 years),1337,80.00%,76.00%,83.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_27Sep-28Oct2021,"January 27, 2022",National,Belgium,BEL,,,"September 27, 2021","October 28, 2021",Assisted living and long-term care facilities,Adults (18-64 years),1012,80.00%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_30May-30Jun2021,"January 27, 2022",National,Belgium,BEL,,,"May 30, 2021","June 30, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1480,86.00%,83.00%,88.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_29Jul-31Aug2021,"January 27, 2022",National,Belgium,BEL,,,"July 29, 2021","August 31, 2021",Assisted living and long-term care facilities,Adults (18-64 years),1012,86.00%,83.00%,89.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_31Mar-1May2021,"January 27, 2022",National,Belgium,BEL,,,"March 31, 2021","May 1, 2021",Assisted living and long-term care facilities,Adults (18-64 years),1290,92.00%,90.00%,94.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_30May-30Jun2021,"January 27, 2022",National,Belgium,BEL,,,"May 30, 2021","June 30, 2021",Assisted living and long-term care facilities,Adults (18-64 years),1184,94.00%,92.00%,95.00%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,2/18/2022,3/2/2024,Unverified
220121_Leuven_UniversityOfOxford,"January 21, 2022",Local,Belgium,BEL,,Leuven,"May 26, 2020","September 24, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,862,5.68%,,,Convenience,"Roche Diagnostics,Siemens",Not reported,Total Antibody,,,High,Presentation or Conference,S Y Wong,University of Oxford,https://dx.doi.org/10.1093/ecco-jcc/jjab232.469,3/9/2022,3/2/2024,Unverified
220302_Flanders_GhentUniversity_Residents,"March 2, 2022",Regional,Belgium,BEL,Region of Flanders,,"October 19, 2020","November 13, 2020",Assisted living and long-term care facilities,Seniors (65+ years),615,18.90%,15.90%,22.20%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heidi Janssens,Ghent University,https://dx.doi.org/10.1017/S095026882200036X,3/10/2022,3/2/2024,Unverified
220302_Flanders_GhentUniversity_Staff,"March 2, 2022",Regional,Belgium,BEL,Region of Flanders,,"October 19, 2020","November 13, 2020",Health care workers and caregivers,Adults (18-64 years),478,14.90%,11.90%,18.40%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heidi Janssens,Ghent University,https://dx.doi.org/10.1017/S095026882200036X,3/10/2022,3/2/2024,Unverified
220306_Belgium_UniversityofAntwerp_c1_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"March 30, 2020","April 5, 2020",Residual sera,Multiple groups,3910,1.83%,1.00%,2.61%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c2_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"April 20, 2020","April 26, 2020",Residual sera,Multiple groups,3397,5.25%,4.22%,6.35%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c3_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"May 18, 2020","May 25, 2020",Residual sera,Multiple groups,3242,6.20%,5.05%,7.31%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c4_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"June 8, 2020","June 13, 2020",Residual sera,Multiple groups,2960,4.74%,3.65%,5.85%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c5_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"June 29, 2020","July 4, 2020",Residual sera,Multiple groups,3023,3.66%,2.64%,4.70%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c6_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"September 7, 2020","September 12, 2020",Residual sera,Multiple groups,3047,3.28%,2.29%,4.32%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220306_Belgium_UniversityofAntwerp_c7_OverallPopAdj,"March 3, 2022",National,Belgium,BEL,,,"October 12, 2020","October 17, 2020",Residual sera,Multiple groups,2966,4.18%,3.12%,5.20%,Stratified probability,EUROIMMUN,ELISA,IgG,84.90%,98.70%,Moderate,Journal Article (Peer-Reviewed),Sereina Herzog,University of Antwerp,https://dx.doi.org/10.2807/1560-7917.ES.2022.27.9.2100419,3/23/2022,8/15/2023,Unverified
220325_Liege_CHUofLiege_Phase3,"March 25, 2022",Local,Belgium,BEL,,Liege,"July 5, 2020","August 5, 2020",Health care workers and caregivers,Multiple groups,2498,11.50%,,,Convenience,DiaSorin,CLIA,IgG,,99.30%,High,Journal Article (Peer-Reviewed),Pascale Huynen,CHU of Liege,https://dx.doi.org/10.1038/s41598-022-09215-8,4/5/2022,3/2/2024,Unverified
220401_Belgium_UniversityHospitalsLeuven_antiN/S,"April 1, 2022",Local,Belgium,BEL,Flemish Brabant,Leuven,"May 1, 2020","March 18, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,168,5.40%,,,Entire sample,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Jef Verbeek,University Hospitals Leuven,https://journals.lww.com/transplantjournal/Fulltext/2022/04000/Liver_or_Kidney_Transplantation_After_SARS_CoV_2.29.aspx,4/12/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_10-11Oct2021,"January 27, 2022",National,Belgium,BEL,,,"October 10, 2021","October 11, 2021",Blood donors,Multiple groups,1192,99.00%,,,Convenience,NA,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,5/17/2022,7/17/2022,Unverified
220127_Belgium_Sciensano_06-08Dec2021,"January 27, 2022",National,Belgium,BEL,,,"December 6, 2021","December 8, 2021",Blood donors,Multiple groups,1122,100.00%,,,Convenience,NA,Not reported,Total Antibody,,,High,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,5/17/2022,7/17/2022,Unverified
220613_Liege_CHUofLiege_Phase1_Overall,"June 13, 2022",Local,Belgium,BEL,,Liege,"April 6, 2020","May 5, 2020",Multiple populations,Multiple groups,3776,8.90%,,,Convenience,DiaSorin,CLIA,IgG,100.00%,97.90%,High,Journal Article (Peer-Reviewed),Celine Gregoire,CHU of Liege,https://doi.org/10.1038/s41598-022-13450-4,6/21/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeStaff_26Nov-27Dec2021,"January 27, 2022",National,Belgium,BEL,,,"November 26, 2021","December 27, 2021",Assisted living and long-term care facilities,Adults (18-64 years),876,88.10%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,6/23/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_26Nov-27Dec2021,"January 27, 2022",National,Belgium,BEL,,,"November 26, 2021","December 27, 2021",Assisted living and long-term care facilities,Seniors (65+ years),1199,97.70%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,6/23/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_28Feb-22Mar2022,"January 27, 2022",National,Belgium,BEL,,,"February 28, 2022","March 24, 2022",Assisted living and long-term care facilities,Seniors (65+ years),472,99.60%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,6/23/2022,3/2/2024,Unverified
220713_Belgium_UCLouvain_Children,"July 13, 2022",Regional,Belgium,BEL,Wallonia and Brussels-Capital Regions,Angleur; Berchem-Ste Agathe; Jette; Koekelberg; Herve; Seraing; Beauraing; Châtelineau; La Hulpe; Farciennes,"January 14, 2021","May 18, 2021",Students and Daycares,Children and Youth (0-17 years),922,21.26%,,,Stratified non-probability,"Avioq Bio-Tech, Shandong, China",LFIA,"IgG,IgM",68.80%,95.80%,High,Preprint,Kelly Cremer,Université catholique de Louvain (UCLouvain),https://doi.org/10.21203/rs.3.rs-1781857/v1,7/19/2022,7/19/2022,Unverified
220713_Belgium_UCLouvain_SchoolStaff,"July 13, 2022",Regional,Belgium,BEL,Wallonia and Brussels-Capital Regions,Angleur; Berchem-Ste Agathe; Jette; Koekelberg; Herve; Seraing; Beauraing; Châtelineau; La Hulpe; Farciennes,"January 14, 2021","May 18, 2021",Essential non-healthcare workers,Adults (18-64 years),240,28.33%,,,Stratified non-probability,"Avioq Bio-Tech, Shandong, China",LFIA,"IgG,IgM",68.80%,95.80%,High,Preprint,Kelly Cremer,Université catholique de Louvain (UCLouvain),https://doi.org/10.21203/rs.3.rs-1781857/v1,7/19/2022,7/19/2022,Unverified
220714_Charleroi_GrandHopitalDeCharleroi_Summer2020_Overall,"July 14, 2022",Local,Belgium,BEL,Walloon Region,Charleroi,"June 20, 2020","August 11, 2020",Health care workers and caregivers,Multiple groups,2817,10.72%,9.63%,11.92%,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Nathalie de Visscher,Grand Hôpital de Charleroi,https://dx.doi.org/10.3390/v14071535,8/3/2022,3/2/2024,Unverified
220714_Charleroi_GrandHopitalDeCharleroi_Winter2021_Overall,"July 14, 2022",Local,Belgium,BEL,Walloon Region,Charleroi,"February 6, 2021","March 31, 2021",Health care workers and caregivers,Multiple groups,1191,33.92%,31.29%,36.66%,Convenience,DiaSorin,Not reported,IgG,,,High,Journal Article (Peer-Reviewed),Nathalie de Visscher,Grand Hôpital de Charleroi,https://dx.doi.org/10.3390/v14071535,8/3/2022,3/2/2024,Unverified
220127_Belgium_Sciensano_NursingHomeResidents_25May-22Jun2022,"January 27, 2022",National,Belgium,BEL,,,"May 25, 2022","June 22, 2022",Assisted living and long-term care facilities,Seniors (65+ years),428,99.60%,,,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",92.90%,96.30%,Moderate,Institutional Report,Sciensano,Sciensano,https://datastudio.google.com/embed/u/0/reporting/7e11980c-3350-4ee3-8291-3065cc4e90c2/page/ZwmOB,8/11/2022,3/2/2024,Unverified
220808_Liege_UniversityOfLiegeHospital_Period1_Primary,"August 8, 2022",Local,Belgium,BEL,Wallonia,Liege,"March 1, 2020","September 30, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,525,2.86%,,,Sequential,DiaSorin,CLIA,IgG,89.00%,97.80%,High,Journal Article (Peer-Reviewed),Louis Firket,University of Liege Hospital,https://dx.doi.org/10.1080/17843286.2022.2108978,8/18/2022,3/2/2024,Unverified
220808_Liege_UniversityOfLiegeHospital_Period2_Primary,"August 8, 2022",Local,Belgium,BEL,Wallonia,Liege,"October 1, 2020","May 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,471,4.67%,,,Sequential,DiaSorin,CLIA,IgG,89.00%,97.80%,High,Journal Article (Peer-Reviewed),Louis Firket,University of Liege Hospital,https://dx.doi.org/10.1080/17843286.2022.2108978,8/18/2022,3/2/2024,Unverified
220817_UniversiteLibredeBruxelles_Brussels_Overall,"August 17, 2022",Local,Belgium,BEL,,Brussels,"September 15, 2020","December 31, 2020",Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),42,31.00%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Benedetta Chiodini,Vrije Universiteit Brussel,https://dx.doi.org/10.1007/s00467-022-05702-2,9/1/2022,9/23/2022,Unverified
230418_Belgium_Sciensano_2022Feb21-Mar20,"April 18, 2023",National,Belgium,BEL,,,"February 21, 2022","March 20, 2022",Household and community samples,Multiple groups,242,92.30%,86.80%,97.90%,Stratified probability,Beijing Wantai Biological,ELISA,IgG,95.10%,96.70%,,Preprint,Johan Van der Heyden,Sciensano,http://doi.org/10.21203/rs.3.rs-2802349/v1,5/9/2023,3/2/2024,Unverified
230330_Belgium_UniversityOfAntwerp,"March 30, 2023",National,Belgium,BEL,,,"December 24, 2020","December 26, 2021",Health care workers and caregivers,Adults (18-64 years),1073,24.90%,,,Convenience,"Roche Diagnostics,Siemens,DiaSorin",Multiple Types,"IgG,IgM,IgA",,,,Journal Article (Peer-Reviewed),Julie Domen,University of Antwerp,https://dx.doi.org/10.1136/bmjopen-2022-069997,6/3/2023,3/2/2024,Unverified
230624_Belgium_MountSinai,"June 24, 2023",National,Belgium,BEL,,,"May 15, 2020","December 15, 2021",Patients seeking care for non-COVID-19 reasons,Multiple groups,862,6.73%,,,Convenience,Roche Diagnostics,LFIA,"IgG,IgM",,,,Journal Article (Peer-Reviewed),Serre-Yu Wong,Mount Sinai,https://dx.doi.org/10.1093/ibd/izad097,8/3/2023,3/2/2024,Unverified
230807_Belgium_GhentUniversityHospital_Overall,"August 7, 2023",Local,Belgium,BEL,East Flanders province,Ghent,"November 1, 2020","September 30, 2021",Residual sera,Children and Youth (0-17 years),525,9.70%,7.50%,12.60%,Convenience,Abbott Laboratories,CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Levi Hoste,Ghent University Hospital,https://dx.doi.org/10.3389/fped.2023.1210181,9/16/2023,3/2/2024,Unverified
211031_Belarus_StPetersburgPasteurInstitute_Overall,"October 31, 2021",National,Belarus,BLR,,,"May 14, 2021","May 19, 2021",Household and community samples,Multiple groups,12926,38.40%,37.60%,45.50%,Simplified probability,NA,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Anna Popova,St. Petersburg Pasteur Institute,https://dx.doi.org/10.15789/2220-7619-HIT-1798,1/14/2022,7/17/2022,Unverified
210905_Razarbag_BRACUniversity_GroupII_Overall,"September 5, 2021",Local,Bangladesh,BGD,Dhaka District,Dhaka,"May 15, 2020","June 15, 2020",Residual sera,Multiple groups,100,20.00%,,,Stratified non-probability,NA,LFIA,IgG,,96.00%,High,Journal Article (Peer-Reviewed),Md Ahsanul Haq,BRAC University,http://dx.doi.org/10.3329/BJMS.V20I5.55407,10/13/2021,7/17/2022,Verified
220110_SitakundaSubdistrict_icddrb_Overall_PopTestClusterAdj,"January 10, 2022",Local,Bangladesh,BGD,,Sitakunda subdistrict,"March 27, 2021","June 13, 2021",Household and community samples,Multiple groups,2307,64.10%,60.00%,68.10%,Stratified probability,Beijing Wantai Biological,ELISA,"IgA,IgM,IgG",87.70%,99.10%,Low,Journal Article (Peer-Reviewed),Taufiqur Bhuiyan,"icddr,b [International Centre for Diarrhoeal Disease Research, Bangladesh]",https://dx.doi.org/10.3201/eid2802.211689,2/2/2022,8/15/2023,Verified
220127_Dhaka_BRiCM,"January 27, 2022",Local,Bangladesh,BGD,,Dhaka,"October 15, 2020","February 15, 2021",Household and community samples,Adults (18-64 years),239,42.20%,,,Convenience,Erba Manneim,ELISA,IgG,98.30%,98.10%,High,Journal Article (Peer-Reviewed),Zabed Ahmed,Bangladesh Reference Institute for Chemical Measurements ,https://dx.doi.org/10.1155/2022/4451144,2/8/2022,3/2/2024,Verified
220209_Chattogram_ChattogramVeterinaryandAnimalSciencesUniversity_Overall_TestAdjusted,"February 9, 2022",Local,Bangladesh,BGD,Chittagong Division,Chattogram,"February 15, 2021","September 15, 2021",Multiple populations,Multiple groups,748,66.99%,63.40%,70.40%,Stratified probability,Kewei Diagnostic,ELISA,IgG,93.80%,97.30%,High,Preprint,Jahan Ara,Chattogram Veterinary and Animal Sciences University,https://www.medrxiv.org/content/10.1101/2022.02.09.22270717v1.full-text,2/18/2022,8/15/2023,Unverified
220325_Dhaka_icddrb_Day28_HighDensity_IgG,"March 25, 2022",Local,Bangladesh,BGD,,Dhaka,"June 27, 2020","September 26, 2020",Contacts of COVID patients,Multiple groups,442,63.35%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Syed Moinuddin Satter,"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)",https://dx.doi.org/10.3390/tropicalmed7040053,5/2/2022,7/17/2022,Unverified
220325_Dhaka_icddrb_Day28_LowDensity_IgG,"March 25, 2022",Local,Bangladesh,BGD,,Dhaka,"June 27, 2020","September 26, 2020",Contacts of COVID patients,Multiple groups,118,65.25%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Syed Moinuddin Satter,"International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)",https://dx.doi.org/10.3390/tropicalmed7040053,5/2/2022,7/17/2022,Unverified
220523_Bangladesh_icddrb_Overall,"May 23, 2022",National,Bangladesh,BGD,,"Dhaka, Chattogram","October 15, 2020","February 15, 2021",Household and community samples,Multiple groups,3220,67.30%,65.20%,69.30%,Stratified probability,Roche Diagnostics,Not reported,"IgG,IgM",93.30%,100.00%,Moderate,Journal Article (Peer-Reviewed),Rubhana Raqib,icddrb,https://dx.doi.org/10.1371/journal.pone.0268093,6/2/2022,3/30/2024,Verified
220202_Bangladesh_InternationalCentreforDiarrhoealDiseaseResearch,"February 2, 2022",National,Bangladesh,BGD,,,"April 15, 2020","October 15, 2020",Household and community samples,Multiple groups,2582,30.40%,24.00%,37.00%,Simplified probability,NA,ELISA,"IgG,IgM",100.00%,98.00%,Low,Journal Article (Peer-Reviewed),Taufiqur Bhuiyan,International Centre for Diarrhoeal Disease Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809641/,6/30/2022,1/20/2024,Verified
220723_Bangladesh_JohnsHopkins_Mothers,"July 23, 2022",Local,Bangladesh,BGD,Sylhet Division,Zakiganj Upazila,"March 1, 2021","July 31, 2021",Perinatal,Adults (18-64 years),2041,35.80%,33.70%,37.90%,Unclear,NA,Not reported,Not reported,99.50%,99.80%,,Journal Article (Peer-Reviewed),Rasheda Khanam,Johns Hopkins,https://dx.doi.org/10.7189/jogh.12.05030,8/9/2022,2/2/2024,Unverified
221107_Bangladesh_QuestBangladesh_overall,"November 7, 2022",Local,Bangladesh,BGD,,Dhaka,"July 15, 2021","December 15, 2021",Non-essential workers and unemployed persons,Adults (18-64 years),402,81.00%,,,Convenience,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,IgG,,,High,Preprint,Abu Syed Mosa,Quest Bangladesh, https://doi.org/10.21203/rs.3.rs-2238518/v1,11/17/2022,3/2/2024,Unverified
221101_Cox'sBazar_InstituteOfEpidemiologyDiseaseControlAndResearch_PopTestAdj,"November 1, 2022",Local,Bangladesh,BGD,Chittagong Division,Cox's Bazar,"December 1, 2020","December 31, 2020",Persons living in slums,Multiple groups,3446,48.30%,45.30%,51.40%,Stratified probability,NA,ELISA,"IgM,IgG",97.80%,99.80%,Moderate,Journal Article (Peer-Reviewed),Mahbubur Rahman,Institute of Epidemiology Disease Control and Research,https://dx.doi.org/10.1136/bmjopen-2022-066653,12/16/2022,3/25/2024,Verified
221212_USA_RTIInternational_Bangladesh,"December 12, 2022",National,Bangladesh,BGD,,,"November 1, 2020","November 30, 2020",Pregnant or parturient women,Adults (18-64 years),2049,22.50%,,,Convenience,Zeus,,,,,High,Journal Article (Peer-Reviewed),Robert L. Goldenberg,RTI International,https://dx.doi.org/10.1111/1471-0528.17366,12/25/2022,3/2/2024,Unverified
221121_Dhaka_BangladeshMedicalCollegeHospital,"November 21, 2022",Local,Bangladesh,BGD,Dhaka Division,Dhaka,"July 15, 2021","August 15, 2021",Health care workers and caregivers,Adults (18-64 years),251,17.10%,,,Unclear,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Tarek Alam,Shomman Foundation,https://dx.doi.org/10.4103/ecdt.ecdt_7_22,1/26/2023,3/20/2023,Unverified
230417_Bangladesh_UniversityOfDhaka,"April 17, 2023",National,Bangladesh,BGD,,,"August 25, 2021","October 1, 2021",Household and community samples,Multiple groups,753,58.30%,,,Convenience,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Abdullah Al Saba,University Of Dhaka,https://dx.doi.org/10.1016/j.jiph.2023.04.013,5/17/2023,6/3/2023,Unverified
230720_Bangladesh_JawaharlalNehruMedicalCollege_Overall,"July 20, 2023",National,Bangladesh,BGD,,,"October 1, 2020","June 30, 2022",Pregnant or parturient women,Adults (18-64 years),2976,35.60%,,,Stratified non-probability,NA,Not reported,Not reported,,,,Journal Article (Peer-Reviewed),Avinash Kavi,Jawaharlal Nehru Medical College,https://dx.doi.org/10.1111/1471-0528.17604,8/23/2023,8/23/2023,Unverified
220115_Azerbaijan_WorldHealthOrganization_Overall,"January 15, 2023",Local,Azerbaijan,AZE,,Buka,"May 3, 2021","July 11, 2021",Health care workers and caregivers,Multiple groups,1582,90.00%,,,Convenience,"Bio-rad,Beijing Wantai Biological",ELISA,Total Antibody,,,,Preprint,Mark Katz,World Health Organization,http://doi.org/10.22541/au.167394784.44174107/v1,2/11/2023,3/2/2024,Unverified
200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,"July 20, 2020",Regional,Austria,AUT,Tyrol,,"March 20, 2020","March 27, 2020",Health care workers and caregivers,Adults (18-64 years),377,0.30%,0.01%,1.50%,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Dorothea Orth-Holler,Innsbruck Clinical Microbiology Laboratory,https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690,8/1/2020,3/2/2024,Verified
200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM,"August 19, 2020",Local,Austria,AUT,,,"April 1, 2020","April 30, 2020",Health care workers and caregivers,Adults (18-64 years),130,2.30%,,,Convenience,"Epitope Diagnostics, Inc.",ELISA,"IgG,IgM",,,High,Preprint,Klaus Hackner,Karl Landsteiner University of Health Sciences,https://www.researchsquare.com/article/rs-50887/v1,10/19/2020,3/2/2024,Verified
200808_Vienna_MedicalUniversityOfVienna_HCP,"September 2, 2020",Local,Austria,AUT,Vienna,Vienna,"April 1, 2020","June 4, 2020",Health care workers and caregivers,Adults (18-64 years),62,3.20%,0.40%,11.20%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/6/2020,3/2/2024,Verified
200808_Vienna_MedicalUniversityOfVienna_Patients,"September 2, 2020",Local,Austria,AUT,Vienna,Vienna,"March 21, 2020","June 4, 2020",Patients seeking care for non-COVID-19 reasons,Multiple groups,84,2.40%,0.30%,8.30%,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,"Total Antibody,IgG",,,High,Journal Article (Peer-Reviewed),Thorsten Fuereder,Medical University of Vienna,https://dx.doi.org/10.1136/esmoopen-2020-000889,11/6/2020,3/2/2024,Verified
201222_Vienna_MedicalUniversityofVienna_Overall,"December 22, 2020",Local,Austria,AUT,Vienna,Vienna,"April 2, 2020","April 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1655,10.15%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,High,Preprint,Angelika Wagner,Medical University of Vienna,https://www.medrxiv.org/content/10.1101/2020.12.22.20248604v1,1/24/2021,3/2/2024,Verified
210129_Vienna_MedicalUniversityOfVienna_Overall,"January 29, 2021",Local,Austria,AUT,Vienna,Vienna,"May 18, 2020","July 2, 2020",Students and Daycares,Children and Youth (0-17 years),2042,1.27%,,,Convenience,"Beijing Wantai Biological,NA,EUROIMMUN",Multiple Types,"Total Antibody,IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Zsolt Szepfalusi,Medical University of Vienna,https://dx.doi.org/10.1111/pai.13459,2/16/2021,3/2/2024,Unverified
210203_Austria_MedicalUniversityOfVienna_Overall,"February 3, 2021",National,Austria,AUT,,,"May 11, 2020","December 21, 2020",Health care workers and caregivers,Adults (18-64 years),3301,0.51%,,,Convenience,"DiaSorin,Roche Diagnostics",Multiple Types,"IgA,IgM,IgG",,,High,Preprint,Iris Leister,Medical University of Vienna,10.1101/2021.02.01.21250898,2/18/2021,3/2/2024,Verified
210107_Austria_UniversityCollegeLondon_PaediatricHCW,"January 27, 2021",Local,Austria,AUT,,Vienna,"July 17, 2020","July 24, 2020",Health care workers and caregivers,Adults (18-64 years),196,0.00%,0.00%,1.92%,Convenience,"Epitope Diagnostics, Inc.,Meso Scale Discovery",ELISA,IgG,,,High,Journal Article (Peer-Reviewed),D Goldblatt,University College London,http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/14/2021,3/2/2024,Unverified
210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW,"January 8, 2021",Local,Austria,AUT,Upper Austria,Linz,"June 15, 2020","July 15, 2020",Health care workers and caregivers,Adults (18-64 years),1757,2.00%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Margot Egger,Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz  ,https://dx.doi.org/10.1515/cclm-2020-1681,3/20/2021,3/2/2024,Verified
210212_Ischgl_MedicalUniversityofInnsbruck_overall,"February 12, 2021",Local,Austria,AUT,Tyrol,Ischgl,"April 21, 2020","April 27, 2020",Household and community samples,Multiple groups,451,43.70%,,,Entire sample,"Abbott Laboratories,EUROIMMUN,NA",Multiple Types,"IgG,IgA",,,High,Journal Article (Peer-Reviewed),Jens Lehmann, Medical University of Innsbruck,https://dx.doi.org/10.1017/S0950268821000418,3/28/2021,3/2/2024,Verified
210409_Vienna_MedicalUniversityofVienna,"April 9, 2021",Local,Austria,AUT,Vienna,Vienna,"March 22, 2020","March 31, 2020",Health care workers and caregivers,Adults (18-64 years),235,25.50%,20.40%,31.50%,Convenience,NA,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Thomas Reiter,Medical University of Vienna,https://dx.doi.org/10.1007/s00508-021-01848-5,4/24/2021,7/17/2022,Unverified
210404_Vienna_MedicalUniversityofVienna_Overall_2months,"April 15, 2021",Local,Austria,AUT,Vienna,Vienna,"April 1, 2020","June 1, 2020",Health care workers and caregivers,Adults (18-64 years),553,1.50%,,,Convenience,Abbott Laboratories,Other,IgG,,,High,Journal Article (Peer-Reviewed),Lorenz Schubert,Medical University of Vienna,http://dx.doi.org/10.3390/ijerph18084201,5/17/2021,3/2/2024,Verified
201211_Austria_StatistikAustria_overall_PopAdj,"December 11, 2020",National,Austria,AUT,,,"November 12, 2020","November 14, 2020",Household and community samples,Multiple groups,2229,4.70%,3.80%,5.60%,Simplified probability,NA,Multiple Types,Not reported,,,Moderate,Institutional Report,Statistik Austria,StatistikAustria,http://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&dDocName=124957,5/21/2021,7/17/2022,Unverified
210428_Austria_HanuschHospital,"April 28, 2021",National,Austria,AUT,,,"July 1, 2020","July 31, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),7858,1.12%,0.90%,1.38%,Convenience,"Abbott Laboratories,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Johann Bartko,Hanusch Hospital,https://dx.doi.org/10.3390/jcm10091909,5/22/2021,3/2/2024,Verified
210512_Vienna_LudwigBoltzmannInstituteForLungHealth_overall,"May 12, 2021",Local,Austria,AUT,,Vienna,"April 20, 2020","May 20, 2020",Household and community samples,Multiple groups,12419,1.31%,,,Stratified probability,"Roche Diagnostics,EUROIMMUN,NA",Multiple Types,"IgG,Neutralizing ",,,Moderate,Journal Article (Peer-Reviewed),Marie Kathrin Breyer,Ludwig Boltzmann Institute for Lung Health,https://dx.doi.org/10.1038/s41598-021-89711-5,5/28/2021,3/2/2024,Verified
201212_Europe_UniversityOfGlasgow_Austria3,"December 12, 2020",National,Austria,AUT,,"Klagenfurt, Vienna and Wels","April 15, 2020","June 30, 2020",Health care workers and caregivers,Adults (18-64 years),72,2.78%,0.77%,9.58%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.60%,High,Journal Article (Peer-Reviewed),Scott M Nelson,University of Glasgow,https://dx.doi.org/10.1093/hropen/hoaa056,6/7/2021,3/2/2024,Verified
210811_Ischgl_MedicalUniversityOfInnsbruck,"August 1, 2021",Local,Austria,AUT,Tyrol,Ischgl,"November 2, 2020","November 8, 2020",Household and community samples,Adults (18-64 years),801,45.40%,42.00%,49.00%,Convenience,"EUROIMMUN,Abbott Laboratories,Roche Diagnostics,NA",Multiple Types,"IgG,IgA",,,Moderate,Journal Article (Peer-Reviewed),Wegene Borena,Medical University Of Innsbruck,https://dx.doi.org/10.1016/j.ebiom.2021.103534,8/29/2021,3/2/2024,Verified
210616_Austria_UniversityHospitalOfSalzburg_Overall,"June 16, 2021",National,Austria,AUT,,,"June 5, 2020","December 4, 2020",Blood donors,Multiple groups,20228,2.50%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,100.00%,99.81%,Low,Journal Article (Peer-Reviewed),Lisa Weidner, University Hospital of Salzburg,https://dx.doi.org/10.1007/s15010-021-01639-0,9/9/2021,3/2/2024,Verified
211026_Tyrol_TirolKlinikenGmbH_Abbott_Primary,"October 26, 2021",Regional,Austria,AUT,"Tyrol
",,"June 8, 2020","September 4, 2020",Blood donors,Multiple groups,5345,3.10%,2.60%,3.60%,Convenience,Abbott Laboratories,CLIA,IgG,100.00%,99.63%,Moderate,Journal Article (Peer-Reviewed),Anita Siller,Tirol Kliniken GmbH,https://dx.doi.org/10.1007/s00508-021-01963-3,11/4/2021,3/2/2024,Unverified
220309_Tyrol_MedicalUniversityofInnsbruck_Overall_UnAdj,"March 9, 2022",Regional,Austria,AUT,Tyrol,,"March 19, 2021","September 30, 2021",Blood donors,Multiple groups,19792,63.24%,,,Sequential,Abbott Laboratories,CLIA,IgG,99.35%,99.60%,Moderate,Journal Article (Peer-Reviewed),Anita Siller,Medical University of Innsbruck ,https://dx.doi.org/10.3390/v14030568,4/8/2022,3/2/2024,Verified
220411_Austria_LKHHochsteiermarkLeobenVordernbergerstr_Primary,"April 21, 2022",Local,Austria,AUT,,Vienna,"November 30, 2021","January 13, 2022",Multiple populations,Multiple groups,1217,21.70%,17.60%,25.40%,Unclear,Viramed Biotech AG,IFA,IgG,,,High,Presentation or Conference,Reinhold Kerbl,LKH Hochsteiermark Leoben Vordernbergerstr,https://dx.doi.org/10.1007/s00112-022-01491-y,5/3/2022,3/2/2024,Verified
210714_Vienna_MedicalUniversityofVienna_Overall,"July 14, 2021",Local,Austria,AUT,Vienna,Vienna,"April 2, 2020","April 17, 2020",Non-essential workers and unemployed persons,Adults (18-64 years),1655,10.15%,,,Convenience,EUROIMMUN,ELISA,"IgA,IgG",,,High,Journal Article (Peer-Reviewed),Angelika Wagner,Medical University of Vienna,https://dx.doi.org/10.1038/s43856-021-00012-4,6/3/2022,3/2/2024,Unverified
220524_Vorarlberg_VIVIT_t1,"May 24, 2022",Regional,Austria,AUT,Vorarlberg,,"June 26, 2020","August 19, 2020",Health care workers and caregivers,Adults (18-64 years),395,6.10%,,,Self-referral,Technoclone,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Michele Atzl,Vorarlberg Institute for Vascular Investigation and Treatment,https://dx.doi.org/10.1136/bmjopen-2021-052130,6/6/2022,3/2/2024,Unverified
220727_Weißenkirchen_DanubePrivateUniversity_Overall,"July 27, 2022",Local,Austria,AUT,,Weißenkirchen,"February 13, 2021","February 13, 2021",Household and community samples,Multiple groups,552,25.00%,,,Convenience,EUROIMMUN,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Heike Rebholz,Danube Private University,https://dx.doi.org/10.1371/journal.pone.0271382,8/4/2022,3/2/2024,Verified
220909_Tyrol_MedicalUniversityOfInnsbruck_AntiS,"September 9, 2022",Local,Austria,AUT,Tyrol,Schwaz,"March 1, 2021","March 31, 2021",Household and community samples,Multiple groups,2474,51.40%,,,Convenience,Abbott Laboratories,Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Peter Willeit,Medical University of Innsbruck ,https://dx.doi.org/10.3389/fpubh.2022.989337,10/5/2022,3/2/2024,Unverified
221019_Tyrol_MedicalUniversityOfInnsbruck_Overall,"October 19, 2022",Local,Austria,AUT,Tyrolean District,Schwaz,"May 1, 2021","August 30, 2021",Blood donors,Children and Youth (0-17 years),369,35.70%,,,Convenience,"Abbott Laboratories,Roche Diagnostics",CLIA,IgG,,,High,Journal Article (Peer-Reviewed),Teresa Harthaller,Medical University of Innsbruck,https://dx.doi.org/10.3390/v14102294,11/2/2022,3/2/2024,Unverified
230118_Vienna_MedicalUniversityOfVienna_HCWs_Overall,"January 18, 2023",Local,Austria,AUT,,Vienna,"August 24, 2020","November 23, 2021",Health care workers and caregivers,Adults (18-64 years),812,12.10%,10.00%,14.50%,Sequential,Roche Diagnostics,,,99.00%,99.00%,,Journal Article (Peer-Reviewed),Martin Riesenhuber,Medical University of Vienna,https://dx.doi.org/10.1136/bmjopen-2022-063760,2/11/2023,3/2/2024,Unverified
230118_Vienna_MedicalUniversityOfVienna_Patients_Overall,"January 18, 2023",Local,Austria,AUT,,Vienna,"August 24, 2020","November 23, 2021",Residual sera,Multiple groups,8451,7.79%,,,Sequential,Roche Diagnostics,,,99.00%,99.00%,,Journal Article (Peer-Reviewed),Martin Riesenhuber,Medical University of Vienna,https://dx.doi.org/10.1136/bmjopen-2022-063760,2/11/2023,3/2/2024,Unverified
211215_Austria_UniversityofAppliedScienceWienerNeustadt_NonVac,"December 15, 2021",Local,Austria,AUT,,Wiener Neustadt,"February 15, 2021","March 3, 2021",Multiple populations,Adults (18-64 years),311,11.30%,,,Self-referral,NA,ELISA,IgG,,,,Journal Article (Peer-Reviewed),Elisabeth Mara,University of Applied Science Wiener Neustadt,https://dx.doi.org/10.1016/j.clicom.2021.08.002,4/1/2023,4/12/2023,Unverified
230602_Vienna_MedicalUniversityofVienna,"June 2, 2023",Local,Austria,AUT,,Vienna,"May 15, 2020","March 15, 2021",Health care workers and caregivers,Adults (18-64 years),221,7.70%,,,Convenience,Roche Diagnostics,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Sebastian Jensen,Medical University of Vienna,https://dx.doi.org/10.1016/j.jiph.2023.05.041,8/2/2023,8/15/2023,Unverified
220825_Tyrol_MedicalUniversityOfInnsbruck_Overall,"August 25, 2022",Regional,Austria,AUT,"Tyrol
",,"October 1, 2021","April 28, 2022",Blood donors,Multiple groups,22607,91.90%,,,Convenience,Abbott Laboratories,CLIA,IgG,99.35%,99.60%,Moderate,Journal Article (Peer-Reviewed),Lisa Seekircher,Medical University of Innsbruck,https://doi.org/10.3390/v14091877,4/16/2024,4/16/2024,Unverified
200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting,"August 3, 2020",Regional,Australia,AUS,New South Wales,,"January 25, 2020","April 10, 2020",Contacts of COVID patients,Multiple groups,173,2.31%,,,Convenience,NA,Other,"IgG,IgA,IgM",91.30%,98.90%,Moderate,Journal Article (Peer-Reviewed),Kristine Macartney,University of Sydney,https://dx.doi.org/10.1016/S2352-4642(20)30251-0,10/17/2020,7/17/2022,Verified
210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj,"February 3, 2021",Local,Australia,AUS,New South Wales,Sydney,"April 20, 2020","May 22, 2020",Residual sera,Multiple groups,3231,0.15%,0.04%,0.41%,Stratified probability,NA,IFA,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,7/17/2022,Unverified
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,"February 3, 2021",Local,Australia,AUS,New South Wales,Sydney,"May 5, 2020","June 2, 2020",Blood donors,Adults (18-64 years),1548,0.29%,0.04%,0.75%,Stratified probability,NA,Other,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,7/17/2022,Unverified
210203_Sydney_Children'sHospitalAtWestmead_AntenatalScreening_overall_TestAdj,"February 3, 2021",Local,Australia,AUS,New South Wales,Sydney,"May 4, 2020","May 23, 2020",Pregnant or parturient women,Adults (18-64 years),560,0.79%,0.04%,1.88%,Stratified probability,NA,IFA,IgG,90.70%,99.30%,Moderate,Journal Article (Peer-Reviewed),Heather F Gidding,Children's Hospital at Westmead,https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,7/17/2022,Unverified
210109_Australia_AustralianNationalUniversity_overall_adj,"January 9, 2021",National,Australia,AUS,"New South Wales, South Australia, Victoria and Western Australia",,"June 2, 2020","July 17, 2020",Residual sera,Multiple groups,2991,0.16%,0.00%,0.47%,Sequential,NA,ELISA,IgG,100.00%,98.90%,Low,Journal Article (Peer-Reviewed),Nicholas Coatsworth ,Australian National University,https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564,3/20/2021,7/17/2022,Verified
210413_Melbourne_EasternHealth_OverallHCW,"August 1, 2021",Local,Australia,AUS,Victoria,Melbourne,"November 9, 2020","December 4, 2020",Health care workers and caregivers,Multiple groups,736,2.17%,,,Convenience,"Roche Diagnostics,NA",Multiple Types,IgG,,,Moderate,Journal Article (Peer-Reviewed),Jillian SY Lau,Eastern Health,https://dx.doi.org/10.1016/j.idh.2021.03.004,5/20/2021,3/2/2024,Verified
210703_Melbourne_RoyalChildrensHospital_Primary,"July 3, 2021",Local,Australia,AUS,,Melbourne,"October 21, 2020","October 30, 2020",Health care workers and caregivers,Adults (18-64 years),318,0.00%,,,Convenience,"DiaSorin,EUROIMMUN,GenScript,Beijing Wantai Biological",Multiple Types,"IgA,IgG,IgM",,,High,Journal Article (Peer-Reviewed),Jane Tuckerman,Royal Children's Hospital,https://dx.doi.org/10.1111/jpc.15585,7/13/2021,3/2/2024,Verified
211111_Australia_NSWWestmeadHospital_Primary,"November 11, 2021",National,Australia,AUS,"Australia (Western Australia, South Australia, Tasmania, Victoria
and the Australian Capital Territory) and countries (New Zealand)",,"January 24, 2020","July 31, 2020",Multiple populations,Multiple groups,10595,9.80%,,,Sequential,NA,IFA,"IgA,IgG,IgM",91.30%,98.90%,High,Journal Article (Peer-Reviewed),Tasnim Hasan,New South Wales Westmead Hospital,https://dx.doi.org/10.1111/1753-6405.13155,11/19/2021,7/17/2022,Verified
220131_Australia_UniversityOfSydney_Antenatal_Overall_TestAdjustment,"January 31, 2022",National,Australia,AUS,,,"June 19, 2020","August 6, 2020",Pregnant or parturient women,Adults (18-64 years),2972,0.23%,0.04%,0.54%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,2/23/2022,8/15/2023,Verified
220131_Australia_UniversityOfSydney_GeneralPathology_Overall_TestAdjustment,"January 31, 2022",National,Australia,AUS,,,"June 19, 2020","August 6, 2020",Residual sera,Multiple groups,5132,0.25%,0.03%,0.54%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,2/23/2022,8/15/2023,Verified
220131_Australia_UniversityOfSydney_BloodDonors_Overall_TestAdjustment,"January 31, 2022",National,Australia,AUS,,,"June 19, 2020","August 6, 2020",Blood donors,Multiple groups,3213,0.47%,0.04%,0.89%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Journal Article (Peer-Reviewed),Kaitlyn Vette,University of Sydney,https://dx.doi.org/10.1093/ofid/ofac002,2/23/2022,8/15/2023,Verified
220313_Melbourne_UniversityofNewSouthWales_OverallPopTestAdjust,"March 13, 2022",Local,Australia,AUS,Victoria,Metropolitan Melbourne,"November 23, 2020","December 17, 2020",Blood donors,Adults (18-64 years),4799,0.90%,,,Stratified probability,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,Moderate,Preprint,Dorothy Machalek,University of New South Wales,https://www.medrxiv.org/content/10.1101/2022.03.11.22272185v1.full-text,3/22/2022,8/15/2023,Verified
220416_NewSouthWales_DouglassHanlyMoirPathology,"April 16, 2022",Local,Australia,AUS,New South Wales and the Australian Capital Territory,,"July 9, 2020","September 19, 2021",Residual sera,Multiple groups,545,8.40%,,,Sequential,"Roche Diagnostics,Abbott Laboratories",CLIA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Michael Wehrhahn,Douglass Hanly Moir Pathology,https://dx.doi.org/10.1016/j.pathol.2022.03.001,4/29/2022,3/2/2024,Unverified
220521_Australia_UniversityOfSydney_ELISA_TestAdj_Overall,"May 21, 2022",National,Australia,AUS,Queensland; New South Wales; Victoria; South Australia; Western Australia.,Brisbane; Sydney; Melbourne; Adelaide; Perth.,"November 3, 2020","March 12, 2021",Residual sera,Children and Youth (0-17 years),1685,0.23%,0.06%,0.57%,Convenience,Beijing Wantai Biological,ELISA,Total Antibody,95.10%,99.60%,High,Journal Article (Peer-Reviewed),Archana Koirala,University of Sydney,https://dx.doi.org/10.5694/mja2.51542,6/5/2022,3/23/2024,Verified
220603_Australia_KirbyInstitute_antiS,"June 3, 2022",National,Australia,AUS,,,"February 23, 2022","March 3, 2022",Blood donors,Multiple groups,5185,98.10%,97.70%,98.50%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-february-march,8/5/2022,3/2/2024,Unverified
220726_Australia_KirbyInstitute_antiS,"July 26, 2022",National,Australia,AUS,,,"June 9, 2022","June 18, 2022",Blood donors,Multiple groups,5138,99.00%,98.70%,99.20%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/report/seroprevalence-sars-cov-2-specific-antibodies-among-australian-blood-donors-may-june-2022,8/5/2022,4/7/2024,Verified
210921_Australia_HarryPerkinsInstituteOfMedicalResearch,"September 21, 2022",Regional,Australia,AUS,,,"June 1, 2020","August 31, 2020",Health care workers and caregivers,Adults (18-64 years),799,0.38%,,,Convenience,NA,ELISA,IgG,,,High,Journal Article (Peer-Reviewed),Herbert Ludewick,Harry Perkins Institute of Medical Research,https://dx.doi.org/10.1007/s44197-022-00065-1,10/20/2022,10/20/2022,Unverified
220916_Australia_AustralianRedCrossLifeblood_antiS,"September 16, 2022",National,Australia,AUS,,,"February 23, 2022","March 3, 2022",Blood donors,Multiple groups,5177,98.10%,97.70%,98.50%,Simplified probability,Roche Diagnostics,CLIA,Not reported,,,High,Presentation or Conference,Rena Hirani,Australian Red Cross Lifeblood,https://dx.doi.org/10.1111/trf.17058,11/10/2022,4/12/2024,Verified
221103_Australia_KirbyInstitute_antiS,"November 3, 2022",National,Australia,AUS,,,"August 23, 2022","September 2, 2022",Blood donors,Multiple groups,5005,99.60%,99.30%,99.70%,Convenience,Roche Diagnostics,Not reported,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/project/serosurveillance-sars-cov-2-infection-inform-public-health-responses,11/15/2022,4/17/2024,Verified
221103_Australia_PAEDS_Overall,"November 3, 2022",National,Australia,AUS,"New South Wales, Victoria, South Australia, Western Australia, Northern Territory, Queensland","Westmead, Sydney, Melbourne, Adelaide, Perth, Darwin, Brisbane","June 8, 2022","August 31, 2022",Residual sera,Children and Youth (0-17 years),2045,89.63%,,,Convenience,Roche Diagnostics,CLIA,Total Antibody,,,High,Institutional Report,Paediatric Active Enhanced Disease Surveillance (PAEDS),Paediatric Active Enhanced Disease Surveillance (PAEDS),https://paeds.org.au/sites/default/files/2022-11/PAEDS%20NCIRS_COVID-19%20Paediatric%20Serosurvey%202022%20Report_3-11-2022_Final_1.pdf,11/17/2022,4/18/2024,Verified
230119_Australia_UniversityofNewSouthWales,"January 19, 2023",Local,Australia,AUS,,,"January 1, 2021","March 31, 2021",Household and community samples,Multiple groups,99,8.08%,,,Convenience,NA,LFIA,"IgG,IgA,IgM,Total Antibody",,,,Journal Article (Peer-Reviewed),Justin Jackson,University of New South Wales,https://dx.doi.org/10.1016/j.anzjph.2022.100003,2/9/2023,3/20/2023,Unverified
230119_Burnie_DepartmentofHealthTasmania_Round1_Overall,"January 19, 2023",Local,Australia,AUS,Tasmani,Burnie,"July 6, 2020","August 14, 2020",Health care workers and caregivers,Multiple groups,261,14.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Michelle McPherson,"Public Health Services, Department of Health, Tasmania, Australia",https://dx.doi.org/10.33321/cdi.2023.47.6,2/9/2023,3/2/2024,Unverified
230119_Burnie_DepartmentofHealthTasmania_Round2_Overall,"January 19, 2023",Local,Australia,AUS,Tasmani,Burnie,"December 7, 2020","December 24, 2020",Health care workers and caregivers,Multiple groups,129,11.60%,,,Convenience,Abbott Laboratories,CLIA,IgG,,,,Journal Article (Peer-Reviewed),Michelle McPherson,"Public Health Services, Department of Health, Tasmania, Australia",https://dx.doi.org/10.33321/cdi.2023.47.6,2/9/2023,3/2/2024,Unverified
230208_Australia_KirbyInstitute_AntiS,"February 8, 2023",National,Australia,AUS,,,"November 29, 2022","December 13, 2022",Blood donors,Multiple groups,4996,99.60%,99.40%,99.70%,Sequential,Roche Diagnostics,CLIA,Not reported,,,Moderate,Institutional Report,The Australian COVID-19 Serosurveillance Network,The Kirby Institute,https://kirby.unsw.edu.au/project/serosurveillance-sars-cov-2-infection-inform-public-health-responses,4/1/2023,4/13/2024,Verified
200630_Yerevan_ArmeniaMinistryofHealth_HCWs,"June 30, 2020",Local,Armenia,ARM,Yerevan,Yerevan,,"June 29, 2020",Health care workers and caregivers,Adults (18-64 years),380,16.05%,,,Convenience,NA,Not reported,Not reported,100.00%,99.80%,High,News and Media,Anna Grigoryan,Ministry of Health of the Republic of Armenia,https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA,8/1/2020,7/17/2022,Verified
211021_Armenia_EcoSenseDiagnosticCenter,"October 21, 2021",National,Armenia,ARM,,,"March 15, 2020","December 15, 2020",Household and community samples,Multiple groups,837,25.33%,,,Self-referral,NovaTec Immundiagnostics GmbH,ELISA,IgG,,,High,Presentation or Conference,I Nazaryan,EcoSense Diagnostic Center,http://dx.doi.org/10.1515/cclm-2021-5027,12/14/2021,3/2/2024,Unverified
230401_Armenia_FederalServiceforSupervisionofConsumerRightsProtectionandHumanWelfare,"April 1, 2023",National,Armenia,ARM,,,"April 12, 2022","April 16, 2022",Household and community samples,Multiple groups,6057,98.60%,98.10%,98.70%,Convenience,NA,ELISA,Not reported,,,,Journal Article (Peer-Reviewed),Anna Yu Popova,Federal Service for Supervision of Consumer Rights Protection and Human Welfare,https://dx.doi.org/10.15789/2220-7619-SCI-2450,6/1/2023,6/1/2023,Unverified
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless","July 18, 2020",Local,Argentina,ARG,Buenos Aires,Buenos Aires,"June 10, 2020","July 1, 2020",Persons experiencing homelessness,Multiple groups,60,36.00%,,,Convenience,CONICET,ELISA,IgG,95.00%,100.00%,High,Preprint,Silvana Figar,"Minister of Health, Buenos Aires City",https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,7/18/2020,7/17/2022,Verified
200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall,"September 9, 2020",Local,Argentina,ARG,Buenos Aires,Buenos Aires,"June 3, 2020","July 6, 2020",Health care workers and caregivers,Multiple groups,738,0.75%,0.00%,8.13%,Stratified probability,CONICET,ELISA,"IgG,IgM",,,Moderate,Preprint,Andrea Silva,Instituto Nacional de Epidemiologia,https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1,11/11/2020,7/17/2022,Verified
201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall,"December 1, 2020",Local,Argentina,ARG,Province of Buenos Aires,Autonomous City of Buenos Aires,"June 8, 2020","June 9, 2020",Health care workers and caregivers,Adults (18-64 years),116,0.90%,0.10%,5.50%,Simplified probability,Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co. Ltd),CLIA,"IgG,IgM",95.60%,96.00%,High,Journal Article (Peer-Reviewed),Claudia Insua,Hospital General de Niños Pedro de Elizalde,https://dx.doi.org/10.5546/aap.2020.eng.381,1/26/2021,3/2/2024,Verified
210107_BuenosAires_UniversityOfBuenosAires_Primary,"January 7, 2021",Local,Argentina,ARG,,Buenos Aires,"March 1, 2020","October 31, 2020",Health care workers and caregivers,Adults (18-64 years),317,3.00%,2.00%,5.00%,Stratified non-probability,NA,ELISA,Not reported,85.00%,95.00%,High,Journal Article (Peer-Reviewed),Puia Sebastian ,University of Buenos Aires,https://dx.doi.org/10.1016/j.jobcr.2021.01.006,2/19/2021,7/17/2022,Verified
200828_VillaAzul_MinisterioDeSaludDeLaProvinciaDeBuenosAires_overall,"August 28, 2020",Local,Argentina,ARG,Buenos Aires,Quilmes,"July 15, 2020","July 16, 2020",Household and community samples,Multiple groups,284,14.80%,11.10%,19.50%,Stratified non-probability,COVIDAR,ELISA,IgG,95.00%,100.00%,Moderate,Preprint,Laura Munoz,Ministerio de Salud de la Provincia de Buenos Aires,https://preprints.scielo.org/index.php/scielo/preprint/view/1147,4/22/2021,7/17/2022,Verified
210121_BarrioMugica_MinistryOfHealthOfTheCityOfBuenosAires,"January 21, 2021",Local,Argentina,ARG,Buenos Aires,Buenos Aires,"June 10, 2020","June 26, 2020",Persons living in slums,Multiple groups,873,53.40%,52.80%,54.10%,Simplified probability,CONICET,ELISA,IgG,90.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Silvana Figar,Ministry of Health of the City of Buenos Aires,https://www.medicinabuenosaires.com/revistas/vol81-21/destacado/original_7453.pdf,4/22/2021,7/17/2022,Verified
210122_BuenosAires_GovernmentOfTheProvinceOfBuenosAires,"January 22, 2021",Local,Argentina,ARG,Buenos Aires,Metropolitan Area of Buenos Aires,"July 15, 2020","December 15, 2020",Household and community samples,Multiple groups,9000,13.00%,,,Unclear,NA,ELISA,Not reported,,,High,News and Media,Government of the Province of Buenos Aires,Government of the Province of Buenos Aires,https://www.gba.gob.ar/saludprovincia/noticias/s%C3%B3lo_el_13_por_ciento_de_los_vecinos_y_vecinas_de_30_barrios_populares_del,5/17/2021,7/17/2022,Unverified
201230_ArgentinaHurlingham_UniversidadNacionalHurlingham,"December 30, 2020",Local,Argentina,ARG,Buenos Aires,Buenos Aires,"December 1, 2020","December 30, 2020",Household and community samples,Multiple groups,1182,12.10%,10.00%,14.20%,Stratified probability,COVIDAR,ELISA,IgG,,,High,Institutional Report,Universidad Nacional De Hurlingham,Universidad Nacional De Hurlingham,http://www.unahur.edu.ar/es/se-presentaron-los-resultados-del-estudio-de-seroprevalencia-de-covid-19-que-realizo-la-universidad,5/22/2021,7/17/2022,Verified
210615_SantaFe_UniversidadNacionalDelLitoral_genpop_overall,"June 15, 2021",Local,Argentina,ARG,,Santa Fe,"July 1, 2020","November 30, 2020",Multiple general populations,Multiple groups,3000,8.83%,,,Convenience,COVIDAR,ELISA,IgG,96.70%,100.00%,Moderate,Journal Article (Peer-Reviewed),Luz Maria Rodeles,Universidad Nacional del Litoral,https://dx.doi.org/10.26633/RPSP.2021.66,7/6/2021,7/17/2022,Unverified
220314_PuertoMadryn_UniversidadAustral_Overall,"March 14, 2022",Local,Argentina,ARG,Chubut,Puerto Madryn,"March 3, 2021","April 17, 2021",Household and community samples,Multiple groups,987,39.21%,36.20%,42.30%,Stratified probability,COVIDAR,Not reported,IgG,100.00%,100.00%,Moderate,Journal Article (Peer-Reviewed),Daniel Schonfeld,Universidad Austra,https://dx.doi.org/10.1371/journal.pone.0263679,3/23/2022,7/17/2022,Unverified
220520_Córdoba_MinistryOfHealth_Overall,"May 9, 2022",Local,Argentina,ARG,Córdoba,Córdoba,"December 15, 2020","January 15, 2021",Household and community samples,Multiple groups,3225,16.68%,15.41%,18.01%,Stratified probability,Abbott Laboratories,CLIA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Laura Aballay,Ministry of Health of the Province of Córdoba,https://dx.doi.org/10.1590/0102-311XES219821,6/2/2022,3/23/2024,Verified
220613_SantaFe_UniversidadNacionaldelLitoral,"June 13, 2022",Regional,Argentina,ARG,Santa Fe province,Santa Fe,"November 1, 2021","December 23, 2021",Household and community samples,Multiple groups,1455,88.70%,,,Convenience,COVIDAR,ELISA,IgG,,,Moderate,Preprint,Ayelen Eberhardt,Universidad Nacional del Litoral,https://dx.doi.org/10.1101/2022.05.18.22275138,9/14/2022,9/22/2022,Unverified
210506_Luanda_InstitutoNacionaldeInvestigaçãoemSaúde_IgG,"May 6, 2021",Local,Angola,AGO,Luanda Province,Luanda,"July 15, 2020","September 15, 2020",Residual sera,Multiple groups,660,1.10%,,,Convenience,Biomerieux,Other,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cruz Sebastiao,Instituto Nacional de Investigação em Saúde,https://dx.doi.org/10.1002/hsr2.280,5/30/2021,3/2/2024,Verified
211102_Luanda_UniversidadeAgostinhoNeto_Primary,"November 2, 2021",Local,Angola,AGO,Luanda,Luanda,"December 15, 2019","September 15, 2020",Blood donors,Adults (18-64 years),343,4.70%,,,Convenience,Biomerieux,ELISA,"IgG,IgM",,,High,Journal Article (Peer-Reviewed),Cruz Sebastiao,Instituto Nacional de Investigação em Saúde,https://dx.doi.org/10.1186/s12879-021-06814-0,11/11/2021,3/2/2024,Verified
210521_Andorra_ISGlobal_Overall,"May 21, 2021",National,Andorra,AND,,,"May 4, 2020","May 28, 2020",Household and community samples,Multiple groups,72964,11.00%,,,Entire sample,Zhuhai Livzon Diagnostics Inc,LFIA,"IgM,IgG",92.00%,100.00%,Low,Journal Article (Peer-Reviewed),Cristina Royo Cebrecos,ISGlobal,https://www.sciencedirect.com/science/article/pii/S266677622100096X,7/30/2021,3/2/2024,Verified
210921_Andorra_HospitalNostraSenyoradeMeritxell_November,"September 21, 2021",Local,Andorra,AND,,,"November 1, 2020","November 30, 2020",Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),156,6.41%,,,Convenience,NA,Not reported,Not reported,,,High,Presentation or Conference,C Royo-Cebrecos,Hospital Nostra Senyora de Meritxell,http://dx.doi.org/10.1016/j.annonc.2021.08.1594,9/29/2021,7/17/2022,Unverified
220412_Andorra_HospitalNostraSenyoradeMeritxell_Primary,"April 12, 2022",National,Andorra,AND,,,"May 15, 2020","June 15, 2021",Representative patient population,Multiple groups,373,18.20%,,,Convenience,"Zhuhai Livzon Diagnostics Inc,Roche Diagnostics",Multiple Types,"IgG,IgM,IgA",,,High,Preprint,Cristina Royo-Cebrecos,Hospital Nostra Senyora de Meritxell,10.21203/rs.3.rs-1538781/v1,4/22/2022,3/2/2024,Unverified
230607_Oran_UniversityofOran_Overall,"June 7, 2023",Regional,Algeria,DZA,"Oran
",,"January 7, 2021","January 20, 2021",Household and community samples,Multiple groups,1185,35.60%,32.94%,38.38%,Stratified probability,Zhejiang Orient Gene Biotech,LFIA,"IgG,IgM",90.50%,100.00%,Low,Journal Article (Peer-Reviewed),Abdessamad Dali-Ali,University of Oran,https://dx.doi.org/10.1128/spectrum.00876-23,6/30/2023,5/1/2024,Verified
220725_TiranaAndBerat_AcademyOfSciencesOfAlbania_Overall,"July 25, 2022",Local,Albania,ALB,,"Tirana, Berat","June 15, 2021","July 15, 2021",Household and community samples,Multiple groups,1527,73.35%,,,Simplified probability,EUROIMMUN,ELISA,IgG,,,Moderate,Journal Article (Peer-Reviewed),Fabian Cenko,Academy of Sciences of Albania,https://dx.doi.org/10.7189/jogh.12.03054,8/12/2022,3/16/2024,Verified
230227_Albania_WorldHealthOrganization,"February 27, 2023",Local,Albania,ALB,,,"February 19, 2021","May 7, 2021",Health care workers and caregivers,Multiple groups,1452,71.80%,,,Convenience,Beijing Wantai Biological,,,,,,Journal Article (Peer-Reviewed),Pernille Jorgensen,World Health Organization,https://dx.doi.org/10.1016/j.lanepe.2023.100584,5/4/2023,3/2/2024,Unverified
230802_TiranaAndBeratCity_GeorgeMasonUniversity_2021_AntiS,"August 2, 2023",Local,Albania,ALB,,"Tirana, Berat City","July 15, 2021","August 15, 2021",Multiple populations,Multiple groups,1716,71.79%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.40%,99.60%,,Preprint,Genc Sulcebe,George Mason University,https://doi.org/10.20944/preprints202308.0151.v1,9/23/2023,3/2/2024,Unverified
230802_TiranaAndBeratCity_GeorgeMasonUniversity_2022_AntiS,"August 2, 2023",Local,Albania,ALB,,"Tirana, Berat City","July 15, 2022","August 15, 2022",Multiple populations,Multiple groups,1899,91.15%,,,Stratified probability,EUROIMMUN,ELISA,IgG,94.40%,99.60%,,Preprint,Genc Sulcebe,George Mason University,https://doi.org/10.20944/preprints202308.0151.v1,9/23/2023,3/2/2024,Unverified
230826_Tirana_CatholicUniversityOurLadyOfGoodCounsel_Jul,"August 26, 2023",Local,Albania,ALB,,Tirana,"June 27, 2020","July 3, 2020",Household and community samples,Adults (18-64 years),266,7.50%,4.30%,10.70%,Stratified probability,EUROIMMUN,ELISA,IgG,94.40%,99.60%,Moderate,Journal Article (Peer-Reviewed),Genc Sulcebe,"Catholic University ""Our Lady of Good Counsel""",https://dx.doi.org/10.1016/j.heliyon.2023.e19547,10/11/2023,4/24/2024,Verified
230826_Tirana_CatholicUniversityOurLadyOfGoodCounsel_Dec,"August 26, 2023",Local,Albania,ALB,,Tirana,"December 21, 2020","December 28, 2020",Household and community samples,Adults (18-64 years),815,48.20%,44.80%,51.70%,Stratified probability,EUROIMMUN,ELISA,IgG,94.40%,99.60%,,Journal Article (Peer-Reviewed),Genc Sulcebe,"Catholic University ""Our Lady of Good Counsel""",https://dx.doi.org/10.1016/j.heliyon.2023.e19547,10/11/2023,4/24/2024,Verified
201220_Afghanistan_UnitedStatesAirForce,"December 31, 2020",National,Afghanistan,AFG,NR,,"April 17, 2020","June 1, 2020",Essential non-healthcare workers,Adults (18-64 years),1957,1.90%,,,Unclear,NA,Not reported,"IgG,IgM",,,Unclear,Journal Article (Peer-Reviewed),Brian White,United States Air Force,http://dx.doi.org/10.1093/ofid/ofaa439.666,5/3/2021,12/8/2022,Verified
200801_Afghanistan_AfghanistanMinistryofPublicHealth,"August 1, 2020",National,Afghanistan,AFG,NR,,"June 1, 2020","June 15, 2020",Household and community samples,Multiple groups,9514,31.50%,,,Stratified probability,NA,LFIA,"IgG,IgM",,,Moderate,Journal Article (Peer-Reviewed),Sayed Ataullah Saeedzai,Afghanistan Ministry of Public Health ,https://moph.gov.af/sites/default/files/2020-08/Final%20COVID-19%20Survey%20English%20Report.pdf,5/20/2021,12/8/2022,Verified
230201_Japan_NationalInstituteofInfectiousDiseases_December2021_AntiS_PopAdj,"February 1, 2023",Regional,,,"Miyagi, Tokyo, Aichi, Osaka, and Fukuoka prefectures",,"December 1, 2021","December 31, 2021",Household and community samples,Multiple groups,8147,96.30%,95.80%,96.60%,Stratified probability,Roche Diagnostics,CLIA,,97.70%,100.00%,,Journal Article (Peer-Reviewed),Takeshi Arashiro,,https://dx.doi.org/10.1111/irv.13094,4/3/2024,4/3/2024,Verified
230201_Japan_NationalInstituteofInfectiousDiseases_December2021_AntiN_PopAdj,"February 1, 2023",Regional,,,"Miyagi, Tokyo, Aichi, Osaka, and Fukuoka prefectures",,"December 1, 2021","December 31, 2021",Household and community samples,Multiple groups,8147,2.20%,1.90%,2.50%,Stratified probability,Roche Diagnostics,CLIA,,99.40%,98.10%,,Journal Article (Peer-Reviewed),Takeshi Arashiro,,https://dx.doi.org/10.1111/irv.13094,4/3/2024,4/3/2024,Verified